data_2m72_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m72 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.498 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 35.0 m . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.916 0.388 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 38.2 m-85 -92.1 -143.22 0.2 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.348 0.594 . . . . 0.0 109.907 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.55 14.72 2.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.841 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HB3' HG13 ' A' ' 124' ' ' ILE . 52.4 tt0 50.42 42.85 26.78 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.862 0.839 . . . . 0.0 110.507 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt -92.56 152.01 41.68 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.746 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.52 156.72 55.05 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.343 2.695 . . . . 0.0 111.403 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.64 80.55 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 111.159 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.7 t -125.94 134.29 66.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -90.6 116.58 28.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.713 0.292 . . . . 0.0 110.45 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tp -116.09 173.66 6.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -117.22 128.07 54.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -91.53 -175.31 4.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.869 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 95' ' ' VAL . 29.6 pt -66.66 -21.43 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.913 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -82.17 -10.6 59.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.943 0.402 . . . . 0.0 110.491 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.94 20.19 68.45 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -100.03 141.32 33.01 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.3 m -75.62 110.83 10.35 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.186 0.517 . . . . 0.0 109.897 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 m -116.32 131.02 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.684 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 89.2 mt-30 -90.28 133.06 35.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.587 HG23 ' CE1' ' A' ' 103' ' ' PHE . 16.9 p -66.84 -29.78 69.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.64 -34.32 76.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.29 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -101.94 8.46 41.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.695 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.9 tp -70.45 117.22 11.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.251 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.497 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 46.7 mt-10 -130.09 141.56 50.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.743 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 28.1 t-20 -82.16 -75.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.12 29.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.378 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.498 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 93.98 2.3 64.64 Favored Glycine 0 C--O 1.23 -0.15 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.138 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -109.63 151.85 42.49 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 122.387 0.275 . . . . 0.0 110.999 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 19.9 Cg_exo -63.46 154.16 70.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.038 2.492 . . . . 0.0 112.033 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.743 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 73.6 mtm -132.91 147.86 52.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.683 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.516 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 78.1 mt -121.91 120.68 62.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.9 mt -99.36 119.27 47.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.0 m -102.58 119.21 38.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.85 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.543 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 72.5 m-85 -93.96 118.1 31.02 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.526 ' O ' HG12 ' A' ' 73' ' ' ILE . 20.2 p90 -144.09 162.99 34.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 123.634 0.584 . . . . 0.0 110.795 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.01 176.53 9.74 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.013 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.313 -1.006 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -176.634 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.33 -45.59 90.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.709 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.566 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -70.92 -45.21 64.64 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.862 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.481 HD11 ' CE1' ' A' ' 93' ' ' TYR . 27.2 tp -61.74 -43.43 98.87 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.23 -175.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.61 -48.42 77.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.41 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.37 -46.12 87.98 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.395 0.617 . . . . 0.0 111.197 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.2 mt -64.08 -41.73 93.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.468 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.933 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -54.36 -41.31 68.99 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 111.452 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -66.79 -38.12 85.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.64 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.17 21.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.281 0.563 . . . . 0.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.28 -44.48 88.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.408 0.683 . . . . 0.0 112.391 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.83 84.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.21 -40.98 99.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.979 0.419 . . . . 0.0 110.823 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -69.94 -40.68 75.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.448 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 55.1 mt-30 -64.61 -32.62 74.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.183 0.516 . . . . 0.0 110.739 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.46 -39.79 94.55 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.737 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -86.78 -86.2 0.15 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.394 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 66' ' ' VAL . 3.1 t -79.49 -16.04 56.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.876 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 71.86 17.63 77.0 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.407 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.498 ' H ' HG23 ' A' ' 64' ' ' THR . 10.7 p -63.63 140.21 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.127 0.489 . . . . 0.0 112.232 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.59 163.98 14.26 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.633 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 58.5 mt -112.16 134.56 53.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.482 0.658 . . . . 0.0 111.511 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.458 HD11 ' SD ' ' A' ' 34' ' ' MET . 95.0 mt -111.44 109.95 30.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.809 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.11 111.2 22.25 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.27 133.9 58.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-O 121.959 0.885 . . . . 0.0 112.32 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.608 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.0 m -85.08 120.23 26.36 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.133 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 39' ' ' PHE . 45.5 pt -84.68 36.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 123.987 0.804 . . . . 0.0 110.656 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -131.1 -167.88 1.91 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -95.06 165.92 12.19 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.28 -37.21 92.67 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.384 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 78' ' ' ASN . 27.7 pt20 -60.38 -42.58 96.16 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.915 0.388 . . . . 0.0 111.324 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.404 ' N ' ' HG3' ' A' ' 77' ' ' GLN . 86.8 m-20 -81.69 -32.99 31.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -68.95 -5.63 22.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.424 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -62.35 -12.85 23.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.824 0.345 . . . . 0.0 110.714 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.735 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 37.3 mtmm -93.7 -11.78 30.76 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.713 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 ' OG ' ' A' ' 72' ' ' SER . 20.1 t -68.58 -47.54 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.669 0.747 . . . . 0.0 111.571 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.8 mtpt -64.27 -44.65 77.1 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.722 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 13.1 Cg_endo -60.36 -32.29 93.82 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.194 1.263 . . . . 0.0 111.276 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.94 -43.63 98.28 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.36 92.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.127 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.69 -46.5 63.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.257 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.86 -48.22 68.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.296 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -67.88 -34.56 76.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.0 111.519 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.24 52.31 1.25 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.354 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -84.81 132.62 34.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.929 0.395 . . . . 0.0 110.345 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -103.8 33.07 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.188 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.609 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -145.33 -179.95 6.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -81.8 141.96 33.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 112.267 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 17' ' ' ILE . 38.9 t -120.76 134.75 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD11 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -121.48 138.57 54.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.763 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.6 mp -111.2 120.04 40.94 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 63.2 t0 -74.3 117.69 16.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.494 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.1 p -93.8 2.6 56.18 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -121.96 -37.53 2.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.812 0.339 . . . . 0.0 111.145 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.427 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 90.69 8.49 65.46 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.968 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.73 -17.35 17.77 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.587 ' CE1' HG23 ' A' ' 24' ' ' THR . 68.9 t80 -63.07 -43.62 98.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 110.582 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -59.23 -36.06 74.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -71.95 -41.12 68.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.321 0.581 . . . . 0.0 110.308 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.33 84.75 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 31.0 mmm -96.76 -11.08 25.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.739 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 68.84 93.08 0.08 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.556 0.743 . . . . 0.0 112.006 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.88 83.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.8 m -62.15 -48.9 78.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.973 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.0 tp -151.48 132.43 14.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.592 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 148.16 55.11 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.51 147.82 87.76 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.699 -1.375 . . . . 0.0 112.588 0.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.543 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -114.72 128.98 56.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.851 175.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -114.23 122.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -120.77 115.26 22.96 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 61.7 mt -103.86 131.51 52.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.274 0.559 . . . . 0.0 110.512 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 66.8 t -108.95 130.43 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.946 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.82 165.21 25.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.366 0.666 . . . . 0.0 111.071 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.79 -20.34 47.3 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.073 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -84.31 4.11 32.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.876 0.338 . . . . 0.0 111.06 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.54 48.4 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.88 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -126.68 152.53 46.62 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.456 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.6 mt -75.01 118.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -107.98 -30.69 2.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.268 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.547 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 90.0 t80 -141.58 140.39 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -136.06 130.7 33.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.193 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -141.2 104.1 4.56 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.1 m -104.17 120.19 40.58 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.045 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.69 47.76 66.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.674 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 31.6 p90 -67.59 -43.96 79.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 109.562 176.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.461 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 61.0 p 57.01 87.74 0.06 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.863 1.265 . . . . 0.0 113.036 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 72.07 127.71 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.118 0.967 . . . . 0.0 112.29 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.51 68.07 Favored Glycine 0 CA--C 1.51 -0.264 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.063 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.674 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -73.07 -21.6 79.7 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.249 -0.476 . . . . 0.0 112.257 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.4 mp0 -56.27 -30.6 62.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.818 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.75 92.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.34 -31.24 67.14 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.678 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.585 ' O ' HG21 ' A' ' 143' ' ' VAL . 4.0 mm? -60.38 -52.27 65.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.683 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.405 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.8 tp -69.4 -32.79 54.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.203 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.8 ttpp -62.68 -47.34 84.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.939 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.403 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -66.34 -32.19 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 110.257 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.585 HG21 ' O ' ' A' ' 139' ' ' LEU . 55.4 t -59.41 -43.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.734 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 27.1 mmt180 -64.62 -36.02 82.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 67.2 mm-40 -58.53 -42.3 87.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.715 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 56.9 mt . . . . . 0 C--N 1.334 -0.107 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.314 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.444 -0.766 0 CA-C-O 121.22 0.534 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.541 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 31.6 m-85 -98.96 -134.02 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.95 155.82 40.65 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -74.52 75.84 1.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 81.4 mt -117.98 140.29 27.65 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.885 -174.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.19 155.75 63.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.15 2.567 . . . . 0.0 110.673 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 91.22 0.46 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 154.53 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.888 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -98.01 134.04 41.65 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tp -131.89 165.31 24.17 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -113.2 129.61 56.46 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.223 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 20' ' ' LYS . 46.5 p30 -94.67 -174.88 3.43 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 95' ' ' VAL . 32.4 pt -68.42 -18.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.953 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -84.04 -12.4 55.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.924 0.392 . . . . 0.0 110.432 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 16.87 72.16 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HB3' HD22 ' A' ' 16' ' ' ASN . 86.4 tttt -96.1 145.63 25.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.413 -0.894 . . . . 0.0 110.601 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.7 m -80.38 114.0 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.877 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 m -120.65 134.11 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.969 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.1 mt-30 -88.91 134.95 33.78 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.536 HG21 ' CE1' ' A' ' 103' ' ' PHE . 25.0 p -65.48 -31.04 71.91 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.2 -28.62 69.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.22 16.44 23.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.045 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.6 tp -79.03 101.27 7.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.058 0.456 . . . . 0.0 111.95 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.541 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.1 mt-10 -119.11 122.89 43.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.987 177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -70.88 -43.06 69.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.27 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 0.0 109.464 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.91 33.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.395 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -128.67 151.74 77.54 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 122.415 0.286 . . . . 0.0 110.864 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.95 155.5 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.275 . . . . 0.0 111.621 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 38.2 mtt -129.92 153.43 48.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.93 0.395 . . . . 0.0 111.805 -171.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.8 mt -128.3 117.28 44.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 82.1 mt -96.79 118.16 42.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 m -104.88 116.07 31.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -90.8 115.78 28.13 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -138.2 168.48 19.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.207 0.527 . . . . 0.0 112.119 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.05 166.98 11.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.336 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.612 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.593 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -63.87 -45.96 87.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.582 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -66.2 -46.37 77.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.137 -176.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.544 ' HG ' HE21 ' A' ' 54' ' ' GLN . 33.8 tp -63.8 -42.51 97.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -61.6 -48.44 80.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.562 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -61.37 -42.56 98.9 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.006 0.432 . . . . 0.0 111.02 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.3 mt -64.96 -42.27 94.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.046 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.544 HE21 ' HG ' ' A' ' 50' ' ' LEU . 78.5 mt-30 -55.49 -40.86 72.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 111.298 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.28 -38.13 87.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.742 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 52' ' ' ALA . 18.1 m -116.22 27.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.002 0.43 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 53' ' ' ILE . 65.0 t80 -58.64 -39.6 81.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.627 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.45 87.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.641 0.258 . . . . 0.0 110.846 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.55 -41.71 96.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.297 0.57 . . . . 0.0 110.417 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.61 ' O ' ' HB ' ' A' ' 64' ' ' THR . 11.9 m0 -71.18 -37.03 72.18 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.714 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -80.2 -8.92 59.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.787 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.57 -60.43 3.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.182 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.11 -4.25 3.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.758 0.314 . . . . 0.0 111.796 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 18.1 m -96.11 -35.54 11.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.253 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.08 31.33 65.12 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.853 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.95 128.93 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.447 0.641 . . . . 0.0 112.117 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -94.15 152.24 18.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.381 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 39.3 mt -111.94 130.11 55.95 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.138 0.494 . . . . 0.0 111.165 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 96' ' ' LEU . 91.0 mt -110.01 106.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.16 113.21 25.42 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.616 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 10.8 p -122.47 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.254 0.55 . . . . 0.0 111.84 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.6 p -88.66 143.48 26.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.719 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.0 pt -78.31 -13.99 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.111 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -84.39 153.97 23.12 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.707 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.57 168.1 13.64 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 123.52 0.513 . . . . 0.0 110.087 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -55.47 -40.77 78.73 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.142 0.417 . . . . 0.0 114.142 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.2 -39.37 92.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.224 0.512 . . . . 0.0 111.32 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -83.32 -32.65 26.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.362 0.601 . . . . 0.0 110.53 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -79.01 -2.06 38.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.094 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 99.1 mt-30 -57.86 -16.09 10.63 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.916 -0.49 . . . . 0.0 111.146 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.676 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.7 mttp -84.91 -14.82 46.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.431 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 79' ' ' ALA . 49.8 t -65.68 -47.13 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.805 0.812 . . . . 0.0 112.272 -175.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.0 mtpm? -67.34 -42.87 41.02 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.55 -176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.603 ' HA ' ' OD2' ' A' ' 87' ' ' ASP . 17.9 Cg_endo -61.89 -28.63 81.4 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.107 1.204 . . . . 0.0 111.001 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.96 -42.2 97.36 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' CD2' ' A' ' 91' ' ' TRP . . . -57.99 -49.12 77.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.773 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.603 ' OD2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 p30 -75.0 -35.96 61.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.996 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.28 -49.59 56.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.877 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -74.6 -34.1 62.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.924 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.217 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.477 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 54.4 m0 -95.09 117.79 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.35 47.88 0.93 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -149.23 -169.62 3.42 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.795 -0.184 . . . . 0.0 110.576 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -89.09 135.84 33.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.428 0.633 . . . . 0.0 111.983 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 17' ' ' ILE . 58.8 t -118.07 132.45 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.767 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 8.1 mp -130.3 146.12 51.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.947 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -126.36 127.68 45.88 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -61.01 133.59 56.24 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.1 t -114.75 7.28 15.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.537 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -142.94 -30.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.53 63.09 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.968 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -74.59 -36.87 63.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.418 0.151 . . . . 0.0 111.136 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.536 ' CE1' HG21 ' A' ' 24' ' ' THR . 79.9 t80 -62.19 -48.65 79.07 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -61.59 -35.01 76.63 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.851 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -70.56 -42.43 71.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.375 0.607 . . . . 0.0 110.063 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.43 -37.65 84.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.315 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 28.5 mmm -82.64 -22.77 34.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.317 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.0 t30 72.13 81.75 0.14 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.462 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.91 99.79 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.266 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.2 m -71.71 -69.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.803 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.41 HD23 ' CG2' ' A' ' 132' ' ' THR . 60.4 tp -115.43 131.12 57.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.6 pt -88.67 144.42 33.36 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -80.45 161.58 83.9 Favored 'Cis proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.838 -1.318 . . . . 0.0 113.564 0.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.22 145.08 49.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.958 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.49 130.15 74.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.108 0.48 . . . . 0.0 112.168 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.4 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 82.4 m-85 -125.41 124.86 42.39 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 75.7 mt -114.2 131.07 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.051 0.453 . . . . 0.0 111.057 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 54.8 t -108.92 132.93 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 123.886 0.874 . . . . 0.0 110.057 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -95.04 -171.91 2.55 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.269 0.356 . . . . 0.0 111.111 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.87 66.44 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.983 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -75.09 -2.02 25.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.987 0.393 . . . . 0.0 111.338 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 73.78 30.96 60.88 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.032 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 48.2 mmtm -133.01 168.47 18.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 98.2 mt -90.24 112.37 24.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.082 0.468 . . . . 0.0 110.349 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.69 -31.83 5.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.489 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.546 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.4 t80 -124.55 130.71 52.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.043 0.449 . . . . 0.0 111.337 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -130.06 120.67 25.05 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.057 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -144.36 102.84 3.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.884 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.2 p -102.79 106.76 17.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 113.21 71.14 0.56 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.991 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.592 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -122.22 157.06 32.45 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.41 ' CG2' HD23 ' A' ' 111' ' ' LEU . 27.9 p -127.02 -41.85 1.77 Allowed 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.869 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -167.89 124.05 1.07 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.18 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.39 -3.19 32.83 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.39 -18.71 65.9 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.77 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.0 mp0 -60.22 -20.83 60.48 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.094 0.557 . . . . 0.0 111.369 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.6 94.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.483 0.659 . . . . 0.0 110.706 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.7 -32.06 69.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.708 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -61.82 -47.52 84.73 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.499 HD12 ' NE1' ' A' ' 60' ' ' TRP . 5.1 tp -68.54 -39.54 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.721 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.3 ttpp -60.65 -45.86 92.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.155 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -66.06 -35.16 79.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.385 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -60.78 -42.7 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -64.38 -34.53 78.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.129 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 51.7 mm-40 -61.6 -35.08 76.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.438 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.63 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.471 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 37.3 m . . . . . 0 N--CA 1.439 -1.016 0 CA-C-O 120.961 0.41 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 26' ' ' LYS . 93.2 m-85 -103.48 -80.58 0.52 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.315 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 166.98 -10.77 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 O-C-N 124.514 1.134 . . . . 0.0 110.334 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 63.88 44.79 4.65 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.915 0.864 . . . . 0.0 110.298 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.484 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 18.9 mt -98.16 159.42 30.76 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.912 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.63 148.19 93.59 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.301 2.001 . . . . 0.0 109.617 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.02 84.06 2.27 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.063 0.458 . . . . 0.0 111.2 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -117.92 132.95 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -87.97 109.83 20.12 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.09 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 98' ' ' ASP . 33.3 mt -116.75 175.92 5.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.949 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.57 138.58 40.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.389 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 20' ' ' LYS . 5.6 p30 -101.77 -175.04 2.73 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.426 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 32.4 pt -63.77 -22.57 31.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.97 -12.31 60.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.09 81.69 Favored Glycine 0 CA--C 1.503 -0.689 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HB3' HD22 ' A' ' 16' ' ' ASN . 37.1 ttpt -96.45 141.16 30.08 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.6 m -73.43 115.09 12.39 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 m -122.16 132.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.87 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 79.0 mt-30 -87.77 134.53 33.66 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.484 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 6.7 p -63.76 -28.54 69.94 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.106 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -75.84 -10.68 59.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.72 0.295 . . . . 0.0 111.34 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.483 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -126.48 12.96 7.56 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.489 0.185 . . . . 0.0 111.349 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.09 -48.89 78.19 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -172.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 33.06 97.98 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.419 1.104 . . . . 0.0 113.904 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' OD1' ' HG2' ' A' ' 34' ' ' MET . 13.1 m120 -66.16 -58.39 5.53 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.367 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.69 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.72 4.89 89.88 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.159 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -112.67 150.89 43.42 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.57 150.45 81.63 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.87 2.38 . . . . 0.0 111.751 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.455 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -131.42 154.89 48.19 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.087 0.47 . . . . 0.0 111.065 -176.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.536 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.3 mt -123.08 122.85 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.1 mt -95.73 122.46 47.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.438 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 3.5 m -104.85 118.85 37.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.069 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 72.1 m-85 -95.19 116.86 29.3 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.471 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 28.1 p90 -142.56 171.42 14.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.605 0.566 . . . . 0.0 112.153 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.57 32.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.406 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.409 ' CG2' HG23 ' A' ' 82' ' ' VAL . 48.6 p . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.087 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.471 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 6.6 mt . . . . . 0 CA--C 1.518 -0.27 0 CA-C-O 121.311 0.577 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -57.52 -39.82 77.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.938 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.616 ' HA ' ' OH ' ' A' ' 131' ' ' TYR . 3.8 tm-20 -66.99 -54.83 18.04 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.2 tp -63.11 -40.78 98.63 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.059 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.0 tttt -62.13 -45.24 94.31 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.212 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -58.77 -46.66 87.0 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.467 ' CG2' HD12 ' A' ' 68' ' ' LEU . 58.8 mt -64.69 -43.16 96.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.168 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -54.62 -42.01 70.68 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.08 0.467 . . . . 0.0 110.993 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 51.2 mm-40 -65.88 -37.56 86.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.901 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 52' ' ' ALA . 30.7 m -110.99 17.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.21 -41.38 92.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.79 86.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 19.0 t70 -64.5 -41.75 96.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.148 0.499 . . . . 0.0 110.439 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.494 ' NE1' HD13 ' A' ' 140' ' ' ILE . 28.8 m0 -72.31 -42.33 65.58 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.263 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 18.6 mm-40 -65.79 -24.11 66.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.236 0.541 . . . . 0.0 110.604 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 36.1 t70 -59.62 -46.41 89.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.52 -70.11 0.77 Allowed 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.476 HG22 ' N ' ' A' ' 66' ' ' VAL . 2.8 t -77.41 -22.12 52.06 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.076 0.465 . . . . 0.0 111.221 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 66.45 32.17 80.97 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.28 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.476 ' N ' HG22 ' A' ' 64' ' ' THR . 14.8 p -63.28 136.56 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -102.63 156.38 17.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.069 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD11 ' CE2' ' A' ' 93' ' ' TYR . 68.9 mt -116.18 133.15 56.33 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.075 0.464 . . . . 0.0 111.206 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.459 HG23 HD11 ' A' ' 96' ' ' LEU . 86.4 mt -110.02 102.99 14.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.67 118.06 29.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.2 p -122.43 133.1 69.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.212 0 CA-C-O 121.634 0.731 . . . . 0.0 111.727 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.657 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 21.4 p -84.71 140.86 30.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.551 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.0 pt -80.81 -15.52 12.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.28 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.657 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -84.63 159.46 20.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.687 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HB2' ' OE1' ' A' ' 77' ' ' GLN . 43.2 mt-10 -72.38 178.22 4.1 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.277 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.64 -48.99 67.64 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 115.423 0.929 . . . . 0.0 115.423 -173.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.496 ' OE1' ' HB2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -65.43 -40.7 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.734 0.767 . . . . 0.0 111.338 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -69.13 -39.63 78.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.229 0.537 . . . . 0.0 110.959 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.638 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -72.22 -4.16 27.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.152 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.6 -13.69 15.86 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.656 -0.653 . . . . 0.0 111.346 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.712 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.9 tttp -92.58 -10.45 37.49 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 122.764 0.425 . . . . 0.0 111.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 79' ' ' ALA . 12.6 t -66.96 -47.36 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-O 121.547 0.689 . . . . 0.0 111.804 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 43.2 mtpt -63.64 -45.32 82.51 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.987 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -61.06 -31.16 90.62 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.091 1.194 . . . . 0.0 111.098 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -62.64 -44.2 96.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.22 98.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.415 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.22 -50.88 68.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.523 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.8 -44.86 46.35 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.789 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.58 41.91 3.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.411 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.429 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 53.2 m0 -83.35 108.31 16.45 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.0 42.28 1.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.56 ' CE2' HD11 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -146.23 177.62 8.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.845 -0.161 . . . . 0.0 111.303 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.78 137.77 40.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.391 0.615 . . . . 0.0 112.394 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -119.76 132.5 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.868 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.459 HD11 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -125.36 144.87 50.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.94 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.83 121.92 46.54 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.518 ' HA ' HD23 ' A' ' 14' ' ' LEU . 67.1 t0 -70.08 115.28 9.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.343 -1.343 . . . . 0.0 107.648 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.497 ' H ' HD23 ' A' ' 14' ' ' LEU . 22.6 t -83.41 -15.25 50.47 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -173.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -120.18 -29.89 4.77 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.28 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.11 1.4 62.92 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.53 -14.19 28.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 24' ' ' THR . 87.5 t80 -64.91 -44.96 87.85 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -63.19 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.2 -34.8 76.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.245 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.78 76.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.105 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.6 mmt -84.87 -18.25 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.395 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 68.22 78.91 0.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.441 0.696 . . . . 0.0 110.332 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.42 89.4 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.6 m -68.83 -44.85 72.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.792 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.2 tp -137.12 134.74 36.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.5 pt -91.36 156.33 43.59 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.61 151.48 94.57 Favored 'Cis proline' 0 C--O 1.238 0.492 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.503 0.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -115.33 130.53 56.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.54 HG23 ' HG3' ' A' ' 49' ' ' GLU . 24.2 t -110.99 126.27 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 123.291 0.369 . . . . 0.0 111.373 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -128.03 115.06 17.9 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 60.5 mt -105.71 132.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.295 0.569 . . . . 0.0 111.452 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -109.68 134.88 50.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.478 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -90.16 -172.76 3.6 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.238 0.336 . . . . 0.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.93 -30.32 76.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.447 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -69.41 -14.53 62.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.58 0.705 . . . . 0.0 109.67 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 82.75 31.74 28.87 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.601 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -123.43 157.38 33.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.443 . . . . 0.0 110.111 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 7' ' ' ALA . 49.7 mt -74.66 100.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.035 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -88.03 -39.0 12.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.675 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.556 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 81.9 t80 -131.81 136.63 47.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.818 0.342 . . . . 0.0 111.652 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -131.03 134.63 46.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.099 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.556 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.2 t60 -148.95 103.09 3.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.5 m -103.2 118.88 37.77 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.11 0.481 . . . . 0.0 111.829 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.74 45.41 44.26 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.674 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 15.0 p90 -68.08 -37.51 81.31 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.081 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 43.2 p 77.41 -59.94 0.45 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.163 1.785 . . . . 0.0 112.278 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -147.8 142.87 27.06 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.582 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.11 19.17 67.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.674 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.98 -27.02 20.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.255 -0.473 . . . . 0.0 113.122 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 140' ' ' ILE . 5.7 pm0 -60.51 -22.18 63.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.337 0.255 . . . . 0.0 111.662 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.12 99.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.398 0.618 . . . . 0.0 110.112 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.434 ' HB3' ' HH ' ' A' ' 126' ' ' TYR . 42.0 mt-10 -73.0 -37.7 66.89 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.414 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 143' ' ' VAL . 10.8 mp -63.21 -46.56 86.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.543 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.494 HD13 ' NE1' ' A' ' 60' ' ' TRP . 7.2 tp -66.34 -34.79 72.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.819 0.342 . . . . 0.0 110.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.1 ttmt -56.43 -54.3 47.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.888 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 29.0 mmmt -66.04 -32.81 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 139' ' ' LEU . 52.9 t -62.0 -43.74 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.287 0.565 . . . . 0.0 109.934 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -84.27 -18.63 35.77 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.312 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 61.2 mm-40 -69.92 -30.16 67.5 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.415 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.0 mt . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 110.105 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.438 ' HA ' ' CA ' ' A' ' 122' ' ' GLY . 40.0 m . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 121.334 0.588 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.527 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 89.1 m-85 -100.87 -101.38 0.25 Allowed 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -177.41 11.5 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.485 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 25.4 tt0 54.57 34.8 22.06 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.793 0.806 . . . . 0.0 110.579 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.448 HD12 ' OG1' ' A' ' 24' ' ' THR . 79.3 mt -89.84 150.45 43.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.652 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.44 151.89 82.75 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.717 2.278 . . . . 0.0 111.476 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.31 84.13 2.45 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.905 0.383 . . . . 0.0 110.981 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.578 ' O ' HG21 ' A' ' 24' ' ' THR . 72.3 t -121.38 136.76 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -78.07 126.35 30.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 tp -134.34 173.07 12.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.536 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -116.28 133.56 55.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -97.84 -179.89 4.58 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 95' ' ' VAL . 17.5 pt -64.3 -22.17 30.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -77.94 -16.64 58.01 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.901 0.381 . . . . 0.0 110.828 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.56 58.83 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.92 140.36 36.31 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.673 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.1 m -74.38 116.54 15.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.119 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.82 156.81 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.976 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.22 134.83 46.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.578 HG21 ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -67.16 -16.38 64.28 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -93.05 7.52 43.8 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 121.774 -0.579 . . . . 0.0 112.09 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.45 16.35 3.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.836 -0.54 . . . . 0.0 111.297 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.8 -67.52 0.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.34 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.527 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 35.1 mt-10 64.52 175.66 0.19 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.701 0.762 . . . . 0.0 112.516 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.492 ' HB2' ' HE1' ' A' ' 34' ' ' MET . 0.3 OUTLIER -139.25 -78.27 0.33 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.539 178.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.77 31.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.261 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.45 34.15 29.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.298 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -123.47 145.9 48.23 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 122.141 0.176 . . . . 0.0 111.008 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -67.82 155.22 70.72 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.813 2.342 . . . . 0.0 111.832 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.492 ' HE1' ' HB2' ' A' ' 29' ' ' ASN . 36.6 mtt -133.97 160.68 36.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.169 0.509 . . . . 0.0 111.61 -174.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.428 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 97.2 mt -132.48 118.78 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -99.37 118.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 m -104.1 122.97 46.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.178 0.513 . . . . 0.0 110.191 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.407 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 62.8 m-85 -94.16 114.88 27.09 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.236 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.448 ' HB2' HD23 ' A' ' 47' ' ' LEU . 25.0 p90 -135.25 170.73 15.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.641 0.588 . . . . 0.0 111.284 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.81 153.92 29.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.998 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.674 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.448 HD23 ' HB2' ' A' ' 39' ' ' PHE . 34.8 mt . . . . . 0 C--O 1.223 -0.325 0 CA-C-O 120.363 0.125 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? 61.15 -80.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.585 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.4 pt-20 -52.87 -52.86 55.86 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 112.229 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.409 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 47.0 tp -61.51 -42.7 99.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.634 0.254 . . . . 0.0 110.598 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 88.6 tttt -67.09 -46.92 72.8 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.626 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.95 97.56 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.0 mt -64.01 -41.38 92.31 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.817 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.726 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.51 -36.99 67.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.768 0.318 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 13.6 mm-40 -69.92 -39.65 76.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.488 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 m -114.84 27.35 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.178 0.513 . . . . 0.0 112.116 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 85.7 t80 -59.4 -35.61 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.749 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.669 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.72 -42.98 94.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.951 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.56 -36.81 76.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 0.0 110.59 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -82.08 -7.67 59.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -58.03 -48.99 78.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.039 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -131.95 -44.19 0.96 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -39.67 94.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 40.79 96.11 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.117 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.54 133.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.79 159.78 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.508 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 54.7 mt -108.28 139.3 43.17 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.267 0.556 . . . . 0.0 111.196 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.2 mt -115.81 110.94 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.611 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.76 114.1 26.56 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.52 131.75 63.16 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.936 0.874 . . . . 0.0 111.627 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.1 m -88.69 119.39 29.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.146 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 pt -77.75 -17.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.939 0.774 . . . . 0.0 109.738 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.504 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 4.5 m-20 -73.09 146.34 45.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.155 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.5 -173.82 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.159 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -43.13 -58.32 3.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.858 -1.064 . . . . 0.0 115.403 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.413 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 13.9 pt20 -65.85 -45.17 83.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.408 0.604 . . . . 0.0 112.088 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.504 ' CB ' ' HB3' ' A' ' 74' ' ' ASP . 7.3 m-20 -66.7 -41.4 88.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.575 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -72.88 -5.31 37.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 79.4 mt-30 -66.01 -10.56 40.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.802 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.752 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 96.0 mttt -94.87 -11.04 29.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.549 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 79' ' ' ALA . 14.1 t -68.65 -50.77 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.564 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 40.6 mtpt -66.26 -40.35 34.78 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.605 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 5.9 Cg_endo -58.69 -34.3 98.84 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.185 1.256 . . . . 0.0 110.334 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -64.05 -42.21 97.11 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.44 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -61.08 -43.48 98.82 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.25 -40.41 67.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.89 -42.32 92.92 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.309 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -88.86 -15.73 33.73 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.952 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.6 61.09 4.61 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.734 -0.667 . . . . 0.0 113.276 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.44 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 31.4 m0 -82.41 134.54 35.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.896 0.379 . . . . 0.0 110.323 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -94.65 30.83 1.92 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.383 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -132.15 171.52 13.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.921 -172.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -81.85 136.17 35.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.595 ' O ' HG22 ' A' ' 17' ' ' ILE . 13.9 t -116.66 144.19 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.072 0.463 . . . . 0.0 110.59 -176.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mp -124.64 142.46 51.36 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.037 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 79' ' ' ALA . 9.9 mp -114.76 117.38 30.61 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -81.16 115.16 20.44 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 t -96.17 -8.19 33.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.383 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -111.65 -30.98 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.835 0.35 . . . . 0.0 111.163 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.27 14.54 68.62 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.56 -27.15 16.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.927 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.52 -45.92 90.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.043 0.449 . . . . 0.0 110.782 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -62.82 -38.91 92.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.191 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -70.69 -41.5 71.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.421 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.59 74.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.882 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.428 ' HE2' ' HA ' ' A' ' 107' ' ' MET . 1.0 OUTLIER -86.57 -9.65 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.898 178.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.83 52.23 3.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.978 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.31 89.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.928 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.6 m -69.33 -45.34 69.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.317 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.92 142.28 36.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.983 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 pt -101.83 153.12 38.16 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.528 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 96.0 Cg_endo -78.52 154.32 92.23 Favored 'Cis proline' 0 C--O 1.244 0.778 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.186 0.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -116.65 136.25 53.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.089 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -114.91 127.9 72.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.089 0.471 . . . . 0.0 111.651 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -128.19 114.56 17.13 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.281 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.5 mt -103.05 129.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 CA-C-O 121.199 0.523 . . . . 0.0 110.627 -178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.8 t -106.46 128.52 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.114 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -76.61 161.89 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.59 -21.45 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 114.08 0.392 . . . . 0.0 114.08 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' A' ' 123' ' ' LYS . 6.3 p30 -74.07 -16.45 61.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.687 0.743 . . . . 0.0 111.253 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 5' ' ' THR . . . 101.38 17.91 20.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.222 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' OD1' ' A' ' 121' ' ' ASN . 13.6 mptt -121.94 152.16 39.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.227 0.537 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.1 mt -75.45 111.54 11.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.583 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.12 -19.12 6.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.487 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 68.2 t80 -144.43 130.25 19.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.292 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -138.3 129.04 26.64 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.957 0.408 . . . . 0.0 110.305 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 112.64 8.49 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.092 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.8 p -95.8 106.67 18.83 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.776 0.322 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.24 59.14 2.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.23 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.606 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 41.4 p90 -67.55 -35.81 79.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 109.052 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 80.7 p 69.37 -88.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.216 1.807 . . . . 0.0 113.622 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -119.2 119.1 33.12 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.098 -0.377 . . . . 0.0 111.386 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.58 33.56 16.05 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.527 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -89.89 -27.11 22.54 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.694 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.83 -26.0 32.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.641 0.776 . . . . 0.0 112.804 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.19 94.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 0.0 110.856 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.93 -33.41 68.24 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.547 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.676 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.6 -53.38 55.52 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.492 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.2 tp -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.961 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -63.03 -44.38 96.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.16 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 126' ' ' TYR . 44.6 tptt -68.33 -31.34 70.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 139' ' ' LEU . 69.3 t -59.17 -42.45 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.279 0.561 . . . . 0.0 109.489 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -64.31 -35.75 81.88 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.091 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -62.07 -32.02 72.51 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.601 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.243 0.544 . . . . 0.0 110.038 179.294 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.44 -0.949 0 CA-C-O 121.031 0.443 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 29.0 m-85 -92.68 -136.57 0.17 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.54 19.27 1.69 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.451 ' HB3' HG13 ' A' ' 124' ' ' ILE . 50.9 tt0 53.67 38.83 29.26 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.012 0.91 . . . . 0.0 110.444 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.3 162.28 30.48 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.75 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.68 168.6 23.26 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.273 2.649 . . . . 0.0 110.963 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.69 79.12 6.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.114 0.483 . . . . 0.0 110.61 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.22 134.43 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.1 m -96.68 116.18 28.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.849 0.357 . . . . 0.0 110.157 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 HD21 ' HA ' ' A' ' 98' ' ' ASP . 47.4 mt -113.35 176.28 5.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.799 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -109.41 127.24 54.23 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.288 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.413 HD22 ' HB3' ' A' ' 20' ' ' LYS . 47.8 p30 -89.71 -174.34 4.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.111 0.481 . . . . 0.0 111.706 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 39.5 pt -71.41 -14.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.403 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -93.84 -1.61 54.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.774 0.321 . . . . 0.0 111.184 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.46 24.07 68.93 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HB3' HD22 ' A' ' 16' ' ' ASN . 62.6 tttp -101.54 139.53 37.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -82.51 109.82 17.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.08 142.67 23.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.791 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -100.32 133.11 45.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.875 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.415 HG22 ' CE1' ' A' ' 103' ' ' PHE . 20.9 p -68.89 -32.31 71.86 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -70.05 -17.21 63.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.448 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 8.68 12.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.96 105.83 11.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.331 0.586 . . . . 0.0 112.044 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.442 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 56.4 mt-10 -108.63 139.69 43.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.078 175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.81 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 15.1 t-20 -76.05 -75.66 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.004 0.43 . . . . 0.0 110.328 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.55 33.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.249 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 28.51 51.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -123.0 148.97 55.67 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.123 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.28 149.86 88.0 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.34 2.027 . . . . 0.0 110.634 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.81 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 67.2 mtm -133.66 145.65 50.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.45 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 92.5 mt -122.63 125.45 72.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.38 122.37 51.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.238 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -106.47 115.87 30.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.531 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 66.3 m-85 -94.21 118.24 31.28 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -146.36 167.03 24.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.574 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.01 146.56 26.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.578 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.442 HG22 ' OD2' ' A' ' 74' ' ' ASP . 7.0 t . . . . . 0 C--N 1.314 -0.969 0 CA-C-O 120.857 0.36 . . . . 0.0 111.4 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.903 0.382 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.452 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 26.1 mmt85 -64.11 -39.93 95.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.443 0.639 . . . . 0.0 109.537 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.562 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 tm-20 -64.04 -55.21 23.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.545 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.45 HD13 ' CE2' ' A' ' 93' ' ' TYR . 43.4 tp -62.12 -41.22 98.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.618 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 58.7 tttm -62.21 -48.64 79.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -63.57 -39.72 95.13 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.245 0.545 . . . . 0.0 110.925 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 49' ' ' GLU . 58.9 mt -65.33 -42.73 94.43 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.466 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.21 -30.33 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.804 0.335 . . . . 0.0 110.301 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 77.9 mm-40 -59.2 -48.25 82.33 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.786 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -122.02 30.86 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.488 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' ILE . 88.9 t80 -59.12 -34.74 72.4 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.46 -39.69 88.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.607 0.241 . . . . 0.0 110.471 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.28 -42.33 93.28 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 110.87 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.499 ' O ' ' HB ' ' A' ' 64' ' ' THR . 12.0 m0 -65.57 -37.2 85.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.307 0.575 . . . . 0.0 110.468 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -84.37 -8.22 59.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -53.55 -64.24 0.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.61 -31.22 3.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 19.0 m -63.05 -41.83 99.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.065 0.459 . . . . 0.0 110.07 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.76 31.98 79.92 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.194 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.02 131.78 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.603 0.716 . . . . 0.0 111.438 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 9.1 mmm180 -102.58 141.42 35.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.386 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 50.0 mt -102.24 138.0 39.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.003 0.43 . . . . 0.0 110.295 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.528 HD12 ' SD ' ' A' ' 34' ' ' MET . 91.8 mt -115.06 113.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.44 113.61 25.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.738 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 14.4 p -121.59 132.13 71.47 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-O 121.466 0.651 . . . . 0.0 111.751 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -88.55 131.55 34.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.557 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 pt -77.67 -16.93 14.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 124.357 1.036 . . . . 0.0 110.864 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.442 ' OD2' HG22 ' A' ' 41' ' ' THR . 29.2 m-20 -80.5 160.66 25.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.987 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.89 171.96 7.25 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.83 0.348 . . . . 0.0 110.982 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -56.5 -41.14 88.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.804 -0.634 . . . . 0.0 114.151 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -62.47 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.07 0.435 . . . . 0.0 111.59 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -72.75 -39.3 66.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.4 0.619 . . . . 0.0 110.925 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.53 -4.85 12.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.201 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 47.2 mt-30 -63.88 -9.51 15.58 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.013 -0.429 . . . . 0.0 110.39 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.699 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.8 mttm -96.2 -10.51 27.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -63.66 -47.1 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.683 0.754 . . . . 0.0 111.836 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 23.2 mtmt -70.69 -43.13 14.98 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.159 -175.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.5 Cg_endo -61.17 -30.54 88.92 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 121.012 1.141 . . . . 0.0 110.932 174.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -64.96 -41.27 95.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . -60.62 -40.13 90.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.587 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -46.21 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.126 0.489 . . . . 0.0 111.006 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.26 93.67 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.998 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -87.36 -16.18 35.74 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.304 0.552 . . . . 0.0 112.053 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.31 40.42 6.93 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.725 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -89.04 104.36 16.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -99.1 73.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.353 0.597 . . . . 0.0 109.995 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.596 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -137.18 167.23 21.97 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.411 ' CD ' HH21 ' A' ' 67' ' ' ARG . 2.2 mp0 -70.39 102.6 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 48.0 t -92.74 128.36 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.148 0.499 . . . . 0.0 110.465 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.417 HD12 HG23 ' A' ' 69' ' ' ILE . 10.7 mp -124.75 138.07 54.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.349 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 79' ' ' ALA . 8.1 mp -108.02 117.61 34.58 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.47 ' HA ' HD21 ' A' ' 14' ' ' LEU . 63.5 t0 -78.46 115.62 18.29 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.712 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 p -82.6 -9.85 59.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -127.81 -21.76 3.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.4 19.5 60.3 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.918 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.95 -21.57 19.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.249 0.525 . . . . 0.0 112.107 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 24' ' ' THR . 75.0 t80 -63.68 -43.3 97.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 110.542 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -63.06 -33.14 74.79 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.9 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 -69.52 -39.59 77.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.168 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.01 83.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.248 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.3 mmt -88.04 -3.3 58.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.737 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.72 44.06 14.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.688 0.756 . . . . 0.0 110.615 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.62 96.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.426 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.9 m -88.4 -58.94 2.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.9 tp -112.37 127.09 55.91 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.951 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -87.52 156.84 53.32 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.458 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.5 Cg_endo -82.17 150.11 72.39 Favored 'Cis proline' 0 C--O 1.242 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.304 -0.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -111.19 134.36 52.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.07 127.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.397 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 72.0 m-85 -128.46 116.95 20.5 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.9 mt -105.52 130.02 57.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.092 0.472 . . . . 0.0 110.993 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.18 133.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.745 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -85.46 -172.27 4.05 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.968 0.414 . . . . 0.0 111.23 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.8 -22.53 68.4 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.706 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -85.08 2.07 45.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.785 0.326 . . . . 0.0 110.711 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.44 65.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.401 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -115.73 153.97 30.41 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.451 HG13 ' HB3' ' A' ' 8' ' ' GLN . 80.8 mt -80.93 114.87 22.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.44 -19.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.403 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.576 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 67.0 t80 -144.33 136.99 26.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.716 0.293 . . . . 0.0 110.587 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.88 135.21 24.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -158.36 122.85 4.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 p -103.79 112.35 25.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.128 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.93 66.52 1.8 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.856 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.649 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 27.9 p90 -69.03 -40.02 78.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.256 0.55 . . . . 0.0 110.26 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 81.5 p 55.47 81.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.764 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 64.72 120.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.032 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.54 55.93 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.85 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.649 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.73 -37.58 6.41 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 1.9 pm0 -60.78 -17.51 49.64 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.235 0.614 . . . . 0.0 111.849 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.44 96.59 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.526 0.679 . . . . 0.0 109.739 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -73.41 -31.95 64.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.354 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.541 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -62.24 -47.89 82.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 tp -68.66 -37.31 77.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 110.072 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.772 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -65.21 -36.06 82.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.266 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 139' ' ' LEU . 66.7 t -60.66 -46.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.172 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 5.4 mmp_? -68.76 -36.19 78.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.573 0.701 . . . . 0.0 109.767 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 142' ' ' LYS . 34.6 tt0 -62.06 -27.27 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.19 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 94.4 mt . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.517 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 23.8 m . . . . . 0 N--CA 1.439 -1.003 0 CA-C-O 121.208 0.528 . . . . 0.0 111.405 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -116.16 -120.08 0.31 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.42 13.48 0.66 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.445 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 61.7 tt0 50.38 33.43 7.59 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.867 0.841 . . . . 0.0 110.98 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.7 mt -80.85 156.11 72.68 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.111 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.56 155.3 63.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.871 2.381 . . . . 0.0 110.798 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 80.04 1.28 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.125 0.488 . . . . 0.0 111.315 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.89 132.77 70.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.753 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.8 m -92.42 105.33 17.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.308 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.2 mt -104.41 178.15 4.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.971 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 19' ' ' GLY . 3.2 tppp? -108.54 135.91 49.02 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.105 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.69 -179.96 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.404 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.477 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 42.3 pt -68.32 -11.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -96.24 -4.66 41.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 111.098 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.471 ' C ' ' HD2' ' A' ' 15' ' ' LYS . . . 82.32 20.28 62.75 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.576 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.43 149.6 27.72 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 m -75.12 122.69 23.98 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.057 0.455 . . . . 0.0 110.875 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.09 135.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.645 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 94.4 mt-30 -95.62 133.99 39.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.473 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.6 p -67.41 -27.74 67.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -63.56 -33.74 76.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.204 0.526 . . . . 0.0 110.224 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -105.03 13.0 31.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.246 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.35 124.11 29.1 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.155 0.502 . . . . 0.0 112.105 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -146.74 173.81 12.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.258 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.456 ' OD1' ' HB2' ' A' ' 32' ' ' LYS . 8.2 p30 -112.61 -56.71 2.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.082 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.35 39.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.377 0.671 . . . . 0.0 109.651 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.24 26.86 72.77 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.741 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 45.6 mmtm -117.19 152.84 49.53 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 122.239 0.216 . . . . 0.0 110.713 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.81 151.83 78.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.625 2.217 . . . . 0.0 111.398 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.494 ' SD ' HD13 ' A' ' 69' ' ' ILE . 56.7 mtm -136.32 154.53 50.83 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.476 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 84.0 mt -127.01 125.66 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.0 118.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.8 m -102.93 123.43 46.54 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.563 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -97.15 115.99 28.54 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.675 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -137.3 166.13 24.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.67 0.606 . . . . 0.0 111.212 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.03 161.46 15.49 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.669 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 C--N 1.321 -0.656 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 178.838 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.45 -47.25 84.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.013 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.601 ' O ' HG13 ' A' ' 53' ' ' ILE . 15.5 pt-20 -58.43 -56.51 21.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 111.237 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.557 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 34.6 tp -65.73 -42.85 90.53 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.975 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -65.08 -47.47 77.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.02 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.02 -41.47 99.56 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 120.822 0.344 . . . . 0.0 110.976 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.0 mt -65.55 -42.53 93.26 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.719 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.9 -40.06 66.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 110.654 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -62.45 -46.43 88.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.29 26.86 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.615 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.3 t80 -59.79 -39.44 84.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.276 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.494 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.81 -42.51 81.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.3 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -67.21 -40.51 86.45 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.42 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 32.0 mm-40 -73.6 -15.8 61.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.12 -45.73 93.48 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.799 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.14 -68.23 0.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.304 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -62.83 -31.32 72.3 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.722 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 63.17 45.37 95.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.147 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.79 131.68 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.413 0.625 . . . . 0.0 112.295 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 13.3 mmm180 -96.57 159.02 15.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.948 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 76.0 mt -121.01 129.41 53.38 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.891 0.377 . . . . 0.0 111.285 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.494 HD13 ' SD ' ' A' ' 34' ' ' MET . 89.8 mt -109.32 108.64 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.81 107.43 19.21 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.01 131.47 56.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 CA-C-O 121.913 0.863 . . . . 0.0 112.396 -175.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB3' HG23 ' A' ' 82' ' ' VAL . 26.1 p -84.16 127.89 34.21 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.465 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 46.4 pt -83.46 -15.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.346 1.029 . . . . 0.0 111.001 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -85.28 152.09 23.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.014 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.16 171.36 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.19 -49.41 63.54 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.76 -41.86 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.748 0.774 . . . . 0.0 111.178 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -67.74 -38.27 83.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -72.56 -4.97 33.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.321 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -62.73 -9.51 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.961 -0.462 . . . . 0.0 110.948 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.698 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 98.9 mttt -92.68 -11.26 34.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.523 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 61.3 t -65.3 -49.28 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.631 0.729 . . . . 0.0 112.356 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 14.1 mtpp -71.04 -38.9 7.61 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.02 -28.41 80.43 Favored 'Trans proline' 0 C--N 1.364 1.37 0 CA-C-N 120.051 1.054 . . . . 0.0 110.666 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.08 -45.92 91.4 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.458 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -60.43 -36.94 79.37 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.787 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.03 -32.25 73.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.159 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.77 -44.58 5.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.772 -0.727 . . . . 0.0 113.902 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 17.9 p30 -82.29 -15.77 51.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.27 58.44 3.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.456 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -78.05 112.79 15.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.99 35.79 1.51 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.714 0.769 . . . . 0.0 110.754 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.505 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -141.21 -171.33 3.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.478 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.39 137.36 32.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.628 0.728 . . . . 0.0 112.689 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 19.4 t -106.71 140.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.965 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.1 131.56 54.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -111.98 95.06 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.612 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -77.49 116.07 17.76 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.085 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.3 p -89.82 -14.35 34.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 102' ' ' ASP . 5.8 t30 -104.07 -39.19 6.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.97 0.414 . . . . 0.0 110.983 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.64 43.09 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.423 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . 19.3 t70 -89.76 -29.59 18.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.0 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CE1' HG21 ' A' ' 24' ' ' THR . 86.0 t80 -60.58 -43.34 97.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.491 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 21.8 pttp -62.44 -38.2 88.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.709 0.29 . . . . 0.0 111.279 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -66.01 -42.63 89.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.37 80.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.897 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 2.1 mmt -84.9 -5.06 59.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.264 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 107' ' ' MET . 93.0 m-20 71.43 35.47 1.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.297 0.373 . . . . 0.0 111.803 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.07 108.61 15.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 120.931 0.396 . . . . 0.0 110.906 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.9 m -100.66 -64.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 tp -95.46 126.25 40.63 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -94.31 147.73 33.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.66 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.0 Cg_endo -82.75 167.05 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.117 -1.201 . . . . 0.0 112.971 1.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -131.73 141.94 49.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.45 127.34 73.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 O-C-N 123.344 0.402 . . . . 0.0 111.507 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -126.17 118.45 25.24 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.639 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 67.8 mt -106.96 131.72 56.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.201 0.524 . . . . 0.0 110.763 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.4 131.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -74.82 -179.54 4.26 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.009 0.818 . . . . 0.0 112.557 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.2 -30.83 78.8 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.749 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' THR . 3.3 t-20 -67.25 -41.07 86.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.169 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 121.5 21.23 3.06 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.7 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.56 163.45 14.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.02 109.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.0 -40.22 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.27 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 70.1 t80 -128.29 122.49 31.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.809 0.338 . . . . 0.0 110.62 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.5 120.91 29.36 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.116 0.484 . . . . 0.0 110.82 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -136.79 105.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.8 p -97.34 123.96 41.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 92.71 49.29 2.76 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.509 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.66 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 1.0 OUTLIER -90.11 135.82 33.43 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 173.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.6 p -123.67 69.0 1.03 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.501 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 69.85 119.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.176 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.04 8.8 35.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.67 -18.1 46.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.77 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -59.73 -19.84 52.61 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.78 95.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.39 0.614 . . . . 0.0 109.907 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.34 -32.94 69.14 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.666 ' O ' HG22 ' A' ' 143' ' ' VAL . 10.8 mp -62.02 -51.35 68.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -36.87 74.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.615 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.3 ttpp -60.03 -48.17 82.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.049 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.595 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 55.0 tptt -66.16 -30.27 70.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.213 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 139' ' ' LEU . 70.2 t -58.88 -44.64 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 4.6 mmp_? -68.32 -37.86 80.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.347 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.615 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.5 mm-40 -59.73 -36.29 76.28 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.722 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 83.1 mt . . . . . 0 CA--C 1.514 -0.428 0 CA-C-O 121.024 0.44 . . . . 0.0 110.27 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.416 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 m . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.36 0.6 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.438 ' O ' HG12 ' A' ' 118' ' ' VAL . 21.0 m-85 -97.37 -134.23 0.23 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB1' HD22 ' A' ' 9' ' ' LEU . . . -145.24 21.14 1.56 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.792 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 51.0 tt0 50.28 38.14 16.83 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.878 0.847 . . . . 0.0 109.504 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.574 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 1.0 OUTLIER -103.9 147.93 35.05 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.175 -174.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.632 ' HD2' ' SD ' ' A' ' 107' ' ' MET . 48.1 Cg_exo -55.14 146.7 58.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.647 2.898 . . . . 0.0 112.474 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 25' ' ' ASN . . . -72.44 90.45 1.31 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.755 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.4 132.7 68.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 p -77.5 100.22 5.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.187 0.517 . . . . 0.0 109.964 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.41 HD23 HD23 ' A' ' 96' ' ' LEU . 4.7 tp -106.33 177.23 4.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.177 -176.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' CE ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -118.76 137.75 53.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.02 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -98.9 -178.8 4.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.041 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 95' ' ' VAL . 33.2 pt -67.05 -19.55 25.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.674 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.42 -10.81 59.44 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.326 0.584 . . . . 0.0 110.236 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.43 17.45 75.95 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.427 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 88.3 tttt -95.71 137.12 35.22 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.235 -0.483 . . . . 0.0 109.9 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.486 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 99.7 m -74.6 100.69 3.99 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.6 p -117.17 132.3 67.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.294 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 48.3 mt-30 -82.62 136.7 34.72 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.146 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.574 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 20.1 p -64.15 -36.24 83.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.43 -176.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 11' ' ' ALA . 64.1 t30 -69.43 -16.95 63.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.354 . . . . 0.0 111.575 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -110.08 6.74 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.08 113.56 22.94 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.68 154.94 41.65 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.716 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 25.6 t30 -87.53 -68.19 0.77 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 174.45 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.581 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.416 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 150.08 -13.58 0.97 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.507 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.2 mptm? -91.4 147.96 36.53 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.753 -0.224 . . . . 0.0 110.61 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 17.9 Cg_exo -65.06 156.6 61.81 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.199 2.599 . . . . 0.0 112.832 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 70.6 mtm -138.67 159.75 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.74 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.43 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 81.4 mt -129.65 128.63 65.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.6 mt -99.81 122.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.9 m -115.84 122.82 46.52 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.02 0.438 . . . . 0.0 110.602 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 56.3 m-85 -88.71 117.14 27.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 22.0 p90 -134.91 167.9 20.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 123.439 0.462 . . . . 0.0 110.681 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.5 149.01 30.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.307 -1.274 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.933 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.444 -0.767 0 CA-C-O 120.414 0.15 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.436 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . 12.0 mmm180 -60.21 -43.51 95.89 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.681 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.586 ' O ' HG13 ' A' ' 53' ' ' ILE . 74.0 tt0 -52.63 -64.37 0.84 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.663 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD12 ' CE2' ' A' ' 93' ' ' TYR . 34.2 tp -62.85 -41.54 99.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.272 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.05 -47.68 83.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.054 0.221 . . . . 0.0 111.281 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.42 87.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.682 0.277 . . . . 0.0 111.042 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.9 mt -65.26 -41.01 90.46 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.83 -30.3 32.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.056 0.455 . . . . 0.0 111.016 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -82.67 -37.61 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.978 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.24 23.99 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -62.65 -35.09 78.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.764 0.316 . . . . 0.0 111.115 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.35 88.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.27 -43.87 96.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.423 ' NE1' HD12 ' A' ' 140' ' ' ILE . 13.8 m0 -68.7 -31.65 70.9 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.701 0.762 . . . . 0.0 110.136 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -81.36 -6.6 59.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.575 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.68 -51.76 46.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.09 -34.23 0.55 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.422 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 15.3 m -60.57 -42.58 96.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.87 74.0 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.839 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 11.2 p -75.62 127.43 37.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.112 0.482 . . . . 0.0 111.07 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -106.39 163.58 12.73 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 53' ' ' ILE . 61.2 mt -109.05 129.7 55.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.09 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.45 HG21 HD13 ' A' ' 96' ' ' LEU . 97.3 mt -101.25 107.01 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 39' ' ' PHE . . . -93.89 113.81 25.91 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.307 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.4 129.49 67.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 121.379 0.609 . . . . 0.0 111.418 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 97' ' ' LEU . 39.4 p -83.94 130.47 34.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.311 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.0 pt -72.2 -23.75 21.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.35 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -82.54 147.11 28.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 89.7 mt-10 -61.48 163.53 6.74 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.491 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.13 -39.48 57.92 Favored Glycine 0 C--O 1.23 -0.124 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -174.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -63.87 -38.94 92.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 117.386 0.593 . . . . 0.0 111.114 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -79.89 -37.24 35.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.306 0.574 . . . . 0.0 110.096 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -65.53 -3.9 5.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.793 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.12 -11.21 8.03 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.016 -0.427 . . . . 0.0 110.54 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.722 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.0 mttp -96.55 -10.91 26.21 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.387 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 79' ' ' ALA . 14.6 t -66.53 -47.12 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-O 121.668 0.747 . . . . 0.0 111.627 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 17' ' ' ILE . 41.7 mtpt -64.13 -45.06 79.23 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.054 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.8 Cg_endo -62.08 -29.82 81.78 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.115 1.21 . . . . 0.0 111.19 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -63.09 -41.46 99.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.29 86.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.167 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.27 -46.56 66.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.355 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.5 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.123 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -91.37 -11.14 38.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.912 0.356 . . . . 0.0 111.706 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.28 38.83 28.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -82.19 111.8 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 0.0 110.5 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -97.07 60.38 1.7 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.084 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.461 ' CE2' HD12 ' A' ' 50' ' ' LEU . 6.0 m-85 -138.18 -177.79 4.99 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.961 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.98 117.75 31.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.648 ' O ' HG22 ' A' ' 17' ' ' ILE . 12.4 t -99.27 139.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.24 -174.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.45 HD13 HG21 ' A' ' 69' ' ' ILE . 10.9 mp -125.92 142.89 51.31 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.795 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.498 ' HA ' ' OG ' ' A' ' 72' ' ' SER . 8.7 mp -113.74 121.56 44.45 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 59.8 t0 -74.04 115.14 13.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 118.176 -1.41 . . . . 0.0 107.96 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 p -96.02 -6.0 39.81 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.962 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -117.65 -39.39 3.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.764 0.316 . . . . 0.0 111.647 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -8.51 68.58 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.16 -30.66 66.73 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.868 -0.666 . . . . 0.0 111.388 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.495 ' O ' ' HG2' ' A' ' 107' ' ' MET . 44.7 t80 -61.43 -43.44 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.817 -176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.28 -42.18 94.91 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 110.265 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -69.56 -42.31 74.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.53 94.78 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.138 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.632 ' SD ' ' HD2' ' A' ' 10' ' ' PRO . 39.2 mmm -84.49 -24.12 29.56 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.204 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 129' ' ' THR . 55.5 t30 75.23 100.89 0.07 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.778 0.831 . . . . 0.0 111.041 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.04 132.78 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -84.52 -96.01 0.06 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.561 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.4 pt? -119.47 3.34 11.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.16 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.2 pt 61.29 151.06 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 124.828 1.251 . . . . 0.0 111.888 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.3 Cg_endo -76.58 157.89 97.48 Favored 'Cis proline' 0 N--CA 1.479 0.633 0 C-N-CA 124.19 -1.171 . . . . 0.0 112.303 -1.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -114.78 136.21 53.33 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.2 t -116.67 127.27 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.767 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 77.9 m-85 -124.93 113.0 17.27 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.0 mt -100.68 124.75 54.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-O 121.027 0.441 . . . . 0.0 110.049 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 54.1 t -116.87 132.88 65.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.774 -175.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.97 164.58 24.28 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.649 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.1 -20.64 50.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.612 -0.267 . . . . 0.0 112.984 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -73.57 -5.65 41.61 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.279 0.561 . . . . 0.0 110.196 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.15 19.73 64.26 Favored Glycine 0 CA--C 1.5 -0.863 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.763 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 74.6 mmtt -116.87 151.1 37.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.3 mt -77.95 127.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -104.92 -28.61 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.809 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.444 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.7 t80 -141.56 133.19 27.03 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.793 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -137.12 123.78 21.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -151.02 111.79 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.987 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.427 HG22 ' HB1' ' A' ' 114' ' ' ALA . 19.6 p -93.51 111.63 23.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 83.57 68.11 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.986 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.586 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.7 p90 -68.86 -39.66 79.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 64.2 p 53.31 80.67 0.1 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.296 1.038 . . . . 0.0 113.581 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.96 108.51 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.1 0.96 . . . . 0.0 112.776 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.97 -2.77 27.16 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.586 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -72.2 -41.81 52.34 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.1 -0.55 . . . . 0.0 112.783 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.436 ' OE2' ' HB3' ' A' ' 48' ' ' ARG . 1.7 pm0 -53.59 -24.17 13.04 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.61 88.01 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.513 0.673 . . . . 0.0 110.674 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.4 -32.3 64.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.841 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.78 -47.94 81.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.439 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.423 HD12 ' NE1' ' A' ' 60' ' ' TRP . 8.8 tp -66.57 -33.49 63.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 110.278 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.67 -51.59 69.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.779 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.502 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 31.1 mmmt -68.47 -34.42 75.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.196 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.4 t -59.97 -45.37 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.045 0.45 . . . . 0.0 110.778 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -72.83 -29.33 63.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.466 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -64.99 -30.02 70.98 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.586 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 95.6 mt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.319 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.447 -0.576 0 CA-C-O 120.986 0.422 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 72.7 m-85 -101.54 -133.78 0.29 Allowed 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.551 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -149.45 9.25 0.72 Allowed 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.991 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 47.42 67.69 0.77 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.684 0.754 . . . . 0.0 110.824 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 24' ' ' THR . 32.4 mt -118.84 161.5 35.84 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.852 -175.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.12 160.05 46.59 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.706 2.271 . . . . 0.0 111.169 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.6 81.25 2.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.208 0.528 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.34 136.47 59.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.824 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -98.07 116.2 29.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.454 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 98' ' ' ASP . 56.3 mt -123.77 177.19 5.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.928 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -107.18 140.57 39.84 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.769 0.318 . . . . 0.0 110.798 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -91.31 -173.47 3.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.45 -13.78 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -90.03 -10.98 42.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.98 19.82 66.59 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.8 149.06 21.53 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.7 m -79.35 110.02 14.24 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.272 0.558 . . . . 0.0 110.187 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 137.07 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.051 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -95.78 133.68 39.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.496 HG21 ' CE1' ' A' ' 103' ' ' PHE . 23.6 p -65.86 -32.41 73.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.287 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.6 -31.73 73.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.951 0.405 . . . . 0.0 110.778 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.573 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -103.02 8.78 38.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.343 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 36.3 tp -65.91 121.71 15.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.27 156.92 46.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.22 0.533 . . . . 0.0 112.002 -174.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.603 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 45.2 t-20 -99.5 -83.23 0.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.583 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 170.02 25.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.92 0.762 . . . . 0.0 110.775 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.47 -2.37 39.75 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.233 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -110.08 150.23 41.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.408 0.146 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -68.53 159.88 51.64 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 123.218 2.612 . . . . 0.0 112.782 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 72.5 mtm -139.83 153.11 46.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.106 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 91.1 mt -128.33 127.71 67.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.57 124.56 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -113.04 122.75 48.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.698 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.472 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 57.9 m-85 -93.85 122.41 36.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 25.4 p90 -140.38 165.16 28.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 123.502 0.501 . . . . 0.0 111.542 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.88 151.37 24.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.897 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 p . . . . . 0 C--N 1.312 -1.026 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.646 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 15.0 mt . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 120.583 0.23 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -58.59 -42.35 87.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.551 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.547 ' CD ' HG23 ' A' ' 115' ' ' VAL . 75.2 tt0 -55.08 -64.69 0.76 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.959 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.539 HD11 ' CE2' ' A' ' 93' ' ' TYR . 44.0 tp -61.85 -41.15 97.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.6 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.42 -47.84 83.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.98 -42.48 76.48 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.999 0.428 . . . . 0.0 111.304 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.3 mt -64.38 -41.66 93.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.164 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -52.63 -42.0 64.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.711 0.291 . . . . 0.0 110.926 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.59 -42.26 91.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.17 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.8 m -105.24 15.65 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.25 -38.44 83.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.38 85.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.834 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.16 -36.24 71.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.837 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -69.15 -38.35 78.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.505 0.669 . . . . 0.0 109.553 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -76.59 -11.13 59.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.151 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.341 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -134.96 -45.51 0.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.802 0.334 . . . . 0.0 110.549 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.13 23.59 77.1 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.83 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -78.83 129.2 37.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.0 0.429 . . . . 0.0 111.379 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.8 mtm-85 -104.77 165.71 10.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.47 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.543 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 73.9 mt -109.84 140.02 44.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -113.8 106.47 20.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.28 112.19 23.98 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.28 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.3 p -110.72 132.03 60.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 CA-C-O 121.636 0.731 . . . . 0.0 112.229 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.504 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 20.8 p -81.29 141.39 34.12 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.871 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.9 pt -95.73 -6.91 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.463 1.102 . . . . 0.0 111.09 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 13.9 p-10 -93.88 152.35 18.93 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -63.13 174.04 1.27 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.45 88.91 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -172.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -46.59 81.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.549 0.674 . . . . 0.0 111.012 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -69.62 -41.77 75.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.76 -6.59 33.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.238 -176.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -64.36 -14.95 59.32 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.346 0.593 . . . . 0.0 109.941 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.743 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.9 mttp -94.16 -6.23 45.32 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.873 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 79' ' ' ALA . 51.2 t -63.96 -48.37 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.569 0.7 . . . . 0.0 111.747 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.504 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 19.4 mtpp -68.17 -42.32 29.97 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.221 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.5 Cg_endo -62.33 -28.99 79.17 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 120.902 1.068 . . . . 0.0 110.783 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.743 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.5 mt -64.16 -41.69 97.04 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 83' ' ' LYS . . . -58.49 -45.39 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.677 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.93 -40.68 91.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.301 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.06 88.56 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.821 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -89.42 -14.42 35.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.993 0.396 . . . . 0.0 112.011 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.96 12.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.431 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.429 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 39.3 m0 -79.02 96.44 5.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.268 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.74 68.67 10.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 111.93 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 4.5 m-85 -144.03 177.04 8.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.98 113.48 25.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.81 0.814 . . . . 0.0 109.43 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.71 137.3 21.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.005 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 12.1 tp -115.63 131.18 57.01 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tp -105.71 100.87 10.42 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.301 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.54 ' HA ' HD23 ' A' ' 14' ' ' LEU . 66.3 t0 -77.89 115.22 17.47 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 118.13 -1.428 . . . . 0.0 108.304 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.2 p -108.73 -6.04 16.08 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.934 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -93.71 -41.27 9.78 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.419 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.59 8.49 76.98 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.183 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -99.43 -22.31 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.199 . . . . 0.0 111.302 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CE1' HG21 ' A' ' 24' ' ' THR . 71.4 t80 -62.67 -44.46 96.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.45 -32.76 74.53 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.326 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -68.96 -41.55 77.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.098 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.35 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.8 mmt -83.72 -9.4 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.431 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.9 t30 61.18 47.03 7.47 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.424 0.63 . . . . 0.0 110.654 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.62 96.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -81.36 -55.34 4.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.537 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.03 147.79 45.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 pt -103.43 154.49 37.76 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.1 Cg_endo -77.71 153.45 93.9 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 124.101 -1.208 . . . . 0.0 112.598 0.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -112.36 123.98 51.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.547 HG23 ' CD ' ' A' ' 49' ' ' GLU . 17.9 t -108.4 130.04 61.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.08 0.467 . . . . 0.0 112.133 -173.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 96.5 m-85 -131.71 112.96 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.616 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.3 mt -99.91 130.29 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.864 0.364 . . . . 0.0 110.395 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 53.5 t -113.46 133.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.779 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -85.29 -175.91 5.91 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.314 0.384 . . . . 0.0 111.269 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.29 -31.07 77.93 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.993 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -73.5 -6.0 43.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.326 0.584 . . . . 0.0 110.501 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.407 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 78.63 35.04 33.39 Favored Glycine 0 N--CA 1.433 -1.546 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.764 178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 47.0 mmtm -126.36 156.33 40.66 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.0 mt -76.54 113.48 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.262 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.81 -28.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.913 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.462 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 86.7 t80 -139.23 127.55 22.76 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.507 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -132.06 125.48 31.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -144.87 106.06 4.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.64 108.1 18.93 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.035 -177.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 77.3 1.26 Allowed Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.52 -0.764 . . . . 0.0 114.657 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.627 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -104.53 143.54 32.91 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.002 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 73.9 p -104.68 -49.5 3.51 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.063 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.64 147.41 25.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.689 0.281 . . . . 0.0 111.384 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.89 28.41 73.08 Favored Glycine 0 N--CA 1.453 -0.231 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.105 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.3 -33.1 7.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.242 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -56.01 -20.64 17.48 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.466 0.706 . . . . 0.0 112.439 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.76 93.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.39 0.614 . . . . 0.0 110.215 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -70.51 -37.35 74.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.373 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.581 ' O ' HG21 ' A' ' 143' ' ' VAL . 10.6 mp -61.43 -48.21 82.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.208 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -32.0 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.03 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.7 ttmt -61.06 -50.21 74.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.574 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 45.1 mttp -68.69 -29.86 68.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 139' ' ' LEU . 54.5 t -59.31 -45.31 93.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.109 0.48 . . . . 0.0 109.898 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -68.38 -34.35 75.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.404 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 62.7 mm-40 -56.41 -40.88 75.43 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.146 0.498 . . . . 0.0 110.322 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 49.7 mt . . . . . 0 CA--C 1.54 0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.593 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 43.4 m . . . . . 0 N--CA 1.44 -0.949 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -88.71 -124.03 0.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.067 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.62 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -151.43 16.75 0.72 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.844 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.411 ' OE1' ' HD2' ' A' ' 123' ' ' LYS . 45.2 tt0 50.93 41.49 27.07 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.802 0.81 . . . . 0.0 110.418 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 65.7 mt -87.74 155.74 53.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.71 156.85 55.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.302 2.668 . . . . 0.0 110.875 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.69 84.59 3.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.008 0.432 . . . . 0.0 111.671 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.18 138.84 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 p -90.83 113.62 25.82 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.353 0.597 . . . . 0.0 111.776 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 6.1 mp -107.41 167.22 10.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.196 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -112.45 125.87 54.7 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -87.54 -169.15 2.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.87 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.4 pt -75.48 -12.76 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.537 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.26 -11.74 45.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.067 0.461 . . . . 0.0 110.732 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 14.34 72.27 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -92.43 141.57 28.38 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.103 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -77.58 117.7 19.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.774 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.0 162.32 16.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.286 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 49.0 mt-30 -119.77 132.33 55.59 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.413 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.8 p -67.37 -32.25 73.04 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.26 -36.91 85.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 111.021 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.513 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -103.46 12.5 35.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.597 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.83 123.15 30.13 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.232 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.519 ' HA ' ' HE1' ' A' ' 34' ' ' MET . 8.1 pt-20 -148.03 162.61 39.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.656 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.74 -71.93 0.51 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.113 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.64 47.23 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.183 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' HA2' ' CB ' ' A' ' 5' ' ' THR . . . 80.08 26.86 54.56 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.903 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -122.94 151.66 61.54 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 122.22 0.208 . . . . 0.0 111.018 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.34 155.01 60.98 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.929 2.419 . . . . 0.0 111.403 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' A' ' 28' ' ' GLU . 20.5 mtt -139.99 165.45 27.31 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -171.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.633 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.5 mt -138.03 125.22 28.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 84.3 mt -101.83 131.2 50.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.961 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 m -118.93 122.63 42.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 111.234 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 54.4 m-85 -94.45 125.82 39.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.249 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -137.87 169.82 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 123.722 0.639 . . . . 0.0 111.086 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.77 -169.24 1.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.774 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.235 0.339 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -61.5 -45.67 93.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.659 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.29 -44.94 50.68 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.6 -41.99 98.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.256 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.82 -47.0 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.743 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.42 72.17 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.985 0.422 . . . . 0.0 111.368 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.3 mt -63.82 -30.92 51.21 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.1 -38.53 79.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.485 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -73.89 -39.72 63.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.781 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -107.03 17.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -59.75 -37.83 80.08 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 122.433 0.293 . . . . 0.0 111.701 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.07 81.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.757 0.313 . . . . 0.0 110.825 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.09 -41.91 90.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.924 0.392 . . . . 0.0 111.41 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -68.83 -34.91 76.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.521 0.677 . . . . 0.0 110.748 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -85.15 -7.1 59.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.24 -60.62 3.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.87 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.23 -32.68 1.56 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.19 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -61.78 -41.51 97.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.38 32.09 29.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.165 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 t -67.94 122.55 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.204 0.526 . . . . 0.0 111.936 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -110.14 129.85 55.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.633 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 39.8 mt -97.53 142.96 28.72 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 96' ' ' LEU . 91.4 mt -123.75 116.88 49.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.8 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.63 29.23 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.5 p -123.14 127.45 74.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.43 0.633 . . . . 0.0 111.145 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -90.14 148.76 22.78 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.703 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.3 pt -71.29 -17.69 19.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.804 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.26 164.77 16.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.973 0.416 . . . . 0.0 111.757 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.8 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 3.4 pt-20 -92.65 -88.75 0.21 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -119.92 -68.86 0.3 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.14 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -41.41 -65.36 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 112.168 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.37 -41.71 89.06 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.002 0.43 . . . . 0.0 112.144 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.472 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.38 -2.35 16.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 98.2 mt-30 -57.36 -21.62 36.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.932 0.396 . . . . 0.0 111.068 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.726 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.2 mttp -83.55 -12.82 55.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.853 0.461 . . . . 0.0 111.417 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 79' ' ' ALA . 58.4 t -64.69 -48.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.52 0.676 . . . . 0.0 112.504 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.7 OUTLIER -69.02 -39.77 14.14 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 6.6 Cg_endo -59.77 -32.07 94.99 Favored 'Trans proline' 0 C--N 1.357 1.025 0 CA-C-N 120.074 1.062 . . . . 0.0 110.002 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 92.5 mt -63.73 -41.78 97.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.439 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -55.48 -45.49 76.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.343 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.68 -46.47 46.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.244 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.75 -45.23 96.19 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.255 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.09 -30.66 58.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.681 0.277 . . . . 0.0 111.404 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.42 46.84 3.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.06 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.5 m0 -80.99 117.58 21.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -96.13 27.13 3.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.724 0.773 . . . . 0.0 109.863 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.62 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -117.78 -179.97 3.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.855 -177.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -84.77 128.79 34.78 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.024 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.439 ' C ' HD12 ' A' ' 96' ' ' LEU . 24.3 t -106.98 128.24 61.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 9.6 mp -130.47 148.52 52.29 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.259 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.455 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.3 mp -118.06 124.97 49.39 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.8 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 65.8 t0 -67.65 113.42 5.43 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 118.981 -1.087 . . . . 0.0 108.258 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 t -89.81 -6.39 55.96 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.861 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -104.94 -27.0 11.95 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 120.955 0.407 . . . . 0.0 110.34 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.51 21.4 79.55 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -113.66 -20.62 11.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.637 -0.281 . . . . 0.0 111.286 -176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.413 ' CE1' HG21 ' A' ' 24' ' ' THR . 45.3 t80 -62.91 -39.75 95.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 105' ' ' ARG . 18.9 ptpt -52.16 -47.04 65.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.252 173.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.487 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 50.0 mtm-85 -71.89 -40.25 69.03 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.076 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.75 -42.16 88.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.495 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 33.3 mmm -92.64 -10.72 36.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.445 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 62.11 88.24 0.09 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.761 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.42 HG12 HG23 ' A' ' 112' ' ' ILE . 66.7 t -92.88 129.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.251 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -79.28 -95.72 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.624 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.5 pt? -116.14 6.09 13.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.405 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.6 pt 61.1 152.24 0.1 Allowed Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 124.579 1.151 . . . . 0.0 111.06 -175.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 87.0 Cg_endo -75.58 160.44 96.05 Favored 'Cis proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.794 -0.919 . . . . 0.0 112.973 0.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.7 131.74 54.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.534 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.73 129.38 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 80.8 m-85 -127.71 115.25 18.43 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 68.3 mt -100.52 132.74 45.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 CA-C-O 121.271 0.558 . . . . 0.0 110.468 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.433 ' HB ' ' H ' ' A' ' 34' ' ' MET . 57.1 t -106.43 126.85 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.86 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.438 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 7.9 t70 -70.7 162.18 29.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.479 1.112 . . . . 0.0 110.56 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.61 35.39 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.471 -0.331 . . . . 0.0 113.807 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -86.76 7.01 28.65 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 111.181 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 73.22 40.86 48.6 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.42 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HD2' ' OE1' ' A' ' 8' ' ' GLN . 49.4 mmtm -134.56 152.77 52.01 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.7 mt -70.03 127.07 31.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.899 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.4 p -118.9 -17.34 7.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.659 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.577 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 74.9 t80 -150.11 128.51 12.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.591 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -126.88 120.88 30.28 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.343 0.592 . . . . 0.0 110.654 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.53 101.37 7.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.5 p -98.29 106.47 18.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.341 0.591 . . . . 0.0 112.238 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.2 64.8 2.32 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.542 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.539 ' HH ' ' HG3' ' A' ' 136' ' ' GLU . 1.2 p90 -96.31 154.99 16.95 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p -142.77 89.99 2.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.253 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 69.04 131.67 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.83 2.48 75.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.784 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.3 29.41 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.513 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.539 ' HG3' ' HH ' ' A' ' 131' ' ' TYR . 1.4 mp0 -58.76 -38.49 78.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.412 0.625 . . . . 0.0 109.835 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.08 87.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.85 -38.53 83.28 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.637 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -63.04 -50.39 70.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.373 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 tp -66.92 -38.48 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.144 0.497 . . . . 0.0 110.928 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -60.89 -45.73 93.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.904 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 18.6 tptm -66.14 -30.81 71.36 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.526 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 139' ' ' LEU . 95.4 t -64.75 -41.95 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -73.85 -24.29 59.74 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -61.44 -39.23 90.05 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.8 mt . . . . . 0 C--N 1.333 -0.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 179.354 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.418 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 14.7 m . . . . . 0 N--CA 1.44 -0.928 0 CA-C-O 120.72 0.295 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -74.52 -112.64 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.215 0.531 . . . . 0.0 110.609 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -173.08 -7.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.329 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 69.12 62.16 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.15 159.92 37.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.029 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.96 158.39 57.55 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.814 2.343 . . . . 0.0 110.816 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 81.09 2.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.092 0.472 . . . . 0.0 111.161 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -124.57 133.37 69.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.328 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 m -89.41 110.28 21.11 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.8 mt -107.3 173.25 6.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 109.974 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.404 HD22 ' HB3' ' A' ' 20' ' ' LYS . 3.8 p30 -98.0 -176.62 3.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.431 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 pt -61.57 -22.59 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -81.14 -8.26 59.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.181 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.24 14.94 81.69 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HB3' HD22 ' A' ' 16' ' ' ASN . 87.6 tttt -99.84 139.27 35.75 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.564 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.6 m -74.48 118.6 17.62 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.315 0.579 . . . . 0.0 110.209 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.86 130.74 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.712 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 71.5 mt-30 -92.0 134.02 35.19 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.449 HG23 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -66.16 -29.3 69.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.323 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.646 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.73 122.03 28.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.87 153.52 52.02 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.89 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.574 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 23.7 t-20 -79.91 -80.77 0.13 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.338 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 171.87 28.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.788 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.418 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 95.3 0.26 63.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.491 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 1.4 mptm? -104.48 150.75 38.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.787 0.327 . . . . 0.0 110.548 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.2 159.58 33.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.967 2.445 . . . . 0.0 111.496 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.574 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 74.1 mtm -141.09 159.53 42.02 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 120.781 0.324 . . . . 0.0 111.795 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.426 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.2 mt -128.09 124.86 63.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.5 mt -97.99 119.88 46.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -107.7 121.56 44.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 58.5 m-85 -94.27 117.75 30.57 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.408 ' HB2' HD21 ' A' ' 47' ' ' LEU . 26.5 p90 -138.48 165.47 26.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.856 0.722 . . . . 0.0 111.588 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.35 164.09 13.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.521 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.445 -0.676 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.477 176.718 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 39' ' ' PHE . 18.9 mt . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.919 0.39 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -61.33 -38.9 88.55 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.368 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.595 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.3 pt-20 -60.01 -51.74 68.35 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.045 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.472 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 40.8 tp -63.08 -41.08 99.35 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.402 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.483 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -59.92 -48.78 80.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.474 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.64 70.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.845 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.9 mt -63.76 -41.54 92.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.113 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -52.83 -36.38 58.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.014 0.435 . . . . 0.0 110.361 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.82 -46.73 67.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.883 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.16 25.65 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.45 -40.56 87.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.868 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.93 93.83 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.752 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.12 -41.0 97.4 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.236 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -66.84 -38.52 86.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.252 0.548 . . . . 0.0 110.201 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 30.1 mm-40 -70.17 -21.51 63.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.216 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.59 -48.88 79.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.625 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -104.59 -68.55 0.85 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.265 0.555 . . . . 0.0 111.859 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -63.73 -32.36 73.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.846 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 62.6 41.01 99.85 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.052 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.54 132.44 35.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.085 0.469 . . . . 0.0 112.253 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -104.9 163.6 12.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 58.8 mt -110.86 138.1 47.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.188 0.518 . . . . 0.0 111.398 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.445 HD12 ' SD ' ' A' ' 34' ' ' MET . 87.9 mt -110.78 110.48 32.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.16 116.05 28.38 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.9 p -121.59 131.69 72.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.478 0.656 . . . . 0.0 112.178 -176.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.409 ' OG ' ' HA ' ' A' ' 97' ' ' LEU . 23.3 p -86.38 134.93 33.68 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.07 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.41 ' O ' ' HD3' ' A' ' 104' ' ' LYS . 43.1 pt -86.49 -5.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.238 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 15.1 m-20 -95.82 157.48 15.88 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.766 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.17 179.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.689 0.618 . . . . 0.0 112.565 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 -45.3 95.76 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 114.526 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -61.38 -46.08 91.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.371 0.605 . . . . 0.0 110.758 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 14.3 m120 -67.0 -39.17 87.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.903 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 82' ' ' VAL . . . -68.27 -9.77 49.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.601 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.29 -22.32 52.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.04 0.448 . . . . 0.0 110.74 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.745 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 97.8 mttt -89.41 -13.7 37.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.699 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 79' ' ' ALA . 61.2 t -64.6 -50.2 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.497 0.665 . . . . 0.0 112.549 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mtpm? -68.52 -42.26 26.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.7 Cg_endo -61.41 -29.56 85.62 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.014 1.143 . . . . 0.0 110.821 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.9 mt -63.43 -42.28 98.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.429 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -58.07 -46.4 85.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.748 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -65.74 -45.76 81.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.994 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.71 -41.57 88.94 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.536 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -87.76 -3.12 58.97 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 46.17 45.76 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.386 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.429 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 53.8 m0 -82.78 100.99 10.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.408 0.623 . . . . 0.0 110.655 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -84.71 47.05 1.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.021 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 1.8 m-85 -138.32 175.95 9.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.88 126.42 32.44 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -110.9 131.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.07 0.462 . . . . 0.0 110.102 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 10.9 mp -121.17 134.29 55.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.683 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.409 ' HA ' ' OG ' ' A' ' 72' ' ' SER . 7.9 mp -110.18 115.9 30.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -79.0 114.8 18.24 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.158 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 p -85.63 -13.06 49.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.194 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -90.42 -45.65 8.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.948 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.8 8.85 66.88 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -174.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -96.24 -25.06 15.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.441 -0.88 . . . . 0.0 111.766 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.449 ' CE1' HG23 ' A' ' 24' ' ' THR . 62.3 t80 -61.47 -43.85 98.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 73' ' ' ILE . 22.9 pttp -58.92 -40.11 83.57 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.305 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -71.07 -41.85 70.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.972 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.55 81.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.37 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.67 -25.33 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.069 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.52 95.22 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.228 1.011 . . . . 0.0 111.966 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.68 115.7 50.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.169 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.2 p -82.77 -57.98 3.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.683 0.754 . . . . 0.0 110.076 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 46.3 tp -130.57 134.47 47.04 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.625 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.8 pt -87.59 151.36 50.33 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.531 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.8 Cg_endo -82.88 161.55 74.99 Favored 'Cis proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.704 0.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.61 136.65 54.76 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.448 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.6 t -119.44 124.97 73.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 120.889 0.376 . . . . 0.0 111.188 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 61.1 m-85 -122.05 118.04 27.78 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 62.0 mt -105.86 130.47 57.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.153 0.501 . . . . 0.0 111.0 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.3 t -104.87 135.2 43.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.988 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -87.66 -174.73 4.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 111.014 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.12 -18.43 69.07 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.414 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -88.86 -4.34 58.5 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.545 -0.386 . . . . 0.0 110.981 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.43 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 84.39 28.94 31.64 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.336 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 2.0 mppt? -124.21 154.09 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.161 0.505 . . . . 0.0 111.481 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.0 mt -70.59 99.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.246 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.87 -31.49 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.64 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.57 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.1 t80 -130.67 129.06 42.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.535 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -132.36 121.93 24.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -146.37 102.01 3.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.414 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 p -94.81 116.15 28.38 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.527 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.02 50.75 1.72 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.34 -0.934 . . . . 0.0 114.109 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.531 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.5 OUTLIER -81.64 138.52 35.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.0 p -123.35 -16.11 6.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.372 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -140.5 -101.63 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.35 30.13 2.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.955 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.77 -25.65 74.05 Favored Glycine 0 C--N 1.318 -0.455 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.053 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.6 -29.72 64.72 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.232 0.613 . . . . 0.0 110.626 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.19 96.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.06 -35.12 77.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.579 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.714 ' O ' HG22 ' A' ' 143' ' ' VAL . 11.0 mp -61.22 -53.58 55.09 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.29 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.75 -39.08 81.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.089 0.471 . . . . 0.0 111.395 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 34.1 ttpt -59.06 -48.4 81.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.469 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 39.9 tptt -67.79 -30.97 70.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.216 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 139' ' ' LEU . 48.0 t -58.15 -44.46 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.535 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -77.14 -24.85 51.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.029 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 52.0 mm-40 -64.04 -33.71 76.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.135 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 88.8 mt . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.068 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.652 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.43 -1.462 0 CA-C-O 120.163 0.03 . . . . 0.0 110.992 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -151.79 -140.21 0.09 Allowed 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.74 14.85 2.13 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 49.94 51.07 17.31 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.763 0.792 . . . . 0.0 109.964 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.6 mt -106.66 154.71 39.88 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.327 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.87 152.57 78.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.499 2.799 . . . . 0.0 110.913 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.96 87.05 0.72 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.131 0.491 . . . . 0.0 111.565 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.7 t -126.31 136.54 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.222 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -96.98 112.89 24.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.782 0.325 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 98' ' ' ASP . 53.2 mt -116.48 176.55 5.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -105.33 139.86 39.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.472 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -92.73 -175.14 3.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.285 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.73 -11.37 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.836 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.91 -15.54 27.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.85 61.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.818 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -99.99 146.29 26.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -73.73 120.16 18.94 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.469 0.652 . . . . 0.0 110.716 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.71 131.39 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.611 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.6 mt-30 -92.28 134.57 34.78 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.436 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.544 HG21 ' CE1' ' A' ' 103' ' ' PHE . 7.1 p -67.28 -21.58 65.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -79.57 -9.9 59.7 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.0 0.429 . . . . 0.0 110.495 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.25 16.09 7.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.67 -178.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.3 tp -99.76 125.88 45.74 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.746 -176.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.652 ' HB3' ' O ' ' A' ' 5' ' ' THR . 3.9 pt-20 -141.91 158.65 43.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.084 177.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -81.14 -71.5 0.47 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.64 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.09 38.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.448 0.467 . . . . 0.0 110.963 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 5' ' ' THR . . . 91.83 4.06 67.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.042 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.64 151.73 41.17 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 122.652 0.381 . . . . 0.0 110.387 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.53 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -66.91 155.67 69.69 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 122.994 2.463 . . . . 0.0 112.343 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.4 mtm -138.97 149.33 44.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.65 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.42 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 89.7 mt -127.88 126.11 66.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 77.4 mt -91.52 126.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.8 m -111.03 112.96 25.15 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 40.7 m-85 -86.98 109.46 19.39 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 173.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 70' ' ' ALA . 28.5 p90 -126.21 157.07 39.15 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.853 0.721 . . . . 0.0 110.872 -175.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.96 147.66 34.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.803 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.251 -177.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.446 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 9.6 mt . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.641 ' HG3' ' O ' ' A' ' 132' ' ' THR . 27.0 mmt180 -61.1 -43.39 98.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.8 tm-20 -63.66 -55.13 25.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.474 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.411 HD12 ' CE2' ' A' ' 93' ' ' TYR . 35.5 tp -62.71 -40.85 98.45 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.61 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.94 -48.17 77.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.639 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -44.45 93.23 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.043 0.449 . . . . 0.0 110.868 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.6 mt -64.05 -41.34 92.16 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.77 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.678 ' OE1' ' HA ' ' A' ' 91' ' ' TRP . 26.3 tp60 -51.83 -40.61 60.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.42 -41.57 72.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.974 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.06 19.13 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -59.78 -34.4 72.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.6 84.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.836 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.86 -40.39 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.981 0.419 . . . . 0.0 110.694 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.46 ' NE1' HD13 ' A' ' 140' ' ' ILE . 15.3 m0 -67.27 -38.35 84.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.384 0.611 . . . . 0.0 110.405 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -81.97 -8.8 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.391 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.3 -49.23 78.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.876 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -152.19 64.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.369 0.604 . . . . 0.0 110.706 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.8 m -161.9 -39.74 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.613 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.0 21.08 76.94 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.662 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.2 p -81.93 125.57 39.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.066 0.46 . . . . 0.0 111.888 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -108.46 158.14 17.8 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.233 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.422 HD11 ' CG2' ' A' ' 53' ' ' ILE . 42.8 mt -99.02 134.16 42.26 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.021 0.438 . . . . 0.0 110.843 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 96' ' ' LEU . 90.8 mt -102.75 101.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 39' ' ' PHE . . . -88.54 122.89 32.5 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.1 p -120.54 130.5 74.41 Favored 'Isoleucine or valine' 0 C--O 1.256 1.412 0 CA-C-O 121.594 0.711 . . . . 0.0 111.769 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.453 ' CB ' HG23 ' A' ' 82' ' ' VAL . 24.1 p -83.37 132.01 35.02 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.898 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 45.1 pt -87.49 19.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 125.369 1.668 . . . . 0.0 113.858 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -122.38 -159.26 0.82 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.733 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.485 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 49.2 mt-10 -96.17 179.83 4.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.749 0.309 . . . . 0.0 110.381 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.563 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . -61.84 -43.32 99.38 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' A' ' 75' ' ' GLU . 6.0 pm0 -64.38 -41.78 96.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.648 0.724 . . . . 0.0 112.306 -177.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -77.03 -38.84 52.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.873 0.368 . . . . 0.0 111.549 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.402 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.46 -5.66 34.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 86.3 mm-40 -60.75 -24.1 65.47 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.919 -0.488 . . . . 0.0 110.722 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.69 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 30.6 mtpp -84.05 -9.83 58.32 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.725 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 61.6 t -65.75 -48.23 83.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.698 0.761 . . . . 0.0 112.53 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.9 mtpm? -66.65 -41.85 41.71 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.144 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.2 Cg_endo -62.9 -28.99 75.74 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.175 1.25 . . . . 0.0 110.884 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 97.5 mt -62.51 -42.84 99.78 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.42 91.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.797 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.85 -46.4 53.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.99 94.32 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.439 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -75.33 -23.95 57.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.797 0.332 . . . . 0.0 111.153 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.09 37.7 28.2 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.728 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.678 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 26.4 m0 -59.67 -42.28 92.53 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 66.13 27.3 10.49 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.598 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 6.1 m-85 -111.91 -167.65 1.21 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.475 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -104.3 129.21 52.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.496 0.665 . . . . 0.0 111.954 -172.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.432 HD11 HG21 ' A' ' 69' ' ' ILE . 11.0 mp -114.32 133.94 55.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.343 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.476 HD21 ' HA2' ' A' ' 76' ' ' GLY . 10.4 tt -108.71 111.85 23.84 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.253 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.504 ' HA ' HD22 ' A' ' 14' ' ' LEU . 68.2 t0 -80.12 128.19 33.21 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.271 174.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -110.09 0.65 18.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.991 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -114.23 -36.2 4.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.41 7.61 75.82 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.02 -21.97 25.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.544 ' CE1' HG21 ' A' ' 24' ' ' THR . 52.3 t80 -64.15 -35.42 80.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 110.22 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.485 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 52.1 mtmt -59.8 -44.84 93.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.55 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.1 -37.96 72.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.07 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.56 82.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.173 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.5 mmm -91.64 -10.4 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.244 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 64.71 69.25 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.379 0.609 . . . . 0.0 110.466 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.86 120.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.805 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.3 t -95.79 -75.88 0.51 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.227 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD23 HG22 ' A' ' 132' ' ' THR . 41.6 tp -98.26 160.73 14.1 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.2 pt -116.05 153.05 48.33 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.2 Cg_endo -79.56 156.9 89.71 Favored 'Cis proline' 0 C--O 1.241 0.656 0 C-N-CA 123.882 -1.299 . . . . 0.0 112.801 1.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -113.17 135.13 54.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.457 HG21 ' HG3' ' A' ' 49' ' ' GLU . 22.1 t -120.29 131.45 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -173.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 89.7 m-85 -126.73 112.83 15.88 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 173.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.5 mt -99.82 123.17 52.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.76 127.95 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.867 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.05 163.01 27.09 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 110.952 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -18.33 43.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.13 -0.486 . . . . 0.0 113.473 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -86.6 1.57 51.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.813 0.307 . . . . 0.0 111.085 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 83.55 26.38 43.01 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.005 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -124.98 157.0 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.943 0.372 . . . . 0.0 110.056 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.4 115.37 21.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.138 0.494 . . . . 0.0 110.055 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.434 HG11 HD21 ' A' ' 146' ' ' LEU . 7.8 p -94.67 -38.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.15 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 72.0 t80 -134.26 128.73 34.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.203 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -131.21 128.93 40.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.411 . . . . 0.0 110.219 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 12.7 t60 -138.38 102.85 4.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 102.65 15.39 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.199 0.523 . . . . 0.0 111.911 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.17 105.45 0.75 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.653 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.546 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 3.6 p90 -138.23 163.78 30.88 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.641 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.7 p -109.62 -42.28 4.34 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.001 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -172.94 151.69 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.68 79.95 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.85 -34.33 8.43 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.5 pm0 -61.4 -15.55 37.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.35 0.66 . . . . 0.0 112.143 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.92 94.46 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.519 0.676 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.88 -26.82 36.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.227 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.1 mp -62.07 -49.31 76.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.721 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.46 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.8 tp -68.9 -34.84 66.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.879 0.371 . . . . 0.0 110.257 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 41.8 ttmt -58.91 -49.07 79.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.176 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -66.21 -36.73 83.83 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 139' ' ' LEU . 72.8 t -59.76 -45.07 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.123 0.487 . . . . 0.0 109.804 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -72.0 -25.02 61.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.209 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 75.7 mm-40 -64.37 -36.09 83.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.434 HD21 HG11 ' A' ' 125' ' ' VAL . 81.8 mt . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 121.353 0.597 . . . . 0.0 109.487 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.436 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 4.4 t . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.329 0.585 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.46 ' N ' ' HA3' ' A' ' 122' ' ' GLY . 85.7 m-85 -87.8 -90.57 0.12 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.314 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.57 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 169.92 -25.49 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.579 -176.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.458 HE21 ' HD2' ' A' ' 123' ' ' LYS . 8.5 tt0 65.9 83.14 0.17 Allowed 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.547 -176.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 mt -133.19 167.28 23.74 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.385 -174.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.71 159.87 49.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.913 2.409 . . . . 0.0 111.109 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.42 83.44 3.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -126.36 134.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.209 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.1 p -98.7 112.76 24.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.204 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -117.67 176.4 5.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -108.63 135.28 50.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.437 0.16 . . . . 0.0 110.607 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -87.23 -171.92 3.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.41 HG22 ' H ' ' A' ' 95' ' ' VAL . 27.5 pt -66.21 -24.04 32.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -77.42 -30.81 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.491 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.85 14.95 21.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.2 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -93.78 147.76 22.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.8 m -75.07 115.86 15.17 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.281 0.562 . . . . 0.0 110.269 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.44 131.65 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.895 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.526 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 44.2 mt-30 -98.06 132.7 43.38 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.71 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.601 HG22 ' CE1' ' A' ' 103' ' ' PHE . 14.8 p -68.17 -24.36 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -78.7 -4.04 47.16 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.815 0.34 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -134.25 11.9 3.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -67.89 124.81 24.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -147.88 161.8 40.57 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.599 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 35.1 p-10 -107.27 -56.48 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.94 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.86 25.59 0.03 OUTLIER Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -129.13 151.22 77.34 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.67 153.57 77.58 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.324 2.016 . . . . 0.0 111.753 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 29' ' ' ASN . 74.4 mtm -136.62 155.43 49.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.918 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.13 123.15 61.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.1 123.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -113.96 124.46 52.21 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 60.9 m-85 -93.76 119.76 33.15 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.559 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 24.2 p90 -137.94 170.16 16.53 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.606 0.566 . . . . 0.0 111.95 -175.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.65 33.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.565 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 C--N 1.314 -0.964 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.921 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.559 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 8.2 mt . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -64.45 -39.5 93.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.728 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.588 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -67.96 -52.76 32.28 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.499 HD13 ' CE2' ' A' ' 93' ' ' TYR . 43.6 tp -61.6 -41.25 97.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.806 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.07 -49.68 76.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.513 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.05 -44.09 66.5 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.853 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 49' ' ' GLU . 66.6 mt -63.72 -42.44 96.0 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.767 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.691 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -52.7 -40.32 62.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -68.32 -44.8 74.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.36 20.51 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -60.81 -32.68 72.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.761 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.9 92.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.818 0.342 . . . . 0.0 110.407 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -66.8 -39.05 87.6 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.37 -36.37 82.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.545 0.688 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -82.39 -9.12 59.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.579 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.83 -52.94 63.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.502 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.04 -50.46 2.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.435 HG21 HG12 ' A' ' 143' ' ' VAL . 6.5 m -61.77 -38.8 89.36 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.33 29.04 74.17 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.431 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.66 127.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.92 0.391 . . . . 0.0 111.865 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -106.37 140.49 39.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.605 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 72.1 mt -84.63 144.62 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.586 HD12 ' SD ' ' A' ' 34' ' ' MET . 94.8 mt -119.5 109.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 39' ' ' PHE . . . -100.38 127.99 46.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.35 136.43 59.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 CA-C-O 121.612 0.72 . . . . 0.0 111.706 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.495 ' HB3' HG23 ' A' ' 82' ' ' VAL . 37.2 p -83.61 126.34 32.73 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.437 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 pt -80.79 16.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 125.107 1.504 . . . . 0.0 112.351 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.598 ' OD1' ' HB2' ' A' ' 78' ' ' ASN . 4.2 t70 -130.14 165.88 21.39 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -78.43 175.38 10.35 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.338 0.399 . . . . 0.0 111.268 -174.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 80' ' ' GLN . . . -56.83 -22.85 42.7 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.111 -177.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -65.04 -57.57 8.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.119 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.598 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 91.7 m-20 -85.42 -38.97 18.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.137 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.94 -3.2 21.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.456 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 6.7 tt0 -63.98 -12.28 36.32 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.761 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.7 mmtm -95.77 -3.08 46.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.975 0.51 . . . . 0.0 112.054 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 72' ' ' SER . 61.7 t -65.26 -49.19 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.39 0.614 . . . . 0.0 112.547 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.4 mtpt -65.62 -43.69 62.19 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.803 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.15 -28.45 79.73 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.23 1.287 . . . . 0.0 111.312 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.6 mt -62.87 -41.94 99.58 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.97 92.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.9 -46.81 83.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.28 -40.76 80.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.631 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -92.97 -0.4 57.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.66 38.93 61.06 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.358 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -81.78 96.5 7.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.7 70.84 7.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 11.2 m-85 -145.47 172.13 13.65 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.87 120.34 20.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 17' ' ' ILE . 20.7 t -109.21 123.75 65.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.0 mp -111.23 138.1 48.11 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.646 0.736 . . . . 0.0 111.525 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.8 tp -103.76 109.36 21.05 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.792 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HA ' HD21 ' A' ' 14' ' ' LEU . 68.0 t0 -82.27 116.37 21.76 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 117.751 -1.58 . . . . 0.0 108.531 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -107.27 5.48 27.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.202 0.525 . . . . 0.0 110.185 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -110.8 -43.62 3.78 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.951 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.02 -1.97 78.57 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.682 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -83.18 -25.57 31.68 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.602 -0.352 . . . . 0.0 111.454 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.601 ' CE1' HG22 ' A' ' 24' ' ' THR . 47.6 t80 -64.01 -44.46 92.52 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -61.49 -36.71 81.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.852 0.358 . . . . 0.0 110.61 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -70.24 -41.57 73.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 110.359 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.62 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.591 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.9 mmt -86.76 -8.29 57.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.021 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.2 t30 59.03 71.18 0.6 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.379 0.609 . . . . 0.0 111.26 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.432 HG21 ' CD2' ' A' ' 38' ' ' PHE . 44.8 t -98.76 96.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.21 0.529 . . . . 0.0 110.63 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -88.89 -62.24 1.53 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.432 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 47.1 tp -105.93 129.9 53.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.281 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.7 pt -91.55 152.87 43.91 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 67.2 Cg_endo -83.62 157.04 72.06 Favored 'Cis proline' 0 C--O 1.242 0.721 0 C-N-CA 124.277 -1.135 . . . . 0.0 112.859 1.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -112.98 130.03 56.28 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.54 127.87 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-O 121.327 0.584 . . . . 0.0 112.161 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 86.6 m-85 -127.64 112.69 15.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.765 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.2 mt -101.74 130.73 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.213 0.53 . . . . 0.0 110.874 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 76.4 t -107.61 129.54 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.26 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.45 -175.42 5.46 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.301 0.376 . . . . 0.0 111.177 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.7 61.64 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.713 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -86.04 -1.66 57.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.479 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.46 ' HA3' ' N ' ' A' ' 6' ' ' TYR . . . 70.89 42.6 60.13 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.395 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.458 ' HD2' HE21 ' A' ' 8' ' ' GLN . 72.2 mmtt -127.11 155.54 43.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 7' ' ' ALA . 88.5 mt -71.66 100.14 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.8 -34.16 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.457 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 87.7 t80 -132.5 130.33 40.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.723 0.296 . . . . 0.0 110.701 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -131.74 115.9 16.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.049 0.452 . . . . 0.0 110.78 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.458 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 2.0 t60 -132.81 102.87 5.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.405 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.02 116.32 29.01 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.089 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 78.5 65.35 1.86 Allowed Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.41 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.462 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 2.7 p90 -104.58 154.77 19.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.832 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.9 p -142.68 94.62 2.66 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.257 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 63.73 108.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.731 0.812 . . . . 0.0 112.273 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.17 23.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.862 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.34 -18.97 40.19 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.944 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.57 -30.28 67.04 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.368 0.667 . . . . 0.0 111.174 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.23 -40.26 93.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.787 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.42 -36.66 79.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.789 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.626 ' O ' HG21 ' A' ' 143' ' ' VAL . 11.2 mp -63.0 -48.81 77.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.713 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.2 tp -67.82 -39.76 82.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.903 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -60.43 -45.51 93.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.803 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.636 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 37.8 tptt -66.38 -35.72 81.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.31 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.626 HG21 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -59.48 -46.73 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 0.0 110.711 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 4.6 ptp180 -78.98 -18.57 53.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.059 0.457 . . . . 0.0 110.91 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -69.93 -37.51 75.92 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.862 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 58.1 mt . . . . . 0 N--CA 1.465 0.286 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.667 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 41.7 m-85 -97.89 -135.64 0.26 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.246 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.57 11.52 0.44 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 52.8 tp60 51.74 31.75 8.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.826 0.822 . . . . 0.0 111.656 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.1 mt -79.87 161.68 65.25 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.022 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.13 154.09 72.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.457 2.105 . . . . 0.0 111.133 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.28 76.64 1.33 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.312 0.577 . . . . 0.0 111.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.21 134.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 t -97.33 114.94 26.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 98' ' ' ASP . 30.0 mt -105.33 173.64 6.22 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -113.48 127.08 55.97 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.505 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.401 ' ND2' ' HD3' ' A' ' 20' ' ' LYS . 86.8 m-20 -79.59 178.71 7.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.074 0.464 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.554 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 47.3 pt -65.57 -26.2 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.186 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.99 -17.54 60.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.21 19.58 60.52 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 44.6 tttp -79.81 136.16 36.65 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.728 -0.736 . . . . 0.0 109.918 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -83.71 108.76 16.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.74 144.32 38.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.021 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.621 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 85.9 mt-30 -103.99 135.19 45.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.419 HG21 ' CE1' ' A' ' 103' ' ' PHE . 12.8 p -64.38 -30.68 71.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -73.66 -14.2 61.12 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.071 0.462 . . . . 0.0 111.068 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -114.65 8.88 16.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 111.297 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 38.4 tp -80.51 115.8 20.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.231 -175.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 160.73 36.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.314 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.507 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 8.3 p30 -112.89 -58.21 2.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.645 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.96 -45.54 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.565 0.746 . . . . 0.0 109.882 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.87 26.57 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.828 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -119.46 152.01 52.31 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.48 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 12.3 Cg_exo -72.1 158.89 51.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.932 2.421 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.507 ' SD ' ' ND2' ' A' ' 29' ' ' ASN . 5.0 mpp? -132.14 156.96 45.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.93 123.66 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -103.43 121.66 55.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.72 122.83 46.51 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 71.7 m-85 -96.1 119.63 34.94 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -147.83 161.46 41.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.984 0.421 . . . . 0.0 111.692 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.29 152.7 32.32 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.242 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 74' ' ' ASP . 3.1 p . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -61.26 -38.19 85.84 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.202 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.668 ' OE2' ' HB2' ' A' ' 113' ' ' PRO . 50.7 mt-10 -53.04 -67.28 0.26 Allowed 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.659 0.742 . . . . 0.0 110.235 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.542 HD13 ' CE2' ' A' ' 93' ' ' TYR . 30.4 tp -60.86 -41.04 95.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.747 -173.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.52 -53.98 43.43 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.095 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 -42.74 94.77 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.8 mt -65.03 -42.77 95.48 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.949 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.68 -38.05 71.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.652 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.88 -35.7 81.37 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.869 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -120.59 25.26 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 53' ' ' ILE . 86.9 t80 -60.53 -34.45 74.13 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.54 92.21 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.425 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.89 -42.32 94.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.796 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -63.77 -35.76 81.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.754 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -79.13 -15.63 57.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.272 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.94 -43.73 98.24 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.75 -58.8 1.93 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.541 -0.463 . . . . 0.0 112.025 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 m -62.69 -39.62 94.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.684 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.43 28.16 73.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.656 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.72 131.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 122.658 0.383 . . . . 0.0 111.929 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -106.79 146.52 30.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.627 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 60.8 mt -91.69 148.12 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.402 0.62 . . . . 0.0 111.457 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 92.3 mt -122.44 118.68 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.575 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.44 111.56 23.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.52 127.83 72.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 CA-C-O 121.66 0.743 . . . . 0.0 111.245 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -85.6 133.11 34.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.713 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.0 pt -84.93 2.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.843 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' HB2' HG23 ' A' ' 41' ' ' THR . 49.2 m-20 -102.33 157.27 17.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.71 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.03 156.42 5.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.492 0.495 . . . . 0.0 111.07 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.23 -34.04 72.46 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.489 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.61 -40.57 92.35 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.701 0.286 . . . . 0.0 111.708 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -85.3 -32.52 22.46 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.384 0.612 . . . . 0.0 110.367 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -67.31 -4.24 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.624 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.65 -8.97 11.52 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.025 -0.422 . . . . 0.0 110.143 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.648 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 35.4 mmtp -85.93 -17.56 35.12 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.183 0.593 . . . . 0.0 111.788 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 79' ' ' ALA . 11.6 t -64.48 -46.25 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.843 0.83 . . . . 0.0 111.324 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.499 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 18.7 mtmt -68.53 -44.23 33.28 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.17 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.4 Cg_endo -60.2 -32.39 94.36 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.009 1.139 . . . . 0.0 110.785 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.3 mt -64.35 -42.45 96.22 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 83' ' ' LYS . . . -60.48 -41.82 95.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.783 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.82 -41.53 95.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.532 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.65 -51.67 6.36 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.314 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.71 -34.81 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.95 2.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.216 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -88.35 104.96 17.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.01 65.33 2.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 110.035 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.559 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 11.4 m-85 -140.12 178.96 6.91 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.79 120.87 24.66 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.554 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 20.0 t -107.12 126.7 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.678 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.52 139.89 53.38 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.128 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.49 118.74 37.06 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.502 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.1 t0 -72.09 115.44 11.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.527 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.0 t -94.99 6.4 49.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.497 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -124.9 -38.73 2.32 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.097 0.475 . . . . 0.0 110.855 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.0 4.1 72.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -97.91 -20.65 17.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 24' ' ' THR . 74.0 t80 -62.19 -43.77 98.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.949 0.404 . . . . 0.0 110.158 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -58.02 -41.67 83.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.699 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -70.5 -39.52 74.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 111.026 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.21 99.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.317 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.65 -12.98 59.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 68.19 79.9 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.042 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.7 t -110.57 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.346 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.8 m -75.65 -46.52 31.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.2 tp -136.12 132.61 36.3 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.879 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.4 pt -87.38 154.0 53.84 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.668 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 95.2 Cg_endo -80.38 153.71 84.74 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.569 -0.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -116.17 125.97 53.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.326 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 t -101.34 124.93 55.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.8 -175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -124.73 112.63 16.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.729 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.24 128.87 53.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.124 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 76.4 t -106.38 129.72 59.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.678 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.478 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 12.0 t70 -70.68 157.77 37.41 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.922 0.764 . . . . 0.0 109.568 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.32 -25.52 62.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.315 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.28 -25.11 66.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.118 0.485 . . . . 0.0 110.59 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 26.06 6.72 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.644 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.97 157.01 38.89 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 122.491 0.316 . . . . 0.0 110.548 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.28 122.44 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.5 p -109.03 -32.64 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.405 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 58.0 t80 -147.62 131.5 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.297 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.017 0.437 . . . . 0.0 110.17 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.51 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 36.9 t60 -143.57 106.48 4.49 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.5 m -100.41 123.29 44.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.043 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.98 60.11 5.09 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.315 0.886 . . . . 0.0 115.315 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.678 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 27.2 p90 -86.18 -39.53 16.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 117.637 0.719 . . . . 0.0 109.597 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.0 p 73.39 -44.99 0.6 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.979 1.711 . . . . 0.0 113.53 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.07 138.95 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.04 18.65 74.3 Favored Glycine 0 C--N 1.327 0.059 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.848 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.678 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.91 -25.72 19.06 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.452 -177.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -60.93 -25.69 66.95 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.06 94.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 110.391 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.54 -38.32 89.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.511 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.606 ' O ' HG21 ' A' ' 143' ' ' VAL . 10.1 mp -63.33 -47.14 83.46 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.685 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.4 mm -61.63 -41.45 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.7 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.2 ttpp -57.29 -49.94 74.49 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.889 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.5 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 32.9 mmmt -68.39 -38.21 81.13 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 139' ' ' LEU . 52.6 t -58.94 -46.55 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.854 0.359 . . . . 0.0 111.575 -177.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.93 -22.42 42.72 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.638 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.7 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 73.6 mm-40 -66.28 -37.29 85.1 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.513 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 80.6 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.53 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.671 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 94.9 m . . . . . 0 C--O 1.215 -0.723 0 CA-C-O 121.156 0.503 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 54.9 m-85 -124.15 -112.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -171.62 159.57 5.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.447 ' O ' HD11 ' A' ' 124' ' ' ILE . 8.4 tt0 -81.65 80.66 7.93 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.6 mt -120.5 151.75 54.35 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.94 147.86 75.11 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.8 2.333 . . . . 0.0 108.358 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.7 94.77 1.04 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.258 0.551 . . . . 0.0 111.467 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.9 149.33 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.948 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 p -110.21 117.29 33.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.475 HD21 ' HA ' ' A' ' 98' ' ' ASP . 42.3 mt -112.03 175.06 5.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.326 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -105.37 136.59 44.63 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.821 0.343 . . . . 0.0 111.513 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.77 -173.86 2.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.429 HG21 ' HB ' ' A' ' 95' ' ' VAL . 34.0 pt -67.14 -21.02 27.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.357 0.599 . . . . 0.0 110.354 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -86.02 -15.53 41.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.13 20.01 51.02 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -87.96 140.12 29.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.9 m -79.7 115.07 19.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.227 0.537 . . . . 0.0 110.892 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 m -119.39 130.6 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.391 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.3 mt-30 -89.13 134.9 33.84 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.503 HG21 ' CE1' ' A' ' 103' ' ' PHE . 22.8 p -63.69 -30.53 71.62 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.857 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.401 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.9 OUTLIER -78.96 -4.46 50.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.83 -178.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.63 13.78 7.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.1 tp -71.37 112.48 7.54 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.464 -177.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -137.3 143.3 42.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -178.012 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.434 ' O ' ' HB1' ' A' ' 30' ' ' ALA . 35.6 p-10 -112.01 -38.22 4.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 29' ' ' ASN . . . 167.79 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.51 0.506 . . . . 0.0 111.525 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.84 32.63 58.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.496 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -125.04 151.88 69.67 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 122.269 0.228 . . . . 0.0 110.913 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 149.76 89.28 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.245 1.963 . . . . 0.0 110.741 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.6 mtm -135.51 144.91 46.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.587 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.43 122.46 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.33 112.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.04 124.07 48.37 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.47 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -96.11 119.57 34.84 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.984 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -143.57 178.64 7.64 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.529 0.518 . . . . 0.0 111.271 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.2 155.25 25.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.522 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.428 -1.54 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.503 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.223 -0.3 0 CA-C-O 120.701 0.286 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -57.91 -45.75 86.03 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' O ' HG13 ' A' ' 53' ' ' ILE . 77.0 tt0 -55.96 -59.88 4.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.275 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.7 -41.78 99.3 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.871 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 54.8 tptt -64.05 -46.82 82.72 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.66 94.21 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.738 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.1 mt -65.0 -40.94 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.908 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.468 ' HA ' ' OH ' ' A' ' 93' ' ' TYR . 63.9 tt0 -53.61 -39.96 65.36 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 110.984 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 42.9 mm-40 -67.32 -40.24 85.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.18 18.95 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.64 -36.89 82.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.19 84.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.566 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.99 -43.57 98.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.198 0.523 . . . . 0.0 110.388 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -69.23 -42.38 75.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -72.11 -15.23 61.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.909 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.54 -47.95 83.53 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.337 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.21 -49.28 1.44 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.401 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -62.38 -41.02 98.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.528 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.61 31.0 77.3 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.045 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 133.08 30.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 122.532 0.333 . . . . 0.0 111.271 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.403 ' NH2' ' HB2' ' A' ' 29' ' ' ASN . 10.5 mtm180 -104.79 158.22 16.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 78.6 mt -107.14 135.82 48.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.079 0.466 . . . . 0.0 110.629 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.18 110.83 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.11 104.84 16.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.836 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.69 127.62 67.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.553 0.692 . . . . 0.0 111.067 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -91.02 137.27 32.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.539 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.9 pt -73.56 -20.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.997 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -67.79 142.58 56.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.098 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -65.09 176.16 1.36 Allowed 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.614 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.55 -45.82 92.71 Favored Glycine 0 N--CA 1.461 0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.123 -174.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 28.9 pt20 -70.5 -32.44 69.94 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -85.48 -24.12 27.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.165 0.507 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.684 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -85.62 -3.45 58.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.383 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 13.9 pt20 -64.98 -4.42 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.715 -0.615 . . . . 0.0 110.743 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.595 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.9 mttm -97.97 -10.66 24.11 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.355 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 79' ' ' ALA . 13.3 t -64.88 -47.1 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 121.949 0.88 . . . . 0.0 110.822 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.494 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.6 mtpt -65.62 -46.76 68.02 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.248 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.6 Cg_endo -59.51 -29.06 89.05 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.336 1.358 . . . . 0.0 111.32 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.5 mt -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -61.27 -34.29 74.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.69 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -65.94 -29.11 69.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.189 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.18 -49.25 3.56 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.349 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.497 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 12.0 p30 -77.88 -27.04 49.59 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.1 46.38 4.17 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.903 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.6 95.86 4.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 0.0 109.977 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -78.8 42.72 0.46 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.564 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -127.05 168.53 14.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.18 113.38 19.98 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.31 0.576 . . . . 0.0 109.469 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 17' ' ' ILE . 13.7 t -97.31 136.89 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.788 -175.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.2 mp -129.09 148.32 51.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.237 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.485 ' HG ' ' CB ' ' A' ' 79' ' ' ALA . 8.7 mp -114.42 117.73 31.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.141 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.593 ' OD2' ' HG2' ' A' ' 104' ' ' LYS . 11.9 t70 -90.74 114.96 27.44 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.636 172.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.5 m -93.99 -88.97 0.23 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.51 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -112.27 19.46 17.68 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.322 0.582 . . . . 0.0 110.273 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.23 73.52 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.634 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.4 t70 55.05 23.85 5.54 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 109.902 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 24' ' ' THR . 69.5 t80 -62.26 -42.45 99.34 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -177.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.593 ' HG2' ' OD2' ' A' ' 98' ' ' ASP . 11.4 pttm -54.78 -50.72 67.79 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -70.55 -36.12 73.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.659 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.03 87.62 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.074 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 35.8 mmm -82.54 -8.73 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.564 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 76.08 53.64 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.653 0.739 . . . . 0.0 111.553 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.88 129.86 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.38 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -130.98 -71.52 0.57 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.564 ' O ' HG12 ' A' ' 112' ' ' ILE . 52.1 tp -64.35 -39.16 93.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.861 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 111' ' ' LEU . 4.2 pt 64.55 145.21 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 125.081 1.352 . . . . 0.0 111.319 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.625 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.6 Cg_endo -82.29 179.05 27.98 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.933 -0.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.75 142.75 48.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.768 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 128' ' ' HIS . 21.9 t -117.99 126.57 74.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 123.466 0.479 . . . . 0.0 111.36 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 69.9 m-85 -126.44 114.93 18.82 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 64.8 mt -106.06 125.63 61.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-O 121.287 0.565 . . . . 0.0 111.835 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.28 130.6 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.7 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -81.27 -173.32 4.27 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.539 0.524 . . . . 0.0 111.602 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.07 -34.02 88.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.611 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -64.62 -40.59 95.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.163 0.506 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 114.44 33.89 1.68 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.257 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.21 155.05 46.9 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 8' ' ' GLN . 96.7 mt -74.55 108.82 6.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 146' ' ' LEU . 12.2 p -97.91 -29.28 3.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.123 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 89.8 t80 -129.71 132.7 46.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.147 0.499 . . . . 0.0 111.328 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -128.87 127.99 42.94 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.772 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 2.2 t60 -134.27 101.63 5.08 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.1 p -109.7 116.64 32.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.14 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.79 19.05 7.98 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.823 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.625 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -75.98 143.39 41.55 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.513 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.0 p -119.68 -43.3 2.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.236 -0.585 . . . . 0.0 112.019 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -160.32 125.19 3.83 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.11 17.13 41.48 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.025 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.23 -14.86 55.32 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 139' ' ' LEU . 2.2 mp0 -59.75 -26.99 66.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.129 0.49 . . . . 0.0 111.063 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.26 90.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.21 -31.62 71.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.744 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.0 mm? -61.3 -56.66 17.99 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.402 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 tp -66.45 -38.5 81.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 120.914 0.388 . . . . 0.0 111.388 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.26 -48.99 79.39 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.671 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 20.3 tptp -67.6 -31.39 71.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.261 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.1 t -59.33 -44.48 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -67.79 -33.06 74.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.567 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 50.8 mm-40 -56.34 -33.15 65.37 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.153 0.501 . . . . 0.0 109.928 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.409 ' CD2' HG12 ' A' ' 125' ' ' VAL . 84.3 mt . . . . . 0 CA--C 1.531 0.243 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.07 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.518 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.7 m . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 120.812 0.339 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.512 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 60.3 m-85 -87.38 -112.5 0.05 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.082 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . . . -162.89 11.56 0.06 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.566 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 52.58 42.31 31.41 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.995 0.903 . . . . 0.0 110.714 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 44.3 mt -96.6 164.01 19.13 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.406 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.19 157.16 63.06 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.736 2.291 . . . . 0.0 110.854 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.18 82.87 2.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.958 0.409 . . . . 0.0 111.354 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.18 134.85 65.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 p -95.08 114.59 26.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.989 0.423 . . . . 0.0 110.608 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -112.0 172.86 6.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 35.3 mmtm -97.84 131.89 43.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.385 0.612 . . . . 0.0 112.243 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -85.86 166.21 16.19 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.514 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 36.6 pt -61.45 -24.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.344 . . . . 0.0 111.671 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -77.26 -4.9 47.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.57 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.23 16.65 75.9 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -95.68 140.44 30.49 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.891 -0.654 . . . . 0.0 109.827 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.8 m -74.57 120.34 20.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.6 131.72 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.2 mt-30 -91.09 134.93 34.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.901 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.523 HG21 ' CE1' ' A' ' 103' ' ' PHE . 10.2 p -64.33 -31.9 73.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.923 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.36 -10.8 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.703 0.287 . . . . 0.0 111.593 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -119.08 3.49 11.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.09 -0.382 . . . . 0.0 111.214 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.36 109.45 19.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.527 0.68 . . . . 0.0 111.911 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.512 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.8 mt-10 -117.1 132.23 56.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.16 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' ND2' HH21 ' A' ' 67' ' ' ARG . 2.4 t-20 -72.3 -71.19 0.3 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.233 178.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.27 35.74 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.798 0.332 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.43 24.24 59.25 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.165 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -117.93 152.54 50.31 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.251 -0.475 . . . . 0.0 110.25 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.61 151.76 58.75 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.389 2.059 . . . . 0.0 111.893 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -134.98 156.27 49.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.04 0.448 . . . . 0.0 111.571 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 83.7 mt -126.64 126.68 69.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.68 125.36 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 120.688 0.28 . . . . 0.0 110.456 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -110.11 120.06 41.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.861 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.509 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 67.5 m-85 -96.37 121.98 38.76 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.177 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -147.68 169.35 19.88 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.5 0.5 . . . . 0.0 110.818 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.67 140.28 32.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.027 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.438 HG21 ' CG ' ' A' ' 74' ' ' ASP . 15.4 t . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.346 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 111.455 0.169 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.44 -79.58 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.169 0.588 . . . . 0.0 112.118 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 8.5 tm-20 -42.29 -60.58 1.43 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.952 1.701 . . . . 0.0 112.104 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.43 HD12 ' CE2' ' A' ' 93' ' ' TYR . 32.7 tp -61.21 -39.07 88.86 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.576 -176.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.28 -48.69 69.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.259 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.03 97.55 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-O 121.344 0.592 . . . . 0.0 111.072 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.2 mt -64.14 -41.38 92.24 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.86 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -52.81 -38.83 61.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.29 -38.42 87.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.444 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.57 24.33 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 53' ' ' ILE . 83.5 t80 -62.99 -40.63 98.32 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.68 85.11 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.035 0.445 . . . . 0.0 110.383 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.14 -43.3 99.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.247 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.419 ' NE1' HD11 ' A' ' 140' ' ' ILE . 24.8 m0 -65.47 -37.56 87.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -74.5 -9.16 58.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.64 -64.33 0.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -115.78 -39.59 3.48 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.419 HG23 HG13 ' A' ' 143' ' ' VAL . 7.4 m -62.29 -40.23 95.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.32 33.29 86.3 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.111 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.05 138.95 18.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.754 0.311 . . . . 0.0 110.649 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.521 HH21 ' ND2' ' A' ' 29' ' ' ASN . 23.8 mtm180 -123.65 152.87 41.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.052 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.495 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 62.9 mt -96.43 144.88 26.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.1 mt -119.73 112.52 37.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.81 120.1 33.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.682 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.92 130.65 73.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.478 0.656 . . . . 0.0 111.262 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 p -88.77 135.83 33.31 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.487 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.8 pt -82.24 -11.26 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.149 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.438 ' CG ' HG21 ' A' ' 41' ' ' THR . 8.3 m-20 -83.2 149.75 26.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.429 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -58.75 168.57 1.18 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.312 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.0 -35.98 86.19 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 114.28 0.472 . . . . 0.0 114.28 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.45 -53.26 57.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.186 0.493 . . . . 0.0 111.067 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -68.67 -37.94 80.0 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.591 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -66.88 -6.66 17.3 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.589 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.57 -17.57 62.97 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.397 0.617 . . . . 0.0 109.422 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.701 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.6 mttm -93.75 -8.28 41.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.284 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 79' ' ' ALA . 13.6 t -66.45 -46.23 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.73 0.776 . . . . 0.0 110.767 -177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.3 mtpt -62.55 -48.86 85.56 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.872 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -60.6 -29.93 89.51 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.357 1.371 . . . . 0.0 111.403 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.4 mt -63.68 -43.99 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -63.34 -41.92 98.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.494 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.28 -50.1 67.03 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.833 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.61 85.48 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.337 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -73.32 -23.42 60.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.87 0.335 . . . . 0.0 111.607 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.05 39.55 19.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.892 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.582 ' HB3' ' CD2' ' A' ' 93' ' ' TYR . 26.6 m0 -64.4 -47.2 80.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.758 0.313 . . . . 0.0 111.644 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 32.9 tt0 72.11 1.97 4.13 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 2.8 m-85 -88.18 174.15 8.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.11 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.72 137.03 45.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.421 ' C ' HD12 ' A' ' 96' ' ' LEU . 25.5 t -122.66 128.02 75.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.759 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 11.2 mp -124.09 137.36 54.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.703 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.94 116.49 32.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HA ' HD23 ' A' ' 14' ' ' LEU . 49.6 t0 -86.13 113.7 22.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.552 174.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.0 t -97.21 -10.64 25.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.021 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -82.52 -48.39 11.08 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.897 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.61 1.05 78.19 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.17 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -91.97 -24.61 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.79 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.523 ' CE1' HG21 ' A' ' 24' ' ' THR . 81.1 t80 -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 -177.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.67 -33.09 74.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.442 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.8 ttm-85 -69.96 -43.03 72.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.935 0.398 . . . . 0.0 110.468 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.7 91.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.228 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.459 ' HE1' ' HA ' ' A' ' 107' ' ' MET . 2.3 mmt -76.01 -23.72 55.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.991 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t30 72.42 84.29 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.201 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.419 ' HA ' HG21 ' A' ' 129' ' ' THR . 61.9 t -105.65 97.48 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.54 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -73.31 -54.58 8.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.3 tp -138.71 138.05 37.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.652 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.31 154.08 46.62 Favored Pre-proline 0 C--N 1.313 -1.022 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.49 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.2 Cg_endo -76.32 150.36 93.23 Favored 'Cis proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.852 1.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -111.1 136.42 50.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.986 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.25 126.25 74.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.209 0.528 . . . . 0.0 111.969 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -126.37 116.08 20.64 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.943 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 59.9 mt -104.72 131.51 53.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 111.099 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.4 130.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.413 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.02 -175.41 5.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.626 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.67 -16.0 49.44 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.814 -0.63 . . . . 0.0 114.058 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.401 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 48.3 m-80 -88.82 -1.2 57.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.008 0.404 . . . . 0.0 110.576 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 71.2 34.27 64.45 Favored Glycine 0 CA--C 1.501 -0.797 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.653 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 121' ' ' ASN . 28.6 mmtp -124.8 157.78 34.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 83.1 mt -74.79 116.24 17.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.01 -26.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.29 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.509 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 90.3 t80 -147.34 135.74 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.502 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.51 122.05 21.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.968 0.413 . . . . 0.0 110.723 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.509 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.9 t60 -134.56 102.3 5.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.419 HG21 ' HA ' ' A' ' 109' ' ' VAL . 30.3 m -117.63 124.22 48.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.624 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.27 -8.3 13.98 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.702 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -67.13 148.12 52.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.8 p -116.23 -47.29 2.76 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.701 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -156.4 131.94 9.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.667 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.77 15.54 56.34 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.915 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.19 -14.1 56.5 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.75 -18.49 55.08 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.997 0.919 . . . . 0.0 111.943 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.07 -39.21 94.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.467 0.651 . . . . 0.0 111.136 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.57 -32.13 67.75 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.629 ' O ' HG21 ' A' ' 143' ' ' VAL . 11.0 mp -62.47 -48.02 81.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.386 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.419 HD11 ' NE1' ' A' ' 60' ' ' TRP . 5.4 tp -66.21 -37.13 79.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.505 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.653 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.4 ttpp -60.73 -46.54 90.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.683 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.34 -35.69 81.22 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.694 0.283 . . . . 0.0 111.495 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.629 HG21 ' O ' ' A' ' 139' ' ' LEU . 96.0 t -59.93 -44.37 94.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 109.395 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 12.9 mmm180 -69.26 -34.86 75.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.056 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.6 mm-40 -55.75 -42.53 75.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.038 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 52.3 mt . . . . . 0 CA--C 1.533 0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.533 -179.379 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.424 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 18.0 m . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 121.102 0.477 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -87.48 -137.21 0.09 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.697 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -135.17 -23.81 1.47 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.252 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.617 ' NE2' ' HZ2' ' A' ' 123' ' ' LYS . 36.6 tt0 67.38 70.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.691 0.758 . . . . 0.0 111.205 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 162.49 26.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.416 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HG2' ' SD ' ' A' ' 107' ' ' MET . 8.8 Cg_exo -39.93 138.03 1.13 Allowed 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.091 3.194 . . . . 0.0 113.111 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.77 97.24 9.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.099 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.43 134.67 61.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 t -80.1 112.08 17.08 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.913 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' A' ' 98' ' ' ASP . 19.0 mt -121.99 169.85 10.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -105.47 130.13 53.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.813 0.339 . . . . 0.0 111.572 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -83.29 -167.91 1.88 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.043 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.524 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 41.9 pt -71.32 -17.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.23 -14.01 51.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.715 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.64 15.35 76.01 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -93.7 145.67 24.4 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.377 -0.912 . . . . 0.0 109.461 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -74.03 118.67 17.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.349 0.595 . . . . 0.0 110.926 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -128.82 132.44 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.412 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 95.6 mt-30 -95.33 135.21 37.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.543 HG23 ' CE1' ' A' ' 103' ' ' PHE . 15.9 p -61.5 -34.83 76.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.14 -20.69 63.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.02 0.438 . . . . 0.0 111.397 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.08 11.36 20.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 110.719 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.0 tp -97.06 125.19 41.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.289 0.566 . . . . 0.0 111.067 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -125.11 155.66 39.52 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.543 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.7 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 22.8 t-20 -78.97 -75.38 0.24 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.198 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.68 22.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.944 0.402 . . . . 0.0 110.682 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.424 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 97.53 -10.19 64.8 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -105.08 151.45 39.51 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.247 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -65.02 160.1 43.21 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.933 2.422 . . . . 0.0 112.522 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 11.2 ptt? -149.32 164.3 35.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.939 -175.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.41 ' CD1' ' HZ3' ' A' ' 60' ' ' TRP . 76.5 mt -128.46 127.92 67.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 92.9 mt -99.85 115.14 40.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -104.48 130.65 52.39 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.869 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 66.7 m-85 -96.38 121.14 37.86 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.22 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.455 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 24.9 p90 -142.0 164.38 30.32 Favored 'General case' 0 C--O 1.238 0.493 0 O-C-N 123.97 0.793 . . . . 0.0 110.494 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.13 17.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.663 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 29.2 mmt180 -58.48 -46.2 87.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.6 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.553 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.7 pt-20 -62.87 -49.57 74.34 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.038 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.423 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 42.6 tp -62.25 -41.41 98.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.138 -177.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 tttt -63.67 -49.37 73.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.58 96.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.331 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.9 mt -64.4 -42.71 96.12 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -58.77 -36.39 74.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 62.1 mm-40 -66.58 -39.09 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.697 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.26 24.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.884 0.373 . . . . 0.0 111.886 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -58.67 -39.52 80.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.79 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.92 92.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.02 -38.43 90.87 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.638 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.498 ' CZ2' HG12 ' A' ' 140' ' ' ILE . 17.7 m0 -67.6 -37.03 81.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.576 0.703 . . . . 0.0 110.22 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -75.58 -8.11 55.94 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.675 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.09 -43.76 70.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.345 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -142.72 -40.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.958 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.424 HG22 HG11 ' A' ' 143' ' ' VAL . 7.8 m -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.811 0.339 . . . . 0.0 110.313 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.6 24.5 73.94 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 5.6 p -78.37 124.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 122.864 0.465 . . . . 0.0 111.715 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -106.17 165.58 11.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.639 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 84.3 mt -108.06 146.12 33.04 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.279 0.561 . . . . 0.0 111.853 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.511 HG23 HD11 ' A' ' 96' ' ' LEU . 93.7 mt -120.88 110.36 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.201 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -92.45 118.6 31.12 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.0 132.52 68.66 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.3 p -84.17 128.42 34.55 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.254 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.509 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 42.4 pt -76.4 -14.83 14.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 O-C-N 124.78 1.3 . . . . 0.0 111.344 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 7.0 m-20 -77.63 175.76 9.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.075 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -88.69 178.87 6.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.429 ' HA2' HD22 ' A' ' 97' ' ' LEU . . . -58.04 -23.27 51.5 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.987 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.5 -65.09 0.74 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.89 0.376 . . . . 0.0 111.234 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 63.9 m-20 -66.35 -35.33 80.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.691 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.555 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . . . -65.81 -4.72 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -64.48 -9.37 18.2 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.311 0.577 . . . . 0.0 110.523 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.77 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 94.4 mttt -92.98 -12.75 29.95 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.745 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 79' ' ' ALA . 50.6 t -64.88 -49.71 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 13.1 mptt -68.76 -41.6 21.62 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 14.5 Cg_endo -60.3 -31.06 92.39 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.025 1.15 . . . . 0.0 110.946 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.77 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.7 mt -63.72 -40.92 97.96 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.305 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.431 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -54.72 -48.25 72.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.619 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.91 -42.94 84.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.88 82.87 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.774 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -99.59 3.3 45.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.26 43.34 93.13 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.4 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.431 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.1 m0 -82.33 98.85 9.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.231 0.539 . . . . 0.0 110.159 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -86.5 44.95 1.19 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.005 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -145.89 -176.91 5.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -71.77 136.65 47.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.306 0.574 . . . . 0.0 111.505 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.69 130.31 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.231 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 69' ' ' ILE . 10.6 mp -122.03 154.71 36.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.642 0.734 . . . . 0.0 111.695 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.555 ' HG ' ' CB ' ' A' ' 79' ' ' ALA . 8.8 tt -125.43 113.95 18.19 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.868 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.553 ' HA ' HD21 ' A' ' 14' ' ' LEU . 66.5 t0 -77.6 117.24 18.84 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 118.175 -1.41 . . . . 0.0 108.439 174.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -88.06 -32.3 18.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.413 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -79.02 -38.28 37.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.726 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.64 12.02 76.03 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.56 -6.04 15.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.543 ' CE1' HG23 ' A' ' 24' ' ' THR . 79.6 t80 -64.24 -39.5 94.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.192 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.509 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 24.5 pttm -59.62 -37.2 77.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.269 176.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -70.5 -41.49 72.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.667 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.62 92.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.942 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.585 ' SD ' ' HG2' ' A' ' 10' ' ' PRO . 42.0 mmm -88.66 -11.89 44.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.72 83.3 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.741 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.3 109.1 20.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -69.83 -58.53 3.76 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.175 0.512 . . . . 0.0 110.052 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.459 ' HB3' ' HA2' ' A' ' 130' ' ' GLY . 59.5 tp -143.47 136.28 27.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.6 pt -83.27 153.08 65.73 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -74.77 155.91 99.91 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.767 -1.347 . . . . 0.0 112.777 0.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -120.32 130.55 54.49 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.877 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.449 HG23 ' CD ' ' A' ' 49' ' ' GLU . 21.7 t -112.0 129.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.39 0.431 . . . . 0.0 111.997 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.14 113.7 15.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.039 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.7 mt -102.93 129.83 54.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-O 121.245 0.545 . . . . 0.0 110.791 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.18 131.52 63.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.827 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.3 165.34 23.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.632 0.582 . . . . 0.0 110.851 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.81 -21.39 51.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.208 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -73.3 -9.2 58.45 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.999 0.4 . . . . 0.0 111.105 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.23 18.56 45.69 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.951 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.617 ' HZ2' ' NE2' ' A' ' 8' ' ' GLN . 4.0 mptp? -125.56 150.39 47.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.891 0.346 . . . . 0.0 110.612 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.697 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.1 mt -65.07 125.97 23.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.439 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.72 -18.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 89.3 t80 -150.56 132.08 14.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.924 0.392 . . . . 0.0 111.707 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -128.64 128.92 45.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.832 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . 0.543 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.7 t60 -133.26 108.94 9.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.819 0.342 . . . . 0.0 110.828 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 p -120.94 135.14 55.27 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.838 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 111' ' ' LEU . . . 103.93 0.39 45.24 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.393 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.56 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -82.52 149.14 27.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.1 p -123.79 -47.65 1.93 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.986 0.422 . . . . 0.0 110.735 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.481 ' HB3' ' HE ' ' A' ' 48' ' ' ARG . 11.0 pt-20 -160.59 144.74 13.93 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.147 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.49 72.17 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.89 -13.93 55.77 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -60.21 -26.2 66.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.066 0.546 . . . . 0.0 111.234 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.88 90.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.587 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.62 -38.54 87.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.992 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 143' ' ' VAL . 10.9 mp -62.14 -52.4 64.0 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.457 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.498 HG12 ' CZ2' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -65.47 -38.89 83.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 -175.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.703 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 40.0 ttmt -59.57 -53.28 59.94 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.528 ' HD3' ' HB2' ' A' ' 126' ' ' TYR . 64.5 tttt -69.47 -30.3 68.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.066 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 139' ' ' LEU . 55.8 t -58.91 -46.06 91.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.923 0.392 . . . . 0.0 110.178 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 5.5 mmm180 -71.77 -34.61 69.59 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.767 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.703 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 5.7 mm-40 -56.01 -34.64 65.99 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 62.7 mt . . . . . 0 C--O 1.227 -0.108 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.475 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 7.4 t . . . . . 0 CA--C 1.565 1.542 0 CA-C-O 120.991 0.424 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 76.7 m-85 -117.88 1.25 12.07 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.032 0.444 . . . . 0.0 111.123 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 74.61 11.55 3.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.258 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 54.82 36.48 26.57 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.772 0.796 . . . . 0.0 110.501 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.45 153.79 73.86 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.346 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.16 157.43 61.77 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.093 2.529 . . . . 0.0 111.132 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.98 82.45 2.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.0 133.46 68.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.129 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -91.35 105.0 17.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.03 0.443 . . . . 0.0 110.629 -177.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mp -100.54 176.47 5.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.313 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -114.61 125.15 53.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -90.28 -172.46 3.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.253 0.549 . . . . 0.0 112.19 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.563 ' HA ' ' CD ' ' A' ' 83' ' ' LYS . 37.5 pt -65.01 -28.6 45.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.308 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.62 -25.93 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.413 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.83 49.27 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -100.03 144.26 29.28 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.459 -0.87 . . . . 0.0 110.148 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.24 106.17 13.01 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.23 137.87 56.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.135 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.593 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 37.5 mt-30 -89.16 139.2 30.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.428 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 p -65.32 -32.17 73.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.96 -14.41 62.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.847 0.356 . . . . 0.0 111.29 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -116.62 5.85 13.31 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.645 -179.15 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -92.57 120.25 32.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 5' ' ' THR . 4.9 pt-20 -118.68 145.26 45.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.136 0.493 . . . . 0.0 111.94 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 26.5 t-20 -76.13 -67.81 0.64 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.924 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 169.23 -25.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.032 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.12 -6.57 1.55 Allowed Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.084 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -97.21 151.6 37.78 Favored Pre-proline 0 C--N 1.315 -0.926 0 C-N-CA 122.765 0.426 . . . . 0.0 110.774 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.6 Cg_exo -66.66 158.64 54.95 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.971 2.447 . . . . 0.0 112.427 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.448 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 4.1 ptt? -147.46 154.68 41.11 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.637 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.435 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.1 mt -125.91 130.77 72.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.5 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -110.93 118.75 36.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.443 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 38.8 m-85 -95.29 117.75 30.84 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -144.41 168.76 19.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 123.73 0.644 . . . . 0.0 110.506 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.69 146.26 29.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.74 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.471 HG21 ' OD2' ' A' ' 74' ' ' ASP . 13.4 t . . . . . 0 C--N 1.313 -0.988 0 CA-C-O 121.079 0.466 . . . . 0.0 110.879 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 120.869 0.366 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.403 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 14.8 mmm180 -58.08 -44.78 87.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.274 0.559 . . . . 0.0 110.713 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.501 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.4 tm-20 -62.8 -55.19 28.66 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.536 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.493 HD11 ' CE2' ' A' ' 93' ' ' TYR . 33.2 tp -65.4 -41.06 94.06 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.45 -48.51 77.41 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.8 89.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.093 0.473 . . . . 0.0 110.881 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.5 mt -63.76 -41.07 91.36 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.844 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.928 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -50.78 -40.46 55.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.882 0.373 . . . . 0.0 110.829 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -70.42 -40.82 73.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -110.24 21.15 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.433 ' HH ' ' NE2' ' A' ' 61' ' ' GLN . 83.3 t80 -62.14 -40.46 96.03 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.646 -176.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.01 82.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.813 0.339 . . . . 0.0 110.395 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.87 -41.79 99.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.269 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -69.26 -38.93 78.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.572 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.433 ' NE2' ' HH ' ' A' ' 57' ' ' TYR . 39.8 mt-30 -77.88 -8.34 57.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.59 -50.23 68.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.254 0.346 . . . . 0.0 111.758 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.46 -38.2 1.19 Allowed 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.314 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.427 HG21 HG11 ' A' ' 143' ' ' VAL . 9.5 m -63.57 -41.48 98.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.07 78.56 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.247 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 8.3 p -74.63 137.26 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.773 0.321 . . . . 0.0 111.763 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.41 ' HG2' HE21 ' A' ' 61' ' ' GLN . 44.4 mtm-85 -115.46 169.15 9.38 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 78.5 mt -114.11 139.95 48.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.305 0.574 . . . . 0.0 111.319 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 96' ' ' LEU . 88.6 mt -111.78 99.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.96 115.63 24.48 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.9 129.49 75.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.346 0.593 . . . . 0.0 110.737 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.7 t -89.34 136.27 33.12 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.477 ' HB ' ' HE3' ' A' ' 104' ' ' LYS . 46.3 pt -75.25 -19.02 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.616 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' OD2' HG21 ' A' ' 41' ' ' THR . 13.4 m-20 -72.2 142.99 49.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.559 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 60.0 mt-10 -68.5 171.05 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -52.71 -41.81 58.08 Favored Glycine 0 C--N 1.329 0.159 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -172.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.97 -55.59 27.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.23 0.515 . . . . 0.0 111.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -69.96 -36.97 75.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.948 0.404 . . . . 0.0 111.704 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.611 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.01 -4.19 9.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 27.3 mt-30 -61.25 -10.12 6.27 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.761 -0.587 . . . . 0.0 110.892 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.633 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.4 mttm -92.85 -13.04 29.57 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.538 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -65.54 -46.21 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.588 0.709 . . . . 0.0 111.249 -177.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.563 ' CD ' ' HA ' ' A' ' 17' ' ' ILE . 28.7 mtmt -73.65 -37.68 3.62 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.0 Cg_endo -61.61 -31.08 86.7 Favored 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 120.372 1.168 . . . . 0.0 110.058 171.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -63.94 -42.4 97.34 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.471 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -57.48 -47.68 81.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.775 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.98 -45.65 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.144 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.48 92.04 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.204 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.54 -33.32 66.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.56 50.29 2.98 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.019 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.471 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 45.6 m0 -80.77 122.59 27.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.06 0.457 . . . . 0.0 109.949 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.67 32.88 1.17 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.041 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.493 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -139.63 171.07 14.77 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.285 -0.259 . . . . 0.0 110.797 -176.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.15 136.25 37.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.057 0.455 . . . . 0.0 111.249 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.8 t -118.17 131.14 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.031 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.405 HD11 HG23 ' A' ' 69' ' ' ILE . 10.2 mp -121.2 145.82 47.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.362 0.601 . . . . 0.0 111.201 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 79' ' ' ALA . 7.6 mp -112.91 119.58 38.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 64.7 t0 -85.5 114.39 22.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 117.846 -1.542 . . . . 0.0 108.715 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.1 t -93.24 -3.87 52.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.147 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -103.22 -58.3 1.9 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.398 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 104' ' ' LYS . . . 100.53 -13.25 59.73 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -64.08 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.416 0.686 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.4 -42.25 98.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.869 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.477 ' HE3' ' HB ' ' A' ' 73' ' ' ILE . 4.4 mtpm? -59.16 -43.78 92.12 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -68.26 -39.01 82.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.696 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.19 79.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.697 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 25.8 mmt -88.9 -7.38 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.207 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 57.91 52.78 7.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 0.0 110.539 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.77 89.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -77.05 -49.36 15.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.964 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 tp -127.35 138.65 53.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.291 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.1 pt -102.21 154.19 37.56 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.418 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 84.5 Cg_endo -78.62 147.05 80.76 Favored 'Cis proline' 0 C--O 1.241 0.635 0 C-N-CA 123.619 -1.409 . . . . 0.0 112.108 -0.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -108.94 138.06 45.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -122.92 131.4 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 84.3 m-85 -128.63 118.32 22.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.007 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.95 131.92 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.159 0.504 . . . . 0.0 110.694 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 34' ' ' MET . 53.6 t -115.61 134.0 60.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.925 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.49 -175.15 4.61 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.414 0.446 . . . . 0.0 111.509 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.16 89.22 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.31 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.25 -14.59 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.504 0.669 . . . . 0.0 110.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 85.17 41.64 7.4 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.949 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -121.76 155.81 34.48 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 7' ' ' ALA . 89.7 mt -77.43 125.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 p -120.03 -30.06 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.835 0.35 . . . . 0.0 111.902 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.573 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.6 t80 -121.86 126.83 49.63 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 122.175 -0.328 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.516 ' ND2' ' HE2' ' A' ' 116' ' ' PHE . 9.0 t-20 -131.85 109.31 10.02 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.334 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -147.82 109.03 4.28 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.072 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 p -91.23 106.14 18.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.608 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.2 72.08 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.596 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.566 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 31.7 p90 -70.85 -42.83 69.63 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.353 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.435 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 27.0 p 49.81 84.64 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.912 -1.494 . . . . 0.0 113.392 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 64.85 112.82 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.227 1.011 . . . . 0.0 112.8 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.08 -8.87 50.05 Favored Glycine 0 CA--C 1.51 -0.24 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.566 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -68.65 -37.88 85.29 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.344 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -52.89 -30.86 36.61 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.913 0.885 . . . . 0.0 111.531 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.56 99.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.481 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -73.82 -29.82 62.36 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.379 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -61.36 -48.43 81.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.926 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.6 tp -66.68 -36.04 76.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.591 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -57.92 -48.03 81.11 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.416 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.695 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 20.8 mttp -76.85 -22.19 53.91 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 139' ' ' LEU . 77.0 t -60.64 -44.28 96.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -68.51 -36.85 79.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.031 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -63.43 -30.59 71.69 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 120.649 0.261 . . . . 0.0 110.855 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.5 mt . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 121.376 0.608 . . . . 0.0 109.665 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.514 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 6.9 m . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 121.575 0.703 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 71.3 m-85 -97.57 -122.89 0.13 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.779 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -152.23 14.04 0.59 Allowed 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.377 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 47.6 tt0 50.43 33.8 8.26 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.619 0.723 . . . . 0.0 111.424 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.8 mt -83.28 151.43 62.78 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.005 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.18 150.38 79.83 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.925 2.416 . . . . 0.0 110.559 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.74 84.69 2.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.987 0.422 . . . . 0.0 111.698 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.3 t -125.75 133.67 68.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 p -86.84 103.92 15.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.773 0.321 . . . . 0.0 111.176 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.0 mt -99.6 176.31 5.52 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -112.88 134.06 54.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.563 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -86.46 165.55 16.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.966 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 pt -67.7 -17.35 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -84.24 -3.67 58.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.858 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.97 78.07 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.76 142.5 27.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.247 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -82.18 111.86 18.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.417 0.627 . . . . 0.0 110.01 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -116.11 128.32 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.643 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.533 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.1 mt-30 -89.58 134.34 34.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.417 HG22 ' CE1' ' A' ' 103' ' ' PHE . 8.5 p -65.85 -29.85 70.37 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -68.55 -20.7 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.936 0.398 . . . . 0.0 110.942 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.21 13.95 20.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.978 179.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.65 102.66 3.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.239 0.543 . . . . 0.0 112.01 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.442 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 46.5 mt-10 -114.78 104.24 11.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.361 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -71.56 -44.9 63.71 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.44 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.514 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 64.4 31.48 81.0 Favored Glycine 0 C--O 1.227 -0.306 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.177 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -128.55 153.6 79.43 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 123.106 0.562 . . . . 0.0 109.717 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.592 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 32.0 Cg_exo -56.59 146.78 73.97 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 122.264 1.976 . . . . 0.0 111.563 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.41 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 25.2 mtt -135.18 170.6 15.67 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.068 -173.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 68' ' ' LEU . 7.6 tt -150.1 127.11 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.433 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.1 mt -101.61 126.05 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.122 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -104.15 111.83 24.59 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.398 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.518 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 23.6 m-85 -94.03 119.58 33.1 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.18 168.54 20.13 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.843 0.714 . . . . 0.0 110.717 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.7 -167.59 0.72 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.113 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 74' ' ' ASP . 16.7 p . . . . . 0 C--N 1.316 -0.852 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.43 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.1 mt . . . . . 0 CA--C 1.516 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -58.23 -41.75 84.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.029 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 tm-20 -62.93 -58.73 6.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.136 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.408 HD13 ' CE2' ' A' ' 93' ' ' TYR . 40.4 tp -62.68 -41.47 99.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.238 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.54 -46.71 87.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.87 92.72 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.099 0.476 . . . . 0.0 110.663 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.4 mt -68.71 -33.24 58.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.438 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -56.23 -27.72 55.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.226 0.536 . . . . 0.0 110.377 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -85.55 -41.23 15.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.881 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.7 15.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 84.1 t80 -61.07 -40.63 94.4 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.672 0.272 . . . . 0.0 111.511 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.39 80.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.082 0.468 . . . . 0.0 110.42 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.38 -41.26 98.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.053 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.427 ' NE1' HD11 ' A' ' 140' ' ' ILE . 20.7 m0 -69.88 -36.13 75.22 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.481 0.658 . . . . 0.0 110.441 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -78.04 -7.12 56.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.118 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -53.99 -50.81 65.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.836 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 -30.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.204 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 m -62.53 -41.85 99.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 0.0 111.413 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.91 25.06 74.78 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.061 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -77.53 133.75 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.577 0.227 . . . . 0.0 111.086 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtm-85 -117.67 148.16 42.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.65 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.524 ' HA ' HG22 ' A' ' 35' ' ' ILE . 78.2 mt -86.37 135.46 33.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.577 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 75.0 mt -112.84 101.42 12.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.27 103.6 14.36 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.171 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.5 127.3 73.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.501 0.667 . . . . 0.0 111.883 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -89.13 138.81 31.09 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.836 176.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.564 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 38.1 pt -90.86 -3.89 10.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 O-C-N 125.133 1.521 . . . . 0.0 113.615 -171.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.401 ' HB2' ' CG2' ' A' ' 41' ' ' THR . 21.4 m-20 -86.38 176.7 7.74 Favored 'General case' 0 C--O 1.214 -0.763 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.423 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.49 176.21 9.1 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.512 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -60.99 -34.04 86.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.661 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.21 -55.0 40.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.269 0.557 . . . . 0.0 110.813 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -67.93 -37.27 81.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.014 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -70.63 -5.0 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 81.1 mt-30 -61.87 -19.51 62.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.691 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 51.8 mtmt -90.02 -10.61 44.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.815 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 79' ' ' ALA . 57.7 t -63.89 -47.75 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.0 mptp? -73.71 -38.71 4.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.9 Cg_endo -60.37 -32.91 94.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 119.909 1.003 . . . . 0.0 110.283 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.2 mt -64.52 -42.39 95.82 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.625 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -56.73 -50.36 72.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.675 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -68.35 -44.52 75.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.756 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.81 98.14 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.172 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -79.87 -32.66 40.41 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.69 45.98 3.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.217 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.625 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 40.2 m0 -82.79 114.52 21.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 111.054 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.18 37.38 0.72 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.502 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.449 ' CE1' HD11 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -130.58 167.03 19.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.28 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.36 116.97 19.16 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.805 0.812 . . . . 0.0 110.313 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.452 HG12 ' HZ2' ' A' ' 83' ' ' LYS . 15.5 t -98.88 132.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.356 -177.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 tp -109.87 163.28 13.68 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.401 ' HB2' ' HE2' ' A' ' 83' ' ' LYS . 11.7 tp -126.68 99.63 5.86 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -75.57 117.57 17.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 117.542 -1.663 . . . . 0.0 108.101 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 p -97.79 -5.22 35.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.152 0.501 . . . . 0.0 110.954 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -101.02 -42.17 6.5 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.701 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.8 5.23 89.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -97.51 -14.66 20.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.787 0.327 . . . . 0.0 111.312 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CE1' HG22 ' A' ' 24' ' ' THR . 44.9 t80 -64.42 -38.54 91.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.844 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.564 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 22.1 pttm -55.41 -44.32 76.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.801 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -65.68 -42.94 90.69 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.249 0.547 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.59 85.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -86.23 -3.68 59.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.619 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.71 36.35 2.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.512 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -73.07 88.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.646 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 t -74.31 -45.68 45.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.613 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.85 149.98 50.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.169 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.2 pt -105.86 155.33 38.47 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.44 142.23 68.12 Favored 'Cis proline' 0 C--O 1.239 0.561 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.603 -0.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -106.11 132.58 52.02 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.11 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.426 HG23 HD21 ' A' ' 139' ' ' LEU . 70.9 t -117.8 129.66 73.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 94.1 m-85 -125.48 115.66 20.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.416 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.8 mt -101.28 130.03 51.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.166 0.508 . . . . 0.0 110.51 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.41 ' HB ' ' H ' ' A' ' 34' ' ' MET . 74.2 t -103.91 131.06 53.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.705 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -83.52 -175.53 5.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.12 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.88 8.29 37.59 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.1 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -111.44 -1.27 15.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.683 0.754 . . . . 0.0 109.475 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.87 23.83 63.3 Favored Glycine 0 CA--C 1.504 -0.638 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.206 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 8.3 mptt -115.89 163.15 16.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.848 0.356 . . . . 0.0 110.484 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.45 102.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.298 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.25 -35.37 9.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.74 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.495 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 76.2 t80 -137.45 133.11 34.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.707 0.289 . . . . 0.0 110.861 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -141.22 124.6 16.62 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.153 0.502 . . . . 0.0 110.649 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -141.53 116.11 9.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.601 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 p -96.61 109.01 21.71 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.41 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.47 64.12 2.84 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.821 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.715 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.5 p90 -63.57 -41.54 98.38 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.321 0.581 . . . . 0.0 109.934 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' THR . . . . . 0.425 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 79.8 p 56.35 79.23 0.18 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.633 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 70.7 113.55 0.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.793 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.0 13.22 46.96 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.938 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.715 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -92.1 -36.88 6.15 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.501 -0.38 . . . . 0.0 112.474 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.2 pm0 -60.37 -18.9 53.44 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.984 0.513 . . . . 0.0 112.284 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.95 94.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.88 -33.52 68.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.593 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.649 ' O ' HG21 ' A' ' 143' ' ' VAL . 10.8 mp -60.98 -50.62 72.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.265 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.557 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.3 tp -66.24 -39.19 83.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.4 ttpp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.582 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 14.8 tptp -66.87 -33.95 76.73 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.152 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.649 HG21 ' O ' ' A' ' 139' ' ' LEU . 72.9 t -60.01 -44.84 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.33 0.586 . . . . 0.0 109.62 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 22.6 mmm180 -71.41 -23.61 61.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.43 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 55.9 mm-40 -62.06 -38.5 89.03 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 109.479 175.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.462 0.134 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 178.341 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.497 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 26.0 m . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.881 0.372 . . . . 0.0 111.656 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -102.78 -134.11 0.31 Allowed 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.707 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -137.73 -4.01 1.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.609 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 54.52 74.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.656 0.741 . . . . 0.0 110.25 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.4 mt -122.67 162.1 40.35 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.7 148.92 91.95 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.141 1.894 . . . . 0.0 110.215 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.24 80.19 0.99 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.211 0.529 . . . . 0.0 111.307 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.5 134.53 65.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.219 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -92.89 113.17 25.37 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.566 HD22 ' HA ' ' A' ' 98' ' ' ASP . 29.1 mt -110.9 176.59 4.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -110.12 134.52 52.1 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.313 0.577 . . . . 0.0 112.017 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -75.97 177.02 7.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.325 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.427 HG23 ' HB ' ' A' ' 95' ' ' VAL . 33.3 pt -55.0 -41.53 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -81.44 -8.41 59.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.12 20.18 31.25 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.21 -176.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -78.3 141.18 38.67 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 m -78.66 108.24 11.92 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.007 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.58 134.4 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.219 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.485 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 77.9 mt-30 -100.9 134.75 43.41 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.581 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -64.74 -30.24 71.24 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -72.09 -13.15 61.5 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -125.12 14.88 8.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.2 tp -74.69 125.03 27.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.4 OUTLIER -136.69 140.23 42.53 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -101.22 -48.87 4.25 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.597 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 168.73 31.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.735 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.497 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 71.38 36.09 63.2 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.581 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 46.1 mmtm -128.39 151.2 76.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.879 -0.16 . . . . 0.0 111.262 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.69 151.66 82.45 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.691 2.261 . . . . 0.0 111.547 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.441 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 38.4 mtt -131.75 152.77 50.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -172.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.9 mt -130.22 118.13 42.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.413 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 86.0 mt -94.12 123.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.5 m -112.39 116.97 31.18 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.252 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 53.8 m-85 -88.16 111.22 21.37 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.401 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 30.7 p90 -123.86 154.72 39.26 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 123.68 0.613 . . . . 0.0 110.776 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.42 153.15 23.57 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.124 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.475 -177.788 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.236 0.358 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -64.63 -39.91 94.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.32 -176.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.646 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -64.34 -48.54 75.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.729 -179.213 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.404 HD11 ' CE2' ' A' ' 93' ' ' TYR . 52.2 tp -63.62 -42.38 98.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.71 -46.32 88.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.963 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -61.91 -40.7 96.36 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.258 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.1 mt -64.79 -41.43 92.18 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.646 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -54.34 -30.97 53.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.24 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -79.47 -31.86 42.47 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 52' ' ' ALA . 16.1 m -122.42 23.68 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.0 t80 -63.37 -41.56 98.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.312 -0.242 . . . . 0.0 111.206 -177.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.3 83.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.164 0.507 . . . . 0.0 110.185 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.414 ' OD1' ' HA ' ' A' ' 56' ' ' VAL . 6.7 m-20 -64.68 -43.1 94.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.39 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.476 ' NE1' HD13 ' A' ' 140' ' ' ILE . 19.0 m0 -70.05 -37.77 75.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -79.13 -6.81 57.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.869 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.2 -49.65 66.31 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.739 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -160.54 73.82 0.51 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.523 0.678 . . . . 0.0 110.27 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -158.95 -41.64 0.06 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.345 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 32' ' ' LYS . . . 72.02 32.1 63.67 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.479 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.27 121.51 42.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.076 0.465 . . . . 0.0 110.914 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -105.85 164.19 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.687 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.1 mt -105.37 134.48 48.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.499 . . . . 0.0 111.568 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.1 mt -109.56 109.17 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 39' ' ' PHE . . . -95.71 123.72 39.41 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.233 -178.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.73 131.6 72.76 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.378 0.609 . . . . 0.0 111.32 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.415 ' CB ' HG23 ' A' ' 82' ' ' VAL . 17.0 p -83.57 134.53 34.81 Favored 'General case' 0 C--O 1.257 1.473 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.242 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.7 pt -78.9 -14.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.698 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 178.51 5.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.06 179.7 5.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.507 ' HA2' HD22 ' A' ' 97' ' ' LEU . . . -59.3 -33.1 74.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.943 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -63.54 -47.11 82.97 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -89.99 -29.63 18.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.415 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -69.6 -3.68 15.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -59.52 -24.04 63.33 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 121.798 -0.564 . . . . 0.0 111.274 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.718 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 73.9 mmtt -88.69 -1.21 57.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 95.4 t -65.49 -46.71 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -67.41 -42.77 39.72 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.886 -176.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.7 Cg_endo -62.2 -29.84 81.06 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 121.104 1.203 . . . . 0.0 110.902 175.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -62.88 -41.6 99.46 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -59.7 -42.38 92.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.698 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -45.41 65.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.76 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.57 -36.72 92.82 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.126 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -92.58 5.2 51.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.31 40.86 91.92 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.263 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.593 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 51.1 m0 -88.32 95.45 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.87 59.85 5.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.348 0.594 . . . . 0.0 110.737 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -137.56 -172.41 3.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.35 134.35 35.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.427 ' HB ' HG23 ' A' ' 17' ' ' ILE . 42.8 t -119.95 132.66 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.536 0.684 . . . . 0.0 110.738 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -120.16 152.25 37.93 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.451 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.55 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 10.1 tt -120.71 117.78 28.38 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.377 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.566 ' HA ' HD22 ' A' ' 14' ' ' LEU . 13.3 t0 -81.52 117.25 21.77 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.762 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 t -113.86 -11.18 12.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.476 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 1.6 m120 -84.83 -41.69 15.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 110.726 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.488 ' HA2' ' NZ ' ' A' ' 104' ' ' LYS . . . 94.92 -18.32 57.53 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.59 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 100' ' ' ASN . 5.2 p-10 -91.38 -8.55 47.66 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.581 ' CE1' HG21 ' A' ' 24' ' ' THR . 88.0 t80 -63.85 -49.14 73.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.184 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.488 ' NZ ' ' HA2' ' A' ' 101' ' ' GLY . 13.1 pttm -62.42 -36.15 81.46 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.961 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -66.91 -43.54 83.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.283 0.563 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.86 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.939 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.444 ' HE2' ' HA ' ' A' ' 107' ' ' MET . 1.7 mmt -78.5 -7.91 57.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.243 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.54 43.09 3.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.67 0.748 . . . . 0.0 111.043 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.23 98.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.328 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -85.83 -66.4 0.91 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.564 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 57.2 tp -107.89 129.65 55.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 pt -85.55 148.16 48.47 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 85.2 Cg_endo -82.75 166.91 67.92 Favored 'Cis proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.242 -1.149 . . . . 0.0 112.882 0.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -125.75 144.36 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.724 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.97 131.69 70.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 86.5 m-85 -126.64 124.15 39.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.4 mt -109.77 129.21 65.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.178 0.513 . . . . 0.0 110.467 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 34' ' ' MET . 85.5 t -103.62 128.74 56.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 20.3 t70 -75.88 162.73 27.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.653 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.59 -22.6 52.98 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.878 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -69.46 -18.87 63.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.996 0.426 . . . . 0.0 110.882 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 93.88 31.14 8.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.192 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.78 154.61 51.53 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.707 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.3 mt -69.9 123.87 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.371 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 13.7 p -105.08 -30.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.9 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.5 t80 -132.89 125.26 29.53 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.019 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -131.24 122.35 26.35 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.274 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -145.39 107.9 4.43 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.846 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.3 p -102.15 107.19 18.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.658 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 114.92 74.65 0.6 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.767 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.618 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -126.76 156.76 40.69 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 32.6 p -124.92 -58.46 1.47 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.015 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -144.39 136.07 25.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.418 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 3.98 63.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.288 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.18 -20.96 53.94 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.077 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.17 -22.7 64.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.271 0.558 . . . . 0.0 111.116 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.3 94.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.038 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -71.49 -31.63 67.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.694 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -61.64 -48.88 78.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.276 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.476 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.1 tp -67.96 -38.11 79.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.34 -42.25 98.37 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.526 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.9 mmpt? -65.45 -40.39 93.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 139' ' ' LEU . 99.2 t -59.84 -46.68 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.359 0.6 . . . . 0.0 110.213 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -66.94 -36.32 81.96 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.517 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -60.38 -34.1 73.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.58 0.229 . . . . 0.0 111.207 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 59.2 mt . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.209 0.528 . . . . 0.0 109.921 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 16.3 m . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.646 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 43.5 m-85 -82.85 -140.39 0.05 Allowed 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.411 0.624 . . . . 0.0 109.791 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.6 12.89 1.17 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.843 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 49.33 60.76 3.53 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.654 0.74 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.2 mt -112.56 158.8 36.36 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.427 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.0 159.21 53.06 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.049 2.5 . . . . 0.0 110.681 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.22 82.34 2.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.04 134.96 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.572 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.0 p -92.76 108.13 19.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.979 0.418 . . . . 0.0 111.131 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -112.58 174.93 5.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.592 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -108.81 136.57 48.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.793 0.33 . . . . 0.0 110.799 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -90.86 -171.43 3.01 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.783 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.19 -20.04 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -86.0 -21.65 27.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.243 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.98 10.35 58.75 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -175.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -85.85 146.33 26.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -74.4 116.91 15.6 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.404 0.621 . . . . 0.0 109.828 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.485 ' HB ' HD22 ' A' ' 27' ' ' LEU . 3.3 m -117.52 128.04 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.404 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.542 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 48.5 mt-30 -90.01 132.17 35.51 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.457 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 15.0 p -65.9 -29.47 69.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.629 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.44 -34.44 78.19 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -98.39 5.23 48.33 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 85.5 mt -73.51 117.0 14.75 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.734 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -132.5 154.18 50.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.566 177.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.58 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 63.3 t30 -89.52 -80.95 0.29 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.783 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 172.57 32.33 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.633 0.583 . . . . 0.0 110.755 -176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.66 -14.76 62.8 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -100.14 143.42 26.48 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.7 164.73 34.73 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.209 2.606 . . . . 0.0 112.846 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 73.4 mtm -138.69 160.5 39.48 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.729 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.48 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 73.1 mt -129.43 125.67 62.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.8 mt -97.11 126.78 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 m -114.47 122.24 45.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.188 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 73.1 m-85 -97.45 115.06 27.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -135.55 163.04 31.0 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.86 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.86 162.93 13.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.486 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 CA--C 1.54 0.571 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.296 -178.861 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.226 -0.157 0 CA-C-O 121.169 0.509 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.51 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 23.4 mmm180 -58.87 -48.95 79.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.247 -175.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.587 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.38 -52.62 31.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.614 -176.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.475 HD11 ' CE1' ' A' ' 93' ' ' TYR . 29.8 tp -63.55 -42.27 98.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.824 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -66.61 -49.53 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.69 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.517 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -63.21 -42.65 99.31 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.233 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.1 mt -64.03 -43.04 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.411 ' HB2' ' OH ' ' A' ' 93' ' ' TYR . 9.0 tt0 -59.23 -40.32 85.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.679 0.276 . . . . 0.0 110.846 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -66.7 -37.21 84.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 52' ' ' ALA . 31.3 m -107.36 19.17 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.071 0.462 . . . . 0.0 111.19 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -58.15 -40.49 81.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.883 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.6 81.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.619 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.43 -41.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.525 ' CH2' HG12 ' A' ' 53' ' ' ILE . 16.8 m0 -73.58 -42.42 61.62 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.253 0.549 . . . . 0.0 110.552 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -70.36 -9.8 57.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.208 0.603 . . . . 0.0 111.941 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.5 -49.35 64.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.063 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -136.6 -36.32 0.71 Allowed 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.036 -0.666 . . . . 0.0 112.77 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.461 HG22 HG12 ' A' ' 143' ' ' VAL . 17.6 m -65.74 -43.32 89.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.813 0.34 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.65 41.98 99.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.775 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.8 p -91.33 117.71 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -94.5 162.98 13.59 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.503 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.48 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 62.7 mt -105.47 148.19 27.46 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.265 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.578 HD13 ' SD ' ' A' ' 34' ' ' MET . 88.9 mt -122.11 110.82 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.39 111.15 22.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.412 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.482 HG21 ' HZ1' ' A' ' 104' ' ' LYS . 9.0 p -116.59 123.49 71.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 CA-C-O 121.587 0.708 . . . . 0.0 111.555 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.478 ' HB2' HG21 ' A' ' 82' ' ' VAL . 35.4 t -80.06 131.89 35.86 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.83 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.505 ' HA ' ' NZ ' ' A' ' 104' ' ' LYS . 40.5 pt -79.96 -13.92 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.397 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.71 -177.89 5.95 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -94.99 176.99 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.48 66.5 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.205 -0.452 . . . . 0.0 114.065 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.75 -49.47 75.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.176 0.512 . . . . 0.0 111.54 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -90.41 -37.05 14.23 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.619 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.502 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -76.79 -3.95 40.99 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -63.02 -13.53 36.57 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.447 -0.783 . . . . 0.0 111.104 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.66 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 58.4 mttp -85.53 -8.3 58.4 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.8 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 59.6 t -66.58 -46.0 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.692 0.758 . . . . 0.0 111.723 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 10.7 mtpp -67.32 -41.61 34.06 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.913 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.3 Cg_endo -61.97 -30.64 83.62 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 120.965 1.11 . . . . 0.0 110.6 173.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.98 -42.74 97.12 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 83' ' ' LYS . . . -57.25 -48.28 79.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.992 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.06 -44.58 46.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.816 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.72 -47.71 80.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.256 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -73.93 -34.8 64.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.941 0.401 . . . . 0.0 111.308 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.79 49.21 1.98 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -77.27 109.36 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.136 0.493 . . . . 0.0 110.044 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.0 42.31 0.92 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.338 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.475 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -152.93 -179.72 7.91 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -72.75 140.16 47.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.384 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.27 129.57 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.421 HD12 HG21 ' A' ' 69' ' ' ILE . 11.1 mp -119.71 135.8 54.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.518 0.675 . . . . 0.0 111.58 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.0 tp -105.85 105.49 15.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.678 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.644 ' OD2' ' HE3' ' A' ' 104' ' ' LYS . 47.6 t0 -86.42 138.07 32.06 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 118.072 -1.451 . . . . 0.0 109.639 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.9 m -123.11 -0.36 8.92 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.397 0.617 . . . . 0.0 109.751 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.49 -59.22 1.92 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.278 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.52 -11.87 63.12 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.123 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.2 -24.37 43.2 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -61.46 -43.49 98.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.644 ' HE3' ' OD2' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.49 -41.99 95.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.042 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -66.72 -36.51 82.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.129 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.99 74.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.542 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 mmt -90.48 -9.35 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.069 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 63.19 59.86 1.24 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.352 0.596 . . . . 0.0 110.829 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.5 t -77.32 93.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.335 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.3 t -79.31 -58.82 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.648 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.3 tp -110.75 138.43 47.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.924 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 pt -100.25 152.98 37.99 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.589 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.7 Cg_endo -82.86 154.77 74.83 Favored 'Cis proline' 0 N--CA 1.476 0.487 0 C-N-CA 124.039 -1.234 . . . . 0.0 112.012 -1.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -105.57 138.66 41.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.397 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.5 130.79 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.63 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.19 125.53 33.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.093 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 59.4 mt -106.73 132.62 53.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 6' ' ' TYR . 55.8 t -109.52 130.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.043 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.91 166.6 23.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.223 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -23.58 58.42 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.751 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -71.26 -11.05 60.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.76 0.79 . . . . 0.0 109.559 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.84 34.51 Favored Glycine 0 CA--C 1.498 -0.971 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.823 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.29 154.03 36.9 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 94.6 mt -76.26 117.7 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 -20.57 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.514 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 69.1 t80 -137.53 126.6 24.38 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -134.91 114.91 13.01 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.159 0.504 . . . . 0.0 110.595 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -146.51 116.39 7.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.942 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 p -95.82 106.24 18.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.102 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.67 69.45 1.3 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.454 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.589 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 39.6 p90 -65.99 -44.83 83.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.999 0.4 . . . . 0.0 110.326 177.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p 49.07 85.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.305 1.042 . . . . 0.0 112.68 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 68.05 130.46 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.255 1.022 . . . . 0.0 112.489 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.77 2.33 90.5 Favored Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.644 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.567 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -70.94 -42.01 60.73 Favored Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 121.543 -0.36 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -58.55 -25.37 62.41 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.937 0.399 . . . . 0.0 111.384 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 96.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.497 0.665 . . . . 0.0 109.765 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.03 -30.21 63.58 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.08 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.4 mm? -60.13 -50.71 72.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.862 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.449 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -70.37 -36.77 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.314 0.578 . . . . 0.0 109.881 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -61.37 -44.9 96.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 41.0 tptt -66.57 -31.31 71.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 110.38 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.0 t -58.97 -44.23 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -66.32 -28.53 68.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.279 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 61.3 mm-40 -63.79 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.241 176.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.9 mt . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.223 0.535 . . . . 0.0 110.611 178.426 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p30 . . . . . 0 C--O 1.237 0.44 0 CA-C-O 120.851 0.358 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.498 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 35.0 m -155.26 72.83 0.84 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.331 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 38.2 m-85 -92.1 -143.22 0.2 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.348 0.594 . . . . 0.0 109.907 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.55 14.72 2.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.841 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.456 ' HB3' HG13 ' A' ' 124' ' ' ILE . 52.4 tt0 50.42 42.85 26.78 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.862 0.839 . . . . 0.0 110.507 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt -92.56 152.01 41.68 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.746 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.52 156.72 55.05 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.343 2.695 . . . . 0.0 111.403 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.64 80.55 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 111.159 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.7 t -125.94 134.29 66.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -90.6 116.58 28.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.713 0.292 . . . . 0.0 110.45 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tp -116.09 173.66 6.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -117.22 128.07 54.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -91.53 -175.31 4.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.869 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 95' ' ' VAL . 29.6 pt -66.66 -21.43 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.913 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -82.17 -10.6 59.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.943 0.402 . . . . 0.0 110.491 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.94 20.19 68.45 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -100.03 141.32 33.01 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.3 m -75.62 110.83 10.35 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.186 0.517 . . . . 0.0 109.897 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 m -116.32 131.02 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.684 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 89.2 mt-30 -90.28 133.06 35.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.587 HG23 ' CE1' ' A' ' 103' ' ' PHE . 16.9 p -66.84 -29.78 69.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.64 -34.32 76.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.29 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -101.94 8.46 41.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.695 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.9 tp -70.45 117.22 11.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.251 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.497 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 46.7 mt-10 -130.09 141.56 50.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.743 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 28.1 t-20 -82.16 -75.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.12 29.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.378 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.498 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 93.98 2.3 64.64 Favored Glycine 0 C--O 1.23 -0.15 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.138 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -109.63 151.85 42.49 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 122.387 0.275 . . . . 0.0 110.999 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 19.9 Cg_exo -63.46 154.16 70.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.038 2.492 . . . . 0.0 112.033 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.743 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 73.6 mtm -132.91 147.86 52.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.683 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.516 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 78.1 mt -121.91 120.68 62.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.9 mt -99.36 119.27 47.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.0 m -102.58 119.21 38.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.85 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.543 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 72.5 m-85 -93.96 118.1 31.02 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.526 ' O ' HG12 ' A' ' 73' ' ' ILE . 20.2 p90 -144.09 162.99 34.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 123.634 0.584 . . . . 0.0 110.795 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.402 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . . . -81.01 176.53 9.74 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.013 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -84.35 7.41 19.56 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -161.88 82.16 0.57 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.707 0.289 . . . . 0.0 110.566 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 40' ' ' ALA . 84.7 m -151.12 148.0 27.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.554 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 59.9 mttp -127.65 -61.27 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.864 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.435 ' HD2' ' H ' ' A' ' 44' ' ' LYS . 63.1 Cg_endo -72.97 -16.87 25.56 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 121.815 1.677 . . . . 0.0 111.923 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 46.9 m -69.86 -25.84 63.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.504 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt -85.98 58.16 4.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.33 -45.59 90.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.709 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.566 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -70.92 -45.21 64.64 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.862 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.481 HD11 ' CE1' ' A' ' 93' ' ' TYR . 27.2 tp -61.74 -43.43 98.87 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.23 -175.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.61 -48.42 77.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.41 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.37 -46.12 87.98 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.395 0.617 . . . . 0.0 111.197 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.2 mt -64.08 -41.73 93.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.468 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.933 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -54.36 -41.31 68.99 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 111.452 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -66.79 -38.12 85.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.64 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.17 21.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.281 0.563 . . . . 0.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.28 -44.48 88.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.408 0.683 . . . . 0.0 112.391 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.83 84.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.21 -40.98 99.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.979 0.419 . . . . 0.0 110.823 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -69.94 -40.68 75.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.448 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 55.1 mt-30 -64.61 -32.62 74.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.183 0.516 . . . . 0.0 110.739 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.46 -39.79 94.55 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.737 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -86.78 -86.2 0.15 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.394 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 66' ' ' VAL . 3.1 t -79.49 -16.04 56.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.876 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 71.86 17.63 77.0 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.407 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.498 ' H ' HG23 ' A' ' 64' ' ' THR . 10.7 p -63.63 140.21 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.127 0.489 . . . . 0.0 112.232 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.59 163.98 14.26 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.633 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.609 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 58.5 mt -112.16 134.56 53.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.482 0.658 . . . . 0.0 111.511 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.458 HD11 ' SD ' ' A' ' 34' ' ' MET . 95.0 mt -111.44 109.95 30.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.809 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.11 111.2 22.25 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.27 133.9 58.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-O 121.959 0.885 . . . . 0.0 112.32 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.608 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.0 m -85.08 120.23 26.36 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.133 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 39' ' ' PHE . 45.5 pt -84.68 36.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 123.987 0.804 . . . . 0.0 110.656 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -131.1 -167.88 1.91 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -95.06 165.92 12.19 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.28 -37.21 92.67 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.384 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 78' ' ' ASN . 27.7 pt20 -60.38 -42.58 96.16 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.915 0.388 . . . . 0.0 111.324 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.404 ' N ' ' HG3' ' A' ' 77' ' ' GLN . 86.8 m-20 -81.69 -32.99 31.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -68.95 -5.63 22.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.424 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -62.35 -12.85 23.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.824 0.345 . . . . 0.0 110.714 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.735 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 37.3 mtmm -93.7 -11.78 30.76 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.713 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.608 HG21 ' OG ' ' A' ' 72' ' ' SER . 20.1 t -68.58 -47.54 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.669 0.747 . . . . 0.0 111.571 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.8 mtpt -64.27 -44.65 77.1 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.722 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 13.1 Cg_endo -60.36 -32.29 93.82 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.194 1.263 . . . . 0.0 111.276 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.94 -43.63 98.28 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.36 92.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.127 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.69 -46.5 63.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.257 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.86 -48.22 68.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.296 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -67.88 -34.56 76.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.0 111.519 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.24 52.31 1.25 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.354 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -84.81 132.62 34.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.929 0.395 . . . . 0.0 110.345 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -103.8 33.07 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.188 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.609 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -145.33 -179.95 6.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -81.8 141.96 33.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 112.267 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.55 ' O ' HG23 ' A' ' 17' ' ' ILE . 38.9 t -120.76 134.75 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD11 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -121.48 138.57 54.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.763 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.6 mp -111.2 120.04 40.94 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 63.2 t0 -74.3 117.69 16.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.494 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.1 p -93.8 2.6 56.18 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -121.96 -37.53 2.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.812 0.339 . . . . 0.0 111.145 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.427 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 90.69 8.49 65.46 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.968 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.73 -17.35 17.77 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.587 ' CE1' HG23 ' A' ' 24' ' ' THR . 68.9 t80 -63.07 -43.62 98.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 110.582 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -59.23 -36.06 74.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -71.95 -41.12 68.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.321 0.581 . . . . 0.0 110.308 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.33 84.75 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 31.0 mmm -96.76 -11.08 25.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.739 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 68.84 93.08 0.08 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.556 0.743 . . . . 0.0 112.006 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.88 83.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.8 m -62.15 -48.9 78.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.973 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.0 tp -151.48 132.43 14.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.592 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 148.16 55.11 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.51 147.82 87.76 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.699 -1.375 . . . . 0.0 112.588 0.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.543 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -114.72 128.98 56.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.851 175.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.8 t -114.23 122.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -120.77 115.26 22.96 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 61.7 mt -103.86 131.51 52.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.274 0.559 . . . . 0.0 110.512 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 66.8 t -108.95 130.43 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.946 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.82 165.21 25.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.366 0.666 . . . . 0.0 111.071 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.79 -20.34 47.3 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.073 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -84.31 4.11 32.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.876 0.338 . . . . 0.0 111.06 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.54 48.4 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.88 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -126.68 152.53 46.62 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.456 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.6 mt -75.01 118.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -107.98 -30.69 2.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.268 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.547 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 90.0 t80 -141.58 140.39 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -136.06 130.7 33.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.193 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.525 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -141.2 104.1 4.56 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.189 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.1 m -104.17 120.19 40.58 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.045 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.69 47.76 66.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.674 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 31.6 p90 -67.59 -43.96 79.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 109.562 176.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.461 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 61.0 p 57.01 87.74 0.06 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.863 1.265 . . . . 0.0 113.036 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 72.07 127.71 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.118 0.967 . . . . 0.0 112.29 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.51 68.07 Favored Glycine 0 CA--C 1.51 -0.264 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.063 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.674 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -73.07 -21.6 79.7 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.249 -0.476 . . . . 0.0 112.257 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.4 mp0 -56.27 -30.6 62.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.818 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.75 92.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.34 -31.24 67.14 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.678 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.585 ' O ' HG21 ' A' ' 143' ' ' VAL . 4.0 mm? -60.38 -52.27 65.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.683 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.405 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.8 tp -69.4 -32.79 54.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.203 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.8 ttpp -62.68 -47.34 84.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.939 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.403 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -66.34 -32.19 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 110.257 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.585 HG21 ' O ' ' A' ' 139' ' ' LEU . 55.4 t -59.41 -43.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.734 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 27.1 mmt180 -64.62 -36.02 82.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 67.2 mm-40 -58.53 -42.3 87.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.715 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 56.9 mt -64.81 -40.3 94.99 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.314 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 143' ' ' VAL . 99.6 t -62.47 -46.72 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.773 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.69 -37.01 86.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.602 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.03 -33.11 73.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.043 0.449 . . . . 0.0 110.02 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.17 82.03 0.9 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.562 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 42.7 t-80 -75.02 148.34 39.95 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -80.04 113.34 18.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 60.33 17.77 7.4 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.595 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.562 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 25.9 t-80 -159.91 176.59 11.7 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -122.01 10.49 10.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.721 0.296 . . . . 0.0 111.513 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.9 t60 . . . . . 0 C--N 1.315 -0.914 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.194 -178.807 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.433 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 92.9 m-20 . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -100.96 61.65 0.97 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.22 0.534 . . . . 0.0 111.946 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.541 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 31.6 m-85 -98.96 -134.02 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.95 155.82 40.65 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -74.52 75.84 1.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 81.4 mt -117.98 140.29 27.65 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.885 -174.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -64.19 155.75 63.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.15 2.567 . . . . 0.0 110.673 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 91.22 0.46 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 154.53 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.888 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -98.01 134.04 41.65 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tp -131.89 165.31 24.17 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -113.2 129.61 56.46 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.223 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 20' ' ' LYS . 46.5 p30 -94.67 -174.88 3.43 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 95' ' ' VAL . 32.4 pt -68.42 -18.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.953 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -84.04 -12.4 55.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.924 0.392 . . . . 0.0 110.432 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 16.87 72.16 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HB3' HD22 ' A' ' 16' ' ' ASN . 86.4 tttt -96.1 145.63 25.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.413 -0.894 . . . . 0.0 110.601 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.7 m -80.38 114.0 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.877 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 m -120.65 134.11 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.969 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.1 mt-30 -88.91 134.95 33.78 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.536 HG21 ' CE1' ' A' ' 103' ' ' PHE . 25.0 p -65.48 -31.04 71.91 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.2 -28.62 69.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.513 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.22 16.44 23.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.045 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.6 tp -79.03 101.27 7.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.058 0.456 . . . . 0.0 111.95 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.541 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.1 mt-10 -119.11 122.89 43.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.987 177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -70.88 -43.06 69.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.27 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 0.0 109.464 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.91 33.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.395 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -128.67 151.74 77.54 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 122.415 0.286 . . . . 0.0 110.864 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.95 155.5 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.275 . . . . 0.0 111.621 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 38.2 mtt -129.92 153.43 48.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.93 0.395 . . . . 0.0 111.805 -171.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.8 mt -128.3 117.28 44.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 82.1 mt -96.79 118.16 42.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 m -104.88 116.07 31.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -90.8 115.78 28.13 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -138.2 168.48 19.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.207 0.527 . . . . 0.0 112.119 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.53 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -94.05 166.98 11.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.336 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.48 125.77 29.68 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.593 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.7 t30 57.99 35.59 25.38 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.601 -1.182 . . . . 0.0 113.458 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 78.2 m -106.34 84.55 2.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.504 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 48.2 mttm -64.59 -55.45 29.27 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -173.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 11.4 Cg_exo -67.71 -20.3 46.57 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 122.634 2.222 . . . . 0.0 112.899 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 58.8 m -72.13 -19.14 61.83 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 43' ' ' CYS . 17.3 mt -87.37 60.34 6.02 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -63.87 -45.96 87.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.582 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -66.2 -46.37 77.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.137 -176.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.544 ' HG ' HE21 ' A' ' 54' ' ' GLN . 33.8 tp -63.8 -42.51 97.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -61.6 -48.44 80.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.562 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -61.37 -42.56 98.9 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.006 0.432 . . . . 0.0 111.02 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.3 mt -64.96 -42.27 94.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.046 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.544 HE21 ' HG ' ' A' ' 50' ' ' LEU . 78.5 mt-30 -55.49 -40.86 72.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 111.298 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.28 -38.13 87.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.742 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 52' ' ' ALA . 18.1 m -116.22 27.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.002 0.43 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 53' ' ' ILE . 65.0 t80 -58.64 -39.6 81.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.627 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.45 87.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.641 0.258 . . . . 0.0 110.846 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.55 -41.71 96.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.297 0.57 . . . . 0.0 110.417 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.61 ' O ' ' HB ' ' A' ' 64' ' ' THR . 11.9 m0 -71.18 -37.03 72.18 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.714 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -80.2 -8.92 59.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.787 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.57 -60.43 3.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.182 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.11 -4.25 3.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.758 0.314 . . . . 0.0 111.796 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 18.1 m -96.11 -35.54 11.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.253 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.08 31.33 65.12 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.853 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.95 128.93 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.447 0.641 . . . . 0.0 112.117 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -94.15 152.24 18.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.381 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 39.3 mt -111.94 130.11 55.95 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.138 0.494 . . . . 0.0 111.165 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 96' ' ' LEU . 91.0 mt -110.01 106.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.16 113.21 25.42 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.616 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 10.8 p -122.47 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.254 0.55 . . . . 0.0 111.84 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.6 p -88.66 143.48 26.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.719 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.0 pt -78.31 -13.99 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.111 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -84.39 153.97 23.12 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.707 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.57 168.1 13.64 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 123.52 0.513 . . . . 0.0 110.087 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.53 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -55.47 -40.77 78.73 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.142 0.417 . . . . 0.0 114.142 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.2 -39.37 92.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.224 0.512 . . . . 0.0 111.32 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -83.32 -32.65 26.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.362 0.601 . . . . 0.0 110.53 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.461 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -79.01 -2.06 38.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.094 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 99.1 mt-30 -57.86 -16.09 10.63 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.916 -0.49 . . . . 0.0 111.146 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.676 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.7 mttp -84.91 -14.82 46.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.431 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 79' ' ' ALA . 49.8 t -65.68 -47.13 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.805 0.812 . . . . 0.0 112.272 -175.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.0 mtpm? -67.34 -42.87 41.02 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.55 -176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.603 ' HA ' ' OD2' ' A' ' 87' ' ' ASP . 17.9 Cg_endo -61.89 -28.63 81.4 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.107 1.204 . . . . 0.0 111.001 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.96 -42.2 97.36 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HA ' ' CD2' ' A' ' 91' ' ' TRP . . . -57.99 -49.12 77.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.773 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.603 ' OD2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 p30 -75.0 -35.96 61.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.996 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.28 -49.59 56.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.877 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -74.6 -34.1 62.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.924 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.217 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.477 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 54.4 m0 -95.09 117.79 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.35 47.88 0.93 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -149.23 -169.62 3.42 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.795 -0.184 . . . . 0.0 110.576 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -89.09 135.84 33.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.428 0.633 . . . . 0.0 111.983 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 17' ' ' ILE . 58.8 t -118.07 132.45 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.767 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.695 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 8.1 mp -130.3 146.12 51.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.947 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.507 HD23 ' N ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -126.36 127.68 45.88 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -61.01 133.59 56.24 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.1 t -114.75 7.28 15.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.537 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -142.94 -30.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.53 63.09 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.968 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -74.59 -36.87 63.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.418 0.151 . . . . 0.0 111.136 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.536 ' CE1' HG21 ' A' ' 24' ' ' THR . 79.9 t80 -62.19 -48.65 79.07 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -61.59 -35.01 76.63 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.851 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -70.56 -42.43 71.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.375 0.607 . . . . 0.0 110.063 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.43 -37.65 84.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.315 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 28.5 mmm -82.64 -22.77 34.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.317 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.0 t30 72.13 81.75 0.14 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.462 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.91 99.79 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.266 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.2 m -71.71 -69.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.803 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.41 HD23 ' CG2' ' A' ' 132' ' ' THR . 60.4 tp -115.43 131.12 57.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.6 pt -88.67 144.42 33.36 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.592 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -80.45 161.58 83.9 Favored 'Cis proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.838 -1.318 . . . . 0.0 113.564 0.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.22 145.08 49.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.958 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.49 130.15 74.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.108 0.48 . . . . 0.0 112.168 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.4 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 82.4 m-85 -125.41 124.86 42.39 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 75.7 mt -114.2 131.07 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.051 0.453 . . . . 0.0 111.057 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 54.8 t -108.92 132.93 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 123.886 0.874 . . . . 0.0 110.057 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -95.04 -171.91 2.55 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.269 0.356 . . . . 0.0 111.111 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.87 66.44 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.983 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -75.09 -2.02 25.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.987 0.393 . . . . 0.0 111.338 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 73.78 30.96 60.88 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.032 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.428 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 48.2 mmtm -133.01 168.47 18.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 98.2 mt -90.24 112.37 24.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.082 0.468 . . . . 0.0 110.349 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.69 -31.83 5.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.489 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.546 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.4 t80 -124.55 130.71 52.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.043 0.449 . . . . 0.0 111.337 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -130.06 120.67 25.05 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.057 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -144.36 102.84 3.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.884 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.2 p -102.79 106.76 17.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 113.21 71.14 0.56 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.991 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.592 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -122.22 157.06 32.45 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.41 ' CG2' HD23 ' A' ' 111' ' ' LEU . 27.9 p -127.02 -41.85 1.77 Allowed 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.869 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -167.89 124.05 1.07 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.18 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.39 -3.19 32.83 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.39 -18.71 65.9 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.77 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.0 mp0 -60.22 -20.83 60.48 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.094 0.557 . . . . 0.0 111.369 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.6 94.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.483 0.659 . . . . 0.0 110.706 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.7 -32.06 69.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.708 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.496 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -61.82 -47.52 84.73 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.499 HD12 ' NE1' ' A' ' 60' ' ' TRP . 5.1 tp -68.54 -39.54 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.721 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.3 ttpp -60.65 -45.86 92.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.155 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -66.06 -35.16 79.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.385 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -60.78 -42.7 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -64.38 -34.53 78.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.129 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 51.7 mm-40 -61.6 -35.08 76.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.438 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.5 -38.98 92.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.11 -27.33 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.236 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 145' ' ' GLU . 10.8 tmtt? -58.78 -38.01 77.58 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.477 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -72.81 2.0 7.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.003 0.43 . . . . 0.0 111.681 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -61.95 -32.97 83.98 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -121.95 133.82 54.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.299 -0.451 . . . . 0.0 109.968 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -79.17 167.51 20.9 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.639 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 73.04 -67.05 0.28 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.699 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -161.13 136.59 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -62.05 -45.76 92.14 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.792 0.329 . . . . 0.0 111.198 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 . . . . . 0 C--N 1.314 -0.968 0 CA-C-O 118.282 -0.865 . . . . 0.0 109.884 178.302 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 CA--C 1.514 -0.442 0 CA-C-O 121.017 0.437 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.471 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 37.3 m -79.72 81.19 6.02 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.12 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.466 ' CE2' ' HA ' ' A' ' 26' ' ' LYS . 93.2 m-85 -103.48 -80.58 0.52 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.315 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 166.98 -10.77 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 O-C-N 124.514 1.134 . . . . 0.0 110.334 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 63.88 44.79 4.65 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.915 0.864 . . . . 0.0 110.298 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.484 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 18.9 mt -98.16 159.42 30.76 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.912 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.63 148.19 93.59 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.301 2.001 . . . . 0.0 109.617 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.02 84.06 2.27 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.063 0.458 . . . . 0.0 111.2 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -117.92 132.95 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -87.97 109.83 20.12 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.09 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 98' ' ' ASP . 33.3 mt -116.75 175.92 5.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.949 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.57 138.58 40.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.389 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.42 HD22 ' HB3' ' A' ' 20' ' ' LYS . 5.6 p30 -101.77 -175.04 2.73 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.426 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 32.4 pt -63.77 -22.57 31.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.97 -12.31 60.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.09 81.69 Favored Glycine 0 CA--C 1.503 -0.689 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' HB3' HD22 ' A' ' 16' ' ' ASN . 37.1 ttpt -96.45 141.16 30.08 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.6 m -73.43 115.09 12.39 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 m -122.16 132.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.87 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 79.0 mt-30 -87.77 134.53 33.66 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.484 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 6.7 p -63.76 -28.54 69.94 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.106 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -75.84 -10.68 59.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.72 0.295 . . . . 0.0 111.34 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.483 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -126.48 12.96 7.56 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.489 0.185 . . . . 0.0 111.349 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.09 -48.89 78.19 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -172.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 33.06 97.98 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.419 1.104 . . . . 0.0 113.904 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' OD1' ' HG2' ' A' ' 34' ' ' MET . 13.1 m120 -66.16 -58.39 5.53 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.367 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.69 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.72 4.89 89.88 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.159 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -112.67 150.89 43.42 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.57 150.45 81.63 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.87 2.38 . . . . 0.0 111.751 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.455 ' HG2' ' OD1' ' A' ' 29' ' ' ASN . 0.6 OUTLIER -131.42 154.89 48.19 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.087 0.47 . . . . 0.0 111.065 -176.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.536 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.3 mt -123.08 122.85 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.1 mt -95.73 122.46 47.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.438 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 3.5 m -104.85 118.85 37.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.069 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 72.1 m-85 -95.19 116.86 29.3 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.471 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 28.1 p90 -142.56 171.42 14.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.605 0.566 . . . . 0.0 112.153 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.57 32.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.406 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.409 ' CG2' HG23 ' A' ' 82' ' ' VAL . 48.6 p -78.28 -12.68 60.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.087 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -103.4 9.63 37.72 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 46' ' ' CYS . 17.2 t -143.32 122.21 12.73 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.547 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 52.4 mtmt -87.26 -48.55 0.47 Allowed Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 44' ' ' LYS . 27.3 Cg_endo -63.78 -20.55 68.81 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.423 2.082 . . . . 0.0 112.058 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.469 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 44.1 t -68.73 -17.9 64.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.471 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 6.6 mt -85.51 40.82 0.86 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.311 0.577 . . . . 0.0 109.607 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -57.52 -39.82 77.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.938 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.616 ' HA ' ' OH ' ' A' ' 131' ' ' TYR . 3.8 tm-20 -66.99 -54.83 18.04 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.2 tp -63.11 -40.78 98.63 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.059 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.0 tttt -62.13 -45.24 94.31 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.212 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -58.77 -46.66 87.0 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.467 ' CG2' HD12 ' A' ' 68' ' ' LEU . 58.8 mt -64.69 -43.16 96.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.168 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -54.62 -42.01 70.68 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.08 0.467 . . . . 0.0 110.993 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 51.2 mm-40 -65.88 -37.56 86.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.901 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 52' ' ' ALA . 30.7 m -110.99 17.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.21 -41.38 92.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.79 86.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 19.0 t70 -64.5 -41.75 96.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.148 0.499 . . . . 0.0 110.439 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.494 ' NE1' HD13 ' A' ' 140' ' ' ILE . 28.8 m0 -72.31 -42.33 65.58 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.263 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 18.6 mm-40 -65.79 -24.11 66.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.236 0.541 . . . . 0.0 110.604 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 36.1 t70 -59.62 -46.41 89.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.52 -70.11 0.77 Allowed 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.476 HG22 ' N ' ' A' ' 66' ' ' VAL . 2.8 t -77.41 -22.12 52.06 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.076 0.465 . . . . 0.0 111.221 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 66.45 32.17 80.97 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.28 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.476 ' N ' HG22 ' A' ' 64' ' ' THR . 14.8 p -63.28 136.56 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -102.63 156.38 17.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.069 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD11 ' CE2' ' A' ' 93' ' ' TYR . 68.9 mt -116.18 133.15 56.33 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.075 0.464 . . . . 0.0 111.206 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.459 HG23 HD11 ' A' ' 96' ' ' LEU . 86.4 mt -110.02 102.99 14.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.67 118.06 29.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.2 p -122.43 133.1 69.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.212 0 CA-C-O 121.634 0.731 . . . . 0.0 111.727 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.657 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 21.4 p -84.71 140.86 30.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.551 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.0 pt -80.81 -15.52 12.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.28 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.657 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -84.63 159.46 20.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.687 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.496 ' HB2' ' OE1' ' A' ' 77' ' ' GLN . 43.2 mt-10 -72.38 178.22 4.1 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.277 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.64 -48.99 67.64 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 115.423 0.929 . . . . 0.0 115.423 -173.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.496 ' OE1' ' HB2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -65.43 -40.7 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.734 0.767 . . . . 0.0 111.338 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -69.13 -39.63 78.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.229 0.537 . . . . 0.0 110.959 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.638 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -72.22 -4.16 27.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.152 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.6 -13.69 15.86 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.656 -0.653 . . . . 0.0 111.346 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.712 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.9 tttp -92.58 -10.45 37.49 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 122.764 0.425 . . . . 0.0 111.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 79' ' ' ALA . 12.6 t -66.96 -47.36 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-O 121.547 0.689 . . . . 0.0 111.804 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.508 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 43.2 mtpt -63.64 -45.32 82.51 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.987 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -61.06 -31.16 90.62 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.091 1.194 . . . . 0.0 111.098 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.712 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -62.64 -44.2 96.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.22 98.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.415 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.22 -50.88 68.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.523 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.8 -44.86 46.35 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.789 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.58 41.91 3.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.411 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.429 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 53.2 m0 -83.35 108.31 16.45 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.0 42.28 1.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.56 ' CE2' HD11 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -146.23 177.62 8.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.845 -0.161 . . . . 0.0 111.303 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.78 137.77 40.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.391 0.615 . . . . 0.0 112.394 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -119.76 132.5 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.868 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.459 HD11 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -125.36 144.87 50.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.94 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.83 121.92 46.54 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.518 ' HA ' HD23 ' A' ' 14' ' ' LEU . 67.1 t0 -70.08 115.28 9.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.343 -1.343 . . . . 0.0 107.648 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.497 ' H ' HD23 ' A' ' 14' ' ' LEU . 22.6 t -83.41 -15.25 50.47 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -173.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -120.18 -29.89 4.77 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.28 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.11 1.4 62.92 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.53 -14.19 28.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 24' ' ' THR . 87.5 t80 -64.91 -44.96 87.85 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -63.19 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.2 -34.8 76.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.245 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.78 76.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.105 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 23.6 mmt -84.87 -18.25 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.395 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 68.22 78.91 0.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.441 0.696 . . . . 0.0 110.332 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.42 89.4 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.6 m -68.83 -44.85 72.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.792 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.2 tp -137.12 134.74 36.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.42 HG13 ' SG ' ' A' ' 46' ' ' CYS . 11.5 pt -91.36 156.33 43.59 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.61 151.48 94.57 Favored 'Cis proline' 0 C--O 1.238 0.492 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.503 0.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -115.33 130.53 56.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.54 HG23 ' HG3' ' A' ' 49' ' ' GLU . 24.2 t -110.99 126.27 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 123.291 0.369 . . . . 0.0 111.373 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -128.03 115.06 17.9 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 60.5 mt -105.71 132.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.295 0.569 . . . . 0.0 111.452 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -109.68 134.88 50.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.478 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -90.16 -172.76 3.6 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.238 0.336 . . . . 0.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.93 -30.32 76.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.447 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -69.41 -14.53 62.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.58 0.705 . . . . 0.0 109.67 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 82.75 31.74 28.87 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.601 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -123.43 157.38 33.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.443 . . . . 0.0 110.111 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 7' ' ' ALA . 49.7 mt -74.66 100.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.035 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -88.03 -39.0 12.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.675 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.556 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 81.9 t80 -131.81 136.63 47.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.818 0.342 . . . . 0.0 111.652 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -131.03 134.63 46.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.099 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.556 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.2 t60 -148.95 103.09 3.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.5 m -103.2 118.88 37.77 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.11 0.481 . . . . 0.0 111.829 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.74 45.41 44.26 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.674 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 15.0 p90 -68.08 -37.51 81.31 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.081 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 43.2 p 77.41 -59.94 0.45 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.163 1.785 . . . . 0.0 112.278 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -147.8 142.87 27.06 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.582 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.11 19.17 67.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.674 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.98 -27.02 20.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.255 -0.473 . . . . 0.0 113.122 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.403 ' O ' HG23 ' A' ' 140' ' ' ILE . 5.7 pm0 -60.51 -22.18 63.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.337 0.255 . . . . 0.0 111.662 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.12 99.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.398 0.618 . . . . 0.0 110.112 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.434 ' HB3' ' HH ' ' A' ' 126' ' ' TYR . 42.0 mt-10 -73.0 -37.7 66.89 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.414 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 143' ' ' VAL . 10.8 mp -63.21 -46.56 86.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.543 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.494 HD13 ' NE1' ' A' ' 60' ' ' TRP . 7.2 tp -66.34 -34.79 72.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.819 0.342 . . . . 0.0 110.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.1 ttmt -56.43 -54.3 47.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.888 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.557 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 29.0 mmmt -66.04 -32.81 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 139' ' ' LEU . 52.9 t -62.0 -43.74 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.287 0.565 . . . . 0.0 109.934 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -84.27 -18.63 35.77 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.312 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 61.2 mm-40 -69.92 -30.16 67.5 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.415 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.0 mt -61.4 -40.49 94.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 110.105 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.85 -44.02 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 121.487 0.66 . . . . 0.0 109.712 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.408 ' HD3' ' OE1' ' A' ' 145' ' ' GLU . 71.5 tttt -59.84 -44.3 94.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.194 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -77.06 7.79 4.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.093 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.04 -5.42 40.36 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.697 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 154' ' ' HIS . 69.6 t60 -49.77 -25.68 3.24 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.701 0.8 . . . . 0.0 111.499 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -57.76 -36.93 72.77 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.813 0.34 . . . . 0.0 110.13 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -81.51 -60.67 2.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 151' ' ' HIS . 48.5 p-80 -158.07 156.73 31.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.516 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -72.99 99.75 2.8 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.718 0.294 . . . . 0.0 111.324 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 62.2 m80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.314 -0.85 . . . . 0.0 112.551 176.572 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.0 p30 . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.438 ' HA ' ' CA ' ' A' ' 122' ' ' GLY . 40.0 m 65.54 76.12 0.33 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.334 0.588 . . . . 0.0 110.76 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.527 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 89.1 m-85 -100.87 -101.38 0.25 Allowed 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -177.41 11.5 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.485 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 25.4 tt0 54.57 34.8 22.06 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.793 0.806 . . . . 0.0 110.579 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.448 HD12 ' OG1' ' A' ' 24' ' ' THR . 79.3 mt -89.84 150.45 43.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.652 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.44 151.89 82.75 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.717 2.278 . . . . 0.0 111.476 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.31 84.13 2.45 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.905 0.383 . . . . 0.0 110.981 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.578 ' O ' HG21 ' A' ' 24' ' ' THR . 72.3 t -121.38 136.76 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -78.07 126.35 30.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.9 tp -134.34 173.07 12.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.536 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -116.28 133.56 55.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -97.84 -179.89 4.58 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 95' ' ' VAL . 17.5 pt -64.3 -22.17 30.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -77.94 -16.64 58.01 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.901 0.381 . . . . 0.0 110.828 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.56 58.83 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.92 140.36 36.31 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.673 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.1 m -74.38 116.54 15.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.119 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.82 156.81 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.976 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.22 134.83 46.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 176.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.578 HG21 ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -67.16 -16.38 64.28 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.378 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -93.05 7.52 43.8 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 121.774 -0.579 . . . . 0.0 112.09 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.45 16.35 3.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.836 -0.54 . . . . 0.0 111.297 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.8 -67.52 0.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.34 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.527 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 35.1 mt-10 64.52 175.66 0.19 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.701 0.762 . . . . 0.0 112.516 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.492 ' HB2' ' HE1' ' A' ' 34' ' ' MET . 0.3 OUTLIER -139.25 -78.27 0.33 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.539 178.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.77 31.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.261 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.45 34.15 29.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.298 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -123.47 145.9 48.23 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 122.141 0.176 . . . . 0.0 111.008 -177.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -67.82 155.22 70.72 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.813 2.342 . . . . 0.0 111.832 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.492 ' HE1' ' HB2' ' A' ' 29' ' ' ASN . 36.6 mtt -133.97 160.68 36.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.169 0.509 . . . . 0.0 111.61 -174.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 97.2 mt -132.48 118.78 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -99.37 118.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 m -104.1 122.97 46.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.178 0.513 . . . . 0.0 110.191 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.407 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 62.8 m-85 -94.16 114.88 27.09 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.236 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.448 ' HB2' HD23 ' A' ' 47' ' ' LEU . 25.0 p90 -135.25 170.73 15.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.641 0.588 . . . . 0.0 111.284 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.81 153.92 29.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.998 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p -69.86 -21.23 63.36 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -94.37 12.64 26.34 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.747 0.308 . . . . 0.0 111.452 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 61.0 m -126.55 126.49 43.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.744 0.307 . . . . 0.0 111.497 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 57.4 mttp -117.71 -58.5 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.133 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.515 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 3.3 Cg_exo -79.79 -22.16 7.86 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.095 1.864 . . . . 0.0 112.446 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.7 m -76.42 -3.97 39.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.991 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.448 HD23 ' HB2' ' A' ' 39' ' ' PHE . 34.8 mt -62.97 -38.44 91.13 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.826 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? 61.15 -80.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.585 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.4 pt-20 -52.87 -52.86 55.86 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 112.229 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.409 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 47.0 tp -61.51 -42.7 99.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.634 0.254 . . . . 0.0 110.598 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 88.6 tttt -67.09 -46.92 72.8 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.626 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.95 97.56 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.0 mt -64.01 -41.38 92.31 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.817 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.726 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.51 -36.99 67.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.768 0.318 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 13.6 mm-40 -69.92 -39.65 76.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.488 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 m -114.84 27.35 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.178 0.513 . . . . 0.0 112.116 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 85.7 t80 -59.4 -35.61 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.749 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.669 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.72 -42.98 94.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.951 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.56 -36.81 76.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 0.0 110.59 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -82.08 -7.67 59.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -58.03 -48.99 78.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.039 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -131.95 -44.19 0.96 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -39.67 94.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 40.79 96.11 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.117 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.54 133.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.79 159.78 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.508 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 54.7 mt -108.28 139.3 43.17 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.267 0.556 . . . . 0.0 111.196 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 79.2 mt -115.81 110.94 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.611 177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.76 114.1 26.56 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.52 131.75 63.16 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.936 0.874 . . . . 0.0 111.627 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.1 m -88.69 119.39 29.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.146 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 pt -77.75 -17.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.939 0.774 . . . . 0.0 109.738 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.504 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 4.5 m-20 -73.09 146.34 45.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.155 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.5 -173.82 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.159 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.501 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -43.13 -58.32 3.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.858 -1.064 . . . . 0.0 115.403 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.413 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 13.9 pt20 -65.85 -45.17 83.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.408 0.604 . . . . 0.0 112.088 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.504 ' CB ' ' HB3' ' A' ' 74' ' ' ASP . 7.3 m-20 -66.7 -41.4 88.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.575 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -72.88 -5.31 37.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 79.4 mt-30 -66.01 -10.56 40.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.802 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.752 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 96.0 mttt -94.87 -11.04 29.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.549 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 79' ' ' ALA . 14.1 t -68.65 -50.77 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.564 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 40.6 mtpt -66.26 -40.35 34.78 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.605 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 5.9 Cg_endo -58.69 -34.3 98.84 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.185 1.256 . . . . 0.0 110.334 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.752 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -64.05 -42.21 97.11 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.44 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -61.08 -43.48 98.82 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.25 -40.41 67.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.89 -42.32 92.92 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.309 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -88.86 -15.73 33.73 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.952 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.6 61.09 4.61 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.734 -0.667 . . . . 0.0 113.276 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.44 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 31.4 m0 -82.41 134.54 35.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.896 0.379 . . . . 0.0 110.323 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -94.65 30.83 1.92 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.383 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -132.15 171.52 13.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.921 -172.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -81.85 136.17 35.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.595 ' O ' HG22 ' A' ' 17' ' ' ILE . 13.9 t -116.66 144.19 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.072 0.463 . . . . 0.0 110.59 -176.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mp -124.64 142.46 51.36 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.037 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' A' ' 79' ' ' ALA . 9.9 mp -114.76 117.38 30.61 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -81.16 115.16 20.44 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 t -96.17 -8.19 33.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.383 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -111.65 -30.98 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.835 0.35 . . . . 0.0 111.163 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.27 14.54 68.62 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.56 -27.15 16.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.927 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.52 -45.92 90.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.043 0.449 . . . . 0.0 110.782 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -62.82 -38.91 92.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.191 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -70.69 -41.5 71.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.421 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.59 74.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.882 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.428 ' HE2' ' HA ' ' A' ' 107' ' ' MET . 1.0 OUTLIER -86.57 -9.65 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.898 178.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.83 52.23 3.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.978 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.31 89.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.928 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.6 m -69.33 -45.34 69.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.317 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.92 142.28 36.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.983 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 pt -101.83 153.12 38.16 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.528 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 96.0 Cg_endo -78.52 154.32 92.23 Favored 'Cis proline' 0 C--O 1.244 0.778 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.186 0.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -116.65 136.25 53.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.089 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -114.91 127.9 72.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.089 0.471 . . . . 0.0 111.651 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -128.19 114.56 17.13 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.281 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.5 mt -103.05 129.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 CA-C-O 121.199 0.523 . . . . 0.0 110.627 -178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.8 t -106.46 128.52 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.114 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -76.61 161.89 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.59 -21.45 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 114.08 0.392 . . . . 0.0 114.08 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.483 ' OD1' ' HB2' ' A' ' 123' ' ' LYS . 6.3 p30 -74.07 -16.45 61.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.687 0.743 . . . . 0.0 111.253 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 5' ' ' THR . . . 101.38 17.91 20.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.222 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.483 ' HB2' ' OD1' ' A' ' 121' ' ' ASN . 13.6 mptt -121.94 152.16 39.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.227 0.537 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.1 mt -75.45 111.54 11.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.583 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.12 -19.12 6.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.487 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 68.2 t80 -144.43 130.25 19.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.292 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -138.3 129.04 26.64 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.957 0.408 . . . . 0.0 110.305 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 112.64 8.49 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.092 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.8 p -95.8 106.67 18.83 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.776 0.322 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.24 59.14 2.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.23 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.606 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 41.4 p90 -67.55 -35.81 79.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 109.052 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 80.7 p 69.37 -88.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.216 1.807 . . . . 0.0 113.622 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -119.2 119.1 33.12 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.098 -0.377 . . . . 0.0 111.386 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.58 33.56 16.05 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.527 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.606 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -89.89 -27.11 22.54 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.694 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -54.83 -26.0 32.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.641 0.776 . . . . 0.0 112.804 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.19 94.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 0.0 110.856 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.93 -33.41 68.24 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.547 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.676 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.6 -53.38 55.52 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.492 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.2 tp -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.961 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -63.03 -44.38 96.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.16 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 126' ' ' TYR . 44.6 tptt -68.33 -31.34 70.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.676 HG23 ' O ' ' A' ' 139' ' ' LEU . 69.3 t -59.17 -42.45 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.279 0.561 . . . . 0.0 109.489 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -64.31 -35.75 81.88 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.091 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -62.07 -32.02 72.51 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.601 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.22 -41.38 98.34 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.243 0.544 . . . . 0.0 110.038 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 53.8 t -64.56 -43.35 96.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.033 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -61.54 -45.25 94.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.183 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.74 -36.97 85.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.015 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -116.28 59.45 0.45 Allowed Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.815 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.617 ' HB2' ' O ' ' A' ' 147' ' ' VAL . 21.8 t-80 -119.57 -60.25 1.74 Allowed 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.494 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -100.05 150.14 22.77 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.232 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -60.64 -42.07 96.19 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.332 0.395 . . . . 0.0 111.027 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 155' ' ' HIS . 27.7 p-80 -101.06 -2.43 31.6 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.542 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 77.6 m80 72.61 143.96 0.07 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.805 0.69 . . . . 0.0 110.012 -174.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 43.8 m80 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 123.158 0.583 . . . . 0.0 111.981 178.439 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.467 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 14.4 m120 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.21 0.529 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -91.02 64.31 5.34 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.944 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.467 ' CE2' ' HA ' ' A' ' 4' ' ' ASN . 29.0 m-85 -92.68 -136.57 0.17 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.54 19.27 1.69 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.451 ' HB3' HG13 ' A' ' 124' ' ' ILE . 50.9 tt0 53.67 38.83 29.26 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.012 0.91 . . . . 0.0 110.444 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 65.6 mt -92.3 162.28 30.48 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.75 -175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.68 168.6 23.26 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.273 2.649 . . . . 0.0 110.963 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.69 79.12 6.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.114 0.483 . . . . 0.0 110.61 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.22 134.43 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.1 m -96.68 116.18 28.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.849 0.357 . . . . 0.0 110.157 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 HD21 ' HA ' ' A' ' 98' ' ' ASP . 47.4 mt -113.35 176.28 5.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.799 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -109.41 127.24 54.23 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.288 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.413 HD22 ' HB3' ' A' ' 20' ' ' LYS . 47.8 p30 -89.71 -174.34 4.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.111 0.481 . . . . 0.0 111.706 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 39.5 pt -71.41 -14.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.403 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -93.84 -1.61 54.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.774 0.321 . . . . 0.0 111.184 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.46 24.07 68.93 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HB3' HD22 ' A' ' 16' ' ' ASN . 62.6 tttp -101.54 139.53 37.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -82.51 109.82 17.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.08 142.67 23.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.791 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -100.32 133.11 45.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.875 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.415 HG22 ' CE1' ' A' ' 103' ' ' PHE . 20.9 p -68.89 -32.31 71.86 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -70.05 -17.21 63.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.448 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 8.68 12.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.96 105.83 11.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.331 0.586 . . . . 0.0 112.044 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.442 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 56.4 mt-10 -108.63 139.69 43.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.078 175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.81 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 15.1 t-20 -76.05 -75.66 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.004 0.43 . . . . 0.0 110.328 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.55 33.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.249 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 28.51 51.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -123.0 148.97 55.67 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.123 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -65.28 149.86 88.0 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.34 2.027 . . . . 0.0 110.634 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.81 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 67.2 mtm -133.66 145.65 50.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.45 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 92.5 mt -122.63 125.45 72.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.38 122.37 51.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.238 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -106.47 115.87 30.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.531 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 66.3 m-85 -94.21 118.24 31.28 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -146.36 167.03 24.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.574 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -100.01 146.56 26.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.578 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.442 HG22 ' OD2' ' A' ' 74' ' ' ASP . 7.0 t -72.99 -13.75 61.29 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.857 0.36 . . . . 0.0 111.4 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -94.52 2.75 55.69 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.978 0.418 . . . . 0.0 111.293 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 30.1 p -124.82 119.45 28.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.805 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.419 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 52.8 mtmt -104.2 -49.66 0.14 Allowed Pre-proline 0 CA--C 1.56 1.33 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.419 ' HD2' ' H ' ' A' ' 44' ' ' LYS . 55.5 Cg_endo -72.51 -8.96 23.47 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.248 1.966 . . . . 0.0 112.228 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' ' 43' ' ' CYS . 61.3 m -78.88 -15.87 57.78 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.99 56.93 4.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.531 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.452 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 26.1 mmt85 -64.11 -39.93 95.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.443 0.639 . . . . 0.0 109.537 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.562 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 tm-20 -64.04 -55.21 23.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.545 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.45 HD13 ' CE2' ' A' ' 93' ' ' TYR . 43.4 tp -62.12 -41.22 98.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.618 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 58.7 tttm -62.21 -48.64 79.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -63.57 -39.72 95.13 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.245 0.545 . . . . 0.0 110.925 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 49' ' ' GLU . 58.9 mt -65.33 -42.73 94.43 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.466 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.21 -30.33 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.804 0.335 . . . . 0.0 110.301 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.548 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 77.9 mm-40 -59.2 -48.25 82.33 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.786 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -122.02 30.86 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.488 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' ILE . 88.9 t80 -59.12 -34.74 72.4 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.46 -39.69 88.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.607 0.241 . . . . 0.0 110.471 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.28 -42.33 93.28 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 110.87 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.499 ' O ' ' HB ' ' A' ' 64' ' ' THR . 12.0 m0 -65.57 -37.2 85.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.307 0.575 . . . . 0.0 110.468 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -84.37 -8.22 59.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -53.55 -64.24 0.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.61 -31.22 3.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 19.0 m -63.05 -41.83 99.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.065 0.459 . . . . 0.0 110.07 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.76 31.98 79.92 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.194 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.02 131.78 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.603 0.716 . . . . 0.0 111.438 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.481 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 9.1 mmm180 -102.58 141.42 35.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.386 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.596 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 50.0 mt -102.24 138.0 39.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.003 0.43 . . . . 0.0 110.295 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.528 HD12 ' SD ' ' A' ' 34' ' ' MET . 91.8 mt -115.06 113.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.44 113.61 25.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.738 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 14.4 p -121.59 132.13 71.47 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-O 121.466 0.651 . . . . 0.0 111.751 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -88.55 131.55 34.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.557 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 pt -77.67 -16.93 14.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 124.357 1.036 . . . . 0.0 110.864 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.442 ' OD2' HG22 ' A' ' 41' ' ' THR . 29.2 m-20 -80.5 160.66 25.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.987 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.89 171.96 7.25 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.83 0.348 . . . . 0.0 110.982 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -56.5 -41.14 88.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.804 -0.634 . . . . 0.0 114.151 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -62.47 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.07 0.435 . . . . 0.0 111.59 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -72.75 -39.3 66.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.4 0.619 . . . . 0.0 110.925 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.665 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.53 -4.85 12.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.201 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 47.2 mt-30 -63.88 -9.51 15.58 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.013 -0.429 . . . . 0.0 110.39 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.699 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.8 mttm -96.2 -10.51 27.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -63.66 -47.1 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.683 0.754 . . . . 0.0 111.836 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 23.2 mtmt -70.69 -43.13 14.98 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.159 -175.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.5 Cg_endo -61.17 -30.54 88.92 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 121.012 1.141 . . . . 0.0 110.932 174.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -64.96 -41.27 95.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . -60.62 -40.13 90.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.587 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -46.21 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.126 0.489 . . . . 0.0 111.006 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.26 93.67 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.998 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -87.36 -16.18 35.74 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.304 0.552 . . . . 0.0 112.053 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.31 40.42 6.93 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.725 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -89.04 104.36 16.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -99.1 73.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.353 0.597 . . . . 0.0 109.995 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.596 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -137.18 167.23 21.97 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.411 ' CD ' HH21 ' A' ' 67' ' ' ARG . 2.2 mp0 -70.39 102.6 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 48.0 t -92.74 128.36 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.148 0.499 . . . . 0.0 110.465 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.417 HD12 HG23 ' A' ' 69' ' ' ILE . 10.7 mp -124.75 138.07 54.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.349 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.406 ' HG ' ' HB2' ' A' ' 79' ' ' ALA . 8.1 mp -108.02 117.61 34.58 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.47 ' HA ' HD21 ' A' ' 14' ' ' LEU . 63.5 t0 -78.46 115.62 18.29 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.712 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 p -82.6 -9.85 59.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -127.81 -21.76 3.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.4 19.5 60.3 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.918 176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -93.95 -21.57 19.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.249 0.525 . . . . 0.0 112.107 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 24' ' ' THR . 75.0 t80 -63.68 -43.3 97.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 110.542 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -63.06 -33.14 74.79 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.9 176.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 60.6 mtp85 -69.52 -39.59 77.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.168 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.01 83.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.248 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.3 mmt -88.04 -3.3 58.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.737 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.72 44.06 14.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.688 0.756 . . . . 0.0 110.615 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.62 96.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.426 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.9 m -88.4 -58.94 2.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.9 tp -112.37 127.09 55.91 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.951 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -87.52 156.84 53.32 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.458 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.5 Cg_endo -82.17 150.11 72.39 Favored 'Cis proline' 0 C--O 1.242 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.304 -0.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -111.19 134.36 52.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.07 127.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.397 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 72.0 m-85 -128.46 116.95 20.5 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.9 mt -105.52 130.02 57.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.092 0.472 . . . . 0.0 110.993 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.9 t -114.18 133.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.745 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -85.46 -172.27 4.05 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.968 0.414 . . . . 0.0 111.23 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.8 -22.53 68.4 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.706 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -85.08 2.07 45.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.785 0.326 . . . . 0.0 110.711 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.44 65.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.401 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -115.73 153.97 30.41 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.451 HG13 ' HB3' ' A' ' 8' ' ' GLN . 80.8 mt -80.93 114.87 22.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.44 -19.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.403 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.576 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 67.0 t80 -144.33 136.99 26.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.716 0.293 . . . . 0.0 110.587 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.88 135.21 24.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -158.36 122.85 4.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 p -103.79 112.35 25.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.128 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.93 66.52 1.8 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.856 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.649 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 27.9 p90 -69.03 -40.02 78.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.256 0.55 . . . . 0.0 110.26 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 81.5 p 55.47 81.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.764 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 64.72 120.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.032 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.54 55.93 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.85 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.649 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.73 -37.58 6.41 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 1.9 pm0 -60.78 -17.51 49.64 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.235 0.614 . . . . 0.0 111.849 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.44 96.59 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.526 0.679 . . . . 0.0 109.739 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -73.41 -31.95 64.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.354 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.541 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -62.24 -47.89 82.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 tp -68.66 -37.31 77.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 110.072 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.772 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -65.21 -36.06 82.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.266 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 139' ' ' LEU . 66.7 t -60.66 -46.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.172 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 5.4 mmp_? -68.76 -36.19 78.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.573 0.701 . . . . 0.0 109.767 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 142' ' ' LYS . 34.6 tt0 -62.06 -27.27 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.19 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 94.4 mt -62.15 -37.91 87.0 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.21 -42.94 98.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.596 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -76.72 -10.38 59.34 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.555 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -66.48 -36.39 82.64 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -79.87 157.8 41.94 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 70.73 13.44 7.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.314 0.578 . . . . 0.0 110.449 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -62.54 100.47 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.384 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.1 t60 59.53 86.68 0.09 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.792 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 25.8 m80 69.28 174.13 0.29 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.894 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -116.09 153.05 32.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.389 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 57.5 t60 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.371 -178.273 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.85 0.357 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.517 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 23.8 m -86.56 85.34 7.3 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.208 0.528 . . . . 0.0 111.405 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -116.16 -120.08 0.31 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.42 13.48 0.66 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.445 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 61.7 tt0 50.38 33.43 7.59 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.867 0.841 . . . . 0.0 110.98 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.7 mt -80.85 156.11 72.68 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.111 -176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.56 155.3 63.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.871 2.381 . . . . 0.0 110.798 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 80.04 1.28 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.125 0.488 . . . . 0.0 111.315 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.89 132.77 70.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.753 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.8 m -92.42 105.33 17.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.308 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 71.2 mt -104.41 178.15 4.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.971 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HD2' ' C ' ' A' ' 19' ' ' GLY . 3.2 tppp? -108.54 135.91 49.02 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.105 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.69 -179.96 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.404 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.477 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 42.3 pt -68.32 -11.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -96.24 -4.66 41.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 111.098 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.471 ' C ' ' HD2' ' A' ' 15' ' ' LYS . . . 82.32 20.28 62.75 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.576 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.43 149.6 27.72 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 m -75.12 122.69 23.98 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.057 0.455 . . . . 0.0 110.875 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.09 135.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.645 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 94.4 mt-30 -95.62 133.99 39.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.473 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.6 p -67.41 -27.74 67.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -63.56 -33.74 76.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.204 0.526 . . . . 0.0 110.224 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -105.03 13.0 31.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.246 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.35 124.11 29.1 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.155 0.502 . . . . 0.0 112.105 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -146.74 173.81 12.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.258 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.456 ' OD1' ' HB2' ' A' ' 32' ' ' LYS . 8.2 p30 -112.61 -56.71 2.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.082 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.35 39.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.377 0.671 . . . . 0.0 109.651 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.24 26.86 72.77 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.741 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.456 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 45.6 mmtm -117.19 152.84 49.53 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 122.239 0.216 . . . . 0.0 110.713 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.81 151.83 78.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.625 2.217 . . . . 0.0 111.398 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.494 ' SD ' HD13 ' A' ' 69' ' ' ILE . 56.7 mtm -136.32 154.53 50.83 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.476 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 84.0 mt -127.01 125.66 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.0 118.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.8 m -102.93 123.43 46.54 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.563 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -97.15 115.99 28.54 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.675 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -137.3 166.13 24.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.67 0.606 . . . . 0.0 111.212 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.03 161.46 15.49 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.669 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.3 p -65.14 -32.79 74.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -94.79 63.92 2.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.541 0.686 . . . . 0.0 110.822 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.3 p -61.14 128.08 34.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.568 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.458 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 29.4 ttpp -117.26 -39.05 0.06 OUTLIER Pre-proline 0 CA--C 1.56 1.331 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.458 ' CD ' ' H ' ' A' ' 44' ' ' LYS . 94.5 Cg_endo -85.19 21.02 1.15 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.584 1.522 . . . . 0.0 112.578 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 56.0 m 61.69 15.97 7.39 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.171 0.588 . . . . 0.0 111.277 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt 47.26 72.38 0.25 Allowed 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.45 -47.25 84.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.013 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.601 ' O ' HG13 ' A' ' 53' ' ' ILE . 15.5 pt-20 -58.43 -56.51 21.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 111.237 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 34.6 tp -65.73 -42.85 90.53 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.975 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -65.08 -47.47 77.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.02 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.02 -41.47 99.56 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 120.822 0.344 . . . . 0.0 110.976 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.0 mt -65.55 -42.53 93.26 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.719 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.9 -40.06 66.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 110.654 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -62.45 -46.43 88.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.29 26.86 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.615 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.3 t80 -59.79 -39.44 84.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.276 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.494 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.81 -42.51 81.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.3 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -67.21 -40.51 86.45 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.42 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 32.0 mm-40 -73.6 -15.8 61.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.12 -45.73 93.48 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.799 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.14 -68.23 0.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.304 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -62.83 -31.32 72.3 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.722 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 63.17 45.37 95.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.147 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.79 131.68 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.413 0.625 . . . . 0.0 112.295 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 13.3 mmm180 -96.57 159.02 15.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.948 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 76.0 mt -121.01 129.41 53.38 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.891 0.377 . . . . 0.0 111.285 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.494 HD13 ' SD ' ' A' ' 34' ' ' MET . 89.8 mt -109.32 108.64 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.81 107.43 19.21 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.01 131.47 56.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 CA-C-O 121.913 0.863 . . . . 0.0 112.396 -175.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB3' HG23 ' A' ' 82' ' ' VAL . 26.1 p -84.16 127.89 34.21 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.465 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 46.4 pt -83.46 -15.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.346 1.029 . . . . 0.0 111.001 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -85.28 152.09 23.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.014 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.16 171.36 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.19 -49.41 63.54 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.76 -41.86 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.748 0.774 . . . . 0.0 111.178 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -67.74 -38.27 83.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.417 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -72.56 -4.97 33.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.321 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -62.73 -9.51 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.961 -0.462 . . . . 0.0 110.948 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.698 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 98.9 mttt -92.68 -11.26 34.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.523 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 61.3 t -65.3 -49.28 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.631 0.729 . . . . 0.0 112.356 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 14.1 mtpp -71.04 -38.9 7.61 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.02 -28.41 80.43 Favored 'Trans proline' 0 C--N 1.364 1.37 0 CA-C-N 120.051 1.054 . . . . 0.0 110.666 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.08 -45.92 91.4 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.458 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -60.43 -36.94 79.37 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.787 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.03 -32.25 73.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.159 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.77 -44.58 5.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.772 -0.727 . . . . 0.0 113.902 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.458 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 17.9 p30 -82.29 -15.77 51.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.27 58.44 3.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.456 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -78.05 112.79 15.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.99 35.79 1.51 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.714 0.769 . . . . 0.0 110.754 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.505 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -141.21 -171.33 3.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.478 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.39 137.36 32.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.628 0.728 . . . . 0.0 112.689 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 19.4 t -106.71 140.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.965 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.1 131.56 54.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -111.98 95.06 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.612 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -77.49 116.07 17.76 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.085 174.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.3 p -89.82 -14.35 34.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.423 ' ND2' ' HB2' ' A' ' 102' ' ' ASP . 5.8 t30 -104.07 -39.19 6.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.97 0.414 . . . . 0.0 110.983 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.64 43.09 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.423 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . 19.3 t70 -89.76 -29.59 18.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.0 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CE1' HG21 ' A' ' 24' ' ' THR . 86.0 t80 -60.58 -43.34 97.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.491 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 21.8 pttp -62.44 -38.2 88.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.709 0.29 . . . . 0.0 111.279 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -66.01 -42.63 89.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.37 80.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.897 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.436 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 2.1 mmt -84.9 -5.06 59.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.264 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 107' ' ' MET . 93.0 m-20 71.43 35.47 1.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.297 0.373 . . . . 0.0 111.803 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.07 108.61 15.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 120.931 0.396 . . . . 0.0 110.906 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.9 m -100.66 -64.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 tp -95.46 126.25 40.63 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -94.31 147.73 33.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.66 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.0 Cg_endo -82.75 167.05 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.117 -1.201 . . . . 0.0 112.971 1.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -131.73 141.94 49.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.45 127.34 73.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 O-C-N 123.344 0.402 . . . . 0.0 111.507 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -126.17 118.45 25.24 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.639 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 67.8 mt -106.96 131.72 56.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.201 0.524 . . . . 0.0 110.763 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.4 131.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -74.82 -179.54 4.26 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.009 0.818 . . . . 0.0 112.557 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.2 -30.83 78.8 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.749 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' THR . 3.3 t-20 -67.25 -41.07 86.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.169 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 121.5 21.23 3.06 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.7 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.56 163.45 14.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.02 109.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.0 -40.22 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.27 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 70.1 t80 -128.29 122.49 31.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.809 0.338 . . . . 0.0 110.62 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.5 120.91 29.36 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.116 0.484 . . . . 0.0 110.82 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -136.79 105.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.8 p -97.34 123.96 41.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 92.71 49.29 2.76 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.509 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.66 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 1.0 OUTLIER -90.11 135.82 33.43 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 173.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.6 p -123.67 69.0 1.03 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.501 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 69.85 119.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.176 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.04 8.8 35.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.67 -18.1 46.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.77 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -59.73 -19.84 52.61 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.78 95.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.39 0.614 . . . . 0.0 109.907 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.34 -32.94 69.14 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.666 ' O ' HG22 ' A' ' 143' ' ' VAL . 10.8 mp -62.02 -51.35 68.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -36.87 74.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.615 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.3 ttpp -60.03 -48.17 82.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.049 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.595 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 55.0 tptt -66.16 -30.27 70.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.213 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 139' ' ' LEU . 70.2 t -58.88 -44.64 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 4.6 mmp_? -68.32 -37.86 80.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.347 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.615 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.5 mm-40 -59.73 -36.29 76.28 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.722 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 83.1 mt -59.74 -42.35 92.96 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.024 0.44 . . . . 0.0 110.27 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.99 -46.21 92.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.184 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -69.33 -47.84 63.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.049 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -72.0 -37.42 69.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.904 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 107.77 -57.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.696 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -126.8 -76.26 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.621 0.248 . . . . 0.0 111.606 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -120.97 -46.47 2.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.964 0.411 . . . . 0.0 110.789 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -147.05 -34.44 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.418 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -119.12 167.38 11.86 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -61.14 -34.94 75.8 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.778 177.138 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.416 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 m -146.25 65.92 1.2 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.36 0.6 . . . . 0.0 110.536 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.438 ' O ' HG12 ' A' ' 118' ' ' VAL . 21.0 m-85 -97.37 -134.23 0.23 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HB1' HD22 ' A' ' 9' ' ' LEU . . . -145.24 21.14 1.56 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.792 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 51.0 tt0 50.28 38.14 16.83 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.878 0.847 . . . . 0.0 109.504 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.574 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 1.0 OUTLIER -103.9 147.93 35.05 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.175 -174.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.632 ' HD2' ' SD ' ' A' ' 107' ' ' MET . 48.1 Cg_exo -55.14 146.7 58.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.647 2.898 . . . . 0.0 112.474 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 25' ' ' ASN . . . -72.44 90.45 1.31 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.755 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.4 132.7 68.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 p -77.5 100.22 5.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.187 0.517 . . . . 0.0 109.964 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.41 HD23 HD23 ' A' ' 96' ' ' LEU . 4.7 tp -106.33 177.23 4.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.177 -176.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' CE ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -118.76 137.75 53.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.02 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -98.9 -178.8 4.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.041 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 95' ' ' VAL . 33.2 pt -67.05 -19.55 25.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.674 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.42 -10.81 59.44 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.326 0.584 . . . . 0.0 110.236 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.43 17.45 75.95 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.427 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 88.3 tttt -95.71 137.12 35.22 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.235 -0.483 . . . . 0.0 109.9 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.486 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 99.7 m -74.6 100.69 3.99 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.6 p -117.17 132.3 67.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.294 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 48.3 mt-30 -82.62 136.7 34.72 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.146 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.574 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 20.1 p -64.15 -36.24 83.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.43 -176.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 11' ' ' ALA . 64.1 t30 -69.43 -16.95 63.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.354 . . . . 0.0 111.575 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -110.08 6.74 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.08 113.56 22.94 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.68 154.94 41.65 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.716 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 25.6 t30 -87.53 -68.19 0.77 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 174.45 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.581 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.416 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 150.08 -13.58 0.97 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.507 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.2 mptm? -91.4 147.96 36.53 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.753 -0.224 . . . . 0.0 110.61 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.574 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 17.9 Cg_exo -65.06 156.6 61.81 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.199 2.599 . . . . 0.0 112.832 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 70.6 mtm -138.67 159.75 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.74 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.43 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 81.4 mt -129.65 128.63 65.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.6 mt -99.81 122.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.9 m -115.84 122.82 46.52 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.02 0.438 . . . . 0.0 110.602 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 56.3 m-85 -88.71 117.14 27.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 22.0 p90 -134.91 167.9 20.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 123.439 0.462 . . . . 0.0 110.681 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.611 ' HB1' ' SG ' ' A' ' 43' ' ' CYS . . . -110.5 149.01 30.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -32.38 73.74 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.933 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -99.5 10.46 41.33 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.611 ' SG ' ' HB1' ' A' ' 40' ' ' ALA . 86.8 m -104.85 137.78 42.11 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.532 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.586 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 66.9 mttm -130.62 -57.3 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.754 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 8.4 Cg_exo -68.65 -25.53 34.14 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.137 1.892 . . . . 0.0 111.304 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 m -66.08 -23.67 66.56 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.743 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt -87.18 61.54 6.78 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.923 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.436 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . 12.0 mmm180 -60.21 -43.51 95.89 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.681 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.586 ' O ' HG13 ' A' ' 53' ' ' ILE . 74.0 tt0 -52.63 -64.37 0.84 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.663 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD12 ' CE2' ' A' ' 93' ' ' TYR . 34.2 tp -62.85 -41.54 99.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.272 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.05 -47.68 83.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.054 0.221 . . . . 0.0 111.281 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.42 87.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.682 0.277 . . . . 0.0 111.042 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.9 mt -65.26 -41.01 90.46 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.83 -30.3 32.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.056 0.455 . . . . 0.0 111.016 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -82.67 -37.61 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.978 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.24 23.99 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -62.65 -35.09 78.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.764 0.316 . . . . 0.0 111.115 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.35 88.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.27 -43.87 96.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.423 ' NE1' HD12 ' A' ' 140' ' ' ILE . 13.8 m0 -68.7 -31.65 70.9 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.701 0.762 . . . . 0.0 110.136 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -81.36 -6.6 59.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.575 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.68 -51.76 46.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.09 -34.23 0.55 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.422 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 15.3 m -60.57 -42.58 96.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.87 74.0 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.839 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.574 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 11.2 p -75.62 127.43 37.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.112 0.482 . . . . 0.0 111.07 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -106.39 163.58 12.73 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 53' ' ' ILE . 61.2 mt -109.05 129.7 55.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.09 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.45 HG21 HD13 ' A' ' 96' ' ' LEU . 97.3 mt -101.25 107.01 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 39' ' ' PHE . . . -93.89 113.81 25.91 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.307 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.4 129.49 67.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 121.379 0.609 . . . . 0.0 111.418 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 97' ' ' LEU . 39.4 p -83.94 130.47 34.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.311 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.0 pt -72.2 -23.75 21.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.35 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -82.54 147.11 28.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 89.7 mt-10 -61.48 163.53 6.74 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.491 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.13 -39.48 57.92 Favored Glycine 0 C--O 1.23 -0.124 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -174.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -63.87 -38.94 92.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 117.386 0.593 . . . . 0.0 111.114 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -79.89 -37.24 35.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.306 0.574 . . . . 0.0 110.096 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -65.53 -3.9 5.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.793 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.12 -11.21 8.03 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.016 -0.427 . . . . 0.0 110.54 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.722 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.0 mttp -96.55 -10.91 26.21 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.387 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 79' ' ' ALA . 14.6 t -66.53 -47.12 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-O 121.668 0.747 . . . . 0.0 111.627 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 17' ' ' ILE . 41.7 mtpt -64.13 -45.06 79.23 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.054 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.8 Cg_endo -62.08 -29.82 81.78 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.115 1.21 . . . . 0.0 111.19 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.722 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -63.09 -41.46 99.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.29 86.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.167 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.27 -46.56 66.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.355 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.5 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.123 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -91.37 -11.14 38.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.912 0.356 . . . . 0.0 111.706 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.28 38.83 28.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -82.19 111.8 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 0.0 110.5 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -97.07 60.38 1.7 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.084 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.461 ' CE2' HD12 ' A' ' 50' ' ' LEU . 6.0 m-85 -138.18 -177.79 4.99 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.961 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.98 117.75 31.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.648 ' O ' HG22 ' A' ' 17' ' ' ILE . 12.4 t -99.27 139.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.24 -174.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.45 HD13 HG21 ' A' ' 69' ' ' ILE . 10.9 mp -125.92 142.89 51.31 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.795 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.498 ' HA ' ' OG ' ' A' ' 72' ' ' SER . 8.7 mp -113.74 121.56 44.45 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 59.8 t0 -74.04 115.14 13.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 118.176 -1.41 . . . . 0.0 107.96 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 p -96.02 -6.0 39.81 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.962 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -117.65 -39.39 3.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.764 0.316 . . . . 0.0 111.647 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -8.51 68.58 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.16 -30.66 66.73 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.868 -0.666 . . . . 0.0 111.388 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.495 ' O ' ' HG2' ' A' ' 107' ' ' MET . 44.7 t80 -61.43 -43.44 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.817 -176.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.28 -42.18 94.91 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 110.265 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -69.56 -42.31 74.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.53 94.78 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.138 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.632 ' SD ' ' HD2' ' A' ' 10' ' ' PRO . 39.2 mmm -84.49 -24.12 29.56 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.204 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 129' ' ' THR . 55.5 t30 75.23 100.89 0.07 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.778 0.831 . . . . 0.0 111.041 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.04 132.78 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -84.52 -96.01 0.06 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.561 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.4 pt? -119.47 3.34 11.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.16 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.2 pt 61.29 151.06 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 124.828 1.251 . . . . 0.0 111.888 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.485 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.3 Cg_endo -76.58 157.89 97.48 Favored 'Cis proline' 0 N--CA 1.479 0.633 0 C-N-CA 124.19 -1.171 . . . . 0.0 112.303 -1.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -114.78 136.21 53.33 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.2 t -116.67 127.27 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.767 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.415 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 77.9 m-85 -124.93 113.0 17.27 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.0 mt -100.68 124.75 54.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-O 121.027 0.441 . . . . 0.0 110.049 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.464 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 54.1 t -116.87 132.88 65.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.774 -175.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.97 164.58 24.28 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.649 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.1 -20.64 50.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.612 -0.267 . . . . 0.0 112.984 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -73.57 -5.65 41.61 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.279 0.561 . . . . 0.0 110.196 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.15 19.73 64.26 Favored Glycine 0 CA--C 1.5 -0.863 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.763 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 74.6 mmtt -116.87 151.1 37.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.3 mt -77.95 127.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 10.9 p -104.92 -28.61 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.809 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.444 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.7 t80 -141.56 133.19 27.03 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.793 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -137.12 123.78 21.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -151.02 111.79 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.987 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.427 HG22 ' HB1' ' A' ' 114' ' ' ALA . 19.6 p -93.51 111.63 23.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 83.57 68.11 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.986 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.586 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.7 p90 -68.86 -39.66 79.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 64.2 p 53.31 80.67 0.1 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.296 1.038 . . . . 0.0 113.581 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.96 108.51 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.1 0.96 . . . . 0.0 112.776 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.97 -2.77 27.16 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.586 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -72.2 -41.81 52.34 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.1 -0.55 . . . . 0.0 112.783 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.436 ' OE2' ' HB3' ' A' ' 48' ' ' ARG . 1.7 pm0 -53.59 -24.17 13.04 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.61 88.01 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.513 0.673 . . . . 0.0 110.674 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -73.4 -32.3 64.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.841 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.78 -47.94 81.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.439 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.423 HD12 ' NE1' ' A' ' 60' ' ' TRP . 8.8 tp -66.57 -33.49 63.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 110.278 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.67 -51.59 69.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.779 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.502 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 31.1 mmmt -68.47 -34.42 75.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.196 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.4 t -59.97 -45.37 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.045 0.45 . . . . 0.0 110.778 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -72.83 -29.33 63.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.466 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.49 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -64.99 -30.02 70.98 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.586 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 95.6 mt -60.84 -39.98 91.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.319 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.5 t -60.62 -46.9 94.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.658 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -67.18 -34.64 77.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.227 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.4 -37.75 87.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.29 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.43 -49.38 65.62 Favored Glycine 0 C--N 1.328 0.117 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.265 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 155' ' ' HIS . 58.3 m-70 -130.08 99.13 4.96 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.937 0.398 . . . . 0.0 110.464 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -70.23 -41.05 74.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.412 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -97.0 91.4 5.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.01 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 63.5 111.02 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.995 0.809 . . . . 0.0 111.431 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 151' ' ' HIS . 38.5 t60 -58.91 -48.99 79.49 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.198 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.6 p80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.356 179.056 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.1 m -146.12 73.36 1.33 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.531 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.468 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 72.7 m-85 -101.54 -133.78 0.29 Allowed 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.551 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -149.45 9.25 0.72 Allowed 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.991 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 47.42 67.69 0.77 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.684 0.754 . . . . 0.0 110.824 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 24' ' ' THR . 32.4 mt -118.84 161.5 35.84 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.852 -175.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.12 160.05 46.59 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.706 2.271 . . . . 0.0 111.169 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.6 81.25 2.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.208 0.528 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.34 136.47 59.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.824 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -98.07 116.2 29.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.454 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 98' ' ' ASP . 56.3 mt -123.77 177.19 5.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.928 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -107.18 140.57 39.84 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.769 0.318 . . . . 0.0 110.798 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -91.31 -173.47 3.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.45 -13.78 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -90.03 -10.98 42.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.98 19.82 66.59 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.8 149.06 21.53 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.7 m -79.35 110.02 14.24 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.272 0.558 . . . . 0.0 110.187 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 137.07 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.051 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -95.78 133.68 39.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.496 HG21 ' CE1' ' A' ' 103' ' ' PHE . 23.6 p -65.86 -32.41 73.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.287 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.6 -31.73 73.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.951 0.405 . . . . 0.0 110.778 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.573 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -103.02 8.78 38.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.343 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 36.3 tp -65.91 121.71 15.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.27 156.92 46.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.22 0.533 . . . . 0.0 112.002 -174.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.603 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 45.2 t-20 -99.5 -83.23 0.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.583 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 170.02 25.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.92 0.762 . . . . 0.0 110.775 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.47 -2.37 39.75 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.233 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -110.08 150.23 41.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.408 0.146 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -68.53 159.88 51.64 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 123.218 2.612 . . . . 0.0 112.782 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.603 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 72.5 mtm -139.83 153.11 46.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.106 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 91.1 mt -128.33 127.71 67.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.57 124.56 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -113.04 122.75 48.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.698 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.472 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 57.9 m-85 -93.85 122.41 36.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.518 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 25.4 p90 -140.38 165.16 28.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 123.502 0.501 . . . . 0.0 111.542 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.88 151.37 24.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.897 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.6 p -78.83 30.67 0.2 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -158.37 -33.96 0.07 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.027 0.442 . . . . 0.0 111.086 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.52 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 34.2 m -77.92 66.21 3.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.478 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 39.6 ttpt -62.72 -50.31 78.51 Favored Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 44' ' ' LYS . 37.8 Cg_endo -67.21 -17.18 50.04 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.12 1.88 . . . . 0.0 112.045 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 59.9 m -78.27 -14.64 59.34 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.876 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 15.0 mt -81.17 57.66 3.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.953 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -58.59 -42.35 87.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.551 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.547 ' CD ' HG23 ' A' ' 115' ' ' VAL . 75.2 tt0 -55.08 -64.69 0.76 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.959 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.539 HD11 ' CE2' ' A' ' 93' ' ' TYR . 44.0 tp -61.85 -41.15 97.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.6 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.42 -47.84 83.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.98 -42.48 76.48 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.999 0.428 . . . . 0.0 111.304 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.3 mt -64.38 -41.66 93.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.164 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -52.63 -42.0 64.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.711 0.291 . . . . 0.0 110.926 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.59 -42.26 91.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.17 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.8 m -105.24 15.65 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.25 -38.44 83.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.38 85.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.834 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.16 -36.24 71.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.837 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -69.15 -38.35 78.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.505 0.669 . . . . 0.0 109.553 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -76.59 -11.13 59.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.151 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.341 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -134.96 -45.51 0.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.802 0.334 . . . . 0.0 110.549 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.13 23.59 77.1 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.83 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -78.83 129.2 37.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.0 0.429 . . . . 0.0 111.379 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.8 mtm-85 -104.77 165.71 10.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.47 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.543 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 73.9 mt -109.84 140.02 44.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -113.8 106.47 20.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.28 112.19 23.98 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.28 -176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.3 p -110.72 132.03 60.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 CA-C-O 121.636 0.731 . . . . 0.0 112.229 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.504 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 20.8 p -81.29 141.39 34.12 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.871 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.9 pt -95.73 -6.91 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.463 1.102 . . . . 0.0 111.09 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.504 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 13.9 p-10 -93.88 152.35 18.93 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -63.13 174.04 1.27 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.45 88.91 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -172.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -46.59 81.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.549 0.674 . . . . 0.0 111.012 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -69.62 -41.77 75.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.76 -6.59 33.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.238 -176.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -64.36 -14.95 59.32 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.346 0.593 . . . . 0.0 109.941 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.743 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.9 mttp -94.16 -6.23 45.32 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.873 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 79' ' ' ALA . 51.2 t -63.96 -48.37 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.569 0.7 . . . . 0.0 111.747 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.504 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 19.4 mtpp -68.17 -42.32 29.97 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.221 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.5 Cg_endo -62.33 -28.99 79.17 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 120.902 1.068 . . . . 0.0 110.783 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.743 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.5 mt -64.16 -41.69 97.04 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 83' ' ' LYS . . . -58.49 -45.39 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.677 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.93 -40.68 91.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.301 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.06 88.56 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.821 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -89.42 -14.42 35.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.993 0.396 . . . . 0.0 112.011 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.96 12.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.431 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.429 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 39.3 m0 -79.02 96.44 5.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.268 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.74 68.67 10.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 111.93 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.543 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 4.5 m-85 -144.03 177.04 8.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.98 113.48 25.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.81 0.814 . . . . 0.0 109.43 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.71 137.3 21.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.005 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 12.1 tp -115.63 131.18 57.01 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.9 tp -105.71 100.87 10.42 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.301 -176.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.54 ' HA ' HD23 ' A' ' 14' ' ' LEU . 66.3 t0 -77.89 115.22 17.47 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 118.13 -1.428 . . . . 0.0 108.304 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.2 p -108.73 -6.04 16.08 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.934 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -93.71 -41.27 9.78 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.419 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.59 8.49 76.98 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.183 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -99.43 -22.31 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.199 . . . . 0.0 111.302 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.496 ' CE1' HG21 ' A' ' 24' ' ' THR . 71.4 t80 -62.67 -44.46 96.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.45 -32.76 74.53 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.326 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -68.96 -41.55 77.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.098 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.35 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.8 mmt -83.72 -9.4 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.431 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.9 t30 61.18 47.03 7.47 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.424 0.63 . . . . 0.0 110.654 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.62 96.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -81.36 -55.34 4.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.537 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.03 147.79 45.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 pt -103.43 154.49 37.76 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.627 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.1 Cg_endo -77.71 153.45 93.9 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 124.101 -1.208 . . . . 0.0 112.598 0.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.472 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -112.36 123.98 51.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.547 HG23 ' CD ' ' A' ' 49' ' ' GLU . 17.9 t -108.4 130.04 61.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.08 0.467 . . . . 0.0 112.133 -173.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 96.5 m-85 -131.71 112.96 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.616 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.3 mt -99.91 130.29 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.864 0.364 . . . . 0.0 110.395 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 53.5 t -113.46 133.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.779 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -85.29 -175.91 5.91 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.314 0.384 . . . . 0.0 111.269 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.29 -31.07 77.93 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.993 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -73.5 -6.0 43.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.326 0.584 . . . . 0.0 110.501 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.407 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 78.63 35.04 33.39 Favored Glycine 0 N--CA 1.433 -1.546 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.764 178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 47.0 mmtm -126.36 156.33 40.66 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.0 mt -76.54 113.48 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.262 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.81 -28.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.913 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.462 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 86.7 t80 -139.23 127.55 22.76 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.507 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -132.06 125.48 31.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -144.87 106.06 4.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.64 108.1 18.93 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.035 -177.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 77.3 1.26 Allowed Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.52 -0.764 . . . . 0.0 114.657 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.627 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -104.53 143.54 32.91 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.002 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 73.9 p -104.68 -49.5 3.51 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.063 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.64 147.41 25.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.689 0.281 . . . . 0.0 111.384 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.89 28.41 73.08 Favored Glycine 0 N--CA 1.453 -0.231 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.105 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.415 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.3 -33.1 7.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.242 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -56.01 -20.64 17.48 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.466 0.706 . . . . 0.0 112.439 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.76 93.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.39 0.614 . . . . 0.0 110.215 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -70.51 -37.35 74.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.373 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.581 ' O ' HG21 ' A' ' 143' ' ' VAL . 10.6 mp -61.43 -48.21 82.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.208 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -32.0 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.03 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.7 ttmt -61.06 -50.21 74.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.574 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 45.1 mttp -68.69 -29.86 68.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 139' ' ' LEU . 54.5 t -59.31 -45.31 93.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.109 0.48 . . . . 0.0 109.898 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -68.38 -34.35 75.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.404 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 62.7 mm-40 -56.41 -40.88 75.43 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.146 0.498 . . . . 0.0 110.322 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 49.7 mt -64.51 -40.95 96.6 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.593 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.21 -23.42 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.587 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -60.51 -23.29 64.43 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -95.79 -6.17 40.17 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 120.948 0.404 . . . . 0.0 111.828 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.16 -166.58 44.44 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.156 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -95.07 -0.77 53.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.865 0.364 . . . . 0.0 111.544 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -129.42 -94.7 0.41 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.265 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -157.13 129.84 7.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.0 t60 57.7 25.0 11.26 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.102 0.477 . . . . 0.0 109.774 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 33.4 p80 48.85 22.4 0.55 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.466 1.106 . . . . 0.0 112.601 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.633 -0.699 . . . . 0.0 110.004 -179.301 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 43.4 m -153.33 67.06 0.77 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.803 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -88.71 -124.03 0.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.067 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.62 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -151.43 16.75 0.72 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.844 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.411 ' OE1' ' HD2' ' A' ' 123' ' ' LYS . 45.2 tt0 50.93 41.49 27.07 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.802 0.81 . . . . 0.0 110.418 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 65.7 mt -87.74 155.74 53.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.71 156.85 55.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.302 2.668 . . . . 0.0 110.875 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.69 84.59 3.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.008 0.432 . . . . 0.0 111.671 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.18 138.84 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 p -90.83 113.62 25.82 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.353 0.597 . . . . 0.0 111.776 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 6.1 mp -107.41 167.22 10.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.196 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -112.45 125.87 54.7 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -87.54 -169.15 2.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.87 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.4 pt -75.48 -12.76 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.537 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.26 -11.74 45.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.067 0.461 . . . . 0.0 110.732 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 14.34 72.27 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -92.43 141.57 28.38 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.103 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -77.58 117.7 19.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.774 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.0 162.32 16.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.286 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 49.0 mt-30 -119.77 132.33 55.59 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.413 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.8 p -67.37 -32.25 73.04 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.26 -36.91 85.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 111.021 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.513 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -103.46 12.5 35.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.597 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.83 123.15 30.13 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.232 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.519 ' HA ' ' HE1' ' A' ' 34' ' ' MET . 8.1 pt-20 -148.03 162.61 39.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.656 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -85.74 -71.93 0.51 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.113 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.64 47.23 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.183 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' HA2' ' CB ' ' A' ' 5' ' ' THR . . . 80.08 26.86 54.56 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.903 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -122.94 151.66 61.54 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 122.22 0.208 . . . . 0.0 111.018 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.34 155.01 60.98 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.929 2.419 . . . . 0.0 111.403 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.519 ' HE1' ' HA ' ' A' ' 28' ' ' GLU . 20.5 mtt -139.99 165.45 27.31 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -171.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.633 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.5 mt -138.03 125.22 28.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 84.3 mt -101.83 131.2 50.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.961 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 m -118.93 122.63 42.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 111.234 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 54.4 m-85 -94.45 125.82 39.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.249 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -137.87 169.82 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 123.722 0.639 . . . . 0.0 111.086 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.77 -169.24 1.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.774 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -41.88 79.05 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -148.65 101.2 3.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.418 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 46' ' ' CYS . 47.9 t -152.26 153.39 33.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.855 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 51.4 mtmt -132.45 -62.78 0.02 OUTLIER Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 56.3 Cg_endo -70.27 -22.24 30.0 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.474 2.116 . . . . 0.0 114.157 -174.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.683 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 64.8 m -72.5 -21.46 61.2 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.6 68.78 9.95 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -61.5 -45.67 93.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.659 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.521 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.29 -44.94 50.68 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.6 -41.99 98.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.256 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.82 -47.0 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.743 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.42 72.17 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.985 0.422 . . . . 0.0 111.368 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.3 mt -63.82 -30.92 51.21 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.1 -38.53 79.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.485 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -73.89 -39.72 63.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.781 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -107.03 17.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -59.75 -37.83 80.08 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 122.433 0.293 . . . . 0.0 111.701 -177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.07 81.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.757 0.313 . . . . 0.0 110.825 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.09 -41.91 90.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.924 0.392 . . . . 0.0 111.41 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -68.83 -34.91 76.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.521 0.677 . . . . 0.0 110.748 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -85.15 -7.1 59.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.24 -60.62 3.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.87 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.23 -32.68 1.56 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.19 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -61.78 -41.51 97.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.38 32.09 29.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.165 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 t -67.94 122.55 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.204 0.526 . . . . 0.0 111.936 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -110.14 129.85 55.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.633 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 39.8 mt -97.53 142.96 28.72 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 96' ' ' LEU . 91.4 mt -123.75 116.88 49.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.8 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.63 29.23 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.5 p -123.14 127.45 74.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.43 0.633 . . . . 0.0 111.145 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -90.14 148.76 22.78 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.703 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.3 pt -71.29 -17.69 19.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.804 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.26 164.77 16.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.973 0.416 . . . . 0.0 111.757 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.8 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 3.4 pt-20 -92.65 -88.75 0.21 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.515 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -119.92 -68.86 0.3 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.14 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -41.41 -65.36 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 112.168 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.37 -41.71 89.06 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.002 0.43 . . . . 0.0 112.144 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.472 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.38 -2.35 16.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 98.2 mt-30 -57.36 -21.62 36.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.932 0.396 . . . . 0.0 111.068 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.726 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.2 mttp -83.55 -12.82 55.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.853 0.461 . . . . 0.0 111.417 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 79' ' ' ALA . 58.4 t -64.69 -48.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.52 0.676 . . . . 0.0 112.504 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.7 OUTLIER -69.02 -39.77 14.14 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 6.6 Cg_endo -59.77 -32.07 94.99 Favored 'Trans proline' 0 C--N 1.357 1.025 0 CA-C-N 120.074 1.062 . . . . 0.0 110.002 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 92.5 mt -63.73 -41.78 97.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.439 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -55.48 -45.49 76.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.343 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.68 -46.47 46.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.244 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.75 -45.23 96.19 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.255 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.09 -30.66 58.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.681 0.277 . . . . 0.0 111.404 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.42 46.84 3.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.06 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.5 m0 -80.99 117.58 21.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -96.13 27.13 3.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.724 0.773 . . . . 0.0 109.863 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.62 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -117.78 -179.97 3.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.855 -177.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -84.77 128.79 34.78 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.024 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.439 ' C ' HD12 ' A' ' 96' ' ' LEU . 24.3 t -106.98 128.24 61.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 9.6 mp -130.47 148.52 52.29 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.259 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.455 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.3 mp -118.06 124.97 49.39 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.8 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 65.8 t0 -67.65 113.42 5.43 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 118.981 -1.087 . . . . 0.0 108.258 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 t -89.81 -6.39 55.96 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.861 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -104.94 -27.0 11.95 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 120.955 0.407 . . . . 0.0 110.34 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.51 21.4 79.55 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -113.66 -20.62 11.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.637 -0.281 . . . . 0.0 111.286 -176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.413 ' CE1' HG21 ' A' ' 24' ' ' THR . 45.3 t80 -62.91 -39.75 95.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 105' ' ' ARG . 18.9 ptpt -52.16 -47.04 65.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.252 173.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.487 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 50.0 mtm-85 -71.89 -40.25 69.03 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.076 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.75 -42.16 88.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.495 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 33.3 mmm -92.64 -10.72 36.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.445 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 62.11 88.24 0.09 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.761 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.42 HG12 HG23 ' A' ' 112' ' ' ILE . 66.7 t -92.88 129.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.251 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -79.28 -95.72 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.624 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.5 pt? -116.14 6.09 13.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.405 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.6 pt 61.1 152.24 0.1 Allowed Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 124.579 1.151 . . . . 0.0 111.06 -175.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 87.0 Cg_endo -75.58 160.44 96.05 Favored 'Cis proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.794 -0.919 . . . . 0.0 112.973 0.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.476 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.7 131.74 54.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.534 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.73 129.38 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 80.8 m-85 -127.71 115.25 18.43 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 68.3 mt -100.52 132.74 45.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 CA-C-O 121.271 0.558 . . . . 0.0 110.468 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.433 ' HB ' ' H ' ' A' ' 34' ' ' MET . 57.1 t -106.43 126.85 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.86 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.438 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 7.9 t70 -70.7 162.18 29.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.479 1.112 . . . . 0.0 110.56 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.61 35.39 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.471 -0.331 . . . . 0.0 113.807 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -86.76 7.01 28.65 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 111.181 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 73.22 40.86 48.6 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.42 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HD2' ' OE1' ' A' ' 8' ' ' GLN . 49.4 mmtm -134.56 152.77 52.01 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.62 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.7 mt -70.03 127.07 31.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.899 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.4 p -118.9 -17.34 7.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.659 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.577 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 74.9 t80 -150.11 128.51 12.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.591 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -126.88 120.88 30.28 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.343 0.592 . . . . 0.0 110.654 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.53 101.37 7.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.5 p -98.29 106.47 18.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.341 0.591 . . . . 0.0 112.238 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.2 64.8 2.32 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.542 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.539 ' HH ' ' HG3' ' A' ' 136' ' ' GLU . 1.2 p90 -96.31 154.99 16.95 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p -142.77 89.99 2.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.253 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 69.04 131.67 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.83 2.48 75.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.784 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.3 29.41 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.513 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.539 ' HG3' ' HH ' ' A' ' 131' ' ' TYR . 1.4 mp0 -58.76 -38.49 78.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.412 0.625 . . . . 0.0 109.835 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.08 87.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.85 -38.53 83.28 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.637 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -63.04 -50.39 70.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.373 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 tp -66.92 -38.48 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.144 0.497 . . . . 0.0 110.928 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -60.89 -45.73 93.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.904 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.424 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 18.6 tptm -66.14 -30.81 71.36 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.526 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.637 HG23 ' O ' ' A' ' 139' ' ' LEU . 95.4 t -64.75 -41.95 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -73.85 -24.29 59.74 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -61.44 -39.23 90.05 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.63 -41.11 97.04 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.49 -44.67 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.308 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -64.95 -35.97 82.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.473 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -63.68 -38.95 93.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -95.64 92.97 1.51 Allowed Glycine 0 C--O 1.236 0.273 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.427 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -116.44 -34.53 4.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.927 0.394 . . . . 0.0 111.57 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -111.17 141.32 44.83 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.818 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 63.0 -85.66 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.288 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -133.64 -60.87 0.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.86 0.362 . . . . 0.0 110.387 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -134.12 21.48 3.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.25 0.547 . . . . 0.0 109.718 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.018 -178.438 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 p30 . . . . . 0 CA--C 1.515 -0.384 0 CA-C-O 121.363 0.602 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.418 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 14.7 m -94.49 68.47 3.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.697 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -74.52 -112.64 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.215 0.531 . . . . 0.0 110.609 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -173.08 -7.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.329 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 69.12 62.16 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.5 mp -116.15 159.92 37.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.029 -178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.96 158.39 57.55 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.814 2.343 . . . . 0.0 110.816 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 81.09 2.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.092 0.472 . . . . 0.0 111.161 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -124.57 133.37 69.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.328 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 m -89.41 110.28 21.11 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.8 mt -107.3 173.25 6.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 109.974 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.404 HD22 ' HB3' ' A' ' 20' ' ' LYS . 3.8 p30 -98.0 -176.62 3.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.431 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 pt -61.57 -22.59 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -81.14 -8.26 59.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.181 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.24 14.94 81.69 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HB3' HD22 ' A' ' 16' ' ' ASN . 87.6 tttt -99.84 139.27 35.75 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.564 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.6 m -74.48 118.6 17.62 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.315 0.579 . . . . 0.0 110.209 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.86 130.74 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.712 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 71.5 mt-30 -92.0 134.02 35.19 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.449 HG23 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -66.16 -29.3 69.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.323 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.646 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.73 122.03 28.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.87 153.52 52.02 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.89 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.574 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 23.7 t-20 -79.91 -80.77 0.13 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.338 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 171.87 28.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.788 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.418 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 95.3 0.26 63.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.491 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 1.4 mptm? -104.48 150.75 38.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.787 0.327 . . . . 0.0 110.548 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.2 159.58 33.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.967 2.445 . . . . 0.0 111.496 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.574 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 74.1 mtm -141.09 159.53 42.02 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 120.781 0.324 . . . . 0.0 111.795 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.426 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.2 mt -128.09 124.86 63.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.5 mt -97.99 119.88 46.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -107.7 121.56 44.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 58.5 m-85 -94.27 117.75 30.57 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.408 ' HB2' HD21 ' A' ' 47' ' ' LEU . 26.5 p90 -138.48 165.47 26.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.856 0.722 . . . . 0.0 111.588 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.35 164.09 13.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.521 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.5 p -64.93 118.63 9.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.477 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 t30 63.67 87.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.403 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 19.7 p -156.64 151.0 25.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.528 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.456 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 24.1 ttpp -139.46 -51.73 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 44' ' ' LYS . 36.0 Cg_exo -60.45 -31.05 92.07 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.154 1.902 . . . . 0.0 111.699 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 54.0 t -69.82 -16.32 63.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.409 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 39' ' ' PHE . 18.9 mt -98.95 52.47 0.97 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.664 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -61.33 -38.9 88.55 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.368 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.595 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.3 pt-20 -60.01 -51.74 68.35 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.045 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.472 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 40.8 tp -63.08 -41.08 99.35 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.402 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.483 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -59.92 -48.78 80.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.474 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.64 70.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.845 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.9 mt -63.76 -41.54 92.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.113 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -52.83 -36.38 58.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.014 0.435 . . . . 0.0 110.361 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.82 -46.73 67.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.883 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.16 25.65 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.45 -40.56 87.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.868 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.93 93.83 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.752 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.12 -41.0 97.4 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.236 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -66.84 -38.52 86.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.252 0.548 . . . . 0.0 110.201 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.419 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 30.1 mm-40 -70.17 -21.51 63.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.216 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.59 -48.88 79.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.625 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -104.59 -68.55 0.85 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.265 0.555 . . . . 0.0 111.859 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -63.73 -32.36 73.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.846 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 62.6 41.01 99.85 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.052 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.54 132.44 35.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.085 0.469 . . . . 0.0 112.253 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 13.2 mtm180 -104.9 163.6 12.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 58.8 mt -110.86 138.1 47.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.188 0.518 . . . . 0.0 111.398 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.445 HD12 ' SD ' ' A' ' 34' ' ' MET . 87.9 mt -110.78 110.48 32.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.16 116.05 28.38 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.9 p -121.59 131.69 72.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.478 0.656 . . . . 0.0 112.178 -176.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.409 ' OG ' ' HA ' ' A' ' 97' ' ' LEU . 23.3 p -86.38 134.93 33.68 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.07 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.41 ' O ' ' HD3' ' A' ' 104' ' ' LYS . 43.1 pt -86.49 -5.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.238 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 15.1 m-20 -95.82 157.48 15.88 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.766 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.17 179.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.689 0.618 . . . . 0.0 112.565 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 -45.3 95.76 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 114.526 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -61.38 -46.08 91.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.371 0.605 . . . . 0.0 110.758 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.414 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 14.3 m120 -67.0 -39.17 87.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.903 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 82' ' ' VAL . . . -68.27 -9.77 49.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.601 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.29 -22.32 52.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.04 0.448 . . . . 0.0 110.74 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.745 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 97.8 mttt -89.41 -13.7 37.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.699 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' HA ' ' A' ' 79' ' ' ALA . 61.2 t -64.6 -50.2 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.497 0.665 . . . . 0.0 112.549 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mtpm? -68.52 -42.26 26.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.7 Cg_endo -61.41 -29.56 85.62 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.014 1.143 . . . . 0.0 110.821 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.745 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.9 mt -63.43 -42.28 98.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.429 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -58.07 -46.4 85.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.748 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -65.74 -45.76 81.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.994 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.71 -41.57 88.94 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.536 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -87.76 -3.12 58.97 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 46.17 45.76 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.386 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.429 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 53.8 m0 -82.78 100.99 10.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.408 0.623 . . . . 0.0 110.655 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -84.71 47.05 1.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.021 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 1.8 m-85 -138.32 175.95 9.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.88 126.42 32.44 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -110.9 131.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.07 0.462 . . . . 0.0 110.102 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 10.9 mp -121.17 134.29 55.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.683 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.409 ' HA ' ' OG ' ' A' ' 72' ' ' SER . 7.9 mp -110.18 115.9 30.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -79.0 114.8 18.24 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.158 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 p -85.63 -13.06 49.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.194 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -90.42 -45.65 8.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.948 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.8 8.85 66.88 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -174.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -96.24 -25.06 15.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.441 -0.88 . . . . 0.0 111.766 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.449 ' CE1' HG23 ' A' ' 24' ' ' THR . 62.3 t80 -61.47 -43.85 98.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 73' ' ' ILE . 22.9 pttp -58.92 -40.11 83.57 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.305 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -71.07 -41.85 70.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.972 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.55 81.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.37 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.67 -25.33 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.069 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.52 95.22 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.228 1.011 . . . . 0.0 111.966 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.68 115.7 50.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.169 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.2 p -82.77 -57.98 3.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.683 0.754 . . . . 0.0 110.076 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 46.3 tp -130.57 134.47 47.04 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.625 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.8 pt -87.59 151.36 50.33 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.531 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.8 Cg_endo -82.88 161.55 74.99 Favored 'Cis proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.704 0.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.43 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.61 136.65 54.76 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.448 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.6 t -119.44 124.97 73.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 120.889 0.376 . . . . 0.0 111.188 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.402 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 61.1 m-85 -122.05 118.04 27.78 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.57 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 62.0 mt -105.86 130.47 57.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.153 0.501 . . . . 0.0 111.0 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 53.3 t -104.87 135.2 43.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.988 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -87.66 -174.73 4.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 111.014 -178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.12 -18.43 69.07 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.414 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -88.86 -4.34 58.5 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.545 -0.386 . . . . 0.0 110.981 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.43 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 84.39 28.94 31.64 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.336 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 2.0 mppt? -124.21 154.09 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.161 0.505 . . . . 0.0 111.481 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.0 mt -70.59 99.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.246 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.2 p -83.87 -31.49 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.64 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.57 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.1 t80 -130.67 129.06 42.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.535 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -132.36 121.93 24.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -146.37 102.01 3.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.414 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 p -94.81 116.15 28.38 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.527 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.02 50.75 1.72 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.34 -0.934 . . . . 0.0 114.109 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.531 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.5 OUTLIER -81.64 138.52 35.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.363 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.0 p -123.35 -16.11 6.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.372 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -140.5 -101.63 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.35 30.13 2.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.955 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.77 -25.65 74.05 Favored Glycine 0 C--N 1.318 -0.455 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.053 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.6 -29.72 64.72 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.232 0.613 . . . . 0.0 110.626 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.19 96.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.06 -35.12 77.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.579 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.714 ' O ' HG22 ' A' ' 143' ' ' VAL . 11.0 mp -61.22 -53.58 55.09 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.29 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.1 tp -67.75 -39.08 81.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.089 0.471 . . . . 0.0 111.395 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 34.1 ttpt -59.06 -48.4 81.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.469 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.522 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 39.9 tptt -67.79 -30.97 70.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.216 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 139' ' ' LEU . 48.0 t -58.15 -44.46 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.535 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -77.14 -24.85 51.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.029 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 52.0 mm-40 -64.04 -33.71 76.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.135 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 88.8 mt -63.11 -41.79 99.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.068 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.8 t -69.18 -26.41 31.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.57 0.7 . . . . 0.0 110.236 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -66.62 -30.88 71.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.239 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -63.56 -38.44 91.13 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.781 0.324 . . . . 0.0 111.63 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.41 -114.73 4.36 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.243 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 71.9 -30.76 0.21 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.187 0.995 . . . . 0.0 112.779 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -57.72 -43.48 85.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.084 0.468 . . . . 0.0 109.984 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -124.12 80.25 1.81 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.7 p80 47.83 -164.33 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.091 0.956 . . . . 0.0 112.013 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -98.0 120.26 38.08 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.151 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.287 -179.299 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 CA--C 1.511 -0.535 0 CA-C-O 121.316 0.579 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.652 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -86.26 128.76 34.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.992 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -151.79 -140.21 0.09 Allowed 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.74 14.85 2.13 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 49.94 51.07 17.31 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.763 0.792 . . . . 0.0 109.964 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.6 mt -106.66 154.71 39.88 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.327 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.87 152.57 78.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.499 2.799 . . . . 0.0 110.913 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.96 87.05 0.72 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.131 0.491 . . . . 0.0 111.565 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.7 t -126.31 136.54 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.222 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -96.98 112.89 24.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.782 0.325 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 98' ' ' ASP . 53.2 mt -116.48 176.55 5.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -105.33 139.86 39.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.472 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -92.73 -175.14 3.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.285 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.73 -11.37 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.836 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.91 -15.54 27.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.85 61.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.818 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -99.99 146.29 26.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -73.73 120.16 18.94 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.469 0.652 . . . . 0.0 110.716 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.71 131.39 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.611 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.499 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.6 mt-30 -92.28 134.57 34.78 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.436 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.544 HG21 ' CE1' ' A' ' 103' ' ' PHE . 7.1 p -67.28 -21.58 65.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -79.57 -9.9 59.7 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.0 0.429 . . . . 0.0 110.495 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.25 16.09 7.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.67 -178.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.3 tp -99.76 125.88 45.74 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.746 -176.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.652 ' HB3' ' O ' ' A' ' 5' ' ' THR . 3.9 pt-20 -141.91 158.65 43.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.084 177.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -81.14 -71.5 0.47 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.64 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.09 38.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.448 0.467 . . . . 0.0 110.963 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.456 ' HA2' HG21 ' A' ' 5' ' ' THR . . . 91.83 4.06 67.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.042 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.64 151.73 41.17 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 122.652 0.381 . . . . 0.0 110.387 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.53 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -66.91 155.67 69.69 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 122.994 2.463 . . . . 0.0 112.343 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.4 mtm -138.97 149.33 44.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.65 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.42 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 89.7 mt -127.88 126.11 66.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.455 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 77.4 mt -91.52 126.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.8 m -111.03 112.96 25.15 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 40.7 m-85 -86.98 109.46 19.39 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 173.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.54 ' CE1' ' HB3' ' A' ' 70' ' ' ALA . 28.5 p90 -126.21 157.07 39.15 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.853 0.721 . . . . 0.0 110.872 -175.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.96 147.66 34.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.803 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 m -63.07 -43.39 98.73 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.251 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -124.44 27.5 6.96 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 17.6 t -133.59 135.38 44.22 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.174 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 95.9 mttt -101.75 -47.83 0.19 Allowed Pre-proline 0 CA--C 1.564 1.481 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 44' ' ' LYS . 29.6 Cg_endo -64.12 -22.1 67.6 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.187 1.924 . . . . 0.0 113.225 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 71.3 m -76.0 -15.71 60.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.986 0.422 . . . . 0.0 110.227 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.446 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 9.6 mt -90.31 61.01 4.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.0 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.641 ' HG3' ' O ' ' A' ' 132' ' ' THR . 27.0 mmt180 -61.1 -43.39 98.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.8 tm-20 -63.66 -55.13 25.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.474 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.411 HD12 ' CE2' ' A' ' 93' ' ' TYR . 35.5 tp -62.71 -40.85 98.45 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.61 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.94 -48.17 77.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.639 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -44.45 93.23 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.043 0.449 . . . . 0.0 110.868 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.6 mt -64.05 -41.34 92.16 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.77 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.678 ' OE1' ' HA ' ' A' ' 91' ' ' TRP . 26.3 tp60 -51.83 -40.61 60.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.42 -41.57 72.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.974 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.06 19.13 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -59.78 -34.4 72.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.6 84.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.836 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.86 -40.39 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.981 0.419 . . . . 0.0 110.694 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.46 ' NE1' HD13 ' A' ' 140' ' ' ILE . 15.3 m0 -67.27 -38.35 84.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.384 0.611 . . . . 0.0 110.405 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -81.97 -8.8 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.391 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.3 -49.23 78.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.876 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -152.19 64.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.369 0.604 . . . . 0.0 110.706 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.8 m -161.9 -39.74 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.613 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.0 21.08 76.94 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.662 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.2 p -81.93 125.57 39.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.066 0.46 . . . . 0.0 111.888 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -108.46 158.14 17.8 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.233 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.422 HD11 ' CG2' ' A' ' 53' ' ' ILE . 42.8 mt -99.02 134.16 42.26 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.021 0.438 . . . . 0.0 110.843 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 96' ' ' LEU . 90.8 mt -102.75 101.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 39' ' ' PHE . . . -88.54 122.89 32.5 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.1 p -120.54 130.5 74.41 Favored 'Isoleucine or valine' 0 C--O 1.256 1.412 0 CA-C-O 121.594 0.711 . . . . 0.0 111.769 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.453 ' CB ' HG23 ' A' ' 82' ' ' VAL . 24.1 p -83.37 132.01 35.02 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.898 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 45.1 pt -87.49 19.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 125.369 1.668 . . . . 0.0 113.858 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -122.38 -159.26 0.82 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.733 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.485 ' HB2' ' NE2' ' A' ' 77' ' ' GLN . 49.2 mt-10 -96.17 179.83 4.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.749 0.309 . . . . 0.0 110.381 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.563 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . -61.84 -43.32 99.38 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.485 ' NE2' ' HB2' ' A' ' 75' ' ' GLU . 6.0 pm0 -64.38 -41.78 96.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.648 0.724 . . . . 0.0 112.306 -177.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -77.03 -38.84 52.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.873 0.368 . . . . 0.0 111.549 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.402 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.46 -5.66 34.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 86.3 mm-40 -60.75 -24.1 65.47 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.919 -0.488 . . . . 0.0 110.722 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.69 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 30.6 mtpp -84.05 -9.83 58.32 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.725 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 61.6 t -65.75 -48.23 83.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.698 0.761 . . . . 0.0 112.53 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.9 mtpm? -66.65 -41.85 41.71 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.144 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.2 Cg_endo -62.9 -28.99 75.74 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.175 1.25 . . . . 0.0 110.884 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 97.5 mt -62.51 -42.84 99.78 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.42 91.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.797 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.85 -46.4 53.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.99 94.32 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.439 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -75.33 -23.95 57.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.797 0.332 . . . . 0.0 111.153 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.09 37.7 28.2 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.728 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.678 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 26.4 m0 -59.67 -42.28 92.53 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 66.13 27.3 10.49 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.598 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 6.1 m-85 -111.91 -167.65 1.21 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.475 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -104.3 129.21 52.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.496 0.665 . . . . 0.0 111.954 -172.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.432 HD11 HG21 ' A' ' 69' ' ' ILE . 11.0 mp -114.32 133.94 55.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.343 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.476 HD21 ' HA2' ' A' ' 76' ' ' GLY . 10.4 tt -108.71 111.85 23.84 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.253 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.504 ' HA ' HD22 ' A' ' 14' ' ' LEU . 68.2 t0 -80.12 128.19 33.21 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.271 174.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -110.09 0.65 18.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.991 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -114.23 -36.2 4.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.41 7.61 75.82 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.02 -21.97 25.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.544 ' CE1' HG21 ' A' ' 24' ' ' THR . 52.3 t80 -64.15 -35.42 80.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 110.22 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.485 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 52.1 mtmt -59.8 -44.84 93.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.55 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.1 -37.96 72.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.07 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.56 82.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.173 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.5 mmm -91.64 -10.4 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.244 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 64.71 69.25 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.379 0.609 . . . . 0.0 110.466 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.86 120.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.805 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.3 t -95.79 -75.88 0.51 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.227 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD23 HG22 ' A' ' 132' ' ' THR . 41.6 tp -98.26 160.73 14.1 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.2 pt -116.05 153.05 48.33 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.2 Cg_endo -79.56 156.9 89.71 Favored 'Cis proline' 0 C--O 1.241 0.656 0 C-N-CA 123.882 -1.299 . . . . 0.0 112.801 1.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -113.17 135.13 54.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.457 HG21 ' HG3' ' A' ' 49' ' ' GLU . 22.1 t -120.29 131.45 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -173.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 89.7 m-85 -126.73 112.83 15.88 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 173.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.5 mt -99.82 123.17 52.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.76 127.95 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.867 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.05 163.01 27.09 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 110.952 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -18.33 43.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.13 -0.486 . . . . 0.0 113.473 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -86.6 1.57 51.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.813 0.307 . . . . 0.0 111.085 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 83.55 26.38 43.01 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.005 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -124.98 157.0 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.943 0.372 . . . . 0.0 110.056 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.4 115.37 21.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.138 0.494 . . . . 0.0 110.055 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.434 HG11 HD21 ' A' ' 146' ' ' LEU . 7.8 p -94.67 -38.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.15 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 72.0 t80 -134.26 128.73 34.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.203 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -131.21 128.93 40.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.411 . . . . 0.0 110.219 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 12.7 t60 -138.38 102.85 4.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 102.65 15.39 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.199 0.523 . . . . 0.0 111.911 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.17 105.45 0.75 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.653 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.546 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 3.6 p90 -138.23 163.78 30.88 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.641 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.7 p -109.62 -42.28 4.34 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.001 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -172.94 151.69 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.68 79.95 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.85 -34.33 8.43 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.5 pm0 -61.4 -15.55 37.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.35 0.66 . . . . 0.0 112.143 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.92 94.46 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.519 0.676 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.88 -26.82 36.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.227 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.586 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.1 mp -62.07 -49.31 76.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.721 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.46 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.8 tp -68.9 -34.84 66.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.879 0.371 . . . . 0.0 110.257 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 41.8 ttmt -58.91 -49.07 79.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.176 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -66.21 -36.73 83.83 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 139' ' ' LEU . 72.8 t -59.76 -45.07 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.123 0.487 . . . . 0.0 109.804 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -72.0 -25.02 61.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.209 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 75.7 mm-40 -64.37 -36.09 83.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.434 HD21 HG11 ' A' ' 125' ' ' VAL . 81.8 mt -62.44 -43.84 97.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.353 0.597 . . . . 0.0 109.487 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.76 -39.76 82.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.672 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -60.36 -41.29 93.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.541 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.0 -12.99 45.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.238 0.542 . . . . 0.0 110.863 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -86.35 102.49 2.71 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.507 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -115.07 -179.53 3.66 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 122.61 -0.347 . . . . 0.0 110.578 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -63.64 -38.24 90.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -94.81 163.26 13.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.073 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -71.09 89.3 0.82 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.854 0.359 . . . . 0.0 111.884 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 54.2 m80 68.59 -45.25 0.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.327 1.051 . . . . 0.0 113.693 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 C--N 1.312 -1.022 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.431 -178.767 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.436 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 4.4 t -84.18 89.7 7.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.329 0.585 . . . . 0.0 110.471 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.46 ' N ' ' HA3' ' A' ' 122' ' ' GLY . 85.7 m-85 -87.8 -90.57 0.12 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.314 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.57 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 169.92 -25.49 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.579 -176.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.458 HE21 ' HD2' ' A' ' 123' ' ' LYS . 8.5 tt0 65.9 83.14 0.17 Allowed 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.547 -176.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.7 mt -133.19 167.28 23.74 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.385 -174.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.71 159.87 49.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.913 2.409 . . . . 0.0 111.109 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.42 83.44 3.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -126.36 134.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.209 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.1 p -98.7 112.76 24.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.204 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -117.67 176.4 5.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -108.63 135.28 50.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.437 0.16 . . . . 0.0 110.607 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -87.23 -171.92 3.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.41 HG22 ' H ' ' A' ' 95' ' ' VAL . 27.5 pt -66.21 -24.04 32.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -77.42 -30.81 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.491 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.85 14.95 21.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.2 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -93.78 147.76 22.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.8 m -75.07 115.86 15.17 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.281 0.562 . . . . 0.0 110.269 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.44 131.65 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.895 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.526 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 44.2 mt-30 -98.06 132.7 43.38 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.71 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.601 HG22 ' CE1' ' A' ' 103' ' ' PHE . 14.8 p -68.17 -24.36 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -78.7 -4.04 47.16 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.815 0.34 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -134.25 11.9 3.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -67.89 124.81 24.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -147.88 161.8 40.57 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.599 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 35.1 p-10 -107.27 -56.48 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.94 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.86 25.59 0.03 OUTLIER Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -129.13 151.22 77.34 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.67 153.57 77.58 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.324 2.016 . . . . 0.0 111.753 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 29' ' ' ASN . 74.4 mtm -136.62 155.43 49.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.918 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.13 123.15 61.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.1 123.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -113.96 124.46 52.21 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 60.9 m-85 -93.76 119.76 33.15 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.559 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 24.2 p90 -137.94 170.16 16.53 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.606 0.566 . . . . 0.0 111.95 -175.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.65 33.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.565 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -68.69 -35.75 77.6 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -103.54 17.11 24.82 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 63.8 m -123.34 107.47 11.68 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.099 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 50.5 mtmt -93.87 -53.73 0.24 Allowed Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 35.2 Cg_exo -65.11 -22.34 61.82 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.692 2.261 . . . . 0.0 111.447 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 67.9 m -65.93 -31.62 72.65 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.727 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.559 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 8.2 mt -81.62 66.6 7.25 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -64.45 -39.5 93.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.728 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.588 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -67.96 -52.76 32.28 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.499 HD13 ' CE2' ' A' ' 93' ' ' TYR . 43.6 tp -61.6 -41.25 97.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.806 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.07 -49.68 76.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.513 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.05 -44.09 66.5 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.853 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 49' ' ' GLU . 66.6 mt -63.72 -42.44 96.0 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.767 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.691 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -52.7 -40.32 62.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -68.32 -44.8 74.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.36 20.51 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -60.81 -32.68 72.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.761 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.9 92.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.818 0.342 . . . . 0.0 110.407 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -66.8 -39.05 87.6 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.37 -36.37 82.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.545 0.688 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -82.39 -9.12 59.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.579 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.83 -52.94 63.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.502 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.04 -50.46 2.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.435 HG21 HG12 ' A' ' 143' ' ' VAL . 6.5 m -61.77 -38.8 89.36 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.33 29.04 74.17 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.431 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.66 127.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.92 0.391 . . . . 0.0 111.865 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -106.37 140.49 39.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.605 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.509 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 72.1 mt -84.63 144.62 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.586 HD12 ' SD ' ' A' ' 34' ' ' MET . 94.8 mt -119.5 109.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.54 ' HB3' ' CE1' ' A' ' 39' ' ' PHE . . . -100.38 127.99 46.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.35 136.43 59.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 CA-C-O 121.612 0.72 . . . . 0.0 111.706 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.495 ' HB3' HG23 ' A' ' 82' ' ' VAL . 37.2 p -83.61 126.34 32.73 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.437 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 pt -80.79 16.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 125.107 1.504 . . . . 0.0 112.351 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.598 ' OD1' ' HB2' ' A' ' 78' ' ' ASN . 4.2 t70 -130.14 165.88 21.39 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -78.43 175.38 10.35 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.338 0.399 . . . . 0.0 111.268 -174.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 80' ' ' GLN . . . -56.83 -22.85 42.7 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.111 -177.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -65.04 -57.57 8.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.119 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.598 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 91.7 m-20 -85.42 -38.97 18.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.137 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -71.94 -3.2 21.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.456 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.509 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 6.7 tt0 -63.98 -12.28 36.32 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.761 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.7 mmtm -95.77 -3.08 46.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.975 0.51 . . . . 0.0 112.054 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 72' ' ' SER . 61.7 t -65.26 -49.19 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.39 0.614 . . . . 0.0 112.547 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.4 mtpt -65.62 -43.69 62.19 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.803 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.15 -28.45 79.73 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.23 1.287 . . . . 0.0 111.312 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.6 mt -62.87 -41.94 99.58 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.97 92.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.9 -46.81 83.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.28 -40.76 80.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.631 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -92.97 -0.4 57.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.66 38.93 61.06 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.358 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -81.78 96.5 7.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.7 70.84 7.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.509 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 11.2 m-85 -145.47 172.13 13.65 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.87 120.34 20.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 17' ' ' ILE . 20.7 t -109.21 123.75 65.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.0 mp -111.23 138.1 48.11 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.646 0.736 . . . . 0.0 111.525 -176.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.8 tp -103.76 109.36 21.05 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.792 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.489 ' HA ' HD21 ' A' ' 14' ' ' LEU . 68.0 t0 -82.27 116.37 21.76 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 117.751 -1.58 . . . . 0.0 108.531 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -107.27 5.48 27.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.202 0.525 . . . . 0.0 110.185 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -110.8 -43.62 3.78 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.951 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.02 -1.97 78.57 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.682 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -83.18 -25.57 31.68 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.602 -0.352 . . . . 0.0 111.454 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.601 ' CE1' HG22 ' A' ' 24' ' ' THR . 47.6 t80 -64.01 -44.46 92.52 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -61.49 -36.71 81.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.852 0.358 . . . . 0.0 110.61 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -70.24 -41.57 73.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 110.359 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.62 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.591 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.9 mmt -86.76 -8.29 57.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.021 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.2 t30 59.03 71.18 0.6 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.379 0.609 . . . . 0.0 111.26 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.432 HG21 ' CD2' ' A' ' 38' ' ' PHE . 44.8 t -98.76 96.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.21 0.529 . . . . 0.0 110.63 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -88.89 -62.24 1.53 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.432 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 47.1 tp -105.93 129.9 53.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.281 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.7 pt -91.55 152.87 43.91 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 67.2 Cg_endo -83.62 157.04 72.06 Favored 'Cis proline' 0 C--O 1.242 0.721 0 C-N-CA 124.277 -1.135 . . . . 0.0 112.859 1.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.469 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -112.98 130.03 56.28 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.54 127.87 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-O 121.327 0.584 . . . . 0.0 112.161 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 86.6 m-85 -127.64 112.69 15.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.765 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.2 mt -101.74 130.73 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.213 0.53 . . . . 0.0 110.874 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 76.4 t -107.61 129.54 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.26 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.45 -175.42 5.46 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.301 0.376 . . . . 0.0 111.177 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.7 61.64 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.713 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -86.04 -1.66 57.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.479 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.46 ' HA3' ' N ' ' A' ' 6' ' ' TYR . . . 70.89 42.6 60.13 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.395 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.458 ' HD2' HE21 ' A' ' 8' ' ' GLN . 72.2 mmtt -127.11 155.54 43.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 7' ' ' ALA . 88.5 mt -71.66 100.14 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.8 -34.16 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.457 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 87.7 t80 -132.5 130.33 40.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.723 0.296 . . . . 0.0 110.701 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -131.74 115.9 16.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.049 0.452 . . . . 0.0 110.78 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.458 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 2.0 t60 -132.81 102.87 5.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.405 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.02 116.32 29.01 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.089 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 78.5 65.35 1.86 Allowed Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.41 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.462 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 2.7 p90 -104.58 154.77 19.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.832 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.9 p -142.68 94.62 2.66 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.257 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 63.73 108.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.731 0.812 . . . . 0.0 112.273 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.17 23.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.862 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.34 -18.97 40.19 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.944 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.57 -30.28 67.04 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.368 0.667 . . . . 0.0 111.174 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.23 -40.26 93.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.787 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.42 -36.66 79.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.789 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.626 ' O ' HG21 ' A' ' 143' ' ' VAL . 11.2 mp -63.0 -48.81 77.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.713 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.497 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.2 tp -67.82 -39.76 82.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.903 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -60.43 -45.51 93.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.803 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.636 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 37.8 tptt -66.38 -35.72 81.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.31 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.626 HG21 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -59.48 -46.73 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 0.0 110.711 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 4.6 ptp180 -78.98 -18.57 53.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.059 0.457 . . . . 0.0 110.91 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -69.93 -37.51 75.92 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.862 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 58.1 mt -64.08 -40.1 95.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.667 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.81 -31.68 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.117 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -62.2 -39.86 94.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.564 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.76 -27.13 14.47 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.972 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -80.63 85.07 1.36 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.334 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 95.7 m-70 -92.7 37.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 68.68 -96.64 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.626 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -93.84 -33.88 13.37 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.267 0.556 . . . . 0.0 110.219 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.554 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 58.4 m80 -89.03 144.18 26.33 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.451 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -75.54 -33.09 60.65 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.22 0.533 . . . . 0.0 110.162 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.343 179.704 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 121.151 0.5 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t -144.84 99.89 3.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.224 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 41.7 m-85 -97.89 -135.64 0.26 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.246 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.57 11.52 0.44 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 52.8 tp60 51.74 31.75 8.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.826 0.822 . . . . 0.0 111.656 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.1 mt -79.87 161.68 65.25 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.022 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.13 154.09 72.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.457 2.105 . . . . 0.0 111.133 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.28 76.64 1.33 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.312 0.577 . . . . 0.0 111.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.21 134.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 t -97.33 114.94 26.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 98' ' ' ASP . 30.0 mt -105.33 173.64 6.22 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -113.48 127.08 55.97 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.505 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.401 ' ND2' ' HD3' ' A' ' 20' ' ' LYS . 86.8 m-20 -79.59 178.71 7.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.074 0.464 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.554 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 47.3 pt -65.57 -26.2 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.186 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.99 -17.54 60.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.21 19.58 60.52 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 44.6 tttp -79.81 136.16 36.65 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.728 -0.736 . . . . 0.0 109.918 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -83.71 108.76 16.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.74 144.32 38.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.021 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.621 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 85.9 mt-30 -103.99 135.19 45.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.419 HG21 ' CE1' ' A' ' 103' ' ' PHE . 12.8 p -64.38 -30.68 71.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -73.66 -14.2 61.12 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.071 0.462 . . . . 0.0 111.068 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.621 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -114.65 8.88 16.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 111.297 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 38.4 tp -80.51 115.8 20.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.231 -175.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 160.73 36.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.314 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.507 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 8.3 p30 -112.89 -58.21 2.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.645 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.96 -45.54 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.565 0.746 . . . . 0.0 109.882 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.87 26.57 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.828 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -119.46 152.01 52.31 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.48 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 12.3 Cg_exo -72.1 158.89 51.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.932 2.421 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.507 ' SD ' ' ND2' ' A' ' 29' ' ' ASN . 5.0 mpp? -132.14 156.96 45.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.93 123.66 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -103.43 121.66 55.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.72 122.83 46.51 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.481 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 71.7 m-85 -96.1 119.63 34.94 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -147.83 161.46 41.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.984 0.421 . . . . 0.0 111.692 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.29 152.7 32.32 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.242 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 74' ' ' ASP . 3.1 p -43.3 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -97.64 77.03 2.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.182 0.992 . . . . 0.0 109.781 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.4 t -89.88 -175.83 4.73 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.44 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.569 ' C ' ' H ' ' A' ' 46' ' ' CYS . 64.6 mttp -109.17 -175.12 0.33 Allowed Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.462 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' CD ' ' HB3' ' A' ' 44' ' ' LYS . 52.4 Cg_exo -59.77 19.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.744 2.962 . . . . 0.0 114.151 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.569 ' H ' ' C ' ' A' ' 44' ' ' LYS . 49.8 m -72.66 -15.64 61.7 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 mt -72.91 54.54 0.37 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.447 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -61.26 -38.19 85.84 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.202 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.668 ' OE2' ' HB2' ' A' ' 113' ' ' PRO . 50.7 mt-10 -53.04 -67.28 0.26 Allowed 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.659 0.742 . . . . 0.0 110.235 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.542 HD13 ' CE2' ' A' ' 93' ' ' TYR . 30.4 tp -60.86 -41.04 95.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.747 -173.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.52 -53.98 43.43 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.095 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 -42.74 94.77 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.8 mt -65.03 -42.77 95.48 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.949 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.68 -38.05 71.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.652 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.88 -35.7 81.37 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.869 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -120.59 25.26 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 53' ' ' ILE . 86.9 t80 -60.53 -34.45 74.13 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.54 92.21 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.425 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.89 -42.32 94.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.796 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -63.77 -35.76 81.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.754 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -79.13 -15.63 57.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.272 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.94 -43.73 98.24 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.75 -58.8 1.93 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.541 -0.463 . . . . 0.0 112.025 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 m -62.69 -39.62 94.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.684 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.43 28.16 73.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.656 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.72 131.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 122.658 0.383 . . . . 0.0 111.929 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -106.79 146.52 30.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.627 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.559 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 60.8 mt -91.69 148.12 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.402 0.62 . . . . 0.0 111.457 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 92.3 mt -122.44 118.68 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.575 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.44 111.56 23.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.52 127.83 72.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 CA-C-O 121.66 0.743 . . . . 0.0 111.245 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.0 t -85.6 133.11 34.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.713 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.0 pt -84.93 2.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.843 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' HB2' HG23 ' A' ' 41' ' ' THR . 49.2 m-20 -102.33 157.27 17.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.71 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.03 156.42 5.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.492 0.495 . . . . 0.0 111.07 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.23 -34.04 72.46 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.489 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.61 -40.57 92.35 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.701 0.286 . . . . 0.0 111.708 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -85.3 -32.52 22.46 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.384 0.612 . . . . 0.0 110.367 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.605 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -67.31 -4.24 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.624 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.65 -8.97 11.52 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.025 -0.422 . . . . 0.0 110.143 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.648 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 35.4 mmtp -85.93 -17.56 35.12 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.183 0.593 . . . . 0.0 111.788 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 79' ' ' ALA . 11.6 t -64.48 -46.25 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.843 0.83 . . . . 0.0 111.324 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.499 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 18.7 mtmt -68.53 -44.23 33.28 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.17 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.4 Cg_endo -60.2 -32.39 94.36 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.009 1.139 . . . . 0.0 110.785 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.3 mt -64.35 -42.45 96.22 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 83' ' ' LYS . . . -60.48 -41.82 95.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.783 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.82 -41.53 95.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.532 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.65 -51.67 6.36 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.314 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.71 -34.81 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.95 2.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.216 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -88.35 104.96 17.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.01 65.33 2.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 110.035 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.559 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 11.4 m-85 -140.12 178.96 6.91 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.79 120.87 24.66 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.554 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 20.0 t -107.12 126.7 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.678 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.52 139.89 53.38 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.128 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.49 118.74 37.06 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.502 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.1 t0 -72.09 115.44 11.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.527 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.0 t -94.99 6.4 49.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.497 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -124.9 -38.73 2.32 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.097 0.475 . . . . 0.0 110.855 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.0 4.1 72.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -97.91 -20.65 17.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 24' ' ' THR . 74.0 t80 -62.19 -43.77 98.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.949 0.404 . . . . 0.0 110.158 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -58.02 -41.67 83.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.699 175.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -70.5 -39.52 74.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 111.026 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.21 99.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.317 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.65 -12.98 59.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 68.19 79.9 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.042 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.7 t -110.57 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.346 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.8 m -75.65 -46.52 31.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.2 tp -136.12 132.61 36.3 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.879 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.4 pt -87.38 154.0 53.84 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.668 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 95.2 Cg_endo -80.38 153.71 84.74 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.569 -0.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.481 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -116.17 125.97 53.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.326 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.7 t -101.34 124.93 55.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.8 -175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -124.73 112.63 16.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.729 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.24 128.87 53.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.124 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 76.4 t -106.38 129.72 59.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.678 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.478 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 12.0 t70 -70.68 157.77 37.41 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.922 0.764 . . . . 0.0 109.568 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.32 -25.52 62.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.315 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.28 -25.11 66.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.118 0.485 . . . . 0.0 110.59 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 26.06 6.72 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.644 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.97 157.01 38.89 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 122.491 0.316 . . . . 0.0 110.548 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 69.3 mt -71.28 122.44 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.5 p -109.03 -32.64 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.405 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 58.0 t80 -147.62 131.5 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.297 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.017 0.437 . . . . 0.0 110.17 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.51 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 36.9 t60 -143.57 106.48 4.49 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.5 m -100.41 123.29 44.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.043 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.98 60.11 5.09 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.315 0.886 . . . . 0.0 115.315 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.678 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 27.2 p90 -86.18 -39.53 16.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 117.637 0.719 . . . . 0.0 109.597 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.0 p 73.39 -44.99 0.6 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.979 1.711 . . . . 0.0 113.53 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.07 138.95 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.04 18.65 74.3 Favored Glycine 0 C--N 1.327 0.059 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.848 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.678 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.91 -25.72 19.06 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.452 -177.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -60.93 -25.69 66.95 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.06 94.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 110.391 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.54 -38.32 89.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.511 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.606 ' O ' HG21 ' A' ' 143' ' ' VAL . 10.1 mp -63.33 -47.14 83.46 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.685 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 5.4 mm -61.63 -41.45 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.7 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.2 ttpp -57.29 -49.94 74.49 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.889 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.5 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 32.9 mmmt -68.39 -38.21 81.13 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 139' ' ' LEU . 52.6 t -58.94 -46.55 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.854 0.359 . . . . 0.0 111.575 -177.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.93 -22.42 42.72 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.638 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.7 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 73.6 mm-40 -66.28 -37.29 85.1 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.513 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 80.6 mt -61.38 -41.58 97.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.53 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.9 t -62.93 -47.61 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.86 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -66.68 -44.95 80.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.615 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.5 -38.62 81.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.961 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -90.35 33.77 4.41 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.851 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -158.36 -45.27 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -99.18 144.81 27.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.4 m170 70.43 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.979 0.911 . . . . 0.0 112.007 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -112.71 92.98 4.21 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -114.15 126.85 55.54 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.093 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 37.2 t60 . . . . . 0 C--N 1.313 -1.018 0 CA-C-O 118.14 -0.933 . . . . 0.0 110.227 179.487 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.672 0.272 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.671 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 94.9 m -102.18 87.72 3.14 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.156 0.503 . . . . 0.0 111.227 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 54.9 m-85 -124.15 -112.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -171.62 159.57 5.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.447 ' O ' HD11 ' A' ' 124' ' ' ILE . 8.4 tt0 -81.65 80.66 7.93 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 60.6 mt -120.5 151.75 54.35 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.94 147.86 75.11 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.8 2.333 . . . . 0.0 108.358 170.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.7 94.77 1.04 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.258 0.551 . . . . 0.0 111.467 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.9 149.33 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.948 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 p -110.21 117.29 33.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.475 HD21 ' HA ' ' A' ' 98' ' ' ASP . 42.3 mt -112.03 175.06 5.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.326 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -105.37 136.59 44.63 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.821 0.343 . . . . 0.0 111.513 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.77 -173.86 2.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.429 HG21 ' HB ' ' A' ' 95' ' ' VAL . 34.0 pt -67.14 -21.02 27.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.357 0.599 . . . . 0.0 110.354 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -86.02 -15.53 41.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.13 20.01 51.02 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -87.96 140.12 29.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.9 m -79.7 115.07 19.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.227 0.537 . . . . 0.0 110.892 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 m -119.39 130.6 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.391 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.3 mt-30 -89.13 134.9 33.84 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.503 HG21 ' CE1' ' A' ' 103' ' ' PHE . 22.8 p -63.69 -30.53 71.62 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.857 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.401 ' N ' HD21 ' A' ' 25' ' ' ASN . 0.9 OUTLIER -78.96 -4.46 50.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.83 -178.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.63 13.78 7.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.1 tp -71.37 112.48 7.54 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.464 -177.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -137.3 143.3 42.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -178.012 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.434 ' O ' ' HB1' ' A' ' 30' ' ' ALA . 35.6 p-10 -112.01 -38.22 4.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' HB1' ' O ' ' A' ' 29' ' ' ASN . . . 167.79 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.51 0.506 . . . . 0.0 111.525 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.84 32.63 58.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.496 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -125.04 151.88 69.67 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 122.269 0.228 . . . . 0.0 110.913 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 149.76 89.28 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.245 1.963 . . . . 0.0 110.741 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.6 mtm -135.51 144.91 46.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.587 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.43 122.46 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.33 112.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.04 124.07 48.37 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.47 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -96.11 119.57 34.84 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.984 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -143.57 178.64 7.64 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.529 0.518 . . . . 0.0 111.271 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -113.2 155.25 25.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.522 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -72.67 156.6 38.79 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 59.73 35.3 22.18 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 81.4 m -130.48 152.76 49.51 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.025 0.441 . . . . 0.0 111.655 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 58.7 mttm -134.52 -43.34 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.748 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.564 ' CD ' ' H ' ' A' ' 44' ' ' LYS . 50.7 Cg_exo -57.36 -36.52 98.88 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.497 2.132 . . . . 0.0 113.532 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 56.0 m -86.95 5.99 34.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -97.04 21.97 9.07 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.442 -176.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -57.91 -45.75 86.03 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' O ' HG13 ' A' ' 53' ' ' ILE . 77.0 tt0 -55.96 -59.88 4.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.275 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.7 -41.78 99.3 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.871 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 54.8 tptt -64.05 -46.82 82.72 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.66 94.21 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.738 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.1 mt -65.0 -40.94 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.908 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.468 ' HA ' ' OH ' ' A' ' 93' ' ' TYR . 63.9 tt0 -53.61 -39.96 65.36 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 110.984 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 42.9 mm-40 -67.32 -40.24 85.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.18 18.95 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.64 -36.89 82.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.19 84.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.566 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.99 -43.57 98.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.198 0.523 . . . . 0.0 110.388 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 15.7 m0 -69.23 -42.38 75.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -72.11 -15.23 61.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.909 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.54 -47.95 83.53 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.337 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.21 -49.28 1.44 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.401 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -62.38 -41.02 98.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.528 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.61 31.0 77.3 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.045 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 133.08 30.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 122.532 0.333 . . . . 0.0 111.271 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.403 ' NH2' ' HB2' ' A' ' 29' ' ' ASN . 10.5 mtm180 -104.79 158.22 16.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.564 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 78.6 mt -107.14 135.82 48.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.079 0.466 . . . . 0.0 110.629 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.18 110.83 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.11 104.84 16.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.836 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.69 127.62 67.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.553 0.692 . . . . 0.0 111.067 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -91.02 137.27 32.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.539 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.9 pt -73.56 -20.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.997 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -67.79 142.58 56.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.098 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -65.09 176.16 1.36 Allowed 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.614 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.55 -45.82 92.71 Favored Glycine 0 N--CA 1.461 0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.123 -174.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 28.9 pt20 -70.5 -32.44 69.94 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -85.48 -24.12 27.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.165 0.507 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.684 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -85.62 -3.45 58.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.383 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 13.9 pt20 -64.98 -4.42 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.715 -0.615 . . . . 0.0 110.743 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.595 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.9 mttm -97.97 -10.66 24.11 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.355 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.684 HG21 ' O ' ' A' ' 79' ' ' ALA . 13.3 t -64.88 -47.1 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 121.949 0.88 . . . . 0.0 110.822 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.494 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.6 mtpt -65.62 -46.76 68.02 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.248 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.6 Cg_endo -59.51 -29.06 89.05 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.336 1.358 . . . . 0.0 111.32 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.5 mt -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.497 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -61.27 -34.29 74.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.69 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -65.94 -29.11 69.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.189 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.18 -49.25 3.56 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.349 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.497 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 12.0 p30 -77.88 -27.04 49.59 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.1 46.38 4.17 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.903 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.6 95.86 4.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 0.0 109.977 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -78.8 42.72 0.46 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.564 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -127.05 168.53 14.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.18 113.38 19.98 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.31 0.576 . . . . 0.0 109.469 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.429 ' HB ' HG21 ' A' ' 17' ' ' ILE . 13.7 t -97.31 136.89 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.788 -175.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.2 mp -129.09 148.32 51.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.237 -175.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.485 ' HG ' ' CB ' ' A' ' 79' ' ' ALA . 8.7 mp -114.42 117.73 31.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.141 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.593 ' OD2' ' HG2' ' A' ' 104' ' ' LYS . 11.9 t70 -90.74 114.96 27.44 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.636 172.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.5 m -93.99 -88.97 0.23 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.51 -178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -112.27 19.46 17.68 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.322 0.582 . . . . 0.0 110.273 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.23 73.52 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.634 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 18.4 t70 55.05 23.85 5.54 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 109.902 -174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 24' ' ' THR . 69.5 t80 -62.26 -42.45 99.34 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -177.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.593 ' HG2' ' OD2' ' A' ' 98' ' ' ASP . 11.4 pttm -54.78 -50.72 67.79 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -70.55 -36.12 73.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.659 -178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.03 87.62 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.074 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 35.8 mmm -82.54 -8.73 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.564 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 76.08 53.64 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.653 0.739 . . . . 0.0 111.553 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.5 t -98.88 129.86 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.38 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -130.98 -71.52 0.57 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.564 ' O ' HG12 ' A' ' 112' ' ' ILE . 52.1 tp -64.35 -39.16 93.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.861 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 111' ' ' LEU . 4.2 pt 64.55 145.21 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 125.081 1.352 . . . . 0.0 111.319 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.625 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.6 Cg_endo -82.29 179.05 27.98 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.933 -0.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -133.75 142.75 48.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.768 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 128' ' ' HIS . 21.9 t -117.99 126.57 74.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 123.466 0.479 . . . . 0.0 111.36 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 69.9 m-85 -126.44 114.93 18.82 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 64.8 mt -106.06 125.63 61.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-O 121.287 0.565 . . . . 0.0 111.835 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.28 130.6 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.7 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -81.27 -173.32 4.27 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.539 0.524 . . . . 0.0 111.602 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.07 -34.02 88.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.611 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -64.62 -40.59 95.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.163 0.506 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 114.44 33.89 1.68 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.257 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.21 155.05 46.9 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.447 HD11 ' O ' ' A' ' 8' ' ' GLN . 96.7 mt -74.55 108.82 6.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 146' ' ' LEU . 12.2 p -97.91 -29.28 3.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.123 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 89.8 t80 -129.71 132.7 46.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.147 0.499 . . . . 0.0 111.328 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -128.87 127.99 42.94 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.772 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 2.2 t60 -134.27 101.63 5.08 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.1 p -109.7 116.64 32.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.14 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.79 19.05 7.98 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.823 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.625 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -75.98 143.39 41.55 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.513 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.0 p -119.68 -43.3 2.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.236 -0.585 . . . . 0.0 112.019 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -160.32 125.19 3.83 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.11 17.13 41.48 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.025 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.23 -14.86 55.32 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 139' ' ' LEU . 2.2 mp0 -59.75 -26.99 66.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.129 0.49 . . . . 0.0 111.063 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.26 90.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.21 -31.62 71.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.744 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.623 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.0 mm? -61.3 -56.66 17.99 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.402 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 tp -66.45 -38.5 81.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 120.914 0.388 . . . . 0.0 111.388 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.26 -48.99 79.39 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.671 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 20.3 tptp -67.6 -31.39 71.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.261 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.1 t -59.33 -44.48 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -67.79 -33.06 74.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.567 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 50.8 mm-40 -56.34 -33.15 65.37 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.153 0.501 . . . . 0.0 109.928 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.409 ' CD2' HG12 ' A' ' 125' ' ' VAL . 84.3 mt -63.6 -43.71 96.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.07 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.9 t -71.41 -21.48 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.709 0.766 . . . . 0.0 110.051 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -79.29 -4.1 49.19 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.733 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.47 -16.17 14.06 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.15 -44.44 93.16 Favored Glycine 0 C--O 1.229 -0.188 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.522 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -114.04 117.68 31.97 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -66.43 -37.5 85.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.526 -173.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -111.87 -60.26 1.88 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -124.33 123.68 40.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.456 0.17 . . . . 0.0 110.895 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -66.48 -31.95 73.0 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.146 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 46.2 t60 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.845 -0.598 . . . . 0.0 109.56 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.518 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.7 m -94.16 58.52 2.52 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.627 -175.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.512 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 60.3 m-85 -87.38 -112.5 0.05 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.082 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.417 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . . . -162.89 11.56 0.06 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.566 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 52.58 42.31 31.41 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.995 0.903 . . . . 0.0 110.714 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.476 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 44.3 mt -96.6 164.01 19.13 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.406 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.19 157.16 63.06 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.736 2.291 . . . . 0.0 110.854 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.18 82.87 2.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.958 0.409 . . . . 0.0 111.354 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.18 134.85 65.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 p -95.08 114.59 26.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.989 0.423 . . . . 0.0 110.608 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -112.0 172.86 6.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 35.3 mmtm -97.84 131.89 43.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.385 0.612 . . . . 0.0 112.243 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -85.86 166.21 16.19 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.514 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.44 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 36.6 pt -61.45 -24.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.344 . . . . 0.0 111.671 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -77.26 -4.9 47.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.57 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.23 16.65 75.9 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -95.68 140.44 30.49 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.891 -0.654 . . . . 0.0 109.827 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.8 m -74.57 120.34 20.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.6 131.72 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.2 mt-30 -91.09 134.93 34.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.901 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.523 HG21 ' CE1' ' A' ' 103' ' ' PHE . 10.2 p -64.33 -31.9 73.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.923 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.36 -10.8 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.703 0.287 . . . . 0.0 111.593 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -119.08 3.49 11.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.09 -0.382 . . . . 0.0 111.214 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.36 109.45 19.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.527 0.68 . . . . 0.0 111.911 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.512 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.8 mt-10 -117.1 132.23 56.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.16 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' ND2' HH21 ' A' ' 67' ' ' ARG . 2.4 t-20 -72.3 -71.19 0.3 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.233 178.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.27 35.74 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.798 0.332 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.43 24.24 59.25 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.165 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -117.93 152.54 50.31 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.251 -0.475 . . . . 0.0 110.25 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.61 151.76 58.75 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.389 2.059 . . . . 0.0 111.893 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -134.98 156.27 49.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.04 0.448 . . . . 0.0 111.571 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.495 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 83.7 mt -126.64 126.68 69.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.68 125.36 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 120.688 0.28 . . . . 0.0 110.456 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -110.11 120.06 41.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.861 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.509 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 67.5 m-85 -96.37 121.98 38.76 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.177 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -147.68 169.35 19.88 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.5 0.5 . . . . 0.0 110.818 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.67 140.28 32.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.027 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.438 HG21 ' CG ' ' A' ' 74' ' ' ASP . 15.4 t -67.21 -33.02 74.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.346 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -99.08 69.56 1.75 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.0 t -131.88 175.31 9.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.121 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.64 167.7 20.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.267 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -42.66 82.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 124.149 3.232 . . . . 0.0 115.641 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.3 m -147.51 5.54 0.81 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.754 172.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.0 mt -66.5 -39.85 88.92 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.455 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.44 -79.58 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.169 0.588 . . . . 0.0 112.118 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 8.5 tm-20 -42.29 -60.58 1.43 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.952 1.701 . . . . 0.0 112.104 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.43 HD12 ' CE2' ' A' ' 93' ' ' TYR . 32.7 tp -61.21 -39.07 88.86 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.576 -176.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.28 -48.69 69.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.259 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.03 97.55 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-O 121.344 0.592 . . . . 0.0 111.072 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.2 mt -64.14 -41.38 92.24 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.86 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -52.81 -38.83 61.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.29 -38.42 87.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.444 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.57 24.33 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 53' ' ' ILE . 83.5 t80 -62.99 -40.63 98.32 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.68 85.11 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.035 0.445 . . . . 0.0 110.383 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.14 -43.3 99.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.247 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.419 ' NE1' HD11 ' A' ' 140' ' ' ILE . 24.8 m0 -65.47 -37.56 87.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -74.5 -9.16 58.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.64 -64.33 0.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -115.78 -39.59 3.48 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.419 HG23 HG13 ' A' ' 143' ' ' VAL . 7.4 m -62.29 -40.23 95.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.32 33.29 86.3 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.111 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.05 138.95 18.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.754 0.311 . . . . 0.0 110.649 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.521 HH21 ' ND2' ' A' ' 29' ' ' ASN . 23.8 mtm180 -123.65 152.87 41.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.052 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.495 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 62.9 mt -96.43 144.88 26.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.1 mt -119.73 112.52 37.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.81 120.1 33.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.682 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.92 130.65 73.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.478 0.656 . . . . 0.0 111.262 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 p -88.77 135.83 33.31 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.487 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.8 pt -82.24 -11.26 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.149 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.438 ' CG ' HG21 ' A' ' 41' ' ' THR . 8.3 m-20 -83.2 149.75 26.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.429 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -58.75 168.57 1.18 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.312 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.0 -35.98 86.19 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 114.28 0.472 . . . . 0.0 114.28 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.45 -53.26 57.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.186 0.493 . . . . 0.0 111.067 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -68.67 -37.94 80.0 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.591 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -66.88 -6.66 17.3 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.589 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.57 -17.57 62.97 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.397 0.617 . . . . 0.0 109.422 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.701 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.6 mttm -93.75 -8.28 41.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.284 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 79' ' ' ALA . 13.6 t -66.45 -46.23 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.73 0.776 . . . . 0.0 110.767 -177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.492 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.3 mtpt -62.55 -48.86 85.56 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.872 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -60.6 -29.93 89.51 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.357 1.371 . . . . 0.0 111.403 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.4 mt -63.68 -43.99 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.403 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -63.34 -41.92 98.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.494 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.28 -50.1 67.03 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.833 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.61 85.48 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.337 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -73.32 -23.42 60.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.87 0.335 . . . . 0.0 111.607 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.05 39.55 19.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.892 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.582 ' HB3' ' CD2' ' A' ' 93' ' ' TYR . 26.6 m0 -64.4 -47.2 80.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.758 0.313 . . . . 0.0 111.644 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 32.9 tt0 72.11 1.97 4.13 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 2.8 m-85 -88.18 174.15 8.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.11 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.72 137.03 45.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.421 ' C ' HD12 ' A' ' 96' ' ' LEU . 25.5 t -122.66 128.02 75.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.759 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 11.2 mp -124.09 137.36 54.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.703 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.94 116.49 32.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HA ' HD23 ' A' ' 14' ' ' LEU . 49.6 t0 -86.13 113.7 22.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.552 174.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.0 t -97.21 -10.64 25.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.021 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -82.52 -48.39 11.08 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.897 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.61 1.05 78.19 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.17 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -91.97 -24.61 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.79 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.523 ' CE1' HG21 ' A' ' 24' ' ' THR . 81.1 t80 -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 -177.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.67 -33.09 74.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.442 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.8 ttm-85 -69.96 -43.03 72.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.935 0.398 . . . . 0.0 110.468 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.7 91.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.228 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.459 ' HE1' ' HA ' ' A' ' 107' ' ' MET . 2.3 mmt -76.01 -23.72 55.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.991 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t30 72.42 84.29 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.201 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.419 ' HA ' HG21 ' A' ' 129' ' ' THR . 61.9 t -105.65 97.48 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.54 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -73.31 -54.58 8.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.3 tp -138.71 138.05 37.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.652 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.31 154.08 46.62 Favored Pre-proline 0 C--N 1.313 -1.022 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.49 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.2 Cg_endo -76.32 150.36 93.23 Favored 'Cis proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.852 1.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -111.1 136.42 50.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.986 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.25 126.25 74.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.209 0.528 . . . . 0.0 111.969 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -126.37 116.08 20.64 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.943 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 59.9 mt -104.72 131.51 53.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 111.099 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.4 130.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.413 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.02 -175.41 5.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.626 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.67 -16.0 49.44 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.814 -0.63 . . . . 0.0 114.058 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.401 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 48.3 m-80 -88.82 -1.2 57.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.008 0.404 . . . . 0.0 110.576 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 71.2 34.27 64.45 Favored Glycine 0 CA--C 1.501 -0.797 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.653 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 121' ' ' ASN . 28.6 mmtp -124.8 157.78 34.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 83.1 mt -74.79 116.24 17.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.01 -26.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.29 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.509 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 90.3 t80 -147.34 135.74 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.502 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.51 122.05 21.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.968 0.413 . . . . 0.0 110.723 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.509 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.9 t60 -134.56 102.3 5.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.419 HG21 ' HA ' ' A' ' 109' ' ' VAL . 30.3 m -117.63 124.22 48.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.624 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.27 -8.3 13.98 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.702 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -67.13 148.12 52.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.8 p -116.23 -47.29 2.76 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.701 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -156.4 131.94 9.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.667 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.77 15.54 56.34 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.915 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.19 -14.1 56.5 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.75 -18.49 55.08 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.997 0.919 . . . . 0.0 111.943 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.07 -39.21 94.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.467 0.651 . . . . 0.0 111.136 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.57 -32.13 67.75 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.629 ' O ' HG21 ' A' ' 143' ' ' VAL . 11.0 mp -62.47 -48.02 81.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.386 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.419 HD11 ' NE1' ' A' ' 60' ' ' TRP . 5.4 tp -66.21 -37.13 79.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.505 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.653 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.4 ttpp -60.73 -46.54 90.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.683 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.34 -35.69 81.22 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.694 0.283 . . . . 0.0 111.495 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.629 HG21 ' O ' ' A' ' 139' ' ' LEU . 96.0 t -59.93 -44.37 94.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 109.395 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 12.9 mmm180 -69.26 -34.86 75.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.056 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.653 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.6 mm-40 -55.75 -42.53 75.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.038 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 52.3 mt -61.87 -41.04 97.36 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.533 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.48 -42.61 87.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.299 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -61.94 -48.25 81.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.028 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 145' ' ' GLU . 12.9 pt-20 -67.51 -39.06 85.14 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.74 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 69.94 -48.54 0.65 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.7 m170 69.42 77.44 0.22 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.889 0.476 . . . . 0.0 109.739 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -168.82 -40.69 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.015 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -153.74 -62.52 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.244 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -82.16 167.63 18.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.531 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -136.32 -42.1 0.63 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.275 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 . . . . . 0 C--O 1.242 0.69 0 CA-C-O 118.549 -0.738 . . . . 0.0 110.619 -178.739 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.424 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 18.0 m -113.77 65.22 0.66 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.102 0.477 . . . . 0.0 111.262 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -87.48 -137.21 0.09 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.697 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -135.17 -23.81 1.47 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.252 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.617 ' NE2' ' HZ2' ' A' ' 123' ' ' LYS . 36.6 tt0 67.38 70.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.691 0.758 . . . . 0.0 111.205 -176.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 162.49 26.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.416 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.585 ' HG2' ' SD ' ' A' ' 107' ' ' MET . 8.8 Cg_exo -39.93 138.03 1.13 Allowed 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.091 3.194 . . . . 0.0 113.111 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.77 97.24 9.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.099 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.43 134.67 61.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 t -80.1 112.08 17.08 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.913 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' A' ' 98' ' ' ASP . 19.0 mt -121.99 169.85 10.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -105.47 130.13 53.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.813 0.339 . . . . 0.0 111.572 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -83.29 -167.91 1.88 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.043 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.524 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 41.9 pt -71.32 -17.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.23 -14.01 51.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.715 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.64 15.35 76.01 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -93.7 145.67 24.4 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.377 -0.912 . . . . 0.0 109.461 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -74.03 118.67 17.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.349 0.595 . . . . 0.0 110.926 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -128.82 132.44 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.412 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 95.6 mt-30 -95.33 135.21 37.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.543 HG23 ' CE1' ' A' ' 103' ' ' PHE . 15.9 p -61.5 -34.83 76.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.14 -20.69 63.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.02 0.438 . . . . 0.0 111.397 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.08 11.36 20.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 110.719 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.0 tp -97.06 125.19 41.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.289 0.566 . . . . 0.0 111.067 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -125.11 155.66 39.52 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.543 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.7 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 22.8 t-20 -78.97 -75.38 0.24 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.198 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.68 22.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.944 0.402 . . . . 0.0 110.682 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.424 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 97.53 -10.19 64.8 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -105.08 151.45 39.51 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.247 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.51 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -65.02 160.1 43.21 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.933 2.422 . . . . 0.0 112.522 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 11.2 ptt? -149.32 164.3 35.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.939 -175.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.41 ' CD1' ' HZ3' ' A' ' 60' ' ' TRP . 76.5 mt -128.46 127.92 67.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 92.9 mt -99.85 115.14 40.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -104.48 130.65 52.39 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.869 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.47 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 66.7 m-85 -96.38 121.14 37.86 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.22 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.455 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 24.9 p90 -142.0 164.38 30.32 Favored 'General case' 0 C--O 1.238 0.493 0 O-C-N 123.97 0.793 . . . . 0.0 110.494 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.13 17.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p -65.49 -17.61 64.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -132.04 85.27 2.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.943 0.402 . . . . 0.0 110.396 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 46' ' ' CYS . 33.2 t -164.48 165.11 21.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.201 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 29.3 tptp -154.02 -62.83 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.461 ' HD3' ' HB3' ' A' ' 44' ' ' LYS . 57.1 Cg_endo -69.45 -29.05 25.98 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.267 1.978 . . . . 0.0 113.439 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.646 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 58.5 m -67.39 -18.54 65.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.007 0.432 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.09 62.07 4.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.482 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 29.2 mmt180 -58.48 -46.2 87.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.6 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.553 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.7 pt-20 -62.87 -49.57 74.34 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.038 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.423 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 42.6 tp -62.25 -41.41 98.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.138 -177.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 tttt -63.67 -49.37 73.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.58 96.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.331 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.9 mt -64.4 -42.71 96.12 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -58.77 -36.39 74.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 62.1 mm-40 -66.58 -39.09 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.697 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.26 24.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.884 0.373 . . . . 0.0 111.886 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -58.67 -39.52 80.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.79 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.92 92.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.02 -38.43 90.87 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.638 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.498 ' CZ2' HG12 ' A' ' 140' ' ' ILE . 17.7 m0 -67.6 -37.03 81.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.576 0.703 . . . . 0.0 110.22 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -75.58 -8.11 55.94 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.675 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.09 -43.76 70.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.345 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -142.72 -40.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.958 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.424 HG22 HG11 ' A' ' 143' ' ' VAL . 7.8 m -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.811 0.339 . . . . 0.0 110.313 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.6 24.5 73.94 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 5.6 p -78.37 124.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 122.864 0.465 . . . . 0.0 111.715 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -106.17 165.58 11.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.639 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 84.3 mt -108.06 146.12 33.04 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.279 0.561 . . . . 0.0 111.853 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.511 HG23 HD11 ' A' ' 96' ' ' LEU . 93.7 mt -120.88 110.36 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.201 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.455 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -92.45 118.6 31.12 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.0 132.52 68.66 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.3 p -84.17 128.42 34.55 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.254 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.509 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 42.4 pt -76.4 -14.83 14.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 O-C-N 124.78 1.3 . . . . 0.0 111.344 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 7.0 m-20 -77.63 175.76 9.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.075 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -88.69 178.87 6.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.429 ' HA2' HD22 ' A' ' 97' ' ' LEU . . . -58.04 -23.27 51.5 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.987 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.5 -65.09 0.74 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.89 0.376 . . . . 0.0 111.234 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 63.9 m-20 -66.35 -35.33 80.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.691 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.555 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . . . -65.81 -4.72 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -64.48 -9.37 18.2 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.311 0.577 . . . . 0.0 110.523 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.77 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 94.4 mttt -92.98 -12.75 29.95 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.745 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 79' ' ' ALA . 50.6 t -64.88 -49.71 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 13.1 mptt -68.76 -41.6 21.62 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 14.5 Cg_endo -60.3 -31.06 92.39 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.025 1.15 . . . . 0.0 110.946 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.77 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.7 mt -63.72 -40.92 97.96 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.305 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.431 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -54.72 -48.25 72.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.619 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.91 -42.94 84.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.88 82.87 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.774 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -99.59 3.3 45.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.26 43.34 93.13 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.4 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.431 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.1 m0 -82.33 98.85 9.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.231 0.539 . . . . 0.0 110.159 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -86.5 44.95 1.19 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.005 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -145.89 -176.91 5.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -71.77 136.65 47.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.306 0.574 . . . . 0.0 111.505 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.69 130.31 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.231 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.511 HD11 HG23 ' A' ' 69' ' ' ILE . 10.6 mp -122.03 154.71 36.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.642 0.734 . . . . 0.0 111.695 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.555 ' HG ' ' CB ' ' A' ' 79' ' ' ALA . 8.8 tt -125.43 113.95 18.19 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.868 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.553 ' HA ' HD21 ' A' ' 14' ' ' LEU . 66.5 t0 -77.6 117.24 18.84 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 118.175 -1.41 . . . . 0.0 108.439 174.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -88.06 -32.3 18.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.413 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -79.02 -38.28 37.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.726 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.64 12.02 76.03 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.56 -6.04 15.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.543 ' CE1' HG23 ' A' ' 24' ' ' THR . 79.6 t80 -64.24 -39.5 94.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.192 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.509 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 24.5 pttm -59.62 -37.2 77.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.269 176.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -70.5 -41.49 72.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.667 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.62 92.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.942 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.585 ' SD ' ' HG2' ' A' ' 10' ' ' PRO . 42.0 mmm -88.66 -11.89 44.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.72 83.3 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.741 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.3 109.1 20.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -69.83 -58.53 3.76 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.175 0.512 . . . . 0.0 110.052 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.459 ' HB3' ' HA2' ' A' ' 130' ' ' GLY . 59.5 tp -143.47 136.28 27.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.6 pt -83.27 153.08 65.73 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -74.77 155.91 99.91 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.767 -1.347 . . . . 0.0 112.777 0.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -120.32 130.55 54.49 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.877 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.449 HG23 ' CD ' ' A' ' 49' ' ' GLU . 21.7 t -112.0 129.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.39 0.431 . . . . 0.0 111.997 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.14 113.7 15.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.039 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.7 mt -102.93 129.83 54.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-O 121.245 0.545 . . . . 0.0 110.791 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.18 131.52 63.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.827 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.3 165.34 23.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.632 0.582 . . . . 0.0 110.851 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.81 -21.39 51.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.208 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -73.3 -9.2 58.45 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.999 0.4 . . . . 0.0 111.105 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 91.23 18.56 45.69 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.951 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.617 ' HZ2' ' NE2' ' A' ' 8' ' ' GLN . 4.0 mptp? -125.56 150.39 47.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.891 0.346 . . . . 0.0 110.612 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.697 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.1 mt -65.07 125.97 23.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.439 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.72 -18.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 89.3 t80 -150.56 132.08 14.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.924 0.392 . . . . 0.0 111.707 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -128.64 128.92 45.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.832 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . 0.543 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.7 t60 -133.26 108.94 9.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.819 0.342 . . . . 0.0 110.828 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 p -120.94 135.14 55.27 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.838 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 111' ' ' LEU . . . 103.93 0.39 45.24 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.393 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.56 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -82.52 149.14 27.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.1 p -123.79 -47.65 1.93 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.986 0.422 . . . . 0.0 110.735 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.481 ' HB3' ' HE ' ' A' ' 48' ' ' ARG . 11.0 pt-20 -160.59 144.74 13.93 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.147 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.49 72.17 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.89 -13.93 55.77 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -60.21 -26.2 66.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.066 0.546 . . . . 0.0 111.234 -177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.88 90.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.587 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.62 -38.54 87.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.992 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.625 ' O ' HG22 ' A' ' 143' ' ' VAL . 10.9 mp -62.14 -52.4 64.0 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.457 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.498 HG12 ' CZ2' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -65.47 -38.89 83.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 -175.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.703 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 40.0 ttmt -59.57 -53.28 59.94 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.528 ' HD3' ' HB2' ' A' ' 126' ' ' TYR . 64.5 tttt -69.47 -30.3 68.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.066 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 139' ' ' LEU . 55.8 t -58.91 -46.06 91.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.923 0.392 . . . . 0.0 110.178 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 5.5 mmm180 -71.77 -34.61 69.59 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.767 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.703 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 5.7 mm-40 -56.01 -34.64 65.99 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 62.7 mt -60.98 -42.76 98.98 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.82 -49.68 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.472 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -63.76 -45.78 88.26 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -113.86 -39.47 3.98 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.55 39.04 95.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.944 -176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 50.7 p-80 -58.65 140.62 54.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.003 0.521 . . . . 0.0 111.943 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -105.91 -48.26 3.66 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.613 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -108.51 -32.68 7.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.672 0.272 . . . . 0.0 111.656 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 29.0 p80 -148.91 138.06 21.56 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.654 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -83.7 -22.63 31.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.884 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.7 t60 . . . . . 0 C--N 1.323 -0.571 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.35 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.6 t30 . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 120.328 0.109 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.475 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 7.4 t -176.82 98.18 0.05 Allowed 'General case' 0 CA--C 1.565 1.542 0 O-C-N 123.469 0.48 . . . . 0.0 110.875 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 76.7 m-85 -117.88 1.25 12.07 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.032 0.444 . . . . 0.0 111.123 -177.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 74.61 11.55 3.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.258 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 54.82 36.48 26.57 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.772 0.796 . . . . 0.0 110.501 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 80.5 mt -80.45 153.79 73.86 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.346 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.16 157.43 61.77 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.093 2.529 . . . . 0.0 111.132 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.98 82.45 2.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.0 133.46 68.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.129 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -91.35 105.0 17.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.03 0.443 . . . . 0.0 110.629 -177.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mp -100.54 176.47 5.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.313 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -114.61 125.15 53.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -90.28 -172.46 3.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.253 0.549 . . . . 0.0 112.19 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.563 ' HA ' ' CD ' ' A' ' 83' ' ' LYS . 37.5 pt -65.01 -28.6 45.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.308 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.62 -25.93 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.413 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.83 49.27 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -100.03 144.26 29.28 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.459 -0.87 . . . . 0.0 110.148 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.24 106.17 13.01 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.23 137.87 56.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.135 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.593 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 37.5 mt-30 -89.16 139.2 30.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.428 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 p -65.32 -32.17 73.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.96 -14.41 62.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.847 0.356 . . . . 0.0 111.29 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -116.62 5.85 13.31 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.645 -179.15 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -92.57 120.25 32.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 5' ' ' THR . 4.9 pt-20 -118.68 145.26 45.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.136 0.493 . . . . 0.0 111.94 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 26.5 t-20 -76.13 -67.81 0.64 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.924 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 169.23 -25.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.032 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.12 -6.57 1.55 Allowed Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.084 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -97.21 151.6 37.78 Favored Pre-proline 0 C--N 1.315 -0.926 0 C-N-CA 122.765 0.426 . . . . 0.0 110.774 -178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.47 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.6 Cg_exo -66.66 158.64 54.95 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.971 2.447 . . . . 0.0 112.427 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.448 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 4.1 ptt? -147.46 154.68 41.11 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.637 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.435 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.1 mt -125.91 130.77 72.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.5 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -110.93 118.75 36.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.443 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.489 ' HB2' ' HB2' ' A' ' 114' ' ' ALA . 38.8 m-85 -95.29 117.75 30.84 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -144.41 168.76 19.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 123.73 0.644 . . . . 0.0 110.506 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.69 146.26 29.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.74 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.471 HG21 ' OD2' ' A' ' 74' ' ' ASP . 13.4 t -69.05 -16.8 63.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.079 0.466 . . . . 0.0 110.879 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -84.95 -37.95 19.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.638 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.9 p -77.42 141.94 39.49 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.922 0.392 . . . . 0.0 111.627 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 30.7 mmtp -120.48 -55.15 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.41 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 10.4 Cg_exo -67.96 -21.38 43.61 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.319 2.013 . . . . 0.0 112.258 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 59.8 m -69.21 -15.97 63.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.295 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.3 mt -81.37 47.21 1.01 Allowed 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 120.869 0.366 . . . . 0.0 111.305 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.403 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 14.8 mmm180 -58.08 -44.78 87.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.274 0.559 . . . . 0.0 110.713 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.501 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.4 tm-20 -62.8 -55.19 28.66 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.536 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.493 HD11 ' CE2' ' A' ' 93' ' ' TYR . 33.2 tp -65.4 -41.06 94.06 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.45 -48.51 77.41 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.8 89.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.093 0.473 . . . . 0.0 110.881 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.5 mt -63.76 -41.07 91.36 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.844 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.928 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -50.78 -40.46 55.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.882 0.373 . . . . 0.0 110.829 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -70.42 -40.82 73.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -110.24 21.15 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.433 ' HH ' ' NE2' ' A' ' 61' ' ' GLN . 83.3 t80 -62.14 -40.46 96.03 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.646 -176.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.01 82.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.813 0.339 . . . . 0.0 110.395 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.87 -41.79 99.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.269 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -69.26 -38.93 78.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.572 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.433 ' NE2' ' HH ' ' A' ' 57' ' ' TYR . 39.8 mt-30 -77.88 -8.34 57.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.59 -50.23 68.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.254 0.346 . . . . 0.0 111.758 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.46 -38.2 1.19 Allowed 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.314 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.427 HG21 HG11 ' A' ' 143' ' ' VAL . 9.5 m -63.57 -41.48 98.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.07 78.56 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.247 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 8.3 p -74.63 137.26 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.773 0.321 . . . . 0.0 111.763 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.41 ' HG2' HE21 ' A' ' 61' ' ' GLN . 44.4 mtm-85 -115.46 169.15 9.38 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 78.5 mt -114.11 139.95 48.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.305 0.574 . . . . 0.0 111.319 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 96' ' ' LEU . 88.6 mt -111.78 99.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.96 115.63 24.48 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.9 129.49 75.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.346 0.593 . . . . 0.0 110.737 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.7 t -89.34 136.27 33.12 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.477 ' HB ' ' HE3' ' A' ' 104' ' ' LYS . 46.3 pt -75.25 -19.02 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.616 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' OD2' HG21 ' A' ' 41' ' ' THR . 13.4 m-20 -72.2 142.99 49.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.559 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 60.0 mt-10 -68.5 171.05 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -52.71 -41.81 58.08 Favored Glycine 0 C--N 1.329 0.159 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -172.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.97 -55.59 27.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.23 0.515 . . . . 0.0 111.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -69.96 -36.97 75.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.948 0.404 . . . . 0.0 111.704 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.611 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.01 -4.19 9.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 27.3 mt-30 -61.25 -10.12 6.27 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.761 -0.587 . . . . 0.0 110.892 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.633 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.4 mttm -92.85 -13.04 29.57 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.538 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -65.54 -46.21 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.588 0.709 . . . . 0.0 111.249 -177.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.563 ' CD ' ' HA ' ' A' ' 17' ' ' ILE . 28.7 mtmt -73.65 -37.68 3.62 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.0 Cg_endo -61.61 -31.08 86.7 Favored 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 120.372 1.168 . . . . 0.0 110.058 171.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -63.94 -42.4 97.34 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.471 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -57.48 -47.68 81.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.775 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.98 -45.65 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.144 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.48 92.04 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.204 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.54 -33.32 66.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.56 50.29 2.98 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.019 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.471 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 45.6 m0 -80.77 122.59 27.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.06 0.457 . . . . 0.0 109.949 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.67 32.88 1.17 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.041 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.493 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -139.63 171.07 14.77 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.285 -0.259 . . . . 0.0 110.797 -176.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.15 136.25 37.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.057 0.455 . . . . 0.0 111.249 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 45.8 t -118.17 131.14 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.031 -178.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.405 HD11 HG23 ' A' ' 69' ' ' ILE . 10.2 mp -121.2 145.82 47.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.362 0.601 . . . . 0.0 111.201 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.408 ' HG ' ' HB3' ' A' ' 79' ' ' ALA . 7.6 mp -112.91 119.58 38.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 64.7 t0 -85.5 114.39 22.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 117.846 -1.542 . . . . 0.0 108.715 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.1 t -93.24 -3.87 52.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.147 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -103.22 -58.3 1.9 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.398 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 104' ' ' LYS . . . 100.53 -13.25 59.73 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -64.08 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.416 0.686 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.4 -42.25 98.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.869 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.477 ' HE3' ' HB ' ' A' ' 73' ' ' ILE . 4.4 mtpm? -59.16 -43.78 92.12 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -68.26 -39.01 82.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.696 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.19 79.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.697 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 25.8 mmt -88.9 -7.38 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.207 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 57.91 52.78 7.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 0.0 110.539 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.77 89.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -77.05 -49.36 15.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.964 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 tp -127.35 138.65 53.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.291 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.1 pt -102.21 154.19 37.56 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.418 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 84.5 Cg_endo -78.62 147.05 80.76 Favored 'Cis proline' 0 C--O 1.241 0.635 0 C-N-CA 123.619 -1.409 . . . . 0.0 112.108 -0.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.489 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -108.94 138.06 45.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -122.92 131.4 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 84.3 m-85 -128.63 118.32 22.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.007 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.95 131.92 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.159 0.504 . . . . 0.0 110.694 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 34' ' ' MET . 53.6 t -115.61 134.0 60.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.925 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.49 -175.15 4.61 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.414 0.446 . . . . 0.0 111.509 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.16 89.22 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.31 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.25 -14.59 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.504 0.669 . . . . 0.0 110.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 85.17 41.64 7.4 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.949 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -121.76 155.81 34.48 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 7' ' ' ALA . 89.7 mt -77.43 125.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 p -120.03 -30.06 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.835 0.35 . . . . 0.0 111.902 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.573 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.6 t80 -121.86 126.83 49.63 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 122.175 -0.328 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.516 ' ND2' ' HE2' ' A' ' 116' ' ' PHE . 9.0 t-20 -131.85 109.31 10.02 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.334 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -147.82 109.03 4.28 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.072 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 p -91.23 106.14 18.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.608 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.2 72.08 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.596 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.566 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 31.7 p90 -70.85 -42.83 69.63 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.353 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.435 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 27.0 p 49.81 84.64 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.912 -1.494 . . . . 0.0 113.392 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 64.85 112.82 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.227 1.011 . . . . 0.0 112.8 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.08 -8.87 50.05 Favored Glycine 0 CA--C 1.51 -0.24 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.566 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -68.65 -37.88 85.29 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.344 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -52.89 -30.86 36.61 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.913 0.885 . . . . 0.0 111.531 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.56 99.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.481 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -73.82 -29.82 62.36 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.379 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.659 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -61.36 -48.43 81.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.926 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.6 tp -66.68 -36.04 76.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.591 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -57.92 -48.03 81.11 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.416 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.695 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 20.8 mttp -76.85 -22.19 53.91 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.659 HG23 ' O ' ' A' ' 139' ' ' LEU . 77.0 t -60.64 -44.28 96.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -68.51 -36.85 79.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.031 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -63.43 -30.59 71.69 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 120.649 0.261 . . . . 0.0 110.855 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.695 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.5 mt -61.49 -39.94 92.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.376 0.608 . . . . 0.0 109.665 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.47 -24.38 35.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.377 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -87.7 -4.89 58.89 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.289 -176.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.92 -24.78 26.45 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 120.91 0.386 . . . . 0.0 111.225 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.85 82.73 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.474 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 80.3 t60 -114.58 80.78 1.45 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.809 0.338 . . . . 0.0 111.267 -175.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 151' ' ' HIS . 12.9 t-80 171.3 -75.33 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 174.85 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -113.35 100.11 8.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.017 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -82.1 -33.95 29.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.911 0.386 . . . . 0.0 111.617 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.7 -178.311 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.514 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 6.9 m 65.2 76.08 0.34 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.575 0.703 . . . . 0.0 110.391 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 71.3 m-85 -97.57 -122.89 0.13 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.779 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -152.23 14.04 0.59 Allowed 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.377 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.456 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 47.6 tt0 50.43 33.8 8.26 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.619 0.723 . . . . 0.0 111.424 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.8 mt -83.28 151.43 62.78 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.005 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.18 150.38 79.83 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.925 2.416 . . . . 0.0 110.559 175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.74 84.69 2.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.987 0.422 . . . . 0.0 111.698 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.3 t -125.75 133.67 68.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 p -86.84 103.92 15.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.773 0.321 . . . . 0.0 111.176 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.0 mt -99.6 176.31 5.52 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -112.88 134.06 54.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.563 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -86.46 165.55 16.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.966 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 pt -67.7 -17.35 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -84.24 -3.67 58.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.858 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.97 78.07 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.76 142.5 27.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.247 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -82.18 111.86 18.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.417 0.627 . . . . 0.0 110.01 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -116.11 128.32 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.643 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.533 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.1 mt-30 -89.58 134.34 34.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.417 HG22 ' CE1' ' A' ' 103' ' ' PHE . 8.5 p -65.85 -29.85 70.37 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -68.55 -20.7 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.936 0.398 . . . . 0.0 110.942 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.21 13.95 20.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.978 179.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.65 102.66 3.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.239 0.543 . . . . 0.0 112.01 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.442 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 46.5 mt-10 -114.78 104.24 11.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.361 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -71.56 -44.9 63.71 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.44 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.514 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 64.4 31.48 81.0 Favored Glycine 0 C--O 1.227 -0.306 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.177 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -128.55 153.6 79.43 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 123.106 0.562 . . . . 0.0 109.717 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.592 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 32.0 Cg_exo -56.59 146.78 73.97 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 122.264 1.976 . . . . 0.0 111.563 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.41 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 25.2 mtt -135.18 170.6 15.67 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.068 -173.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 68' ' ' LEU . 7.6 tt -150.1 127.11 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.433 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.1 mt -101.61 126.05 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.122 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -104.15 111.83 24.59 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.398 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.518 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 23.6 m-85 -94.03 119.58 33.1 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.18 168.54 20.13 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.843 0.714 . . . . 0.0 110.717 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.7 -167.59 0.72 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.113 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.401 ' CG2' ' HB2' ' A' ' 74' ' ' ASP . 16.7 p -103.34 -1.4 28.76 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.43 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -147.81 86.7 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.3 p -170.68 152.12 3.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.299 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 83.4 tttt -147.96 -52.83 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.465 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 44' ' ' LYS . 31.5 Cg_exo -61.64 -25.52 79.2 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.005 1.804 . . . . 0.0 112.193 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 45.5 t -78.82 -9.22 59.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.096 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.1 mt -89.04 62.32 6.23 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.0 110.343 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -58.23 -41.75 84.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.029 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 tm-20 -62.93 -58.73 6.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.136 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.408 HD13 ' CE2' ' A' ' 93' ' ' TYR . 40.4 tp -62.68 -41.47 99.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.238 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.54 -46.71 87.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.87 92.72 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.099 0.476 . . . . 0.0 110.663 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.4 mt -68.71 -33.24 58.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.438 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -56.23 -27.72 55.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.226 0.536 . . . . 0.0 110.377 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -85.55 -41.23 15.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.881 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.7 15.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 84.1 t80 -61.07 -40.63 94.4 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.672 0.272 . . . . 0.0 111.511 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.39 80.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.082 0.468 . . . . 0.0 110.42 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.38 -41.26 98.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.053 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.427 ' NE1' HD11 ' A' ' 140' ' ' ILE . 20.7 m0 -69.88 -36.13 75.22 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.481 0.658 . . . . 0.0 110.441 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -78.04 -7.12 56.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.118 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -53.99 -50.81 65.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.836 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 -30.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.204 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 m -62.53 -41.85 99.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 0.0 111.413 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.91 25.06 74.78 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.061 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -77.53 133.75 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.577 0.227 . . . . 0.0 111.086 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtm-85 -117.67 148.16 42.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.65 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.524 ' HA ' HG22 ' A' ' 35' ' ' ILE . 78.2 mt -86.37 135.46 33.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.577 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 75.0 mt -112.84 101.42 12.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.27 103.6 14.36 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.171 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.5 127.3 73.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.501 0.667 . . . . 0.0 111.883 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -89.13 138.81 31.09 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.836 176.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.564 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 38.1 pt -90.86 -3.89 10.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 O-C-N 125.133 1.521 . . . . 0.0 113.615 -171.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.401 ' HB2' ' CG2' ' A' ' 41' ' ' THR . 21.4 m-20 -86.38 176.7 7.74 Favored 'General case' 0 C--O 1.214 -0.763 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.423 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.49 176.21 9.1 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.512 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -60.99 -34.04 86.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.661 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.21 -55.0 40.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.269 0.557 . . . . 0.0 110.813 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -67.93 -37.27 81.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.014 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -70.63 -5.0 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 81.1 mt-30 -61.87 -19.51 62.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.691 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 51.8 mtmt -90.02 -10.61 44.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.815 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 79' ' ' ALA . 57.7 t -63.89 -47.75 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.0 mptp? -73.71 -38.71 4.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.9 Cg_endo -60.37 -32.91 94.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 119.909 1.003 . . . . 0.0 110.283 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.2 mt -64.52 -42.39 95.82 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.625 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -56.73 -50.36 72.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.675 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -68.35 -44.52 75.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.756 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.81 98.14 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.172 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -79.87 -32.66 40.41 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.69 45.98 3.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.217 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.625 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 40.2 m0 -82.79 114.52 21.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 111.054 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.18 37.38 0.72 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.502 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.449 ' CE1' HD11 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -130.58 167.03 19.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.28 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.36 116.97 19.16 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.805 0.812 . . . . 0.0 110.313 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG12 ' HZ2' ' A' ' 83' ' ' LYS . 15.5 t -98.88 132.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.356 -177.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 tp -109.87 163.28 13.68 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.401 ' HB2' ' HE2' ' A' ' 83' ' ' LYS . 11.7 tp -126.68 99.63 5.86 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -75.57 117.57 17.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 117.542 -1.663 . . . . 0.0 108.101 172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 p -97.79 -5.22 35.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.152 0.501 . . . . 0.0 110.954 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -101.02 -42.17 6.5 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.701 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.8 5.23 89.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -97.51 -14.66 20.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.787 0.327 . . . . 0.0 111.312 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CE1' HG22 ' A' ' 24' ' ' THR . 44.9 t80 -64.42 -38.54 91.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.844 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.564 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 22.1 pttm -55.41 -44.32 76.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.801 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -65.68 -42.94 90.69 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.249 0.547 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.59 85.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -86.23 -3.68 59.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.619 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.71 36.35 2.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.512 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -73.07 88.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.646 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 t -74.31 -45.68 45.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.613 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.85 149.98 50.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.169 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.2 pt -105.86 155.33 38.47 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.44 142.23 68.12 Favored 'Cis proline' 0 C--O 1.239 0.561 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.603 -0.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -106.11 132.58 52.02 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.11 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.426 HG23 HD21 ' A' ' 139' ' ' LEU . 70.9 t -117.8 129.66 73.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 94.1 m-85 -125.48 115.66 20.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.416 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.8 mt -101.28 130.03 51.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.166 0.508 . . . . 0.0 110.51 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.41 ' HB ' ' H ' ' A' ' 34' ' ' MET . 74.2 t -103.91 131.06 53.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.705 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -83.52 -175.53 5.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.12 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.88 8.29 37.59 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.1 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -111.44 -1.27 15.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.683 0.754 . . . . 0.0 109.475 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.87 23.83 63.3 Favored Glycine 0 CA--C 1.504 -0.638 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.206 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 8.3 mptt -115.89 163.15 16.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.848 0.356 . . . . 0.0 110.484 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.45 102.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.298 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.25 -35.37 9.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.74 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.495 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 76.2 t80 -137.45 133.11 34.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.707 0.289 . . . . 0.0 110.861 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -141.22 124.6 16.62 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.153 0.502 . . . . 0.0 110.649 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -141.53 116.11 9.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.601 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 p -96.61 109.01 21.71 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.41 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.47 64.12 2.84 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.821 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.715 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.5 p90 -63.57 -41.54 98.38 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.321 0.581 . . . . 0.0 109.934 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.425 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 79.8 p 56.35 79.23 0.18 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.633 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 70.7 113.55 0.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.793 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.0 13.22 46.96 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.938 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.715 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -92.1 -36.88 6.15 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.501 -0.38 . . . . 0.0 112.474 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.2 pm0 -60.37 -18.9 53.44 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.984 0.513 . . . . 0.0 112.284 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.95 94.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.88 -33.52 68.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.593 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.649 ' O ' HG21 ' A' ' 143' ' ' VAL . 10.8 mp -60.98 -50.62 72.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.265 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.557 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.3 tp -66.24 -39.19 83.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.547 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.4 ttpp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.582 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 14.8 tptp -66.87 -33.95 76.73 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.152 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.649 HG21 ' O ' ' A' ' 139' ' ' LEU . 72.9 t -60.01 -44.84 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.33 0.586 . . . . 0.0 109.62 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 22.6 mmm180 -71.41 -23.61 61.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.43 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 55.9 mm-40 -62.06 -38.5 89.03 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 109.479 175.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.28 -41.52 99.0 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.81 -41.28 87.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.313 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -62.32 -6.98 3.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.199 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -59.07 -37.67 77.62 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 150.43 -177.05 28.75 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.988 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 67.3 m80 -106.38 146.86 29.94 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -62.67 -40.89 98.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.096 0.474 . . . . 0.0 110.783 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -122.27 121.36 36.6 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.524 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 20.5 p80 50.47 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.974 0.91 . . . . 0.0 111.91 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -133.67 121.23 21.68 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 C--O 1.242 0.708 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.9 179.224 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.3 m120 . . . . . 0 C--O 1.236 0.36 0 CA-C-O 120.792 0.33 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.497 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 26.0 m -85.07 84.93 7.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.656 -177.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -102.78 -134.11 0.31 Allowed 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.707 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -137.73 -4.01 1.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.609 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 54.52 74.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.656 0.741 . . . . 0.0 110.25 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.4 mt -122.67 162.1 40.35 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 -175.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.7 148.92 91.95 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.141 1.894 . . . . 0.0 110.215 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.24 80.19 0.99 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.211 0.529 . . . . 0.0 111.307 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.5 134.53 65.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.219 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -92.89 113.17 25.37 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.566 HD22 ' HA ' ' A' ' 98' ' ' ASP . 29.1 mt -110.9 176.59 4.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -110.12 134.52 52.1 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.313 0.577 . . . . 0.0 112.017 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -75.97 177.02 7.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.325 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.427 HG23 ' HB ' ' A' ' 95' ' ' VAL . 33.3 pt -55.0 -41.53 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -81.44 -8.41 59.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.12 20.18 31.25 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.21 -176.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -78.3 141.18 38.67 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 m -78.66 108.24 11.92 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.007 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.58 134.4 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.219 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.485 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 77.9 mt-30 -100.9 134.75 43.41 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.581 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -64.74 -30.24 71.24 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -72.09 -13.15 61.5 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -125.12 14.88 8.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.2 tp -74.69 125.03 27.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.4 OUTLIER -136.69 140.23 42.53 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -101.22 -48.87 4.25 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.597 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 168.73 31.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.735 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.497 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 71.38 36.09 63.2 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.581 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 46.1 mmtm -128.39 151.2 76.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.879 -0.16 . . . . 0.0 111.262 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -62.69 151.66 82.45 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.691 2.261 . . . . 0.0 111.547 178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.441 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 38.4 mtt -131.75 152.77 50.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -172.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.9 mt -130.22 118.13 42.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.413 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 86.0 mt -94.12 123.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.5 m -112.39 116.97 31.18 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.252 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 53.8 m-85 -88.16 111.22 21.37 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.401 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 30.7 p90 -123.86 154.72 39.26 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 123.68 0.613 . . . . 0.0 110.776 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.42 153.15 23.57 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.124 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -69.32 95.13 0.76 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.475 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 p30 45.37 35.32 1.83 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.743 1.217 . . . . 0.0 113.408 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 54.1 t -76.98 -81.34 0.09 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.807 0.337 . . . . 0.0 111.873 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 46' ' ' CYS . 68.4 mttm -142.92 158.35 59.35 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.489 -177.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.38 44.83 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 124.166 3.244 . . . . 0.0 113.413 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.429 ' H ' ' C ' ' A' ' 44' ' ' LYS . 59.9 m -80.5 -4.74 55.03 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 173.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.0 58.17 1.46 Allowed 'General case' 0 C--N 1.345 0.37 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.877 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -64.63 -39.91 94.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.32 -176.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.646 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -64.34 -48.54 75.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.729 -179.213 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.404 HD11 ' CE2' ' A' ' 93' ' ' TYR . 52.2 tp -63.62 -42.38 98.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.71 -46.32 88.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.963 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.485 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -61.91 -40.7 96.36 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.258 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.646 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.1 mt -64.79 -41.43 92.18 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.646 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -54.34 -30.97 53.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.24 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -79.47 -31.86 42.47 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 52' ' ' ALA . 16.1 m -122.42 23.68 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.0 t80 -63.37 -41.56 98.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.312 -0.242 . . . . 0.0 111.206 -177.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.3 83.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.164 0.507 . . . . 0.0 110.185 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.414 ' OD1' ' HA ' ' A' ' 56' ' ' VAL . 6.7 m-20 -64.68 -43.1 94.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.39 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.476 ' NE1' HD13 ' A' ' 140' ' ' ILE . 19.0 m0 -70.05 -37.77 75.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -79.13 -6.81 57.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.869 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.2 -49.65 66.31 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.739 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -160.54 73.82 0.51 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.523 0.678 . . . . 0.0 110.27 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -158.95 -41.64 0.06 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.345 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 32' ' ' LYS . . . 72.02 32.1 63.67 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.479 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.27 121.51 42.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.076 0.465 . . . . 0.0 110.914 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -105.85 164.19 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.687 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.1 mt -105.37 134.48 48.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.499 . . . . 0.0 111.568 -178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.1 mt -109.56 109.17 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' ' CE1' ' A' ' 39' ' ' PHE . . . -95.71 123.72 39.41 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.233 -178.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.73 131.6 72.76 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.378 0.609 . . . . 0.0 111.32 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.415 ' CB ' HG23 ' A' ' 82' ' ' VAL . 17.0 p -83.57 134.53 34.81 Favored 'General case' 0 C--O 1.257 1.473 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.242 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.7 pt -78.9 -14.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.698 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 178.51 5.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.06 179.7 5.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.507 ' HA2' HD22 ' A' ' 97' ' ' LEU . . . -59.3 -33.1 74.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.943 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -63.54 -47.11 82.97 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -89.99 -29.63 18.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.415 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -69.6 -3.68 15.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -59.52 -24.04 63.33 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 121.798 -0.564 . . . . 0.0 111.274 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.718 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 73.9 mmtt -88.69 -1.21 57.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 95.4 t -65.49 -46.71 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HE3' ' HB2' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -67.41 -42.77 39.72 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.886 -176.32 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.7 Cg_endo -62.2 -29.84 81.06 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 121.104 1.203 . . . . 0.0 110.902 175.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -62.88 -41.6 99.46 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -59.7 -42.38 92.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.698 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -45.41 65.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.76 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.57 -36.72 92.82 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.126 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -92.58 5.2 51.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.31 40.86 91.92 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.263 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.593 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 51.1 m0 -88.32 95.45 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.87 59.85 5.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.348 0.594 . . . . 0.0 110.737 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -137.56 -172.41 3.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.35 134.35 35.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.427 ' HB ' HG23 ' A' ' 17' ' ' ILE . 42.8 t -119.95 132.66 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.536 0.684 . . . . 0.0 110.738 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -120.16 152.25 37.93 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.451 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.55 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 10.1 tt -120.71 117.78 28.38 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.377 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.566 ' HA ' HD22 ' A' ' 14' ' ' LEU . 13.3 t0 -81.52 117.25 21.77 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.762 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 t -113.86 -11.18 12.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.476 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 1.6 m120 -84.83 -41.69 15.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 110.726 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.488 ' HA2' ' NZ ' ' A' ' 104' ' ' LYS . . . 94.92 -18.32 57.53 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.59 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.476 ' OD1' ' HB3' ' A' ' 100' ' ' ASN . 5.2 p-10 -91.38 -8.55 47.66 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.581 ' CE1' HG21 ' A' ' 24' ' ' THR . 88.0 t80 -63.85 -49.14 73.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.184 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.488 ' NZ ' ' HA2' ' A' ' 101' ' ' GLY . 13.1 pttm -62.42 -36.15 81.46 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.961 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -66.91 -43.54 83.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.283 0.563 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.86 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.939 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.444 ' HE2' ' HA ' ' A' ' 107' ' ' MET . 1.7 mmt -78.5 -7.91 57.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.243 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.54 43.09 3.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.67 0.748 . . . . 0.0 111.043 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.23 98.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.328 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -85.83 -66.4 0.91 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.564 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 57.2 tp -107.89 129.65 55.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 pt -85.55 148.16 48.47 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.618 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 85.2 Cg_endo -82.75 166.91 67.92 Favored 'Cis proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.242 -1.149 . . . . 0.0 112.882 0.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -125.75 144.36 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.724 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.97 131.69 70.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.413 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 86.5 m-85 -126.64 124.15 39.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.4 mt -109.77 129.21 65.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.178 0.513 . . . . 0.0 110.467 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.441 ' HB ' ' H ' ' A' ' 34' ' ' MET . 85.5 t -103.62 128.74 56.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.428 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 20.3 t70 -75.88 162.73 27.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.653 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.59 -22.6 52.98 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.878 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -69.46 -18.87 63.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.996 0.426 . . . . 0.0 110.882 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 93.88 31.14 8.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.192 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.78 154.61 51.53 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.707 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.3 mt -69.9 123.87 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.371 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 13.7 p -105.08 -30.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.9 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.5 t80 -132.89 125.26 29.53 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.019 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -131.24 122.35 26.35 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.274 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -145.39 107.9 4.43 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.846 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.3 p -102.15 107.19 18.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.658 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 114.92 74.65 0.6 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.767 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.618 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -126.76 156.76 40.69 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 32.6 p -124.92 -58.46 1.47 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.015 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -144.39 136.07 25.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.418 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 3.98 63.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.288 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.18 -20.96 53.94 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.077 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.17 -22.7 64.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.271 0.558 . . . . 0.0 111.116 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.3 94.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.038 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -71.49 -31.63 67.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.694 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -61.64 -48.88 78.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.276 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.476 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.1 tp -67.96 -38.11 79.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.34 -42.25 98.37 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.526 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.9 mmpt? -65.45 -40.39 93.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 139' ' ' LEU . 99.2 t -59.84 -46.68 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.359 0.6 . . . . 0.0 110.213 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 148' ' ' LYS . 22.1 mmm180 -66.94 -36.32 81.96 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.517 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 68.2 mm-40 -60.38 -34.1 73.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.58 0.229 . . . . 0.0 111.207 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 59.2 mt -63.43 -43.22 98.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.209 0.528 . . . . 0.0 109.921 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.86 -48.54 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.092 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.413 ' CG ' ' HA ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -66.39 -31.31 72.0 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -74.09 -22.52 59.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.187 0.517 . . . . 0.0 110.424 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -81.27 83.37 1.5 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.194 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 155' ' ' HIS . 57.5 m80 -84.51 123.92 30.81 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -84.54 -18.84 34.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.137 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -60.39 -50.08 75.02 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.082 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 8.33 2.79 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 151' ' ' HIS . 70.7 m80 63.28 13.74 7.23 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.876 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 65.1 t60 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.215 -0.897 . . . . 0.0 110.97 179.759 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.7 t30 . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 16.3 m -156.8 60.9 0.53 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.132 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.646 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 43.5 m-85 -82.85 -140.39 0.05 Allowed 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.411 0.624 . . . . 0.0 109.791 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.6 12.89 1.17 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.843 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 49.33 60.76 3.53 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.654 0.74 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.2 mt -112.56 158.8 36.36 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.427 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.0 159.21 53.06 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.049 2.5 . . . . 0.0 110.681 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.22 82.34 2.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.04 134.96 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.572 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.0 p -92.76 108.13 19.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.979 0.418 . . . . 0.0 111.131 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -112.58 174.93 5.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.592 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -108.81 136.57 48.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.793 0.33 . . . . 0.0 110.799 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -90.86 -171.43 3.01 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.783 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.19 -20.04 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -86.0 -21.65 27.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.243 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.98 10.35 58.75 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -175.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -85.85 146.33 26.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -74.4 116.91 15.6 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.404 0.621 . . . . 0.0 109.828 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.485 ' HB ' HD22 ' A' ' 27' ' ' LEU . 3.3 m -117.52 128.04 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.404 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.542 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 48.5 mt-30 -90.01 132.17 35.51 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.457 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 15.0 p -65.9 -29.47 69.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.629 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.44 -34.44 78.19 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -98.39 5.23 48.33 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.387 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 85.5 mt -73.51 117.0 14.75 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.734 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -132.5 154.18 50.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.566 177.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.58 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 63.3 t30 -89.52 -80.95 0.29 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.783 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 172.57 32.33 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.633 0.583 . . . . 0.0 110.755 -176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.66 -14.76 62.8 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -100.14 143.42 26.48 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.7 164.73 34.73 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.209 2.606 . . . . 0.0 112.846 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . 0.58 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 73.4 mtm -138.69 160.5 39.48 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.729 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.48 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 73.1 mt -129.43 125.67 62.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.8 mt -97.11 126.78 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 m -114.47 122.24 45.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.188 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HB2' ' HB1' ' A' ' 114' ' ' ALA . 73.1 m-85 -97.45 115.06 27.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -135.55 163.04 31.0 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.86 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.86 162.93 13.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.486 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.2 p -66.12 -41.71 90.16 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.296 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -101.31 86.35 2.98 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.1 p -67.48 121.42 15.77 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.796 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 67.1 mttm -102.71 -37.66 0.21 Allowed Pre-proline 0 CA--C 1.555 1.142 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.777 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 44' ' ' LYS . 89.1 Cg_endo -84.2 11.68 3.26 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 121.879 1.719 . . . . 0.0 111.15 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.4 m 62.0 16.89 8.53 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.501 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt 55.91 85.13 0.07 Allowed 'General case' 0 C--N 1.345 0.399 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.787 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.51 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 23.4 mmm180 -58.87 -48.95 79.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.247 -175.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.587 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.38 -52.62 31.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.614 -176.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.475 HD11 ' CE1' ' A' ' 93' ' ' TYR . 29.8 tp -63.55 -42.27 98.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.824 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -66.61 -49.53 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.69 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.517 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -63.21 -42.65 99.31 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.233 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.1 mt -64.03 -43.04 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.411 ' HB2' ' OH ' ' A' ' 93' ' ' TYR . 9.0 tt0 -59.23 -40.32 85.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.679 0.276 . . . . 0.0 110.846 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -66.7 -37.21 84.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 52' ' ' ALA . 31.3 m -107.36 19.17 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.071 0.462 . . . . 0.0 111.19 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -58.15 -40.49 81.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.883 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.6 81.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.619 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.43 -41.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.525 ' CH2' HG12 ' A' ' 53' ' ' ILE . 16.8 m0 -73.58 -42.42 61.62 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.253 0.549 . . . . 0.0 110.552 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -70.36 -9.8 57.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.208 0.603 . . . . 0.0 111.941 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.5 -49.35 64.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.063 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -136.6 -36.32 0.71 Allowed 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.036 -0.666 . . . . 0.0 112.77 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.461 HG22 HG12 ' A' ' 143' ' ' VAL . 17.6 m -65.74 -43.32 89.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.813 0.34 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.65 41.98 99.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.775 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.8 p -91.33 117.71 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -94.5 162.98 13.59 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.503 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.48 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 62.7 mt -105.47 148.19 27.46 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.265 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.578 HD13 ' SD ' ' A' ' 34' ' ' MET . 88.9 mt -122.11 110.82 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.39 111.15 22.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.412 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.482 HG21 ' HZ1' ' A' ' 104' ' ' LYS . 9.0 p -116.59 123.49 71.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 CA-C-O 121.587 0.708 . . . . 0.0 111.555 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.478 ' HB2' HG21 ' A' ' 82' ' ' VAL . 35.4 t -80.06 131.89 35.86 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.83 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.505 ' HA ' ' NZ ' ' A' ' 104' ' ' LYS . 40.5 pt -79.96 -13.92 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.397 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.71 -177.89 5.95 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -94.99 176.99 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.48 66.5 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.205 -0.452 . . . . 0.0 114.065 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.75 -49.47 75.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.176 0.512 . . . . 0.0 111.54 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -90.41 -37.05 14.23 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.619 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.502 ' O ' HG22 ' A' ' 82' ' ' VAL . . . -76.79 -3.95 40.99 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -63.02 -13.53 36.57 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.447 -0.783 . . . . 0.0 111.104 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.66 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 58.4 mttp -85.53 -8.3 58.4 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.8 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 59.6 t -66.58 -46.0 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.692 0.758 . . . . 0.0 111.723 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 10.7 mtpp -67.32 -41.61 34.06 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.913 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.3 Cg_endo -61.97 -30.64 83.62 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 120.965 1.11 . . . . 0.0 110.6 173.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.98 -42.74 97.12 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 83' ' ' LYS . . . -57.25 -48.28 79.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.992 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.06 -44.58 46.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.816 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.72 -47.71 80.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.256 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -73.93 -34.8 64.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.941 0.401 . . . . 0.0 111.308 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.79 49.21 1.98 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -77.27 109.36 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.136 0.493 . . . . 0.0 110.044 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.0 42.31 0.92 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.338 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.475 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -152.93 -179.72 7.91 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -72.75 140.16 47.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.384 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.27 129.57 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD12 HG21 ' A' ' 69' ' ' ILE . 11.1 mp -119.71 135.8 54.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.518 0.675 . . . . 0.0 111.58 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.0 tp -105.85 105.49 15.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.678 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.644 ' OD2' ' HE3' ' A' ' 104' ' ' LYS . 47.6 t0 -86.42 138.07 32.06 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 118.072 -1.451 . . . . 0.0 109.639 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.9 m -123.11 -0.36 8.92 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.397 0.617 . . . . 0.0 109.751 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.49 -59.22 1.92 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.278 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.52 -11.87 63.12 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.123 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.2 -24.37 43.2 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -61.46 -43.49 98.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.644 ' HE3' ' OD2' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.49 -41.99 95.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.042 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -66.72 -36.51 82.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.129 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.99 74.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.542 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 mmt -90.48 -9.35 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.069 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 63.19 59.86 1.24 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.352 0.596 . . . . 0.0 110.829 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.5 t -77.32 93.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.335 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.3 t -79.31 -58.82 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.648 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.3 tp -110.75 138.43 47.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.924 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 pt -100.25 152.98 37.99 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.589 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.7 Cg_endo -82.86 154.77 74.83 Favored 'Cis proline' 0 N--CA 1.476 0.487 0 C-N-CA 124.039 -1.234 . . . . 0.0 112.012 -1.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 38' ' ' PHE . . . -105.57 138.66 41.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.397 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.5 130.79 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.63 -177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.19 125.53 33.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.093 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 59.4 mt -106.73 132.62 53.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 6' ' ' TYR . 55.8 t -109.52 130.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.043 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.91 166.6 23.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.223 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -23.58 58.42 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.751 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -71.26 -11.05 60.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.76 0.79 . . . . 0.0 109.559 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.84 34.51 Favored Glycine 0 CA--C 1.498 -0.971 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.823 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.29 154.03 36.9 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 94.6 mt -76.26 117.7 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 -20.57 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.514 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 69.1 t80 -137.53 126.6 24.38 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -134.91 114.91 13.01 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.159 0.504 . . . . 0.0 110.595 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -146.51 116.39 7.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.942 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 p -95.82 106.24 18.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.102 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.67 69.45 1.3 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.454 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.589 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 39.6 p90 -65.99 -44.83 83.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.999 0.4 . . . . 0.0 110.326 177.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p 49.07 85.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.305 1.042 . . . . 0.0 112.68 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 68.05 130.46 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.255 1.022 . . . . 0.0 112.489 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.77 2.33 90.5 Favored Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.644 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.567 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -70.94 -42.01 60.73 Favored Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 121.543 -0.36 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -58.55 -25.37 62.41 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.937 0.399 . . . . 0.0 111.384 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 96.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.497 0.665 . . . . 0.0 109.765 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.03 -30.21 63.58 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.08 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.4 mm? -60.13 -50.71 72.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.862 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.449 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -70.37 -36.77 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.314 0.578 . . . . 0.0 109.881 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -61.37 -44.9 96.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 41.0 tptt -66.57 -31.31 71.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 110.38 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.0 t -58.97 -44.23 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -66.32 -28.53 68.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.279 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 61.3 mm-40 -63.79 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.241 176.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.9 mt -76.82 -16.18 59.51 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.223 0.535 . . . . 0.0 110.611 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.6 t -98.55 3.68 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.719 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -58.64 -38.95 79.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -88.86 -11.87 43.48 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.11 0.481 . . . . 0.0 111.314 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -79.88 -151.98 7.22 Favored Glycine 0 C--N 1.309 -0.942 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.35 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.626 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -74.52 43.0 0.17 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -57.75 -45.11 86.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -92.79 -30.69 15.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.743 0.306 . . . . 0.0 111.051 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.626 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 52.5 t-80 -176.6 -63.58 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -179.04 -68.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.622 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 79.1 t60 . . . . . 0 C--N 1.315 -0.902 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.273 178.058 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.506 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 35.0 m . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.916 0.388 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.523 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 38.2 m-85 -92.1 -143.22 0.2 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.348 0.594 . . . . 0.0 109.907 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.55 14.72 2.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.841 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.477 ' HB3' HG13 ' A' ' 124' ' ' ILE . 52.4 tt0 50.42 42.85 26.78 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.862 0.839 . . . . 0.0 110.507 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt -92.56 152.01 41.68 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.746 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.52 156.72 55.05 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.343 2.695 . . . . 0.0 111.403 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.64 80.55 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 111.159 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.7 t -125.94 134.29 66.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -90.6 116.58 28.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.713 0.292 . . . . 0.0 110.45 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tp -116.09 173.66 6.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -117.22 128.07 54.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -91.53 -175.31 4.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.869 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 95' ' ' VAL . 29.6 pt -66.66 -21.43 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.913 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -82.17 -10.6 59.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.943 0.402 . . . . 0.0 110.491 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.94 20.19 68.45 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -100.03 141.32 33.01 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.3 m -75.62 110.83 10.35 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.186 0.517 . . . . 0.0 109.897 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 m -116.32 131.02 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.684 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 89.2 mt-30 -90.28 133.06 35.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.583 HG21 ' CE1' ' A' ' 103' ' ' PHE . 16.9 p -66.84 -29.78 69.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.64 -34.32 76.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.29 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -101.94 8.46 41.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.695 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.9 tp -70.45 117.22 11.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.251 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.523 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 46.7 mt-10 -130.09 141.56 50.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.758 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 7.8 t30 -82.16 -75.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.12 29.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.378 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.506 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 93.98 2.3 64.64 Favored Glycine 0 C--O 1.23 -0.15 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.138 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -109.63 151.85 42.49 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 122.387 0.275 . . . . 0.0 110.999 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 19.9 Cg_exo -63.46 154.16 70.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.038 2.492 . . . . 0.0 112.033 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.758 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 73.6 mtm -132.91 147.86 52.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.683 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 78.1 mt -121.91 120.68 62.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.9 mt -99.36 119.27 47.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.0 m -102.58 119.21 38.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.85 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.665 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 72.5 m-85 -93.96 118.1 31.02 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.535 ' O ' HG12 ' A' ' 73' ' ' ILE . 20.2 p90 -144.09 162.99 34.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 123.634 0.584 . . . . 0.0 110.795 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.01 176.53 9.74 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.013 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.313 -1.006 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -176.634 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.33 -45.59 90.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.709 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.555 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -70.92 -45.21 64.64 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.862 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD11 ' CE1' ' A' ' 93' ' ' TYR . 27.2 tp -61.74 -43.43 98.87 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.23 -175.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.61 -48.42 77.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.41 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.37 -46.12 87.98 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.395 0.617 . . . . 0.0 111.197 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.2 mt -64.08 -41.73 93.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.468 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.933 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -54.36 -41.31 68.99 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 111.452 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -66.79 -38.12 85.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.64 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.17 21.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.281 0.563 . . . . 0.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.28 -44.48 88.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.408 0.683 . . . . 0.0 112.391 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.83 84.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.21 -40.98 99.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.979 0.419 . . . . 0.0 110.823 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -69.94 -40.68 75.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 55.1 mt-30 -64.61 -32.62 74.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.183 0.516 . . . . 0.0 110.739 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.46 -39.79 94.55 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.737 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -86.78 -86.2 0.15 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.394 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.566 HG23 ' H ' ' A' ' 66' ' ' VAL . 3.1 t -79.49 -16.04 56.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.876 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 71.86 17.63 77.0 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.407 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.566 ' H ' HG23 ' A' ' 64' ' ' THR . 10.7 p -63.63 140.21 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.127 0.489 . . . . 0.0 112.232 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.59 163.98 14.26 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.633 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 58.5 mt -112.16 134.56 53.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.482 0.658 . . . . 0.0 111.511 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 96' ' ' LEU . 95.0 mt -111.44 109.95 30.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.809 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.11 111.2 22.25 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.27 133.9 58.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-O 121.959 0.885 . . . . 0.0 112.32 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.659 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.0 m -85.08 120.23 26.36 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.133 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 39' ' ' PHE . 45.5 pt -84.68 36.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 123.987 0.804 . . . . 0.0 110.656 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -131.1 -167.88 1.91 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -95.06 165.92 12.19 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . -60.28 -37.21 92.67 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.384 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.409 ' HG3' ' N ' ' A' ' 78' ' ' ASN . 27.7 pt20 -60.38 -42.58 96.16 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.915 0.388 . . . . 0.0 111.324 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.409 ' N ' ' HG3' ' A' ' 77' ' ' GLN . 86.8 m-20 -81.69 -32.99 31.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -68.95 -5.63 22.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.424 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 15.6 mm100 -62.35 -12.85 23.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.824 0.345 . . . . 0.0 110.714 176.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.744 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 37.3 mtmm -93.7 -11.78 30.76 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.713 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG21 ' OG ' ' A' ' 72' ' ' SER . 20.1 t -68.58 -47.54 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.669 0.747 . . . . 0.0 111.571 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.8 mtpt -64.27 -44.65 77.1 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.722 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 13.1 Cg_endo -60.36 -32.29 93.82 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.194 1.263 . . . . 0.0 111.276 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.94 -43.63 98.28 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.36 92.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.127 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.69 -46.5 63.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.257 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.86 -48.22 68.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.296 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -67.88 -34.56 76.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.0 111.519 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.24 52.31 1.25 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.354 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -84.81 132.62 34.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.929 0.395 . . . . 0.0 110.345 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -103.8 33.07 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.188 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -145.33 -179.95 6.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -81.8 141.96 33.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 112.267 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 17' ' ' ILE . 38.9 t -120.76 134.75 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.539 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -121.48 138.57 54.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.763 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.578 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.6 mp -111.2 120.04 40.94 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 63.2 t0 -74.3 117.69 16.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.494 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.1 p -93.8 2.6 56.18 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -121.96 -37.53 2.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.812 0.339 . . . . 0.0 111.145 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.492 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 90.69 8.49 65.46 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.968 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.73 -17.35 17.77 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.583 ' CE1' HG21 ' A' ' 24' ' ' THR . 68.9 t80 -63.07 -43.62 98.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 110.582 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -59.23 -36.06 74.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 105' ' ' ARG . 36.3 ttm180 -71.95 -41.12 68.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.321 0.581 . . . . 0.0 110.308 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.33 84.75 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 31.0 mmm -96.76 -11.08 25.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.739 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 68.84 93.08 0.08 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.556 0.743 . . . . 0.0 112.006 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.88 83.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.8 m -62.15 -48.9 78.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.973 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.0 tp -151.48 132.43 14.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.592 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 148.16 55.11 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.51 147.82 87.76 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.699 -1.375 . . . . 0.0 112.588 0.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -114.72 128.98 56.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.851 175.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 139' ' ' LEU . 41.8 t -114.23 122.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -120.77 115.26 22.96 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.585 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 61.7 mt -103.86 131.51 52.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.274 0.559 . . . . 0.0 110.512 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 66.8 t -108.95 130.43 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.946 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.82 165.21 25.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.366 0.666 . . . . 0.0 111.071 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.79 -20.34 47.3 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.073 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -84.31 4.11 32.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.876 0.338 . . . . 0.0 111.06 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.54 48.4 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.88 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -126.68 152.53 46.62 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.6 mt -75.01 118.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -107.98 -30.69 2.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.268 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.585 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 90.0 t80 -141.58 140.39 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -136.06 130.7 33.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.193 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -141.2 104.1 4.56 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.189 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.1 m -104.17 120.19 40.58 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.045 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.69 47.76 66.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.667 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 31.6 p90 -67.59 -43.96 79.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 109.562 176.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.461 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 61.0 p 57.01 87.74 0.06 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.863 1.265 . . . . 0.0 113.036 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 72.07 127.71 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.118 0.967 . . . . 0.0 112.29 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.51 68.07 Favored Glycine 0 CA--C 1.51 -0.264 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.063 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.667 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -73.07 -21.6 79.7 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.249 -0.476 . . . . 0.0 112.257 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.4 mp0 -56.27 -30.6 62.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.818 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.75 92.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.34 -31.24 67.14 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.678 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.0 mm? -60.38 -52.27 65.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.683 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.8 tp -69.4 -32.79 54.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.203 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.8 ttpp -62.68 -47.34 84.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.939 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -66.34 -32.19 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 110.257 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 139' ' ' LEU . 55.4 t -59.41 -43.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.734 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 27.1 mmt180 -64.62 -36.02 82.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 67.2 mm-40 -58.53 -42.3 87.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.715 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 56.9 mt . . . . . 0 C--N 1.334 -0.107 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.314 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.444 -0.766 0 CA-C-O 121.22 0.534 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.558 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 31.6 m-85 -98.96 -134.02 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.95 155.82 40.65 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.456 ' H ' HG13 ' A' ' 124' ' ' ILE . 53.4 tt0 -74.52 75.84 1.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 81.4 mt -117.98 140.29 27.65 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.885 -174.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 22.6 Cg_exo -64.19 155.75 63.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.15 2.567 . . . . 0.0 110.673 174.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 91.22 0.46 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 154.53 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.888 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -98.01 134.04 41.65 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tp -131.89 165.31 24.17 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 20' ' ' LYS . 1.2 tppp? -113.2 129.61 56.46 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.223 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 20' ' ' LYS . 46.5 p30 -94.67 -174.88 3.43 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 95' ' ' VAL . 32.4 pt -68.42 -18.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.953 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -84.04 -12.4 55.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.924 0.392 . . . . 0.0 110.432 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 16.87 72.16 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' HD21 ' A' ' 16' ' ' ASN . 86.4 tttt -96.1 145.63 25.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.413 -0.894 . . . . 0.0 110.601 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.7 m -80.38 114.0 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.877 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 m -120.65 134.11 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.969 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.423 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.1 mt-30 -88.91 134.95 33.78 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.569 HG21 ' CE1' ' A' ' 103' ' ' PHE . 25.0 p -65.48 -31.04 71.91 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.2 -28.62 69.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.22 16.44 23.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.045 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.6 tp -79.03 101.27 7.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.058 0.456 . . . . 0.0 111.95 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.558 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.1 mt-10 -119.11 122.89 43.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.987 177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -70.88 -43.06 69.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.27 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 0.0 109.464 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.91 33.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.395 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -128.67 151.74 77.54 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 122.415 0.286 . . . . 0.0 110.864 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.95 155.5 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.275 . . . . 0.0 111.621 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.421 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 38.2 mtt -129.92 153.43 48.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.93 0.395 . . . . 0.0 111.805 -171.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.8 mt -128.3 117.28 44.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 82.1 mt -96.79 118.16 42.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 m -104.88 116.07 31.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -90.8 115.78 28.13 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -138.2 168.48 19.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.207 0.527 . . . . 0.0 112.119 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.05 166.98 11.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.336 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.612 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.593 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -63.87 -45.96 87.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.582 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -66.2 -46.37 77.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.137 -176.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD11 ' CE1' ' A' ' 93' ' ' TYR . 33.8 tp -63.8 -42.51 97.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -61.6 -48.44 80.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.562 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -61.37 -42.56 98.9 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.006 0.432 . . . . 0.0 111.02 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.3 mt -64.96 -42.27 94.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.046 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 27.2 mt-30 -55.49 -40.86 72.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 111.298 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.28 -38.13 87.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.742 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 52' ' ' ALA . 18.1 m -116.22 27.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.002 0.43 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 53' ' ' ILE . 65.0 t80 -58.64 -39.6 81.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.627 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.45 87.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.641 0.258 . . . . 0.0 110.846 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.55 -41.71 96.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.297 0.57 . . . . 0.0 110.417 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.612 ' O ' ' HB ' ' A' ' 64' ' ' THR . 11.9 m0 -71.18 -37.03 72.18 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.714 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -80.2 -8.92 59.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.787 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.57 -60.43 3.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.182 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.11 -4.25 3.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.758 0.314 . . . . 0.0 111.796 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 18.1 m -96.11 -35.54 11.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.253 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.08 31.33 65.12 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.853 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.95 128.93 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.447 0.641 . . . . 0.0 112.117 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -94.15 152.24 18.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.381 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 39.3 mt -111.94 130.11 55.95 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.138 0.494 . . . . 0.0 111.165 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 96' ' ' LEU . 91.0 mt -110.01 106.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.16 113.21 25.42 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.616 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 10.8 p -122.47 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.254 0.55 . . . . 0.0 111.84 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.6 p -88.66 143.48 26.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.719 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.0 pt -78.31 -13.99 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.111 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -84.39 153.97 23.12 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.707 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.57 168.1 13.64 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 123.52 0.513 . . . . 0.0 110.087 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -55.47 -40.77 78.73 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.142 0.417 . . . . 0.0 114.142 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.2 -39.37 92.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.224 0.512 . . . . 0.0 111.32 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -83.32 -32.65 26.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.362 0.601 . . . . 0.0 110.53 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -79.01 -2.06 38.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.094 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 99.1 mt-30 -57.86 -16.09 10.63 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.916 -0.49 . . . . 0.0 111.146 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.686 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.7 mttp -84.91 -14.82 46.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.431 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 79' ' ' ALA . 49.8 t -65.68 -47.13 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.805 0.812 . . . . 0.0 112.272 -175.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.0 mtpm? -67.34 -42.87 41.02 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.55 -176.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.622 ' HA ' ' OD2' ' A' ' 87' ' ' ASP . 17.9 Cg_endo -61.89 -28.63 81.4 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.107 1.204 . . . . 0.0 111.001 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.96 -42.2 97.36 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 91' ' ' TRP . . . -57.99 -49.12 77.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.773 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 p30 -75.0 -35.96 61.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.996 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.28 -49.59 56.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.877 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -74.6 -34.1 62.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.924 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.217 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 54.4 m0 -95.09 117.79 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.35 47.88 0.93 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -149.23 -169.62 3.42 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.795 -0.184 . . . . 0.0 110.576 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -89.09 135.84 33.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.428 0.633 . . . . 0.0 111.983 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 17' ' ' ILE . 58.8 t -118.07 132.45 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.767 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 8.1 mp -130.3 146.12 51.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.947 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -126.36 127.68 45.88 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -61.01 133.59 56.24 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.1 t -114.75 7.28 15.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.537 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -142.94 -30.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.53 63.09 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.968 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -74.59 -36.87 63.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.418 0.151 . . . . 0.0 111.136 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.569 ' CE1' HG21 ' A' ' 24' ' ' THR . 79.9 t80 -62.19 -48.65 79.07 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -61.59 -35.01 76.63 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.851 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -70.56 -42.43 71.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.375 0.607 . . . . 0.0 110.063 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 10' ' ' PRO . . . -61.43 -37.65 84.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.315 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 28.5 mmm -82.64 -22.77 34.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.317 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.0 t30 72.13 81.75 0.14 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.462 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.91 99.79 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.266 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.2 m -71.71 -69.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.803 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.405 HD21 ' CG2' ' A' ' 132' ' ' THR . 60.4 tp -115.43 131.12 57.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.6 pt -88.67 144.42 33.36 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -80.45 161.58 83.9 Favored 'Cis proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.838 -1.318 . . . . 0.0 113.564 0.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.22 145.08 49.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.958 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.49 130.15 74.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.108 0.48 . . . . 0.0 112.168 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 82.4 m-85 -125.41 124.86 42.39 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.592 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 75.7 mt -114.2 131.07 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.051 0.453 . . . . 0.0 111.057 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 54.8 t -108.92 132.93 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 123.886 0.874 . . . . 0.0 110.057 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -95.04 -171.91 2.55 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.269 0.356 . . . . 0.0 111.111 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.87 66.44 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.983 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -75.09 -2.02 25.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.987 0.393 . . . . 0.0 111.338 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 73.78 30.96 60.88 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.032 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 48.2 mmtm -133.01 168.47 18.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 8' ' ' GLN . 98.2 mt -90.24 112.37 24.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.082 0.468 . . . . 0.0 110.349 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.69 -31.83 5.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.489 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.592 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.4 t80 -124.55 130.71 52.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.043 0.449 . . . . 0.0 111.337 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -130.06 120.67 25.05 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.057 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -144.36 102.84 3.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.884 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.2 p -102.79 106.76 17.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 113.21 71.14 0.56 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.991 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.584 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -122.22 157.06 32.45 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.405 ' CG2' HD21 ' A' ' 111' ' ' LEU . 27.9 p -127.02 -41.85 1.77 Allowed 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.869 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -167.89 124.05 1.07 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.18 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.39 -3.19 32.83 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.39 -18.71 65.9 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.77 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.51 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 2.0 mp0 -60.22 -20.83 60.48 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.094 0.557 . . . . 0.0 111.369 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.6 94.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.483 0.659 . . . . 0.0 110.706 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.7 -32.06 69.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.708 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -61.82 -47.52 84.73 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.515 HD13 ' NE1' ' A' ' 60' ' ' TRP . 5.1 tp -68.54 -39.54 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.721 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.3 ttpp -60.65 -45.86 92.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.155 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 142' ' ' LYS . 42.1 tptt -66.06 -35.16 79.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.385 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -60.78 -42.7 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 144' ' ' ARG . 6.3 mmp_? -64.38 -34.53 78.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.129 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 51.7 mm-40 -61.6 -35.08 76.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.438 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.63 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.638 HG22 ' HE1' ' A' ' 34' ' ' MET . 37.3 m . . . . . 0 N--CA 1.439 -1.016 0 CA-C-O 120.961 0.41 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.482 ' CE2' ' HA ' ' A' ' 26' ' ' LYS . 93.2 m-85 -103.48 -80.58 0.52 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.315 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 166.98 -10.77 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 O-C-N 124.514 1.134 . . . . 0.0 110.334 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 55.3 tp60 63.88 44.79 4.65 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.915 0.864 . . . . 0.0 110.298 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.499 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 18.9 mt -98.16 159.42 30.76 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.912 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.63 148.19 93.59 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.301 2.001 . . . . 0.0 109.617 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.02 84.06 2.27 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.063 0.458 . . . . 0.0 111.2 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -117.92 132.95 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -87.97 109.83 20.12 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.09 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.768 HD22 ' HA ' ' A' ' 98' ' ' ASP . 33.3 mt -116.75 175.92 5.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.949 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.57 138.58 40.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.389 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.494 HD21 ' HB3' ' A' ' 20' ' ' LYS . 5.6 p30 -101.77 -175.04 2.73 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.439 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 32.4 pt -63.77 -22.57 31.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.97 -12.31 60.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.09 81.69 Favored Glycine 0 CA--C 1.503 -0.689 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.494 ' HB3' HD21 ' A' ' 16' ' ' ASN . 37.1 ttpt -96.45 141.16 30.08 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.6 m -73.43 115.09 12.39 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 16' ' ' ASN . 8.6 m -122.16 132.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.87 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 79.0 mt-30 -87.77 134.53 33.66 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.499 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 6.7 p -63.76 -28.54 69.94 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.106 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -75.84 -10.68 59.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.72 0.295 . . . . 0.0 111.34 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -126.48 12.96 7.56 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.489 0.185 . . . . 0.0 111.349 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.09 -48.89 78.19 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -172.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 33.06 97.98 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.419 1.104 . . . . 0.0 113.904 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 34' ' ' MET . 13.1 m120 -66.16 -58.39 5.53 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.367 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.69 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.72 4.89 89.88 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.159 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -112.67 150.89 43.42 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.57 150.45 81.63 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.87 2.38 . . . . 0.0 111.751 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.638 ' HE1' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -131.42 154.89 48.19 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.087 0.47 . . . . 0.0 111.065 -176.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.55 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.3 mt -123.08 122.85 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.1 mt -95.73 122.46 47.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.42 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 3.5 m -104.85 118.85 37.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.069 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 72.1 m-85 -95.19 116.86 29.3 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.49 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 28.1 p90 -142.56 171.42 14.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.605 0.566 . . . . 0.0 112.153 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.57 32.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.406 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.429 ' CG2' HG22 ' A' ' 82' ' ' VAL . 48.6 p . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.087 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.49 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 6.6 mt . . . . . 0 CA--C 1.518 -0.27 0 CA-C-O 121.311 0.577 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -57.52 -39.82 77.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.938 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.589 ' HA ' ' OH ' ' A' ' 131' ' ' TYR . 3.8 tm-20 -66.99 -54.83 18.04 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.2 tp -63.11 -40.78 98.63 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.059 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.0 tttt -62.13 -45.24 94.31 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.212 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -58.77 -46.66 87.0 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.498 ' CG2' HD11 ' A' ' 68' ' ' LEU . 58.8 mt -64.69 -43.16 96.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.168 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -54.62 -42.01 70.68 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.08 0.467 . . . . 0.0 110.993 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 51.2 mm-40 -65.88 -37.56 86.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.901 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 52' ' ' ALA . 30.7 m -110.99 17.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.21 -41.38 92.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.79 86.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 19.0 t70 -64.5 -41.75 96.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.148 0.499 . . . . 0.0 110.439 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.497 ' NE1' HD13 ' A' ' 140' ' ' ILE . 28.8 m0 -72.31 -42.33 65.58 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.263 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 18.6 mm-40 -65.79 -24.11 66.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.236 0.541 . . . . 0.0 110.604 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 36.1 t70 -59.62 -46.41 89.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.52 -70.11 0.77 Allowed 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.491 HG23 ' N ' ' A' ' 66' ' ' VAL . 2.8 t -77.41 -22.12 52.06 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.076 0.465 . . . . 0.0 111.221 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 66.45 32.17 80.97 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.28 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.491 ' N ' HG23 ' A' ' 64' ' ' THR . 14.8 p -63.28 136.56 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -102.63 156.38 17.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.069 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.575 HD12 ' CE2' ' A' ' 93' ' ' TYR . 68.9 mt -116.18 133.15 56.33 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.075 0.464 . . . . 0.0 111.206 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.548 HG23 HD13 ' A' ' 96' ' ' LEU . 86.4 mt -110.02 102.99 14.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.67 118.06 29.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.2 p -122.43 133.1 69.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.212 0 CA-C-O 121.634 0.731 . . . . 0.0 111.727 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.664 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 21.4 p -84.71 140.86 30.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.551 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.413 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 43.0 pt -80.81 -15.52 12.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.28 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.664 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -84.63 159.46 20.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.687 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.504 ' HB2' ' OE1' ' A' ' 77' ' ' GLN . 43.2 mt-10 -72.38 178.22 4.1 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.277 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.64 -48.99 67.64 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 115.423 0.929 . . . . 0.0 115.423 -173.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.504 ' OE1' ' HB2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -65.43 -40.7 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.734 0.767 . . . . 0.0 111.338 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -69.13 -39.63 78.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.229 0.537 . . . . 0.0 110.959 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -72.22 -4.16 27.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.152 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.6 -13.69 15.86 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.656 -0.653 . . . . 0.0 111.346 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.717 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.9 tttp -92.58 -10.45 37.49 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 122.764 0.425 . . . . 0.0 111.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.6 t -66.96 -47.36 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-O 121.547 0.689 . . . . 0.0 111.804 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 43.2 mtpt -63.64 -45.32 82.51 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.987 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -61.06 -31.16 90.62 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.091 1.194 . . . . 0.0 111.098 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -62.64 -44.2 96.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.22 98.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.415 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.22 -50.88 68.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.523 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.8 -44.86 46.35 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.789 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.58 41.91 3.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.411 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.423 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 53.2 m0 -83.35 108.31 16.45 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.0 42.28 1.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.575 ' CE2' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -146.23 177.62 8.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.845 -0.161 . . . . 0.0 111.303 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.78 137.77 40.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.391 0.615 . . . . 0.0 112.394 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -119.76 132.5 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.868 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.548 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -125.36 144.87 50.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.94 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.83 121.92 46.54 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.768 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.1 t0 -70.08 115.28 9.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.343 -1.343 . . . . 0.0 107.648 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.6 t -83.41 -15.25 50.47 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -173.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -120.18 -29.89 4.77 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.28 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.11 1.4 62.92 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.53 -14.19 28.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.448 ' CE1' HG21 ' A' ' 24' ' ' THR . 87.5 t80 -64.91 -44.96 87.85 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 25.6 pttm -63.19 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.2 -34.8 76.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.245 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.78 76.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.105 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 38' ' ' PHE . 23.6 mmt -84.87 -18.25 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.395 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 68.22 78.91 0.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.441 0.696 . . . . 0.0 110.332 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.42 89.4 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.6 m -68.83 -44.85 72.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.792 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.2 tp -137.12 134.74 36.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.5 pt -91.36 156.33 43.59 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.61 151.48 94.57 Favored 'Cis proline' 0 C--O 1.238 0.492 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.503 0.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -115.33 130.53 56.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 49' ' ' GLU . 24.2 t -110.99 126.27 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 123.291 0.369 . . . . 0.0 111.373 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 69.9 m-85 -128.03 115.06 17.9 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 60.5 mt -105.71 132.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.295 0.569 . . . . 0.0 111.452 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -109.68 134.88 50.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.478 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -90.16 -172.76 3.6 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.238 0.336 . . . . 0.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.93 -30.32 76.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.447 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -69.41 -14.53 62.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.58 0.705 . . . . 0.0 109.67 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 82.75 31.74 28.87 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.601 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 10.2 mptt -123.43 157.38 33.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.443 . . . . 0.0 110.111 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 7' ' ' ALA . 49.7 mt -74.66 100.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.035 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -88.03 -39.0 12.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.675 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 81.9 t80 -131.81 136.63 47.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.818 0.342 . . . . 0.0 111.652 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -131.03 134.63 46.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.099 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.2 t60 -148.95 103.09 3.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.5 m -103.2 118.88 37.77 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.11 0.481 . . . . 0.0 111.829 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.74 45.41 44.26 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.702 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 15.0 p90 -68.08 -37.51 81.31 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.081 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 43.2 p 77.41 -59.94 0.45 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.163 1.785 . . . . 0.0 112.278 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -147.8 142.87 27.06 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.582 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.11 19.17 67.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.702 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.98 -27.02 20.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.255 -0.473 . . . . 0.0 113.122 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 140' ' ' ILE . 5.7 pm0 -60.51 -22.18 63.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.337 0.255 . . . . 0.0 111.662 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.12 99.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.398 0.618 . . . . 0.0 110.112 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.0 -37.7 66.89 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.414 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -63.21 -46.56 86.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.543 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.497 HD13 ' NE1' ' A' ' 60' ' ' TRP . 7.2 tp -66.34 -34.79 72.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.819 0.342 . . . . 0.0 110.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.1 ttmt -56.43 -54.3 47.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.888 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 29.0 mmmt -66.04 -32.81 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 139' ' ' LEU . 52.9 t -62.0 -43.74 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.287 0.565 . . . . 0.0 109.934 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.425 ' NE ' HD11 ' A' ' 140' ' ' ILE . 78.2 mtt180 -84.27 -18.63 35.77 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.312 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 61.2 mm-40 -69.92 -30.16 67.5 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.415 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.0 mt . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 110.105 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.444 ' HA ' ' CA ' ' A' ' 122' ' ' GLY . 40.0 m . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 121.334 0.588 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.546 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 89.1 m-85 -100.87 -101.38 0.25 Allowed 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -177.41 11.5 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 25.4 tt0 54.57 34.8 22.06 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.793 0.806 . . . . 0.0 110.579 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.429 HD13 ' OG1' ' A' ' 24' ' ' THR . 79.3 mt -89.84 150.45 43.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.652 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.44 151.89 82.75 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.717 2.278 . . . . 0.0 111.476 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.31 84.13 2.45 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.905 0.383 . . . . 0.0 110.981 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 24' ' ' THR . 72.3 t -121.38 136.76 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -78.07 126.35 30.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 96' ' ' LEU . 1.9 tp -134.34 173.07 12.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.536 -176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -116.28 133.56 55.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -97.84 -179.89 4.58 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 95' ' ' VAL . 17.5 pt -64.3 -22.17 30.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -77.94 -16.64 58.01 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.901 0.381 . . . . 0.0 110.828 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.56 58.83 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.92 140.36 36.31 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.673 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.1 m -74.38 116.54 15.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.119 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.82 156.81 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.976 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -104.22 134.83 46.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 176.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -67.16 -16.38 64.28 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.378 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -93.05 7.52 43.8 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 121.774 -0.579 . . . . 0.0 112.09 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -136.45 16.35 3.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.836 -0.54 . . . . 0.0 111.297 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.8 -67.52 0.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.34 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.546 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 35.1 mt-10 64.52 175.66 0.19 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.701 0.762 . . . . 0.0 112.516 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.409 ' HB2' ' HE2' ' A' ' 34' ' ' MET . 0.3 OUTLIER -139.25 -78.27 0.33 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.539 178.024 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.77 31.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.261 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.45 34.15 29.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.298 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 71.7 mmtt -123.47 145.9 48.23 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 122.141 0.176 . . . . 0.0 111.008 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 12.8 Cg_exo -67.82 155.22 70.72 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.813 2.342 . . . . 0.0 111.832 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.409 ' HE2' ' HB2' ' A' ' 29' ' ' ASN . 36.6 mtt -133.97 160.68 36.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.169 0.509 . . . . 0.0 111.61 -174.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 97.2 mt -132.48 118.78 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -99.37 118.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 m -104.1 122.97 46.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.178 0.513 . . . . 0.0 110.191 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 62.8 m-85 -94.16 114.88 27.09 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.236 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HB2' HD22 ' A' ' 47' ' ' LEU . 25.0 p90 -135.25 170.73 15.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.641 0.588 . . . . 0.0 111.284 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.81 153.92 29.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.998 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.674 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.547 HD22 ' HB2' ' A' ' 39' ' ' PHE . 34.8 mt . . . . . 0 C--O 1.223 -0.325 0 CA-C-O 120.363 0.125 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? 61.15 -80.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.4 pt-20 -52.87 -52.86 55.86 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 112.229 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.422 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 47.0 tp -61.51 -42.7 99.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.634 0.254 . . . . 0.0 110.598 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 88.6 tttt -67.09 -46.92 72.8 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.626 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.95 97.56 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.0 mt -64.01 -41.38 92.31 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.817 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.726 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.51 -36.99 67.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.768 0.318 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 13.6 mm-40 -69.92 -39.65 76.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.488 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 m -114.84 27.35 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.178 0.513 . . . . 0.0 112.116 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 85.7 t80 -59.4 -35.61 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.749 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.669 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.72 -42.98 94.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.951 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.56 -36.81 76.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 0.0 110.59 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -82.08 -7.67 59.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -58.03 -48.99 78.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.039 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -131.95 -44.19 0.96 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -39.67 94.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 40.79 96.11 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.117 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.54 133.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.79 159.78 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 54.7 mt -108.28 139.3 43.17 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.267 0.556 . . . . 0.0 111.196 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 96' ' ' LEU . 79.2 mt -115.81 110.94 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.611 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -92.76 114.1 26.56 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.52 131.75 63.16 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.936 0.874 . . . . 0.0 111.627 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.576 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.1 m -88.69 119.39 29.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.146 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 pt -77.75 -17.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.939 0.774 . . . . 0.0 109.738 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 4.5 m-20 -73.09 146.34 45.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.155 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.5 -173.82 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.159 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.511 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -43.13 -58.32 3.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.858 -1.064 . . . . 0.0 115.403 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -65.85 -45.17 83.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.408 0.604 . . . . 0.0 112.088 -177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.512 ' CB ' ' HB3' ' A' ' 74' ' ' ASP . 7.3 m-20 -66.7 -41.4 88.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -72.88 -5.31 37.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.5 mt-30 -66.01 -10.56 40.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.802 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.76 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 96.0 mttt -94.87 -11.04 29.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.549 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 79' ' ' ALA . 14.1 t -68.65 -50.77 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 40.6 mtpt -66.26 -40.35 34.78 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.605 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 5.9 Cg_endo -58.69 -34.3 98.84 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.185 1.256 . . . . 0.0 110.334 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -64.05 -42.21 97.11 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.435 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -61.08 -43.48 98.82 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.25 -40.41 67.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.89 -42.32 92.92 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.309 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -88.86 -15.73 33.73 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.952 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.6 61.09 4.61 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.734 -0.667 . . . . 0.0 113.276 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.435 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 31.4 m0 -82.41 134.54 35.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.896 0.379 . . . . 0.0 110.323 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -94.65 30.83 1.92 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.383 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.527 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -132.15 171.52 13.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.921 -172.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -81.85 136.17 35.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 17' ' ' ILE . 13.9 t -116.66 144.19 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.072 0.463 . . . . 0.0 110.59 -176.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 14' ' ' LEU . 11.3 mp -124.64 142.46 51.36 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.037 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.738 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 9.9 mp -114.76 117.38 30.61 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -81.16 115.16 20.44 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 t -96.17 -8.19 33.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.383 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -111.65 -30.98 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.835 0.35 . . . . 0.0 111.163 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.27 14.54 68.62 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.56 -27.15 16.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.927 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.52 -45.92 90.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.043 0.449 . . . . 0.0 110.782 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -62.82 -38.91 92.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.191 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -70.69 -41.5 71.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.421 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.59 74.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.882 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.57 -9.65 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.898 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.83 52.23 3.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.978 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.31 89.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.928 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.6 m -69.33 -45.34 69.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.317 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.92 142.28 36.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.983 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 pt -101.83 153.12 38.16 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.551 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 96.0 Cg_endo -78.52 154.32 92.23 Favored 'Cis proline' 0 C--O 1.244 0.778 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.186 0.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -116.65 136.25 53.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.089 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -114.91 127.9 72.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.089 0.471 . . . . 0.0 111.651 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -128.19 114.56 17.13 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.281 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.5 mt -103.05 129.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 CA-C-O 121.199 0.523 . . . . 0.0 110.627 -178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.8 t -106.46 128.52 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.114 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -76.61 161.89 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.59 -21.45 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 114.08 0.392 . . . . 0.0 114.08 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.485 ' OD1' ' HB2' ' A' ' 123' ' ' LYS . 6.3 p30 -74.07 -16.45 61.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.687 0.743 . . . . 0.0 111.253 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 5' ' ' THR . . . 101.38 17.91 20.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.222 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.485 ' HB2' ' OD1' ' A' ' 121' ' ' ASN . 13.6 mptt -121.94 152.16 39.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.227 0.537 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.1 mt -75.45 111.54 11.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.583 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.12 -19.12 6.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.524 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 68.2 t80 -144.43 130.25 19.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.292 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -138.3 129.04 26.64 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.957 0.408 . . . . 0.0 110.305 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 112.64 8.49 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.092 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.8 p -95.8 106.67 18.83 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.776 0.322 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.24 59.14 2.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.23 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.594 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 41.4 p90 -67.55 -35.81 79.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 109.052 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 80.7 p 69.37 -88.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.216 1.807 . . . . 0.0 113.622 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -119.2 119.1 33.12 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.098 -0.377 . . . . 0.0 111.386 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.58 33.56 16.05 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.527 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.594 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -89.89 -27.11 22.54 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.694 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 140' ' ' ILE . 9.2 pt-20 -54.83 -26.0 32.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.641 0.776 . . . . 0.0 112.804 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.19 94.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 0.0 110.856 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.93 -33.41 68.24 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.547 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.6 -53.38 55.52 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.492 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 136' ' ' GLU . 6.2 tp -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.961 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -63.03 -44.38 96.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.16 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.442 ' HG2' ' HB2' ' A' ' 126' ' ' TYR . 44.6 tptt -68.33 -31.34 70.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 139' ' ' LEU . 69.3 t -59.17 -42.45 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.279 0.561 . . . . 0.0 109.489 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -64.31 -35.75 81.88 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.091 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -62.07 -32.02 72.51 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.601 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.243 0.544 . . . . 0.0 110.038 179.294 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.44 -0.949 0 CA-C-O 121.031 0.443 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.467 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 29.0 m-85 -92.68 -136.57 0.17 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.473 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -144.54 19.27 1.69 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.469 ' HB3' HG13 ' A' ' 124' ' ' ILE . 50.9 tt0 53.67 38.83 29.26 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.012 0.91 . . . . 0.0 110.444 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 65.6 mt -92.3 162.28 30.48 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.75 -175.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.68 168.6 23.26 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.273 2.649 . . . . 0.0 110.963 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.69 79.12 6.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.114 0.483 . . . . 0.0 110.61 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.22 134.43 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.1 m -96.68 116.18 28.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.849 0.357 . . . . 0.0 110.157 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 98' ' ' ASP . 47.4 mt -113.35 176.28 5.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.799 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -109.41 127.24 54.23 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.288 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.434 HD21 ' HB3' ' A' ' 20' ' ' LYS . 47.8 p30 -89.71 -174.34 4.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.111 0.481 . . . . 0.0 111.706 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.487 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 39.5 pt -71.41 -14.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.403 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -93.84 -1.61 54.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.774 0.321 . . . . 0.0 111.184 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.46 24.07 68.93 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HB3' HD21 ' A' ' 16' ' ' ASN . 62.6 tttp -101.54 139.53 37.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -82.51 109.82 17.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.08 142.67 23.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.791 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.46 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 87.9 mt-30 -100.32 133.11 45.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.875 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.415 HG21 ' CE1' ' A' ' 103' ' ' PHE . 20.9 p -68.89 -32.31 71.86 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -70.05 -17.21 63.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.448 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HE3' ' H ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -117.98 8.68 12.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.96 105.83 11.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.331 0.586 . . . . 0.0 112.044 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 56.4 mt-10 -108.63 139.69 43.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.078 175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.821 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 15.1 t-20 -76.05 -75.66 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.004 0.43 . . . . 0.0 110.328 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.55 33.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.249 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 28.51 51.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 66.4 mmtt -123.0 148.97 55.67 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.123 -177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 19.3 Cg_exo -65.28 149.86 88.0 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.34 2.027 . . . . 0.0 110.634 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.821 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 67.2 mtm -133.66 145.65 50.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.462 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 92.5 mt -122.63 125.45 72.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.38 122.37 51.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.238 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -106.47 115.87 30.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 66.3 m-85 -94.21 118.24 31.28 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -146.36 167.03 24.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.574 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 73' ' ' ILE . . . -100.01 146.56 26.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.578 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.446 HG22 ' OD2' ' A' ' 74' ' ' ASP . 7.0 t . . . . . 0 C--N 1.314 -0.969 0 CA-C-O 120.857 0.36 . . . . 0.0 111.4 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.903 0.382 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 26.1 mmt85 -64.11 -39.93 95.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.443 0.639 . . . . 0.0 109.537 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 tm-20 -64.04 -55.21 23.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.545 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD11 ' CE2' ' A' ' 93' ' ' TYR . 43.4 tp -62.12 -41.22 98.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.618 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 58.7 tttm -62.21 -48.64 79.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -63.57 -39.72 95.13 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.245 0.545 . . . . 0.0 110.925 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 49' ' ' GLU . 58.9 mt -65.33 -42.73 94.43 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.466 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.21 -30.33 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.804 0.335 . . . . 0.0 110.301 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 77.9 mm-40 -59.2 -48.25 82.33 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.786 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -122.02 30.86 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.488 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' ILE . 88.9 t80 -59.12 -34.74 72.4 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.46 -39.69 88.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.607 0.241 . . . . 0.0 110.471 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.28 -42.33 93.28 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 110.87 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.507 ' O ' ' HB ' ' A' ' 64' ' ' THR . 12.0 m0 -65.57 -37.2 85.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.307 0.575 . . . . 0.0 110.468 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -84.37 -8.22 59.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -53.55 -64.24 0.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.61 -31.22 3.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 19.0 m -63.05 -41.83 99.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.065 0.459 . . . . 0.0 110.07 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.76 31.98 79.92 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.194 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.02 131.78 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.603 0.716 . . . . 0.0 111.438 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.532 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 9.1 mmm180 -102.58 141.42 35.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.386 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.611 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 50.0 mt -102.24 138.0 39.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.003 0.43 . . . . 0.0 110.295 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.533 HD11 ' SD ' ' A' ' 34' ' ' MET . 91.8 mt -115.06 113.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.44 113.61 25.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.738 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 14.4 p -121.59 132.13 71.47 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-O 121.466 0.651 . . . . 0.0 111.751 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -88.55 131.55 34.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.557 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 40' ' ' ALA . 46.8 pt -77.67 -16.93 14.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 124.357 1.036 . . . . 0.0 110.864 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.446 ' OD2' HG22 ' A' ' 41' ' ' THR . 29.2 m-20 -80.5 160.66 25.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.987 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.89 171.96 7.25 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.83 0.348 . . . . 0.0 110.982 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -56.5 -41.14 88.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.804 -0.634 . . . . 0.0 114.151 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -62.47 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.07 0.435 . . . . 0.0 111.59 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -72.75 -39.3 66.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.4 0.619 . . . . 0.0 110.925 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.53 -4.85 12.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.201 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 47.2 mt-30 -63.88 -9.51 15.58 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.013 -0.429 . . . . 0.0 110.39 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.697 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.8 mttm -96.2 -10.51 27.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -63.66 -47.1 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.683 0.754 . . . . 0.0 111.836 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 23.2 mtmt -70.69 -43.13 14.98 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.159 -175.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.5 Cg_endo -61.17 -30.54 88.92 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 121.012 1.141 . . . . 0.0 110.932 174.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -64.96 -41.27 95.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -60.62 -40.13 90.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.587 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -46.21 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.126 0.489 . . . . 0.0 111.006 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.26 93.67 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.998 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -87.36 -16.18 35.74 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.304 0.552 . . . . 0.0 112.053 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.31 40.42 6.93 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.725 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -89.04 104.36 16.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -99.1 73.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.353 0.597 . . . . 0.0 109.995 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.611 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -137.18 167.23 21.97 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 67' ' ' ARG . 2.2 mp0 -70.39 102.6 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 48.0 t -92.74 128.36 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.148 0.499 . . . . 0.0 110.465 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.447 HD13 HG23 ' A' ' 69' ' ' ILE . 10.7 mp -124.75 138.07 54.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.349 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.58 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.1 mp -108.02 117.61 34.58 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.567 ' HA ' HD22 ' A' ' 14' ' ' LEU . 63.5 t0 -78.46 115.62 18.29 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.712 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 p -82.6 -9.85 59.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -127.81 -21.76 3.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 84.4 19.5 60.3 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.918 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 11.9 m-20 -93.95 -21.57 19.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.249 0.525 . . . . 0.0 112.107 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 24' ' ' THR . 75.0 t80 -63.68 -43.3 97.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 110.542 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 63.1 pttt -63.06 -33.14 74.79 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.9 176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 102' ' ' ASP . 60.6 mtp85 -69.52 -39.59 77.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.168 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.01 83.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.248 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.3 mmt -88.04 -3.3 58.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.737 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.72 44.06 14.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.688 0.756 . . . . 0.0 110.615 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.62 96.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.426 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.9 m -88.4 -58.94 2.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.9 tp -112.37 127.09 55.91 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.951 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -87.52 156.84 53.32 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.488 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.5 Cg_endo -82.17 150.11 72.39 Favored 'Cis proline' 0 C--O 1.242 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.304 -0.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -111.19 134.36 52.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.07 127.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.397 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 72.0 m-85 -128.46 116.95 20.5 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.9 mt -105.52 130.02 57.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.092 0.472 . . . . 0.0 110.993 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 54.9 t -114.18 133.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.745 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -85.46 -172.27 4.05 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.968 0.414 . . . . 0.0 111.23 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.8 -22.53 68.4 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.706 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -85.08 2.07 45.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.785 0.326 . . . . 0.0 110.711 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.44 65.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.401 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 71.3 mmtt -115.73 153.97 30.41 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.469 HG13 ' HB3' ' A' ' 8' ' ' GLN . 80.8 mt -80.93 114.87 22.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.44 -19.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.403 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.626 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 67.0 t80 -144.33 136.99 26.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.716 0.293 . . . . 0.0 110.587 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.88 135.21 24.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -158.36 122.85 4.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 p -103.79 112.35 25.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.128 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.93 66.52 1.8 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.856 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.669 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 27.9 p90 -69.03 -40.02 78.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.256 0.55 . . . . 0.0 110.26 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 81.5 p 55.47 81.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.764 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 64.72 120.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.032 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.54 55.93 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.85 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.669 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.73 -37.58 6.41 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.9 pm0 -60.78 -17.51 49.64 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.235 0.614 . . . . 0.0 111.849 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.44 96.59 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.526 0.679 . . . . 0.0 109.739 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -73.41 -31.95 64.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.354 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -62.24 -47.89 82.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 tp -68.66 -37.31 77.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 110.072 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.772 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.532 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -65.21 -36.06 82.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.266 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 139' ' ' LEU . 66.7 t -60.66 -46.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.172 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 144' ' ' ARG . 5.4 mmp_? -68.76 -36.19 78.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.573 0.701 . . . . 0.0 109.767 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 142' ' ' LYS . 34.6 tt0 -62.06 -27.27 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.19 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 94.4 mt . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.551 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 23.8 m . . . . . 0 N--CA 1.439 -1.003 0 CA-C-O 121.208 0.528 . . . . 0.0 111.405 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -116.16 -120.08 0.31 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -151.42 13.48 0.66 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.445 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 61.7 tt0 50.38 33.43 7.59 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.867 0.841 . . . . 0.0 110.98 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 74.7 mt -80.85 156.11 72.68 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.111 -176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.56 155.3 63.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.871 2.381 . . . . 0.0 110.798 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 80.04 1.28 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.125 0.488 . . . . 0.0 111.315 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.89 132.77 70.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.753 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.8 m -92.42 105.33 17.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.308 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 98' ' ' ASP . 71.2 mt -104.41 178.15 4.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.971 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HD2' ' C ' ' A' ' 19' ' ' GLY . 3.2 tppp? -108.54 135.91 49.02 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.105 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.69 -179.96 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.404 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 42.3 pt -68.32 -11.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -96.24 -4.66 41.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 111.098 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.484 ' C ' ' HD2' ' A' ' 15' ' ' LYS . . . 82.32 20.28 62.75 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.576 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.43 149.6 27.72 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 m -75.12 122.69 23.98 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.057 0.455 . . . . 0.0 110.875 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.09 135.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.645 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 94.4 mt-30 -95.62 133.99 39.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.466 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.6 p -67.41 -27.74 67.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -63.56 -33.74 76.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.204 0.526 . . . . 0.0 110.224 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -105.03 13.0 31.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.246 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.35 124.11 29.1 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.155 0.502 . . . . 0.0 112.105 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -146.74 173.81 12.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.258 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 32' ' ' LYS . 8.2 p30 -112.61 -56.71 2.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.082 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.35 39.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.377 0.671 . . . . 0.0 109.651 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.24 26.86 72.77 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.741 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 45.6 mmtm -117.19 152.84 49.53 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 122.239 0.216 . . . . 0.0 110.713 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.81 151.83 78.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.625 2.217 . . . . 0.0 111.398 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' HD11 ' A' ' 69' ' ' ILE . 56.7 mtm -136.32 154.53 50.83 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 84.0 mt -127.01 125.66 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.0 118.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.8 m -102.93 123.43 46.54 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.563 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -97.15 115.99 28.54 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.675 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -137.3 166.13 24.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.67 0.606 . . . . 0.0 111.212 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 73' ' ' ILE . . . -110.03 161.46 15.49 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.669 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 C--N 1.321 -0.656 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 178.838 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.45 -47.25 84.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.013 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.587 ' O ' HG13 ' A' ' 53' ' ' ILE . 15.5 pt-20 -58.43 -56.51 21.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 111.237 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.567 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 34.6 tp -65.73 -42.85 90.53 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.975 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 22.0 tptm -65.08 -47.47 77.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.02 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.02 -41.47 99.56 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 120.822 0.344 . . . . 0.0 110.976 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.0 mt -65.55 -42.53 93.26 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.719 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.9 -40.06 66.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 110.654 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 47.0 mm-40 -62.45 -46.43 88.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.29 26.86 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.615 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.3 t80 -59.79 -39.44 84.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.276 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.494 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.81 -42.51 81.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.3 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -67.21 -40.51 86.45 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 32.0 mm-40 -73.6 -15.8 61.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.12 -45.73 93.48 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.799 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.14 -68.23 0.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.304 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -62.83 -31.32 72.3 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.722 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 63.17 45.37 95.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.147 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.79 131.68 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.413 0.625 . . . . 0.0 112.295 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.506 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 13.3 mmm180 -96.57 159.02 15.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.948 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.491 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 76.0 mt -121.01 129.41 53.38 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.891 0.377 . . . . 0.0 111.285 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.52 HD11 ' SD ' ' A' ' 34' ' ' MET . 89.8 mt -109.32 108.64 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.81 107.43 19.21 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.01 131.47 56.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 CA-C-O 121.913 0.863 . . . . 0.0 112.396 -175.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.648 ' HB3' HG21 ' A' ' 82' ' ' VAL . 26.1 p -84.16 127.89 34.21 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.465 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 46.4 pt -83.46 -15.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.346 1.029 . . . . 0.0 111.001 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -85.28 152.09 23.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.014 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.16 171.36 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.19 -49.41 63.54 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.76 -41.86 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.748 0.774 . . . . 0.0 111.178 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -67.74 -38.27 83.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -72.56 -4.97 33.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.321 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -62.73 -9.51 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.961 -0.462 . . . . 0.0 110.948 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.704 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 98.9 mttt -92.68 -11.26 34.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.523 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.648 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.3 t -65.3 -49.28 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.631 0.729 . . . . 0.0 112.356 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 14.1 mtpp -71.04 -38.9 7.61 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.02 -28.41 80.43 Favored 'Trans proline' 0 C--N 1.364 1.37 0 CA-C-N 120.051 1.054 . . . . 0.0 110.666 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.08 -45.92 91.4 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.473 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -60.43 -36.94 79.37 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.787 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.03 -32.25 73.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.159 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.77 -44.58 5.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.772 -0.727 . . . . 0.0 113.902 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 17.9 p30 -82.29 -15.77 51.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.27 58.44 3.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.456 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -78.05 112.79 15.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.99 35.79 1.51 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.714 0.769 . . . . 0.0 110.754 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.531 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -141.21 -171.33 3.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.478 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.39 137.36 32.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.628 0.728 . . . . 0.0 112.689 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.489 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 19.4 t -106.71 140.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.965 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.1 131.56 54.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -111.98 95.06 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.612 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.437 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.3 t0 -77.49 116.07 17.76 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.085 174.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.3 p -89.82 -14.35 34.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -104.07 -39.19 6.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.97 0.414 . . . . 0.0 110.983 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.64 43.09 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.76 -29.59 18.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.0 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.466 ' CE1' HG21 ' A' ' 24' ' ' THR . 86.0 t80 -60.58 -43.34 97.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.517 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 21.8 pttp -62.44 -38.2 88.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.709 0.29 . . . . 0.0 111.279 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -66.01 -42.63 89.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.37 80.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.897 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 2.1 mmt -84.9 -5.06 59.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.264 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 107' ' ' MET . 93.0 m-20 71.43 35.47 1.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.297 0.373 . . . . 0.0 111.803 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 104' ' ' LYS . 92.4 t -83.07 108.61 15.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 120.931 0.396 . . . . 0.0 110.906 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.9 m -100.66 -64.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 tp -95.46 126.25 40.63 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -94.31 147.73 33.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.68 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.0 Cg_endo -82.75 167.05 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.117 -1.201 . . . . 0.0 112.971 1.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -131.73 141.94 49.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.45 127.34 73.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 O-C-N 123.344 0.402 . . . . 0.0 111.507 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -126.17 118.45 25.24 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.639 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 67.8 mt -106.96 131.72 56.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.201 0.524 . . . . 0.0 110.763 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.4 131.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -74.82 -179.54 4.26 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.009 0.818 . . . . 0.0 112.557 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.2 -30.83 78.8 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.749 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' THR . 3.3 t-20 -67.25 -41.07 86.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.169 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 121.5 21.23 3.06 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.7 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -113.56 163.45 14.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.02 109.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.0 -40.22 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.27 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 70.1 t80 -128.29 122.49 31.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.809 0.338 . . . . 0.0 110.62 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.5 120.91 29.36 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.116 0.484 . . . . 0.0 110.82 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -136.79 105.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.8 p -97.34 123.96 41.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 92.71 49.29 2.76 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.509 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.68 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 1.0 OUTLIER -90.11 135.82 33.43 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 173.554 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.6 p -123.67 69.0 1.03 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.501 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 69.85 119.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.176 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.04 8.8 35.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.67 -18.1 46.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.77 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -59.73 -19.84 52.61 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.78 95.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.39 0.614 . . . . 0.0 109.907 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.34 -32.94 69.14 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.678 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -62.02 -51.35 68.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -36.87 74.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.624 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.3 ttpp -60.03 -48.17 82.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.049 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 55.0 tptt -66.16 -30.27 70.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.213 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 139' ' ' LEU . 70.2 t -58.88 -44.64 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.478 ' HA ' ' NE ' ' A' ' 144' ' ' ARG . 4.6 mmp_? -68.32 -37.86 80.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.347 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.5 mm-40 -59.73 -36.29 76.28 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.722 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 83.1 mt . . . . . 0 CA--C 1.514 -0.428 0 CA-C-O 121.024 0.44 . . . . 0.0 110.27 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.417 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 m . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.36 0.6 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.434 ' O ' HG11 ' A' ' 118' ' ' VAL . 21.0 m-85 -97.37 -134.23 0.23 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.832 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -145.24 21.14 1.56 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.792 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 51.0 tt0 50.28 38.14 16.83 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.878 0.847 . . . . 0.0 109.504 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.832 HD22 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -103.9 147.93 35.05 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.175 -174.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.647 ' HD2' ' SD ' ' A' ' 107' ' ' MET . 48.1 Cg_exo -55.14 146.7 58.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.647 2.898 . . . . 0.0 112.474 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 25' ' ' ASN . . . -72.44 90.45 1.31 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.755 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.4 132.7 68.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 p -77.5 100.22 5.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.187 0.517 . . . . 0.0 109.964 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.434 HD23 HD23 ' A' ' 96' ' ' LEU . 4.7 tp -106.33 177.23 4.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.177 -176.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.472 ' CE ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -118.76 137.75 53.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.02 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -98.9 -178.8 4.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.041 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 95' ' ' VAL . 33.2 pt -67.05 -19.55 25.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.674 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.42 -10.81 59.44 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.326 0.584 . . . . 0.0 110.236 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.43 17.45 75.95 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 88.3 tttt -95.71 137.12 35.22 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.235 -0.483 . . . . 0.0 109.9 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 99.7 m -74.6 100.69 3.99 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.6 p -117.17 132.3 67.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.294 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.506 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 48.3 mt-30 -82.62 136.7 34.72 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.146 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.586 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 20.1 p -64.15 -36.24 83.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.43 -176.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 11' ' ' ALA . 64.1 t30 -69.43 -16.95 63.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.354 . . . . 0.0 111.575 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.506 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -110.08 6.74 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.08 113.56 22.94 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.68 154.94 41.65 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.73 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 25.6 t30 -87.53 -68.19 0.77 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 174.45 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.581 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.417 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 150.08 -13.58 0.97 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.507 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.2 mptm? -91.4 147.96 36.53 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.753 -0.224 . . . . 0.0 110.61 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.584 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 17.9 Cg_exo -65.06 156.6 61.81 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.199 2.599 . . . . 0.0 112.832 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.73 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 70.6 mtm -138.67 159.75 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.74 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.441 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 81.4 mt -129.65 128.63 65.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.6 mt -99.81 122.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.9 m -115.84 122.82 46.52 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.02 0.438 . . . . 0.0 110.602 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 56.3 m-85 -88.71 117.14 27.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.467 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 22.0 p90 -134.91 167.9 20.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 123.439 0.462 . . . . 0.0 110.681 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.5 149.01 30.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.307 -1.274 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.933 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.444 -0.767 0 CA-C-O 120.414 0.15 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . 12.0 mmm180 -60.21 -43.51 95.89 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.681 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 74.0 tt0 -52.63 -64.37 0.84 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.663 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.524 HD11 ' CE2' ' A' ' 93' ' ' TYR . 34.2 tp -62.85 -41.54 99.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.272 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.05 -47.68 83.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.054 0.221 . . . . 0.0 111.281 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.42 87.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.682 0.277 . . . . 0.0 111.042 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.9 mt -65.26 -41.01 90.46 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.83 -30.3 32.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.056 0.455 . . . . 0.0 111.016 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -82.67 -37.61 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.978 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.24 23.99 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -62.65 -35.09 78.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.764 0.316 . . . . 0.0 111.115 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.35 88.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.27 -43.87 96.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.436 ' NE1' HD13 ' A' ' 140' ' ' ILE . 13.8 m0 -68.7 -31.65 70.9 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.701 0.762 . . . . 0.0 110.136 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -81.36 -6.6 59.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.575 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.68 -51.76 46.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.09 -34.23 0.55 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.422 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 15.3 m -60.57 -42.58 96.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.87 74.0 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.839 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 11.2 p -75.62 127.43 37.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.112 0.482 . . . . 0.0 111.07 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -106.39 163.58 12.73 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 53' ' ' ILE . 61.2 mt -109.05 129.7 55.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.09 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.507 HG23 HD13 ' A' ' 96' ' ' LEU . 97.3 mt -101.25 107.01 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -93.89 113.81 25.91 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.307 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.4 129.49 67.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 121.379 0.609 . . . . 0.0 111.418 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 97' ' ' LEU . 39.4 p -83.94 130.47 34.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.311 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.0 pt -72.2 -23.75 21.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.35 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -82.54 147.11 28.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 89.7 mt-10 -61.48 163.53 6.74 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.491 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.13 -39.48 57.92 Favored Glycine 0 C--O 1.23 -0.124 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -174.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -63.87 -38.94 92.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 117.386 0.593 . . . . 0.0 111.114 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -79.89 -37.24 35.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.306 0.574 . . . . 0.0 110.096 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -65.53 -3.9 5.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.793 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.12 -11.21 8.03 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.016 -0.427 . . . . 0.0 110.54 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.731 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.0 mttp -96.55 -10.91 26.21 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.387 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 79' ' ' ALA . 14.6 t -66.53 -47.12 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-O 121.668 0.747 . . . . 0.0 111.627 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 17' ' ' ILE . 41.7 mtpt -64.13 -45.06 79.23 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.054 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.8 Cg_endo -62.08 -29.82 81.78 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.115 1.21 . . . . 0.0 111.19 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -63.09 -41.46 99.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.29 86.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.167 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.27 -46.56 66.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.355 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.5 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.123 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -91.37 -11.14 38.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.912 0.356 . . . . 0.0 111.706 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.28 38.83 28.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -82.19 111.8 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 0.0 110.5 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -97.07 60.38 1.7 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.084 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.524 ' CE2' HD11 ' A' ' 50' ' ' LEU . 6.0 m-85 -138.18 -177.79 4.99 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.961 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.98 117.75 31.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.657 ' O ' HG23 ' A' ' 17' ' ' ILE . 12.4 t -99.27 139.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.24 -174.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.507 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -125.92 142.89 51.31 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.795 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.613 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.7 mp -113.74 121.56 44.45 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 59.8 t0 -74.04 115.14 13.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 118.176 -1.41 . . . . 0.0 107.96 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 p -96.02 -6.0 39.81 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.962 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -117.65 -39.39 3.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.764 0.316 . . . . 0.0 111.647 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -8.51 68.58 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.16 -30.66 66.73 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.868 -0.666 . . . . 0.0 111.388 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' O ' ' HG2' ' A' ' 107' ' ' MET . 44.7 t80 -61.43 -43.44 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.817 -176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.28 -42.18 94.91 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 110.265 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -69.56 -42.31 74.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.53 94.78 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.138 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.647 ' SD ' ' HD2' ' A' ' 10' ' ' PRO . 39.2 mmm -84.49 -24.12 29.56 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.204 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.425 ' O ' HG21 ' A' ' 129' ' ' THR . 55.5 t30 75.23 100.89 0.07 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.778 0.831 . . . . 0.0 111.041 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.04 132.78 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -84.52 -96.01 0.06 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.4 pt? -119.47 3.34 11.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.16 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.2 pt 61.29 151.06 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 124.828 1.251 . . . . 0.0 111.888 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.3 Cg_endo -76.58 157.89 97.48 Favored 'Cis proline' 0 N--CA 1.479 0.633 0 C-N-CA 124.19 -1.171 . . . . 0.0 112.303 -1.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -114.78 136.21 53.33 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.2 t -116.67 127.27 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.767 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 77.9 m-85 -124.93 113.0 17.27 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.0 mt -100.68 124.75 54.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-O 121.027 0.441 . . . . 0.0 110.049 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.476 HG21 ' HB1' ' A' ' 7' ' ' ALA . 54.1 t -116.87 132.88 65.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.774 -175.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.97 164.58 24.28 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.649 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.1 -20.64 50.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.612 -0.267 . . . . 0.0 112.984 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -73.57 -5.65 41.61 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.279 0.561 . . . . 0.0 110.196 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.15 19.73 64.26 Favored Glycine 0 CA--C 1.5 -0.863 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.763 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 74.6 mmtt -116.87 151.1 37.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.3 mt -77.95 127.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.406 HG11 HD21 ' A' ' 146' ' ' LEU . 10.9 p -104.92 -28.61 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.809 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.7 t80 -141.56 133.19 27.03 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.793 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -137.12 123.78 21.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -151.02 111.79 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.987 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 108' ' ' ASN . 19.6 p -93.51 111.63 23.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 83.57 68.11 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.986 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.608 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.7 p90 -68.86 -39.66 79.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 64.2 p 53.31 80.67 0.1 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.296 1.038 . . . . 0.0 113.581 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.96 108.51 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.1 0.96 . . . . 0.0 112.776 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.97 -2.77 27.16 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.608 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -72.2 -41.81 52.34 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.1 -0.55 . . . . 0.0 112.783 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 48' ' ' ARG . 1.7 pm0 -53.59 -24.17 13.04 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.61 88.01 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.513 0.673 . . . . 0.0 110.674 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 44.5 mt-10 -73.4 -32.3 64.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.841 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.78 -47.94 81.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.439 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.436 HD13 ' NE1' ' A' ' 60' ' ' TRP . 8.8 tp -66.57 -33.49 63.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 110.278 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.67 -51.59 69.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.779 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 31.1 mmmt -68.47 -34.42 75.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.196 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.4 t -59.97 -45.37 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.045 0.45 . . . . 0.0 110.778 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -72.83 -29.33 63.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.466 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -64.99 -30.02 70.98 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.586 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 95.6 mt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.319 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.447 -0.576 0 CA-C-O 120.986 0.422 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 72.7 m-85 -101.54 -133.78 0.29 Allowed 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.551 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -149.45 9.25 0.72 Allowed 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.991 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 47.42 67.69 0.77 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.684 0.754 . . . . 0.0 110.824 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 24' ' ' THR . 32.4 mt -118.84 161.5 35.84 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.852 -175.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.12 160.05 46.59 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.706 2.271 . . . . 0.0 111.169 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.6 81.25 2.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.208 0.528 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.34 136.47 59.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.824 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -98.07 116.2 29.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.454 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD22 ' HA ' ' A' ' 98' ' ' ASP . 56.3 mt -123.77 177.19 5.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.928 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 30.2 mmtp -107.18 140.57 39.84 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.769 0.318 . . . . 0.0 110.798 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -91.31 -173.47 3.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.45 -13.78 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -90.03 -10.98 42.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.98 19.82 66.59 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.8 149.06 21.53 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.7 m -79.35 110.02 14.24 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.272 0.558 . . . . 0.0 110.187 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 137.07 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.051 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -95.78 133.68 39.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.487 HG21 ' CE1' ' A' ' 103' ' ' PHE . 23.6 p -65.86 -32.41 73.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.287 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.6 -31.73 73.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.951 0.405 . . . . 0.0 110.778 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.575 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -103.02 8.78 38.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.343 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 36.3 tp -65.91 121.71 15.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.27 156.92 46.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.22 0.533 . . . . 0.0 112.002 -174.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.607 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 45.2 t-20 -99.5 -83.23 0.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.583 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 170.02 25.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.92 0.762 . . . . 0.0 110.775 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.47 -2.37 39.75 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.233 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -110.08 150.23 41.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.408 0.146 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -68.53 159.88 51.64 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 123.218 2.612 . . . . 0.0 112.782 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 72.5 mtm -139.83 153.11 46.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.106 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 91.1 mt -128.33 127.71 67.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.57 124.56 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -113.04 122.75 48.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.698 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 57.9 m-85 -93.85 122.41 36.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 25.4 p90 -140.38 165.16 28.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 123.502 0.501 . . . . 0.0 111.542 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.88 151.37 24.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.897 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.45 ' CG2' HG22 ' A' ' 82' ' ' VAL . 9.6 p . . . . . 0 C--N 1.312 -1.026 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.55 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 15.0 mt . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 120.583 0.23 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -58.59 -42.35 87.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.551 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.554 ' CD ' HG22 ' A' ' 115' ' ' VAL . 75.2 tt0 -55.08 -64.69 0.76 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.959 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' A' ' 93' ' ' TYR . 44.0 tp -61.85 -41.15 97.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.6 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.42 -47.84 83.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.98 -42.48 76.48 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.999 0.428 . . . . 0.0 111.304 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.3 mt -64.38 -41.66 93.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.164 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -52.63 -42.0 64.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.711 0.291 . . . . 0.0 110.926 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.59 -42.26 91.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.17 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.8 m -105.24 15.65 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.25 -38.44 83.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.38 85.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.834 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.16 -36.24 71.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.837 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -69.15 -38.35 78.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.505 0.669 . . . . 0.0 109.553 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -76.59 -11.13 59.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.151 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.341 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -134.96 -45.51 0.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.802 0.334 . . . . 0.0 110.549 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.13 23.59 77.1 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.83 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -78.83 129.2 37.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.0 0.429 . . . . 0.0 111.379 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.8 mtm-85 -104.77 165.71 10.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.47 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 73.9 mt -109.84 140.02 44.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -113.8 106.47 20.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -94.28 112.19 23.98 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.28 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.3 p -110.72 132.03 60.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 CA-C-O 121.636 0.731 . . . . 0.0 112.229 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.519 ' HB3' HG21 ' A' ' 82' ' ' VAL . 20.8 p -81.29 141.39 34.12 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.871 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.9 pt -95.73 -6.91 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.463 1.102 . . . . 0.0 111.09 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 13.9 p-10 -93.88 152.35 18.93 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -63.13 174.04 1.27 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.45 88.91 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -172.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -46.59 81.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.549 0.674 . . . . 0.0 111.012 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -69.62 -41.77 75.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.76 -6.59 33.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.238 -176.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -64.36 -14.95 59.32 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.346 0.593 . . . . 0.0 109.941 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.747 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.9 mttp -94.16 -6.23 45.32 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.873 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 79' ' ' ALA . 51.2 t -63.96 -48.37 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.569 0.7 . . . . 0.0 111.747 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 19.4 mtpp -68.17 -42.32 29.97 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.221 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.5 Cg_endo -62.33 -28.99 79.17 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 120.902 1.068 . . . . 0.0 110.783 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.5 mt -64.16 -41.69 97.04 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.428 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -58.49 -45.39 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.677 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.93 -40.68 91.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.301 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.06 88.56 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.821 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -89.42 -14.42 35.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.993 0.396 . . . . 0.0 112.011 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.96 12.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.431 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.428 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 39.3 m0 -79.02 96.44 5.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.268 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.74 68.67 10.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 111.93 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.57 ' CE2' HD11 ' A' ' 50' ' ' LEU . 4.5 m-85 -144.03 177.04 8.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.98 113.48 25.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.81 0.814 . . . . 0.0 109.43 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.71 137.3 21.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.005 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 12.1 tp -115.63 131.18 57.01 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 15' ' ' LYS . 6.9 tp -105.71 100.87 10.42 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.301 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.675 ' HA ' HD22 ' A' ' 14' ' ' LEU . 66.3 t0 -77.89 115.22 17.47 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 118.13 -1.428 . . . . 0.0 108.304 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.2 p -108.73 -6.04 16.08 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.934 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.409 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 60.4 m-20 -93.71 -41.27 9.78 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.419 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.59 8.49 76.98 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.183 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HB2' ' A' ' 100' ' ' ASN . 9.6 p-10 -99.43 -22.31 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.199 . . . . 0.0 111.302 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.487 ' CE1' HG21 ' A' ' 24' ' ' THR . 71.4 t80 -62.67 -44.46 96.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.45 -32.76 74.53 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.326 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -68.96 -41.55 77.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.098 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.35 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.8 mmt -83.72 -9.4 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.431 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.9 t30 61.18 47.03 7.47 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.424 0.63 . . . . 0.0 110.654 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.62 96.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -81.36 -55.34 4.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.537 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.03 147.79 45.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 pt -103.43 154.49 37.76 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.1 Cg_endo -77.71 153.45 93.9 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 124.101 -1.208 . . . . 0.0 112.598 0.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -112.36 123.98 51.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.554 HG22 ' CD ' ' A' ' 49' ' ' GLU . 17.9 t -108.4 130.04 61.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.08 0.467 . . . . 0.0 112.133 -173.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 96.5 m-85 -131.71 112.96 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.616 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.3 mt -99.91 130.29 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.864 0.364 . . . . 0.0 110.395 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 53.5 t -113.46 133.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.779 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -85.29 -175.91 5.91 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.314 0.384 . . . . 0.0 111.269 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.29 -31.07 77.93 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.993 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -73.5 -6.0 43.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.326 0.584 . . . . 0.0 110.501 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 78.63 35.04 33.39 Favored Glycine 0 N--CA 1.433 -1.546 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.764 178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 47.0 mmtm -126.36 156.33 40.66 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.0 mt -76.54 113.48 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.262 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.81 -28.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.913 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.508 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 86.7 t80 -139.23 127.55 22.76 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.507 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -132.06 125.48 31.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -144.87 106.06 4.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.64 108.1 18.93 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.035 -177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 77.3 1.26 Allowed Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.52 -0.764 . . . . 0.0 114.657 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.622 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -104.53 143.54 32.91 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.002 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 73.9 p -104.68 -49.5 3.51 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.063 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.64 147.41 25.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.689 0.281 . . . . 0.0 111.384 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.89 28.41 73.08 Favored Glycine 0 N--CA 1.453 -0.231 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.105 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.3 -33.1 7.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.242 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -56.01 -20.64 17.48 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.466 0.706 . . . . 0.0 112.439 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.76 93.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.39 0.614 . . . . 0.0 110.215 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -70.51 -37.35 74.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.373 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.6 mp -61.43 -48.21 82.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.208 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -32.0 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.03 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.7 ttmt -61.06 -50.21 74.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 45.1 mttp -68.69 -29.86 68.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 139' ' ' LEU . 54.5 t -59.31 -45.31 93.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.109 0.48 . . . . 0.0 109.898 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -68.38 -34.35 75.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.404 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 62.7 mm-40 -56.41 -40.88 75.43 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.146 0.498 . . . . 0.0 110.322 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 49.7 mt . . . . . 0 CA--C 1.54 0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.593 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 43.4 m . . . . . 0 N--CA 1.44 -0.949 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -88.71 -124.03 0.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.067 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -151.43 16.75 0.72 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.844 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' ' 123' ' ' LYS . 45.2 tt0 50.93 41.49 27.07 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.802 0.81 . . . . 0.0 110.418 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 65.7 mt -87.74 155.74 53.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.71 156.85 55.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.302 2.668 . . . . 0.0 110.875 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.69 84.59 3.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.008 0.432 . . . . 0.0 111.671 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.18 138.84 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 p -90.83 113.62 25.82 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.353 0.597 . . . . 0.0 111.776 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 6.1 mp -107.41 167.22 10.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.196 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -112.45 125.87 54.7 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -87.54 -169.15 2.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.87 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.418 HG22 ' HZ2' ' A' ' 83' ' ' LYS . 26.4 pt -75.48 -12.76 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.537 -176.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.26 -11.74 45.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.067 0.461 . . . . 0.0 110.732 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 14.34 72.27 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -92.43 141.57 28.38 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.103 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -77.58 117.7 19.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.774 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.0 162.32 16.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.286 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.572 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 49.0 mt-30 -119.77 132.33 55.59 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.419 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.8 p -67.37 -32.25 73.04 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.26 -36.91 85.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 111.021 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -103.46 12.5 35.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.597 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.83 123.15 30.13 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.232 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 5' ' ' THR . 8.1 pt-20 -148.03 162.61 39.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.656 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.424 ' H ' ' HE2' ' A' ' 34' ' ' MET . 8.5 t30 -85.74 -71.93 0.51 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.113 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.64 47.23 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.183 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 5' ' ' THR . . . 80.08 26.86 54.56 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.903 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -122.94 151.66 61.54 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 122.22 0.208 . . . . 0.0 111.018 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.34 155.01 60.98 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.929 2.419 . . . . 0.0 111.403 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.533 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 20.5 mtt -139.99 165.45 27.31 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -171.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.645 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.5 mt -138.03 125.22 28.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 84.3 mt -101.83 131.2 50.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.961 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 m -118.93 122.63 42.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 111.234 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 54.4 m-85 -94.45 125.82 39.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.249 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' ' 82' ' ' VAL . 32.0 p90 -137.87 169.82 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 123.722 0.639 . . . . 0.0 111.086 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.77 -169.24 1.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.774 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.235 0.339 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -61.5 -45.67 93.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.659 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.29 -44.94 50.68 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.6 -41.99 98.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.256 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.82 -47.0 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.743 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.42 72.17 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.985 0.422 . . . . 0.0 111.368 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.3 mt -63.82 -30.92 51.21 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.1 -38.53 79.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.485 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -73.89 -39.72 63.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.781 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -107.03 17.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 89.3 t80 -59.75 -37.83 80.08 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 122.433 0.293 . . . . 0.0 111.701 -177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.07 81.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.757 0.313 . . . . 0.0 110.825 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.09 -41.91 90.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.924 0.392 . . . . 0.0 111.41 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -68.83 -34.91 76.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.521 0.677 . . . . 0.0 110.748 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 66' ' ' VAL . 6.2 mm-40 -85.15 -7.1 59.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.24 -60.62 3.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.87 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.23 -32.68 1.56 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.19 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -61.78 -41.51 97.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.38 32.09 29.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.165 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 7.5 t -67.94 122.55 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.204 0.526 . . . . 0.0 111.936 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -110.14 129.85 55.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.645 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 39.8 mt -97.53 142.96 28.72 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.466 HG23 HD13 ' A' ' 96' ' ' LEU . 91.4 mt -123.75 116.88 49.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.8 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.63 29.23 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.5 p -123.14 127.45 74.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.43 0.633 . . . . 0.0 111.145 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -90.14 148.76 22.78 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.703 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.3 pt -71.29 -17.69 19.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.804 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.26 164.77 16.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.973 0.416 . . . . 0.0 111.757 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.792 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 3.4 pt-20 -92.65 -88.75 0.21 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -119.92 -68.86 0.3 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.14 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -41.41 -65.36 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 112.168 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.37 -41.71 89.06 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.002 0.43 . . . . 0.0 112.144 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -71.38 -2.35 16.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 98.2 mt-30 -57.36 -21.62 36.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.932 0.396 . . . . 0.0 111.068 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.731 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.2 mttp -83.55 -12.82 55.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.853 0.461 . . . . 0.0 111.417 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 58.4 t -64.69 -48.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.52 0.676 . . . . 0.0 112.504 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.7 OUTLIER -69.02 -39.77 14.14 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 6.6 Cg_endo -59.77 -32.07 94.99 Favored 'Trans proline' 0 C--N 1.357 1.025 0 CA-C-N 120.074 1.062 . . . . 0.0 110.002 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 92.5 mt -63.73 -41.78 97.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.439 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -55.48 -45.49 76.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.343 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.68 -46.47 46.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.244 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.75 -45.23 96.19 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.255 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.09 -30.66 58.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.681 0.277 . . . . 0.0 111.404 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.42 46.84 3.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.06 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.5 m0 -80.99 117.58 21.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -96.13 27.13 3.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.724 0.773 . . . . 0.0 109.863 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.628 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -117.78 -179.97 3.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.855 -177.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -84.77 128.79 34.78 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.024 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.485 ' C ' HD12 ' A' ' 96' ' ' LEU . 24.3 t -106.98 128.24 61.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 95' ' ' VAL . 9.6 mp -130.47 148.52 52.29 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.259 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.561 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.3 mp -118.06 124.97 49.39 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.792 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 65.8 t0 -67.65 113.42 5.43 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 118.981 -1.087 . . . . 0.0 108.258 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 t -89.81 -6.39 55.96 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.861 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -104.94 -27.0 11.95 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 120.955 0.407 . . . . 0.0 110.34 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.51 21.4 79.55 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -113.66 -20.62 11.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.637 -0.281 . . . . 0.0 111.286 -176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 24' ' ' THR . 45.3 t80 -62.91 -39.75 95.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 105' ' ' ARG . 18.9 ptpt -52.16 -47.04 65.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.252 173.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.49 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 50.0 mtm-85 -71.89 -40.25 69.03 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.076 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.75 -42.16 88.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.495 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 33.3 mmm -92.64 -10.72 36.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.445 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 62.11 88.24 0.09 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.761 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 112' ' ' ILE . 66.7 t -92.88 129.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.251 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -79.28 -95.72 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.648 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.5 pt? -116.14 6.09 13.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.405 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.6 pt 61.1 152.24 0.1 Allowed Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 124.579 1.151 . . . . 0.0 111.06 -175.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 87.0 Cg_endo -75.58 160.44 96.05 Favored 'Cis proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.794 -0.919 . . . . 0.0 112.973 0.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.709 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.7 131.74 54.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.534 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.73 129.38 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 80.8 m-85 -127.71 115.25 18.43 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 68.3 mt -100.52 132.74 45.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 CA-C-O 121.271 0.558 . . . . 0.0 110.468 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.533 ' HB ' ' H ' ' A' ' 34' ' ' MET . 57.1 t -106.43 126.85 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.86 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.483 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 7.9 t70 -70.7 162.18 29.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.479 1.112 . . . . 0.0 110.56 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.61 35.39 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.471 -0.331 . . . . 0.0 113.807 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -86.76 7.01 28.65 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 111.181 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 73.22 40.86 48.6 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.42 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HD2' ' OE1' ' A' ' 8' ' ' GLN . 49.4 mmtm -134.56 152.77 52.01 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.7 mt -70.03 127.07 31.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.899 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.4 p -118.9 -17.34 7.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.659 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.626 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 74.9 t80 -150.11 128.51 12.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.591 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -126.88 120.88 30.28 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.343 0.592 . . . . 0.0 110.654 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.53 101.37 7.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.5 p -98.29 106.47 18.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.341 0.591 . . . . 0.0 112.238 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.2 64.8 2.32 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.542 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.419 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 1.2 p90 -96.31 154.99 16.95 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p -142.77 89.99 2.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.253 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 69.04 131.67 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.83 2.48 75.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.784 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.3 29.41 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.513 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.4 mp0 -58.76 -38.49 78.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.412 0.625 . . . . 0.0 109.835 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.08 87.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.85 -38.53 83.28 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.637 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -63.04 -50.39 70.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.373 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 tp -66.92 -38.48 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.144 0.497 . . . . 0.0 110.928 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -60.89 -45.73 93.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.904 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 18.6 tptm -66.14 -30.81 71.36 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.526 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 139' ' ' LEU . 95.4 t -64.75 -41.95 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -73.85 -24.29 59.74 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -61.44 -39.23 90.05 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.8 mt . . . . . 0 C--N 1.333 -0.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 179.354 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.418 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 14.7 m . . . . . 0 N--CA 1.44 -0.928 0 CA-C-O 120.72 0.295 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 91.5 m-85 -74.52 -112.64 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.215 0.531 . . . . 0.0 110.609 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.606 ' HB3' HD13 ' A' ' 9' ' ' LEU . . . -173.08 -7.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.329 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.409 ' H ' ' H ' ' A' ' 7' ' ' ALA . 56.6 tp60 69.12 62.16 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 7' ' ' ALA . 10.5 mp -116.15 159.92 37.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.029 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.96 158.39 57.55 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.814 2.343 . . . . 0.0 110.816 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 81.09 2.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.092 0.472 . . . . 0.0 111.161 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -124.57 133.37 69.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.328 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 m -89.41 110.28 21.11 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 98' ' ' ASP . 29.8 mt -107.3 173.25 6.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 109.974 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.474 HD21 ' HB3' ' A' ' 20' ' ' LYS . 3.8 p30 -98.0 -176.62 3.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.431 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 pt -61.57 -22.59 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -81.14 -8.26 59.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.181 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.24 14.94 81.69 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HB3' HD21 ' A' ' 16' ' ' ASN . 87.6 tttt -99.84 139.27 35.75 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.564 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.6 m -74.48 118.6 17.62 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.315 0.579 . . . . 0.0 110.209 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.86 130.74 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.712 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 71.5 mt-30 -92.0 134.02 35.19 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.457 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -66.16 -29.3 69.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.323 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.646 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.73 122.03 28.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -134.87 153.52 52.02 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.89 178.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.583 ' OD1' ' HB2' ' A' ' 32' ' ' LYS . 23.7 t-20 -79.91 -80.77 0.13 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.338 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 171.87 28.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.788 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.418 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 95.3 0.26 63.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.491 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.583 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 1.4 mptm? -104.48 150.75 38.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.787 0.327 . . . . 0.0 110.548 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.2 159.58 33.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.967 2.445 . . . . 0.0 111.496 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.57 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 74.1 mtm -141.09 159.53 42.02 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 120.781 0.324 . . . . 0.0 111.795 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.2 mt -128.09 124.86 63.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.5 mt -97.99 119.88 46.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -107.7 121.56 44.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 58.5 m-85 -94.27 117.75 30.57 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.49 ' HB2' HD21 ' A' ' 47' ' ' LEU . 26.5 p90 -138.48 165.47 26.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.856 0.722 . . . . 0.0 111.588 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.35 164.09 13.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.521 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.445 -0.676 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.477 176.718 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 39' ' ' PHE . 18.9 mt . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.919 0.39 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -61.33 -38.9 88.55 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.368 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.3 pt-20 -60.01 -51.74 68.35 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.045 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.482 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 40.8 tp -63.08 -41.08 99.35 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.402 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -59.92 -48.78 80.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.474 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.64 70.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.845 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.9 mt -63.76 -41.54 92.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.113 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -52.83 -36.38 58.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.014 0.435 . . . . 0.0 110.361 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.82 -46.73 67.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.883 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.16 25.65 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.45 -40.56 87.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.868 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.93 93.83 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.752 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.12 -41.0 97.4 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.236 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.407 ' NE1' HD13 ' A' ' 140' ' ' ILE . 17.4 m0 -66.84 -38.52 86.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.252 0.548 . . . . 0.0 110.201 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.444 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 30.1 mm-40 -70.17 -21.51 63.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.216 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.59 -48.88 79.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.625 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -104.59 -68.55 0.85 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.265 0.555 . . . . 0.0 111.859 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -63.73 -32.36 73.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.846 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 62.6 41.01 99.85 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.052 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.54 132.44 35.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.085 0.469 . . . . 0.0 112.253 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HG2' ' NE2' ' A' ' 61' ' ' GLN . 13.2 mtm180 -104.9 163.6 12.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 58.8 mt -110.86 138.1 47.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.188 0.518 . . . . 0.0 111.398 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.496 HG23 HD13 ' A' ' 96' ' ' LEU . 87.9 mt -110.78 110.48 32.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.16 116.05 28.38 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.9 p -121.59 131.69 72.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.478 0.656 . . . . 0.0 112.178 -176.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.475 ' CB ' HG21 ' A' ' 82' ' ' VAL . 23.3 p -86.38 134.93 33.68 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.07 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.443 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 43.1 pt -86.49 -5.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.238 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 15.1 m-20 -95.82 157.48 15.88 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.766 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.17 179.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.689 0.618 . . . . 0.0 112.565 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 -45.3 95.76 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 114.526 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -61.38 -46.08 91.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.371 0.605 . . . . 0.0 110.758 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 14.3 m120 -67.0 -39.17 87.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.903 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.582 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -68.27 -9.77 49.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.601 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.29 -22.32 52.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.04 0.448 . . . . 0.0 110.74 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.75 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 97.8 mttt -89.41 -13.7 37.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.699 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 79' ' ' ALA . 61.2 t -64.6 -50.2 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.497 0.665 . . . . 0.0 112.549 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mtpm? -68.52 -42.26 26.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.7 Cg_endo -61.41 -29.56 85.62 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.014 1.143 . . . . 0.0 110.821 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.9 mt -63.43 -42.28 98.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -58.07 -46.4 85.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.748 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -65.74 -45.76 81.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.994 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.71 -41.57 88.94 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.536 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -87.76 -3.12 58.97 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 46.17 45.76 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.386 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.427 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 53.8 m0 -82.78 100.99 10.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.408 0.623 . . . . 0.0 110.655 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -84.71 47.05 1.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.021 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 1.8 m-85 -138.32 175.95 9.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.88 126.42 32.44 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -110.9 131.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.07 0.462 . . . . 0.0 110.102 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.496 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -121.17 134.29 55.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.683 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.9 mp -110.18 115.9 30.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.476 ' HA ' HD22 ' A' ' 14' ' ' LEU . 45.8 t0 -79.0 114.8 18.24 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.158 175.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 p -85.63 -13.06 49.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.194 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -90.42 -45.65 8.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.948 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.436 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 89.8 8.85 66.88 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -174.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -96.24 -25.06 15.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.441 -0.88 . . . . 0.0 111.766 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 24' ' ' THR . 62.3 t80 -61.47 -43.85 98.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 22.9 pttp -58.92 -40.11 83.57 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.305 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -71.07 -41.85 70.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.972 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.55 81.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.37 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.67 -25.33 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.069 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.52 95.22 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.228 1.011 . . . . 0.0 111.966 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.68 115.7 50.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.169 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.2 p -82.77 -57.98 3.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.683 0.754 . . . . 0.0 110.076 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 46.3 tp -130.57 134.47 47.04 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.625 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.8 pt -87.59 151.36 50.33 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.567 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.8 Cg_endo -82.88 161.55 74.99 Favored 'Cis proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.704 0.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.61 136.65 54.76 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.448 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.6 t -119.44 124.97 73.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 120.889 0.376 . . . . 0.0 111.188 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 61.1 m-85 -122.05 118.04 27.78 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 62.0 mt -105.86 130.47 57.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.153 0.501 . . . . 0.0 111.0 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.464 HG21 ' HB1' ' A' ' 7' ' ' ALA . 53.3 t -104.87 135.2 43.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.988 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 125' ' ' VAL . 3.2 p-10 -87.66 -174.73 4.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 111.014 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.12 -18.43 69.07 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.414 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -88.86 -4.34 58.5 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.545 -0.386 . . . . 0.0 110.981 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 84.39 28.94 31.64 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.336 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 2.0 mppt? -124.21 154.09 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.161 0.505 . . . . 0.0 111.481 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.0 mt -70.59 99.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.246 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.433 HG11 HD21 ' A' ' 146' ' ' LEU . 7.2 p -83.87 -31.49 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.64 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.618 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.1 t80 -130.67 129.06 42.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.535 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -132.36 121.93 24.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -146.37 102.01 3.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.414 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 p -94.81 116.15 28.38 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.527 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.02 50.75 1.72 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.34 -0.934 . . . . 0.0 114.109 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.567 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.5 OUTLIER -81.64 138.52 35.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.363 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.0 p -123.35 -16.11 6.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.372 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -140.5 -101.63 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.35 30.13 2.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.955 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.77 -25.65 74.05 Favored Glycine 0 C--N 1.318 -0.455 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.053 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.6 -29.72 64.72 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.232 0.613 . . . . 0.0 110.626 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.19 96.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.06 -35.12 77.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.579 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.733 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -61.22 -53.58 55.09 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.29 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.407 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.1 tp -67.75 -39.08 81.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.089 0.471 . . . . 0.0 111.395 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 34.1 ttpt -59.06 -48.4 81.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.469 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.532 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 39.9 tptt -67.79 -30.97 70.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.216 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 139' ' ' LEU . 48.0 t -58.15 -44.46 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.535 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -77.14 -24.85 51.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.029 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 52.0 mm-40 -64.04 -33.71 76.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.135 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 88.8 mt . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.068 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.666 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.43 -1.462 0 CA-C-O 120.163 0.03 . . . . 0.0 110.992 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -151.79 -140.21 0.09 Allowed 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.74 14.85 2.13 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.407 ' HB3' HG13 ' A' ' 124' ' ' ILE . 51.5 tt0 49.94 51.07 17.31 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.763 0.792 . . . . 0.0 109.964 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.404 HD13 ' HB ' ' A' ' 24' ' ' THR . 78.6 mt -106.66 154.71 39.88 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.327 -174.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.87 152.57 78.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.499 2.799 . . . . 0.0 110.913 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.96 87.05 0.72 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.131 0.491 . . . . 0.0 111.565 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.7 t -126.31 136.54 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.222 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -96.98 112.89 24.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.782 0.325 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 98' ' ' ASP . 53.2 mt -116.48 176.55 5.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -105.33 139.86 39.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.472 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -92.73 -175.14 3.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.285 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.73 -11.37 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.836 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.91 -15.54 27.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.85 61.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.818 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -99.99 146.29 26.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -73.73 120.16 18.94 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.469 0.652 . . . . 0.0 110.716 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.71 131.39 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.611 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.6 mt-30 -92.28 134.57 34.78 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.436 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 103' ' ' PHE . 7.1 p -67.28 -21.58 65.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.57 -9.9 59.7 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.0 0.429 . . . . 0.0 110.495 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.25 16.09 7.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.67 -178.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.3 tp -99.76 125.88 45.74 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.746 -176.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.666 ' HB3' ' O ' ' A' ' 5' ' ' THR . 3.9 pt-20 -141.91 158.65 43.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.084 177.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.14 -71.5 0.47 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.64 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.09 38.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.448 0.467 . . . . 0.0 110.963 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.6 ' HA2' HG21 ' A' ' 5' ' ' THR . . . 91.83 4.06 67.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.042 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.64 151.73 41.17 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 122.652 0.381 . . . . 0.0 110.387 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -66.91 155.67 69.69 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 122.994 2.463 . . . . 0.0 112.343 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.4 mtm -138.97 149.33 44.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.65 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.43 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 89.7 mt -127.88 126.11 66.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 77.4 mt -91.52 126.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.8 m -111.03 112.96 25.15 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 40.7 m-85 -86.98 109.46 19.39 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 173.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.61 ' HB2' HD22 ' A' ' 47' ' ' LEU . 28.5 p90 -126.21 157.07 39.15 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.853 0.721 . . . . 0.0 110.872 -175.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.96 147.66 34.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.803 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.251 -177.945 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.61 HD22 ' HB2' ' A' ' 39' ' ' PHE . 9.6 mt . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 132' ' ' THR . 27.0 mmt180 -61.1 -43.39 98.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.8 tm-20 -63.66 -55.13 25.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.474 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.436 HD11 ' CE2' ' A' ' 93' ' ' TYR . 35.5 tp -62.71 -40.85 98.45 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.61 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.94 -48.17 77.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.639 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -44.45 93.23 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.043 0.449 . . . . 0.0 110.868 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 68' ' ' LEU . 62.6 mt -64.05 -41.34 92.16 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.77 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.688 ' OE1' ' HA ' ' A' ' 91' ' ' TRP . 26.3 tp60 -51.83 -40.61 60.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.42 -41.57 72.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.974 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.06 19.13 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -59.78 -34.4 72.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.6 84.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.836 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.86 -40.39 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.981 0.419 . . . . 0.0 110.694 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.469 ' NE1' HD13 ' A' ' 140' ' ' ILE . 15.3 m0 -67.27 -38.35 84.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.384 0.611 . . . . 0.0 110.405 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -81.97 -8.8 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.391 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.3 -49.23 78.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.876 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -152.19 64.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.369 0.604 . . . . 0.0 110.706 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.8 m -161.9 -39.74 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.613 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.0 21.08 76.94 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.662 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.2 p -81.93 125.57 39.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.066 0.46 . . . . 0.0 111.888 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -108.46 158.14 17.8 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.233 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 53' ' ' ILE . 42.8 mt -99.02 134.16 42.26 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.021 0.438 . . . . 0.0 110.843 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.608 HG23 HD13 ' A' ' 96' ' ' LEU . 90.8 mt -102.75 101.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -88.54 122.89 32.5 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.1 p -120.54 130.5 74.41 Favored 'Isoleucine or valine' 0 C--O 1.256 1.412 0 CA-C-O 121.594 0.711 . . . . 0.0 111.769 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 82' ' ' VAL . 24.1 p -83.37 132.01 35.02 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.898 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.524 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 45.1 pt -87.49 19.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 125.369 1.668 . . . . 0.0 113.858 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -122.38 -159.26 0.82 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.733 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.527 ' HB2' HE22 ' A' ' 77' ' ' GLN . 49.2 mt-10 -96.17 179.83 4.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.749 0.309 . . . . 0.0 110.381 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.563 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . -61.84 -43.32 99.38 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.527 HE22 ' HB2' ' A' ' 75' ' ' GLU . 6.0 pm0 -64.38 -41.78 96.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.648 0.724 . . . . 0.0 112.306 -177.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -77.03 -38.84 52.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.873 0.368 . . . . 0.0 111.549 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -71.46 -5.66 34.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 86.3 mm-40 -60.75 -24.1 65.47 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.919 -0.488 . . . . 0.0 110.722 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.699 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 30.6 mtpp -84.05 -9.83 58.32 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.725 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.637 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.6 t -65.75 -48.23 83.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.698 0.761 . . . . 0.0 112.53 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.9 mtpm? -66.65 -41.85 41.71 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.144 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.2 Cg_endo -62.9 -28.99 75.74 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.175 1.25 . . . . 0.0 110.884 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 97.5 mt -62.51 -42.84 99.78 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.42 91.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.797 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.85 -46.4 53.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.99 94.32 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.439 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -75.33 -23.95 57.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.797 0.332 . . . . 0.0 111.153 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.09 37.7 28.2 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.728 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.688 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 26.4 m0 -59.67 -42.28 92.53 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 66.13 27.3 10.49 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.611 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 6.1 m-85 -111.91 -167.65 1.21 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.475 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -104.3 129.21 52.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.496 0.665 . . . . 0.0 111.954 -172.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.608 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -114.32 133.94 55.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.343 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 76' ' ' GLY . 10.4 tt -108.71 111.85 23.84 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.253 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.617 ' HA ' HD22 ' A' ' 14' ' ' LEU . 68.2 t0 -80.12 128.19 33.21 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.271 174.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -110.09 0.65 18.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.991 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -114.23 -36.2 4.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 87.41 7.61 75.82 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.02 -21.97 25.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.554 ' CE1' HG21 ' A' ' 24' ' ' THR . 52.3 t80 -64.15 -35.42 80.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 110.22 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 52.1 mtmt -59.8 -44.84 93.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.55 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.1 -37.96 72.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.07 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.56 82.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.173 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.5 mmm -91.64 -10.4 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.244 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 64.71 69.25 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.379 0.609 . . . . 0.0 110.466 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.86 120.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.805 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.3 t -95.79 -75.88 0.51 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.227 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.499 HD21 HG22 ' A' ' 132' ' ' THR . 41.6 tp -98.26 160.73 14.1 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.2 pt -116.05 153.05 48.33 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.2 Cg_endo -79.56 156.9 89.71 Favored 'Cis proline' 0 C--O 1.241 0.656 0 C-N-CA 123.882 -1.299 . . . . 0.0 112.801 1.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -113.17 135.13 54.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.465 HG22 ' HG3' ' A' ' 49' ' ' GLU . 22.1 t -120.29 131.45 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -173.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.478 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 89.7 m-85 -126.73 112.83 15.88 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 173.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.5 mt -99.82 123.17 52.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.76 127.95 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.867 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.401 ' OD1' HD22 ' A' ' 146' ' ' LEU . 10.2 t70 -70.05 163.01 27.09 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 110.952 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -18.33 43.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.13 -0.486 . . . . 0.0 113.473 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -86.6 1.57 51.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.813 0.307 . . . . 0.0 111.085 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 83.55 26.38 43.01 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.005 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -124.98 157.0 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.943 0.372 . . . . 0.0 110.056 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 8' ' ' GLN . 96.2 mt -79.4 115.37 21.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.138 0.494 . . . . 0.0 110.055 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 146' ' ' LEU . 7.8 p -94.67 -38.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.15 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.438 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 72.0 t80 -134.26 128.73 34.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.203 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -131.21 128.93 40.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.411 . . . . 0.0 110.219 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 12.7 t60 -138.38 102.85 4.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 102.65 15.39 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.199 0.523 . . . . 0.0 111.911 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.17 105.45 0.75 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.653 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.562 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 3.6 p90 -138.23 163.78 30.88 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.662 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.7 p -109.62 -42.28 4.34 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.001 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -172.94 151.69 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.68 79.95 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.85 -34.33 8.43 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 2.5 pm0 -61.4 -15.55 37.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.35 0.66 . . . . 0.0 112.143 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.92 94.46 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.519 0.676 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.88 -26.82 36.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.227 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.1 mp -62.07 -49.31 76.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.721 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.469 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.8 tp -68.9 -34.84 66.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.879 0.371 . . . . 0.0 110.257 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 41.8 ttmt -58.91 -49.07 79.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.176 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -66.21 -36.73 83.83 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LEU . 72.8 t -59.76 -45.07 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.123 0.487 . . . . 0.0 109.804 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 144' ' ' ARG . 30.9 mmt180 -72.0 -25.02 61.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.209 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 75.7 mm-40 -64.37 -36.09 83.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.461 HD21 HG11 ' A' ' 125' ' ' VAL . 81.8 mt . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 121.353 0.597 . . . . 0.0 109.487 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.442 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 4.4 t . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.329 0.585 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.474 ' N ' ' HA3' ' A' ' 122' ' ' GLY . 85.7 m-85 -87.8 -90.57 0.12 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.314 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 169.92 -25.49 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.579 -176.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 65.9 83.14 0.17 Allowed 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.547 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 24' ' ' THR . 15.7 mt -133.19 167.28 23.74 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.385 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.71 159.87 49.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.913 2.409 . . . . 0.0 111.109 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.42 83.44 3.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -126.36 134.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.209 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.1 p -98.7 112.76 24.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.204 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -117.67 176.4 5.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -108.63 135.28 50.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.437 0.16 . . . . 0.0 110.607 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -87.23 -171.92 3.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.527 HG23 ' H ' ' A' ' 95' ' ' VAL . 27.5 pt -66.21 -24.04 32.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -77.42 -30.81 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.491 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.85 14.95 21.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.2 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -93.78 147.76 22.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.8 m -75.07 115.86 15.17 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.281 0.562 . . . . 0.0 110.269 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.44 131.65 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.895 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.592 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 44.2 mt-30 -98.06 132.7 43.38 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.71 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.618 HG21 ' CE1' ' A' ' 103' ' ' PHE . 14.8 p -68.17 -24.36 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -78.7 -4.04 47.16 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.815 0.34 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -134.25 11.9 3.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -67.89 124.81 24.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -147.88 161.8 40.57 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.6 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 35.1 p-10 -107.27 -56.48 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.94 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.86 25.59 0.03 OUTLIER Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 29' ' ' ASN . 14.4 mptt -129.13 151.22 77.34 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.67 153.57 77.58 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.324 2.016 . . . . 0.0 111.753 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.6 ' SD ' ' HB3' ' A' ' 29' ' ' ASN . 74.4 mtm -136.62 155.43 49.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.918 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.13 123.15 61.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.1 123.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -113.96 124.46 52.21 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 60.9 m-85 -93.76 119.76 33.15 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.621 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 24.2 p90 -137.94 170.16 16.53 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.606 0.566 . . . . 0.0 111.95 -175.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.65 33.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.565 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 C--N 1.314 -0.964 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.921 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.591 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 8.2 mt . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -64.45 -39.5 93.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.728 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.577 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -67.96 -52.76 32.28 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.547 HD11 ' CE2' ' A' ' 93' ' ' TYR . 43.6 tp -61.6 -41.25 97.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.806 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.07 -49.68 76.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.513 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.05 -44.09 66.5 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.853 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 49' ' ' GLU . 66.6 mt -63.72 -42.44 96.0 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.767 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.691 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -52.7 -40.32 62.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -68.32 -44.8 74.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.36 20.51 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -60.81 -32.68 72.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.761 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.9 92.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.818 0.342 . . . . 0.0 110.407 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -66.8 -39.05 87.6 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.37 -36.37 82.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.545 0.688 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -82.39 -9.12 59.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.579 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.83 -52.94 63.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.502 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.04 -50.46 2.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 143' ' ' VAL . 6.5 m -61.77 -38.8 89.36 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.33 29.04 74.17 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.431 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.66 127.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.92 0.391 . . . . 0.0 111.865 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -106.37 140.49 39.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.605 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 72.1 mt -84.63 144.62 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.593 HD11 ' SD ' ' A' ' 34' ' ' MET . 94.8 mt -119.5 109.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.621 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -100.38 127.99 46.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.35 136.43 59.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 CA-C-O 121.612 0.72 . . . . 0.0 111.706 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 82' ' ' VAL . 37.2 p -83.61 126.34 32.73 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.437 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 pt -80.79 16.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 125.107 1.504 . . . . 0.0 112.351 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.6 ' OD1' ' HB2' ' A' ' 78' ' ' ASN . 4.2 t70 -130.14 165.88 21.39 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -78.43 175.38 10.35 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.338 0.399 . . . . 0.0 111.268 -174.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 80' ' ' GLN . . . -56.83 -22.85 42.7 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.111 -177.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -65.04 -57.57 8.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.119 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.6 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 91.7 m-20 -85.42 -38.97 18.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.137 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -71.94 -3.2 21.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.456 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 34.8 tt0 -63.98 -12.28 36.32 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.766 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.7 mmtm -95.77 -3.08 46.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.975 0.51 . . . . 0.0 112.054 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.7 t -65.26 -49.19 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.39 0.614 . . . . 0.0 112.547 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.4 mtpt -65.62 -43.69 62.19 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.803 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.15 -28.45 79.73 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.23 1.287 . . . . 0.0 111.312 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.6 mt -62.87 -41.94 99.58 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.97 92.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.9 -46.81 83.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.28 -40.76 80.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.631 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -92.97 -0.4 57.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.66 38.93 61.06 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.358 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -81.78 96.5 7.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.7 70.84 7.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 50' ' ' LEU . 11.2 m-85 -145.47 172.13 13.65 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.87 120.34 20.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.527 ' H ' HG23 ' A' ' 17' ' ' ILE . 20.7 t -109.21 123.75 65.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.495 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -111.23 138.1 48.11 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.646 0.736 . . . . 0.0 111.525 -176.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.8 tp -103.76 109.36 21.05 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.792 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.548 ' HA ' HD22 ' A' ' 14' ' ' LEU . 68.0 t0 -82.27 116.37 21.76 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 117.751 -1.58 . . . . 0.0 108.531 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -107.27 5.48 27.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.202 0.525 . . . . 0.0 110.185 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -110.8 -43.62 3.78 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.951 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.02 -1.97 78.57 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.682 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -83.18 -25.57 31.68 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.602 -0.352 . . . . 0.0 111.454 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 24' ' ' THR . 47.6 t80 -64.01 -44.46 92.52 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -61.49 -36.71 81.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.852 0.358 . . . . 0.0 110.61 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -70.24 -41.57 73.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 110.359 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.62 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.591 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.9 mmt -86.76 -8.29 57.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.021 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.2 t30 59.03 71.18 0.6 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.379 0.609 . . . . 0.0 111.26 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 38' ' ' PHE . 44.8 t -98.76 96.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.21 0.529 . . . . 0.0 110.63 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -88.89 -62.24 1.53 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.432 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.443 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 47.1 tp -105.93 129.9 53.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.281 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.7 pt -91.55 152.87 43.91 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 67.2 Cg_endo -83.62 157.04 72.06 Favored 'Cis proline' 0 C--O 1.242 0.721 0 C-N-CA 124.277 -1.135 . . . . 0.0 112.859 1.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -112.98 130.03 56.28 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.54 127.87 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-O 121.327 0.584 . . . . 0.0 112.161 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 86.6 m-85 -127.64 112.69 15.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.765 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.2 mt -101.74 130.73 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.213 0.53 . . . . 0.0 110.874 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 76.4 t -107.61 129.54 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.26 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.45 -175.42 5.46 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.301 0.376 . . . . 0.0 111.177 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.7 61.64 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.713 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -86.04 -1.66 57.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.479 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.474 ' HA3' ' N ' ' A' ' 6' ' ' TYR . . . 70.89 42.6 60.13 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.395 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 72.2 mmtt -127.11 155.54 43.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 7' ' ' ALA . 88.5 mt -71.66 100.14 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 146' ' ' LEU . 13.8 p -90.8 -34.16 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.457 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 87.7 t80 -132.5 130.33 40.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.723 0.296 . . . . 0.0 110.701 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -131.74 115.9 16.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.049 0.452 . . . . 0.0 110.78 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.465 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 2.0 t60 -132.81 102.87 5.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.405 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.02 116.32 29.01 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.089 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 78.5 65.35 1.86 Allowed Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.41 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.477 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 2.7 p90 -104.58 154.77 19.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.832 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.9 p -142.68 94.62 2.66 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.257 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 63.73 108.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.731 0.812 . . . . 0.0 112.273 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.17 23.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.862 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.34 -18.97 40.19 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.944 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.57 -30.28 67.04 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.368 0.667 . . . . 0.0 111.174 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.23 -40.26 93.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.787 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.42 -36.66 79.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.789 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.2 mp -63.0 -48.81 77.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.713 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.507 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.2 tp -67.82 -39.76 82.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.903 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 27.8 ttpp -60.43 -45.51 93.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.803 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.648 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 37.8 tptt -66.38 -35.72 81.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.31 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -59.48 -46.73 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 0.0 110.711 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 4.6 ptp180 -78.98 -18.57 53.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.059 0.457 . . . . 0.0 110.91 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' LYS . 31.0 tt0 -69.93 -37.51 75.92 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.862 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 58.1 mt . . . . . 0 N--CA 1.465 0.286 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.667 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 41.7 m-85 -97.89 -135.64 0.26 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.246 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.415 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -153.57 11.52 0.44 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 52.8 tp60 51.74 31.75 8.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.826 0.822 . . . . 0.0 111.656 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 33.1 mt -79.87 161.68 65.25 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.022 -177.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.13 154.09 72.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.457 2.105 . . . . 0.0 111.133 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.28 76.64 1.33 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.312 0.577 . . . . 0.0 111.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.21 134.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 9.7 t -97.33 114.94 26.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.097 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 98' ' ' ASP . 30.0 mt -105.33 173.64 6.22 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -113.48 127.08 55.97 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.505 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.409 ' ND2' ' HD3' ' A' ' 20' ' ' LYS . 86.8 m-20 -79.59 178.71 7.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.074 0.464 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.569 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 47.3 pt -65.57 -26.2 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.186 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.99 -17.54 60.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.21 19.58 60.52 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 44.6 tttp -79.81 136.16 36.65 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.728 -0.736 . . . . 0.0 109.918 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -83.71 108.76 16.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.74 144.32 38.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.021 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.633 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 85.9 mt-30 -103.99 135.19 45.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.425 HG21 ' CE1' ' A' ' 103' ' ' PHE . 12.8 p -64.38 -30.68 71.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -73.66 -14.2 61.12 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.071 0.462 . . . . 0.0 111.068 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.633 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -114.65 8.88 16.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 111.297 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 38.4 tp -80.51 115.8 20.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.231 -175.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 160.73 36.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.314 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.507 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 8.3 p30 -112.89 -58.21 2.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.645 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.96 -45.54 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.565 0.746 . . . . 0.0 109.882 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.87 26.57 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.828 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -119.46 152.01 52.31 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.48 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 12.3 Cg_exo -72.1 158.89 51.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.932 2.421 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.507 ' SD ' ' ND2' ' A' ' 29' ' ' ASN . 5.0 mpp? -132.14 156.96 45.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.93 123.66 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -103.43 121.66 55.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.72 122.83 46.51 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 71.7 m-85 -96.1 119.63 34.94 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -147.83 161.46 41.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.984 0.421 . . . . 0.0 111.692 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.29 152.7 32.32 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.242 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 74' ' ' ASP . 3.1 p . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -61.26 -38.19 85.84 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.202 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.678 ' OE2' ' HB2' ' A' ' 113' ' ' PRO . 50.7 mt-10 -53.04 -67.28 0.26 Allowed 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.659 0.742 . . . . 0.0 110.235 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.6 HD11 ' CE2' ' A' ' 93' ' ' TYR . 30.4 tp -60.86 -41.04 95.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.747 -173.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.52 -53.98 43.43 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.095 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 -42.74 94.77 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.8 mt -65.03 -42.77 95.48 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.949 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.68 -38.05 71.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.652 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.88 -35.7 81.37 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.869 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -120.59 25.26 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 53' ' ' ILE . 86.9 t80 -60.53 -34.45 74.13 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.54 92.21 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.425 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.89 -42.32 94.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.796 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.406 ' NE1' HD11 ' A' ' 140' ' ' ILE . 11.7 m0 -63.77 -35.76 81.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.754 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -79.13 -15.63 57.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.272 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.94 -43.73 98.24 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.75 -58.8 1.93 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.541 -0.463 . . . . 0.0 112.025 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 m -62.69 -39.62 94.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.684 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.43 28.16 73.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.656 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.72 131.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 122.658 0.383 . . . . 0.0 111.929 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -106.79 146.52 30.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.627 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 60.8 mt -91.69 148.12 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.402 0.62 . . . . 0.0 111.457 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 92.3 mt -122.44 118.68 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.575 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.44 111.56 23.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.52 127.83 72.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 CA-C-O 121.66 0.743 . . . . 0.0 111.245 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.563 ' HB2' HG21 ' A' ' 82' ' ' VAL . 35.0 t -85.6 133.11 34.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.713 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.408 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 44.0 pt -84.93 2.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.843 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 41' ' ' THR . 49.2 m-20 -102.33 157.27 17.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.71 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.03 156.42 5.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.492 0.495 . . . . 0.0 111.07 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.23 -34.04 72.46 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.489 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.61 -40.57 92.35 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.701 0.286 . . . . 0.0 111.708 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.3 -32.52 22.46 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.384 0.612 . . . . 0.0 110.367 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.31 -4.24 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.624 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.65 -8.97 11.52 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.025 -0.422 . . . . 0.0 110.143 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.645 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 35.4 mmtp -85.93 -17.56 35.12 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.183 0.593 . . . . 0.0 111.788 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 79' ' ' ALA . 11.6 t -64.48 -46.25 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.843 0.83 . . . . 0.0 111.324 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 18.7 mtmt -68.53 -44.23 33.28 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.17 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.4 Cg_endo -60.2 -32.39 94.36 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.009 1.139 . . . . 0.0 110.785 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.3 mt -64.35 -42.45 96.22 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -60.48 -41.82 95.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.783 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.82 -41.53 95.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.532 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.65 -51.67 6.36 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.314 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.71 -34.81 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.95 2.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.216 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -88.35 104.96 17.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.01 65.33 2.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 110.035 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.6 ' CE2' HD11 ' A' ' 50' ' ' LEU . 11.4 m-85 -140.12 178.96 6.91 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.79 120.87 24.66 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.569 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 20.0 t -107.12 126.7 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.678 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.52 139.89 53.38 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.128 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.55 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.4 mp -110.49 118.74 37.06 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.557 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.1 t0 -72.09 115.44 11.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.527 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.0 t -94.99 6.4 49.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.497 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -124.9 -38.73 2.32 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.097 0.475 . . . . 0.0 110.855 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 90.0 4.1 72.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -97.91 -20.65 17.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 24' ' ' THR . 74.0 t80 -62.19 -43.77 98.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.949 0.404 . . . . 0.0 110.158 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 73' ' ' ILE . 21.1 ptmt -58.02 -41.67 83.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.699 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -70.5 -39.52 74.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 111.026 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.21 99.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.317 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.65 -12.98 59.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 68.19 79.9 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.042 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.7 t -110.57 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.346 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.8 m -75.65 -46.52 31.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.2 tp -136.12 132.61 36.3 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.879 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.4 pt -87.38 154.0 53.84 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 95.2 Cg_endo -80.38 153.71 84.74 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.569 -0.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -116.17 125.97 53.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.326 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.462 HG22 ' CD ' ' A' ' 49' ' ' GLU . 13.7 t -101.34 124.93 55.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.8 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -124.73 112.63 16.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.729 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.24 128.87 53.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.124 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 76.4 t -106.38 129.72 59.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.678 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 12.0 t70 -70.68 157.77 37.41 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.922 0.764 . . . . 0.0 109.568 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.32 -25.52 62.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.315 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.28 -25.11 66.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.118 0.485 . . . . 0.0 110.59 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 26.06 6.72 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.644 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.97 157.01 38.89 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 122.491 0.316 . . . . 0.0 110.548 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 7' ' ' ALA . 69.3 mt -71.28 122.44 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.5 p -109.03 -32.64 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 58.0 t80 -147.62 131.5 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.297 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.017 0.437 . . . . 0.0 110.17 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.521 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 36.9 t60 -143.57 106.48 4.49 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.5 m -100.41 123.29 44.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.043 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.98 60.11 5.09 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.315 0.886 . . . . 0.0 115.315 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.662 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 27.2 p90 -86.18 -39.53 16.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 117.637 0.719 . . . . 0.0 109.597 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.0 p 73.39 -44.99 0.6 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.979 1.711 . . . . 0.0 113.53 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.07 138.95 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.04 18.65 74.3 Favored Glycine 0 C--N 1.327 0.059 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.848 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.662 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.91 -25.72 19.06 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.452 -177.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -60.93 -25.69 66.95 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.06 94.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 110.391 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.54 -38.32 89.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.511 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.1 mp -63.33 -47.14 83.46 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.685 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 140' ' ' ILE . 5.4 mm -61.63 -41.45 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.709 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.2 ttpp -57.29 -49.94 74.49 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.889 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 32.9 mmmt -68.39 -38.21 81.13 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 139' ' ' LEU . 52.6 t -58.94 -46.55 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.854 0.359 . . . . 0.0 111.575 -177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.93 -22.42 42.72 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.638 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 73.6 mm-40 -66.28 -37.29 85.1 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.513 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 80.6 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.53 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.681 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 94.9 m . . . . . 0 C--O 1.215 -0.723 0 CA-C-O 121.156 0.503 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 54.9 m-85 -124.15 -112.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -171.62 159.57 5.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.471 ' H ' HG13 ' A' ' 124' ' ' ILE . 48.8 tt0 -81.65 80.66 7.93 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.478 HD13 ' HB ' ' A' ' 24' ' ' THR . 60.6 mt -120.5 151.75 54.35 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 17.2 Cg_exo -67.94 147.86 75.11 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.8 2.333 . . . . 0.0 108.358 170.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.7 94.77 1.04 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.258 0.551 . . . . 0.0 111.467 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.9 149.33 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.948 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 p -110.21 117.29 33.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 98' ' ' ASP . 42.3 mt -112.03 175.06 5.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.326 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 32.8 mmtp -105.37 136.59 44.63 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.821 0.343 . . . . 0.0 111.513 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.77 -173.86 2.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.455 HG22 ' HB ' ' A' ' 95' ' ' VAL . 34.0 pt -67.14 -21.02 27.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.357 0.599 . . . . 0.0 110.354 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -86.02 -15.53 41.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.13 20.01 51.02 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -87.96 140.12 29.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.9 m -79.7 115.07 19.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.227 0.537 . . . . 0.0 110.892 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 m -119.39 130.6 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.391 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.3 mt-30 -89.13 134.9 33.84 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.503 HG21 ' CE1' ' A' ' 103' ' ' PHE . 22.8 p -63.69 -30.53 71.62 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.857 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.96 -4.46 50.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.83 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.63 13.78 7.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.1 tp -71.37 112.48 7.54 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.464 -177.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -137.3 143.3 42.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -178.012 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.42 ' HB2' ' NH2' ' A' ' 67' ' ' ARG . 35.6 p-10 -112.01 -38.22 4.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 29' ' ' ASN . . . 167.79 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.51 0.506 . . . . 0.0 111.525 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.84 32.63 58.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.496 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -125.04 151.88 69.67 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 122.269 0.228 . . . . 0.0 110.913 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 149.76 89.28 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.245 1.963 . . . . 0.0 110.741 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.6 mtm -135.51 144.91 46.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.587 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.406 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.9 mt -120.43 122.46 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.33 112.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.04 124.07 48.37 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.47 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 63.5 m-85 -96.11 119.57 34.84 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.984 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -143.57 178.64 7.64 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.529 0.518 . . . . 0.0 111.271 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.2 155.25 25.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.522 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.428 -1.54 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.503 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.223 -0.3 0 CA-C-O 120.701 0.286 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -57.91 -45.75 86.03 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 53' ' ' ILE . 77.0 tt0 -55.96 -59.88 4.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.275 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.7 -41.78 99.3 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.871 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 54.8 tptt -64.05 -46.82 82.72 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.66 94.21 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.738 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.1 mt -65.0 -40.94 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.908 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.467 ' HA ' ' OH ' ' A' ' 93' ' ' TYR . 63.9 tt0 -53.61 -39.96 65.36 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 110.984 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 42.9 mm-40 -67.32 -40.24 85.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.18 18.95 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.64 -36.89 82.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.19 84.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.566 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.99 -43.57 98.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.198 0.523 . . . . 0.0 110.388 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.423 ' HH2' ' HB3' ' A' ' 139' ' ' LEU . 15.7 m0 -69.23 -42.38 75.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -72.11 -15.23 61.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.909 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.54 -47.95 83.53 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.337 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.21 -49.28 1.44 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.401 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -62.38 -41.02 98.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.528 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.61 31.0 77.3 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.045 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 133.08 30.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 122.532 0.333 . . . . 0.0 111.271 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' NH2' ' HB2' ' A' ' 29' ' ' ASN . 10.5 mtm180 -104.79 158.22 16.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 78.6 mt -107.14 135.82 48.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.079 0.466 . . . . 0.0 110.629 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.18 110.83 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.11 104.84 16.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.836 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.69 127.62 67.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.553 0.692 . . . . 0.0 111.067 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -91.02 137.27 32.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.539 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.9 pt -73.56 -20.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.997 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -67.79 142.58 56.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.098 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 31.6 mp0 -65.09 176.16 1.36 Allowed 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.614 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.55 -45.82 92.71 Favored Glycine 0 N--CA 1.461 0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.123 -174.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 28.9 pt20 -70.5 -32.44 69.94 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -85.48 -24.12 27.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.165 0.507 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -85.62 -3.45 58.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.383 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 13.9 pt20 -64.98 -4.42 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.715 -0.615 . . . . 0.0 110.743 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.601 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.9 mttm -97.97 -10.66 24.11 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.355 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 79' ' ' ALA . 13.3 t -64.88 -47.1 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 121.949 0.88 . . . . 0.0 110.822 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.6 mtpt -65.62 -46.76 68.02 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.248 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.6 Cg_endo -59.51 -29.06 89.05 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.336 1.358 . . . . 0.0 111.32 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.5 mt -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -61.27 -34.29 74.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.69 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -65.94 -29.11 69.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.189 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.18 -49.25 3.56 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.349 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 12.0 p30 -77.88 -27.04 49.59 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.1 46.38 4.17 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.903 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.6 95.86 4.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 0.0 109.977 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -78.8 42.72 0.46 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.582 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -127.05 168.53 14.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.18 113.38 19.98 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.31 0.576 . . . . 0.0 109.469 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 17' ' ' ILE . 13.7 t -97.31 136.89 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.788 -175.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 95' ' ' VAL . 11.2 mp -129.09 148.32 51.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.237 -175.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.578 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.7 mp -114.42 117.73 31.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.141 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.603 ' OD2' ' HG2' ' A' ' 104' ' ' LYS . 11.9 t70 -90.74 114.96 27.44 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.636 172.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 30.5 m -93.99 -88.97 0.23 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.51 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -112.27 19.46 17.68 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.322 0.582 . . . . 0.0 110.273 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.23 73.52 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.634 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' CG ' ' HE ' ' A' ' 105' ' ' ARG . 18.4 t70 55.05 23.85 5.54 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 109.902 -174.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 24' ' ' THR . 69.5 t80 -62.26 -42.45 99.34 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -177.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.603 ' HG2' ' OD2' ' A' ' 98' ' ' ASP . 11.4 pttm -54.78 -50.72 67.79 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HE ' ' CG ' ' A' ' 102' ' ' ASP . 17.6 ttp180 -70.55 -36.12 73.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.659 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.03 87.62 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.074 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 35.8 mmm -82.54 -8.73 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.564 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.4 t30 76.08 53.64 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.653 0.739 . . . . 0.0 111.553 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.435 HG12 HG22 ' A' ' 112' ' ' ILE . 47.5 t -98.88 129.86 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.38 177.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -130.98 -71.52 0.57 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.592 ' O ' HG12 ' A' ' 112' ' ' ILE . 52.1 tp -64.35 -39.16 93.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.861 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 111' ' ' LEU . 4.2 pt 64.55 145.21 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 125.081 1.352 . . . . 0.0 111.319 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.657 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.6 Cg_endo -82.29 179.05 27.98 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.933 -0.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -133.75 142.75 48.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.768 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 128' ' ' HIS . 21.9 t -117.99 126.57 74.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 123.466 0.479 . . . . 0.0 111.36 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 69.9 m-85 -126.44 114.93 18.82 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 139' ' ' LEU . 64.8 mt -106.06 125.63 61.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-O 121.287 0.565 . . . . 0.0 111.835 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.28 130.6 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.7 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -81.27 -173.32 4.27 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.539 0.524 . . . . 0.0 111.602 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.07 -34.02 88.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.611 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -64.62 -40.59 95.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.163 0.506 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 114.44 33.89 1.68 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.257 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.21 155.05 46.9 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.471 HG13 ' H ' ' A' ' 8' ' ' GLN . 96.7 mt -74.55 108.82 6.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.429 HG11 HD21 ' A' ' 146' ' ' LEU . 12.2 p -97.91 -29.28 3.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.123 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.598 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 89.8 t80 -129.71 132.7 46.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.147 0.499 . . . . 0.0 111.328 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -128.87 127.99 42.94 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.772 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.598 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 2.2 t60 -134.27 101.63 5.08 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.1 p -109.7 116.64 32.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.14 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.79 19.05 7.98 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.823 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.657 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -75.98 143.39 41.55 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.513 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.0 p -119.68 -43.3 2.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.236 -0.585 . . . . 0.0 112.019 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -160.32 125.19 3.83 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.11 17.13 41.48 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.025 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.23 -14.86 55.32 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 139' ' ' LEU . 2.2 mp0 -59.75 -26.99 66.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.129 0.49 . . . . 0.0 111.063 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.26 90.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.21 -31.62 71.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.744 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.0 mm? -61.3 -56.66 17.99 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.402 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 tp -66.45 -38.5 81.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 120.914 0.388 . . . . 0.0 111.388 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.26 -48.99 79.39 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.671 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 20.3 tptp -67.6 -31.39 71.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.261 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.1 t -59.33 -44.48 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 144' ' ' ARG . 38.5 mmt180 -67.79 -33.06 74.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.567 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 50.8 mm-40 -56.34 -33.15 65.37 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.153 0.501 . . . . 0.0 109.928 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.429 HD21 HG11 ' A' ' 125' ' ' VAL . 84.3 mt . . . . . 0 CA--C 1.531 0.243 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.07 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.555 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.7 m . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 120.812 0.339 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.532 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 60.3 m-85 -87.38 -112.5 0.05 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.082 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . . . -162.89 11.56 0.06 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.566 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 52.58 42.31 31.41 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.995 0.903 . . . . 0.0 110.714 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 44.3 mt -96.6 164.01 19.13 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.406 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.19 157.16 63.06 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.736 2.291 . . . . 0.0 110.854 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.18 82.87 2.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.958 0.409 . . . . 0.0 111.354 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.18 134.85 65.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 p -95.08 114.59 26.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.989 0.423 . . . . 0.0 110.608 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -112.0 172.86 6.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 35.3 mmtm -97.84 131.89 43.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.385 0.612 . . . . 0.0 112.243 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -85.86 166.21 16.19 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.514 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.45 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 36.6 pt -61.45 -24.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.344 . . . . 0.0 111.671 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -77.26 -4.9 47.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.57 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.23 16.65 75.9 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -95.68 140.44 30.49 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.891 -0.654 . . . . 0.0 109.827 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.8 m -74.57 120.34 20.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.6 131.72 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.2 mt-30 -91.09 134.93 34.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.901 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.54 HG21 ' CE1' ' A' ' 103' ' ' PHE . 10.2 p -64.33 -31.9 73.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.923 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.36 -10.8 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.703 0.287 . . . . 0.0 111.593 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -119.08 3.49 11.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.09 -0.382 . . . . 0.0 111.214 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.36 109.45 19.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.527 0.68 . . . . 0.0 111.911 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.8 mt-10 -117.1 132.23 56.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.16 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.538 ' ND2' HH21 ' A' ' 67' ' ' ARG . 2.4 t-20 -72.3 -71.19 0.3 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.233 178.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.27 35.74 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.798 0.332 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.43 24.24 59.25 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.165 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -117.93 152.54 50.31 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.251 -0.475 . . . . 0.0 110.25 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.61 151.76 58.75 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.389 2.059 . . . . 0.0 111.893 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -134.98 156.27 49.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.04 0.448 . . . . 0.0 111.571 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.502 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 83.7 mt -126.64 126.68 69.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.68 125.36 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 120.688 0.28 . . . . 0.0 110.456 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -110.11 120.06 41.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.861 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 67.5 m-85 -96.37 121.98 38.76 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.177 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 16.3 p90 -147.68 169.35 19.88 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.5 0.5 . . . . 0.0 110.818 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.67 140.28 32.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.027 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.447 HG22 ' CG ' ' A' ' 74' ' ' ASP . 15.4 t . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.346 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 111.455 0.169 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.44 -79.58 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.169 0.588 . . . . 0.0 112.118 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.512 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 8.5 tm-20 -42.29 -60.58 1.43 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.952 1.701 . . . . 0.0 112.104 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD11 ' CE2' ' A' ' 93' ' ' TYR . 32.7 tp -61.21 -39.07 88.86 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.576 -176.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.28 -48.69 69.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.259 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.03 97.55 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-O 121.344 0.592 . . . . 0.0 111.072 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.2 mt -64.14 -41.38 92.24 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.86 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -52.81 -38.83 61.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.29 -38.42 87.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.444 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.57 24.33 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 53' ' ' ILE . 83.5 t80 -62.99 -40.63 98.32 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.68 85.11 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.035 0.445 . . . . 0.0 110.383 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.14 -43.3 99.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.247 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.427 ' NE1' HD13 ' A' ' 140' ' ' ILE . 24.8 m0 -65.47 -37.56 87.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -74.5 -9.16 58.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.64 -64.33 0.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -115.78 -39.59 3.48 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.472 HG21 HG13 ' A' ' 143' ' ' VAL . 7.4 m -62.29 -40.23 95.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.32 33.29 86.3 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.111 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.05 138.95 18.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.754 0.311 . . . . 0.0 110.649 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.538 HH21 ' ND2' ' A' ' 29' ' ' ASN . 23.8 mtm180 -123.65 152.87 41.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.052 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.502 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 62.9 mt -96.43 144.88 26.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.1 mt -119.73 112.52 37.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB1' ' HE1' ' A' ' 39' ' ' PHE . . . -93.81 120.1 33.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.682 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.92 130.65 73.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.478 0.656 . . . . 0.0 111.262 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 p -88.77 135.83 33.31 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.487 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.8 pt -82.24 -11.26 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.149 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.447 ' CG ' HG22 ' A' ' 41' ' ' THR . 8.3 m-20 -83.2 149.75 26.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.429 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -58.75 168.57 1.18 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.312 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.0 -35.98 86.19 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 114.28 0.472 . . . . 0.0 114.28 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.45 -53.26 57.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.186 0.493 . . . . 0.0 111.067 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -68.67 -37.94 80.0 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -66.88 -6.66 17.3 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.589 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.57 -17.57 62.97 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.397 0.617 . . . . 0.0 109.422 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.6 mttm -93.75 -8.28 41.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.284 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 79' ' ' ALA . 13.6 t -66.45 -46.23 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.73 0.776 . . . . 0.0 110.767 -177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.3 mtpt -62.55 -48.86 85.56 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.872 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -60.6 -29.93 89.51 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.357 1.371 . . . . 0.0 111.403 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.4 mt -63.68 -43.99 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.92 98.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.494 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.28 -50.1 67.03 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.833 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.61 85.48 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.337 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -73.32 -23.42 60.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.87 0.335 . . . . 0.0 111.607 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.05 39.55 19.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.892 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.587 ' HB3' ' CD2' ' A' ' 93' ' ' TYR . 26.6 m0 -64.4 -47.2 80.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.758 0.313 . . . . 0.0 111.644 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 32.9 tt0 72.11 1.97 4.13 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 2.8 m-85 -88.18 174.15 8.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.11 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.72 137.03 45.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.404 ' HB ' HG22 ' A' ' 17' ' ' ILE . 25.5 t -122.66 128.02 75.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.759 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 11.2 mp -124.09 137.36 54.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.703 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.94 116.49 32.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.493 ' HA ' HD22 ' A' ' 14' ' ' LEU . 49.6 t0 -86.13 113.7 22.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.552 174.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.0 t -97.21 -10.64 25.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.021 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -82.52 -48.39 11.08 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.897 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.61 1.05 78.19 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.17 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -91.97 -24.61 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.79 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.54 ' CE1' HG21 ' A' ' 24' ' ' THR . 81.1 t80 -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 -177.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.67 -33.09 74.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.442 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.8 ttm-85 -69.96 -43.03 72.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.935 0.398 . . . . 0.0 110.468 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.7 91.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.228 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.3 mmt -76.01 -23.72 55.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.991 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t30 72.42 84.29 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.201 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.445 ' HA ' HG21 ' A' ' 129' ' ' THR . 61.9 t -105.65 97.48 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.54 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -73.31 -54.58 8.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' HB3' ' HA2' ' A' ' 130' ' ' GLY . 58.3 tp -138.71 138.05 37.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.652 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.31 154.08 46.62 Favored Pre-proline 0 C--N 1.313 -1.022 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.516 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.2 Cg_endo -76.32 150.36 93.23 Favored 'Cis proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.852 1.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -111.1 136.42 50.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.986 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.25 126.25 74.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.209 0.528 . . . . 0.0 111.969 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -126.37 116.08 20.64 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.943 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 59.9 mt -104.72 131.51 53.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 111.099 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.4 130.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.413 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.02 -175.41 5.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.626 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.67 -16.0 49.44 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.814 -0.63 . . . . 0.0 114.058 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -88.82 -1.2 57.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.008 0.404 . . . . 0.0 110.576 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 71.2 34.27 64.45 Favored Glycine 0 CA--C 1.501 -0.797 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.653 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -124.8 157.78 34.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 83.1 mt -74.79 116.24 17.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.01 -26.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.29 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.528 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 90.3 t80 -147.34 135.74 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.502 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.51 122.05 21.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.968 0.413 . . . . 0.0 110.723 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.528 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.9 t60 -134.56 102.3 5.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.445 HG21 ' HA ' ' A' ' 109' ' ' VAL . 30.3 m -117.63 124.22 48.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.624 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 111' ' ' LEU . . . 118.27 -8.3 13.98 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.702 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -67.13 148.12 52.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.8 p -116.23 -47.29 2.76 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.701 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -156.4 131.94 9.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.667 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.77 15.54 56.34 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.915 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.19 -14.1 56.5 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.75 -18.49 55.08 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.997 0.919 . . . . 0.0 111.943 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.07 -39.21 94.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.467 0.651 . . . . 0.0 111.136 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.57 -32.13 67.75 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -62.47 -48.02 81.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.386 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.427 HD13 ' NE1' ' A' ' 60' ' ' TRP . 5.4 tp -66.21 -37.13 79.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.505 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.669 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.4 ttpp -60.73 -46.54 90.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.683 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.34 -35.69 81.22 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.694 0.283 . . . . 0.0 111.495 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 139' ' ' LEU . 96.0 t -59.93 -44.37 94.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 109.395 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 12.9 mmm180 -69.26 -34.86 75.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.056 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.6 mm-40 -55.75 -42.53 75.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.038 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 52.3 mt . . . . . 0 CA--C 1.533 0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.533 -179.379 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.426 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 18.0 m . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 121.102 0.477 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -87.48 -137.21 0.09 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.7 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -135.17 -23.81 1.47 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.252 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 67.38 70.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.691 0.758 . . . . 0.0 111.205 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 162.49 26.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.416 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.599 ' HG2' ' SD ' ' A' ' 107' ' ' MET . 8.8 Cg_exo -39.93 138.03 1.13 Allowed 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.091 3.194 . . . . 0.0 113.111 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.77 97.24 9.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.099 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.43 134.67 61.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 t -80.1 112.08 17.08 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.913 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 98' ' ' ASP . 19.0 mt -121.99 169.85 10.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -105.47 130.13 53.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.813 0.339 . . . . 0.0 111.572 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -83.29 -167.91 1.88 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.043 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.589 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 41.9 pt -71.32 -17.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.23 -14.01 51.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.715 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.64 15.35 76.01 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -93.7 145.67 24.4 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.377 -0.912 . . . . 0.0 109.461 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -74.03 118.67 17.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.349 0.595 . . . . 0.0 110.926 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -128.82 132.44 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.412 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 95.6 mt-30 -95.33 135.21 37.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.556 HG21 ' CE1' ' A' ' 103' ' ' PHE . 15.9 p -61.5 -34.83 76.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.14 -20.69 63.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.02 0.438 . . . . 0.0 111.397 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.08 11.36 20.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 110.719 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.0 tp -97.06 125.19 41.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.289 0.566 . . . . 0.0 111.067 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -125.11 155.66 39.52 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.543 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.711 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 9.4 t30 -78.97 -75.38 0.24 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.198 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.68 22.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.944 0.402 . . . . 0.0 110.682 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 97.53 -10.19 64.8 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -105.08 151.45 39.51 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.247 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -65.02 160.1 43.21 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.933 2.422 . . . . 0.0 112.522 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.711 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 11.2 ptt? -149.32 164.3 35.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.939 -175.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.412 ' CD1' ' HZ3' ' A' ' 60' ' ' TRP . 76.5 mt -128.46 127.92 67.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 92.9 mt -99.85 115.14 40.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -104.48 130.65 52.39 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.869 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.616 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 66.7 m-85 -96.38 121.14 37.86 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.22 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.541 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 24.9 p90 -142.0 164.38 30.32 Favored 'General case' 0 C--O 1.238 0.493 0 O-C-N 123.97 0.793 . . . . 0.0 110.494 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.13 17.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.663 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.523 ' HE ' ' HB3' ' A' ' 133' ' ' GLU . 29.2 mmt180 -58.48 -46.2 87.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.6 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.541 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.7 pt-20 -62.87 -49.57 74.34 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.038 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.432 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 42.6 tp -62.25 -41.41 98.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.138 -177.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 tttt -63.67 -49.37 73.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.58 96.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.331 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.9 mt -64.4 -42.71 96.12 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -58.77 -36.39 74.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 62.1 mm-40 -66.58 -39.09 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.697 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.26 24.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.884 0.373 . . . . 0.0 111.886 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -58.67 -39.52 80.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.79 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.92 92.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.02 -38.43 90.87 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.638 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.511 ' CZ2' HG12 ' A' ' 140' ' ' ILE . 17.7 m0 -67.6 -37.03 81.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.576 0.703 . . . . 0.0 110.22 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -75.58 -8.11 55.94 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.675 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.09 -43.76 70.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.345 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -142.72 -40.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.958 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.468 HG21 HG13 ' A' ' 143' ' ' VAL . 7.8 m -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.811 0.339 . . . . 0.0 110.313 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.6 24.5 73.94 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 5.6 p -78.37 124.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 122.864 0.465 . . . . 0.0 111.715 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -106.17 165.58 11.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.639 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 84.3 mt -108.06 146.12 33.04 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.279 0.561 . . . . 0.0 111.853 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.566 HG23 HD13 ' A' ' 96' ' ' LEU . 93.7 mt -120.88 110.36 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.201 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -92.45 118.6 31.12 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.0 132.52 68.66 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.495 ' HB3' HG21 ' A' ' 82' ' ' VAL . 25.3 p -84.17 128.42 34.55 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.254 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.547 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 42.4 pt -76.4 -14.83 14.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 O-C-N 124.78 1.3 . . . . 0.0 111.344 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 7.0 m-20 -77.63 175.76 9.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.075 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -88.69 178.87 6.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.532 ' HA2' HD21 ' A' ' 97' ' ' LEU . . . -58.04 -23.27 51.5 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.987 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.5 -65.09 0.74 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.89 0.376 . . . . 0.0 111.234 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.505 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 63.9 m-20 -66.35 -35.33 80.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.691 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.567 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -65.81 -4.72 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -64.48 -9.37 18.2 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.311 0.577 . . . . 0.0 110.523 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.783 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 94.4 mttt -92.98 -12.75 29.95 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.745 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 72' ' ' SER . 50.6 t -64.88 -49.71 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 17' ' ' ILE . 13.1 mptt -68.76 -41.6 21.62 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 14.5 Cg_endo -60.3 -31.06 92.39 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.025 1.15 . . . . 0.0 110.946 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.7 mt -63.72 -40.92 97.96 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.305 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.431 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -54.72 -48.25 72.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.619 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.91 -42.94 84.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.88 82.87 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.774 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -99.59 3.3 45.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.26 43.34 93.13 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.4 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.431 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.1 m0 -82.33 98.85 9.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.231 0.539 . . . . 0.0 110.159 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -86.5 44.95 1.19 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.005 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -145.89 -176.91 5.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -71.77 136.65 47.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.306 0.574 . . . . 0.0 111.505 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.69 130.31 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.231 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.566 HD13 HG23 ' A' ' 69' ' ' ILE . 10.6 mp -122.03 154.71 36.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.642 0.734 . . . . 0.0 111.695 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.567 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.8 tt -125.43 113.95 18.19 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.868 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.686 ' HA ' HD22 ' A' ' 14' ' ' LEU . 66.5 t0 -77.6 117.24 18.84 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 118.175 -1.41 . . . . 0.0 108.439 174.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -88.06 -32.3 18.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.413 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -79.02 -38.28 37.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.726 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.43 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 84.64 12.02 76.03 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -177.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.56 -6.04 15.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.556 ' CE1' HG21 ' A' ' 24' ' ' THR . 79.6 t80 -64.24 -39.5 94.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.192 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.547 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 24.5 pttm -59.62 -37.2 77.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.269 176.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -70.5 -41.49 72.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.667 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.62 92.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.942 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.599 ' SD ' ' HG2' ' A' ' 10' ' ' PRO . 42.0 mmm -88.66 -11.89 44.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.72 83.3 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.741 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.3 109.1 20.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -69.83 -58.53 3.76 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.175 0.512 . . . . 0.0 110.052 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.483 ' HB3' ' HA2' ' A' ' 130' ' ' GLY . 59.5 tp -143.47 136.28 27.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.6 pt -83.27 153.08 65.73 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.589 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -74.77 155.91 99.91 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.767 -1.347 . . . . 0.0 112.777 0.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.32 130.55 54.49 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.877 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.459 HG22 ' CD ' ' A' ' 49' ' ' GLU . 21.7 t -112.0 129.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.39 0.431 . . . . 0.0 111.997 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.14 113.7 15.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.039 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.7 mt -102.93 129.83 54.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-O 121.245 0.545 . . . . 0.0 110.791 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.18 131.52 63.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.827 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.3 165.34 23.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.632 0.582 . . . . 0.0 110.851 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.81 -21.39 51.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.208 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -73.3 -9.2 58.45 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.999 0.4 . . . . 0.0 111.105 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' A' ' 123' ' ' LYS . . . 91.23 18.56 45.69 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.951 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HD2' ' O ' ' A' ' 122' ' ' GLY . 4.0 mptp? -125.56 150.39 47.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.891 0.346 . . . . 0.0 110.612 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.1 mt -65.07 125.97 23.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.439 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.72 -18.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.556 ' HB2' ' HD3' ' A' ' 142' ' ' LYS . 89.3 t80 -150.56 132.08 14.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.924 0.392 . . . . 0.0 111.707 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -128.64 128.92 45.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.832 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' HIS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.7 t60 -133.26 108.94 9.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.819 0.342 . . . . 0.0 110.828 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 p -120.94 135.14 55.27 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.838 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 111' ' ' LEU . . . 103.93 0.39 45.24 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.393 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.589 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -82.52 149.14 27.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.1 p -123.79 -47.65 1.93 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.986 0.422 . . . . 0.0 110.735 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.523 ' HB3' ' HE ' ' A' ' 48' ' ' ARG . 11.0 pt-20 -160.59 144.74 13.93 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.147 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.49 72.17 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.89 -13.93 55.77 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 2.1 mp0 -60.21 -26.2 66.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.066 0.546 . . . . 0.0 111.234 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.88 90.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.587 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.62 -38.54 87.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.992 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.657 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.14 -52.4 64.0 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.457 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.511 HG12 ' CZ2' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -65.47 -38.89 83.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 -175.528 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.715 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 40.0 ttmt -59.57 -53.28 59.94 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.556 ' HD3' ' HB2' ' A' ' 126' ' ' TYR . 64.5 tttt -69.47 -30.3 68.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.066 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 139' ' ' LEU . 55.8 t -58.91 -46.06 91.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.923 0.392 . . . . 0.0 110.178 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 5.5 mmm180 -71.77 -34.61 69.59 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.767 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.715 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 5.7 mm-40 -56.01 -34.64 65.99 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 62.7 mt . . . . . 0 C--O 1.227 -0.108 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.51 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 7.4 t . . . . . 0 CA--C 1.565 1.542 0 CA-C-O 120.991 0.424 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -117.88 1.25 12.07 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.032 0.444 . . . . 0.0 111.123 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 118' ' ' VAL . . . 74.61 11.55 3.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.258 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 54.82 36.48 26.57 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.772 0.796 . . . . 0.0 110.501 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 80.5 mt -80.45 153.79 73.86 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.346 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.16 157.43 61.77 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.093 2.529 . . . . 0.0 111.132 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.98 82.45 2.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.0 133.46 68.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.129 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -91.35 105.0 17.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.03 0.443 . . . . 0.0 110.629 -177.604 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mp -100.54 176.47 5.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.313 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -114.61 125.15 53.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -90.28 -172.46 3.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.253 0.549 . . . . 0.0 112.19 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.571 ' HA ' ' CD ' ' A' ' 83' ' ' LYS . 37.5 pt -65.01 -28.6 45.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.308 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.62 -25.93 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.413 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.83 49.27 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -100.03 144.26 29.28 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.459 -0.87 . . . . 0.0 110.148 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.24 106.17 13.01 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.23 137.87 56.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.135 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.608 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 37.5 mt-30 -89.16 139.2 30.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.428 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 p -65.32 -32.17 73.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.96 -14.41 62.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.847 0.356 . . . . 0.0 111.29 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -116.62 5.85 13.31 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.645 -179.15 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -92.57 120.25 32.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 4.9 pt-20 -118.68 145.26 45.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.136 0.493 . . . . 0.0 111.94 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.444 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 26.5 t-20 -76.13 -67.81 0.64 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.924 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 169.23 -25.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.032 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.12 -6.57 1.55 Allowed Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.084 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.3 mptm? -97.21 151.6 37.78 Favored Pre-proline 0 C--N 1.315 -0.926 0 C-N-CA 122.765 0.426 . . . . 0.0 110.774 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.6 Cg_exo -66.66 158.64 54.95 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.971 2.447 . . . . 0.0 112.427 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.448 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 4.1 ptt? -147.46 154.68 41.11 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.637 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.446 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.1 mt -125.91 130.77 72.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.5 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -110.93 118.75 36.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.443 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.8 m-85 -95.29 117.75 30.84 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -144.41 168.76 19.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 123.73 0.644 . . . . 0.0 110.506 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.69 146.26 29.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.74 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.494 HG22 ' OD2' ' A' ' 74' ' ' ASP . 13.4 t . . . . . 0 C--N 1.313 -0.988 0 CA-C-O 121.079 0.466 . . . . 0.0 110.879 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 120.869 0.366 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 14.8 mmm180 -58.08 -44.78 87.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.274 0.559 . . . . 0.0 110.713 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.4 tm-20 -62.8 -55.19 28.66 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.536 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.558 HD11 ' CE2' ' A' ' 93' ' ' TYR . 33.2 tp -65.4 -41.06 94.06 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.45 -48.51 77.41 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.8 89.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.093 0.473 . . . . 0.0 110.881 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.5 mt -63.76 -41.07 91.36 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.844 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.928 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -50.78 -40.46 55.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.882 0.373 . . . . 0.0 110.829 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -70.42 -40.82 73.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -110.24 21.15 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -62.14 -40.46 96.03 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.646 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.01 82.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.813 0.339 . . . . 0.0 110.395 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.87 -41.79 99.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.269 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -69.26 -38.93 78.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.572 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -77.88 -8.34 57.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.59 -50.23 68.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.254 0.346 . . . . 0.0 111.758 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.46 -38.2 1.19 Allowed 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.314 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.486 HG21 HG13 ' A' ' 143' ' ' VAL . 9.5 m -63.57 -41.48 98.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.07 78.56 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.247 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 8.3 p -74.63 137.26 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.773 0.321 . . . . 0.0 111.763 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.4 mtm-85 -115.46 169.15 9.38 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 78.5 mt -114.11 139.95 48.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.305 0.574 . . . . 0.0 111.319 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.517 HG23 HD13 ' A' ' 96' ' ' LEU . 88.6 mt -111.78 99.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.96 115.63 24.48 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.9 129.49 75.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.346 0.593 . . . . 0.0 110.737 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.7 t -89.34 136.27 33.12 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.522 ' HB ' ' HE3' ' A' ' 104' ' ' LYS . 46.3 pt -75.25 -19.02 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.616 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.494 ' OD2' HG22 ' A' ' 41' ' ' THR . 13.4 m-20 -72.2 142.99 49.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.559 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 60.0 mt-10 -68.5 171.05 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -52.71 -41.81 58.08 Favored Glycine 0 C--N 1.329 0.159 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -172.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.97 -55.59 27.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.23 0.515 . . . . 0.0 111.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -69.96 -36.97 75.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.948 0.404 . . . . 0.0 111.704 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.01 -4.19 9.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 96.6 mt-30 -61.25 -10.12 6.27 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.761 -0.587 . . . . 0.0 110.892 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.641 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.4 mttm -92.85 -13.04 29.57 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.538 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -65.54 -46.21 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.588 0.709 . . . . 0.0 111.249 -177.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.571 ' CD ' ' HA ' ' A' ' 17' ' ' ILE . 28.7 mtmt -73.65 -37.68 3.62 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.0 Cg_endo -61.61 -31.08 86.7 Favored 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 120.372 1.168 . . . . 0.0 110.058 171.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -63.94 -42.4 97.34 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -57.48 -47.68 81.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.775 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.98 -45.65 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.144 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.48 92.04 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.204 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.54 -33.32 66.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.56 50.29 2.98 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.019 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.464 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 45.6 m0 -80.77 122.59 27.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.06 0.457 . . . . 0.0 109.949 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.67 32.88 1.17 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.041 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -139.63 171.07 14.77 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.285 -0.259 . . . . 0.0 110.797 -176.564 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.15 136.25 37.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.057 0.455 . . . . 0.0 111.249 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' C ' HD12 ' A' ' 96' ' ' LEU . 45.8 t -118.17 131.14 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.031 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.517 HD13 HG23 ' A' ' 69' ' ' ILE . 10.2 mp -121.2 145.82 47.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.362 0.601 . . . . 0.0 111.201 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.554 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.6 mp -112.91 119.58 38.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 64.7 t0 -85.5 114.39 22.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 117.846 -1.542 . . . . 0.0 108.715 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.1 t -93.24 -3.87 52.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.147 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . 7.0 m-80 -103.22 -58.3 1.9 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.398 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 100.53 -13.25 59.73 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 100' ' ' ASN . 45.5 m-20 -64.08 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.416 0.686 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.4 -42.25 98.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.869 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HE3' ' HB ' ' A' ' 73' ' ' ILE . 4.4 mtpm? -59.16 -43.78 92.12 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -68.26 -39.01 82.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.696 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.19 79.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.697 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 25.8 mmt -88.9 -7.38 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.207 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.91 52.78 7.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 0.0 110.539 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.77 89.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -77.05 -49.36 15.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.964 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 tp -127.35 138.65 53.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.291 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.1 pt -102.21 154.19 37.56 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 84.5 Cg_endo -78.62 147.05 80.76 Favored 'Cis proline' 0 C--O 1.241 0.635 0 C-N-CA 123.619 -1.409 . . . . 0.0 112.108 -0.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -108.94 138.06 45.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -122.92 131.4 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 84.3 m-85 -128.63 118.32 22.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.007 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.641 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.95 131.92 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.159 0.504 . . . . 0.0 110.694 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.639 HG21 ' HB1' ' A' ' 7' ' ' ALA . 53.6 t -115.61 134.0 60.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.925 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.49 -175.15 4.61 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.414 0.446 . . . . 0.0 111.509 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.16 89.22 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.31 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -73.25 -14.59 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.504 0.669 . . . . 0.0 110.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 85.17 41.64 7.4 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.949 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -121.76 155.81 34.48 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 7' ' ' ALA . 89.7 mt -77.43 125.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 p -120.03 -30.06 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.835 0.35 . . . . 0.0 111.902 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.641 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.6 t80 -121.86 126.83 49.63 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 122.175 -0.328 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -131.85 109.31 10.02 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.334 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -147.82 109.03 4.28 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.072 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 p -91.23 106.14 18.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.608 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.2 72.08 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.596 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.588 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 31.7 p90 -70.85 -42.83 69.63 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.353 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.435 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 27.0 p 49.81 84.64 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.912 -1.494 . . . . 0.0 113.392 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 64.85 112.82 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.227 1.011 . . . . 0.0 112.8 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.08 -8.87 50.05 Favored Glycine 0 CA--C 1.51 -0.24 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.588 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -68.65 -37.88 85.29 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.344 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -52.89 -30.86 36.61 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.913 0.885 . . . . 0.0 111.531 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.56 99.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.481 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -73.82 -29.82 62.36 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.379 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.669 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -61.36 -48.43 81.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.926 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.6 tp -66.68 -36.04 76.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.591 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 41.2 ttmt -57.92 -48.03 81.11 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.416 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 20.8 mttp -76.85 -22.19 53.91 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 139' ' ' LEU . 77.0 t -60.64 -44.28 96.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -68.51 -36.85 79.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.031 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 25.9 mt-10 -63.43 -30.59 71.69 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 120.649 0.261 . . . . 0.0 110.855 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.5 mt . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 121.376 0.608 . . . . 0.0 109.665 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.545 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 6.9 m . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 121.575 0.703 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.467 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 71.3 m-85 -97.57 -122.89 0.13 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.779 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -152.23 14.04 0.59 Allowed 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.377 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 47.6 tt0 50.43 33.8 8.26 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.619 0.723 . . . . 0.0 111.424 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 51.8 mt -83.28 151.43 62.78 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.005 -176.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 32.3 Cg_exo -60.18 150.38 79.83 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.925 2.416 . . . . 0.0 110.559 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.74 84.69 2.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.987 0.422 . . . . 0.0 111.698 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.3 t -125.75 133.67 68.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 p -86.84 103.92 15.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.773 0.321 . . . . 0.0 111.176 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 103' ' ' PHE . 34.0 mt -99.6 176.31 5.52 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -112.88 134.06 54.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.563 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -86.46 165.55 16.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.966 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 pt -67.7 -17.35 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -84.24 -3.67 58.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.858 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.97 78.07 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.76 142.5 27.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.247 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -82.18 111.86 18.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.417 0.627 . . . . 0.0 110.01 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -116.11 128.32 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.643 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.543 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.1 mt-30 -89.58 134.34 34.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.436 HG21 ' CE1' ' A' ' 103' ' ' PHE . 8.5 p -65.85 -29.85 70.37 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -68.55 -20.7 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.936 0.398 . . . . 0.0 110.942 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.21 13.95 20.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.978 179.751 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.65 102.66 3.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.239 0.543 . . . . 0.0 112.01 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 46.5 mt-10 -114.78 104.24 11.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.361 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -71.56 -44.9 63.71 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.44 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 64.4 31.48 81.0 Favored Glycine 0 C--O 1.227 -0.306 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.177 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -128.55 153.6 79.43 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 123.106 0.562 . . . . 0.0 109.717 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 32.0 Cg_exo -56.59 146.78 73.97 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 122.264 1.976 . . . . 0.0 111.563 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.517 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 25.2 mtt -135.18 170.6 15.67 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.068 -173.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.745 HG23 HD23 ' A' ' 68' ' ' LEU . 7.6 tt -150.1 127.11 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.433 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.1 mt -101.61 126.05 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.122 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -104.15 111.83 24.59 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.398 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 23.6 m-85 -94.03 119.58 33.1 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.18 168.54 20.13 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.843 0.714 . . . . 0.0 110.717 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.7 -167.59 0.72 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.113 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 74' ' ' ASP . 16.7 p . . . . . 0 C--N 1.316 -0.852 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.43 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.1 mt . . . . . 0 CA--C 1.516 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -58.23 -41.75 84.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.029 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 tm-20 -62.93 -58.73 6.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.136 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD11 ' CE2' ' A' ' 93' ' ' TYR . 40.4 tp -62.68 -41.47 99.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.238 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.54 -46.71 87.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.87 92.72 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.099 0.476 . . . . 0.0 110.663 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.4 mt -68.71 -33.24 58.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.438 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -56.23 -27.72 55.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.226 0.536 . . . . 0.0 110.377 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -85.55 -41.23 15.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.881 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.7 15.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 84.1 t80 -61.07 -40.63 94.4 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.672 0.272 . . . . 0.0 111.511 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.39 80.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.082 0.468 . . . . 0.0 110.42 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.38 -41.26 98.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.053 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.433 ' NE1' HD13 ' A' ' 140' ' ' ILE . 20.7 m0 -69.88 -36.13 75.22 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.481 0.658 . . . . 0.0 110.441 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -78.04 -7.12 56.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.118 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -53.99 -50.81 65.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.836 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 -30.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.204 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 m -62.53 -41.85 99.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 0.0 111.413 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.91 25.06 74.78 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.061 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -77.53 133.75 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.577 0.227 . . . . 0.0 111.086 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtm-85 -117.67 148.16 42.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.65 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.745 HD23 HG23 ' A' ' 35' ' ' ILE . 78.2 mt -86.37 135.46 33.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.577 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 75.0 mt -112.84 101.42 12.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.27 103.6 14.36 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.171 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.5 127.3 73.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.501 0.667 . . . . 0.0 111.883 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -89.13 138.81 31.09 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.836 176.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.6 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 38.1 pt -90.86 -3.89 10.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 O-C-N 125.133 1.521 . . . . 0.0 113.615 -171.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 41' ' ' THR . 21.4 m-20 -86.38 176.7 7.74 Favored 'General case' 0 C--O 1.214 -0.763 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.423 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.49 176.21 9.1 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.512 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -60.99 -34.04 86.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.661 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.21 -55.0 40.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.269 0.557 . . . . 0.0 110.813 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -67.93 -37.27 81.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.014 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -70.63 -5.0 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 81.1 mt-30 -61.87 -19.51 62.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.697 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 51.8 mtmt -90.02 -10.61 44.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.815 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 79' ' ' ALA . 57.7 t -63.89 -47.75 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.0 mptp? -73.71 -38.71 4.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.9 Cg_endo -60.37 -32.91 94.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 119.909 1.003 . . . . 0.0 110.283 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.2 mt -64.52 -42.39 95.82 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.624 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -56.73 -50.36 72.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.675 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -68.35 -44.52 75.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.756 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.81 98.14 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.172 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -79.87 -32.66 40.41 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.69 45.98 3.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.217 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.624 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 40.2 m0 -82.79 114.52 21.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 111.054 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.18 37.38 0.72 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.502 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.453 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -130.58 167.03 19.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.28 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.36 116.97 19.16 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.805 0.812 . . . . 0.0 110.313 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 t -98.88 132.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.356 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 tp -109.87 163.28 13.68 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.443 ' HB2' ' HE2' ' A' ' 83' ' ' LYS . 11.7 tp -126.68 99.63 5.86 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 66.2 t0 -75.57 117.57 17.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 117.542 -1.663 . . . . 0.0 108.101 172.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 p -97.79 -5.22 35.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.152 0.501 . . . . 0.0 110.954 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -101.02 -42.17 6.5 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.701 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 82.8 5.23 89.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -97.51 -14.66 20.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.787 0.327 . . . . 0.0 111.312 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.436 ' CE1' HG21 ' A' ' 24' ' ' THR . 44.9 t80 -64.42 -38.54 91.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.844 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.6 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 22.1 pttm -55.41 -44.32 76.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.801 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -65.68 -42.94 90.69 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.249 0.547 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.59 85.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -86.23 -3.68 59.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.619 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.71 36.35 2.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.512 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -73.07 88.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.646 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 t -74.31 -45.68 45.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.613 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.85 149.98 50.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.169 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.2 pt -105.86 155.33 38.47 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.44 142.23 68.12 Favored 'Cis proline' 0 C--O 1.239 0.561 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.603 -0.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -106.11 132.58 52.02 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.11 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.555 HG21 HD21 ' A' ' 139' ' ' LEU . 70.9 t -117.8 129.66 73.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 94.1 m-85 -125.48 115.66 20.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.416 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.8 mt -101.28 130.03 51.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.166 0.508 . . . . 0.0 110.51 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.517 ' HB ' ' H ' ' A' ' 34' ' ' MET . 74.2 t -103.91 131.06 53.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.705 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -83.52 -175.53 5.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.12 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.88 8.29 37.59 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.1 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -111.44 -1.27 15.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.683 0.754 . . . . 0.0 109.475 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.87 23.83 63.3 Favored Glycine 0 CA--C 1.504 -0.638 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.206 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 8.3 mptt -115.89 163.15 16.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.848 0.356 . . . . 0.0 110.484 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.45 102.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.298 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.25 -35.37 9.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.74 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 76.2 t80 -137.45 133.11 34.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.707 0.289 . . . . 0.0 110.861 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -141.22 124.6 16.62 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.153 0.502 . . . . 0.0 110.649 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -141.53 116.11 9.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.601 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 p -96.61 109.01 21.71 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.41 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.47 64.12 2.84 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.821 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.72 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.5 p90 -63.57 -41.54 98.38 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.321 0.581 . . . . 0.0 109.934 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.425 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 79.8 p 56.35 79.23 0.18 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.633 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 70.7 113.55 0.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.793 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.0 13.22 46.96 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.938 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.72 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -92.1 -36.88 6.15 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.501 -0.38 . . . . 0.0 112.474 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 2.2 pm0 -60.37 -18.9 53.44 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.984 0.513 . . . . 0.0 112.284 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.95 94.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.88 -33.52 68.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.593 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -60.98 -50.62 72.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.265 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.3 tp -66.24 -39.19 83.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.4 ttpp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.582 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 14.8 tptp -66.87 -33.95 76.73 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.152 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 139' ' ' LEU . 72.9 t -60.01 -44.84 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.33 0.586 . . . . 0.0 109.62 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 22.6 mmm180 -71.41 -23.61 61.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.43 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 55.9 mm-40 -62.06 -38.5 89.03 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 109.479 175.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.462 0.134 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 178.341 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.511 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 26.0 m . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.881 0.372 . . . . 0.0 111.656 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -102.78 -134.11 0.31 Allowed 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.716 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -137.73 -4.01 1.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.609 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 54.52 74.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.656 0.741 . . . . 0.0 110.25 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.403 HD13 ' HB ' ' A' ' 24' ' ' THR . 23.4 mt -122.67 162.1 40.35 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 -175.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.7 148.92 91.95 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.141 1.894 . . . . 0.0 110.215 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.24 80.19 0.99 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.211 0.529 . . . . 0.0 111.307 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.5 134.53 65.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.219 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -92.89 113.17 25.37 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 98' ' ' ASP . 29.1 mt -110.9 176.59 4.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -110.12 134.52 52.1 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.313 0.577 . . . . 0.0 112.017 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -75.97 177.02 7.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.325 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.462 HG22 ' HB ' ' A' ' 95' ' ' VAL . 33.3 pt -55.0 -41.53 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -81.44 -8.41 59.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.12 20.18 31.25 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.21 -176.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -78.3 141.18 38.67 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 m -78.66 108.24 11.92 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.007 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.58 134.4 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.219 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 77.9 mt-30 -100.9 134.75 43.41 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.589 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -64.74 -30.24 71.24 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -72.09 -13.15 61.5 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -125.12 14.88 8.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.2 tp -74.69 125.03 27.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.4 OUTLIER -136.69 140.23 42.53 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.411 HD22 ' HG2' ' A' ' 34' ' ' MET . 93.0 m-20 -101.22 -48.87 4.25 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.597 -178.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 168.73 31.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.735 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.511 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 71.38 36.09 63.2 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.581 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 46.1 mmtm -128.39 151.2 76.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.879 -0.16 . . . . 0.0 111.262 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 22.0 Cg_exo -62.69 151.66 82.45 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.691 2.261 . . . . 0.0 111.547 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.543 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 38.4 mtt -131.75 152.77 50.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -172.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.9 mt -130.22 118.13 42.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 86.0 mt -94.12 123.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.5 m -112.39 116.97 31.18 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.252 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 53.8 m-85 -88.16 111.22 21.37 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 30.7 p90 -123.86 154.72 39.26 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 123.68 0.613 . . . . 0.0 110.776 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.42 153.15 23.57 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.124 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.475 -177.788 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.236 0.358 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -64.63 -39.91 94.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.32 -176.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.649 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -64.34 -48.54 75.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.729 -179.213 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 93' ' ' TYR . 52.2 tp -63.62 -42.38 98.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.71 -46.32 88.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.963 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -61.91 -40.7 96.36 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.258 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.1 mt -64.79 -41.43 92.18 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.646 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -54.34 -30.97 53.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.24 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -79.47 -31.86 42.47 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 52' ' ' ALA . 16.1 m -122.42 23.68 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.0 t80 -63.37 -41.56 98.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.312 -0.242 . . . . 0.0 111.206 -177.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.3 83.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.164 0.507 . . . . 0.0 110.185 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.68 -43.1 94.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.39 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.487 ' NE1' HD13 ' A' ' 140' ' ' ILE . 19.0 m0 -70.05 -37.77 75.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -79.13 -6.81 57.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.869 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.2 -49.65 66.31 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.739 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -160.54 73.82 0.51 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.523 0.678 . . . . 0.0 110.27 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -158.95 -41.64 0.06 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.345 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' LYS . . . 72.02 32.1 63.67 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.479 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.27 121.51 42.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.076 0.465 . . . . 0.0 110.914 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -105.85 164.19 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.687 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD11 HG21 ' A' ' 53' ' ' ILE . 49.1 mt -105.37 134.48 48.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.499 . . . . 0.0 111.568 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.1 mt -109.56 109.17 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -95.71 123.72 39.41 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.233 -178.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.73 131.6 72.76 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.378 0.609 . . . . 0.0 111.32 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' HG21 ' A' ' 82' ' ' VAL . 17.0 p -83.57 134.53 34.81 Favored 'General case' 0 C--O 1.257 1.473 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.242 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.7 pt -78.9 -14.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.698 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 178.51 5.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.06 179.7 5.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.545 ' HA2' HD21 ' A' ' 97' ' ' LEU . . . -59.3 -33.1 74.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.943 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -63.54 -47.11 82.97 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -89.99 -29.63 18.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.6 -3.68 15.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -59.52 -24.04 63.33 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 121.798 -0.564 . . . . 0.0 111.274 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.726 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 73.9 mmtt -88.69 -1.21 57.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 72' ' ' SER . 95.4 t -65.49 -46.71 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -67.41 -42.77 39.72 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.886 -176.32 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.7 Cg_endo -62.2 -29.84 81.06 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 121.104 1.203 . . . . 0.0 110.902 175.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -62.88 -41.6 99.46 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -59.7 -42.38 92.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.698 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -45.41 65.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.76 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.57 -36.72 92.82 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.126 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -92.58 5.2 51.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.31 40.86 91.92 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.263 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.593 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 51.1 m0 -88.32 95.45 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.87 59.85 5.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.348 0.594 . . . . 0.0 110.737 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -137.56 -172.41 3.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.35 134.35 35.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 17' ' ' ILE . 42.8 t -119.95 132.66 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.536 0.684 . . . . 0.0 110.738 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -120.16 152.25 37.93 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.451 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.594 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 10.1 tt -120.71 117.78 28.38 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.377 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.624 ' HA ' HD22 ' A' ' 14' ' ' LEU . 13.3 t0 -81.52 117.25 21.77 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.762 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 t -113.86 -11.18 12.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 32.0 m-20 -84.83 -41.69 15.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 110.726 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.5 ' HA2' ' NZ ' ' A' ' 104' ' ' LYS . . . 94.92 -18.32 57.53 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.59 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 100' ' ' ASN . 5.2 p-10 -91.38 -8.55 47.66 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CE1' HG21 ' A' ' 24' ' ' THR . 88.0 t80 -63.85 -49.14 73.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.184 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.5 ' NZ ' ' HA2' ' A' ' 101' ' ' GLY . 13.1 pttm -62.42 -36.15 81.46 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.961 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -66.91 -43.54 83.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.283 0.563 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.86 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.939 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 107' ' ' MET . 1.7 mmt -78.5 -7.91 57.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.243 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.54 43.09 3.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.67 0.748 . . . . 0.0 111.043 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.23 98.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.328 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -85.83 -66.4 0.91 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.569 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 57.2 tp -107.89 129.65 55.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 pt -85.55 148.16 48.47 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 85.2 Cg_endo -82.75 166.91 67.92 Favored 'Cis proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.242 -1.149 . . . . 0.0 112.882 0.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -125.75 144.36 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.724 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.97 131.69 70.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 86.5 m-85 -126.64 124.15 39.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.4 mt -109.77 129.21 65.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.178 0.513 . . . . 0.0 110.467 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.543 ' HB ' ' H ' ' A' ' 34' ' ' MET . 85.5 t -103.62 128.74 56.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 20.3 t70 -75.88 162.73 27.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.653 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.59 -22.6 52.98 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.878 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -69.46 -18.87 63.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.996 0.426 . . . . 0.0 110.882 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 93.88 31.14 8.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.192 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.78 154.61 51.53 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.3 mt -69.9 123.87 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.371 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 13.7 p -105.08 -30.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.9 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.572 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.5 t80 -132.89 125.26 29.53 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.019 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -131.24 122.35 26.35 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.274 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -145.39 107.9 4.43 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.846 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.3 p -102.15 107.19 18.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.658 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 114.92 74.65 0.6 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.767 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.628 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -126.76 156.76 40.69 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.404 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 32.6 p -124.92 -58.46 1.47 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.015 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -144.39 136.07 25.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.418 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 3.98 63.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.288 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.18 -20.96 53.94 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.077 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.17 -22.7 64.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.271 0.558 . . . . 0.0 111.116 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.3 94.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.038 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -71.49 -31.63 67.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.694 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -61.64 -48.88 78.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.276 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.487 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.1 tp -67.96 -38.11 79.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.34 -42.25 98.37 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.9 mmpt? -65.45 -40.39 93.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LEU . 99.2 t -59.84 -46.68 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.359 0.6 . . . . 0.0 110.213 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -66.94 -36.32 81.96 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.517 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -60.38 -34.1 73.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.58 0.229 . . . . 0.0 111.207 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 59.2 mt . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.209 0.528 . . . . 0.0 109.921 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 16.3 m . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 43.5 m-85 -82.85 -140.39 0.05 Allowed 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.411 0.624 . . . . 0.0 109.791 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.6 12.89 1.17 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.843 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 49.33 60.76 3.53 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.654 0.74 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.2 mt -112.56 158.8 36.36 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.427 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.0 159.21 53.06 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.049 2.5 . . . . 0.0 110.681 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.22 82.34 2.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 103' ' ' PHE . 57.6 t -119.04 134.96 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.572 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.0 p -92.76 108.13 19.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.979 0.418 . . . . 0.0 111.131 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -112.58 174.93 5.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.592 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -108.81 136.57 48.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.793 0.33 . . . . 0.0 110.799 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -90.86 -171.43 3.01 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.783 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.19 -20.04 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -86.0 -21.65 27.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.243 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.98 10.35 58.75 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -175.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -85.85 146.33 26.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -74.4 116.91 15.6 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.404 0.621 . . . . 0.0 109.828 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.644 ' HB ' HD21 ' A' ' 27' ' ' LEU . 3.3 m -117.52 128.04 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.404 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 48.5 mt-30 -90.01 132.17 35.51 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.492 ' HA ' HD12 ' A' ' 27' ' ' LEU . 15.0 p -65.9 -29.47 69.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.629 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.44 -34.44 78.19 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -98.39 5.23 48.33 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.387 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.644 HD21 ' HB ' ' A' ' 22' ' ' VAL . 85.5 mt -73.51 117.0 14.75 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.734 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -132.5 154.18 50.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.566 177.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.584 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 63.3 t30 -89.52 -80.95 0.29 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.783 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 172.57 32.33 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.633 0.583 . . . . 0.0 110.755 -176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.66 -14.76 62.8 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 4.0 mptp? -100.14 143.42 26.48 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.7 164.73 34.73 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.209 2.606 . . . . 0.0 112.846 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 69' ' ' ILE . 73.4 mtm -138.69 160.5 39.48 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.729 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 73.1 mt -129.43 125.67 62.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.8 mt -97.11 126.78 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 m -114.47 122.24 45.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.188 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 73.1 m-85 -97.45 115.06 27.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -135.55 163.04 31.0 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.86 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.86 162.93 13.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.486 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 CA--C 1.54 0.571 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.296 -178.861 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.226 -0.157 0 CA-C-O 121.169 0.509 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 23.4 mmm180 -58.87 -48.95 79.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.247 -175.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.578 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.38 -52.62 31.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.614 -176.272 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.566 HD11 ' CE1' ' A' ' 93' ' ' TYR . 29.8 tp -63.55 -42.27 98.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.824 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -66.61 -49.53 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.69 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -63.21 -42.65 99.31 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.233 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.1 mt -64.03 -43.04 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.414 ' HB2' ' OH ' ' A' ' 93' ' ' TYR . 48.3 tt0 -59.23 -40.32 85.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.679 0.276 . . . . 0.0 110.846 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -66.7 -37.21 84.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 52' ' ' ALA . 31.3 m -107.36 19.17 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.071 0.462 . . . . 0.0 111.19 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -58.15 -40.49 81.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.883 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.6 81.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.619 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.43 -41.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.527 ' CH2' HG12 ' A' ' 53' ' ' ILE . 16.8 m0 -73.58 -42.42 61.62 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.253 0.549 . . . . 0.0 110.552 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.401 HE22 ' C ' ' A' ' 66' ' ' VAL . 2.2 mp0 -70.36 -9.8 57.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.208 0.603 . . . . 0.0 111.941 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.5 -49.35 64.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.063 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -136.6 -36.32 0.71 Allowed 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.036 -0.666 . . . . 0.0 112.77 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 143' ' ' VAL . 17.6 m -65.74 -43.32 89.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.813 0.34 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 32' ' ' LYS . . . 62.65 41.98 99.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.775 -177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.401 ' C ' HE22 ' A' ' 61' ' ' GLN . 6.8 p -91.33 117.71 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -94.5 162.98 13.59 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.503 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 62.7 mt -105.47 148.19 27.46 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.265 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.585 HD11 ' SD ' ' A' ' 34' ' ' MET . 88.9 mt -122.11 110.82 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.39 111.15 22.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.412 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 ' HZ1' ' A' ' 104' ' ' LYS . 9.0 p -116.59 123.49 71.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 CA-C-O 121.587 0.708 . . . . 0.0 111.555 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.625 ' HB2' HG21 ' A' ' 82' ' ' VAL . 35.4 t -80.06 131.89 35.86 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.83 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.608 ' HA ' ' HZ3' ' A' ' 104' ' ' LYS . 40.5 pt -79.96 -13.92 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.397 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.71 -177.89 5.95 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -94.99 176.99 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.48 66.5 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.205 -0.452 . . . . 0.0 114.065 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.75 -49.47 75.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.176 0.512 . . . . 0.0 111.54 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -90.41 -37.05 14.23 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.619 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.557 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -76.79 -3.95 40.99 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -63.02 -13.53 36.57 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.447 -0.783 . . . . 0.0 111.104 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.674 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 58.4 mttp -85.53 -8.3 58.4 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.8 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.625 HG21 ' HB2' ' A' ' 72' ' ' SER . 59.6 t -66.58 -46.0 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.692 0.758 . . . . 0.0 111.723 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 10.7 mtpp -67.32 -41.61 34.06 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.913 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.3 Cg_endo -61.97 -30.64 83.62 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 120.965 1.11 . . . . 0.0 110.6 173.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.98 -42.74 97.12 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -57.25 -48.28 79.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.992 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.06 -44.58 46.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.816 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.72 -47.71 80.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.256 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -73.93 -34.8 64.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.941 0.401 . . . . 0.0 111.308 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.79 49.21 1.98 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -77.27 109.36 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.136 0.493 . . . . 0.0 110.044 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.0 42.31 0.92 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.338 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.566 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -152.93 -179.72 7.91 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.242 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -72.75 140.16 47.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.384 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.27 129.57 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.494 HD13 HG23 ' A' ' 69' ' ' ILE . 11.1 mp -119.71 135.8 54.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.518 0.675 . . . . 0.0 111.58 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.0 tp -105.85 105.49 15.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.678 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.637 ' OD2' ' HE3' ' A' ' 104' ' ' LYS . 47.6 t0 -86.42 138.07 32.06 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 118.072 -1.451 . . . . 0.0 109.639 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.9 m -123.11 -0.36 8.92 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.397 0.617 . . . . 0.0 109.751 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.49 -59.22 1.92 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.278 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.52 -11.87 63.12 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.123 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.2 -24.37 43.2 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' HB2' HG11 ' A' ' 12' ' ' VAL . 75.8 t80 -61.46 -43.49 98.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.637 ' HE3' ' OD2' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.49 -41.99 95.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.042 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -66.72 -36.51 82.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.129 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.99 74.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.542 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 mmt -90.48 -9.35 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.069 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 63.19 59.86 1.24 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.352 0.596 . . . . 0.0 110.829 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 114' ' ' ALA . 65.5 t -77.32 93.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.335 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.3 t -79.31 -58.82 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.648 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.3 tp -110.75 138.43 47.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.924 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 pt -100.25 152.98 37.99 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.618 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.7 Cg_endo -82.86 154.77 74.83 Favored 'Cis proline' 0 N--CA 1.476 0.487 0 C-N-CA 124.039 -1.234 . . . . 0.0 112.012 -1.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -105.57 138.66 41.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.397 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 139' ' ' LEU . 77.3 t -126.5 130.79 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.63 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.19 125.53 33.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.093 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.662 HD11 HD13 ' A' ' 139' ' ' LEU . 59.4 mt -106.73 132.62 53.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 6' ' ' TYR . 55.8 t -109.52 130.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.043 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.91 166.6 23.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.223 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -23.58 58.42 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.751 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -71.26 -11.05 60.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.76 0.79 . . . . 0.0 109.559 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.84 34.51 Favored Glycine 0 CA--C 1.498 -0.971 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.823 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.29 154.03 36.9 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 94.6 mt -76.26 117.7 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 -20.57 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 69.1 t80 -137.53 126.6 24.38 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -134.91 114.91 13.01 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.159 0.504 . . . . 0.0 110.595 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -146.51 116.39 7.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.942 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 p -95.82 106.24 18.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.102 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.67 69.45 1.3 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.454 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 39.6 p90 -65.99 -44.83 83.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.999 0.4 . . . . 0.0 110.326 177.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p 49.07 85.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.305 1.042 . . . . 0.0 112.68 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 68.05 130.46 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.255 1.022 . . . . 0.0 112.489 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.77 2.33 90.5 Favored Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.644 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -70.94 -42.01 60.73 Favored Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 121.543 -0.36 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -58.55 -25.37 62.41 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.937 0.399 . . . . 0.0 111.384 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 96.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.497 0.665 . . . . 0.0 109.765 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.03 -30.21 63.58 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.08 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.662 HD13 HD11 ' A' ' 117' ' ' ILE . 4.4 mm? -60.13 -50.71 72.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.862 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -70.37 -36.77 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.314 0.578 . . . . 0.0 109.881 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -61.37 -44.9 96.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 41.0 tptt -66.57 -31.31 71.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 110.38 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.0 t -58.97 -44.23 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -66.32 -28.53 68.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.279 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 61.3 mm-40 -63.79 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.241 176.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.9 mt . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.223 0.535 . . . . 0.0 110.611 178.426 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p30 . . . . . 0 C--O 1.237 0.44 0 CA-C-O 120.851 0.358 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.506 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 35.0 m -155.26 72.83 0.84 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.331 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.523 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 38.2 m-85 -92.1 -143.22 0.2 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.348 0.594 . . . . 0.0 109.907 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.55 14.72 2.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.841 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.477 ' HB3' HG13 ' A' ' 124' ' ' ILE . 52.4 tt0 50.42 42.85 26.78 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.862 0.839 . . . . 0.0 110.507 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt -92.56 152.01 41.68 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.746 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.52 156.72 55.05 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.343 2.695 . . . . 0.0 111.403 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.64 80.55 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 111.159 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.7 t -125.94 134.29 66.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -90.6 116.58 28.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.713 0.292 . . . . 0.0 110.45 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tp -116.09 173.66 6.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -117.22 128.07 54.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -91.53 -175.31 4.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.869 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 95' ' ' VAL . 29.6 pt -66.66 -21.43 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.913 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -82.17 -10.6 59.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.943 0.402 . . . . 0.0 110.491 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.94 20.19 68.45 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -100.03 141.32 33.01 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.3 m -75.62 110.83 10.35 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.186 0.517 . . . . 0.0 109.897 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 m -116.32 131.02 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.684 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 89.2 mt-30 -90.28 133.06 35.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.583 HG21 ' CE1' ' A' ' 103' ' ' PHE . 16.9 p -66.84 -29.78 69.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.64 -34.32 76.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.29 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.516 ' HB2' ' NZ ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -101.94 8.46 41.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.695 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.9 tp -70.45 117.22 11.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.251 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.523 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 46.7 mt-10 -130.09 141.56 50.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.758 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 7.8 t30 -82.16 -75.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.12 29.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.378 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 93.98 2.3 64.64 Favored Glycine 0 C--O 1.23 -0.15 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.138 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -109.63 151.85 42.49 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 122.387 0.275 . . . . 0.0 110.999 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 19.9 Cg_exo -63.46 154.16 70.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.038 2.492 . . . . 0.0 112.033 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.758 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 73.6 mtm -132.91 147.86 52.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.683 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 78.1 mt -121.91 120.68 62.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.9 mt -99.36 119.27 47.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.0 m -102.58 119.21 38.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.85 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.665 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 72.5 m-85 -93.96 118.1 31.02 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.535 ' O ' HG12 ' A' ' 73' ' ' ILE . 20.2 p90 -144.09 162.99 34.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 123.634 0.584 . . . . 0.0 110.795 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.434 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -81.01 176.53 9.74 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.013 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -84.35 7.41 19.56 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -161.88 82.16 0.57 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.707 0.289 . . . . 0.0 110.566 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 84.7 m -151.12 148.0 27.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.554 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.552 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 59.9 mttp -127.65 -61.27 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.864 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' HD2' ' H ' ' A' ' 44' ' ' LYS . 63.1 Cg_endo -72.97 -16.87 25.56 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 121.815 1.677 . . . . 0.0 111.923 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 46.9 m -69.86 -25.84 63.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.504 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt -85.98 58.16 4.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.33 -45.59 90.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.709 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.555 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -70.92 -45.21 64.64 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.862 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD11 ' CE1' ' A' ' 93' ' ' TYR . 27.2 tp -61.74 -43.43 98.87 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.23 -175.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.61 -48.42 77.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.41 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.37 -46.12 87.98 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.395 0.617 . . . . 0.0 111.197 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.2 mt -64.08 -41.73 93.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.468 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.933 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -54.36 -41.31 68.99 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 111.452 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -66.79 -38.12 85.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.64 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.17 21.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.281 0.563 . . . . 0.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.28 -44.48 88.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.408 0.683 . . . . 0.0 112.391 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.83 84.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.21 -40.98 99.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.979 0.419 . . . . 0.0 110.823 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -69.94 -40.68 75.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 55.1 mt-30 -64.61 -32.62 74.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.183 0.516 . . . . 0.0 110.739 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.46 -39.79 94.55 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.737 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -86.78 -86.2 0.15 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.394 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.566 HG23 ' H ' ' A' ' 66' ' ' VAL . 3.1 t -79.49 -16.04 56.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.876 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 71.86 17.63 77.0 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.407 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.566 ' H ' HG23 ' A' ' 64' ' ' THR . 10.7 p -63.63 140.21 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.127 0.489 . . . . 0.0 112.232 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.59 163.98 14.26 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.633 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 58.5 mt -112.16 134.56 53.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.482 0.658 . . . . 0.0 111.511 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 96' ' ' LEU . 95.0 mt -111.44 109.95 30.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.809 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.11 111.2 22.25 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.27 133.9 58.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-O 121.959 0.885 . . . . 0.0 112.32 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.659 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.0 m -85.08 120.23 26.36 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.133 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 39' ' ' PHE . 45.5 pt -84.68 36.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 123.987 0.804 . . . . 0.0 110.656 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -131.1 -167.88 1.91 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -95.06 165.92 12.19 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . -60.28 -37.21 92.67 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.384 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.409 ' HG3' ' N ' ' A' ' 78' ' ' ASN . 27.7 pt20 -60.38 -42.58 96.16 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.915 0.388 . . . . 0.0 111.324 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.409 ' N ' ' HG3' ' A' ' 77' ' ' GLN . 86.8 m-20 -81.69 -32.99 31.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -68.95 -5.63 22.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.424 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 15.6 mm100 -62.35 -12.85 23.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.824 0.345 . . . . 0.0 110.714 176.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.744 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 37.3 mtmm -93.7 -11.78 30.76 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.713 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG21 ' OG ' ' A' ' 72' ' ' SER . 20.1 t -68.58 -47.54 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.669 0.747 . . . . 0.0 111.571 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.8 mtpt -64.27 -44.65 77.1 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.722 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 13.1 Cg_endo -60.36 -32.29 93.82 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.194 1.263 . . . . 0.0 111.276 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.94 -43.63 98.28 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.36 92.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.127 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.69 -46.5 63.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.257 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.86 -48.22 68.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.296 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -67.88 -34.56 76.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.0 111.519 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.24 52.31 1.25 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.354 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -84.81 132.62 34.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.929 0.395 . . . . 0.0 110.345 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -103.8 33.07 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.188 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -145.33 -179.95 6.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -81.8 141.96 33.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 112.267 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 17' ' ' ILE . 38.9 t -120.76 134.75 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.539 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -121.48 138.57 54.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.763 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.578 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.6 mp -111.2 120.04 40.94 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 63.2 t0 -74.3 117.69 16.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.494 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.1 p -93.8 2.6 56.18 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -121.96 -37.53 2.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.812 0.339 . . . . 0.0 111.145 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.492 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 90.69 8.49 65.46 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.968 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.73 -17.35 17.77 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.583 ' CE1' HG21 ' A' ' 24' ' ' THR . 68.9 t80 -63.07 -43.62 98.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 110.582 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -59.23 -36.06 74.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 105' ' ' ARG . 36.3 ttm180 -71.95 -41.12 68.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.321 0.581 . . . . 0.0 110.308 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.33 84.75 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 31.0 mmm -96.76 -11.08 25.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.739 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 68.84 93.08 0.08 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.556 0.743 . . . . 0.0 112.006 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.88 83.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.8 m -62.15 -48.9 78.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.973 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.0 tp -151.48 132.43 14.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.592 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 148.16 55.11 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.51 147.82 87.76 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.699 -1.375 . . . . 0.0 112.588 0.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -114.72 128.98 56.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.851 175.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 139' ' ' LEU . 41.8 t -114.23 122.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -120.77 115.26 22.96 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.585 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 61.7 mt -103.86 131.51 52.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.274 0.559 . . . . 0.0 110.512 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 66.8 t -108.95 130.43 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.946 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.82 165.21 25.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.366 0.666 . . . . 0.0 111.071 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.79 -20.34 47.3 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.073 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -84.31 4.11 32.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.876 0.338 . . . . 0.0 111.06 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.54 48.4 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.88 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -126.68 152.53 46.62 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.6 mt -75.01 118.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -107.98 -30.69 2.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.268 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.585 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 90.0 t80 -141.58 140.39 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -136.06 130.7 33.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.193 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -141.2 104.1 4.56 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.1 m -104.17 120.19 40.58 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.045 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.69 47.76 66.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.667 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 31.6 p90 -67.59 -43.96 79.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 109.562 176.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.461 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 61.0 p 57.01 87.74 0.06 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.863 1.265 . . . . 0.0 113.036 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 72.07 127.71 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.118 0.967 . . . . 0.0 112.29 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.51 68.07 Favored Glycine 0 CA--C 1.51 -0.264 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.063 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.667 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -73.07 -21.6 79.7 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.249 -0.476 . . . . 0.0 112.257 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.481 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.4 mp0 -56.27 -30.6 62.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.818 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.75 92.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.34 -31.24 67.14 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.678 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.0 mm? -60.38 -52.27 65.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.683 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.8 tp -69.4 -32.79 54.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.203 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.8 ttpp -62.68 -47.34 84.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.939 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -66.34 -32.19 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 110.257 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 139' ' ' LEU . 55.4 t -59.41 -43.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.734 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 27.1 mmt180 -64.62 -36.02 82.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 67.2 mm-40 -58.53 -42.3 87.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.715 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 56.9 mt -64.81 -40.3 94.99 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.314 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 143' ' ' VAL . 99.6 t -62.47 -46.72 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.773 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.69 -37.01 86.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.602 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.03 -33.11 73.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.043 0.449 . . . . 0.0 110.02 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.17 82.03 0.9 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.566 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 42.7 t-80 -75.02 148.34 39.95 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -80.04 113.34 18.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 60.33 17.77 7.4 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.595 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.566 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 25.9 t-80 -159.91 176.59 11.7 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -122.01 10.49 10.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.721 0.296 . . . . 0.0 111.513 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.9 t60 . . . . . 0 C--N 1.315 -0.914 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.194 -178.807 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 92.9 m-20 . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -100.96 61.65 0.97 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.22 0.534 . . . . 0.0 111.946 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.558 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 31.6 m-85 -98.96 -134.02 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.95 155.82 40.65 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.456 ' H ' HG13 ' A' ' 124' ' ' ILE . 53.4 tt0 -74.52 75.84 1.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 81.4 mt -117.98 140.29 27.65 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.885 -174.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 22.6 Cg_exo -64.19 155.75 63.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.15 2.567 . . . . 0.0 110.673 174.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 91.22 0.46 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 154.53 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.888 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -98.01 134.04 41.65 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tp -131.89 165.31 24.17 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 20' ' ' LYS . 1.2 tppp? -113.2 129.61 56.46 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.223 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 20' ' ' LYS . 46.5 p30 -94.67 -174.88 3.43 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 95' ' ' VAL . 32.4 pt -68.42 -18.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.953 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -84.04 -12.4 55.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.924 0.392 . . . . 0.0 110.432 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 16.87 72.16 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' HD21 ' A' ' 16' ' ' ASN . 86.4 tttt -96.1 145.63 25.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.413 -0.894 . . . . 0.0 110.601 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.7 m -80.38 114.0 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.877 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 m -120.65 134.11 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.969 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.423 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.1 mt-30 -88.91 134.95 33.78 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.569 HG21 ' CE1' ' A' ' 103' ' ' PHE . 25.0 p -65.48 -31.04 71.91 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.2 -28.62 69.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.22 16.44 23.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.045 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.6 tp -79.03 101.27 7.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.058 0.456 . . . . 0.0 111.95 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.558 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.1 mt-10 -119.11 122.89 43.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.987 177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -70.88 -43.06 69.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.27 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 0.0 109.464 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.91 33.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.395 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -128.67 151.74 77.54 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 122.415 0.286 . . . . 0.0 110.864 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.95 155.5 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.275 . . . . 0.0 111.621 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.421 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 38.2 mtt -129.92 153.43 48.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.93 0.395 . . . . 0.0 111.805 -171.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.8 mt -128.3 117.28 44.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 82.1 mt -96.79 118.16 42.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 m -104.88 116.07 31.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -90.8 115.78 28.13 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -138.2 168.48 19.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.207 0.527 . . . . 0.0 112.119 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -94.05 166.98 11.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.336 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.48 125.77 29.68 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.593 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.7 t30 57.99 35.59 25.38 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.601 -1.182 . . . . 0.0 113.458 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 78.2 m -106.34 84.55 2.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 48.2 mttm -64.59 -55.45 29.27 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -173.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 11.4 Cg_exo -67.71 -20.3 46.57 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 122.634 2.222 . . . . 0.0 112.899 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 58.8 m -72.13 -19.14 61.83 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 43' ' ' CYS . 17.3 mt -87.37 60.34 6.02 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -63.87 -45.96 87.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.582 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -66.2 -46.37 77.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.137 -176.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD11 ' CE1' ' A' ' 93' ' ' TYR . 33.8 tp -63.8 -42.51 97.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -61.6 -48.44 80.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.562 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -61.37 -42.56 98.9 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.006 0.432 . . . . 0.0 111.02 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.3 mt -64.96 -42.27 94.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.046 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 50' ' ' LEU . 27.2 mt-30 -55.49 -40.86 72.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 111.298 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.28 -38.13 87.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.742 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 52' ' ' ALA . 18.1 m -116.22 27.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.002 0.43 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 53' ' ' ILE . 65.0 t80 -58.64 -39.6 81.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.627 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.45 87.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.641 0.258 . . . . 0.0 110.846 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.55 -41.71 96.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.297 0.57 . . . . 0.0 110.417 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.612 ' O ' ' HB ' ' A' ' 64' ' ' THR . 11.9 m0 -71.18 -37.03 72.18 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.714 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -80.2 -8.92 59.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.787 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.57 -60.43 3.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.182 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.11 -4.25 3.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.758 0.314 . . . . 0.0 111.796 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 18.1 m -96.11 -35.54 11.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.253 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.08 31.33 65.12 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.853 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.95 128.93 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.447 0.641 . . . . 0.0 112.117 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -94.15 152.24 18.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.381 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 39.3 mt -111.94 130.11 55.95 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.138 0.494 . . . . 0.0 111.165 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 96' ' ' LEU . 91.0 mt -110.01 106.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.16 113.21 25.42 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.616 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 10.8 p -122.47 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.254 0.55 . . . . 0.0 111.84 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.6 p -88.66 143.48 26.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.719 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.0 pt -78.31 -13.99 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.111 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -84.39 153.97 23.12 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.707 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.57 168.1 13.64 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 123.52 0.513 . . . . 0.0 110.087 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -55.47 -40.77 78.73 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.142 0.417 . . . . 0.0 114.142 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.2 -39.37 92.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.224 0.512 . . . . 0.0 111.32 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -83.32 -32.65 26.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.362 0.601 . . . . 0.0 110.53 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -79.01 -2.06 38.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.094 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 99.1 mt-30 -57.86 -16.09 10.63 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.916 -0.49 . . . . 0.0 111.146 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.686 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.7 mttp -84.91 -14.82 46.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.431 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 79' ' ' ALA . 49.8 t -65.68 -47.13 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.805 0.812 . . . . 0.0 112.272 -175.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.0 mtpm? -67.34 -42.87 41.02 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.55 -176.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.622 ' HA ' ' OD2' ' A' ' 87' ' ' ASP . 17.9 Cg_endo -61.89 -28.63 81.4 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.107 1.204 . . . . 0.0 111.001 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.96 -42.2 97.36 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 91' ' ' TRP . . . -57.99 -49.12 77.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.773 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 p30 -75.0 -35.96 61.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.996 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.28 -49.59 56.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.877 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -74.6 -34.1 62.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.924 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.217 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 54.4 m0 -95.09 117.79 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.35 47.88 0.93 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -149.23 -169.62 3.42 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.795 -0.184 . . . . 0.0 110.576 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -89.09 135.84 33.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.428 0.633 . . . . 0.0 111.983 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 17' ' ' ILE . 58.8 t -118.07 132.45 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.767 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 8.1 mp -130.3 146.12 51.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.947 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -126.36 127.68 45.88 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -61.01 133.59 56.24 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.1 t -114.75 7.28 15.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.537 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -142.94 -30.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.53 63.09 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.968 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -74.59 -36.87 63.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.418 0.151 . . . . 0.0 111.136 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.569 ' CE1' HG21 ' A' ' 24' ' ' THR . 79.9 t80 -62.19 -48.65 79.07 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -61.59 -35.01 76.63 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.851 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -70.56 -42.43 71.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.375 0.607 . . . . 0.0 110.063 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 10' ' ' PRO . . . -61.43 -37.65 84.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.315 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 28.5 mmm -82.64 -22.77 34.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.317 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.0 t30 72.13 81.75 0.14 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.462 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.91 99.79 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.266 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.2 m -71.71 -69.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.803 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.405 HD21 ' CG2' ' A' ' 132' ' ' THR . 60.4 tp -115.43 131.12 57.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.6 pt -88.67 144.42 33.36 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -80.45 161.58 83.9 Favored 'Cis proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.838 -1.318 . . . . 0.0 113.564 0.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.22 145.08 49.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.958 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.49 130.15 74.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.108 0.48 . . . . 0.0 112.168 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 82.4 m-85 -125.41 124.86 42.39 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.592 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 75.7 mt -114.2 131.07 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.051 0.453 . . . . 0.0 111.057 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 54.8 t -108.92 132.93 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 123.886 0.874 . . . . 0.0 110.057 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -95.04 -171.91 2.55 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.269 0.356 . . . . 0.0 111.111 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.87 66.44 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.983 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -75.09 -2.02 25.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.987 0.393 . . . . 0.0 111.338 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 73.78 30.96 60.88 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.032 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 48.2 mmtm -133.01 168.47 18.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 8' ' ' GLN . 98.2 mt -90.24 112.37 24.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.082 0.468 . . . . 0.0 110.349 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.69 -31.83 5.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.489 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.592 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.4 t80 -124.55 130.71 52.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.043 0.449 . . . . 0.0 111.337 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -130.06 120.67 25.05 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.057 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -144.36 102.84 3.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.884 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.2 p -102.79 106.76 17.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 113.21 71.14 0.56 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.991 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.584 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -122.22 157.06 32.45 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.405 ' CG2' HD21 ' A' ' 111' ' ' LEU . 27.9 p -127.02 -41.85 1.77 Allowed 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.869 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -167.89 124.05 1.07 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.18 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.39 -3.19 32.83 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.39 -18.71 65.9 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.77 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.51 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 2.0 mp0 -60.22 -20.83 60.48 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.094 0.557 . . . . 0.0 111.369 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.6 94.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.483 0.659 . . . . 0.0 110.706 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.7 -32.06 69.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.708 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -61.82 -47.52 84.73 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.515 HD13 ' NE1' ' A' ' 60' ' ' TRP . 5.1 tp -68.54 -39.54 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.721 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.3 ttpp -60.65 -45.86 92.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.155 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 142' ' ' LYS . 42.1 tptt -66.06 -35.16 79.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.385 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -60.78 -42.7 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 144' ' ' ARG . 6.3 mmp_? -64.38 -34.53 78.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.129 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 51.7 mm-40 -61.6 -35.08 76.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.438 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.5 -38.98 92.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.11 -27.33 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.236 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 145' ' ' GLU . 10.8 tmtt? -58.78 -38.01 77.58 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.477 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -72.81 2.0 7.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.003 0.43 . . . . 0.0 111.681 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -61.95 -32.97 83.98 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -121.95 133.82 54.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.299 -0.451 . . . . 0.0 109.968 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -79.17 167.51 20.9 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.639 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 73.04 -67.05 0.28 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.699 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -161.13 136.59 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 148' ' ' LYS . 34.9 t-80 -62.05 -45.76 92.14 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.792 0.329 . . . . 0.0 111.198 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 . . . . . 0 C--N 1.314 -0.968 0 CA-C-O 118.282 -0.865 . . . . 0.0 109.884 178.302 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 CA--C 1.514 -0.442 0 CA-C-O 121.017 0.437 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.638 HG22 ' HE1' ' A' ' 34' ' ' MET . 37.3 m -79.72 81.19 6.02 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.12 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.482 ' CE2' ' HA ' ' A' ' 26' ' ' LYS . 93.2 m-85 -103.48 -80.58 0.52 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.315 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 166.98 -10.77 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 O-C-N 124.514 1.134 . . . . 0.0 110.334 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 55.3 tp60 63.88 44.79 4.65 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.915 0.864 . . . . 0.0 110.298 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.499 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 18.9 mt -98.16 159.42 30.76 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.912 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.63 148.19 93.59 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.301 2.001 . . . . 0.0 109.617 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.02 84.06 2.27 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.063 0.458 . . . . 0.0 111.2 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -117.92 132.95 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -87.97 109.83 20.12 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.09 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.768 HD22 ' HA ' ' A' ' 98' ' ' ASP . 33.3 mt -116.75 175.92 5.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.949 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.57 138.58 40.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.389 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.494 HD21 ' HB3' ' A' ' 20' ' ' LYS . 5.6 p30 -101.77 -175.04 2.73 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.439 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 32.4 pt -63.77 -22.57 31.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.97 -12.31 60.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.09 81.69 Favored Glycine 0 CA--C 1.503 -0.689 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.494 ' HB3' HD21 ' A' ' 16' ' ' ASN . 37.1 ttpt -96.45 141.16 30.08 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.6 m -73.43 115.09 12.39 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 16' ' ' ASN . 8.6 m -122.16 132.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.87 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 79.0 mt-30 -87.77 134.53 33.66 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.499 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 6.7 p -63.76 -28.54 69.94 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.106 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -75.84 -10.68 59.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.72 0.295 . . . . 0.0 111.34 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -126.48 12.96 7.56 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.489 0.185 . . . . 0.0 111.349 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.09 -48.89 78.19 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -172.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 33.06 97.98 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.419 1.104 . . . . 0.0 113.904 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 34' ' ' MET . 13.1 m120 -66.16 -58.39 5.53 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.367 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.69 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.72 4.89 89.88 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.159 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -112.67 150.89 43.42 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.57 150.45 81.63 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.87 2.38 . . . . 0.0 111.751 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.638 ' HE1' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -131.42 154.89 48.19 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.087 0.47 . . . . 0.0 111.065 -176.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.55 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.3 mt -123.08 122.85 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.1 mt -95.73 122.46 47.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.42 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 3.5 m -104.85 118.85 37.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.069 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 72.1 m-85 -95.19 116.86 29.3 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.49 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 28.1 p90 -142.56 171.42 14.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.605 0.566 . . . . 0.0 112.153 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.57 32.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.406 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.429 ' CG2' HG22 ' A' ' 82' ' ' VAL . 48.6 p -78.28 -12.68 60.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.087 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -103.4 9.63 37.72 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 46' ' ' CYS . 17.2 t -143.32 122.21 12.73 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.547 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 52.4 mtmt -87.26 -48.55 0.47 Allowed Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 44' ' ' LYS . 27.3 Cg_endo -63.78 -20.55 68.81 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.423 2.082 . . . . 0.0 112.058 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 44.1 t -68.73 -17.9 64.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 6.6 mt -85.51 40.82 0.86 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.311 0.577 . . . . 0.0 109.607 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -57.52 -39.82 77.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.938 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.589 ' HA ' ' OH ' ' A' ' 131' ' ' TYR . 3.8 tm-20 -66.99 -54.83 18.04 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.2 tp -63.11 -40.78 98.63 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.059 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.0 tttt -62.13 -45.24 94.31 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.212 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -58.77 -46.66 87.0 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.498 ' CG2' HD11 ' A' ' 68' ' ' LEU . 58.8 mt -64.69 -43.16 96.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.168 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -54.62 -42.01 70.68 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.08 0.467 . . . . 0.0 110.993 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 51.2 mm-40 -65.88 -37.56 86.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.901 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 52' ' ' ALA . 30.7 m -110.99 17.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.21 -41.38 92.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.79 86.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 19.0 t70 -64.5 -41.75 96.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.148 0.499 . . . . 0.0 110.439 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.497 ' NE1' HD13 ' A' ' 140' ' ' ILE . 28.8 m0 -72.31 -42.33 65.58 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.263 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 18.6 mm-40 -65.79 -24.11 66.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.236 0.541 . . . . 0.0 110.604 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 36.1 t70 -59.62 -46.41 89.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.52 -70.11 0.77 Allowed 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.491 HG23 ' N ' ' A' ' 66' ' ' VAL . 2.8 t -77.41 -22.12 52.06 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.076 0.465 . . . . 0.0 111.221 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 66.45 32.17 80.97 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.28 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.491 ' N ' HG23 ' A' ' 64' ' ' THR . 14.8 p -63.28 136.56 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -102.63 156.38 17.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.069 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.575 HD12 ' CE2' ' A' ' 93' ' ' TYR . 68.9 mt -116.18 133.15 56.33 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.075 0.464 . . . . 0.0 111.206 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.548 HG23 HD13 ' A' ' 96' ' ' LEU . 86.4 mt -110.02 102.99 14.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.67 118.06 29.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.2 p -122.43 133.1 69.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.212 0 CA-C-O 121.634 0.731 . . . . 0.0 111.727 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.664 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 21.4 p -84.71 140.86 30.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.551 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.413 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 43.0 pt -80.81 -15.52 12.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.28 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.664 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -84.63 159.46 20.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.687 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.504 ' HB2' ' OE1' ' A' ' 77' ' ' GLN . 43.2 mt-10 -72.38 178.22 4.1 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.277 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.64 -48.99 67.64 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 115.423 0.929 . . . . 0.0 115.423 -173.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.504 ' OE1' ' HB2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -65.43 -40.7 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.734 0.767 . . . . 0.0 111.338 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -69.13 -39.63 78.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.229 0.537 . . . . 0.0 110.959 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -72.22 -4.16 27.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.152 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.6 -13.69 15.86 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.656 -0.653 . . . . 0.0 111.346 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.717 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.9 tttp -92.58 -10.45 37.49 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 122.764 0.425 . . . . 0.0 111.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.6 t -66.96 -47.36 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-O 121.547 0.689 . . . . 0.0 111.804 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 43.2 mtpt -63.64 -45.32 82.51 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.987 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -61.06 -31.16 90.62 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.091 1.194 . . . . 0.0 111.098 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -62.64 -44.2 96.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.22 98.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.415 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.22 -50.88 68.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.523 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.8 -44.86 46.35 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.789 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.58 41.91 3.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.411 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.423 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 53.2 m0 -83.35 108.31 16.45 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.0 42.28 1.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.575 ' CE2' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -146.23 177.62 8.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.845 -0.161 . . . . 0.0 111.303 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.78 137.77 40.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.391 0.615 . . . . 0.0 112.394 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -119.76 132.5 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.868 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.548 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -125.36 144.87 50.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.94 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.83 121.92 46.54 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.768 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.1 t0 -70.08 115.28 9.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.343 -1.343 . . . . 0.0 107.648 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.6 t -83.41 -15.25 50.47 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -173.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -120.18 -29.89 4.77 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.28 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.11 1.4 62.92 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.53 -14.19 28.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.448 ' CE1' HG21 ' A' ' 24' ' ' THR . 87.5 t80 -64.91 -44.96 87.85 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 25.6 pttm -63.19 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.2 -34.8 76.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.245 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.78 76.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.105 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 38' ' ' PHE . 23.6 mmt -84.87 -18.25 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.395 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 68.22 78.91 0.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.441 0.696 . . . . 0.0 110.332 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.42 89.4 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.6 m -68.83 -44.85 72.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.792 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.2 tp -137.12 134.74 36.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.412 HG13 ' SG ' ' A' ' 46' ' ' CYS . 11.5 pt -91.36 156.33 43.59 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.61 151.48 94.57 Favored 'Cis proline' 0 C--O 1.238 0.492 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.503 0.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -115.33 130.53 56.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 49' ' ' GLU . 24.2 t -110.99 126.27 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 123.291 0.369 . . . . 0.0 111.373 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 69.9 m-85 -128.03 115.06 17.9 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 60.5 mt -105.71 132.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.295 0.569 . . . . 0.0 111.452 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -109.68 134.88 50.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.478 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -90.16 -172.76 3.6 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.238 0.336 . . . . 0.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.93 -30.32 76.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.447 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -69.41 -14.53 62.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.58 0.705 . . . . 0.0 109.67 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 82.75 31.74 28.87 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.601 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 10.2 mptt -123.43 157.38 33.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.443 . . . . 0.0 110.111 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 7' ' ' ALA . 49.7 mt -74.66 100.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.035 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -88.03 -39.0 12.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.675 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 81.9 t80 -131.81 136.63 47.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.818 0.342 . . . . 0.0 111.652 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -131.03 134.63 46.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.099 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.2 t60 -148.95 103.09 3.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.5 m -103.2 118.88 37.77 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.11 0.481 . . . . 0.0 111.829 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.74 45.41 44.26 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.702 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 15.0 p90 -68.08 -37.51 81.31 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.081 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 43.2 p 77.41 -59.94 0.45 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.163 1.785 . . . . 0.0 112.278 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -147.8 142.87 27.06 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.582 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.11 19.17 67.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.702 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.98 -27.02 20.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.255 -0.473 . . . . 0.0 113.122 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 140' ' ' ILE . 5.7 pm0 -60.51 -22.18 63.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.337 0.255 . . . . 0.0 111.662 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.12 99.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.398 0.618 . . . . 0.0 110.112 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.0 -37.7 66.89 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.414 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -63.21 -46.56 86.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.543 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.497 HD13 ' NE1' ' A' ' 60' ' ' TRP . 7.2 tp -66.34 -34.79 72.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.819 0.342 . . . . 0.0 110.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.1 ttmt -56.43 -54.3 47.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.888 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 29.0 mmmt -66.04 -32.81 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 139' ' ' LEU . 52.9 t -62.0 -43.74 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.287 0.565 . . . . 0.0 109.934 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.425 ' NE ' HD11 ' A' ' 140' ' ' ILE . 78.2 mtt180 -84.27 -18.63 35.77 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.312 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 61.2 mm-40 -69.92 -30.16 67.5 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.415 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.0 mt -61.4 -40.49 94.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 110.105 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.85 -44.02 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 121.487 0.66 . . . . 0.0 109.712 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.421 ' HD3' ' OE1' ' A' ' 145' ' ' GLU . 71.5 tttt -59.84 -44.3 94.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.194 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -77.06 7.79 4.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.093 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.04 -5.42 40.36 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.697 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 154' ' ' HIS . 69.6 t60 -49.77 -25.68 3.24 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.701 0.8 . . . . 0.0 111.499 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -57.76 -36.93 72.77 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.813 0.34 . . . . 0.0 110.13 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -81.51 -60.67 2.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 151' ' ' HIS . 48.5 p-80 -158.07 156.73 31.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.516 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -72.99 99.75 2.8 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.718 0.294 . . . . 0.0 111.324 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 62.2 m80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.314 -0.85 . . . . 0.0 112.551 176.572 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.0 p30 . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.444 ' HA ' ' CA ' ' A' ' 122' ' ' GLY . 40.0 m 65.54 76.12 0.33 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.334 0.588 . . . . 0.0 110.76 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.546 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 89.1 m-85 -100.87 -101.38 0.25 Allowed 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -177.41 11.5 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 25.4 tt0 54.57 34.8 22.06 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.793 0.806 . . . . 0.0 110.579 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.429 HD13 ' OG1' ' A' ' 24' ' ' THR . 79.3 mt -89.84 150.45 43.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.652 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.44 151.89 82.75 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.717 2.278 . . . . 0.0 111.476 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.31 84.13 2.45 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.905 0.383 . . . . 0.0 110.981 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 24' ' ' THR . 72.3 t -121.38 136.76 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -78.07 126.35 30.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 96' ' ' LEU . 1.9 tp -134.34 173.07 12.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.536 -176.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -116.28 133.56 55.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -97.84 -179.89 4.58 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 95' ' ' VAL . 17.5 pt -64.3 -22.17 30.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -77.94 -16.64 58.01 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.901 0.381 . . . . 0.0 110.828 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.56 58.83 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.92 140.36 36.31 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.673 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.1 m -74.38 116.54 15.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.119 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.82 156.81 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.976 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -104.22 134.83 46.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 176.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -67.16 -16.38 64.28 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.378 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -93.05 7.52 43.8 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 121.774 -0.579 . . . . 0.0 112.09 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -136.45 16.35 3.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.836 -0.54 . . . . 0.0 111.297 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.8 -67.52 0.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.34 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.546 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 35.1 mt-10 64.52 175.66 0.19 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.701 0.762 . . . . 0.0 112.516 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.409 ' HB2' ' HE2' ' A' ' 34' ' ' MET . 0.3 OUTLIER -139.25 -78.27 0.33 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.539 178.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.77 31.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.261 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.45 34.15 29.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.298 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 71.7 mmtt -123.47 145.9 48.23 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 122.141 0.176 . . . . 0.0 111.008 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 12.8 Cg_exo -67.82 155.22 70.72 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.813 2.342 . . . . 0.0 111.832 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.409 ' HE2' ' HB2' ' A' ' 29' ' ' ASN . 36.6 mtt -133.97 160.68 36.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.169 0.509 . . . . 0.0 111.61 -174.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 97.2 mt -132.48 118.78 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -99.37 118.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 m -104.1 122.97 46.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.178 0.513 . . . . 0.0 110.191 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 62.8 m-85 -94.16 114.88 27.09 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.236 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HB2' HD22 ' A' ' 47' ' ' LEU . 25.0 p90 -135.25 170.73 15.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.641 0.588 . . . . 0.0 111.284 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.81 153.92 29.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.998 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p -69.86 -21.23 63.36 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -94.37 12.64 26.34 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.747 0.308 . . . . 0.0 111.452 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 61.0 m -126.55 126.49 43.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.744 0.307 . . . . 0.0 111.497 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 57.4 mttp -117.71 -58.5 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.133 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.515 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 3.3 Cg_exo -79.79 -22.16 7.86 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.095 1.864 . . . . 0.0 112.446 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.7 m -76.42 -3.97 39.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.991 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.547 HD22 ' HB2' ' A' ' 39' ' ' PHE . 34.8 mt -62.97 -38.44 91.13 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.826 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? 61.15 -80.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.4 pt-20 -52.87 -52.86 55.86 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 112.229 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.422 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 47.0 tp -61.51 -42.7 99.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.634 0.254 . . . . 0.0 110.598 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 88.6 tttt -67.09 -46.92 72.8 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.626 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.95 97.56 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.0 mt -64.01 -41.38 92.31 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.817 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.726 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.51 -36.99 67.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.768 0.318 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 13.6 mm-40 -69.92 -39.65 76.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.488 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 m -114.84 27.35 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.178 0.513 . . . . 0.0 112.116 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 85.7 t80 -59.4 -35.61 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.749 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.669 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.72 -42.98 94.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.951 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.56 -36.81 76.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 0.0 110.59 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -82.08 -7.67 59.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -58.03 -48.99 78.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.039 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -131.95 -44.19 0.96 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -39.67 94.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 40.79 96.11 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.117 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.54 133.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.79 159.78 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 54.7 mt -108.28 139.3 43.17 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.267 0.556 . . . . 0.0 111.196 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 96' ' ' LEU . 79.2 mt -115.81 110.94 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.611 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -92.76 114.1 26.56 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.52 131.75 63.16 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.936 0.874 . . . . 0.0 111.627 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.576 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.1 m -88.69 119.39 29.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.146 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 pt -77.75 -17.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.939 0.774 . . . . 0.0 109.738 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 4.5 m-20 -73.09 146.34 45.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.155 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.5 -173.82 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.159 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.511 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -43.13 -58.32 3.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.858 -1.064 . . . . 0.0 115.403 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -65.85 -45.17 83.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.408 0.604 . . . . 0.0 112.088 -177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.512 ' CB ' ' HB3' ' A' ' 74' ' ' ASP . 7.3 m-20 -66.7 -41.4 88.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -72.88 -5.31 37.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 29.5 mt-30 -66.01 -10.56 40.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.802 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.76 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 96.0 mttt -94.87 -11.04 29.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.549 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 79' ' ' ALA . 14.1 t -68.65 -50.77 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 40.6 mtpt -66.26 -40.35 34.78 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.605 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 5.9 Cg_endo -58.69 -34.3 98.84 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.185 1.256 . . . . 0.0 110.334 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -64.05 -42.21 97.11 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.435 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -61.08 -43.48 98.82 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.25 -40.41 67.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.89 -42.32 92.92 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.309 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -88.86 -15.73 33.73 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.952 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.6 61.09 4.61 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.734 -0.667 . . . . 0.0 113.276 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.435 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 31.4 m0 -82.41 134.54 35.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.896 0.379 . . . . 0.0 110.323 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -94.65 30.83 1.92 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.383 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.527 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -132.15 171.52 13.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.921 -172.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -81.85 136.17 35.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 17' ' ' ILE . 13.9 t -116.66 144.19 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.072 0.463 . . . . 0.0 110.59 -176.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 14' ' ' LEU . 11.3 mp -124.64 142.46 51.36 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.037 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.738 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 9.9 mp -114.76 117.38 30.61 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -81.16 115.16 20.44 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 t -96.17 -8.19 33.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.383 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -111.65 -30.98 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.835 0.35 . . . . 0.0 111.163 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.27 14.54 68.62 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.56 -27.15 16.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.927 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.52 -45.92 90.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.043 0.449 . . . . 0.0 110.782 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -62.82 -38.91 92.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.191 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -70.69 -41.5 71.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.421 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.59 74.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.882 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.57 -9.65 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.898 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.83 52.23 3.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.978 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.31 89.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.928 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.6 m -69.33 -45.34 69.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.317 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.92 142.28 36.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.983 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 pt -101.83 153.12 38.16 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.551 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 96.0 Cg_endo -78.52 154.32 92.23 Favored 'Cis proline' 0 C--O 1.244 0.778 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.186 0.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -116.65 136.25 53.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.089 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -114.91 127.9 72.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.089 0.471 . . . . 0.0 111.651 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -128.19 114.56 17.13 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.281 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.5 mt -103.05 129.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 CA-C-O 121.199 0.523 . . . . 0.0 110.627 -178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.8 t -106.46 128.52 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.114 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -76.61 161.89 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.59 -21.45 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 114.08 0.392 . . . . 0.0 114.08 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.485 ' OD1' ' HB2' ' A' ' 123' ' ' LYS . 6.3 p30 -74.07 -16.45 61.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.687 0.743 . . . . 0.0 111.253 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 5' ' ' THR . . . 101.38 17.91 20.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.222 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.485 ' HB2' ' OD1' ' A' ' 121' ' ' ASN . 13.6 mptt -121.94 152.16 39.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.227 0.537 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.1 mt -75.45 111.54 11.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.583 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.12 -19.12 6.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.524 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 68.2 t80 -144.43 130.25 19.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.292 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -138.3 129.04 26.64 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.957 0.408 . . . . 0.0 110.305 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 112.64 8.49 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.092 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.8 p -95.8 106.67 18.83 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.776 0.322 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.24 59.14 2.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.23 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.594 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 41.4 p90 -67.55 -35.81 79.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 109.052 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 80.7 p 69.37 -88.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.216 1.807 . . . . 0.0 113.622 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -119.2 119.1 33.12 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.098 -0.377 . . . . 0.0 111.386 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.58 33.56 16.05 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.527 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.594 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -89.89 -27.11 22.54 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.694 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 140' ' ' ILE . 9.2 pt-20 -54.83 -26.0 32.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.641 0.776 . . . . 0.0 112.804 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.19 94.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 0.0 110.856 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.93 -33.41 68.24 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.547 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.6 -53.38 55.52 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.492 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 136' ' ' GLU . 6.2 tp -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.961 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -63.03 -44.38 96.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.16 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.442 ' HG2' ' HB2' ' A' ' 126' ' ' TYR . 44.6 tptt -68.33 -31.34 70.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 139' ' ' LEU . 69.3 t -59.17 -42.45 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.279 0.561 . . . . 0.0 109.489 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -64.31 -35.75 81.88 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.091 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -62.07 -32.02 72.51 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.601 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.22 -41.38 98.34 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.243 0.544 . . . . 0.0 110.038 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 53.8 t -64.56 -43.35 96.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.033 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -61.54 -45.25 94.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.183 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.74 -36.97 85.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.015 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -116.28 59.45 0.45 Allowed Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.815 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.627 ' HB2' ' O ' ' A' ' 147' ' ' VAL . 21.8 t-80 -119.57 -60.25 1.74 Allowed 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.494 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -100.05 150.14 22.77 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.232 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -60.64 -42.07 96.19 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.332 0.395 . . . . 0.0 111.027 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.465 ' O ' ' HB2' ' A' ' 155' ' ' HIS . 27.7 p-80 -101.06 -2.43 31.6 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.542 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 77.6 m80 72.61 143.96 0.07 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.805 0.69 . . . . 0.0 110.012 -174.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 43.8 m80 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 123.158 0.583 . . . . 0.0 111.981 178.439 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.47 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 93.4 m-20 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.21 0.529 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -91.02 64.31 5.34 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.944 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' CE2' ' HA ' ' A' ' 4' ' ' ASN . 29.0 m-85 -92.68 -136.57 0.17 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.473 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -144.54 19.27 1.69 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.469 ' HB3' HG13 ' A' ' 124' ' ' ILE . 50.9 tt0 53.67 38.83 29.26 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.012 0.91 . . . . 0.0 110.444 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 65.6 mt -92.3 162.28 30.48 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.75 -175.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.68 168.6 23.26 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.273 2.649 . . . . 0.0 110.963 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.69 79.12 6.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.114 0.483 . . . . 0.0 110.61 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.22 134.43 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.1 m -96.68 116.18 28.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.849 0.357 . . . . 0.0 110.157 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 98' ' ' ASP . 47.4 mt -113.35 176.28 5.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.799 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -109.41 127.24 54.23 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.288 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.434 HD21 ' HB3' ' A' ' 20' ' ' LYS . 47.8 p30 -89.71 -174.34 4.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.111 0.481 . . . . 0.0 111.706 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.487 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 39.5 pt -71.41 -14.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.403 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -93.84 -1.61 54.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.774 0.321 . . . . 0.0 111.184 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.46 24.07 68.93 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HB3' HD21 ' A' ' 16' ' ' ASN . 62.6 tttp -101.54 139.53 37.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -82.51 109.82 17.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.08 142.67 23.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.791 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.46 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 87.9 mt-30 -100.32 133.11 45.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.875 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.415 HG21 ' CE1' ' A' ' 103' ' ' PHE . 20.9 p -68.89 -32.31 71.86 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -70.05 -17.21 63.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.448 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HE3' ' H ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -117.98 8.68 12.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.96 105.83 11.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.331 0.586 . . . . 0.0 112.044 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 56.4 mt-10 -108.63 139.69 43.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.078 175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.821 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 15.1 t-20 -76.05 -75.66 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.004 0.43 . . . . 0.0 110.328 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.55 33.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.249 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 28.51 51.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 66.4 mmtt -123.0 148.97 55.67 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.123 -177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 19.3 Cg_exo -65.28 149.86 88.0 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.34 2.027 . . . . 0.0 110.634 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.821 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 67.2 mtm -133.66 145.65 50.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.462 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 92.5 mt -122.63 125.45 72.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.38 122.37 51.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.238 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -106.47 115.87 30.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 66.3 m-85 -94.21 118.24 31.28 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -146.36 167.03 24.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.574 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -100.01 146.56 26.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.578 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.446 HG22 ' OD2' ' A' ' 74' ' ' ASP . 7.0 t -72.99 -13.75 61.29 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.857 0.36 . . . . 0.0 111.4 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -94.52 2.75 55.69 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.978 0.418 . . . . 0.0 111.293 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 30.1 p -124.82 119.45 28.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.805 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 52.8 mtmt -104.2 -49.66 0.14 Allowed Pre-proline 0 CA--C 1.56 1.33 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' HD2' ' H ' ' A' ' 44' ' ' LYS . 55.5 Cg_endo -72.51 -8.96 23.47 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.248 1.966 . . . . 0.0 112.228 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 43' ' ' CYS . 61.3 m -78.88 -15.87 57.78 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.99 56.93 4.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.531 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 26.1 mmt85 -64.11 -39.93 95.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.443 0.639 . . . . 0.0 109.537 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 tm-20 -64.04 -55.21 23.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.545 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD11 ' CE2' ' A' ' 93' ' ' TYR . 43.4 tp -62.12 -41.22 98.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.618 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 58.7 tttm -62.21 -48.64 79.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -63.57 -39.72 95.13 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.245 0.545 . . . . 0.0 110.925 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 49' ' ' GLU . 58.9 mt -65.33 -42.73 94.43 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.466 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.21 -30.33 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.804 0.335 . . . . 0.0 110.301 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 77.9 mm-40 -59.2 -48.25 82.33 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.786 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -122.02 30.86 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.488 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' ILE . 88.9 t80 -59.12 -34.74 72.4 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.46 -39.69 88.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.607 0.241 . . . . 0.0 110.471 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.28 -42.33 93.28 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 110.87 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.507 ' O ' ' HB ' ' A' ' 64' ' ' THR . 12.0 m0 -65.57 -37.2 85.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.307 0.575 . . . . 0.0 110.468 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -84.37 -8.22 59.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -53.55 -64.24 0.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.61 -31.22 3.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 19.0 m -63.05 -41.83 99.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.065 0.459 . . . . 0.0 110.07 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.76 31.98 79.92 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.194 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.02 131.78 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.603 0.716 . . . . 0.0 111.438 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.532 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 9.1 mmm180 -102.58 141.42 35.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.386 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.611 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 50.0 mt -102.24 138.0 39.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.003 0.43 . . . . 0.0 110.295 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.533 HD11 ' SD ' ' A' ' 34' ' ' MET . 91.8 mt -115.06 113.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.44 113.61 25.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.738 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 14.4 p -121.59 132.13 71.47 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-O 121.466 0.651 . . . . 0.0 111.751 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -88.55 131.55 34.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.557 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 40' ' ' ALA . 46.8 pt -77.67 -16.93 14.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 124.357 1.036 . . . . 0.0 110.864 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.446 ' OD2' HG22 ' A' ' 41' ' ' THR . 29.2 m-20 -80.5 160.66 25.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.987 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.89 171.96 7.25 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.83 0.348 . . . . 0.0 110.982 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -56.5 -41.14 88.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.804 -0.634 . . . . 0.0 114.151 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -62.47 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.07 0.435 . . . . 0.0 111.59 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -72.75 -39.3 66.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.4 0.619 . . . . 0.0 110.925 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.53 -4.85 12.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.201 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 47.2 mt-30 -63.88 -9.51 15.58 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.013 -0.429 . . . . 0.0 110.39 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.697 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.8 mttm -96.2 -10.51 27.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -63.66 -47.1 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.683 0.754 . . . . 0.0 111.836 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 23.2 mtmt -70.69 -43.13 14.98 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.159 -175.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.5 Cg_endo -61.17 -30.54 88.92 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 121.012 1.141 . . . . 0.0 110.932 174.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -64.96 -41.27 95.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -60.62 -40.13 90.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.587 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -46.21 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.126 0.489 . . . . 0.0 111.006 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.26 93.67 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.998 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -87.36 -16.18 35.74 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.304 0.552 . . . . 0.0 112.053 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.31 40.42 6.93 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.725 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -89.04 104.36 16.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -99.1 73.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.353 0.597 . . . . 0.0 109.995 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.611 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -137.18 167.23 21.97 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 67' ' ' ARG . 2.2 mp0 -70.39 102.6 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 48.0 t -92.74 128.36 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.148 0.499 . . . . 0.0 110.465 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.447 HD13 HG23 ' A' ' 69' ' ' ILE . 10.7 mp -124.75 138.07 54.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.349 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.58 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.1 mp -108.02 117.61 34.58 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.567 ' HA ' HD22 ' A' ' 14' ' ' LEU . 63.5 t0 -78.46 115.62 18.29 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.712 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 p -82.6 -9.85 59.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -127.81 -21.76 3.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 84.4 19.5 60.3 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.918 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 11.9 m-20 -93.95 -21.57 19.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.249 0.525 . . . . 0.0 112.107 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 24' ' ' THR . 75.0 t80 -63.68 -43.3 97.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 110.542 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 63.1 pttt -63.06 -33.14 74.79 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.9 176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 102' ' ' ASP . 60.6 mtp85 -69.52 -39.59 77.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.168 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.01 83.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.248 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.3 mmt -88.04 -3.3 58.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.737 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.72 44.06 14.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.688 0.756 . . . . 0.0 110.615 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.62 96.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.426 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.9 m -88.4 -58.94 2.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.9 tp -112.37 127.09 55.91 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.951 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -87.52 156.84 53.32 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.488 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.5 Cg_endo -82.17 150.11 72.39 Favored 'Cis proline' 0 C--O 1.242 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.304 -0.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -111.19 134.36 52.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.07 127.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.397 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 72.0 m-85 -128.46 116.95 20.5 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.9 mt -105.52 130.02 57.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.092 0.472 . . . . 0.0 110.993 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 54.9 t -114.18 133.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.745 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -85.46 -172.27 4.05 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.968 0.414 . . . . 0.0 111.23 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.8 -22.53 68.4 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.706 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -85.08 2.07 45.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.785 0.326 . . . . 0.0 110.711 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.44 65.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.401 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 71.3 mmtt -115.73 153.97 30.41 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.469 HG13 ' HB3' ' A' ' 8' ' ' GLN . 80.8 mt -80.93 114.87 22.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.44 -19.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.403 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.626 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 67.0 t80 -144.33 136.99 26.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.716 0.293 . . . . 0.0 110.587 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.88 135.21 24.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -158.36 122.85 4.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 p -103.79 112.35 25.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.128 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.93 66.52 1.8 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.856 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.669 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 27.9 p90 -69.03 -40.02 78.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.256 0.55 . . . . 0.0 110.26 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 81.5 p 55.47 81.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.764 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 64.72 120.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.032 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.54 55.93 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.85 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.669 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.73 -37.58 6.41 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.644 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.9 pm0 -60.78 -17.51 49.64 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.235 0.614 . . . . 0.0 111.849 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.44 96.59 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.526 0.679 . . . . 0.0 109.739 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -73.41 -31.95 64.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.354 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -62.24 -47.89 82.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 tp -68.66 -37.31 77.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 110.072 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.772 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.532 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -65.21 -36.06 82.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.266 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 139' ' ' LEU . 66.7 t -60.66 -46.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.172 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.495 ' HA ' ' NE ' ' A' ' 144' ' ' ARG . 5.4 mmp_? -68.76 -36.19 78.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.573 0.701 . . . . 0.0 109.767 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 142' ' ' LYS . 34.6 tt0 -62.06 -27.27 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.19 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 94.4 mt -62.15 -37.91 87.0 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.21 -42.94 98.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.596 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -76.72 -10.38 59.34 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.555 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -66.48 -36.39 82.64 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -79.87 157.8 41.94 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 70.73 13.44 7.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.314 0.578 . . . . 0.0 110.449 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -62.54 100.47 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.384 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.1 t60 59.53 86.68 0.09 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.792 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 25.8 m80 69.28 174.13 0.29 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.894 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -116.09 153.05 32.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.389 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 57.5 t60 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.371 -178.273 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.85 0.357 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.551 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 23.8 m -86.56 85.34 7.3 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.208 0.528 . . . . 0.0 111.405 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -116.16 -120.08 0.31 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -151.42 13.48 0.66 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.445 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 8' ' ' GLN . 61.7 tt0 50.38 33.43 7.59 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.867 0.841 . . . . 0.0 110.98 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 74.7 mt -80.85 156.11 72.68 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.111 -176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.56 155.3 63.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.871 2.381 . . . . 0.0 110.798 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 80.04 1.28 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.125 0.488 . . . . 0.0 111.315 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.89 132.77 70.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.753 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.8 m -92.42 105.33 17.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.308 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 98' ' ' ASP . 71.2 mt -104.41 178.15 4.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.971 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HD2' ' C ' ' A' ' 19' ' ' GLY . 3.2 tppp? -108.54 135.91 49.02 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.105 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.69 -179.96 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.404 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 42.3 pt -68.32 -11.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -96.24 -4.66 41.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 111.098 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.484 ' C ' ' HD2' ' A' ' 15' ' ' LYS . . . 82.32 20.28 62.75 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.576 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.43 149.6 27.72 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 m -75.12 122.69 23.98 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.057 0.455 . . . . 0.0 110.875 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.09 135.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.645 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 94.4 mt-30 -95.62 133.99 39.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.466 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.6 p -67.41 -27.74 67.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -63.56 -33.74 76.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.204 0.526 . . . . 0.0 110.224 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -105.03 13.0 31.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.246 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.35 124.11 29.1 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.155 0.502 . . . . 0.0 112.105 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -146.74 173.81 12.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.258 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 32' ' ' LYS . 8.2 p30 -112.61 -56.71 2.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.082 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.35 39.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.377 0.671 . . . . 0.0 109.651 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.24 26.86 72.77 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.741 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 45.6 mmtm -117.19 152.84 49.53 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 122.239 0.216 . . . . 0.0 110.713 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.81 151.83 78.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.625 2.217 . . . . 0.0 111.398 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' HD11 ' A' ' 69' ' ' ILE . 56.7 mtm -136.32 154.53 50.83 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 84.0 mt -127.01 125.66 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.0 118.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.8 m -102.93 123.43 46.54 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.563 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -97.15 115.99 28.54 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.675 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -137.3 166.13 24.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.67 0.606 . . . . 0.0 111.212 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 73' ' ' ILE . . . -110.03 161.46 15.49 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.669 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.3 p -65.14 -32.79 74.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -94.79 63.92 2.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.541 0.686 . . . . 0.0 110.822 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.3 p -61.14 128.08 34.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.568 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.539 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 29.4 ttpp -117.26 -39.05 0.06 OUTLIER Pre-proline 0 CA--C 1.56 1.331 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.539 ' CD ' ' H ' ' A' ' 44' ' ' LYS . 94.5 Cg_endo -85.19 21.02 1.15 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.584 1.522 . . . . 0.0 112.578 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 56.0 m 61.69 15.97 7.39 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.171 0.588 . . . . 0.0 111.277 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt 47.26 72.38 0.25 Allowed 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.45 -47.25 84.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.013 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.587 ' O ' HG13 ' A' ' 53' ' ' ILE . 15.5 pt-20 -58.43 -56.51 21.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 111.237 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.567 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 34.6 tp -65.73 -42.85 90.53 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.975 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 22.0 tptm -65.08 -47.47 77.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.02 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.02 -41.47 99.56 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 120.822 0.344 . . . . 0.0 110.976 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.0 mt -65.55 -42.53 93.26 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.719 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.9 -40.06 66.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 110.654 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 47.0 mm-40 -62.45 -46.43 88.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.29 26.86 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.615 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.3 t80 -59.79 -39.44 84.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.276 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.494 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.81 -42.51 81.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.3 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -67.21 -40.51 86.45 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 32.0 mm-40 -73.6 -15.8 61.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.12 -45.73 93.48 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.799 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.14 -68.23 0.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.304 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -62.83 -31.32 72.3 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.722 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 63.17 45.37 95.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.147 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.79 131.68 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.413 0.625 . . . . 0.0 112.295 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.506 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 13.3 mmm180 -96.57 159.02 15.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.948 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.491 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 76.0 mt -121.01 129.41 53.38 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.891 0.377 . . . . 0.0 111.285 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.52 HD11 ' SD ' ' A' ' 34' ' ' MET . 89.8 mt -109.32 108.64 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.81 107.43 19.21 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.01 131.47 56.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 CA-C-O 121.913 0.863 . . . . 0.0 112.396 -175.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.648 ' HB3' HG21 ' A' ' 82' ' ' VAL . 26.1 p -84.16 127.89 34.21 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.465 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 46.4 pt -83.46 -15.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.346 1.029 . . . . 0.0 111.001 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -85.28 152.09 23.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.014 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.16 171.36 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.19 -49.41 63.54 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.76 -41.86 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.748 0.774 . . . . 0.0 111.178 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -67.74 -38.27 83.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -72.56 -4.97 33.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.321 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -62.73 -9.51 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.961 -0.462 . . . . 0.0 110.948 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.704 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 98.9 mttt -92.68 -11.26 34.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.523 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.648 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.3 t -65.3 -49.28 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.631 0.729 . . . . 0.0 112.356 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 14.1 mtpp -71.04 -38.9 7.61 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.02 -28.41 80.43 Favored 'Trans proline' 0 C--N 1.364 1.37 0 CA-C-N 120.051 1.054 . . . . 0.0 110.666 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.08 -45.92 91.4 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.473 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -60.43 -36.94 79.37 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.787 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.03 -32.25 73.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.159 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.77 -44.58 5.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.772 -0.727 . . . . 0.0 113.902 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 17.9 p30 -82.29 -15.77 51.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.27 58.44 3.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.456 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -78.05 112.79 15.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.99 35.79 1.51 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.714 0.769 . . . . 0.0 110.754 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.531 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -141.21 -171.33 3.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.478 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.39 137.36 32.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.628 0.728 . . . . 0.0 112.689 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.489 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 19.4 t -106.71 140.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.965 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.1 131.56 54.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -111.98 95.06 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.612 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.437 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.3 t0 -77.49 116.07 17.76 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.085 174.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.3 p -89.82 -14.35 34.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -104.07 -39.19 6.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.97 0.414 . . . . 0.0 110.983 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.64 43.09 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -89.76 -29.59 18.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.0 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.466 ' CE1' HG21 ' A' ' 24' ' ' THR . 86.0 t80 -60.58 -43.34 97.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.517 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 21.8 pttp -62.44 -38.2 88.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.709 0.29 . . . . 0.0 111.279 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -66.01 -42.63 89.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.37 80.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.897 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 2.1 mmt -84.9 -5.06 59.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.264 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 107' ' ' MET . 93.0 m-20 71.43 35.47 1.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.297 0.373 . . . . 0.0 111.803 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 104' ' ' LYS . 92.4 t -83.07 108.61 15.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 120.931 0.396 . . . . 0.0 110.906 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.9 m -100.66 -64.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 tp -95.46 126.25 40.63 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -94.31 147.73 33.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.68 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.0 Cg_endo -82.75 167.05 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.117 -1.201 . . . . 0.0 112.971 1.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -131.73 141.94 49.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.45 127.34 73.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 O-C-N 123.344 0.402 . . . . 0.0 111.507 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -126.17 118.45 25.24 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.639 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 67.8 mt -106.96 131.72 56.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.201 0.524 . . . . 0.0 110.763 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.4 131.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -74.82 -179.54 4.26 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.009 0.818 . . . . 0.0 112.557 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.2 -30.83 78.8 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.749 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' THR . 3.3 t-20 -67.25 -41.07 86.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.169 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 121.5 21.23 3.06 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.7 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -113.56 163.45 14.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.02 109.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.0 -40.22 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.27 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 70.1 t80 -128.29 122.49 31.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.809 0.338 . . . . 0.0 110.62 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.5 120.91 29.36 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.116 0.484 . . . . 0.0 110.82 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -136.79 105.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.8 p -97.34 123.96 41.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 92.71 49.29 2.76 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.509 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.68 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 1.0 OUTLIER -90.11 135.82 33.43 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 173.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.6 p -123.67 69.0 1.03 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.501 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 69.85 119.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.176 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.04 8.8 35.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.67 -18.1 46.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.77 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -59.73 -19.84 52.61 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.78 95.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.39 0.614 . . . . 0.0 109.907 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.34 -32.94 69.14 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.678 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -62.02 -51.35 68.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -36.87 74.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.624 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.3 ttpp -60.03 -48.17 82.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.049 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 55.0 tptt -66.16 -30.27 70.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.213 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 139' ' ' LEU . 70.2 t -58.88 -44.64 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.478 ' HA ' ' NE ' ' A' ' 144' ' ' ARG . 4.6 mmp_? -68.32 -37.86 80.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.347 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.5 mm-40 -59.73 -36.29 76.28 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.722 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 83.1 mt -59.74 -42.35 92.96 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.024 0.44 . . . . 0.0 110.27 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.99 -46.21 92.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.184 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -69.33 -47.84 63.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.049 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -72.0 -37.42 69.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.904 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 107.77 -57.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.696 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -126.8 -76.26 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.621 0.248 . . . . 0.0 111.606 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -120.97 -46.47 2.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.964 0.411 . . . . 0.0 110.789 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -147.05 -34.44 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.418 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -119.12 167.38 11.86 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -61.14 -34.94 75.8 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.778 177.138 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.417 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 m -146.25 65.92 1.2 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.36 0.6 . . . . 0.0 110.536 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' O ' HG11 ' A' ' 118' ' ' VAL . 21.0 m-85 -97.37 -134.23 0.23 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.832 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -145.24 21.14 1.56 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.792 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 51.0 tt0 50.28 38.14 16.83 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.878 0.847 . . . . 0.0 109.504 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.832 HD22 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -103.9 147.93 35.05 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.175 -174.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.647 ' HD2' ' SD ' ' A' ' 107' ' ' MET . 48.1 Cg_exo -55.14 146.7 58.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.647 2.898 . . . . 0.0 112.474 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 25' ' ' ASN . . . -72.44 90.45 1.31 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.755 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.4 132.7 68.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 p -77.5 100.22 5.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.187 0.517 . . . . 0.0 109.964 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.434 HD23 HD23 ' A' ' 96' ' ' LEU . 4.7 tp -106.33 177.23 4.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.177 -176.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' CE ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -118.76 137.75 53.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.02 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -98.9 -178.8 4.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.041 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 95' ' ' VAL . 33.2 pt -67.05 -19.55 25.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.674 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.42 -10.81 59.44 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.326 0.584 . . . . 0.0 110.236 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.43 17.45 75.95 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 88.3 tttt -95.71 137.12 35.22 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.235 -0.483 . . . . 0.0 109.9 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 99.7 m -74.6 100.69 3.99 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.6 p -117.17 132.3 67.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.294 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.506 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 48.3 mt-30 -82.62 136.7 34.72 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.146 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.586 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 20.1 p -64.15 -36.24 83.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.43 -176.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 11' ' ' ALA . 64.1 t30 -69.43 -16.95 63.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.354 . . . . 0.0 111.575 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.506 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -110.08 6.74 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.08 113.56 22.94 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.68 154.94 41.65 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.73 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 25.6 t30 -87.53 -68.19 0.77 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 174.45 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.581 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.417 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 150.08 -13.58 0.97 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.507 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.2 mptm? -91.4 147.96 36.53 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.753 -0.224 . . . . 0.0 110.61 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.584 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 17.9 Cg_exo -65.06 156.6 61.81 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.199 2.599 . . . . 0.0 112.832 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.73 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 70.6 mtm -138.67 159.75 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.74 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.441 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 81.4 mt -129.65 128.63 65.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.6 mt -99.81 122.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.9 m -115.84 122.82 46.52 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.02 0.438 . . . . 0.0 110.602 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 56.3 m-85 -88.71 117.14 27.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.467 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 22.0 p90 -134.91 167.9 20.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 123.439 0.462 . . . . 0.0 110.681 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.619 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -110.5 149.01 30.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -32.38 73.74 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.933 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -99.5 10.46 41.33 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 86.8 m -104.85 137.78 42.11 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.532 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.617 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 66.9 mttm -130.62 -57.3 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.754 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 8.4 Cg_exo -68.65 -25.53 34.14 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.137 1.892 . . . . 0.0 111.304 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 m -66.08 -23.67 66.56 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.743 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt -87.18 61.54 6.78 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.923 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . 12.0 mmm180 -60.21 -43.51 95.89 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.681 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 74.0 tt0 -52.63 -64.37 0.84 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.663 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.524 HD11 ' CE2' ' A' ' 93' ' ' TYR . 34.2 tp -62.85 -41.54 99.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.272 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.05 -47.68 83.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.054 0.221 . . . . 0.0 111.281 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.42 87.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.682 0.277 . . . . 0.0 111.042 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.9 mt -65.26 -41.01 90.46 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.83 -30.3 32.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.056 0.455 . . . . 0.0 111.016 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -82.67 -37.61 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.978 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.24 23.99 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -62.65 -35.09 78.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.764 0.316 . . . . 0.0 111.115 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.35 88.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.27 -43.87 96.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.436 ' NE1' HD13 ' A' ' 140' ' ' ILE . 13.8 m0 -68.7 -31.65 70.9 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.701 0.762 . . . . 0.0 110.136 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -81.36 -6.6 59.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.575 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.68 -51.76 46.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.09 -34.23 0.55 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.422 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 15.3 m -60.57 -42.58 96.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.87 74.0 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.839 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 11.2 p -75.62 127.43 37.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.112 0.482 . . . . 0.0 111.07 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -106.39 163.58 12.73 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 53' ' ' ILE . 61.2 mt -109.05 129.7 55.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.09 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.507 HG23 HD13 ' A' ' 96' ' ' LEU . 97.3 mt -101.25 107.01 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -93.89 113.81 25.91 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.307 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.4 129.49 67.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 121.379 0.609 . . . . 0.0 111.418 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 97' ' ' LEU . 39.4 p -83.94 130.47 34.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.311 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.0 pt -72.2 -23.75 21.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.35 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -82.54 147.11 28.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 89.7 mt-10 -61.48 163.53 6.74 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.491 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.13 -39.48 57.92 Favored Glycine 0 C--O 1.23 -0.124 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -174.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -63.87 -38.94 92.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 117.386 0.593 . . . . 0.0 111.114 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -79.89 -37.24 35.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.306 0.574 . . . . 0.0 110.096 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -65.53 -3.9 5.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.793 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.12 -11.21 8.03 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.016 -0.427 . . . . 0.0 110.54 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.731 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.0 mttp -96.55 -10.91 26.21 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.387 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 79' ' ' ALA . 14.6 t -66.53 -47.12 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-O 121.668 0.747 . . . . 0.0 111.627 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 17' ' ' ILE . 41.7 mtpt -64.13 -45.06 79.23 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.054 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.8 Cg_endo -62.08 -29.82 81.78 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.115 1.21 . . . . 0.0 111.19 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -63.09 -41.46 99.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.29 86.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.167 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.27 -46.56 66.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.355 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.5 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.123 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -91.37 -11.14 38.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.912 0.356 . . . . 0.0 111.706 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.28 38.83 28.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -82.19 111.8 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 0.0 110.5 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -97.07 60.38 1.7 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.084 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.524 ' CE2' HD11 ' A' ' 50' ' ' LEU . 6.0 m-85 -138.18 -177.79 4.99 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.961 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.98 117.75 31.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.657 ' O ' HG23 ' A' ' 17' ' ' ILE . 12.4 t -99.27 139.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.24 -174.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.507 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -125.92 142.89 51.31 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.795 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.613 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.7 mp -113.74 121.56 44.45 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 59.8 t0 -74.04 115.14 13.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 118.176 -1.41 . . . . 0.0 107.96 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 p -96.02 -6.0 39.81 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.962 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -117.65 -39.39 3.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.764 0.316 . . . . 0.0 111.647 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -8.51 68.58 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.16 -30.66 66.73 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.868 -0.666 . . . . 0.0 111.388 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' O ' ' HG2' ' A' ' 107' ' ' MET . 44.7 t80 -61.43 -43.44 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.817 -176.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.28 -42.18 94.91 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 110.265 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -69.56 -42.31 74.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.53 94.78 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.138 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.647 ' SD ' ' HD2' ' A' ' 10' ' ' PRO . 39.2 mmm -84.49 -24.12 29.56 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.204 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.425 ' O ' HG21 ' A' ' 129' ' ' THR . 55.5 t30 75.23 100.89 0.07 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.778 0.831 . . . . 0.0 111.041 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.04 132.78 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -84.52 -96.01 0.06 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.4 pt? -119.47 3.34 11.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.16 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.2 pt 61.29 151.06 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 124.828 1.251 . . . . 0.0 111.888 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.3 Cg_endo -76.58 157.89 97.48 Favored 'Cis proline' 0 N--CA 1.479 0.633 0 C-N-CA 124.19 -1.171 . . . . 0.0 112.303 -1.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -114.78 136.21 53.33 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.2 t -116.67 127.27 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.767 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 77.9 m-85 -124.93 113.0 17.27 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.0 mt -100.68 124.75 54.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-O 121.027 0.441 . . . . 0.0 110.049 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.476 HG21 ' HB1' ' A' ' 7' ' ' ALA . 54.1 t -116.87 132.88 65.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.774 -175.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.97 164.58 24.28 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.649 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.1 -20.64 50.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.612 -0.267 . . . . 0.0 112.984 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -73.57 -5.65 41.61 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.279 0.561 . . . . 0.0 110.196 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.15 19.73 64.26 Favored Glycine 0 CA--C 1.5 -0.863 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.763 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 74.6 mmtt -116.87 151.1 37.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.3 mt -77.95 127.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.406 HG11 HD21 ' A' ' 146' ' ' LEU . 10.9 p -104.92 -28.61 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.809 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.7 t80 -141.56 133.19 27.03 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.793 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -137.12 123.78 21.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -151.02 111.79 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.987 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 108' ' ' ASN . 19.6 p -93.51 111.63 23.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 83.57 68.11 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.986 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.608 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.7 p90 -68.86 -39.66 79.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 64.2 p 53.31 80.67 0.1 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.296 1.038 . . . . 0.0 113.581 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.96 108.51 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.1 0.96 . . . . 0.0 112.776 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.97 -2.77 27.16 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.608 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -72.2 -41.81 52.34 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.1 -0.55 . . . . 0.0 112.783 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 48' ' ' ARG . 1.7 pm0 -53.59 -24.17 13.04 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.61 88.01 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.513 0.673 . . . . 0.0 110.674 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 44.5 mt-10 -73.4 -32.3 64.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.841 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.78 -47.94 81.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.439 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.436 HD13 ' NE1' ' A' ' 60' ' ' TRP . 8.8 tp -66.57 -33.49 63.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 110.278 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.67 -51.59 69.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.779 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 31.1 mmmt -68.47 -34.42 75.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.196 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.4 t -59.97 -45.37 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.045 0.45 . . . . 0.0 110.778 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -72.83 -29.33 63.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.466 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -64.99 -30.02 70.98 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.586 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 95.6 mt -60.84 -39.98 91.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.319 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.5 t -60.62 -46.9 94.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.658 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -67.18 -34.64 77.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.227 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.4 -37.75 87.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.29 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.43 -49.38 65.62 Favored Glycine 0 C--N 1.328 0.117 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.265 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 155' ' ' HIS . 58.3 m-70 -130.08 99.13 4.96 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.937 0.398 . . . . 0.0 110.464 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -70.23 -41.05 74.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.412 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -97.0 91.4 5.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.01 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 63.5 111.02 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.995 0.809 . . . . 0.0 111.431 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 151' ' ' HIS . 38.5 t60 -58.91 -48.99 79.49 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.198 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.6 p80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.356 179.056 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.1 m -146.12 73.36 1.33 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.531 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 72.7 m-85 -101.54 -133.78 0.29 Allowed 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.551 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -149.45 9.25 0.72 Allowed 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.991 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 47.42 67.69 0.77 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.684 0.754 . . . . 0.0 110.824 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 24' ' ' THR . 32.4 mt -118.84 161.5 35.84 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.852 -175.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.12 160.05 46.59 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.706 2.271 . . . . 0.0 111.169 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.6 81.25 2.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.208 0.528 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.34 136.47 59.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.824 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -98.07 116.2 29.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.454 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD22 ' HA ' ' A' ' 98' ' ' ASP . 56.3 mt -123.77 177.19 5.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.928 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 30.2 mmtp -107.18 140.57 39.84 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.769 0.318 . . . . 0.0 110.798 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -91.31 -173.47 3.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.45 -13.78 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -90.03 -10.98 42.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.98 19.82 66.59 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.8 149.06 21.53 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.7 m -79.35 110.02 14.24 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.272 0.558 . . . . 0.0 110.187 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 137.07 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.051 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -95.78 133.68 39.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.487 HG21 ' CE1' ' A' ' 103' ' ' PHE . 23.6 p -65.86 -32.41 73.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.287 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.6 -31.73 73.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.951 0.405 . . . . 0.0 110.778 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.575 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -103.02 8.78 38.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.343 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 36.3 tp -65.91 121.71 15.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.27 156.92 46.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.22 0.533 . . . . 0.0 112.002 -174.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.607 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 45.2 t-20 -99.5 -83.23 0.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.583 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 170.02 25.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.92 0.762 . . . . 0.0 110.775 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.47 -2.37 39.75 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.233 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -110.08 150.23 41.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.408 0.146 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -68.53 159.88 51.64 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 123.218 2.612 . . . . 0.0 112.782 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 72.5 mtm -139.83 153.11 46.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.106 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 91.1 mt -128.33 127.71 67.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.57 124.56 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -113.04 122.75 48.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.698 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 57.9 m-85 -93.85 122.41 36.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 25.4 p90 -140.38 165.16 28.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 123.502 0.501 . . . . 0.0 111.542 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.88 151.37 24.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.897 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.45 ' CG2' HG22 ' A' ' 82' ' ' VAL . 9.6 p -78.83 30.67 0.2 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -158.37 -33.96 0.07 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.027 0.442 . . . . 0.0 111.086 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 34.2 m -77.92 66.21 3.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.478 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.439 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 39.6 ttpt -62.72 -50.31 78.51 Favored Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 44' ' ' LYS . 37.8 Cg_endo -67.21 -17.18 50.04 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.12 1.88 . . . . 0.0 112.045 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 59.9 m -78.27 -14.64 59.34 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.876 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.55 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 15.0 mt -81.17 57.66 3.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.953 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -58.59 -42.35 87.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.551 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.554 ' CD ' HG22 ' A' ' 115' ' ' VAL . 75.2 tt0 -55.08 -64.69 0.76 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.959 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' A' ' 93' ' ' TYR . 44.0 tp -61.85 -41.15 97.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.6 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.42 -47.84 83.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.98 -42.48 76.48 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.999 0.428 . . . . 0.0 111.304 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.3 mt -64.38 -41.66 93.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.164 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -52.63 -42.0 64.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.711 0.291 . . . . 0.0 110.926 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.59 -42.26 91.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.17 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.8 m -105.24 15.65 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.25 -38.44 83.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.38 85.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.834 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.16 -36.24 71.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.837 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -69.15 -38.35 78.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.505 0.669 . . . . 0.0 109.553 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -76.59 -11.13 59.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.151 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.341 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -134.96 -45.51 0.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.802 0.334 . . . . 0.0 110.549 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.13 23.59 77.1 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.83 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -78.83 129.2 37.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.0 0.429 . . . . 0.0 111.379 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.8 mtm-85 -104.77 165.71 10.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.47 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 73.9 mt -109.84 140.02 44.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -113.8 106.47 20.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -94.28 112.19 23.98 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.28 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.3 p -110.72 132.03 60.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 CA-C-O 121.636 0.731 . . . . 0.0 112.229 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.519 ' HB3' HG21 ' A' ' 82' ' ' VAL . 20.8 p -81.29 141.39 34.12 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.871 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.9 pt -95.73 -6.91 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.463 1.102 . . . . 0.0 111.09 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 13.9 p-10 -93.88 152.35 18.93 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -63.13 174.04 1.27 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.45 88.91 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -172.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -46.59 81.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.549 0.674 . . . . 0.0 111.012 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -69.62 -41.77 75.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.76 -6.59 33.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.238 -176.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -64.36 -14.95 59.32 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.346 0.593 . . . . 0.0 109.941 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.747 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.9 mttp -94.16 -6.23 45.32 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.873 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 79' ' ' ALA . 51.2 t -63.96 -48.37 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.569 0.7 . . . . 0.0 111.747 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 19.4 mtpp -68.17 -42.32 29.97 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.221 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.5 Cg_endo -62.33 -28.99 79.17 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 120.902 1.068 . . . . 0.0 110.783 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.5 mt -64.16 -41.69 97.04 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.428 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -58.49 -45.39 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.677 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.93 -40.68 91.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.301 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.06 88.56 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.821 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -89.42 -14.42 35.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.993 0.396 . . . . 0.0 112.011 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.96 12.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.431 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.428 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 39.3 m0 -79.02 96.44 5.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.268 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.74 68.67 10.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 111.93 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.57 ' CE2' HD11 ' A' ' 50' ' ' LEU . 4.5 m-85 -144.03 177.04 8.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.98 113.48 25.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.81 0.814 . . . . 0.0 109.43 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.71 137.3 21.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.005 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 12.1 tp -115.63 131.18 57.01 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 15' ' ' LYS . 6.9 tp -105.71 100.87 10.42 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.301 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.675 ' HA ' HD22 ' A' ' 14' ' ' LEU . 66.3 t0 -77.89 115.22 17.47 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 118.13 -1.428 . . . . 0.0 108.304 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.2 p -108.73 -6.04 16.08 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.934 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.409 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 60.4 m-20 -93.71 -41.27 9.78 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.419 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.59 8.49 76.98 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.183 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HB2' ' A' ' 100' ' ' ASN . 9.6 p-10 -99.43 -22.31 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.199 . . . . 0.0 111.302 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.487 ' CE1' HG21 ' A' ' 24' ' ' THR . 71.4 t80 -62.67 -44.46 96.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.45 -32.76 74.53 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.326 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -68.96 -41.55 77.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.098 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.35 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.8 mmt -83.72 -9.4 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.431 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.9 t30 61.18 47.03 7.47 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.424 0.63 . . . . 0.0 110.654 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.62 96.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -81.36 -55.34 4.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.537 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.03 147.79 45.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 pt -103.43 154.49 37.76 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.1 Cg_endo -77.71 153.45 93.9 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 124.101 -1.208 . . . . 0.0 112.598 0.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -112.36 123.98 51.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.554 HG22 ' CD ' ' A' ' 49' ' ' GLU . 17.9 t -108.4 130.04 61.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.08 0.467 . . . . 0.0 112.133 -173.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 96.5 m-85 -131.71 112.96 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.616 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.3 mt -99.91 130.29 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.864 0.364 . . . . 0.0 110.395 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 53.5 t -113.46 133.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.779 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -85.29 -175.91 5.91 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.314 0.384 . . . . 0.0 111.269 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.29 -31.07 77.93 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.993 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -73.5 -6.0 43.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.326 0.584 . . . . 0.0 110.501 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 78.63 35.04 33.39 Favored Glycine 0 N--CA 1.433 -1.546 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.764 178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 47.0 mmtm -126.36 156.33 40.66 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.0 mt -76.54 113.48 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.262 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.81 -28.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.913 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.508 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 86.7 t80 -139.23 127.55 22.76 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.507 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -132.06 125.48 31.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -144.87 106.06 4.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.64 108.1 18.93 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.035 -177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 77.3 1.26 Allowed Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.52 -0.764 . . . . 0.0 114.657 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.622 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -104.53 143.54 32.91 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.002 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 73.9 p -104.68 -49.5 3.51 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.063 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.64 147.41 25.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.689 0.281 . . . . 0.0 111.384 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.89 28.41 73.08 Favored Glycine 0 N--CA 1.453 -0.231 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.105 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.3 -33.1 7.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.242 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -56.01 -20.64 17.48 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.466 0.706 . . . . 0.0 112.439 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.76 93.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.39 0.614 . . . . 0.0 110.215 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -70.51 -37.35 74.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.373 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.6 mp -61.43 -48.21 82.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.208 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -32.0 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.03 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.7 ttmt -61.06 -50.21 74.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 45.1 mttp -68.69 -29.86 68.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 139' ' ' LEU . 54.5 t -59.31 -45.31 93.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.109 0.48 . . . . 0.0 109.898 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -68.38 -34.35 75.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.404 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 62.7 mm-40 -56.41 -40.88 75.43 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.146 0.498 . . . . 0.0 110.322 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 49.7 mt -64.51 -40.95 96.6 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.593 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.21 -23.42 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.587 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -60.51 -23.29 64.43 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -95.79 -6.17 40.17 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 120.948 0.404 . . . . 0.0 111.828 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.16 -166.58 44.44 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.156 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -95.07 -0.77 53.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.865 0.364 . . . . 0.0 111.544 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -129.42 -94.7 0.41 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.265 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -157.13 129.84 7.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.0 t60 57.7 25.0 11.26 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.102 0.477 . . . . 0.0 109.774 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 33.4 p80 48.85 22.4 0.55 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.466 1.106 . . . . 0.0 112.601 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.633 -0.699 . . . . 0.0 110.004 -179.301 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 43.4 m -153.33 67.06 0.77 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.803 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -88.71 -124.03 0.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.067 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -151.43 16.75 0.72 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.844 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' ' 123' ' ' LYS . 45.2 tt0 50.93 41.49 27.07 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.802 0.81 . . . . 0.0 110.418 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 65.7 mt -87.74 155.74 53.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.71 156.85 55.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.302 2.668 . . . . 0.0 110.875 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.69 84.59 3.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.008 0.432 . . . . 0.0 111.671 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.18 138.84 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 p -90.83 113.62 25.82 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.353 0.597 . . . . 0.0 111.776 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 6.1 mp -107.41 167.22 10.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.196 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -112.45 125.87 54.7 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -87.54 -169.15 2.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.87 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG22 ' HZ2' ' A' ' 83' ' ' LYS . 26.4 pt -75.48 -12.76 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.537 -176.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.26 -11.74 45.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.067 0.461 . . . . 0.0 110.732 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 14.34 72.27 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -92.43 141.57 28.38 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.103 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -77.58 117.7 19.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.774 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.0 162.32 16.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.286 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.572 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 49.0 mt-30 -119.77 132.33 55.59 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.419 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.8 p -67.37 -32.25 73.04 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.26 -36.91 85.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 111.021 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -103.46 12.5 35.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.597 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.83 123.15 30.13 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.232 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 5' ' ' THR . 8.1 pt-20 -148.03 162.61 39.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.656 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' H ' ' HE2' ' A' ' 34' ' ' MET . 8.5 t30 -85.74 -71.93 0.51 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.113 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.64 47.23 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.183 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 5' ' ' THR . . . 80.08 26.86 54.56 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.903 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -122.94 151.66 61.54 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 122.22 0.208 . . . . 0.0 111.018 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.34 155.01 60.98 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.929 2.419 . . . . 0.0 111.403 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.533 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 20.5 mtt -139.99 165.45 27.31 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -171.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.645 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.5 mt -138.03 125.22 28.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 84.3 mt -101.83 131.2 50.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.961 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 m -118.93 122.63 42.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 111.234 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 54.4 m-85 -94.45 125.82 39.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.249 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' ' 82' ' ' VAL . 32.0 p90 -137.87 169.82 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 123.722 0.639 . . . . 0.0 111.086 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.77 -169.24 1.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.774 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -41.88 79.05 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -148.65 101.2 3.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.418 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 46' ' ' CYS . 47.9 t -152.26 153.39 33.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.855 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 51.4 mtmt -132.45 -62.78 0.02 OUTLIER Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.524 ' HD2' ' H ' ' A' ' 44' ' ' LYS . 56.3 Cg_endo -70.27 -22.24 30.0 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.474 2.116 . . . . 0.0 114.157 -174.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 64.8 m -72.5 -21.46 61.2 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.6 68.78 9.95 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -61.5 -45.67 93.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.659 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.29 -44.94 50.68 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.6 -41.99 98.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.256 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.82 -47.0 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.743 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.42 72.17 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.985 0.422 . . . . 0.0 111.368 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.3 mt -63.82 -30.92 51.21 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.1 -38.53 79.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.485 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -73.89 -39.72 63.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.781 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -107.03 17.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 89.3 t80 -59.75 -37.83 80.08 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 122.433 0.293 . . . . 0.0 111.701 -177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.07 81.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.757 0.313 . . . . 0.0 110.825 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.09 -41.91 90.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.924 0.392 . . . . 0.0 111.41 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -68.83 -34.91 76.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.521 0.677 . . . . 0.0 110.748 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 66' ' ' VAL . 6.2 mm-40 -85.15 -7.1 59.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.24 -60.62 3.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.87 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.23 -32.68 1.56 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.19 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -61.78 -41.51 97.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.38 32.09 29.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.165 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 7.5 t -67.94 122.55 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.204 0.526 . . . . 0.0 111.936 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -110.14 129.85 55.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.645 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 39.8 mt -97.53 142.96 28.72 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.466 HG23 HD13 ' A' ' 96' ' ' LEU . 91.4 mt -123.75 116.88 49.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.8 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.63 29.23 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.5 p -123.14 127.45 74.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.43 0.633 . . . . 0.0 111.145 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -90.14 148.76 22.78 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.703 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.3 pt -71.29 -17.69 19.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.804 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.26 164.77 16.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.973 0.416 . . . . 0.0 111.757 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.792 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 3.4 pt-20 -92.65 -88.75 0.21 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -119.92 -68.86 0.3 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.14 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -41.41 -65.36 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 112.168 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.37 -41.71 89.06 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.002 0.43 . . . . 0.0 112.144 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -71.38 -2.35 16.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 98.2 mt-30 -57.36 -21.62 36.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.932 0.396 . . . . 0.0 111.068 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.731 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.2 mttp -83.55 -12.82 55.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.853 0.461 . . . . 0.0 111.417 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 58.4 t -64.69 -48.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.52 0.676 . . . . 0.0 112.504 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.7 OUTLIER -69.02 -39.77 14.14 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 6.6 Cg_endo -59.77 -32.07 94.99 Favored 'Trans proline' 0 C--N 1.357 1.025 0 CA-C-N 120.074 1.062 . . . . 0.0 110.002 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 92.5 mt -63.73 -41.78 97.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.439 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -55.48 -45.49 76.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.343 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.68 -46.47 46.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.244 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.75 -45.23 96.19 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.255 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.09 -30.66 58.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.681 0.277 . . . . 0.0 111.404 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.42 46.84 3.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.06 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.5 m0 -80.99 117.58 21.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -96.13 27.13 3.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.724 0.773 . . . . 0.0 109.863 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.628 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -117.78 -179.97 3.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.855 -177.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -84.77 128.79 34.78 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.024 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.485 ' C ' HD12 ' A' ' 96' ' ' LEU . 24.3 t -106.98 128.24 61.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 95' ' ' VAL . 9.6 mp -130.47 148.52 52.29 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.259 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.561 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.3 mp -118.06 124.97 49.39 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.792 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 65.8 t0 -67.65 113.42 5.43 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 118.981 -1.087 . . . . 0.0 108.258 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 t -89.81 -6.39 55.96 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.861 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -104.94 -27.0 11.95 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 120.955 0.407 . . . . 0.0 110.34 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.51 21.4 79.55 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -113.66 -20.62 11.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.637 -0.281 . . . . 0.0 111.286 -176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 24' ' ' THR . 45.3 t80 -62.91 -39.75 95.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 105' ' ' ARG . 18.9 ptpt -52.16 -47.04 65.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.252 173.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.49 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 50.0 mtm-85 -71.89 -40.25 69.03 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.076 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.75 -42.16 88.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.495 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 33.3 mmm -92.64 -10.72 36.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.445 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 62.11 88.24 0.09 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.761 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 112' ' ' ILE . 66.7 t -92.88 129.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.251 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -79.28 -95.72 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.648 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.5 pt? -116.14 6.09 13.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.405 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.6 pt 61.1 152.24 0.1 Allowed Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 124.579 1.151 . . . . 0.0 111.06 -175.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 87.0 Cg_endo -75.58 160.44 96.05 Favored 'Cis proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.794 -0.919 . . . . 0.0 112.973 0.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.709 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.7 131.74 54.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.534 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.73 129.38 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 80.8 m-85 -127.71 115.25 18.43 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 68.3 mt -100.52 132.74 45.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 CA-C-O 121.271 0.558 . . . . 0.0 110.468 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.533 ' HB ' ' H ' ' A' ' 34' ' ' MET . 57.1 t -106.43 126.85 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.86 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.483 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 7.9 t70 -70.7 162.18 29.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.479 1.112 . . . . 0.0 110.56 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.61 35.39 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.471 -0.331 . . . . 0.0 113.807 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -86.76 7.01 28.65 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 111.181 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 73.22 40.86 48.6 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.42 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HD2' ' OE1' ' A' ' 8' ' ' GLN . 49.4 mmtm -134.56 152.77 52.01 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.7 mt -70.03 127.07 31.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.899 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.4 p -118.9 -17.34 7.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.659 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.626 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 74.9 t80 -150.11 128.51 12.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.591 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -126.88 120.88 30.28 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.343 0.592 . . . . 0.0 110.654 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.53 101.37 7.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.5 p -98.29 106.47 18.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.341 0.591 . . . . 0.0 112.238 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.2 64.8 2.32 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.542 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.419 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 1.2 p90 -96.31 154.99 16.95 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p -142.77 89.99 2.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.253 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 69.04 131.67 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.83 2.48 75.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.784 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.3 29.41 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.513 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.4 mp0 -58.76 -38.49 78.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.412 0.625 . . . . 0.0 109.835 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.08 87.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.85 -38.53 83.28 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.637 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -63.04 -50.39 70.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.373 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 tp -66.92 -38.48 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.144 0.497 . . . . 0.0 110.928 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -60.89 -45.73 93.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.904 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 18.6 tptm -66.14 -30.81 71.36 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.526 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 139' ' ' LEU . 95.4 t -64.75 -41.95 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -73.85 -24.29 59.74 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -61.44 -39.23 90.05 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.63 -41.11 97.04 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.49 -44.67 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.308 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -64.95 -35.97 82.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.473 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -63.68 -38.95 93.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -95.64 92.97 1.51 Allowed Glycine 0 C--O 1.236 0.273 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.427 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -116.44 -34.53 4.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.927 0.394 . . . . 0.0 111.57 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -111.17 141.32 44.83 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.818 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 63.0 -85.66 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.288 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -133.64 -60.87 0.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.86 0.362 . . . . 0.0 110.387 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -134.12 21.48 3.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.25 0.547 . . . . 0.0 109.718 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.018 -178.438 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 p30 . . . . . 0 CA--C 1.515 -0.384 0 CA-C-O 121.363 0.602 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.418 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 14.7 m -94.49 68.47 3.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.697 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 91.5 m-85 -74.52 -112.64 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.215 0.531 . . . . 0.0 110.609 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.606 ' HB3' HD13 ' A' ' 9' ' ' LEU . . . -173.08 -7.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.329 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.409 ' H ' ' H ' ' A' ' 7' ' ' ALA . 56.6 tp60 69.12 62.16 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 7' ' ' ALA . 10.5 mp -116.15 159.92 37.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.029 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.96 158.39 57.55 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.814 2.343 . . . . 0.0 110.816 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 81.09 2.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.092 0.472 . . . . 0.0 111.161 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -124.57 133.37 69.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.328 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 m -89.41 110.28 21.11 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 98' ' ' ASP . 29.8 mt -107.3 173.25 6.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 109.974 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.474 HD21 ' HB3' ' A' ' 20' ' ' LYS . 3.8 p30 -98.0 -176.62 3.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.431 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 pt -61.57 -22.59 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -81.14 -8.26 59.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.181 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.24 14.94 81.69 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HB3' HD21 ' A' ' 16' ' ' ASN . 87.6 tttt -99.84 139.27 35.75 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.564 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.6 m -74.48 118.6 17.62 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.315 0.579 . . . . 0.0 110.209 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.86 130.74 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.712 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 71.5 mt-30 -92.0 134.02 35.19 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.457 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -66.16 -29.3 69.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.323 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.646 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.73 122.03 28.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -134.87 153.52 52.02 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.89 178.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.583 ' OD1' ' HB2' ' A' ' 32' ' ' LYS . 23.7 t-20 -79.91 -80.77 0.13 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.338 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 171.87 28.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.788 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.418 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 95.3 0.26 63.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.491 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.583 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 1.4 mptm? -104.48 150.75 38.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.787 0.327 . . . . 0.0 110.548 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.2 159.58 33.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.967 2.445 . . . . 0.0 111.496 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.57 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 74.1 mtm -141.09 159.53 42.02 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 120.781 0.324 . . . . 0.0 111.795 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.2 mt -128.09 124.86 63.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.5 mt -97.99 119.88 46.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -107.7 121.56 44.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 58.5 m-85 -94.27 117.75 30.57 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.49 ' HB2' HD21 ' A' ' 47' ' ' LEU . 26.5 p90 -138.48 165.47 26.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.856 0.722 . . . . 0.0 111.588 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.35 164.09 13.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.521 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.5 p -64.93 118.63 9.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.477 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 t30 63.67 87.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.403 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 19.7 p -156.64 151.0 25.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.528 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 24.1 ttpp -139.46 -51.73 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 44' ' ' LYS . 36.0 Cg_exo -60.45 -31.05 92.07 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.154 1.902 . . . . 0.0 111.699 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 54.0 t -69.82 -16.32 63.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.409 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 39' ' ' PHE . 18.9 mt -98.95 52.47 0.97 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.664 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -61.33 -38.9 88.55 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.368 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.3 pt-20 -60.01 -51.74 68.35 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.045 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.482 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 40.8 tp -63.08 -41.08 99.35 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.402 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -59.92 -48.78 80.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.474 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.64 70.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.845 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.9 mt -63.76 -41.54 92.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.113 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -52.83 -36.38 58.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.014 0.435 . . . . 0.0 110.361 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.82 -46.73 67.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.883 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.16 25.65 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.45 -40.56 87.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.868 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.93 93.83 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.752 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.12 -41.0 97.4 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.236 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.407 ' NE1' HD13 ' A' ' 140' ' ' ILE . 17.4 m0 -66.84 -38.52 86.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.252 0.548 . . . . 0.0 110.201 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.444 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 30.1 mm-40 -70.17 -21.51 63.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.216 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.59 -48.88 79.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.625 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -104.59 -68.55 0.85 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.265 0.555 . . . . 0.0 111.859 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -63.73 -32.36 73.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.846 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 62.6 41.01 99.85 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.052 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.54 132.44 35.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.085 0.469 . . . . 0.0 112.253 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HG2' ' NE2' ' A' ' 61' ' ' GLN . 13.2 mtm180 -104.9 163.6 12.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 58.8 mt -110.86 138.1 47.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.188 0.518 . . . . 0.0 111.398 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.496 HG23 HD13 ' A' ' 96' ' ' LEU . 87.9 mt -110.78 110.48 32.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.16 116.05 28.38 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.9 p -121.59 131.69 72.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.478 0.656 . . . . 0.0 112.178 -176.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.475 ' CB ' HG21 ' A' ' 82' ' ' VAL . 23.3 p -86.38 134.93 33.68 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.07 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.443 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 43.1 pt -86.49 -5.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.238 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 15.1 m-20 -95.82 157.48 15.88 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.766 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.17 179.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.689 0.618 . . . . 0.0 112.565 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 -45.3 95.76 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 114.526 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -61.38 -46.08 91.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.371 0.605 . . . . 0.0 110.758 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 14.3 m120 -67.0 -39.17 87.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.903 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.582 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -68.27 -9.77 49.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.601 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.29 -22.32 52.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.04 0.448 . . . . 0.0 110.74 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.75 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 97.8 mttt -89.41 -13.7 37.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.699 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 79' ' ' ALA . 61.2 t -64.6 -50.2 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.497 0.665 . . . . 0.0 112.549 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mtpm? -68.52 -42.26 26.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.7 Cg_endo -61.41 -29.56 85.62 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.014 1.143 . . . . 0.0 110.821 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.9 mt -63.43 -42.28 98.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -58.07 -46.4 85.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.748 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -65.74 -45.76 81.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.994 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.71 -41.57 88.94 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.536 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -87.76 -3.12 58.97 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 46.17 45.76 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.386 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.427 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 53.8 m0 -82.78 100.99 10.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.408 0.623 . . . . 0.0 110.655 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -84.71 47.05 1.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.021 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 1.8 m-85 -138.32 175.95 9.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.88 126.42 32.44 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -110.9 131.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.07 0.462 . . . . 0.0 110.102 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.496 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -121.17 134.29 55.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.683 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.9 mp -110.18 115.9 30.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.476 ' HA ' HD22 ' A' ' 14' ' ' LEU . 45.8 t0 -79.0 114.8 18.24 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.158 175.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 p -85.63 -13.06 49.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.194 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -90.42 -45.65 8.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.948 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.436 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 89.8 8.85 66.88 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -174.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -96.24 -25.06 15.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.441 -0.88 . . . . 0.0 111.766 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 24' ' ' THR . 62.3 t80 -61.47 -43.85 98.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 22.9 pttp -58.92 -40.11 83.57 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.305 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -71.07 -41.85 70.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.972 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.55 81.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.37 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.67 -25.33 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.069 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.52 95.22 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.228 1.011 . . . . 0.0 111.966 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.68 115.7 50.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.169 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.2 p -82.77 -57.98 3.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.683 0.754 . . . . 0.0 110.076 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 46.3 tp -130.57 134.47 47.04 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.625 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.8 pt -87.59 151.36 50.33 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.567 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.8 Cg_endo -82.88 161.55 74.99 Favored 'Cis proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.704 0.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.61 136.65 54.76 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.448 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.6 t -119.44 124.97 73.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 120.889 0.376 . . . . 0.0 111.188 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 61.1 m-85 -122.05 118.04 27.78 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 62.0 mt -105.86 130.47 57.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.153 0.501 . . . . 0.0 111.0 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.464 HG21 ' HB1' ' A' ' 7' ' ' ALA . 53.3 t -104.87 135.2 43.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.988 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 125' ' ' VAL . 3.2 p-10 -87.66 -174.73 4.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 111.014 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.12 -18.43 69.07 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.414 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -88.86 -4.34 58.5 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.545 -0.386 . . . . 0.0 110.981 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 84.39 28.94 31.64 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.336 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 2.0 mppt? -124.21 154.09 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.161 0.505 . . . . 0.0 111.481 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.0 mt -70.59 99.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.246 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.433 HG11 HD21 ' A' ' 146' ' ' LEU . 7.2 p -83.87 -31.49 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.64 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.618 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.1 t80 -130.67 129.06 42.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.535 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -132.36 121.93 24.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -146.37 102.01 3.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.414 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 p -94.81 116.15 28.38 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.527 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.02 50.75 1.72 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.34 -0.934 . . . . 0.0 114.109 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.567 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.5 OUTLIER -81.64 138.52 35.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.363 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.0 p -123.35 -16.11 6.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.372 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -140.5 -101.63 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.35 30.13 2.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.955 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.77 -25.65 74.05 Favored Glycine 0 C--N 1.318 -0.455 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.053 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.6 -29.72 64.72 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.232 0.613 . . . . 0.0 110.626 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.19 96.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.06 -35.12 77.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.579 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.733 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -61.22 -53.58 55.09 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.29 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.407 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.1 tp -67.75 -39.08 81.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.089 0.471 . . . . 0.0 111.395 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 34.1 ttpt -59.06 -48.4 81.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.469 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.532 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 39.9 tptt -67.79 -30.97 70.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.216 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 139' ' ' LEU . 48.0 t -58.15 -44.46 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.535 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -77.14 -24.85 51.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.029 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 52.0 mm-40 -64.04 -33.71 76.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.135 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 88.8 mt -63.11 -41.79 99.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.068 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.8 t -69.18 -26.41 31.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.57 0.7 . . . . 0.0 110.236 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -66.62 -30.88 71.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.239 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -63.56 -38.44 91.13 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.781 0.324 . . . . 0.0 111.63 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.41 -114.73 4.36 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.243 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 71.9 -30.76 0.21 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.187 0.995 . . . . 0.0 112.779 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -57.72 -43.48 85.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.084 0.468 . . . . 0.0 109.984 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -124.12 80.25 1.81 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.7 p80 47.83 -164.33 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.091 0.956 . . . . 0.0 112.013 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -98.0 120.26 38.08 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.151 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.287 -179.299 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 CA--C 1.511 -0.535 0 CA-C-O 121.316 0.579 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.666 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -86.26 128.76 34.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.992 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -151.79 -140.21 0.09 Allowed 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.74 14.85 2.13 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.407 ' HB3' HG13 ' A' ' 124' ' ' ILE . 51.5 tt0 49.94 51.07 17.31 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.763 0.792 . . . . 0.0 109.964 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.404 HD13 ' HB ' ' A' ' 24' ' ' THR . 78.6 mt -106.66 154.71 39.88 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.327 -174.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.87 152.57 78.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.499 2.799 . . . . 0.0 110.913 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.96 87.05 0.72 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.131 0.491 . . . . 0.0 111.565 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.7 t -126.31 136.54 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.222 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -96.98 112.89 24.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.782 0.325 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 98' ' ' ASP . 53.2 mt -116.48 176.55 5.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -105.33 139.86 39.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.472 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -92.73 -175.14 3.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.285 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.73 -11.37 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.836 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.91 -15.54 27.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.85 61.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.818 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -99.99 146.29 26.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -73.73 120.16 18.94 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.469 0.652 . . . . 0.0 110.716 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.71 131.39 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.611 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.6 mt-30 -92.28 134.57 34.78 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.436 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 103' ' ' PHE . 7.1 p -67.28 -21.58 65.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.57 -9.9 59.7 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.0 0.429 . . . . 0.0 110.495 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.25 16.09 7.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.67 -178.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.3 tp -99.76 125.88 45.74 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.746 -176.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.666 ' HB3' ' O ' ' A' ' 5' ' ' THR . 3.9 pt-20 -141.91 158.65 43.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.084 177.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -81.14 -71.5 0.47 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.64 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.09 38.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.448 0.467 . . . . 0.0 110.963 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.6 ' HA2' HG21 ' A' ' 5' ' ' THR . . . 91.83 4.06 67.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.042 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.64 151.73 41.17 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 122.652 0.381 . . . . 0.0 110.387 -178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -66.91 155.67 69.69 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 122.994 2.463 . . . . 0.0 112.343 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.4 mtm -138.97 149.33 44.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.65 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.43 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 89.7 mt -127.88 126.11 66.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 77.4 mt -91.52 126.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.8 m -111.03 112.96 25.15 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 40.7 m-85 -86.98 109.46 19.39 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 173.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.61 ' HB2' HD22 ' A' ' 47' ' ' LEU . 28.5 p90 -126.21 157.07 39.15 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.853 0.721 . . . . 0.0 110.872 -175.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.96 147.66 34.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.803 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 m -63.07 -43.39 98.73 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.251 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -124.44 27.5 6.96 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.486 ' HG ' ' HG ' ' A' ' 46' ' ' CYS . 17.6 t -133.59 135.38 44.22 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.174 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 95.9 mttt -101.75 -47.83 0.19 Allowed Pre-proline 0 CA--C 1.564 1.481 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.51 ' HD2' ' H ' ' A' ' 44' ' ' LYS . 29.6 Cg_endo -64.12 -22.1 67.6 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.187 1.924 . . . . 0.0 113.225 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 71.3 m -76.0 -15.71 60.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.986 0.422 . . . . 0.0 110.227 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.61 HD22 ' HB2' ' A' ' 39' ' ' PHE . 9.6 mt -90.31 61.01 4.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.0 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 132' ' ' THR . 27.0 mmt180 -61.1 -43.39 98.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.8 tm-20 -63.66 -55.13 25.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.474 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD11 ' CE2' ' A' ' 93' ' ' TYR . 35.5 tp -62.71 -40.85 98.45 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.61 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.94 -48.17 77.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.639 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -44.45 93.23 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.043 0.449 . . . . 0.0 110.868 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 68' ' ' LEU . 62.6 mt -64.05 -41.34 92.16 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.77 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.688 ' OE1' ' HA ' ' A' ' 91' ' ' TRP . 26.3 tp60 -51.83 -40.61 60.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.42 -41.57 72.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.974 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.06 19.13 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -59.78 -34.4 72.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.6 84.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.836 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.86 -40.39 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.981 0.419 . . . . 0.0 110.694 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.469 ' NE1' HD13 ' A' ' 140' ' ' ILE . 15.3 m0 -67.27 -38.35 84.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.384 0.611 . . . . 0.0 110.405 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -81.97 -8.8 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.391 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.3 -49.23 78.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.876 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -152.19 64.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.369 0.604 . . . . 0.0 110.706 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.8 m -161.9 -39.74 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.613 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.0 21.08 76.94 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.662 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.2 p -81.93 125.57 39.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.066 0.46 . . . . 0.0 111.888 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -108.46 158.14 17.8 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.233 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 53' ' ' ILE . 42.8 mt -99.02 134.16 42.26 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.021 0.438 . . . . 0.0 110.843 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.608 HG23 HD13 ' A' ' 96' ' ' LEU . 90.8 mt -102.75 101.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -88.54 122.89 32.5 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.1 p -120.54 130.5 74.41 Favored 'Isoleucine or valine' 0 C--O 1.256 1.412 0 CA-C-O 121.594 0.711 . . . . 0.0 111.769 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 82' ' ' VAL . 24.1 p -83.37 132.01 35.02 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.898 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.524 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 45.1 pt -87.49 19.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 125.369 1.668 . . . . 0.0 113.858 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -122.38 -159.26 0.82 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.733 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.527 ' HB2' HE22 ' A' ' 77' ' ' GLN . 49.2 mt-10 -96.17 179.83 4.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.749 0.309 . . . . 0.0 110.381 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.563 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . -61.84 -43.32 99.38 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.527 HE22 ' HB2' ' A' ' 75' ' ' GLU . 6.0 pm0 -64.38 -41.78 96.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.648 0.724 . . . . 0.0 112.306 -177.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -77.03 -38.84 52.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.873 0.368 . . . . 0.0 111.549 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -71.46 -5.66 34.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 86.3 mm-40 -60.75 -24.1 65.47 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.919 -0.488 . . . . 0.0 110.722 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.699 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 30.6 mtpp -84.05 -9.83 58.32 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.725 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.637 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.6 t -65.75 -48.23 83.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.698 0.761 . . . . 0.0 112.53 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.9 mtpm? -66.65 -41.85 41.71 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.144 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.2 Cg_endo -62.9 -28.99 75.74 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.175 1.25 . . . . 0.0 110.884 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 97.5 mt -62.51 -42.84 99.78 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.42 91.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.797 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.85 -46.4 53.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.99 94.32 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.439 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -75.33 -23.95 57.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.797 0.332 . . . . 0.0 111.153 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.09 37.7 28.2 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.728 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.688 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 26.4 m0 -59.67 -42.28 92.53 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 66.13 27.3 10.49 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.611 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 6.1 m-85 -111.91 -167.65 1.21 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.475 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -104.3 129.21 52.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.496 0.665 . . . . 0.0 111.954 -172.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.608 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -114.32 133.94 55.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.343 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 76' ' ' GLY . 10.4 tt -108.71 111.85 23.84 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.253 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.617 ' HA ' HD22 ' A' ' 14' ' ' LEU . 68.2 t0 -80.12 128.19 33.21 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.271 174.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -110.09 0.65 18.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.991 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -114.23 -36.2 4.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 87.41 7.61 75.82 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.02 -21.97 25.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.554 ' CE1' HG21 ' A' ' 24' ' ' THR . 52.3 t80 -64.15 -35.42 80.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 110.22 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 52.1 mtmt -59.8 -44.84 93.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.55 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.1 -37.96 72.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.07 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.56 82.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.173 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.5 mmm -91.64 -10.4 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.244 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 64.71 69.25 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.379 0.609 . . . . 0.0 110.466 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.86 120.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.805 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.3 t -95.79 -75.88 0.51 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.227 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.499 HD21 HG22 ' A' ' 132' ' ' THR . 41.6 tp -98.26 160.73 14.1 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.2 pt -116.05 153.05 48.33 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.2 Cg_endo -79.56 156.9 89.71 Favored 'Cis proline' 0 C--O 1.241 0.656 0 C-N-CA 123.882 -1.299 . . . . 0.0 112.801 1.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -113.17 135.13 54.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.465 HG22 ' HG3' ' A' ' 49' ' ' GLU . 22.1 t -120.29 131.45 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -173.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.478 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 89.7 m-85 -126.73 112.83 15.88 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 173.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.5 mt -99.82 123.17 52.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.76 127.95 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.867 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.401 ' OD1' HD22 ' A' ' 146' ' ' LEU . 10.2 t70 -70.05 163.01 27.09 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 110.952 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -18.33 43.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.13 -0.486 . . . . 0.0 113.473 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -86.6 1.57 51.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.813 0.307 . . . . 0.0 111.085 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 83.55 26.38 43.01 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.005 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -124.98 157.0 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.943 0.372 . . . . 0.0 110.056 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 8' ' ' GLN . 96.2 mt -79.4 115.37 21.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.138 0.494 . . . . 0.0 110.055 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 146' ' ' LEU . 7.8 p -94.67 -38.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.15 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.438 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 72.0 t80 -134.26 128.73 34.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.203 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -131.21 128.93 40.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.411 . . . . 0.0 110.219 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 12.7 t60 -138.38 102.85 4.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 102.65 15.39 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.199 0.523 . . . . 0.0 111.911 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.17 105.45 0.75 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.653 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.562 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 3.6 p90 -138.23 163.78 30.88 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.662 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.7 p -109.62 -42.28 4.34 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.001 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -172.94 151.69 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.68 79.95 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.85 -34.33 8.43 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.55 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 2.5 pm0 -61.4 -15.55 37.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.35 0.66 . . . . 0.0 112.143 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.92 94.46 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.519 0.676 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.88 -26.82 36.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.227 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.1 mp -62.07 -49.31 76.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.721 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.469 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.8 tp -68.9 -34.84 66.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.879 0.371 . . . . 0.0 110.257 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 41.8 ttmt -58.91 -49.07 79.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.176 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -66.21 -36.73 83.83 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LEU . 72.8 t -59.76 -45.07 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.123 0.487 . . . . 0.0 109.804 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 144' ' ' ARG . 30.9 mmt180 -72.0 -25.02 61.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.209 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 75.7 mm-40 -64.37 -36.09 83.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.461 HD21 HG11 ' A' ' 125' ' ' VAL . 81.8 mt -62.44 -43.84 97.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.353 0.597 . . . . 0.0 109.487 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.76 -39.76 82.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.672 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -60.36 -41.29 93.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.541 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.0 -12.99 45.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.238 0.542 . . . . 0.0 110.863 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -86.35 102.49 2.71 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.507 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -115.07 -179.53 3.66 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 122.61 -0.347 . . . . 0.0 110.578 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -63.64 -38.24 90.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -94.81 163.26 13.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.073 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -71.09 89.3 0.82 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.854 0.359 . . . . 0.0 111.884 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 54.2 m80 68.59 -45.25 0.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.327 1.051 . . . . 0.0 113.693 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 C--N 1.312 -1.022 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.431 -178.767 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.442 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 4.4 t -84.18 89.7 7.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.329 0.585 . . . . 0.0 110.471 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.474 ' N ' ' HA3' ' A' ' 122' ' ' GLY . 85.7 m-85 -87.8 -90.57 0.12 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.314 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 169.92 -25.49 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.579 -176.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 65.9 83.14 0.17 Allowed 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.547 -176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 24' ' ' THR . 15.7 mt -133.19 167.28 23.74 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.385 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.71 159.87 49.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.913 2.409 . . . . 0.0 111.109 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.42 83.44 3.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -126.36 134.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.209 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.1 p -98.7 112.76 24.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.204 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -117.67 176.4 5.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -108.63 135.28 50.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.437 0.16 . . . . 0.0 110.607 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -87.23 -171.92 3.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.527 HG23 ' H ' ' A' ' 95' ' ' VAL . 27.5 pt -66.21 -24.04 32.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -77.42 -30.81 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.491 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.85 14.95 21.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.2 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -93.78 147.76 22.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.8 m -75.07 115.86 15.17 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.281 0.562 . . . . 0.0 110.269 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.44 131.65 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.895 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.592 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 44.2 mt-30 -98.06 132.7 43.38 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.71 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.618 HG21 ' CE1' ' A' ' 103' ' ' PHE . 14.8 p -68.17 -24.36 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -78.7 -4.04 47.16 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.815 0.34 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -134.25 11.9 3.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -67.89 124.81 24.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -147.88 161.8 40.57 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.6 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 35.1 p-10 -107.27 -56.48 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.94 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.86 25.59 0.03 OUTLIER Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 29' ' ' ASN . 14.4 mptt -129.13 151.22 77.34 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.67 153.57 77.58 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.324 2.016 . . . . 0.0 111.753 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.6 ' SD ' ' HB3' ' A' ' 29' ' ' ASN . 74.4 mtm -136.62 155.43 49.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.918 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.13 123.15 61.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.1 123.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -113.96 124.46 52.21 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 60.9 m-85 -93.76 119.76 33.15 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.621 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 24.2 p90 -137.94 170.16 16.53 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.606 0.566 . . . . 0.0 111.95 -175.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.65 33.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.565 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -68.69 -35.75 77.6 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -103.54 17.11 24.82 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 63.8 m -123.34 107.47 11.68 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.099 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 50.5 mtmt -93.87 -53.73 0.24 Allowed Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 35.2 Cg_exo -65.11 -22.34 61.82 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.692 2.261 . . . . 0.0 111.447 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 67.9 m -65.93 -31.62 72.65 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.727 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.591 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 8.2 mt -81.62 66.6 7.25 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -64.45 -39.5 93.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.728 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.577 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -67.96 -52.76 32.28 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.547 HD11 ' CE2' ' A' ' 93' ' ' TYR . 43.6 tp -61.6 -41.25 97.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.806 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.07 -49.68 76.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.513 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.05 -44.09 66.5 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.853 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 49' ' ' GLU . 66.6 mt -63.72 -42.44 96.0 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.767 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.691 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -52.7 -40.32 62.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -68.32 -44.8 74.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.36 20.51 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -60.81 -32.68 72.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.761 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.9 92.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.818 0.342 . . . . 0.0 110.407 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -66.8 -39.05 87.6 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.37 -36.37 82.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.545 0.688 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -82.39 -9.12 59.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.579 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.83 -52.94 63.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.502 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.04 -50.46 2.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 143' ' ' VAL . 6.5 m -61.77 -38.8 89.36 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.33 29.04 74.17 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.431 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.66 127.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.92 0.391 . . . . 0.0 111.865 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -106.37 140.49 39.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.605 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 72.1 mt -84.63 144.62 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.593 HD11 ' SD ' ' A' ' 34' ' ' MET . 94.8 mt -119.5 109.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.621 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -100.38 127.99 46.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.35 136.43 59.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 CA-C-O 121.612 0.72 . . . . 0.0 111.706 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 82' ' ' VAL . 37.2 p -83.61 126.34 32.73 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.437 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 pt -80.79 16.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 125.107 1.504 . . . . 0.0 112.351 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.6 ' OD1' ' HB2' ' A' ' 78' ' ' ASN . 4.2 t70 -130.14 165.88 21.39 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -78.43 175.38 10.35 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.338 0.399 . . . . 0.0 111.268 -174.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 80' ' ' GLN . . . -56.83 -22.85 42.7 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.111 -177.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -65.04 -57.57 8.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.119 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.6 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 91.7 m-20 -85.42 -38.97 18.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.137 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -71.94 -3.2 21.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.456 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 34.8 tt0 -63.98 -12.28 36.32 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.766 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.7 mmtm -95.77 -3.08 46.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.975 0.51 . . . . 0.0 112.054 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.7 t -65.26 -49.19 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.39 0.614 . . . . 0.0 112.547 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.4 mtpt -65.62 -43.69 62.19 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.803 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.15 -28.45 79.73 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.23 1.287 . . . . 0.0 111.312 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.6 mt -62.87 -41.94 99.58 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.97 92.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.9 -46.81 83.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.28 -40.76 80.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.631 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -92.97 -0.4 57.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.66 38.93 61.06 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.358 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -81.78 96.5 7.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.7 70.84 7.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 50' ' ' LEU . 11.2 m-85 -145.47 172.13 13.65 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.87 120.34 20.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.527 ' H ' HG23 ' A' ' 17' ' ' ILE . 20.7 t -109.21 123.75 65.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.495 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -111.23 138.1 48.11 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.646 0.736 . . . . 0.0 111.525 -176.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.8 tp -103.76 109.36 21.05 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.792 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.548 ' HA ' HD22 ' A' ' 14' ' ' LEU . 68.0 t0 -82.27 116.37 21.76 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 117.751 -1.58 . . . . 0.0 108.531 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -107.27 5.48 27.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.202 0.525 . . . . 0.0 110.185 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -110.8 -43.62 3.78 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.951 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.02 -1.97 78.57 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.682 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -83.18 -25.57 31.68 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.602 -0.352 . . . . 0.0 111.454 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 24' ' ' THR . 47.6 t80 -64.01 -44.46 92.52 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -61.49 -36.71 81.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.852 0.358 . . . . 0.0 110.61 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -70.24 -41.57 73.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 110.359 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.62 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.591 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.9 mmt -86.76 -8.29 57.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.021 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.2 t30 59.03 71.18 0.6 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.379 0.609 . . . . 0.0 111.26 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 38' ' ' PHE . 44.8 t -98.76 96.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.21 0.529 . . . . 0.0 110.63 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -88.89 -62.24 1.53 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.432 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.443 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 47.1 tp -105.93 129.9 53.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.281 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.7 pt -91.55 152.87 43.91 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 67.2 Cg_endo -83.62 157.04 72.06 Favored 'Cis proline' 0 C--O 1.242 0.721 0 C-N-CA 124.277 -1.135 . . . . 0.0 112.859 1.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -112.98 130.03 56.28 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.54 127.87 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-O 121.327 0.584 . . . . 0.0 112.161 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 86.6 m-85 -127.64 112.69 15.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.765 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.2 mt -101.74 130.73 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.213 0.53 . . . . 0.0 110.874 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 76.4 t -107.61 129.54 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.26 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.45 -175.42 5.46 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.301 0.376 . . . . 0.0 111.177 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.7 61.64 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.713 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -86.04 -1.66 57.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.479 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.474 ' HA3' ' N ' ' A' ' 6' ' ' TYR . . . 70.89 42.6 60.13 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.395 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 72.2 mmtt -127.11 155.54 43.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 7' ' ' ALA . 88.5 mt -71.66 100.14 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 146' ' ' LEU . 13.8 p -90.8 -34.16 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.457 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 87.7 t80 -132.5 130.33 40.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.723 0.296 . . . . 0.0 110.701 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -131.74 115.9 16.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.049 0.452 . . . . 0.0 110.78 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.465 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 2.0 t60 -132.81 102.87 5.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.405 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.02 116.32 29.01 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.089 -178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 78.5 65.35 1.86 Allowed Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.41 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.477 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 2.7 p90 -104.58 154.77 19.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.832 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.9 p -142.68 94.62 2.66 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.257 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 63.73 108.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.731 0.812 . . . . 0.0 112.273 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.17 23.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.862 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.34 -18.97 40.19 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.944 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.57 -30.28 67.04 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.368 0.667 . . . . 0.0 111.174 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.23 -40.26 93.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.787 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.42 -36.66 79.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.789 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.2 mp -63.0 -48.81 77.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.713 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.507 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.2 tp -67.82 -39.76 82.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.903 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 27.8 ttpp -60.43 -45.51 93.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.803 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.648 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 37.8 tptt -66.38 -35.72 81.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.31 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -59.48 -46.73 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 0.0 110.711 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 4.6 ptp180 -78.98 -18.57 53.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.059 0.457 . . . . 0.0 110.91 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' LYS . 31.0 tt0 -69.93 -37.51 75.92 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.862 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 58.1 mt -64.08 -40.1 95.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.667 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.81 -31.68 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.117 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -62.2 -39.86 94.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.564 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.76 -27.13 14.47 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.972 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -80.63 85.07 1.36 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.334 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.57 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 95.7 m-70 -92.7 37.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 68.68 -96.64 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.626 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -93.84 -33.88 13.37 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.267 0.556 . . . . 0.0 110.219 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.57 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 58.4 m80 -89.03 144.18 26.33 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.451 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -75.54 -33.09 60.65 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.22 0.533 . . . . 0.0 110.162 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.343 179.704 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 121.151 0.5 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t -144.84 99.89 3.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.224 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 41.7 m-85 -97.89 -135.64 0.26 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.246 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -153.57 11.52 0.44 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 52.8 tp60 51.74 31.75 8.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.826 0.822 . . . . 0.0 111.656 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 33.1 mt -79.87 161.68 65.25 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.022 -177.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.13 154.09 72.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.457 2.105 . . . . 0.0 111.133 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.28 76.64 1.33 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.312 0.577 . . . . 0.0 111.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.21 134.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 9.7 t -97.33 114.94 26.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.097 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 98' ' ' ASP . 30.0 mt -105.33 173.64 6.22 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -113.48 127.08 55.97 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.505 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.409 ' ND2' ' HD3' ' A' ' 20' ' ' LYS . 86.8 m-20 -79.59 178.71 7.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.074 0.464 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.569 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 47.3 pt -65.57 -26.2 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.186 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.99 -17.54 60.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.21 19.58 60.52 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 44.6 tttp -79.81 136.16 36.65 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.728 -0.736 . . . . 0.0 109.918 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -83.71 108.76 16.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.74 144.32 38.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.021 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.633 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 85.9 mt-30 -103.99 135.19 45.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.425 HG21 ' CE1' ' A' ' 103' ' ' PHE . 12.8 p -64.38 -30.68 71.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -73.66 -14.2 61.12 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.071 0.462 . . . . 0.0 111.068 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.633 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -114.65 8.88 16.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 111.297 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 38.4 tp -80.51 115.8 20.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.231 -175.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 160.73 36.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.314 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.507 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 8.3 p30 -112.89 -58.21 2.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.645 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.96 -45.54 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.565 0.746 . . . . 0.0 109.882 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.87 26.57 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.828 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -119.46 152.01 52.31 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.48 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 12.3 Cg_exo -72.1 158.89 51.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.932 2.421 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.507 ' SD ' ' ND2' ' A' ' 29' ' ' ASN . 5.0 mpp? -132.14 156.96 45.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.93 123.66 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -103.43 121.66 55.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.72 122.83 46.51 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 71.7 m-85 -96.1 119.63 34.94 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -147.83 161.46 41.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.984 0.421 . . . . 0.0 111.692 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.29 152.7 32.32 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.242 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 74' ' ' ASP . 3.1 p -43.3 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -97.64 77.03 2.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.182 0.992 . . . . 0.0 109.781 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.4 t -89.88 -175.83 4.73 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.44 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.576 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 64.6 mttp -109.17 -175.12 0.33 Allowed Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.462 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 44' ' ' LYS . 52.4 Cg_exo -59.77 19.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.744 2.962 . . . . 0.0 114.151 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.54 ' H ' ' C ' ' A' ' 44' ' ' LYS . 49.8 m -72.66 -15.64 61.7 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 mt -72.91 54.54 0.37 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.447 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -61.26 -38.19 85.84 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.202 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.678 ' OE2' ' HB2' ' A' ' 113' ' ' PRO . 50.7 mt-10 -53.04 -67.28 0.26 Allowed 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.659 0.742 . . . . 0.0 110.235 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.6 HD11 ' CE2' ' A' ' 93' ' ' TYR . 30.4 tp -60.86 -41.04 95.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.747 -173.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.52 -53.98 43.43 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.095 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 -42.74 94.77 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.8 mt -65.03 -42.77 95.48 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.949 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.68 -38.05 71.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.652 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.88 -35.7 81.37 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.869 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -120.59 25.26 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 53' ' ' ILE . 86.9 t80 -60.53 -34.45 74.13 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.54 92.21 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.425 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.89 -42.32 94.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.796 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.406 ' NE1' HD11 ' A' ' 140' ' ' ILE . 11.7 m0 -63.77 -35.76 81.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.754 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -79.13 -15.63 57.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.272 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.94 -43.73 98.24 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.75 -58.8 1.93 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.541 -0.463 . . . . 0.0 112.025 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 m -62.69 -39.62 94.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.684 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.43 28.16 73.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.656 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.72 131.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 122.658 0.383 . . . . 0.0 111.929 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -106.79 146.52 30.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.627 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 60.8 mt -91.69 148.12 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.402 0.62 . . . . 0.0 111.457 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 92.3 mt -122.44 118.68 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.575 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.44 111.56 23.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.52 127.83 72.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 CA-C-O 121.66 0.743 . . . . 0.0 111.245 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.563 ' HB2' HG21 ' A' ' 82' ' ' VAL . 35.0 t -85.6 133.11 34.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.713 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.408 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 44.0 pt -84.93 2.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.843 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 41' ' ' THR . 49.2 m-20 -102.33 157.27 17.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.71 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.03 156.42 5.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.492 0.495 . . . . 0.0 111.07 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.23 -34.04 72.46 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.489 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.61 -40.57 92.35 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.701 0.286 . . . . 0.0 111.708 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -85.3 -32.52 22.46 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.384 0.612 . . . . 0.0 110.367 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.31 -4.24 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.624 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.65 -8.97 11.52 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.025 -0.422 . . . . 0.0 110.143 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.645 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 35.4 mmtp -85.93 -17.56 35.12 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.183 0.593 . . . . 0.0 111.788 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 79' ' ' ALA . 11.6 t -64.48 -46.25 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.843 0.83 . . . . 0.0 111.324 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 18.7 mtmt -68.53 -44.23 33.28 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.17 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.4 Cg_endo -60.2 -32.39 94.36 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.009 1.139 . . . . 0.0 110.785 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.3 mt -64.35 -42.45 96.22 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -60.48 -41.82 95.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.783 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.82 -41.53 95.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.532 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.65 -51.67 6.36 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.314 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.71 -34.81 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.95 2.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.216 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -88.35 104.96 17.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.01 65.33 2.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 110.035 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.6 ' CE2' HD11 ' A' ' 50' ' ' LEU . 11.4 m-85 -140.12 178.96 6.91 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.79 120.87 24.66 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.569 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 20.0 t -107.12 126.7 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.678 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.52 139.89 53.38 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.128 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.55 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.4 mp -110.49 118.74 37.06 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.557 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.1 t0 -72.09 115.44 11.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.527 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.0 t -94.99 6.4 49.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.497 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -124.9 -38.73 2.32 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.097 0.475 . . . . 0.0 110.855 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 90.0 4.1 72.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -97.91 -20.65 17.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 24' ' ' THR . 74.0 t80 -62.19 -43.77 98.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.949 0.404 . . . . 0.0 110.158 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 73' ' ' ILE . 21.1 ptmt -58.02 -41.67 83.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.699 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -70.5 -39.52 74.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 111.026 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.21 99.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.317 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.65 -12.98 59.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 68.19 79.9 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.042 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.7 t -110.57 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.346 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.8 m -75.65 -46.52 31.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.2 tp -136.12 132.61 36.3 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.879 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.4 pt -87.38 154.0 53.84 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 95.2 Cg_endo -80.38 153.71 84.74 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.569 -0.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -116.17 125.97 53.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.326 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.462 HG22 ' CD ' ' A' ' 49' ' ' GLU . 13.7 t -101.34 124.93 55.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.8 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -124.73 112.63 16.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.729 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.24 128.87 53.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.124 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 76.4 t -106.38 129.72 59.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.678 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 12.0 t70 -70.68 157.77 37.41 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.922 0.764 . . . . 0.0 109.568 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.32 -25.52 62.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.315 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.28 -25.11 66.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.118 0.485 . . . . 0.0 110.59 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 26.06 6.72 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.644 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.97 157.01 38.89 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 122.491 0.316 . . . . 0.0 110.548 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 7' ' ' ALA . 69.3 mt -71.28 122.44 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.5 p -109.03 -32.64 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 58.0 t80 -147.62 131.5 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.297 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.017 0.437 . . . . 0.0 110.17 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.521 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 36.9 t60 -143.57 106.48 4.49 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.5 m -100.41 123.29 44.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.043 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.98 60.11 5.09 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.315 0.886 . . . . 0.0 115.315 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.662 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 27.2 p90 -86.18 -39.53 16.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 117.637 0.719 . . . . 0.0 109.597 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.0 p 73.39 -44.99 0.6 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.979 1.711 . . . . 0.0 113.53 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.07 138.95 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.04 18.65 74.3 Favored Glycine 0 C--N 1.327 0.059 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.848 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.662 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.91 -25.72 19.06 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.452 -177.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -60.93 -25.69 66.95 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.06 94.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 110.391 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.54 -38.32 89.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.511 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.1 mp -63.33 -47.14 83.46 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.685 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 140' ' ' ILE . 5.4 mm -61.63 -41.45 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.709 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.2 ttpp -57.29 -49.94 74.49 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.889 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 32.9 mmmt -68.39 -38.21 81.13 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 139' ' ' LEU . 52.6 t -58.94 -46.55 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.854 0.359 . . . . 0.0 111.575 -177.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.93 -22.42 42.72 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.638 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 73.6 mm-40 -66.28 -37.29 85.1 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.513 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 80.6 mt -61.38 -41.58 97.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.53 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.9 t -62.93 -47.61 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.86 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -66.68 -44.95 80.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.615 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.5 -38.62 81.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.961 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -90.35 33.77 4.41 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.851 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -158.36 -45.27 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -99.18 144.81 27.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.4 m170 70.43 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.979 0.911 . . . . 0.0 112.007 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -112.71 92.98 4.21 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -114.15 126.85 55.54 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.093 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 37.2 t60 . . . . . 0 C--N 1.313 -1.018 0 CA-C-O 118.14 -0.933 . . . . 0.0 110.227 179.487 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.672 0.272 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.681 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 94.9 m -102.18 87.72 3.14 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.156 0.503 . . . . 0.0 111.227 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 54.9 m-85 -124.15 -112.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -171.62 159.57 5.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.471 ' H ' HG13 ' A' ' 124' ' ' ILE . 48.8 tt0 -81.65 80.66 7.93 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.478 HD13 ' HB ' ' A' ' 24' ' ' THR . 60.6 mt -120.5 151.75 54.35 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 17.2 Cg_exo -67.94 147.86 75.11 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.8 2.333 . . . . 0.0 108.358 170.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.7 94.77 1.04 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.258 0.551 . . . . 0.0 111.467 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.9 149.33 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.948 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 p -110.21 117.29 33.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 98' ' ' ASP . 42.3 mt -112.03 175.06 5.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.326 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 32.8 mmtp -105.37 136.59 44.63 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.821 0.343 . . . . 0.0 111.513 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.77 -173.86 2.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.455 HG22 ' HB ' ' A' ' 95' ' ' VAL . 34.0 pt -67.14 -21.02 27.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.357 0.599 . . . . 0.0 110.354 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -86.02 -15.53 41.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.13 20.01 51.02 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -87.96 140.12 29.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.9 m -79.7 115.07 19.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.227 0.537 . . . . 0.0 110.892 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 m -119.39 130.6 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.391 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.3 mt-30 -89.13 134.9 33.84 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.503 HG21 ' CE1' ' A' ' 103' ' ' PHE . 22.8 p -63.69 -30.53 71.62 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.857 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -78.96 -4.46 50.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.83 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.63 13.78 7.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.1 tp -71.37 112.48 7.54 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.464 -177.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -137.3 143.3 42.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -178.012 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.42 ' HB2' ' NH2' ' A' ' 67' ' ' ARG . 35.6 p-10 -112.01 -38.22 4.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 29' ' ' ASN . . . 167.79 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.51 0.506 . . . . 0.0 111.525 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.84 32.63 58.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.496 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -125.04 151.88 69.67 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 122.269 0.228 . . . . 0.0 110.913 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 149.76 89.28 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.245 1.963 . . . . 0.0 110.741 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.6 mtm -135.51 144.91 46.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.587 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.406 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.9 mt -120.43 122.46 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.33 112.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.04 124.07 48.37 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.47 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 63.5 m-85 -96.11 119.57 34.84 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.984 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -143.57 178.64 7.64 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.529 0.518 . . . . 0.0 111.271 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -113.2 155.25 25.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.522 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -72.67 156.6 38.79 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.535 ' H ' HD11 ' A' ' 85' ' ' LEU . 95.5 m-20 59.73 35.3 22.18 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 81.4 m -130.48 152.76 49.51 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.025 0.441 . . . . 0.0 111.655 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.659 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 58.7 mttm -134.52 -43.34 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.748 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.659 ' CD ' ' H ' ' A' ' 44' ' ' LYS . 50.7 Cg_exo -57.36 -36.52 98.88 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.497 2.132 . . . . 0.0 113.532 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 56.0 m -86.95 5.99 34.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -97.04 21.97 9.07 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.442 -176.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -57.91 -45.75 86.03 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 53' ' ' ILE . 77.0 tt0 -55.96 -59.88 4.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.275 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.7 -41.78 99.3 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.871 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 54.8 tptt -64.05 -46.82 82.72 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.66 94.21 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.738 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.1 mt -65.0 -40.94 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.908 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.467 ' HA ' ' OH ' ' A' ' 93' ' ' TYR . 63.9 tt0 -53.61 -39.96 65.36 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 110.984 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 42.9 mm-40 -67.32 -40.24 85.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.18 18.95 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.64 -36.89 82.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.19 84.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.566 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.99 -43.57 98.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.198 0.523 . . . . 0.0 110.388 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.423 ' HH2' ' HB3' ' A' ' 139' ' ' LEU . 15.7 m0 -69.23 -42.38 75.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -72.11 -15.23 61.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.909 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.54 -47.95 83.53 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.337 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.21 -49.28 1.44 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.401 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -62.38 -41.02 98.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.528 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.61 31.0 77.3 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.045 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 133.08 30.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 122.532 0.333 . . . . 0.0 111.271 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' NH2' ' HB2' ' A' ' 29' ' ' ASN . 10.5 mtm180 -104.79 158.22 16.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 78.6 mt -107.14 135.82 48.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.079 0.466 . . . . 0.0 110.629 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.18 110.83 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.11 104.84 16.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.836 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.69 127.62 67.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.553 0.692 . . . . 0.0 111.067 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -91.02 137.27 32.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.539 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.9 pt -73.56 -20.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.997 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -67.79 142.58 56.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.098 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 31.6 mp0 -65.09 176.16 1.36 Allowed 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.614 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.55 -45.82 92.71 Favored Glycine 0 N--CA 1.461 0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.123 -174.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 28.9 pt20 -70.5 -32.44 69.94 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -85.48 -24.12 27.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.165 0.507 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -85.62 -3.45 58.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.383 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 13.9 pt20 -64.98 -4.42 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.715 -0.615 . . . . 0.0 110.743 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.601 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.9 mttm -97.97 -10.66 24.11 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.355 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 79' ' ' ALA . 13.3 t -64.88 -47.1 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 121.949 0.88 . . . . 0.0 110.822 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.6 mtpt -65.62 -46.76 68.02 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.248 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.6 Cg_endo -59.51 -29.06 89.05 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.336 1.358 . . . . 0.0 111.32 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.5 mt -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -61.27 -34.29 74.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.69 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -65.94 -29.11 69.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.189 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.18 -49.25 3.56 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.349 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 12.0 p30 -77.88 -27.04 49.59 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.1 46.38 4.17 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.903 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.6 95.86 4.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 0.0 109.977 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -78.8 42.72 0.46 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.582 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -127.05 168.53 14.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.18 113.38 19.98 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.31 0.576 . . . . 0.0 109.469 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 17' ' ' ILE . 13.7 t -97.31 136.89 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.788 -175.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 95' ' ' VAL . 11.2 mp -129.09 148.32 51.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.237 -175.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.578 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.7 mp -114.42 117.73 31.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.141 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.603 ' OD2' ' HG2' ' A' ' 104' ' ' LYS . 11.9 t70 -90.74 114.96 27.44 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.636 172.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 30.5 m -93.99 -88.97 0.23 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.51 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -112.27 19.46 17.68 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.322 0.582 . . . . 0.0 110.273 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.23 73.52 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.634 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' CG ' ' HE ' ' A' ' 105' ' ' ARG . 18.4 t70 55.05 23.85 5.54 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 109.902 -174.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 24' ' ' THR . 69.5 t80 -62.26 -42.45 99.34 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -177.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.603 ' HG2' ' OD2' ' A' ' 98' ' ' ASP . 11.4 pttm -54.78 -50.72 67.79 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HE ' ' CG ' ' A' ' 102' ' ' ASP . 17.6 ttp180 -70.55 -36.12 73.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.659 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.03 87.62 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.074 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 35.8 mmm -82.54 -8.73 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.564 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 62.4 t30 76.08 53.64 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.653 0.739 . . . . 0.0 111.553 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.435 HG12 HG22 ' A' ' 112' ' ' ILE . 47.5 t -98.88 129.86 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.38 177.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -130.98 -71.52 0.57 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.592 ' O ' HG12 ' A' ' 112' ' ' ILE . 52.1 tp -64.35 -39.16 93.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.861 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 111' ' ' LEU . 4.2 pt 64.55 145.21 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 125.081 1.352 . . . . 0.0 111.319 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.657 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.6 Cg_endo -82.29 179.05 27.98 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.933 -0.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -133.75 142.75 48.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.768 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 128' ' ' HIS . 21.9 t -117.99 126.57 74.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 123.466 0.479 . . . . 0.0 111.36 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 69.9 m-85 -126.44 114.93 18.82 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 139' ' ' LEU . 64.8 mt -106.06 125.63 61.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-O 121.287 0.565 . . . . 0.0 111.835 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.28 130.6 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.7 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -81.27 -173.32 4.27 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.539 0.524 . . . . 0.0 111.602 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.07 -34.02 88.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.611 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -64.62 -40.59 95.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.163 0.506 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 114.44 33.89 1.68 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.257 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.21 155.05 46.9 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.471 HG13 ' H ' ' A' ' 8' ' ' GLN . 96.7 mt -74.55 108.82 6.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.429 HG11 HD21 ' A' ' 146' ' ' LEU . 12.2 p -97.91 -29.28 3.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.123 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.598 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 89.8 t80 -129.71 132.7 46.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.147 0.499 . . . . 0.0 111.328 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -128.87 127.99 42.94 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.772 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.598 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 2.2 t60 -134.27 101.63 5.08 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.1 p -109.7 116.64 32.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.14 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.79 19.05 7.98 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.823 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.657 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -75.98 143.39 41.55 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.513 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.0 p -119.68 -43.3 2.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.236 -0.585 . . . . 0.0 112.019 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -160.32 125.19 3.83 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.11 17.13 41.48 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.025 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.23 -14.86 55.32 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 139' ' ' LEU . 2.2 mp0 -59.75 -26.99 66.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.129 0.49 . . . . 0.0 111.063 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.26 90.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.21 -31.62 71.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.744 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.0 mm? -61.3 -56.66 17.99 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.402 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 tp -66.45 -38.5 81.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 120.914 0.388 . . . . 0.0 111.388 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.26 -48.99 79.39 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.671 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 20.3 tptp -67.6 -31.39 71.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.261 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.1 t -59.33 -44.48 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' A' ' 144' ' ' ARG . 38.5 mmt180 -67.79 -33.06 74.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.567 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 50.8 mm-40 -56.34 -33.15 65.37 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.153 0.501 . . . . 0.0 109.928 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.429 HD21 HG11 ' A' ' 125' ' ' VAL . 84.3 mt -63.6 -43.71 96.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.07 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.9 t -71.41 -21.48 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.709 0.766 . . . . 0.0 110.051 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -79.29 -4.1 49.19 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.733 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.47 -16.17 14.06 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.15 -44.44 93.16 Favored Glycine 0 C--O 1.229 -0.188 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.522 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -114.04 117.68 31.97 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -66.43 -37.5 85.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.526 -173.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -111.87 -60.26 1.88 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -124.33 123.68 40.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.456 0.17 . . . . 0.0 110.895 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -66.48 -31.95 73.0 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.146 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 46.2 t60 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.845 -0.598 . . . . 0.0 109.56 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.555 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.7 m -94.16 58.52 2.52 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.627 -175.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.532 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 60.3 m-85 -87.38 -112.5 0.05 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.082 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . . . -162.89 11.56 0.06 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.566 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 52.58 42.31 31.41 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.995 0.903 . . . . 0.0 110.714 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 44.3 mt -96.6 164.01 19.13 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.406 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.19 157.16 63.06 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.736 2.291 . . . . 0.0 110.854 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.18 82.87 2.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.958 0.409 . . . . 0.0 111.354 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.18 134.85 65.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 p -95.08 114.59 26.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.989 0.423 . . . . 0.0 110.608 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -112.0 172.86 6.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 35.3 mmtm -97.84 131.89 43.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.385 0.612 . . . . 0.0 112.243 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -85.86 166.21 16.19 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.514 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.45 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 36.6 pt -61.45 -24.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.344 . . . . 0.0 111.671 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -77.26 -4.9 47.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.57 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.23 16.65 75.9 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -95.68 140.44 30.49 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.891 -0.654 . . . . 0.0 109.827 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.8 m -74.57 120.34 20.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.6 131.72 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.2 mt-30 -91.09 134.93 34.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.901 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.54 HG21 ' CE1' ' A' ' 103' ' ' PHE . 10.2 p -64.33 -31.9 73.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.923 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.36 -10.8 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.703 0.287 . . . . 0.0 111.593 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -119.08 3.49 11.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.09 -0.382 . . . . 0.0 111.214 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.36 109.45 19.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.527 0.68 . . . . 0.0 111.911 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.8 mt-10 -117.1 132.23 56.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.16 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.538 ' ND2' HH21 ' A' ' 67' ' ' ARG . 2.4 t-20 -72.3 -71.19 0.3 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.233 178.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.27 35.74 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.798 0.332 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.43 24.24 59.25 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.165 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -117.93 152.54 50.31 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.251 -0.475 . . . . 0.0 110.25 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.61 151.76 58.75 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.389 2.059 . . . . 0.0 111.893 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -134.98 156.27 49.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.04 0.448 . . . . 0.0 111.571 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.502 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 83.7 mt -126.64 126.68 69.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.68 125.36 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 120.688 0.28 . . . . 0.0 110.456 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -110.11 120.06 41.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.861 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 67.5 m-85 -96.37 121.98 38.76 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.177 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 16.3 p90 -147.68 169.35 19.88 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.5 0.5 . . . . 0.0 110.818 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.67 140.28 32.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.027 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.447 HG22 ' CG ' ' A' ' 74' ' ' ASP . 15.4 t -67.21 -33.02 74.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.346 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -99.08 69.56 1.75 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.0 t -131.88 175.31 9.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.121 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.64 167.7 20.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.267 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -42.66 82.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 124.149 3.232 . . . . 0.0 115.641 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.3 m -147.51 5.54 0.81 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.754 172.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.0 mt -66.5 -39.85 88.92 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.455 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.44 -79.58 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.169 0.588 . . . . 0.0 112.118 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.512 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 8.5 tm-20 -42.29 -60.58 1.43 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.952 1.701 . . . . 0.0 112.104 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD11 ' CE2' ' A' ' 93' ' ' TYR . 32.7 tp -61.21 -39.07 88.86 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.576 -176.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.28 -48.69 69.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.259 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.03 97.55 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-O 121.344 0.592 . . . . 0.0 111.072 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.2 mt -64.14 -41.38 92.24 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.86 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -52.81 -38.83 61.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.29 -38.42 87.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.444 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.57 24.33 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 53' ' ' ILE . 83.5 t80 -62.99 -40.63 98.32 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.68 85.11 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.035 0.445 . . . . 0.0 110.383 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.14 -43.3 99.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.247 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.427 ' NE1' HD13 ' A' ' 140' ' ' ILE . 24.8 m0 -65.47 -37.56 87.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -74.5 -9.16 58.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.64 -64.33 0.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -115.78 -39.59 3.48 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.472 HG21 HG13 ' A' ' 143' ' ' VAL . 7.4 m -62.29 -40.23 95.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.32 33.29 86.3 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.111 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.05 138.95 18.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.754 0.311 . . . . 0.0 110.649 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.538 HH21 ' ND2' ' A' ' 29' ' ' ASN . 23.8 mtm180 -123.65 152.87 41.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.052 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.502 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 62.9 mt -96.43 144.88 26.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.1 mt -119.73 112.52 37.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB1' ' HE1' ' A' ' 39' ' ' PHE . . . -93.81 120.1 33.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.682 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.92 130.65 73.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.478 0.656 . . . . 0.0 111.262 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 p -88.77 135.83 33.31 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.487 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.8 pt -82.24 -11.26 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.149 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.447 ' CG ' HG22 ' A' ' 41' ' ' THR . 8.3 m-20 -83.2 149.75 26.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.429 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -58.75 168.57 1.18 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.312 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.0 -35.98 86.19 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 114.28 0.472 . . . . 0.0 114.28 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.45 -53.26 57.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.186 0.493 . . . . 0.0 111.067 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -68.67 -37.94 80.0 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -66.88 -6.66 17.3 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.589 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.57 -17.57 62.97 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.397 0.617 . . . . 0.0 109.422 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.6 mttm -93.75 -8.28 41.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.284 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 79' ' ' ALA . 13.6 t -66.45 -46.23 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.73 0.776 . . . . 0.0 110.767 -177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.3 mtpt -62.55 -48.86 85.56 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.872 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -60.6 -29.93 89.51 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.357 1.371 . . . . 0.0 111.403 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.4 mt -63.68 -43.99 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.92 98.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.494 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.28 -50.1 67.03 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.833 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.61 85.48 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.337 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -73.32 -23.42 60.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.87 0.335 . . . . 0.0 111.607 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.05 39.55 19.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.892 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.587 ' HB3' ' CD2' ' A' ' 93' ' ' TYR . 26.6 m0 -64.4 -47.2 80.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.758 0.313 . . . . 0.0 111.644 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 32.9 tt0 72.11 1.97 4.13 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 2.8 m-85 -88.18 174.15 8.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.11 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.72 137.03 45.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.404 ' HB ' HG22 ' A' ' 17' ' ' ILE . 25.5 t -122.66 128.02 75.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.759 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 11.2 mp -124.09 137.36 54.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.703 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.94 116.49 32.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.493 ' HA ' HD22 ' A' ' 14' ' ' LEU . 49.6 t0 -86.13 113.7 22.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.552 174.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.0 t -97.21 -10.64 25.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.021 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -82.52 -48.39 11.08 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.897 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.61 1.05 78.19 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.17 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -91.97 -24.61 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.79 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.54 ' CE1' HG21 ' A' ' 24' ' ' THR . 81.1 t80 -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 -177.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.67 -33.09 74.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.442 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.8 ttm-85 -69.96 -43.03 72.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.935 0.398 . . . . 0.0 110.468 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.7 91.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.228 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.3 mmt -76.01 -23.72 55.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.991 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t30 72.42 84.29 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.201 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.445 ' HA ' HG21 ' A' ' 129' ' ' THR . 61.9 t -105.65 97.48 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.54 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -73.31 -54.58 8.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' HB3' ' HA2' ' A' ' 130' ' ' GLY . 58.3 tp -138.71 138.05 37.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.652 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.31 154.08 46.62 Favored Pre-proline 0 C--N 1.313 -1.022 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.516 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.2 Cg_endo -76.32 150.36 93.23 Favored 'Cis proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.852 1.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -111.1 136.42 50.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.986 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.25 126.25 74.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.209 0.528 . . . . 0.0 111.969 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -126.37 116.08 20.64 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.943 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 59.9 mt -104.72 131.51 53.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 111.099 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.4 130.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.413 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.02 -175.41 5.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.626 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.67 -16.0 49.44 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.814 -0.63 . . . . 0.0 114.058 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -88.82 -1.2 57.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.008 0.404 . . . . 0.0 110.576 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 71.2 34.27 64.45 Favored Glycine 0 CA--C 1.501 -0.797 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.653 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -124.8 157.78 34.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 83.1 mt -74.79 116.24 17.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.01 -26.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.29 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.528 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 90.3 t80 -147.34 135.74 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.502 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.51 122.05 21.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.968 0.413 . . . . 0.0 110.723 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.528 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.9 t60 -134.56 102.3 5.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.445 HG21 ' HA ' ' A' ' 109' ' ' VAL . 30.3 m -117.63 124.22 48.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.624 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 111' ' ' LEU . . . 118.27 -8.3 13.98 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.702 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -67.13 148.12 52.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.8 p -116.23 -47.29 2.76 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.701 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -156.4 131.94 9.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.667 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.77 15.54 56.34 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.915 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.19 -14.1 56.5 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.75 -18.49 55.08 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.997 0.919 . . . . 0.0 111.943 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.07 -39.21 94.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.467 0.651 . . . . 0.0 111.136 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.57 -32.13 67.75 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -62.47 -48.02 81.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.386 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.427 HD13 ' NE1' ' A' ' 60' ' ' TRP . 5.4 tp -66.21 -37.13 79.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.505 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.669 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.4 ttpp -60.73 -46.54 90.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.683 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.34 -35.69 81.22 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.694 0.283 . . . . 0.0 111.495 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 139' ' ' LEU . 96.0 t -59.93 -44.37 94.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 109.395 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 12.9 mmm180 -69.26 -34.86 75.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.056 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.6 mm-40 -55.75 -42.53 75.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.038 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 52.3 mt -61.87 -41.04 97.36 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.533 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.48 -42.61 87.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.299 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -61.94 -48.25 81.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.028 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 145' ' ' GLU . 12.9 pt-20 -67.51 -39.06 85.14 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.74 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 69.94 -48.54 0.65 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.7 m170 69.42 77.44 0.22 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.889 0.476 . . . . 0.0 109.739 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -168.82 -40.69 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.015 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -153.74 -62.52 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.244 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -82.16 167.63 18.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.531 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -136.32 -42.1 0.63 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.275 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 . . . . . 0 C--O 1.242 0.69 0 CA-C-O 118.549 -0.738 . . . . 0.0 110.619 -178.739 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.426 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 18.0 m -113.77 65.22 0.66 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.102 0.477 . . . . 0.0 111.262 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -87.48 -137.21 0.09 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.7 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -135.17 -23.81 1.47 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.252 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 67.38 70.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.691 0.758 . . . . 0.0 111.205 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 162.49 26.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.416 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.599 ' HG2' ' SD ' ' A' ' 107' ' ' MET . 8.8 Cg_exo -39.93 138.03 1.13 Allowed 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.091 3.194 . . . . 0.0 113.111 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.77 97.24 9.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.099 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.43 134.67 61.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 t -80.1 112.08 17.08 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.913 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 98' ' ' ASP . 19.0 mt -121.99 169.85 10.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -105.47 130.13 53.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.813 0.339 . . . . 0.0 111.572 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -83.29 -167.91 1.88 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.043 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.589 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 41.9 pt -71.32 -17.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.23 -14.01 51.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.715 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.64 15.35 76.01 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -93.7 145.67 24.4 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.377 -0.912 . . . . 0.0 109.461 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -74.03 118.67 17.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.349 0.595 . . . . 0.0 110.926 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -128.82 132.44 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.412 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 95.6 mt-30 -95.33 135.21 37.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.556 HG21 ' CE1' ' A' ' 103' ' ' PHE . 15.9 p -61.5 -34.83 76.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.14 -20.69 63.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.02 0.438 . . . . 0.0 111.397 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.08 11.36 20.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 110.719 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.0 tp -97.06 125.19 41.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.289 0.566 . . . . 0.0 111.067 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -125.11 155.66 39.52 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.543 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.711 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 9.4 t30 -78.97 -75.38 0.24 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.198 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.68 22.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.944 0.402 . . . . 0.0 110.682 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 97.53 -10.19 64.8 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -105.08 151.45 39.51 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.247 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -65.02 160.1 43.21 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.933 2.422 . . . . 0.0 112.522 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.711 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 11.2 ptt? -149.32 164.3 35.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.939 -175.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.412 ' CD1' ' HZ3' ' A' ' 60' ' ' TRP . 76.5 mt -128.46 127.92 67.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 92.9 mt -99.85 115.14 40.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -104.48 130.65 52.39 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.869 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.616 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 66.7 m-85 -96.38 121.14 37.86 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.22 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.541 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 24.9 p90 -142.0 164.38 30.32 Favored 'General case' 0 C--O 1.238 0.493 0 O-C-N 123.97 0.793 . . . . 0.0 110.494 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.13 17.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p -65.49 -17.61 64.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -132.04 85.27 2.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.943 0.402 . . . . 0.0 110.396 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 46' ' ' CYS . 33.2 t -164.48 165.11 21.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.201 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 29.3 tptp -154.02 -62.83 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 44' ' ' LYS . 57.1 Cg_endo -69.45 -29.05 25.98 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.267 1.978 . . . . 0.0 113.439 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.638 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 58.5 m -67.39 -18.54 65.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.007 0.432 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.09 62.07 4.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.523 ' HE ' ' HB3' ' A' ' 133' ' ' GLU . 29.2 mmt180 -58.48 -46.2 87.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.6 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.541 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.7 pt-20 -62.87 -49.57 74.34 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.038 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.432 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 42.6 tp -62.25 -41.41 98.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.138 -177.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 tttt -63.67 -49.37 73.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.58 96.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.331 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.9 mt -64.4 -42.71 96.12 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -58.77 -36.39 74.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 62.1 mm-40 -66.58 -39.09 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.697 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.26 24.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.884 0.373 . . . . 0.0 111.886 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -58.67 -39.52 80.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.79 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.92 92.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.02 -38.43 90.87 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.638 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.511 ' CZ2' HG12 ' A' ' 140' ' ' ILE . 17.7 m0 -67.6 -37.03 81.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.576 0.703 . . . . 0.0 110.22 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -75.58 -8.11 55.94 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.675 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.09 -43.76 70.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.345 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -142.72 -40.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.958 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.468 HG21 HG13 ' A' ' 143' ' ' VAL . 7.8 m -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.811 0.339 . . . . 0.0 110.313 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.6 24.5 73.94 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 5.6 p -78.37 124.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 122.864 0.465 . . . . 0.0 111.715 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.0 mtm-85 -106.17 165.58 11.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.639 177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 84.3 mt -108.06 146.12 33.04 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.279 0.561 . . . . 0.0 111.853 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.566 HG23 HD13 ' A' ' 96' ' ' LEU . 93.7 mt -120.88 110.36 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.201 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -92.45 118.6 31.12 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.0 132.52 68.66 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.495 ' HB3' HG21 ' A' ' 82' ' ' VAL . 25.3 p -84.17 128.42 34.55 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.254 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.547 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 42.4 pt -76.4 -14.83 14.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 O-C-N 124.78 1.3 . . . . 0.0 111.344 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 7.0 m-20 -77.63 175.76 9.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.075 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -88.69 178.87 6.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.532 ' HA2' HD21 ' A' ' 97' ' ' LEU . . . -58.04 -23.27 51.5 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.987 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.5 -65.09 0.74 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.89 0.376 . . . . 0.0 111.234 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.505 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 63.9 m-20 -66.35 -35.33 80.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.691 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.567 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -65.81 -4.72 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -64.48 -9.37 18.2 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.311 0.577 . . . . 0.0 110.523 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.783 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 94.4 mttt -92.98 -12.75 29.95 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.745 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 72' ' ' SER . 50.6 t -64.88 -49.71 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 17' ' ' ILE . 13.1 mptt -68.76 -41.6 21.62 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 14.5 Cg_endo -60.3 -31.06 92.39 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.025 1.15 . . . . 0.0 110.946 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.7 mt -63.72 -40.92 97.96 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.305 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.431 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -54.72 -48.25 72.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.619 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.91 -42.94 84.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.88 82.87 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.774 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -99.59 3.3 45.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.26 43.34 93.13 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.4 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.431 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.1 m0 -82.33 98.85 9.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.231 0.539 . . . . 0.0 110.159 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -86.5 44.95 1.19 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.005 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -145.89 -176.91 5.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -71.77 136.65 47.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.306 0.574 . . . . 0.0 111.505 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.69 130.31 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.231 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.566 HD13 HG23 ' A' ' 69' ' ' ILE . 10.6 mp -122.03 154.71 36.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.642 0.734 . . . . 0.0 111.695 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.567 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.8 tt -125.43 113.95 18.19 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.868 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.686 ' HA ' HD22 ' A' ' 14' ' ' LEU . 66.5 t0 -77.6 117.24 18.84 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 118.175 -1.41 . . . . 0.0 108.439 174.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -88.06 -32.3 18.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.413 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -79.02 -38.28 37.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.726 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 84.64 12.02 76.03 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -177.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.56 -6.04 15.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.556 ' CE1' HG21 ' A' ' 24' ' ' THR . 79.6 t80 -64.24 -39.5 94.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.192 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.547 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 24.5 pttm -59.62 -37.2 77.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.269 176.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -70.5 -41.49 72.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.667 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.62 92.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.942 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.599 ' SD ' ' HG2' ' A' ' 10' ' ' PRO . 42.0 mmm -88.66 -11.89 44.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.72 83.3 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.741 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.3 109.1 20.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -69.83 -58.53 3.76 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.175 0.512 . . . . 0.0 110.052 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.483 ' HB3' ' HA2' ' A' ' 130' ' ' GLY . 59.5 tp -143.47 136.28 27.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.6 pt -83.27 153.08 65.73 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.589 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -74.77 155.91 99.91 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.767 -1.347 . . . . 0.0 112.777 0.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.32 130.55 54.49 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.877 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.459 HG22 ' CD ' ' A' ' 49' ' ' GLU . 21.7 t -112.0 129.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.39 0.431 . . . . 0.0 111.997 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.14 113.7 15.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.039 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.7 mt -102.93 129.83 54.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-O 121.245 0.545 . . . . 0.0 110.791 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.18 131.52 63.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.827 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.3 165.34 23.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.632 0.582 . . . . 0.0 110.851 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.81 -21.39 51.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.208 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -73.3 -9.2 58.45 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.999 0.4 . . . . 0.0 111.105 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' A' ' 123' ' ' LYS . . . 91.23 18.56 45.69 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.951 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HD2' ' O ' ' A' ' 122' ' ' GLY . 4.0 mptp? -125.56 150.39 47.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.891 0.346 . . . . 0.0 110.612 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.1 mt -65.07 125.97 23.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.439 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.72 -18.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.556 ' HB2' ' HD3' ' A' ' 142' ' ' LYS . 89.3 t80 -150.56 132.08 14.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.924 0.392 . . . . 0.0 111.707 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -128.64 128.92 45.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.832 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.7 t60 -133.26 108.94 9.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.819 0.342 . . . . 0.0 110.828 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 p -120.94 135.14 55.27 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.838 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 111' ' ' LEU . . . 103.93 0.39 45.24 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.393 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.589 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -82.52 149.14 27.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.1 p -123.79 -47.65 1.93 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.986 0.422 . . . . 0.0 110.735 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.523 ' HB3' ' HE ' ' A' ' 48' ' ' ARG . 11.0 pt-20 -160.59 144.74 13.93 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.147 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.49 72.17 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.89 -13.93 55.77 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 2.1 mp0 -60.21 -26.2 66.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.066 0.546 . . . . 0.0 111.234 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.88 90.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.587 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.62 -38.54 87.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.992 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.657 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.14 -52.4 64.0 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.457 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.511 HG12 ' CZ2' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -65.47 -38.89 83.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 -175.528 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.715 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 40.0 ttmt -59.57 -53.28 59.94 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.556 ' HD3' ' HB2' ' A' ' 126' ' ' TYR . 64.5 tttt -69.47 -30.3 68.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.066 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 139' ' ' LEU . 55.8 t -58.91 -46.06 91.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.923 0.392 . . . . 0.0 110.178 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 5.5 mmm180 -71.77 -34.61 69.59 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.767 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.715 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 5.7 mm-40 -56.01 -34.64 65.99 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 62.7 mt -60.98 -42.76 98.98 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.82 -49.68 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.472 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -63.76 -45.78 88.26 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -113.86 -39.47 3.98 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.55 39.04 95.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.944 -176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 50.7 p-80 -58.65 140.62 54.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.003 0.521 . . . . 0.0 111.943 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -105.91 -48.26 3.66 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.613 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -108.51 -32.68 7.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.672 0.272 . . . . 0.0 111.656 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 29.0 p80 -148.91 138.06 21.56 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.654 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -83.7 -22.63 31.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.884 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.7 t60 . . . . . 0 C--N 1.323 -0.571 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.35 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.6 t30 . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 120.328 0.109 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.51 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 7.4 t -176.82 98.18 0.05 Allowed 'General case' 0 CA--C 1.565 1.542 0 O-C-N 123.469 0.48 . . . . 0.0 110.875 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -117.88 1.25 12.07 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.032 0.444 . . . . 0.0 111.123 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 118' ' ' VAL . . . 74.61 11.55 3.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.258 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 54.82 36.48 26.57 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.772 0.796 . . . . 0.0 110.501 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 80.5 mt -80.45 153.79 73.86 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.346 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.16 157.43 61.77 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.093 2.529 . . . . 0.0 111.132 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.98 82.45 2.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.0 133.46 68.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.129 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -91.35 105.0 17.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.03 0.443 . . . . 0.0 110.629 -177.604 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mp -100.54 176.47 5.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.313 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -114.61 125.15 53.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -90.28 -172.46 3.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.253 0.549 . . . . 0.0 112.19 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.571 ' HA ' ' CD ' ' A' ' 83' ' ' LYS . 37.5 pt -65.01 -28.6 45.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.308 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.62 -25.93 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.413 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.83 49.27 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -174.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -100.03 144.26 29.28 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.459 -0.87 . . . . 0.0 110.148 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.24 106.17 13.01 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.23 137.87 56.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.135 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.608 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 37.5 mt-30 -89.16 139.2 30.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.428 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 p -65.32 -32.17 73.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.96 -14.41 62.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.847 0.356 . . . . 0.0 111.29 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -116.62 5.85 13.31 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.645 -179.15 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -92.57 120.25 32.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 4.9 pt-20 -118.68 145.26 45.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.136 0.493 . . . . 0.0 111.94 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.444 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 26.5 t-20 -76.13 -67.81 0.64 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.924 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 169.23 -25.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.032 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.12 -6.57 1.55 Allowed Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.084 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.3 mptm? -97.21 151.6 37.78 Favored Pre-proline 0 C--N 1.315 -0.926 0 C-N-CA 122.765 0.426 . . . . 0.0 110.774 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.6 Cg_exo -66.66 158.64 54.95 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.971 2.447 . . . . 0.0 112.427 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.448 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 4.1 ptt? -147.46 154.68 41.11 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.637 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.446 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.1 mt -125.91 130.77 72.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.5 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -110.93 118.75 36.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.443 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.8 m-85 -95.29 117.75 30.84 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -144.41 168.76 19.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 123.73 0.644 . . . . 0.0 110.506 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.69 146.26 29.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.74 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.494 HG22 ' OD2' ' A' ' 74' ' ' ASP . 13.4 t -69.05 -16.8 63.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.079 0.466 . . . . 0.0 110.879 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -84.95 -37.95 19.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.638 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.9 p -77.42 141.94 39.49 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.922 0.392 . . . . 0.0 111.627 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 30.7 mmtp -120.48 -55.15 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.41 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 10.4 Cg_exo -67.96 -21.38 43.61 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.319 2.013 . . . . 0.0 112.258 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 59.8 m -69.21 -15.97 63.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.295 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.3 mt -81.37 47.21 1.01 Allowed 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 120.869 0.366 . . . . 0.0 111.305 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 14.8 mmm180 -58.08 -44.78 87.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.274 0.559 . . . . 0.0 110.713 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.4 tm-20 -62.8 -55.19 28.66 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.536 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.558 HD11 ' CE2' ' A' ' 93' ' ' TYR . 33.2 tp -65.4 -41.06 94.06 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.45 -48.51 77.41 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.8 89.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.093 0.473 . . . . 0.0 110.881 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.5 mt -63.76 -41.07 91.36 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.844 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.928 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -50.78 -40.46 55.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.882 0.373 . . . . 0.0 110.829 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -70.42 -40.82 73.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -110.24 21.15 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -62.14 -40.46 96.03 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.646 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.01 82.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.813 0.339 . . . . 0.0 110.395 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.87 -41.79 99.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.269 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -69.26 -38.93 78.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.572 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -77.88 -8.34 57.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.59 -50.23 68.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.254 0.346 . . . . 0.0 111.758 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.46 -38.2 1.19 Allowed 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.314 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.486 HG21 HG13 ' A' ' 143' ' ' VAL . 9.5 m -63.57 -41.48 98.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.07 78.56 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.247 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 8.3 p -74.63 137.26 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.773 0.321 . . . . 0.0 111.763 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.4 mtm-85 -115.46 169.15 9.38 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 78.5 mt -114.11 139.95 48.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.305 0.574 . . . . 0.0 111.319 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.517 HG23 HD13 ' A' ' 96' ' ' LEU . 88.6 mt -111.78 99.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.96 115.63 24.48 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.9 129.49 75.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.346 0.593 . . . . 0.0 110.737 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.7 t -89.34 136.27 33.12 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.522 ' HB ' ' HE3' ' A' ' 104' ' ' LYS . 46.3 pt -75.25 -19.02 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.616 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.494 ' OD2' HG22 ' A' ' 41' ' ' THR . 13.4 m-20 -72.2 142.99 49.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.559 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 60.0 mt-10 -68.5 171.05 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -52.71 -41.81 58.08 Favored Glycine 0 C--N 1.329 0.159 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -172.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.97 -55.59 27.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.23 0.515 . . . . 0.0 111.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -69.96 -36.97 75.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.948 0.404 . . . . 0.0 111.704 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.01 -4.19 9.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 96.6 mt-30 -61.25 -10.12 6.27 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.761 -0.587 . . . . 0.0 110.892 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.641 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.4 mttm -92.85 -13.04 29.57 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.538 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -65.54 -46.21 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.588 0.709 . . . . 0.0 111.249 -177.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.571 ' CD ' ' HA ' ' A' ' 17' ' ' ILE . 28.7 mtmt -73.65 -37.68 3.62 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.0 Cg_endo -61.61 -31.08 86.7 Favored 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 120.372 1.168 . . . . 0.0 110.058 171.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -63.94 -42.4 97.34 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -57.48 -47.68 81.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.775 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.98 -45.65 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.144 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.48 92.04 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.204 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.54 -33.32 66.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.56 50.29 2.98 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.019 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.464 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 45.6 m0 -80.77 122.59 27.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.06 0.457 . . . . 0.0 109.949 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.67 32.88 1.17 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.041 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -139.63 171.07 14.77 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.285 -0.259 . . . . 0.0 110.797 -176.564 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.15 136.25 37.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.057 0.455 . . . . 0.0 111.249 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' C ' HD12 ' A' ' 96' ' ' LEU . 45.8 t -118.17 131.14 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.031 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.517 HD13 HG23 ' A' ' 69' ' ' ILE . 10.2 mp -121.2 145.82 47.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.362 0.601 . . . . 0.0 111.201 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.554 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.6 mp -112.91 119.58 38.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 64.7 t0 -85.5 114.39 22.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 117.846 -1.542 . . . . 0.0 108.715 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.1 t -93.24 -3.87 52.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.147 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . 7.0 m-80 -103.22 -58.3 1.9 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.398 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 100.53 -13.25 59.73 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 100' ' ' ASN . 45.5 m-20 -64.08 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.416 0.686 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.4 -42.25 98.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.869 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HE3' ' HB ' ' A' ' 73' ' ' ILE . 4.4 mtpm? -59.16 -43.78 92.12 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -68.26 -39.01 82.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.696 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.19 79.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.697 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 25.8 mmt -88.9 -7.38 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.207 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.91 52.78 7.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 0.0 110.539 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.77 89.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -77.05 -49.36 15.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.964 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 tp -127.35 138.65 53.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.291 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.1 pt -102.21 154.19 37.56 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 84.5 Cg_endo -78.62 147.05 80.76 Favored 'Cis proline' 0 C--O 1.241 0.635 0 C-N-CA 123.619 -1.409 . . . . 0.0 112.108 -0.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -108.94 138.06 45.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -122.92 131.4 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 84.3 m-85 -128.63 118.32 22.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.007 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.641 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.95 131.92 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.159 0.504 . . . . 0.0 110.694 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.639 HG21 ' HB1' ' A' ' 7' ' ' ALA . 53.6 t -115.61 134.0 60.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.925 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.49 -175.15 4.61 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.414 0.446 . . . . 0.0 111.509 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.16 89.22 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.31 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -73.25 -14.59 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.504 0.669 . . . . 0.0 110.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 85.17 41.64 7.4 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.949 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -121.76 155.81 34.48 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 7' ' ' ALA . 89.7 mt -77.43 125.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 p -120.03 -30.06 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.835 0.35 . . . . 0.0 111.902 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.641 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.6 t80 -121.86 126.83 49.63 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 122.175 -0.328 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -131.85 109.31 10.02 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.334 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -147.82 109.03 4.28 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.072 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 p -91.23 106.14 18.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.608 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.2 72.08 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.596 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.588 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 31.7 p90 -70.85 -42.83 69.63 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.353 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.435 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 27.0 p 49.81 84.64 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.912 -1.494 . . . . 0.0 113.392 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 64.85 112.82 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.227 1.011 . . . . 0.0 112.8 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.08 -8.87 50.05 Favored Glycine 0 CA--C 1.51 -0.24 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.588 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -68.65 -37.88 85.29 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.344 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -52.89 -30.86 36.61 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.913 0.885 . . . . 0.0 111.531 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.56 99.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.481 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -73.82 -29.82 62.36 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.379 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.669 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -61.36 -48.43 81.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.926 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.6 tp -66.68 -36.04 76.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.591 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 41.2 ttmt -57.92 -48.03 81.11 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.416 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 20.8 mttp -76.85 -22.19 53.91 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 139' ' ' LEU . 77.0 t -60.64 -44.28 96.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -68.51 -36.85 79.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.031 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 25.9 mt-10 -63.43 -30.59 71.69 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 120.649 0.261 . . . . 0.0 110.855 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.5 mt -61.49 -39.94 92.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.376 0.608 . . . . 0.0 109.665 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.42 HG13 ' CG ' ' A' ' 151' ' ' HIS . 61.1 t -63.47 -24.38 35.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.377 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -87.7 -4.89 58.89 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.289 -176.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.92 -24.78 26.45 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 120.91 0.386 . . . . 0.0 111.225 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.85 82.73 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 80.3 t60 -114.58 80.78 1.45 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.809 0.338 . . . . 0.0 111.267 -175.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 151' ' ' HIS . 12.9 t-80 171.3 -75.33 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' A' ' 152' ' ' HIS . 18.9 p-80 174.85 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -113.35 100.11 8.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.017 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -82.1 -33.95 29.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.911 0.386 . . . . 0.0 111.617 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.7 -178.311 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.545 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 6.9 m 65.2 76.08 0.34 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.575 0.703 . . . . 0.0 110.391 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.467 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 71.3 m-85 -97.57 -122.89 0.13 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.779 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -152.23 14.04 0.59 Allowed 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.377 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 47.6 tt0 50.43 33.8 8.26 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.619 0.723 . . . . 0.0 111.424 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 51.8 mt -83.28 151.43 62.78 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.005 -176.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 32.3 Cg_exo -60.18 150.38 79.83 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.925 2.416 . . . . 0.0 110.559 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.74 84.69 2.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.987 0.422 . . . . 0.0 111.698 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.3 t -125.75 133.67 68.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 p -86.84 103.92 15.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.773 0.321 . . . . 0.0 111.176 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 103' ' ' PHE . 34.0 mt -99.6 176.31 5.52 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -112.88 134.06 54.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.563 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -86.46 165.55 16.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.966 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 pt -67.7 -17.35 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -84.24 -3.67 58.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.858 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.97 78.07 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.76 142.5 27.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.247 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -82.18 111.86 18.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.417 0.627 . . . . 0.0 110.01 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -116.11 128.32 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.643 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.543 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.1 mt-30 -89.58 134.34 34.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.436 HG21 ' CE1' ' A' ' 103' ' ' PHE . 8.5 p -65.85 -29.85 70.37 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -68.55 -20.7 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.936 0.398 . . . . 0.0 110.942 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.21 13.95 20.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.978 179.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.65 102.66 3.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.239 0.543 . . . . 0.0 112.01 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 46.5 mt-10 -114.78 104.24 11.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.361 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -71.56 -44.9 63.71 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.44 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 64.4 31.48 81.0 Favored Glycine 0 C--O 1.227 -0.306 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.177 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -128.55 153.6 79.43 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 123.106 0.562 . . . . 0.0 109.717 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 32.0 Cg_exo -56.59 146.78 73.97 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 122.264 1.976 . . . . 0.0 111.563 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.517 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 25.2 mtt -135.18 170.6 15.67 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.068 -173.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.745 HG23 HD23 ' A' ' 68' ' ' LEU . 7.6 tt -150.1 127.11 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.433 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.1 mt -101.61 126.05 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.122 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -104.15 111.83 24.59 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.398 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 23.6 m-85 -94.03 119.58 33.1 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.18 168.54 20.13 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.843 0.714 . . . . 0.0 110.717 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.7 -167.59 0.72 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.113 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 74' ' ' ASP . 16.7 p -103.34 -1.4 28.76 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.43 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -147.81 86.7 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.3 p -170.68 152.12 3.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.299 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 83.4 tttt -147.96 -52.83 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.465 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 44' ' ' LYS . 31.5 Cg_exo -61.64 -25.52 79.2 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.005 1.804 . . . . 0.0 112.193 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 45.5 t -78.82 -9.22 59.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.096 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.1 mt -89.04 62.32 6.23 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.0 110.343 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -58.23 -41.75 84.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.029 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 tm-20 -62.93 -58.73 6.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.136 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD11 ' CE2' ' A' ' 93' ' ' TYR . 40.4 tp -62.68 -41.47 99.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.238 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.54 -46.71 87.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.87 92.72 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.099 0.476 . . . . 0.0 110.663 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.4 mt -68.71 -33.24 58.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.438 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -56.23 -27.72 55.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.226 0.536 . . . . 0.0 110.377 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -85.55 -41.23 15.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.881 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.7 15.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 84.1 t80 -61.07 -40.63 94.4 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.672 0.272 . . . . 0.0 111.511 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.39 80.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.082 0.468 . . . . 0.0 110.42 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.38 -41.26 98.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.053 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.433 ' NE1' HD13 ' A' ' 140' ' ' ILE . 20.7 m0 -69.88 -36.13 75.22 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.481 0.658 . . . . 0.0 110.441 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -78.04 -7.12 56.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.118 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -53.99 -50.81 65.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.836 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 -30.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.204 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 m -62.53 -41.85 99.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 0.0 111.413 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.91 25.06 74.78 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.061 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -77.53 133.75 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.577 0.227 . . . . 0.0 111.086 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtm-85 -117.67 148.16 42.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.65 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.745 HD23 HG23 ' A' ' 35' ' ' ILE . 78.2 mt -86.37 135.46 33.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.577 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 75.0 mt -112.84 101.42 12.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.27 103.6 14.36 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.171 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.5 127.3 73.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.501 0.667 . . . . 0.0 111.883 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -89.13 138.81 31.09 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.836 176.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.6 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 38.1 pt -90.86 -3.89 10.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 O-C-N 125.133 1.521 . . . . 0.0 113.615 -171.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 41' ' ' THR . 21.4 m-20 -86.38 176.7 7.74 Favored 'General case' 0 C--O 1.214 -0.763 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.423 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.49 176.21 9.1 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.512 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -60.99 -34.04 86.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.661 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.21 -55.0 40.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.269 0.557 . . . . 0.0 110.813 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -67.93 -37.27 81.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.014 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -70.63 -5.0 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 81.1 mt-30 -61.87 -19.51 62.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.697 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 51.8 mtmt -90.02 -10.61 44.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.815 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 79' ' ' ALA . 57.7 t -63.89 -47.75 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.0 mptp? -73.71 -38.71 4.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.9 Cg_endo -60.37 -32.91 94.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 119.909 1.003 . . . . 0.0 110.283 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.2 mt -64.52 -42.39 95.82 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.624 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -56.73 -50.36 72.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.675 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -68.35 -44.52 75.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.756 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.81 98.14 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.172 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -79.87 -32.66 40.41 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.69 45.98 3.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.217 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.624 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 40.2 m0 -82.79 114.52 21.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 111.054 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.18 37.38 0.72 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.502 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.453 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -130.58 167.03 19.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.28 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.36 116.97 19.16 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.805 0.812 . . . . 0.0 110.313 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 t -98.88 132.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.356 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 tp -109.87 163.28 13.68 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' HB2' ' HE2' ' A' ' 83' ' ' LYS . 11.7 tp -126.68 99.63 5.86 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 66.2 t0 -75.57 117.57 17.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 117.542 -1.663 . . . . 0.0 108.101 172.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 p -97.79 -5.22 35.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.152 0.501 . . . . 0.0 110.954 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -101.02 -42.17 6.5 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.701 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 82.8 5.23 89.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -97.51 -14.66 20.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.787 0.327 . . . . 0.0 111.312 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.436 ' CE1' HG21 ' A' ' 24' ' ' THR . 44.9 t80 -64.42 -38.54 91.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.844 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.6 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 22.1 pttm -55.41 -44.32 76.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.801 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -65.68 -42.94 90.69 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.249 0.547 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.59 85.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -86.23 -3.68 59.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.619 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.71 36.35 2.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.512 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -73.07 88.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.646 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 t -74.31 -45.68 45.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.613 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.85 149.98 50.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.169 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.2 pt -105.86 155.33 38.47 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.44 142.23 68.12 Favored 'Cis proline' 0 C--O 1.239 0.561 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.603 -0.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -106.11 132.58 52.02 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.11 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.555 HG21 HD21 ' A' ' 139' ' ' LEU . 70.9 t -117.8 129.66 73.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 94.1 m-85 -125.48 115.66 20.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.416 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.8 mt -101.28 130.03 51.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.166 0.508 . . . . 0.0 110.51 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.517 ' HB ' ' H ' ' A' ' 34' ' ' MET . 74.2 t -103.91 131.06 53.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.705 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -83.52 -175.53 5.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.12 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.88 8.29 37.59 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.1 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -111.44 -1.27 15.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.683 0.754 . . . . 0.0 109.475 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.87 23.83 63.3 Favored Glycine 0 CA--C 1.504 -0.638 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.206 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 8.3 mptt -115.89 163.15 16.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.848 0.356 . . . . 0.0 110.484 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.45 102.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.298 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.25 -35.37 9.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.74 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 76.2 t80 -137.45 133.11 34.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.707 0.289 . . . . 0.0 110.861 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -141.22 124.6 16.62 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.153 0.502 . . . . 0.0 110.649 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -141.53 116.11 9.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.601 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 p -96.61 109.01 21.71 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.41 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.47 64.12 2.84 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.821 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.72 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.5 p90 -63.57 -41.54 98.38 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.321 0.581 . . . . 0.0 109.934 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.425 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 79.8 p 56.35 79.23 0.18 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.633 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 70.7 113.55 0.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.793 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.0 13.22 46.96 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.938 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.72 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -92.1 -36.88 6.15 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.501 -0.38 . . . . 0.0 112.474 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 2.2 pm0 -60.37 -18.9 53.44 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.984 0.513 . . . . 0.0 112.284 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.95 94.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.88 -33.52 68.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.593 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -60.98 -50.62 72.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.265 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.3 tp -66.24 -39.19 83.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.4 ttpp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.582 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 14.8 tptp -66.87 -33.95 76.73 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.152 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 139' ' ' LEU . 72.9 t -60.01 -44.84 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.33 0.586 . . . . 0.0 109.62 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 22.6 mmm180 -71.41 -23.61 61.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.43 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 55.9 mm-40 -62.06 -38.5 89.03 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 109.479 175.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.28 -41.52 99.0 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.81 -41.28 87.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.313 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -62.32 -6.98 3.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.199 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -59.07 -37.67 77.62 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 150.43 -177.05 28.75 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.988 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 67.3 m80 -106.38 146.86 29.94 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -62.67 -40.89 98.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.096 0.474 . . . . 0.0 110.783 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -122.27 121.36 36.6 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 24.5 p-80 50.47 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.974 0.91 . . . . 0.0 111.91 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -133.67 121.23 21.68 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 C--O 1.242 0.708 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.9 179.224 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.3 m120 . . . . . 0 C--O 1.236 0.36 0 CA-C-O 120.792 0.33 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.511 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 26.0 m -85.07 84.93 7.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.656 -177.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -102.78 -134.11 0.31 Allowed 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.716 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -137.73 -4.01 1.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.609 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 54.52 74.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.656 0.741 . . . . 0.0 110.25 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.403 HD13 ' HB ' ' A' ' 24' ' ' THR . 23.4 mt -122.67 162.1 40.35 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 -175.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.7 148.92 91.95 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.141 1.894 . . . . 0.0 110.215 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.24 80.19 0.99 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.211 0.529 . . . . 0.0 111.307 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.5 134.53 65.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.219 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -92.89 113.17 25.37 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 98' ' ' ASP . 29.1 mt -110.9 176.59 4.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -110.12 134.52 52.1 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.313 0.577 . . . . 0.0 112.017 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -75.97 177.02 7.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.325 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.462 HG22 ' HB ' ' A' ' 95' ' ' VAL . 33.3 pt -55.0 -41.53 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -81.44 -8.41 59.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.12 20.18 31.25 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.21 -176.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -78.3 141.18 38.67 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 m -78.66 108.24 11.92 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.007 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.58 134.4 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.219 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 77.9 mt-30 -100.9 134.75 43.41 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.589 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -64.74 -30.24 71.24 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -72.09 -13.15 61.5 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -125.12 14.88 8.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.2 tp -74.69 125.03 27.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.4 OUTLIER -136.69 140.23 42.53 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.411 HD22 ' HG2' ' A' ' 34' ' ' MET . 93.0 m-20 -101.22 -48.87 4.25 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.597 -178.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 168.73 31.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.735 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.511 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 71.38 36.09 63.2 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.581 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 46.1 mmtm -128.39 151.2 76.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.879 -0.16 . . . . 0.0 111.262 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 22.0 Cg_exo -62.69 151.66 82.45 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.691 2.261 . . . . 0.0 111.547 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.543 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 38.4 mtt -131.75 152.77 50.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -172.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.9 mt -130.22 118.13 42.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 86.0 mt -94.12 123.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.5 m -112.39 116.97 31.18 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.252 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 53.8 m-85 -88.16 111.22 21.37 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 30.7 p90 -123.86 154.72 39.26 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 123.68 0.613 . . . . 0.0 110.776 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.42 153.15 23.57 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.124 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -69.32 95.13 0.76 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.475 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 45.37 35.32 1.83 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.743 1.217 . . . . 0.0 113.408 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 54.1 t -76.98 -81.34 0.09 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.807 0.337 . . . . 0.0 111.873 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -142.92 158.35 59.35 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.489 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.38 44.83 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 124.166 3.244 . . . . 0.0 113.413 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 59.9 m -80.5 -4.74 55.03 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 173.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.0 58.17 1.46 Allowed 'General case' 0 C--N 1.345 0.37 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.877 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -64.63 -39.91 94.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.32 -176.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.649 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -64.34 -48.54 75.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.729 -179.213 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 93' ' ' TYR . 52.2 tp -63.62 -42.38 98.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.71 -46.32 88.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.963 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -61.91 -40.7 96.36 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.258 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.1 mt -64.79 -41.43 92.18 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.646 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -54.34 -30.97 53.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.24 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -79.47 -31.86 42.47 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 52' ' ' ALA . 16.1 m -122.42 23.68 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.0 t80 -63.37 -41.56 98.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.312 -0.242 . . . . 0.0 111.206 -177.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.3 83.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.164 0.507 . . . . 0.0 110.185 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.68 -43.1 94.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.39 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.487 ' NE1' HD13 ' A' ' 140' ' ' ILE . 19.0 m0 -70.05 -37.77 75.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -79.13 -6.81 57.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.869 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.2 -49.65 66.31 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.739 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -160.54 73.82 0.51 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.523 0.678 . . . . 0.0 110.27 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -158.95 -41.64 0.06 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.345 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' LYS . . . 72.02 32.1 63.67 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.479 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.27 121.51 42.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.076 0.465 . . . . 0.0 110.914 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -105.85 164.19 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.687 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD11 HG21 ' A' ' 53' ' ' ILE . 49.1 mt -105.37 134.48 48.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.499 . . . . 0.0 111.568 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.1 mt -109.56 109.17 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -95.71 123.72 39.41 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.233 -178.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.73 131.6 72.76 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.378 0.609 . . . . 0.0 111.32 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' HG21 ' A' ' 82' ' ' VAL . 17.0 p -83.57 134.53 34.81 Favored 'General case' 0 C--O 1.257 1.473 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.242 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.7 pt -78.9 -14.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.698 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 178.51 5.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.06 179.7 5.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.545 ' HA2' HD21 ' A' ' 97' ' ' LEU . . . -59.3 -33.1 74.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.943 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -63.54 -47.11 82.97 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -89.99 -29.63 18.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.6 -3.68 15.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -59.52 -24.04 63.33 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 121.798 -0.564 . . . . 0.0 111.274 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.726 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 73.9 mmtt -88.69 -1.21 57.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 72' ' ' SER . 95.4 t -65.49 -46.71 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -67.41 -42.77 39.72 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.886 -176.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.7 Cg_endo -62.2 -29.84 81.06 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 121.104 1.203 . . . . 0.0 110.902 175.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -62.88 -41.6 99.46 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -59.7 -42.38 92.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.698 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -45.41 65.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.76 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.57 -36.72 92.82 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.126 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -92.58 5.2 51.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.31 40.86 91.92 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.263 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.593 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 51.1 m0 -88.32 95.45 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.87 59.85 5.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.348 0.594 . . . . 0.0 110.737 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -137.56 -172.41 3.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.35 134.35 35.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 17' ' ' ILE . 42.8 t -119.95 132.66 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.536 0.684 . . . . 0.0 110.738 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -120.16 152.25 37.93 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.451 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.594 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 10.1 tt -120.71 117.78 28.38 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.377 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.624 ' HA ' HD22 ' A' ' 14' ' ' LEU . 13.3 t0 -81.52 117.25 21.77 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.762 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 t -113.86 -11.18 12.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 32.0 m-20 -84.83 -41.69 15.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 110.726 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.5 ' HA2' ' NZ ' ' A' ' 104' ' ' LYS . . . 94.92 -18.32 57.53 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.59 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 100' ' ' ASN . 5.2 p-10 -91.38 -8.55 47.66 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CE1' HG21 ' A' ' 24' ' ' THR . 88.0 t80 -63.85 -49.14 73.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.184 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.5 ' NZ ' ' HA2' ' A' ' 101' ' ' GLY . 13.1 pttm -62.42 -36.15 81.46 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.961 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -66.91 -43.54 83.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.283 0.563 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.86 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.939 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 107' ' ' MET . 1.7 mmt -78.5 -7.91 57.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.243 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.54 43.09 3.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.67 0.748 . . . . 0.0 111.043 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.23 98.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.328 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -85.83 -66.4 0.91 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.569 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 57.2 tp -107.89 129.65 55.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 pt -85.55 148.16 48.47 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 85.2 Cg_endo -82.75 166.91 67.92 Favored 'Cis proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.242 -1.149 . . . . 0.0 112.882 0.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -125.75 144.36 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.724 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.97 131.69 70.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 86.5 m-85 -126.64 124.15 39.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.4 mt -109.77 129.21 65.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.178 0.513 . . . . 0.0 110.467 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.543 ' HB ' ' H ' ' A' ' 34' ' ' MET . 85.5 t -103.62 128.74 56.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 20.3 t70 -75.88 162.73 27.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.653 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.59 -22.6 52.98 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.878 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -69.46 -18.87 63.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.996 0.426 . . . . 0.0 110.882 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 93.88 31.14 8.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.192 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.78 154.61 51.53 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.3 mt -69.9 123.87 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.371 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 13.7 p -105.08 -30.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.9 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.572 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.5 t80 -132.89 125.26 29.53 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.019 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -131.24 122.35 26.35 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.274 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -145.39 107.9 4.43 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.846 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.3 p -102.15 107.19 18.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.658 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 114.92 74.65 0.6 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.767 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.628 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -126.76 156.76 40.69 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.404 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 32.6 p -124.92 -58.46 1.47 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.015 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -144.39 136.07 25.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.418 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 3.98 63.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.288 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.18 -20.96 53.94 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.077 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.17 -22.7 64.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.271 0.558 . . . . 0.0 111.116 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.3 94.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.038 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -71.49 -31.63 67.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.694 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -61.64 -48.88 78.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.276 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.487 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.1 tp -67.96 -38.11 79.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.34 -42.25 98.37 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.9 mmpt? -65.45 -40.39 93.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LEU . 99.2 t -59.84 -46.68 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.359 0.6 . . . . 0.0 110.213 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 148' ' ' LYS . 22.1 mmm180 -66.94 -36.32 81.96 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.517 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.417 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 68.2 mm-40 -60.38 -34.1 73.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.58 0.229 . . . . 0.0 111.207 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 59.2 mt -63.43 -43.22 98.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.209 0.528 . . . . 0.0 109.921 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.86 -48.54 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.092 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -66.39 -31.31 72.0 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -74.09 -22.52 59.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.187 0.517 . . . . 0.0 110.424 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -81.27 83.37 1.5 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.194 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.429 ' O ' ' HA ' ' A' ' 155' ' ' HIS . 57.5 m80 -84.51 123.92 30.81 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -84.54 -18.84 34.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.137 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -60.39 -50.08 75.02 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.082 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 8.33 2.79 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 151' ' ' HIS . 70.7 m80 63.28 13.74 7.23 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.876 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 65.1 t60 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.215 -0.897 . . . . 0.0 110.97 179.759 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.7 t30 . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 16.3 m -156.8 60.9 0.53 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.132 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 43.5 m-85 -82.85 -140.39 0.05 Allowed 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.411 0.624 . . . . 0.0 109.791 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.6 12.89 1.17 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.843 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 49.33 60.76 3.53 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.654 0.74 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.2 mt -112.56 158.8 36.36 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.427 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.0 159.21 53.06 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.049 2.5 . . . . 0.0 110.681 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.22 82.34 2.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 103' ' ' PHE . 57.6 t -119.04 134.96 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.572 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.0 p -92.76 108.13 19.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.979 0.418 . . . . 0.0 111.131 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -112.58 174.93 5.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.592 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -108.81 136.57 48.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.793 0.33 . . . . 0.0 110.799 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -90.86 -171.43 3.01 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.783 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.19 -20.04 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -86.0 -21.65 27.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.243 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.98 10.35 58.75 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -175.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -85.85 146.33 26.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -74.4 116.91 15.6 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.404 0.621 . . . . 0.0 109.828 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.644 ' HB ' HD21 ' A' ' 27' ' ' LEU . 3.3 m -117.52 128.04 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.404 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 48.5 mt-30 -90.01 132.17 35.51 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.492 ' HA ' HD12 ' A' ' 27' ' ' LEU . 15.0 p -65.9 -29.47 69.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.629 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.44 -34.44 78.19 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -98.39 5.23 48.33 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.387 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.644 HD21 ' HB ' ' A' ' 22' ' ' VAL . 85.5 mt -73.51 117.0 14.75 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.734 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -132.5 154.18 50.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.566 177.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.584 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 63.3 t30 -89.52 -80.95 0.29 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.783 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 172.57 32.33 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.633 0.583 . . . . 0.0 110.755 -176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.66 -14.76 62.8 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 4.0 mptp? -100.14 143.42 26.48 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.7 164.73 34.73 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.209 2.606 . . . . 0.0 112.846 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 69' ' ' ILE . 73.4 mtm -138.69 160.5 39.48 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.729 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 73.1 mt -129.43 125.67 62.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.8 mt -97.11 126.78 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 m -114.47 122.24 45.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.188 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 73.1 m-85 -97.45 115.06 27.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -135.55 163.04 31.0 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.86 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.86 162.93 13.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.486 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.2 p -66.12 -41.71 90.16 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.296 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -101.31 86.35 2.98 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.1 p -67.48 121.42 15.77 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.796 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 67.1 mttm -102.71 -37.66 0.21 Allowed Pre-proline 0 CA--C 1.555 1.142 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.777 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 44' ' ' LYS . 89.1 Cg_endo -84.2 11.68 3.26 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 121.879 1.719 . . . . 0.0 111.15 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.4 m 62.0 16.89 8.53 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.501 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt 55.91 85.13 0.07 Allowed 'General case' 0 C--N 1.345 0.399 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.787 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 23.4 mmm180 -58.87 -48.95 79.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.247 -175.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.578 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.38 -52.62 31.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.614 -176.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.566 HD11 ' CE1' ' A' ' 93' ' ' TYR . 29.8 tp -63.55 -42.27 98.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.824 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -66.61 -49.53 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.69 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -63.21 -42.65 99.31 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.233 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.1 mt -64.03 -43.04 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.414 ' HB2' ' OH ' ' A' ' 93' ' ' TYR . 48.3 tt0 -59.23 -40.32 85.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.679 0.276 . . . . 0.0 110.846 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -66.7 -37.21 84.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 52' ' ' ALA . 31.3 m -107.36 19.17 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.071 0.462 . . . . 0.0 111.19 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -58.15 -40.49 81.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.883 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.6 81.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.619 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.43 -41.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.527 ' CH2' HG12 ' A' ' 53' ' ' ILE . 16.8 m0 -73.58 -42.42 61.62 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.253 0.549 . . . . 0.0 110.552 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.401 HE22 ' C ' ' A' ' 66' ' ' VAL . 2.2 mp0 -70.36 -9.8 57.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.208 0.603 . . . . 0.0 111.941 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.5 -49.35 64.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.063 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -136.6 -36.32 0.71 Allowed 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.036 -0.666 . . . . 0.0 112.77 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 143' ' ' VAL . 17.6 m -65.74 -43.32 89.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.813 0.34 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 32' ' ' LYS . . . 62.65 41.98 99.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.775 -177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.401 ' C ' HE22 ' A' ' 61' ' ' GLN . 6.8 p -91.33 117.71 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -94.5 162.98 13.59 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.503 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 62.7 mt -105.47 148.19 27.46 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.265 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.585 HD11 ' SD ' ' A' ' 34' ' ' MET . 88.9 mt -122.11 110.82 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.39 111.15 22.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.412 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 ' HZ1' ' A' ' 104' ' ' LYS . 9.0 p -116.59 123.49 71.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 CA-C-O 121.587 0.708 . . . . 0.0 111.555 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.625 ' HB2' HG21 ' A' ' 82' ' ' VAL . 35.4 t -80.06 131.89 35.86 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.83 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.608 ' HA ' ' HZ3' ' A' ' 104' ' ' LYS . 40.5 pt -79.96 -13.92 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.397 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.71 -177.89 5.95 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -94.99 176.99 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.48 66.5 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.205 -0.452 . . . . 0.0 114.065 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.75 -49.47 75.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.176 0.512 . . . . 0.0 111.54 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -90.41 -37.05 14.23 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.619 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.557 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -76.79 -3.95 40.99 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -63.02 -13.53 36.57 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.447 -0.783 . . . . 0.0 111.104 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.674 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 58.4 mttp -85.53 -8.3 58.4 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.8 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.625 HG21 ' HB2' ' A' ' 72' ' ' SER . 59.6 t -66.58 -46.0 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.692 0.758 . . . . 0.0 111.723 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 10.7 mtpp -67.32 -41.61 34.06 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.913 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.3 Cg_endo -61.97 -30.64 83.62 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 120.965 1.11 . . . . 0.0 110.6 173.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.98 -42.74 97.12 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -57.25 -48.28 79.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.992 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.06 -44.58 46.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.816 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.72 -47.71 80.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.256 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -73.93 -34.8 64.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.941 0.401 . . . . 0.0 111.308 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.79 49.21 1.98 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -77.27 109.36 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.136 0.493 . . . . 0.0 110.044 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.0 42.31 0.92 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.338 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.566 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -152.93 -179.72 7.91 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.242 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -72.75 140.16 47.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.384 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.27 129.57 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.494 HD13 HG23 ' A' ' 69' ' ' ILE . 11.1 mp -119.71 135.8 54.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.518 0.675 . . . . 0.0 111.58 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.0 tp -105.85 105.49 15.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.678 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.637 ' OD2' ' HE3' ' A' ' 104' ' ' LYS . 47.6 t0 -86.42 138.07 32.06 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 118.072 -1.451 . . . . 0.0 109.639 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.9 m -123.11 -0.36 8.92 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.397 0.617 . . . . 0.0 109.751 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.49 -59.22 1.92 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.278 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.52 -11.87 63.12 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.123 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.2 -24.37 43.2 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' HB2' HG11 ' A' ' 12' ' ' VAL . 75.8 t80 -61.46 -43.49 98.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.637 ' HE3' ' OD2' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.49 -41.99 95.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.042 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -66.72 -36.51 82.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.129 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.99 74.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.542 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 mmt -90.48 -9.35 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.069 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 63.19 59.86 1.24 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.352 0.596 . . . . 0.0 110.829 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 114' ' ' ALA . 65.5 t -77.32 93.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.335 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.3 t -79.31 -58.82 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.648 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.3 tp -110.75 138.43 47.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.924 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 pt -100.25 152.98 37.99 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.618 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.7 Cg_endo -82.86 154.77 74.83 Favored 'Cis proline' 0 N--CA 1.476 0.487 0 C-N-CA 124.039 -1.234 . . . . 0.0 112.012 -1.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -105.57 138.66 41.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.397 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 139' ' ' LEU . 77.3 t -126.5 130.79 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.63 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.19 125.53 33.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.093 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.662 HD11 HD13 ' A' ' 139' ' ' LEU . 59.4 mt -106.73 132.62 53.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 6' ' ' TYR . 55.8 t -109.52 130.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.043 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.91 166.6 23.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.223 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -23.58 58.42 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.751 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -71.26 -11.05 60.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.76 0.79 . . . . 0.0 109.559 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.84 34.51 Favored Glycine 0 CA--C 1.498 -0.971 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.823 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.29 154.03 36.9 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 94.6 mt -76.26 117.7 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 -20.57 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 69.1 t80 -137.53 126.6 24.38 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -134.91 114.91 13.01 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.159 0.504 . . . . 0.0 110.595 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -146.51 116.39 7.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.942 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 p -95.82 106.24 18.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.102 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.67 69.45 1.3 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.454 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 39.6 p90 -65.99 -44.83 83.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.999 0.4 . . . . 0.0 110.326 177.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p 49.07 85.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.305 1.042 . . . . 0.0 112.68 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 68.05 130.46 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.255 1.022 . . . . 0.0 112.489 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.77 2.33 90.5 Favored Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.644 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -70.94 -42.01 60.73 Favored Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 121.543 -0.36 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -58.55 -25.37 62.41 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.937 0.399 . . . . 0.0 111.384 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 96.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.497 0.665 . . . . 0.0 109.765 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.03 -30.21 63.58 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.08 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.662 HD13 HD11 ' A' ' 117' ' ' ILE . 4.4 mm? -60.13 -50.71 72.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.862 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -70.37 -36.77 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.314 0.578 . . . . 0.0 109.881 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -61.37 -44.9 96.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 41.0 tptt -66.57 -31.31 71.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 110.38 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.0 t -58.97 -44.23 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -66.32 -28.53 68.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.279 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 61.3 mm-40 -63.79 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.241 176.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.9 mt -76.82 -16.18 59.51 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.223 0.535 . . . . 0.0 110.611 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.6 t -98.55 3.68 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.719 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -58.64 -38.95 79.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -88.86 -11.87 43.48 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.11 0.481 . . . . 0.0 111.314 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -79.88 -151.98 7.22 Favored Glycine 0 C--N 1.309 -0.942 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.35 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.641 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -74.52 43.0 0.17 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -57.75 -45.11 86.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -92.79 -30.69 15.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.743 0.306 . . . . 0.0 111.051 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.641 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 52.5 t-80 -176.6 -63.58 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -179.04 -68.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.622 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 79.1 t60 . . . . . 0 C--N 1.315 -0.902 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.273 178.058 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.506 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 35.0 m . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.916 0.388 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.523 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 38.2 m-85 -92.1 -143.22 0.2 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.348 0.594 . . . . 0.0 109.907 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.55 14.72 2.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.841 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.477 ' HB3' HG13 ' A' ' 124' ' ' ILE . 52.4 tt0 50.42 42.85 26.78 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.862 0.839 . . . . 0.0 110.507 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt -92.56 152.01 41.68 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.746 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.52 156.72 55.05 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.343 2.695 . . . . 0.0 111.403 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.64 80.55 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 111.159 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.7 t -125.94 134.29 66.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -90.6 116.58 28.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.713 0.292 . . . . 0.0 110.45 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tp -116.09 173.66 6.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -117.22 128.07 54.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -91.53 -175.31 4.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.869 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 95' ' ' VAL . 29.6 pt -66.66 -21.43 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.913 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -82.17 -10.6 59.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.943 0.402 . . . . 0.0 110.491 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.94 20.19 68.45 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -100.03 141.32 33.01 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.3 m -75.62 110.83 10.35 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.186 0.517 . . . . 0.0 109.897 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 m -116.32 131.02 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.684 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 89.2 mt-30 -90.28 133.06 35.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.583 HG21 ' CE1' ' A' ' 103' ' ' PHE . 16.9 p -66.84 -29.78 69.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.64 -34.32 76.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.29 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.516 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -101.94 8.46 41.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.695 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.9 tp -70.45 117.22 11.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.251 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.523 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 46.7 mt-10 -130.09 141.56 50.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.758 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 28.1 t-20 -82.16 -75.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.12 29.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.378 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.506 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 93.98 2.3 64.64 Favored Glycine 0 C--O 1.23 -0.15 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.138 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -109.63 151.85 42.49 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 122.387 0.275 . . . . 0.0 110.999 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 19.9 Cg_exo -63.46 154.16 70.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.038 2.492 . . . . 0.0 112.033 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.758 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 73.6 mtm -132.91 147.86 52.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.683 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 78.1 mt -121.91 120.68 62.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.9 mt -99.36 119.27 47.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.0 m -102.58 119.21 38.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.85 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.665 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 72.5 m-85 -93.96 118.1 31.02 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.535 ' O ' HG12 ' A' ' 73' ' ' ILE . 20.2 p90 -144.09 162.99 34.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 123.634 0.584 . . . . 0.0 110.795 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.01 176.53 9.74 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.013 -177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p . . . . . 0 C--N 1.313 -1.006 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -176.634 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.33 -45.59 90.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.709 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.555 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -70.92 -45.21 64.64 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.862 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD11 ' CE1' ' A' ' 93' ' ' TYR . 27.2 tp -61.74 -43.43 98.87 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.23 -175.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.61 -48.42 77.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.41 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.37 -46.12 87.98 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.395 0.617 . . . . 0.0 111.197 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.2 mt -64.08 -41.73 93.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.468 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.933 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -54.36 -41.31 68.99 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 111.452 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -66.79 -38.12 85.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.64 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.17 21.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.281 0.563 . . . . 0.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.28 -44.48 88.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.408 0.683 . . . . 0.0 112.391 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.83 84.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.21 -40.98 99.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.979 0.419 . . . . 0.0 110.823 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -69.94 -40.68 75.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 55.1 mt-30 -64.61 -32.62 74.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.183 0.516 . . . . 0.0 110.739 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.46 -39.79 94.55 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.737 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -86.78 -86.2 0.15 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.394 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.566 HG23 ' H ' ' A' ' 66' ' ' VAL . 3.1 t -79.49 -16.04 56.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.876 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 71.86 17.63 77.0 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.407 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.566 ' H ' HG23 ' A' ' 64' ' ' THR . 10.7 p -63.63 140.21 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.127 0.489 . . . . 0.0 112.232 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.423 ' NE ' HD21 ' A' ' 29' ' ' ASN . 0.6 OUTLIER -113.59 163.98 14.26 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.633 177.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 58.5 mt -112.16 134.56 53.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.482 0.658 . . . . 0.0 111.511 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 96' ' ' LEU . 95.0 mt -111.44 109.95 30.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.809 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.11 111.2 22.25 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.27 133.9 58.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-O 121.959 0.885 . . . . 0.0 112.32 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.659 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.0 m -85.08 120.23 26.36 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.133 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 39' ' ' PHE . 45.5 pt -84.68 36.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 123.987 0.804 . . . . 0.0 110.656 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -131.1 -167.88 1.91 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -95.06 165.92 12.19 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . -60.28 -37.21 92.67 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.384 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.409 ' HG3' ' N ' ' A' ' 78' ' ' ASN . 27.7 pt20 -60.38 -42.58 96.16 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.915 0.388 . . . . 0.0 111.324 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.409 ' N ' ' HG3' ' A' ' 77' ' ' GLN . 86.8 m-20 -81.69 -32.99 31.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -68.95 -5.63 22.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.424 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 15.6 mm100 -62.35 -12.85 23.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.824 0.345 . . . . 0.0 110.714 176.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.744 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 37.3 mtmm -93.7 -11.78 30.76 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.713 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.659 HG21 ' OG ' ' A' ' 72' ' ' SER . 20.1 t -68.58 -47.54 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.669 0.747 . . . . 0.0 111.571 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.8 mtpt -64.27 -44.65 77.1 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.722 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 13.1 Cg_endo -60.36 -32.29 93.82 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.194 1.263 . . . . 0.0 111.276 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.94 -43.63 98.28 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.36 92.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.127 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.69 -46.5 63.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.257 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.86 -48.22 68.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.296 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -67.88 -34.56 76.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.0 111.519 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.24 52.31 1.25 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.354 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -84.81 132.62 34.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.929 0.395 . . . . 0.0 110.345 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -103.8 33.07 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.188 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -145.33 -179.95 6.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -81.8 141.96 33.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 112.267 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 17' ' ' ILE . 38.9 t -120.76 134.75 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.539 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -121.48 138.57 54.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.763 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.578 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.6 mp -111.2 120.04 40.94 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 63.2 t0 -74.3 117.69 16.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.494 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.1 p -93.8 2.6 56.18 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -121.96 -37.53 2.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.812 0.339 . . . . 0.0 111.145 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.492 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 90.69 8.49 65.46 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.968 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.73 -17.35 17.77 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.583 ' CE1' HG21 ' A' ' 24' ' ' THR . 68.9 t80 -63.07 -43.62 98.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 110.582 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -59.23 -36.06 74.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 105' ' ' ARG . 36.3 ttm180 -71.95 -41.12 68.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.321 0.581 . . . . 0.0 110.308 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.33 84.75 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 31.0 mmm -96.76 -11.08 25.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.739 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 68.84 93.08 0.08 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.556 0.743 . . . . 0.0 112.006 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.88 83.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.8 m -62.15 -48.9 78.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.973 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.0 tp -151.48 132.43 14.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.592 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 148.16 55.11 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.51 147.82 87.76 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.699 -1.375 . . . . 0.0 112.588 0.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -114.72 128.98 56.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.851 175.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 139' ' ' LEU . 41.8 t -114.23 122.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -120.77 115.26 22.96 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.585 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 61.7 mt -103.86 131.51 52.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.274 0.559 . . . . 0.0 110.512 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 66.8 t -108.95 130.43 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.946 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.82 165.21 25.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.366 0.666 . . . . 0.0 111.071 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.79 -20.34 47.3 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.073 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -84.31 4.11 32.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.876 0.338 . . . . 0.0 111.06 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.54 48.4 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.88 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -126.68 152.53 46.62 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.6 mt -75.01 118.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -107.98 -30.69 2.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.268 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.585 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 90.0 t80 -141.58 140.39 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -136.06 130.7 33.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.193 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -141.2 104.1 4.56 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.1 m -104.17 120.19 40.58 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.045 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.69 47.76 66.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.667 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 31.6 p90 -67.59 -43.96 79.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 109.562 176.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.461 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 61.0 p 57.01 87.74 0.06 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.863 1.265 . . . . 0.0 113.036 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 72.07 127.71 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.118 0.967 . . . . 0.0 112.29 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.51 68.07 Favored Glycine 0 CA--C 1.51 -0.264 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.063 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.667 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -73.07 -21.6 79.7 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.249 -0.476 . . . . 0.0 112.257 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 1.4 mp0 -56.27 -30.6 62.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.818 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.75 92.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.34 -31.24 67.14 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.678 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.0 mm? -60.38 -52.27 65.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.683 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.8 tp -69.4 -32.79 54.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.203 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.8 ttpp -62.68 -47.34 84.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.939 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -66.34 -32.19 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 110.257 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 139' ' ' LEU . 55.4 t -59.41 -43.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.734 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 27.1 mmt180 -64.62 -36.02 82.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 67.2 mm-40 -58.53 -42.3 87.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.715 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 56.9 mt . . . . . 0 C--N 1.334 -0.107 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.314 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.444 -0.766 0 CA-C-O 121.22 0.534 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.558 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 31.6 m-85 -98.96 -134.02 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.95 155.82 40.65 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.456 ' H ' HG13 ' A' ' 124' ' ' ILE . 53.4 tt0 -74.52 75.84 1.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 81.4 mt -117.98 140.29 27.65 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.885 -174.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 22.6 Cg_exo -64.19 155.75 63.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.15 2.567 . . . . 0.0 110.673 174.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 91.22 0.46 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 154.53 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.888 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -98.01 134.04 41.65 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tp -131.89 165.31 24.17 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 20' ' ' LYS . 1.2 tppp? -113.2 129.61 56.46 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.223 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 20' ' ' LYS . 46.5 p30 -94.67 -174.88 3.43 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 95' ' ' VAL . 32.4 pt -68.42 -18.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.953 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -84.04 -12.4 55.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.924 0.392 . . . . 0.0 110.432 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 16.87 72.16 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' HD21 ' A' ' 16' ' ' ASN . 86.4 tttt -96.1 145.63 25.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.413 -0.894 . . . . 0.0 110.601 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.7 m -80.38 114.0 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.877 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 m -120.65 134.11 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.969 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.423 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.1 mt-30 -88.91 134.95 33.78 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.569 HG21 ' CE1' ' A' ' 103' ' ' PHE . 25.0 p -65.48 -31.04 71.91 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.2 -28.62 69.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.22 16.44 23.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.045 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.6 tp -79.03 101.27 7.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.058 0.456 . . . . 0.0 111.95 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.558 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.1 mt-10 -119.11 122.89 43.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.987 177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -70.88 -43.06 69.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.27 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 0.0 109.464 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.91 33.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.395 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -128.67 151.74 77.54 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 122.415 0.286 . . . . 0.0 110.864 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.95 155.5 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.275 . . . . 0.0 111.621 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.421 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 38.2 mtt -129.92 153.43 48.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.93 0.395 . . . . 0.0 111.805 -171.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.8 mt -128.3 117.28 44.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 82.1 mt -96.79 118.16 42.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 m -104.88 116.07 31.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -90.8 115.78 28.13 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -138.2 168.48 19.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.207 0.527 . . . . 0.0 112.119 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.05 166.98 11.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.336 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.612 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.593 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -63.87 -45.96 87.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.582 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -66.2 -46.37 77.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.137 -176.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.598 ' HG ' HE21 ' A' ' 54' ' ' GLN . 33.8 tp -63.8 -42.51 97.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -61.6 -48.44 80.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.562 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -61.37 -42.56 98.9 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.006 0.432 . . . . 0.0 111.02 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.3 mt -64.96 -42.27 94.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.046 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.598 HE21 ' HG ' ' A' ' 50' ' ' LEU . 78.5 mt-30 -55.49 -40.86 72.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 111.298 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.28 -38.13 87.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.742 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 52' ' ' ALA . 18.1 m -116.22 27.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.002 0.43 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 53' ' ' ILE . 65.0 t80 -58.64 -39.6 81.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.627 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.45 87.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.641 0.258 . . . . 0.0 110.846 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.55 -41.71 96.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.297 0.57 . . . . 0.0 110.417 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.612 ' O ' ' HB ' ' A' ' 64' ' ' THR . 11.9 m0 -71.18 -37.03 72.18 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.714 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -80.2 -8.92 59.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.787 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.57 -60.43 3.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.182 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.11 -4.25 3.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.758 0.314 . . . . 0.0 111.796 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 18.1 m -96.11 -35.54 11.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.253 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.08 31.33 65.12 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.853 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.95 128.93 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.447 0.641 . . . . 0.0 112.117 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -94.15 152.24 18.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.381 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 39.3 mt -111.94 130.11 55.95 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.138 0.494 . . . . 0.0 111.165 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 96' ' ' LEU . 91.0 mt -110.01 106.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.16 113.21 25.42 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.616 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 10.8 p -122.47 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.254 0.55 . . . . 0.0 111.84 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.6 p -88.66 143.48 26.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.719 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.0 pt -78.31 -13.99 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.111 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -84.39 153.97 23.12 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.707 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.57 168.1 13.64 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 123.52 0.513 . . . . 0.0 110.087 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -55.47 -40.77 78.73 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.142 0.417 . . . . 0.0 114.142 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.2 -39.37 92.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.224 0.512 . . . . 0.0 111.32 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -83.32 -32.65 26.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.362 0.601 . . . . 0.0 110.53 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -79.01 -2.06 38.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.094 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 99.1 mt-30 -57.86 -16.09 10.63 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.916 -0.49 . . . . 0.0 111.146 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.686 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.7 mttp -84.91 -14.82 46.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.431 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 79' ' ' ALA . 49.8 t -65.68 -47.13 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.805 0.812 . . . . 0.0 112.272 -175.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.0 mtpm? -67.34 -42.87 41.02 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.55 -176.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.622 ' HA ' ' OD2' ' A' ' 87' ' ' ASP . 17.9 Cg_endo -61.89 -28.63 81.4 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.107 1.204 . . . . 0.0 111.001 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.96 -42.2 97.36 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 91' ' ' TRP . . . -57.99 -49.12 77.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.773 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 p30 -75.0 -35.96 61.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.996 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.28 -49.59 56.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.877 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -74.6 -34.1 62.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.924 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.217 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 54.4 m0 -95.09 117.79 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.35 47.88 0.93 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -149.23 -169.62 3.42 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.795 -0.184 . . . . 0.0 110.576 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -89.09 135.84 33.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.428 0.633 . . . . 0.0 111.983 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 17' ' ' ILE . 58.8 t -118.07 132.45 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.767 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 8.1 mp -130.3 146.12 51.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.947 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -126.36 127.68 45.88 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -61.01 133.59 56.24 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.1 t -114.75 7.28 15.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.537 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -142.94 -30.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.53 63.09 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.968 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -74.59 -36.87 63.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.418 0.151 . . . . 0.0 111.136 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.569 ' CE1' HG21 ' A' ' 24' ' ' THR . 79.9 t80 -62.19 -48.65 79.07 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -61.59 -35.01 76.63 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.851 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -70.56 -42.43 71.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.375 0.607 . . . . 0.0 110.063 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 10' ' ' PRO . . . -61.43 -37.65 84.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.315 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 28.5 mmm -82.64 -22.77 34.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.317 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.0 t30 72.13 81.75 0.14 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.462 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.91 99.79 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.266 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.2 m -71.71 -69.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.803 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.405 HD21 ' CG2' ' A' ' 132' ' ' THR . 60.4 tp -115.43 131.12 57.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.6 pt -88.67 144.42 33.36 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -80.45 161.58 83.9 Favored 'Cis proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.838 -1.318 . . . . 0.0 113.564 0.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.22 145.08 49.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.958 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.49 130.15 74.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.108 0.48 . . . . 0.0 112.168 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 82.4 m-85 -125.41 124.86 42.39 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.592 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 75.7 mt -114.2 131.07 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.051 0.453 . . . . 0.0 111.057 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 54.8 t -108.92 132.93 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 123.886 0.874 . . . . 0.0 110.057 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -95.04 -171.91 2.55 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.269 0.356 . . . . 0.0 111.111 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.87 66.44 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.983 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -75.09 -2.02 25.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.987 0.393 . . . . 0.0 111.338 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 73.78 30.96 60.88 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.032 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 48.2 mmtm -133.01 168.47 18.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 8' ' ' GLN . 98.2 mt -90.24 112.37 24.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.082 0.468 . . . . 0.0 110.349 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.69 -31.83 5.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.489 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.592 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.4 t80 -124.55 130.71 52.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.043 0.449 . . . . 0.0 111.337 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -130.06 120.67 25.05 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.057 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -144.36 102.84 3.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.884 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.2 p -102.79 106.76 17.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 113.21 71.14 0.56 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.991 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.584 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -122.22 157.06 32.45 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.405 ' CG2' HD21 ' A' ' 111' ' ' LEU . 27.9 p -127.02 -41.85 1.77 Allowed 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.869 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -167.89 124.05 1.07 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.18 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.39 -3.19 32.83 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.39 -18.71 65.9 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.77 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.0 mp0 -60.22 -20.83 60.48 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.094 0.557 . . . . 0.0 111.369 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.6 94.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.483 0.659 . . . . 0.0 110.706 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.7 -32.06 69.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.708 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -61.82 -47.52 84.73 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.515 HD13 ' NE1' ' A' ' 60' ' ' TRP . 5.1 tp -68.54 -39.54 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.721 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.3 ttpp -60.65 -45.86 92.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.155 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 142' ' ' LYS . 42.1 tptt -66.06 -35.16 79.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.385 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -60.78 -42.7 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 144' ' ' ARG . 6.3 mmp_? -64.38 -34.53 78.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.129 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 51.7 mm-40 -61.6 -35.08 76.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.438 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.63 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.638 HG22 ' HE1' ' A' ' 34' ' ' MET . 37.3 m . . . . . 0 N--CA 1.439 -1.016 0 CA-C-O 120.961 0.41 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.482 ' CE2' ' HA ' ' A' ' 26' ' ' LYS . 93.2 m-85 -103.48 -80.58 0.52 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.315 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.56 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 166.98 -10.77 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 O-C-N 124.514 1.134 . . . . 0.0 110.334 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 55.3 tp60 63.88 44.79 4.65 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.915 0.864 . . . . 0.0 110.298 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.499 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 18.9 mt -98.16 159.42 30.76 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.912 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.63 148.19 93.59 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.301 2.001 . . . . 0.0 109.617 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.02 84.06 2.27 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.063 0.458 . . . . 0.0 111.2 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -117.92 132.95 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -87.97 109.83 20.12 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.09 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.768 HD22 ' HA ' ' A' ' 98' ' ' ASP . 33.3 mt -116.75 175.92 5.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.949 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.57 138.58 40.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.389 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.494 HD21 ' HB3' ' A' ' 20' ' ' LYS . 5.6 p30 -101.77 -175.04 2.73 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.439 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 32.4 pt -63.77 -22.57 31.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.97 -12.31 60.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.09 81.69 Favored Glycine 0 CA--C 1.503 -0.689 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.494 ' HB3' HD21 ' A' ' 16' ' ' ASN . 37.1 ttpt -96.45 141.16 30.08 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.6 m -73.43 115.09 12.39 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 16' ' ' ASN . 8.6 m -122.16 132.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.87 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 79.0 mt-30 -87.77 134.53 33.66 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.499 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 6.7 p -63.76 -28.54 69.94 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.106 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -75.84 -10.68 59.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.72 0.295 . . . . 0.0 111.34 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -126.48 12.96 7.56 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.489 0.185 . . . . 0.0 111.349 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.09 -48.89 78.19 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -172.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 33.06 97.98 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.419 1.104 . . . . 0.0 113.904 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 34' ' ' MET . 13.1 m120 -66.16 -58.39 5.53 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.367 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.69 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.72 4.89 89.88 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.159 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -112.67 150.89 43.42 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.57 150.45 81.63 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.87 2.38 . . . . 0.0 111.751 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.638 ' HE1' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -131.42 154.89 48.19 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.087 0.47 . . . . 0.0 111.065 -176.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.55 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.3 mt -123.08 122.85 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.1 mt -95.73 122.46 47.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.42 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 3.5 m -104.85 118.85 37.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.069 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 72.1 m-85 -95.19 116.86 29.3 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.49 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 28.1 p90 -142.56 171.42 14.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.605 0.566 . . . . 0.0 112.153 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.57 32.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.406 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.429 ' CG2' HG22 ' A' ' 82' ' ' VAL . 48.6 p . . . . . 0 C--N 1.319 -0.757 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.087 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.49 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 6.6 mt . . . . . 0 CA--C 1.518 -0.27 0 CA-C-O 121.311 0.577 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -57.52 -39.82 77.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.938 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.589 ' HA ' ' OH ' ' A' ' 131' ' ' TYR . 3.8 tm-20 -66.99 -54.83 18.04 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.2 tp -63.11 -40.78 98.63 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.059 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.0 tttt -62.13 -45.24 94.31 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.212 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -58.77 -46.66 87.0 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.498 ' CG2' HD11 ' A' ' 68' ' ' LEU . 58.8 mt -64.69 -43.16 96.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.168 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -54.62 -42.01 70.68 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.08 0.467 . . . . 0.0 110.993 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 51.2 mm-40 -65.88 -37.56 86.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.901 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 52' ' ' ALA . 30.7 m -110.99 17.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.21 -41.38 92.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.79 86.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 19.0 t70 -64.5 -41.75 96.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.148 0.499 . . . . 0.0 110.439 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.497 ' NE1' HD13 ' A' ' 140' ' ' ILE . 28.8 m0 -72.31 -42.33 65.58 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.263 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 18.6 mm-40 -65.79 -24.11 66.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.236 0.541 . . . . 0.0 110.604 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 36.1 t70 -59.62 -46.41 89.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.52 -70.11 0.77 Allowed 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.491 HG23 ' N ' ' A' ' 66' ' ' VAL . 2.8 t -77.41 -22.12 52.06 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.076 0.465 . . . . 0.0 111.221 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 66.45 32.17 80.97 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.28 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.491 ' N ' HG23 ' A' ' 64' ' ' THR . 14.8 p -63.28 136.56 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -102.63 156.38 17.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.069 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.575 HD12 ' CE2' ' A' ' 93' ' ' TYR . 68.9 mt -116.18 133.15 56.33 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.075 0.464 . . . . 0.0 111.206 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.548 HG23 HD13 ' A' ' 96' ' ' LEU . 86.4 mt -110.02 102.99 14.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.67 118.06 29.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.2 p -122.43 133.1 69.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.212 0 CA-C-O 121.634 0.731 . . . . 0.0 111.727 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.664 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 21.4 p -84.71 140.86 30.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.551 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.413 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 43.0 pt -80.81 -15.52 12.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.28 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.664 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -84.63 159.46 20.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.687 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.504 ' HB2' ' OE1' ' A' ' 77' ' ' GLN . 43.2 mt-10 -72.38 178.22 4.1 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.277 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.64 -48.99 67.64 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 115.423 0.929 . . . . 0.0 115.423 -173.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.504 ' OE1' ' HB2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -65.43 -40.7 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.734 0.767 . . . . 0.0 111.338 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -69.13 -39.63 78.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.229 0.537 . . . . 0.0 110.959 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -72.22 -4.16 27.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.152 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.6 -13.69 15.86 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.656 -0.653 . . . . 0.0 111.346 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.717 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.9 tttp -92.58 -10.45 37.49 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 122.764 0.425 . . . . 0.0 111.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.6 t -66.96 -47.36 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-O 121.547 0.689 . . . . 0.0 111.804 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 43.2 mtpt -63.64 -45.32 82.51 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.987 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -61.06 -31.16 90.62 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.091 1.194 . . . . 0.0 111.098 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -62.64 -44.2 96.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.22 98.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.415 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.22 -50.88 68.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.523 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.8 -44.86 46.35 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.789 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.58 41.91 3.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.411 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.423 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 53.2 m0 -83.35 108.31 16.45 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.0 42.28 1.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.575 ' CE2' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -146.23 177.62 8.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.845 -0.161 . . . . 0.0 111.303 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.78 137.77 40.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.391 0.615 . . . . 0.0 112.394 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -119.76 132.5 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.868 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.548 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -125.36 144.87 50.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.94 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.83 121.92 46.54 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.768 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.1 t0 -70.08 115.28 9.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.343 -1.343 . . . . 0.0 107.648 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.6 t -83.41 -15.25 50.47 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -173.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -120.18 -29.89 4.77 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.28 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.11 1.4 62.92 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.53 -14.19 28.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.448 ' CE1' HG21 ' A' ' 24' ' ' THR . 87.5 t80 -64.91 -44.96 87.85 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 25.6 pttm -63.19 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.2 -34.8 76.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.245 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.78 76.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.105 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 38' ' ' PHE . 23.6 mmt -84.87 -18.25 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.395 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 68.22 78.91 0.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.441 0.696 . . . . 0.0 110.332 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.42 89.4 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.6 m -68.83 -44.85 72.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.792 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.2 tp -137.12 134.74 36.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 11.5 pt -91.36 156.33 43.59 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.61 151.48 94.57 Favored 'Cis proline' 0 C--O 1.238 0.492 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.503 0.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -115.33 130.53 56.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 49' ' ' GLU . 24.2 t -110.99 126.27 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 123.291 0.369 . . . . 0.0 111.373 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 69.9 m-85 -128.03 115.06 17.9 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 60.5 mt -105.71 132.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.295 0.569 . . . . 0.0 111.452 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -109.68 134.88 50.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.478 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -90.16 -172.76 3.6 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.238 0.336 . . . . 0.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.93 -30.32 76.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.447 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -69.41 -14.53 62.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.58 0.705 . . . . 0.0 109.67 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 82.75 31.74 28.87 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.601 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 10.2 mptt -123.43 157.38 33.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.443 . . . . 0.0 110.111 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 7' ' ' ALA . 49.7 mt -74.66 100.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.035 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -88.03 -39.0 12.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.675 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 81.9 t80 -131.81 136.63 47.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.818 0.342 . . . . 0.0 111.652 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -131.03 134.63 46.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.099 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.2 t60 -148.95 103.09 3.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.5 m -103.2 118.88 37.77 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.11 0.481 . . . . 0.0 111.829 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.74 45.41 44.26 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.702 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 15.0 p90 -68.08 -37.51 81.31 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.081 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 43.2 p 77.41 -59.94 0.45 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.163 1.785 . . . . 0.0 112.278 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -147.8 142.87 27.06 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.582 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.11 19.17 67.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.702 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.98 -27.02 20.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.255 -0.473 . . . . 0.0 113.122 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 140' ' ' ILE . 5.7 pm0 -60.51 -22.18 63.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.337 0.255 . . . . 0.0 111.662 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.12 99.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.398 0.618 . . . . 0.0 110.112 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.0 -37.7 66.89 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.414 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -63.21 -46.56 86.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.543 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.497 HD13 ' NE1' ' A' ' 60' ' ' TRP . 7.2 tp -66.34 -34.79 72.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.819 0.342 . . . . 0.0 110.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.1 ttmt -56.43 -54.3 47.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.888 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 29.0 mmmt -66.04 -32.81 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 139' ' ' LEU . 52.9 t -62.0 -43.74 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.287 0.565 . . . . 0.0 109.934 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.425 ' NE ' HD11 ' A' ' 140' ' ' ILE . 78.2 mtt180 -84.27 -18.63 35.77 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.312 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 61.2 mm-40 -69.92 -30.16 67.5 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.415 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.0 mt . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 110.105 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.444 ' HA ' ' CA ' ' A' ' 122' ' ' GLY . 40.0 m . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 121.334 0.588 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.546 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 89.1 m-85 -100.87 -101.38 0.25 Allowed 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -177.41 11.5 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 25.4 tt0 54.57 34.8 22.06 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.793 0.806 . . . . 0.0 110.579 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.429 HD13 ' OG1' ' A' ' 24' ' ' THR . 79.3 mt -89.84 150.45 43.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.652 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.44 151.89 82.75 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.717 2.278 . . . . 0.0 111.476 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.31 84.13 2.45 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.905 0.383 . . . . 0.0 110.981 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 24' ' ' THR . 72.3 t -121.38 136.76 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -78.07 126.35 30.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 96' ' ' LEU . 1.9 tp -134.34 173.07 12.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.536 -176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -116.28 133.56 55.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -97.84 -179.89 4.58 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 95' ' ' VAL . 17.5 pt -64.3 -22.17 30.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -77.94 -16.64 58.01 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.901 0.381 . . . . 0.0 110.828 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.56 58.83 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.92 140.36 36.31 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.673 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.1 m -74.38 116.54 15.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.119 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.82 156.81 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.976 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -104.22 134.83 46.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 176.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -67.16 -16.38 64.28 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -93.05 7.52 43.8 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 121.774 -0.579 . . . . 0.0 112.09 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -136.45 16.35 3.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.836 -0.54 . . . . 0.0 111.297 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.8 -67.52 0.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.34 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.546 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 35.1 mt-10 64.52 175.66 0.19 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.701 0.762 . . . . 0.0 112.516 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.409 ' HB2' ' HE2' ' A' ' 34' ' ' MET . 0.3 OUTLIER -139.25 -78.27 0.33 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.539 178.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.77 31.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.261 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.45 34.15 29.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.298 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 71.7 mmtt -123.47 145.9 48.23 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 122.141 0.176 . . . . 0.0 111.008 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 12.8 Cg_exo -67.82 155.22 70.72 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.813 2.342 . . . . 0.0 111.832 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.409 ' HE2' ' HB2' ' A' ' 29' ' ' ASN . 36.6 mtt -133.97 160.68 36.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.169 0.509 . . . . 0.0 111.61 -174.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 97.2 mt -132.48 118.78 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -99.37 118.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 m -104.1 122.97 46.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.178 0.513 . . . . 0.0 110.191 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 62.8 m-85 -94.16 114.88 27.09 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.236 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HB2' HD22 ' A' ' 47' ' ' LEU . 25.0 p90 -135.25 170.73 15.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.641 0.588 . . . . 0.0 111.284 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.81 153.92 29.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.998 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.674 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.547 HD22 ' HB2' ' A' ' 39' ' ' PHE . 34.8 mt . . . . . 0 C--O 1.223 -0.325 0 CA-C-O 120.363 0.125 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? 61.15 -80.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.4 pt-20 -52.87 -52.86 55.86 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 112.229 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.422 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 47.0 tp -61.51 -42.7 99.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.634 0.254 . . . . 0.0 110.598 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 88.6 tttt -67.09 -46.92 72.8 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.626 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.95 97.56 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.0 mt -64.01 -41.38 92.31 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.817 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.726 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.51 -36.99 67.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.768 0.318 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 13.6 mm-40 -69.92 -39.65 76.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.488 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 m -114.84 27.35 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.178 0.513 . . . . 0.0 112.116 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 85.7 t80 -59.4 -35.61 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.749 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.669 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.72 -42.98 94.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.951 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.56 -36.81 76.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 0.0 110.59 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -82.08 -7.67 59.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -58.03 -48.99 78.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.039 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -131.95 -44.19 0.96 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -39.67 94.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 40.79 96.11 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.117 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.54 133.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.79 159.78 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 54.7 mt -108.28 139.3 43.17 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.267 0.556 . . . . 0.0 111.196 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 96' ' ' LEU . 79.2 mt -115.81 110.94 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.611 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -92.76 114.1 26.56 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.52 131.75 63.16 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.936 0.874 . . . . 0.0 111.627 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.576 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.1 m -88.69 119.39 29.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.146 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 pt -77.75 -17.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.939 0.774 . . . . 0.0 109.738 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 4.5 m-20 -73.09 146.34 45.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.155 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.5 -173.82 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.159 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.511 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -43.13 -58.32 3.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.858 -1.064 . . . . 0.0 115.403 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 13.9 pt20 -65.85 -45.17 83.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.408 0.604 . . . . 0.0 112.088 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.512 ' CB ' ' HB3' ' A' ' 74' ' ' ASP . 7.3 m-20 -66.7 -41.4 88.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -72.88 -5.31 37.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 79.4 mt-30 -66.01 -10.56 40.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.802 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.76 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 96.0 mttt -94.87 -11.04 29.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.549 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 79' ' ' ALA . 14.1 t -68.65 -50.77 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 40.6 mtpt -66.26 -40.35 34.78 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.605 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 5.9 Cg_endo -58.69 -34.3 98.84 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.185 1.256 . . . . 0.0 110.334 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -64.05 -42.21 97.11 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.435 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -61.08 -43.48 98.82 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.25 -40.41 67.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.89 -42.32 92.92 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.309 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -88.86 -15.73 33.73 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.952 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.6 61.09 4.61 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.734 -0.667 . . . . 0.0 113.276 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.435 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 31.4 m0 -82.41 134.54 35.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.896 0.379 . . . . 0.0 110.323 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -94.65 30.83 1.92 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.383 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.527 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -132.15 171.52 13.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.921 -172.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -81.85 136.17 35.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 17' ' ' ILE . 13.9 t -116.66 144.19 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.072 0.463 . . . . 0.0 110.59 -176.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 14' ' ' LEU . 11.3 mp -124.64 142.46 51.36 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.037 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.738 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 9.9 mp -114.76 117.38 30.61 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -81.16 115.16 20.44 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 t -96.17 -8.19 33.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.383 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -111.65 -30.98 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.835 0.35 . . . . 0.0 111.163 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.27 14.54 68.62 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.56 -27.15 16.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.927 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.52 -45.92 90.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.043 0.449 . . . . 0.0 110.782 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -62.82 -38.91 92.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.191 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -70.69 -41.5 71.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.421 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.59 74.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.882 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.57 -9.65 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.898 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.83 52.23 3.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.978 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.31 89.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.928 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.6 m -69.33 -45.34 69.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.317 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.92 142.28 36.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.983 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 pt -101.83 153.12 38.16 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.551 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 96.0 Cg_endo -78.52 154.32 92.23 Favored 'Cis proline' 0 C--O 1.244 0.778 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.186 0.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -116.65 136.25 53.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.089 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -114.91 127.9 72.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.089 0.471 . . . . 0.0 111.651 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -128.19 114.56 17.13 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.281 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.5 mt -103.05 129.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 CA-C-O 121.199 0.523 . . . . 0.0 110.627 -178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.8 t -106.46 128.52 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.114 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -76.61 161.89 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.59 -21.45 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 114.08 0.392 . . . . 0.0 114.08 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.485 ' OD1' ' HB2' ' A' ' 123' ' ' LYS . 6.3 p30 -74.07 -16.45 61.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.687 0.743 . . . . 0.0 111.253 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 5' ' ' THR . . . 101.38 17.91 20.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.222 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.485 ' HB2' ' OD1' ' A' ' 121' ' ' ASN . 13.6 mptt -121.94 152.16 39.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.227 0.537 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.1 mt -75.45 111.54 11.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.583 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.12 -19.12 6.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.524 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 68.2 t80 -144.43 130.25 19.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.292 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -138.3 129.04 26.64 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.957 0.408 . . . . 0.0 110.305 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 112.64 8.49 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.092 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.8 p -95.8 106.67 18.83 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.776 0.322 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.24 59.14 2.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.23 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.594 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 41.4 p90 -67.55 -35.81 79.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 109.052 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 80.7 p 69.37 -88.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.216 1.807 . . . . 0.0 113.622 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -119.2 119.1 33.12 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.098 -0.377 . . . . 0.0 111.386 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.58 33.56 16.05 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.527 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.594 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -89.89 -27.11 22.54 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.694 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 140' ' ' ILE . 9.2 pt-20 -54.83 -26.0 32.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.641 0.776 . . . . 0.0 112.804 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.19 94.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 0.0 110.856 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.93 -33.41 68.24 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.547 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.6 -53.38 55.52 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.492 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 136' ' ' GLU . 6.2 tp -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.961 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -63.03 -44.38 96.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.16 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.442 ' HG2' ' HB2' ' A' ' 126' ' ' TYR . 44.6 tptt -68.33 -31.34 70.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 139' ' ' LEU . 69.3 t -59.17 -42.45 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.279 0.561 . . . . 0.0 109.489 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -64.31 -35.75 81.88 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.091 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -62.07 -32.02 72.51 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.601 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--O 1.237 0.429 0 CA-C-O 121.243 0.544 . . . . 0.0 110.038 179.294 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.44 -0.949 0 CA-C-O 121.031 0.443 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.467 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 29.0 m-85 -92.68 -136.57 0.17 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.473 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -144.54 19.27 1.69 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.469 ' HB3' HG13 ' A' ' 124' ' ' ILE . 50.9 tt0 53.67 38.83 29.26 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.012 0.91 . . . . 0.0 110.444 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 65.6 mt -92.3 162.28 30.48 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.75 -175.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.68 168.6 23.26 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.273 2.649 . . . . 0.0 110.963 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.69 79.12 6.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.114 0.483 . . . . 0.0 110.61 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.22 134.43 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.1 m -96.68 116.18 28.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.849 0.357 . . . . 0.0 110.157 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 98' ' ' ASP . 47.4 mt -113.35 176.28 5.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.799 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -109.41 127.24 54.23 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.288 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.434 HD21 ' HB3' ' A' ' 20' ' ' LYS . 47.8 p30 -89.71 -174.34 4.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.111 0.481 . . . . 0.0 111.706 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.487 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 39.5 pt -71.41 -14.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.403 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -93.84 -1.61 54.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.774 0.321 . . . . 0.0 111.184 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.46 24.07 68.93 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HB3' HD21 ' A' ' 16' ' ' ASN . 62.6 tttp -101.54 139.53 37.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -82.51 109.82 17.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.08 142.67 23.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.791 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.46 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 87.9 mt-30 -100.32 133.11 45.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.875 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.415 HG21 ' CE1' ' A' ' 103' ' ' PHE . 20.9 p -68.89 -32.31 71.86 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -70.05 -17.21 63.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.448 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HE3' ' H ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -117.98 8.68 12.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.96 105.83 11.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.331 0.586 . . . . 0.0 112.044 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 56.4 mt-10 -108.63 139.69 43.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.078 175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.821 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 15.1 t-20 -76.05 -75.66 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.004 0.43 . . . . 0.0 110.328 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.55 33.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.249 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 28.51 51.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 66.4 mmtt -123.0 148.97 55.67 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.123 -177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 19.3 Cg_exo -65.28 149.86 88.0 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.34 2.027 . . . . 0.0 110.634 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.821 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 67.2 mtm -133.66 145.65 50.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.462 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 92.5 mt -122.63 125.45 72.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.38 122.37 51.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.238 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -106.47 115.87 30.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 66.3 m-85 -94.21 118.24 31.28 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -146.36 167.03 24.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.574 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HB2' HD11 ' A' ' 73' ' ' ILE . . . -100.01 146.56 26.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.578 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.446 HG22 ' OD2' ' A' ' 74' ' ' ASP . 7.0 t . . . . . 0 C--N 1.314 -0.969 0 CA-C-O 120.857 0.36 . . . . 0.0 111.4 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt . . . . . 0 C--O 1.233 0.221 0 CA-C-O 120.903 0.382 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 26.1 mmt85 -64.11 -39.93 95.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.443 0.639 . . . . 0.0 109.537 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 tm-20 -64.04 -55.21 23.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.545 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD11 ' CE2' ' A' ' 93' ' ' TYR . 43.4 tp -62.12 -41.22 98.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.618 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 58.7 tttm -62.21 -48.64 79.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -63.57 -39.72 95.13 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.245 0.545 . . . . 0.0 110.925 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 49' ' ' GLU . 58.9 mt -65.33 -42.73 94.43 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.466 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.21 -30.33 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.804 0.335 . . . . 0.0 110.301 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 77.9 mm-40 -59.2 -48.25 82.33 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.786 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -122.02 30.86 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.488 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' ILE . 88.9 t80 -59.12 -34.74 72.4 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.46 -39.69 88.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.607 0.241 . . . . 0.0 110.471 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.28 -42.33 93.28 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 110.87 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.507 ' O ' ' HB ' ' A' ' 64' ' ' THR . 12.0 m0 -65.57 -37.2 85.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.307 0.575 . . . . 0.0 110.468 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -84.37 -8.22 59.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -53.55 -64.24 0.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.61 -31.22 3.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 19.0 m -63.05 -41.83 99.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.065 0.459 . . . . 0.0 110.07 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.76 31.98 79.92 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.194 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.02 131.78 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.603 0.716 . . . . 0.0 111.438 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.532 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 9.1 mmm180 -102.58 141.42 35.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.386 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.611 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 50.0 mt -102.24 138.0 39.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.003 0.43 . . . . 0.0 110.295 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.533 HD11 ' SD ' ' A' ' 34' ' ' MET . 91.8 mt -115.06 113.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.44 113.61 25.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.738 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 14.4 p -121.59 132.13 71.47 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-O 121.466 0.651 . . . . 0.0 111.751 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -88.55 131.55 34.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.557 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 40' ' ' ALA . 46.8 pt -77.67 -16.93 14.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 124.357 1.036 . . . . 0.0 110.864 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.446 ' OD2' HG22 ' A' ' 41' ' ' THR . 29.2 m-20 -80.5 160.66 25.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.987 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.89 171.96 7.25 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.83 0.348 . . . . 0.0 110.982 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -56.5 -41.14 88.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.804 -0.634 . . . . 0.0 114.151 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -62.47 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.07 0.435 . . . . 0.0 111.59 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -72.75 -39.3 66.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.4 0.619 . . . . 0.0 110.925 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.53 -4.85 12.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.201 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 47.2 mt-30 -63.88 -9.51 15.58 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.013 -0.429 . . . . 0.0 110.39 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.697 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.8 mttm -96.2 -10.51 27.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -63.66 -47.1 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.683 0.754 . . . . 0.0 111.836 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 23.2 mtmt -70.69 -43.13 14.98 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.159 -175.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.5 Cg_endo -61.17 -30.54 88.92 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 121.012 1.141 . . . . 0.0 110.932 174.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -64.96 -41.27 95.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -60.62 -40.13 90.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.587 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -46.21 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.126 0.489 . . . . 0.0 111.006 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.26 93.67 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.998 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -87.36 -16.18 35.74 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.304 0.552 . . . . 0.0 112.053 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.31 40.42 6.93 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.725 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -89.04 104.36 16.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -99.1 73.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.353 0.597 . . . . 0.0 109.995 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.611 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -137.18 167.23 21.97 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 67' ' ' ARG . 2.2 mp0 -70.39 102.6 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 48.0 t -92.74 128.36 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.148 0.499 . . . . 0.0 110.465 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.447 HD13 HG23 ' A' ' 69' ' ' ILE . 10.7 mp -124.75 138.07 54.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.349 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.58 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.1 mp -108.02 117.61 34.58 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.567 ' HA ' HD22 ' A' ' 14' ' ' LEU . 63.5 t0 -78.46 115.62 18.29 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.712 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 p -82.6 -9.85 59.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -127.81 -21.76 3.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 84.4 19.5 60.3 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.918 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 11.9 m-20 -93.95 -21.57 19.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.249 0.525 . . . . 0.0 112.107 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 24' ' ' THR . 75.0 t80 -63.68 -43.3 97.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 110.542 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 63.1 pttt -63.06 -33.14 74.79 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.9 176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 102' ' ' ASP . 60.6 mtp85 -69.52 -39.59 77.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.168 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.01 83.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.248 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.3 mmt -88.04 -3.3 58.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.737 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.72 44.06 14.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.688 0.756 . . . . 0.0 110.615 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.62 96.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.426 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.9 m -88.4 -58.94 2.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.9 tp -112.37 127.09 55.91 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.951 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -87.52 156.84 53.32 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.488 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.5 Cg_endo -82.17 150.11 72.39 Favored 'Cis proline' 0 C--O 1.242 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.304 -0.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -111.19 134.36 52.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.07 127.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.397 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 72.0 m-85 -128.46 116.95 20.5 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.9 mt -105.52 130.02 57.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.092 0.472 . . . . 0.0 110.993 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 54.9 t -114.18 133.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.745 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -85.46 -172.27 4.05 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.968 0.414 . . . . 0.0 111.23 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.8 -22.53 68.4 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.706 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -85.08 2.07 45.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.785 0.326 . . . . 0.0 110.711 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.44 65.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.401 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 71.3 mmtt -115.73 153.97 30.41 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.469 HG13 ' HB3' ' A' ' 8' ' ' GLN . 80.8 mt -80.93 114.87 22.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.44 -19.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.403 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.626 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 67.0 t80 -144.33 136.99 26.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.716 0.293 . . . . 0.0 110.587 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.88 135.21 24.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -158.36 122.85 4.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 p -103.79 112.35 25.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.128 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.93 66.52 1.8 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.856 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.669 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 27.9 p90 -69.03 -40.02 78.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.256 0.55 . . . . 0.0 110.26 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 81.5 p 55.47 81.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.764 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 64.72 120.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.032 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.54 55.93 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.85 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.669 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.73 -37.58 6.41 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 1.9 pm0 -60.78 -17.51 49.64 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.235 0.614 . . . . 0.0 111.849 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.44 96.59 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.526 0.679 . . . . 0.0 109.739 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -73.41 -31.95 64.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.354 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -62.24 -47.89 82.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 tp -68.66 -37.31 77.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 110.072 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.772 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.532 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -65.21 -36.06 82.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.266 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 139' ' ' LEU . 66.7 t -60.66 -46.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.172 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.495 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 5.4 mmp_? -68.76 -36.19 78.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.573 0.701 . . . . 0.0 109.767 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 142' ' ' LYS . 34.6 tt0 -62.06 -27.27 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.19 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 94.4 mt . . . . . 0 N--CA 1.464 0.247 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.551 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 23.8 m . . . . . 0 N--CA 1.439 -1.003 0 CA-C-O 121.208 0.528 . . . . 0.0 111.405 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -116.16 -120.08 0.31 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -151.42 13.48 0.66 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.445 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 61.7 tt0 50.38 33.43 7.59 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.867 0.841 . . . . 0.0 110.98 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 74.7 mt -80.85 156.11 72.68 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.111 -176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.56 155.3 63.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.871 2.381 . . . . 0.0 110.798 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 80.04 1.28 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.125 0.488 . . . . 0.0 111.315 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.89 132.77 70.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.753 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.8 m -92.42 105.33 17.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.308 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 98' ' ' ASP . 71.2 mt -104.41 178.15 4.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.971 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HD2' ' C ' ' A' ' 19' ' ' GLY . 3.2 tppp? -108.54 135.91 49.02 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.105 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.69 -179.96 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.404 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.489 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 42.3 pt -68.32 -11.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -96.24 -4.66 41.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 111.098 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.484 ' C ' ' HD2' ' A' ' 15' ' ' LYS . . . 82.32 20.28 62.75 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.576 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.43 149.6 27.72 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 m -75.12 122.69 23.98 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.057 0.455 . . . . 0.0 110.875 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.09 135.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.645 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 94.4 mt-30 -95.62 133.99 39.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.466 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.6 p -67.41 -27.74 67.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -63.56 -33.74 76.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.204 0.526 . . . . 0.0 110.224 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -105.03 13.0 31.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.246 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.35 124.11 29.1 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.155 0.502 . . . . 0.0 112.105 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -146.74 173.81 12.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.258 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 32' ' ' LYS . 8.2 p30 -112.61 -56.71 2.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.082 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.35 39.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.377 0.671 . . . . 0.0 109.651 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.24 26.86 72.77 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.741 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 45.6 mmtm -117.19 152.84 49.53 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 122.239 0.216 . . . . 0.0 110.713 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.81 151.83 78.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.625 2.217 . . . . 0.0 111.398 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' HD11 ' A' ' 69' ' ' ILE . 56.7 mtm -136.32 154.53 50.83 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 84.0 mt -127.01 125.66 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.0 118.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.8 m -102.93 123.43 46.54 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.563 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -97.15 115.99 28.54 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.675 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -137.3 166.13 24.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.67 0.606 . . . . 0.0 111.212 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 73' ' ' ILE . . . -110.03 161.46 15.49 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.669 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 C--N 1.321 -0.656 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 178.838 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.45 -47.25 84.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.013 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.587 ' O ' HG13 ' A' ' 53' ' ' ILE . 15.5 pt-20 -58.43 -56.51 21.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 111.237 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.567 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 34.6 tp -65.73 -42.85 90.53 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.975 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 22.0 tptm -65.08 -47.47 77.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.02 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.02 -41.47 99.56 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 120.822 0.344 . . . . 0.0 110.976 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.0 mt -65.55 -42.53 93.26 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.719 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.9 -40.06 66.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 110.654 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 47.0 mm-40 -62.45 -46.43 88.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.29 26.86 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.615 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.3 t80 -59.79 -39.44 84.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.276 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.494 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.81 -42.51 81.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.3 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -67.21 -40.51 86.45 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 32.0 mm-40 -73.6 -15.8 61.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.12 -45.73 93.48 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.799 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.14 -68.23 0.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.304 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -62.83 -31.32 72.3 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.722 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 63.17 45.37 95.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.147 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.79 131.68 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.413 0.625 . . . . 0.0 112.295 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.506 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 13.3 mmm180 -96.57 159.02 15.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.948 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.491 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 76.0 mt -121.01 129.41 53.38 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.891 0.377 . . . . 0.0 111.285 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.52 HD11 ' SD ' ' A' ' 34' ' ' MET . 89.8 mt -109.32 108.64 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.81 107.43 19.21 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.01 131.47 56.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 CA-C-O 121.913 0.863 . . . . 0.0 112.396 -175.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.648 ' HB3' HG21 ' A' ' 82' ' ' VAL . 26.1 p -84.16 127.89 34.21 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.465 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 46.4 pt -83.46 -15.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.346 1.029 . . . . 0.0 111.001 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -85.28 152.09 23.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.014 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.16 171.36 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.19 -49.41 63.54 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.76 -41.86 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.748 0.774 . . . . 0.0 111.178 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -67.74 -38.27 83.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -72.56 -4.97 33.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.321 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -62.73 -9.51 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.961 -0.462 . . . . 0.0 110.948 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.704 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 98.9 mttt -92.68 -11.26 34.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.523 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.648 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.3 t -65.3 -49.28 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.631 0.729 . . . . 0.0 112.356 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 14.1 mtpp -71.04 -38.9 7.61 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.02 -28.41 80.43 Favored 'Trans proline' 0 C--N 1.364 1.37 0 CA-C-N 120.051 1.054 . . . . 0.0 110.666 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.08 -45.92 91.4 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.473 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -60.43 -36.94 79.37 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.787 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.03 -32.25 73.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.159 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.77 -44.58 5.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.772 -0.727 . . . . 0.0 113.902 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 17.9 p30 -82.29 -15.77 51.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.27 58.44 3.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.456 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -78.05 112.79 15.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.99 35.79 1.51 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.714 0.769 . . . . 0.0 110.754 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.531 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -141.21 -171.33 3.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.478 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.39 137.36 32.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.628 0.728 . . . . 0.0 112.689 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.489 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 19.4 t -106.71 140.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.965 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.1 131.56 54.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -111.98 95.06 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.612 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.437 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.3 t0 -77.49 116.07 17.76 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.085 174.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.3 p -89.82 -14.35 34.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.462 HD22 ' HB2' ' A' ' 102' ' ' ASP . 5.8 t30 -104.07 -39.19 6.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.97 0.414 . . . . 0.0 110.983 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.64 43.09 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.462 ' HB2' HD22 ' A' ' 100' ' ' ASN . 19.3 t70 -89.76 -29.59 18.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.0 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.466 ' CE1' HG21 ' A' ' 24' ' ' THR . 86.0 t80 -60.58 -43.34 97.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.517 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 21.8 pttp -62.44 -38.2 88.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.709 0.29 . . . . 0.0 111.279 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -66.01 -42.63 89.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.37 80.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.897 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 2.1 mmt -84.9 -5.06 59.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.264 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 107' ' ' MET . 93.0 m-20 71.43 35.47 1.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.297 0.373 . . . . 0.0 111.803 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 104' ' ' LYS . 92.4 t -83.07 108.61 15.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 120.931 0.396 . . . . 0.0 110.906 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.9 m -100.66 -64.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 tp -95.46 126.25 40.63 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -94.31 147.73 33.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.68 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.0 Cg_endo -82.75 167.05 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.117 -1.201 . . . . 0.0 112.971 1.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -131.73 141.94 49.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.45 127.34 73.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 O-C-N 123.344 0.402 . . . . 0.0 111.507 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -126.17 118.45 25.24 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.639 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 67.8 mt -106.96 131.72 56.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.201 0.524 . . . . 0.0 110.763 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.4 131.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -74.82 -179.54 4.26 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.009 0.818 . . . . 0.0 112.557 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.2 -30.83 78.8 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.749 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' THR . 3.3 t-20 -67.25 -41.07 86.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.169 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 121.5 21.23 3.06 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.7 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -113.56 163.45 14.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.02 109.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.0 -40.22 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.27 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 70.1 t80 -128.29 122.49 31.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.809 0.338 . . . . 0.0 110.62 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.5 120.91 29.36 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.116 0.484 . . . . 0.0 110.82 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -136.79 105.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.8 p -97.34 123.96 41.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 92.71 49.29 2.76 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.509 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.68 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 1.0 OUTLIER -90.11 135.82 33.43 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 173.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.6 p -123.67 69.0 1.03 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.501 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 69.85 119.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.176 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.04 8.8 35.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.67 -18.1 46.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.77 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -59.73 -19.84 52.61 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.78 95.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.39 0.614 . . . . 0.0 109.907 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.34 -32.94 69.14 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.678 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -62.02 -51.35 68.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -36.87 74.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.624 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.3 ttpp -60.03 -48.17 82.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.049 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 55.0 tptt -66.16 -30.27 70.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.213 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 139' ' ' LEU . 70.2 t -58.88 -44.64 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 4.6 mmp_? -68.32 -37.86 80.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.347 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.5 mm-40 -59.73 -36.29 76.28 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.722 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 83.1 mt . . . . . 0 CA--C 1.514 -0.428 0 CA-C-O 121.024 0.44 . . . . 0.0 110.27 -176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.417 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 m . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.36 0.6 . . . . 0.0 110.536 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.434 ' O ' HG11 ' A' ' 118' ' ' VAL . 21.0 m-85 -97.37 -134.23 0.23 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.832 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -145.24 21.14 1.56 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.792 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 51.0 tt0 50.28 38.14 16.83 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.878 0.847 . . . . 0.0 109.504 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.832 HD22 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -103.9 147.93 35.05 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.175 -174.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.647 ' HD2' ' SD ' ' A' ' 107' ' ' MET . 48.1 Cg_exo -55.14 146.7 58.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.647 2.898 . . . . 0.0 112.474 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 25' ' ' ASN . . . -72.44 90.45 1.31 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.755 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.4 132.7 68.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 p -77.5 100.22 5.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.187 0.517 . . . . 0.0 109.964 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.434 HD23 HD23 ' A' ' 96' ' ' LEU . 4.7 tp -106.33 177.23 4.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.177 -176.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.472 ' CE ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -118.76 137.75 53.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.02 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -98.9 -178.8 4.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.041 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 95' ' ' VAL . 33.2 pt -67.05 -19.55 25.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.674 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.42 -10.81 59.44 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.326 0.584 . . . . 0.0 110.236 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.43 17.45 75.95 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 88.3 tttt -95.71 137.12 35.22 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.235 -0.483 . . . . 0.0 109.9 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 99.7 m -74.6 100.69 3.99 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.6 p -117.17 132.3 67.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.294 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.506 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 48.3 mt-30 -82.62 136.7 34.72 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.146 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.586 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 20.1 p -64.15 -36.24 83.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.43 -176.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 11' ' ' ALA . 64.1 t30 -69.43 -16.95 63.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.354 . . . . 0.0 111.575 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.506 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -110.08 6.74 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.08 113.56 22.94 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.68 154.94 41.65 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.73 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 25.6 t30 -87.53 -68.19 0.77 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 174.45 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.581 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.417 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 150.08 -13.58 0.97 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.507 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.2 mptm? -91.4 147.96 36.53 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.753 -0.224 . . . . 0.0 110.61 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.584 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 17.9 Cg_exo -65.06 156.6 61.81 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.199 2.599 . . . . 0.0 112.832 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.73 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 70.6 mtm -138.67 159.75 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.74 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.441 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 81.4 mt -129.65 128.63 65.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.6 mt -99.81 122.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.9 m -115.84 122.82 46.52 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.02 0.438 . . . . 0.0 110.602 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 56.3 m-85 -88.71 117.14 27.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.467 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 22.0 p90 -134.91 167.9 20.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 123.439 0.462 . . . . 0.0 110.681 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -110.5 149.01 30.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.307 -1.274 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.933 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 N--CA 1.444 -0.767 0 CA-C-O 120.414 0.15 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . 12.0 mmm180 -60.21 -43.51 95.89 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.681 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 74.0 tt0 -52.63 -64.37 0.84 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.663 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.524 HD11 ' CE2' ' A' ' 93' ' ' TYR . 34.2 tp -62.85 -41.54 99.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.272 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.05 -47.68 83.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.054 0.221 . . . . 0.0 111.281 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.42 87.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.682 0.277 . . . . 0.0 111.042 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.9 mt -65.26 -41.01 90.46 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.83 -30.3 32.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.056 0.455 . . . . 0.0 111.016 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -82.67 -37.61 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.978 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.24 23.99 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -62.65 -35.09 78.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.764 0.316 . . . . 0.0 111.115 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.35 88.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.27 -43.87 96.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.436 ' NE1' HD13 ' A' ' 140' ' ' ILE . 13.8 m0 -68.7 -31.65 70.9 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.701 0.762 . . . . 0.0 110.136 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -81.36 -6.6 59.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.575 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.68 -51.76 46.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.09 -34.23 0.55 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.422 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 15.3 m -60.57 -42.58 96.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.87 74.0 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.839 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 11.2 p -75.62 127.43 37.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.112 0.482 . . . . 0.0 111.07 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -106.39 163.58 12.73 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 53' ' ' ILE . 61.2 mt -109.05 129.7 55.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.09 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.507 HG23 HD13 ' A' ' 96' ' ' LEU . 97.3 mt -101.25 107.01 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -93.89 113.81 25.91 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.307 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.4 129.49 67.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 121.379 0.609 . . . . 0.0 111.418 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 97' ' ' LEU . 39.4 p -83.94 130.47 34.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.311 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.0 pt -72.2 -23.75 21.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.35 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -82.54 147.11 28.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 89.7 mt-10 -61.48 163.53 6.74 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.491 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.13 -39.48 57.92 Favored Glycine 0 C--O 1.23 -0.124 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -174.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -63.87 -38.94 92.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 117.386 0.593 . . . . 0.0 111.114 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -79.89 -37.24 35.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.306 0.574 . . . . 0.0 110.096 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -65.53 -3.9 5.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.793 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.12 -11.21 8.03 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.016 -0.427 . . . . 0.0 110.54 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.731 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.0 mttp -96.55 -10.91 26.21 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.387 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 79' ' ' ALA . 14.6 t -66.53 -47.12 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-O 121.668 0.747 . . . . 0.0 111.627 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 17' ' ' ILE . 41.7 mtpt -64.13 -45.06 79.23 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.054 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.8 Cg_endo -62.08 -29.82 81.78 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.115 1.21 . . . . 0.0 111.19 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -63.09 -41.46 99.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.29 86.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.167 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.27 -46.56 66.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.355 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.5 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.123 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -91.37 -11.14 38.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.912 0.356 . . . . 0.0 111.706 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.28 38.83 28.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -82.19 111.8 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 0.0 110.5 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -97.07 60.38 1.7 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.084 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.524 ' CE2' HD11 ' A' ' 50' ' ' LEU . 6.0 m-85 -138.18 -177.79 4.99 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.961 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.98 117.75 31.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.657 ' O ' HG23 ' A' ' 17' ' ' ILE . 12.4 t -99.27 139.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.24 -174.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.507 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -125.92 142.89 51.31 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.795 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.613 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.7 mp -113.74 121.56 44.45 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 59.8 t0 -74.04 115.14 13.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 118.176 -1.41 . . . . 0.0 107.96 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 p -96.02 -6.0 39.81 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.962 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -117.65 -39.39 3.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.764 0.316 . . . . 0.0 111.647 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -8.51 68.58 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.16 -30.66 66.73 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.868 -0.666 . . . . 0.0 111.388 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.497 ' O ' ' HG2' ' A' ' 107' ' ' MET . 44.7 t80 -61.43 -43.44 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.817 -176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.28 -42.18 94.91 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 110.265 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -69.56 -42.31 74.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.53 94.78 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.138 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.647 ' SD ' ' HD2' ' A' ' 10' ' ' PRO . 39.2 mmm -84.49 -24.12 29.56 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.204 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.425 ' O ' HG21 ' A' ' 129' ' ' THR . 55.5 t30 75.23 100.89 0.07 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.778 0.831 . . . . 0.0 111.041 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.04 132.78 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -84.52 -96.01 0.06 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.4 pt? -119.47 3.34 11.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.16 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.2 pt 61.29 151.06 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 124.828 1.251 . . . . 0.0 111.888 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.3 Cg_endo -76.58 157.89 97.48 Favored 'Cis proline' 0 N--CA 1.479 0.633 0 C-N-CA 124.19 -1.171 . . . . 0.0 112.303 -1.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -114.78 136.21 53.33 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.2 t -116.67 127.27 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.767 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 77.9 m-85 -124.93 113.0 17.27 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.0 mt -100.68 124.75 54.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-O 121.027 0.441 . . . . 0.0 110.049 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.476 HG21 ' HB1' ' A' ' 7' ' ' ALA . 54.1 t -116.87 132.88 65.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.774 -175.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.97 164.58 24.28 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.649 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.1 -20.64 50.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.612 -0.267 . . . . 0.0 112.984 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -73.57 -5.65 41.61 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.279 0.561 . . . . 0.0 110.196 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.15 19.73 64.26 Favored Glycine 0 CA--C 1.5 -0.863 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.763 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 74.6 mmtt -116.87 151.1 37.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.3 mt -77.95 127.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.406 HG11 HD21 ' A' ' 146' ' ' LEU . 10.9 p -104.92 -28.61 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.809 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.7 t80 -141.56 133.19 27.03 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.793 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -137.12 123.78 21.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -151.02 111.79 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.987 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 108' ' ' ASN . 19.6 p -93.51 111.63 23.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 83.57 68.11 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.986 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.608 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.7 p90 -68.86 -39.66 79.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 64.2 p 53.31 80.67 0.1 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.296 1.038 . . . . 0.0 113.581 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.96 108.51 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.1 0.96 . . . . 0.0 112.776 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.97 -2.77 27.16 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.608 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -72.2 -41.81 52.34 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.1 -0.55 . . . . 0.0 112.783 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 48' ' ' ARG . 1.7 pm0 -53.59 -24.17 13.04 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.61 88.01 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.513 0.673 . . . . 0.0 110.674 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 44.5 mt-10 -73.4 -32.3 64.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.841 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.78 -47.94 81.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.439 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.436 HD13 ' NE1' ' A' ' 60' ' ' TRP . 8.8 tp -66.57 -33.49 63.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 110.278 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.67 -51.59 69.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.779 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 31.1 mmmt -68.47 -34.42 75.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.196 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.4 t -59.97 -45.37 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.045 0.45 . . . . 0.0 110.778 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -72.83 -29.33 63.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.466 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -64.99 -30.02 70.98 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.586 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 95.6 mt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.319 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.447 -0.576 0 CA-C-O 120.986 0.422 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 72.7 m-85 -101.54 -133.78 0.29 Allowed 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.551 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -149.45 9.25 0.72 Allowed 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.991 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 47.42 67.69 0.77 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.684 0.754 . . . . 0.0 110.824 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 24' ' ' THR . 32.4 mt -118.84 161.5 35.84 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.852 -175.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.12 160.05 46.59 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.706 2.271 . . . . 0.0 111.169 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.6 81.25 2.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.208 0.528 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.34 136.47 59.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.824 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -98.07 116.2 29.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.454 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD22 ' HA ' ' A' ' 98' ' ' ASP . 56.3 mt -123.77 177.19 5.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.928 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 30.2 mmtp -107.18 140.57 39.84 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.769 0.318 . . . . 0.0 110.798 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -91.31 -173.47 3.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.45 -13.78 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -90.03 -10.98 42.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.98 19.82 66.59 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.8 149.06 21.53 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.7 m -79.35 110.02 14.24 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.272 0.558 . . . . 0.0 110.187 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 137.07 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.051 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -95.78 133.68 39.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.487 HG21 ' CE1' ' A' ' 103' ' ' PHE . 23.6 p -65.86 -32.41 73.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.287 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.6 -31.73 73.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.951 0.405 . . . . 0.0 110.778 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.575 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -103.02 8.78 38.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.343 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 36.3 tp -65.91 121.71 15.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.27 156.92 46.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.22 0.533 . . . . 0.0 112.002 -174.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.607 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 45.2 t-20 -99.5 -83.23 0.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.583 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 170.02 25.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.92 0.762 . . . . 0.0 110.775 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.47 -2.37 39.75 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.233 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -110.08 150.23 41.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.408 0.146 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -68.53 159.88 51.64 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 123.218 2.612 . . . . 0.0 112.782 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 72.5 mtm -139.83 153.11 46.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.106 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 91.1 mt -128.33 127.71 67.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.57 124.56 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -113.04 122.75 48.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.698 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 57.9 m-85 -93.85 122.41 36.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.55 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 25.4 p90 -140.38 165.16 28.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 123.502 0.501 . . . . 0.0 111.542 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.88 151.37 24.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.897 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.45 ' CG2' HG22 ' A' ' 82' ' ' VAL . 9.6 p . . . . . 0 C--N 1.312 -1.026 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.55 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 15.0 mt . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 120.583 0.23 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -58.59 -42.35 87.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.551 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.554 ' CD ' HG22 ' A' ' 115' ' ' VAL . 75.2 tt0 -55.08 -64.69 0.76 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.959 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' A' ' 93' ' ' TYR . 44.0 tp -61.85 -41.15 97.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.6 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.42 -47.84 83.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.98 -42.48 76.48 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.999 0.428 . . . . 0.0 111.304 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.3 mt -64.38 -41.66 93.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.164 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -52.63 -42.0 64.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.711 0.291 . . . . 0.0 110.926 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.59 -42.26 91.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.17 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.8 m -105.24 15.65 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.25 -38.44 83.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.38 85.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.834 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.16 -36.24 71.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.837 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -69.15 -38.35 78.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.505 0.669 . . . . 0.0 109.553 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -76.59 -11.13 59.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.151 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.341 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -134.96 -45.51 0.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.802 0.334 . . . . 0.0 110.549 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.13 23.59 77.1 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.83 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -78.83 129.2 37.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.0 0.429 . . . . 0.0 111.379 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.8 mtm-85 -104.77 165.71 10.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.47 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 73.9 mt -109.84 140.02 44.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -113.8 106.47 20.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -94.28 112.19 23.98 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.28 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.3 p -110.72 132.03 60.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 CA-C-O 121.636 0.731 . . . . 0.0 112.229 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.519 ' HB3' HG21 ' A' ' 82' ' ' VAL . 20.8 p -81.29 141.39 34.12 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.871 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.9 pt -95.73 -6.91 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.463 1.102 . . . . 0.0 111.09 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 13.9 p-10 -93.88 152.35 18.93 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -63.13 174.04 1.27 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.45 88.91 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -172.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -46.59 81.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.549 0.674 . . . . 0.0 111.012 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -69.62 -41.77 75.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.76 -6.59 33.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.238 -176.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -64.36 -14.95 59.32 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.346 0.593 . . . . 0.0 109.941 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.747 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.9 mttp -94.16 -6.23 45.32 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.873 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 79' ' ' ALA . 51.2 t -63.96 -48.37 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.569 0.7 . . . . 0.0 111.747 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 19.4 mtpp -68.17 -42.32 29.97 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.221 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.5 Cg_endo -62.33 -28.99 79.17 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 120.902 1.068 . . . . 0.0 110.783 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.5 mt -64.16 -41.69 97.04 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.428 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -58.49 -45.39 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.677 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.93 -40.68 91.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.301 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.06 88.56 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.821 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -89.42 -14.42 35.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.993 0.396 . . . . 0.0 112.011 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.96 12.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.431 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.428 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 39.3 m0 -79.02 96.44 5.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.268 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.74 68.67 10.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 111.93 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.57 ' CE2' HD11 ' A' ' 50' ' ' LEU . 4.5 m-85 -144.03 177.04 8.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.98 113.48 25.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.81 0.814 . . . . 0.0 109.43 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.71 137.3 21.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.005 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 12.1 tp -115.63 131.18 57.01 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 15' ' ' LYS . 6.9 tp -105.71 100.87 10.42 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.301 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.675 ' HA ' HD22 ' A' ' 14' ' ' LEU . 66.3 t0 -77.89 115.22 17.47 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 118.13 -1.428 . . . . 0.0 108.304 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.2 p -108.73 -6.04 16.08 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.934 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.409 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 60.4 m-20 -93.71 -41.27 9.78 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.419 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.59 8.49 76.98 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.183 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HB2' ' A' ' 100' ' ' ASN . 9.6 p-10 -99.43 -22.31 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.199 . . . . 0.0 111.302 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.487 ' CE1' HG21 ' A' ' 24' ' ' THR . 71.4 t80 -62.67 -44.46 96.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.45 -32.76 74.53 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.326 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -68.96 -41.55 77.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.098 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.35 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.8 mmt -83.72 -9.4 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.431 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.9 t30 61.18 47.03 7.47 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.424 0.63 . . . . 0.0 110.654 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.62 96.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -81.36 -55.34 4.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.537 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.03 147.79 45.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 pt -103.43 154.49 37.76 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.1 Cg_endo -77.71 153.45 93.9 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 124.101 -1.208 . . . . 0.0 112.598 0.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -112.36 123.98 51.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.554 HG22 ' CD ' ' A' ' 49' ' ' GLU . 17.9 t -108.4 130.04 61.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.08 0.467 . . . . 0.0 112.133 -173.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 96.5 m-85 -131.71 112.96 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.616 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.3 mt -99.91 130.29 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.864 0.364 . . . . 0.0 110.395 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 53.5 t -113.46 133.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.779 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -85.29 -175.91 5.91 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.314 0.384 . . . . 0.0 111.269 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.29 -31.07 77.93 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.993 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -73.5 -6.0 43.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.326 0.584 . . . . 0.0 110.501 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 78.63 35.04 33.39 Favored Glycine 0 N--CA 1.433 -1.546 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.764 178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 47.0 mmtm -126.36 156.33 40.66 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.0 mt -76.54 113.48 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.262 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.81 -28.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.913 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.508 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 86.7 t80 -139.23 127.55 22.76 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.507 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -132.06 125.48 31.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -144.87 106.06 4.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.64 108.1 18.93 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.035 -177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 77.3 1.26 Allowed Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.52 -0.764 . . . . 0.0 114.657 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.622 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -104.53 143.54 32.91 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 73.9 p -104.68 -49.5 3.51 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.063 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.64 147.41 25.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.689 0.281 . . . . 0.0 111.384 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.89 28.41 73.08 Favored Glycine 0 N--CA 1.453 -0.231 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.105 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.3 -33.1 7.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.242 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -56.01 -20.64 17.48 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.466 0.706 . . . . 0.0 112.439 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.76 93.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.39 0.614 . . . . 0.0 110.215 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -70.51 -37.35 74.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.373 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.6 mp -61.43 -48.21 82.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.208 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -32.0 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.03 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.7 ttmt -61.06 -50.21 74.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 45.1 mttp -68.69 -29.86 68.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 139' ' ' LEU . 54.5 t -59.31 -45.31 93.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.109 0.48 . . . . 0.0 109.898 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -68.38 -34.35 75.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.404 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 62.7 mm-40 -56.41 -40.88 75.43 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.146 0.498 . . . . 0.0 110.322 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 49.7 mt . . . . . 0 CA--C 1.54 0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.593 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 43.4 m . . . . . 0 N--CA 1.44 -0.949 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -88.71 -124.03 0.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.067 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -151.43 16.75 0.72 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.844 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' ' 123' ' ' LYS . 45.2 tt0 50.93 41.49 27.07 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.802 0.81 . . . . 0.0 110.418 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 65.7 mt -87.74 155.74 53.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.71 156.85 55.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.302 2.668 . . . . 0.0 110.875 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.69 84.59 3.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.008 0.432 . . . . 0.0 111.671 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.18 138.84 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 p -90.83 113.62 25.82 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.353 0.597 . . . . 0.0 111.776 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 6.1 mp -107.41 167.22 10.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.196 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -112.45 125.87 54.7 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -87.54 -169.15 2.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.87 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.418 HG22 ' HZ2' ' A' ' 83' ' ' LYS . 26.4 pt -75.48 -12.76 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.537 -176.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.26 -11.74 45.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.067 0.461 . . . . 0.0 110.732 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 14.34 72.27 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -92.43 141.57 28.38 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.103 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -77.58 117.7 19.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.774 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.0 162.32 16.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.286 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.572 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 49.0 mt-30 -119.77 132.33 55.59 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.419 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.8 p -67.37 -32.25 73.04 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.26 -36.91 85.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 111.021 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -103.46 12.5 35.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.597 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.83 123.15 30.13 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.232 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 5' ' ' THR . 8.1 pt-20 -148.03 162.61 39.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.656 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.424 ' H ' ' HE2' ' A' ' 34' ' ' MET . 8.5 t30 -85.74 -71.93 0.51 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.113 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.64 47.23 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.183 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 5' ' ' THR . . . 80.08 26.86 54.56 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.903 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -122.94 151.66 61.54 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 122.22 0.208 . . . . 0.0 111.018 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.34 155.01 60.98 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.929 2.419 . . . . 0.0 111.403 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.533 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 20.5 mtt -139.99 165.45 27.31 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -171.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.645 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.5 mt -138.03 125.22 28.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 84.3 mt -101.83 131.2 50.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.961 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 m -118.93 122.63 42.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 111.234 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 54.4 m-85 -94.45 125.82 39.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.249 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' ' 82' ' ' VAL . 32.0 p90 -137.87 169.82 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 123.722 0.639 . . . . 0.0 111.086 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.77 -169.24 1.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.774 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.311 -1.096 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.235 0.339 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -61.5 -45.67 93.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.659 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.29 -44.94 50.68 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.6 -41.99 98.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.256 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.82 -47.0 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.743 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.42 72.17 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.985 0.422 . . . . 0.0 111.368 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.3 mt -63.82 -30.92 51.21 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.1 -38.53 79.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.485 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -73.89 -39.72 63.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.781 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -107.03 17.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 89.3 t80 -59.75 -37.83 80.08 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 122.433 0.293 . . . . 0.0 111.701 -177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.07 81.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.757 0.313 . . . . 0.0 110.825 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.09 -41.91 90.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.924 0.392 . . . . 0.0 111.41 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -68.83 -34.91 76.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.521 0.677 . . . . 0.0 110.748 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 66' ' ' VAL . 6.2 mm-40 -85.15 -7.1 59.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.24 -60.62 3.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.87 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.23 -32.68 1.56 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.19 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -61.78 -41.51 97.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.38 32.09 29.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.165 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 7.5 t -67.94 122.55 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.204 0.526 . . . . 0.0 111.936 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -110.14 129.85 55.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.645 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 39.8 mt -97.53 142.96 28.72 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.466 HG23 HD13 ' A' ' 96' ' ' LEU . 91.4 mt -123.75 116.88 49.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.8 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.63 29.23 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.5 p -123.14 127.45 74.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.43 0.633 . . . . 0.0 111.145 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -90.14 148.76 22.78 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.703 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.3 pt -71.29 -17.69 19.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.804 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.26 164.77 16.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.973 0.416 . . . . 0.0 111.757 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.792 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 3.4 pt-20 -92.65 -88.75 0.21 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -119.92 -68.86 0.3 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.14 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -41.41 -65.36 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 112.168 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.37 -41.71 89.06 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.002 0.43 . . . . 0.0 112.144 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -71.38 -2.35 16.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 98.2 mt-30 -57.36 -21.62 36.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.932 0.396 . . . . 0.0 111.068 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.731 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.2 mttp -83.55 -12.82 55.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.853 0.461 . . . . 0.0 111.417 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 58.4 t -64.69 -48.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.52 0.676 . . . . 0.0 112.504 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.7 OUTLIER -69.02 -39.77 14.14 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 6.6 Cg_endo -59.77 -32.07 94.99 Favored 'Trans proline' 0 C--N 1.357 1.025 0 CA-C-N 120.074 1.062 . . . . 0.0 110.002 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 92.5 mt -63.73 -41.78 97.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.439 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -55.48 -45.49 76.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.343 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.68 -46.47 46.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.244 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.75 -45.23 96.19 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.255 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.09 -30.66 58.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.681 0.277 . . . . 0.0 111.404 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.42 46.84 3.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.06 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.5 m0 -80.99 117.58 21.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -96.13 27.13 3.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.724 0.773 . . . . 0.0 109.863 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.628 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -117.78 -179.97 3.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.855 -177.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -84.77 128.79 34.78 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.024 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.485 ' C ' HD12 ' A' ' 96' ' ' LEU . 24.3 t -106.98 128.24 61.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 95' ' ' VAL . 9.6 mp -130.47 148.52 52.29 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.259 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.561 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.3 mp -118.06 124.97 49.39 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.792 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 65.8 t0 -67.65 113.42 5.43 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 118.981 -1.087 . . . . 0.0 108.258 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 t -89.81 -6.39 55.96 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.861 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -104.94 -27.0 11.95 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 120.955 0.407 . . . . 0.0 110.34 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.51 21.4 79.55 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -113.66 -20.62 11.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.637 -0.281 . . . . 0.0 111.286 -176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 24' ' ' THR . 45.3 t80 -62.91 -39.75 95.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 105' ' ' ARG . 18.9 ptpt -52.16 -47.04 65.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.252 173.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.49 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 50.0 mtm-85 -71.89 -40.25 69.03 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.076 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.75 -42.16 88.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.495 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 33.3 mmm -92.64 -10.72 36.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.445 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 62.11 88.24 0.09 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.761 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 112' ' ' ILE . 66.7 t -92.88 129.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.251 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -79.28 -95.72 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.648 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.5 pt? -116.14 6.09 13.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.405 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.6 pt 61.1 152.24 0.1 Allowed Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 124.579 1.151 . . . . 0.0 111.06 -175.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 87.0 Cg_endo -75.58 160.44 96.05 Favored 'Cis proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.794 -0.919 . . . . 0.0 112.973 0.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.709 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.7 131.74 54.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.534 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.73 129.38 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 80.8 m-85 -127.71 115.25 18.43 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 68.3 mt -100.52 132.74 45.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 CA-C-O 121.271 0.558 . . . . 0.0 110.468 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.533 ' HB ' ' H ' ' A' ' 34' ' ' MET . 57.1 t -106.43 126.85 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.86 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.483 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 7.9 t70 -70.7 162.18 29.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.479 1.112 . . . . 0.0 110.56 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.61 35.39 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.471 -0.331 . . . . 0.0 113.807 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -86.76 7.01 28.65 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 111.181 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 73.22 40.86 48.6 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.42 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HD2' ' OE1' ' A' ' 8' ' ' GLN . 49.4 mmtm -134.56 152.77 52.01 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.7 mt -70.03 127.07 31.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.899 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.4 p -118.9 -17.34 7.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.659 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.626 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 74.9 t80 -150.11 128.51 12.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.591 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -126.88 120.88 30.28 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.343 0.592 . . . . 0.0 110.654 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.53 101.37 7.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.5 p -98.29 106.47 18.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.341 0.591 . . . . 0.0 112.238 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.2 64.8 2.32 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.542 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.419 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 1.2 p90 -96.31 154.99 16.95 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p -142.77 89.99 2.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.253 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 69.04 131.67 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.83 2.48 75.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.784 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.3 29.41 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.513 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.4 mp0 -58.76 -38.49 78.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.412 0.625 . . . . 0.0 109.835 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.08 87.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.85 -38.53 83.28 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.637 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -63.04 -50.39 70.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.373 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 tp -66.92 -38.48 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.144 0.497 . . . . 0.0 110.928 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -60.89 -45.73 93.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.904 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 18.6 tptm -66.14 -30.81 71.36 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.526 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 139' ' ' LEU . 95.4 t -64.75 -41.95 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -73.85 -24.29 59.74 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -61.44 -39.23 90.05 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.8 mt . . . . . 0 C--N 1.333 -0.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 179.354 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.418 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 14.7 m . . . . . 0 N--CA 1.44 -0.928 0 CA-C-O 120.72 0.295 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 91.5 m-85 -74.52 -112.64 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.215 0.531 . . . . 0.0 110.609 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.606 ' HB3' HD13 ' A' ' 9' ' ' LEU . . . -173.08 -7.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.329 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.409 ' H ' ' H ' ' A' ' 7' ' ' ALA . 56.6 tp60 69.12 62.16 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 7' ' ' ALA . 10.5 mp -116.15 159.92 37.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.029 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.96 158.39 57.55 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.814 2.343 . . . . 0.0 110.816 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 81.09 2.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.092 0.472 . . . . 0.0 111.161 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -124.57 133.37 69.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.328 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 m -89.41 110.28 21.11 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 98' ' ' ASP . 29.8 mt -107.3 173.25 6.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 109.974 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.474 HD21 ' HB3' ' A' ' 20' ' ' LYS . 3.8 p30 -98.0 -176.62 3.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.431 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 pt -61.57 -22.59 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -81.14 -8.26 59.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.181 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.24 14.94 81.69 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HB3' HD21 ' A' ' 16' ' ' ASN . 87.6 tttt -99.84 139.27 35.75 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.564 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.6 m -74.48 118.6 17.62 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.315 0.579 . . . . 0.0 110.209 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.86 130.74 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.712 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 71.5 mt-30 -92.0 134.02 35.19 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.457 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -66.16 -29.3 69.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.323 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.646 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.73 122.03 28.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -134.87 153.52 52.02 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.89 178.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.583 ' OD1' ' HB2' ' A' ' 32' ' ' LYS . 23.7 t-20 -79.91 -80.77 0.13 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.338 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 171.87 28.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.788 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.418 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 95.3 0.26 63.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.491 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.583 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 1.4 mptm? -104.48 150.75 38.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.787 0.327 . . . . 0.0 110.548 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.2 159.58 33.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.967 2.445 . . . . 0.0 111.496 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.57 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 74.1 mtm -141.09 159.53 42.02 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 120.781 0.324 . . . . 0.0 111.795 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.439 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.2 mt -128.09 124.86 63.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.5 mt -97.99 119.88 46.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -107.7 121.56 44.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 58.5 m-85 -94.27 117.75 30.57 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.49 ' HB2' HD21 ' A' ' 47' ' ' LEU . 26.5 p90 -138.48 165.47 26.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.856 0.722 . . . . 0.0 111.588 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.35 164.09 13.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.521 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.445 -0.676 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.477 176.718 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 39' ' ' PHE . 18.9 mt . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 120.919 0.39 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -61.33 -38.9 88.55 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.368 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.3 pt-20 -60.01 -51.74 68.35 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.045 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.482 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 40.8 tp -63.08 -41.08 99.35 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.402 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -59.92 -48.78 80.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.474 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.64 70.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.845 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.9 mt -63.76 -41.54 92.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.113 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -52.83 -36.38 58.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.014 0.435 . . . . 0.0 110.361 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.82 -46.73 67.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.883 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.16 25.65 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.45 -40.56 87.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.868 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.93 93.83 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.752 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.12 -41.0 97.4 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.236 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.407 ' NE1' HD13 ' A' ' 140' ' ' ILE . 17.4 m0 -66.84 -38.52 86.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.252 0.548 . . . . 0.0 110.201 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.444 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 30.1 mm-40 -70.17 -21.51 63.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.216 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.59 -48.88 79.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.625 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -104.59 -68.55 0.85 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.265 0.555 . . . . 0.0 111.859 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -63.73 -32.36 73.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.846 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 62.6 41.01 99.85 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.052 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.54 132.44 35.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.085 0.469 . . . . 0.0 112.253 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HG2' ' NE2' ' A' ' 61' ' ' GLN . 13.2 mtm180 -104.9 163.6 12.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 58.8 mt -110.86 138.1 47.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.188 0.518 . . . . 0.0 111.398 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.496 HG23 HD13 ' A' ' 96' ' ' LEU . 87.9 mt -110.78 110.48 32.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.16 116.05 28.38 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.9 p -121.59 131.69 72.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.478 0.656 . . . . 0.0 112.178 -176.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.475 ' CB ' HG21 ' A' ' 82' ' ' VAL . 23.3 p -86.38 134.93 33.68 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.07 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.443 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 43.1 pt -86.49 -5.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.238 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 15.1 m-20 -95.82 157.48 15.88 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.766 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.17 179.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.689 0.618 . . . . 0.0 112.565 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 -45.3 95.76 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 114.526 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -61.38 -46.08 91.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.371 0.605 . . . . 0.0 110.758 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 14.3 m120 -67.0 -39.17 87.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.903 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.582 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -68.27 -9.77 49.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.601 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.29 -22.32 52.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.04 0.448 . . . . 0.0 110.74 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.75 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 97.8 mttt -89.41 -13.7 37.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.699 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 79' ' ' ALA . 61.2 t -64.6 -50.2 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.497 0.665 . . . . 0.0 112.549 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mtpm? -68.52 -42.26 26.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.7 Cg_endo -61.41 -29.56 85.62 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.014 1.143 . . . . 0.0 110.821 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.9 mt -63.43 -42.28 98.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -58.07 -46.4 85.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.748 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -65.74 -45.76 81.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.994 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.71 -41.57 88.94 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.536 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -87.76 -3.12 58.97 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 46.17 45.76 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.386 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.427 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 53.8 m0 -82.78 100.99 10.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.408 0.623 . . . . 0.0 110.655 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -84.71 47.05 1.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.021 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 1.8 m-85 -138.32 175.95 9.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.88 126.42 32.44 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -110.9 131.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.07 0.462 . . . . 0.0 110.102 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.496 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -121.17 134.29 55.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.683 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.478 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.9 mp -110.18 115.9 30.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.476 ' HA ' HD22 ' A' ' 14' ' ' LEU . 45.8 t0 -79.0 114.8 18.24 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.158 175.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 p -85.63 -13.06 49.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.194 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -90.42 -45.65 8.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.948 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.436 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 89.8 8.85 66.88 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -174.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -96.24 -25.06 15.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.441 -0.88 . . . . 0.0 111.766 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 24' ' ' THR . 62.3 t80 -61.47 -43.85 98.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 22.9 pttp -58.92 -40.11 83.57 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.305 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -71.07 -41.85 70.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.972 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.55 81.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.37 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.67 -25.33 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.069 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.52 95.22 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.228 1.011 . . . . 0.0 111.966 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.68 115.7 50.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.169 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.2 p -82.77 -57.98 3.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.683 0.754 . . . . 0.0 110.076 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 46.3 tp -130.57 134.47 47.04 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.625 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.8 pt -87.59 151.36 50.33 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.567 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.8 Cg_endo -82.88 161.55 74.99 Favored 'Cis proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.704 0.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.61 136.65 54.76 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.448 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.6 t -119.44 124.97 73.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 120.889 0.376 . . . . 0.0 111.188 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 61.1 m-85 -122.05 118.04 27.78 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 62.0 mt -105.86 130.47 57.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.153 0.501 . . . . 0.0 111.0 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.464 HG21 ' HB1' ' A' ' 7' ' ' ALA . 53.3 t -104.87 135.2 43.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.988 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 125' ' ' VAL . 3.2 p-10 -87.66 -174.73 4.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 111.014 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.12 -18.43 69.07 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.414 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -88.86 -4.34 58.5 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.545 -0.386 . . . . 0.0 110.981 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 84.39 28.94 31.64 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.336 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 2.0 mppt? -124.21 154.09 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.161 0.505 . . . . 0.0 111.481 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.0 mt -70.59 99.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.246 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.433 HG11 HD21 ' A' ' 146' ' ' LEU . 7.2 p -83.87 -31.49 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.64 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.618 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.1 t80 -130.67 129.06 42.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.535 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -132.36 121.93 24.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -146.37 102.01 3.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.414 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 p -94.81 116.15 28.38 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.527 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.02 50.75 1.72 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.34 -0.934 . . . . 0.0 114.109 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.567 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.5 OUTLIER -81.64 138.52 35.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.0 p -123.35 -16.11 6.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.372 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -140.5 -101.63 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.35 30.13 2.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.955 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.77 -25.65 74.05 Favored Glycine 0 C--N 1.318 -0.455 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.053 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.6 -29.72 64.72 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.232 0.613 . . . . 0.0 110.626 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.19 96.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.06 -35.12 77.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.579 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.733 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -61.22 -53.58 55.09 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.29 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.407 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.1 tp -67.75 -39.08 81.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.089 0.471 . . . . 0.0 111.395 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 34.1 ttpt -59.06 -48.4 81.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.469 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.532 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 39.9 tptt -67.79 -30.97 70.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.216 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 139' ' ' LEU . 48.0 t -58.15 -44.46 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.535 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -77.14 -24.85 51.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.029 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 52.0 mm-40 -64.04 -33.71 76.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.135 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 88.8 mt . . . . . 0 C--N 1.322 -0.606 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.068 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.666 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.43 -1.462 0 CA-C-O 120.163 0.03 . . . . 0.0 110.992 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -151.79 -140.21 0.09 Allowed 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.74 14.85 2.13 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.407 ' HB3' HG13 ' A' ' 124' ' ' ILE . 51.5 tt0 49.94 51.07 17.31 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.763 0.792 . . . . 0.0 109.964 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.404 HD13 ' HB ' ' A' ' 24' ' ' THR . 78.6 mt -106.66 154.71 39.88 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.327 -174.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.87 152.57 78.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.499 2.799 . . . . 0.0 110.913 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.96 87.05 0.72 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.131 0.491 . . . . 0.0 111.565 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.7 t -126.31 136.54 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.222 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -96.98 112.89 24.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.782 0.325 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 98' ' ' ASP . 53.2 mt -116.48 176.55 5.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -105.33 139.86 39.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.472 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -92.73 -175.14 3.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.285 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.73 -11.37 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.836 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.91 -15.54 27.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.85 61.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.818 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -99.99 146.29 26.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -73.73 120.16 18.94 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.469 0.652 . . . . 0.0 110.716 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.71 131.39 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.611 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.6 mt-30 -92.28 134.57 34.78 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.436 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 103' ' ' PHE . 7.1 p -67.28 -21.58 65.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -79.57 -9.9 59.7 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.0 0.429 . . . . 0.0 110.495 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.25 16.09 7.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.67 -178.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.3 tp -99.76 125.88 45.74 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.746 -176.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.666 ' HB3' ' O ' ' A' ' 5' ' ' THR . 3.9 pt-20 -141.91 158.65 43.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.084 177.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' A' ' 32' ' ' LYS . 37.0 t30 -81.14 -71.5 0.47 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.64 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.09 38.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.448 0.467 . . . . 0.0 110.963 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.6 ' HA2' HG21 ' A' ' 5' ' ' THR . . . 91.83 4.06 67.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.042 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HB2' HD22 ' A' ' 29' ' ' ASN . 1.0 OUTLIER -107.64 151.73 41.17 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 122.652 0.381 . . . . 0.0 110.387 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -66.91 155.67 69.69 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 122.994 2.463 . . . . 0.0 112.343 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.4 mtm -138.97 149.33 44.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.65 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.43 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 89.7 mt -127.88 126.11 66.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 77.4 mt -91.52 126.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.8 m -111.03 112.96 25.15 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 40.7 m-85 -86.98 109.46 19.39 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 173.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.61 ' HB2' HD22 ' A' ' 47' ' ' LEU . 28.5 p90 -126.21 157.07 39.15 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.853 0.721 . . . . 0.0 110.872 -175.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.96 147.66 34.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.803 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.251 -177.945 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.61 HD22 ' HB2' ' A' ' 39' ' ' PHE . 9.6 mt . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 132' ' ' THR . 27.0 mmt180 -61.1 -43.39 98.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.8 tm-20 -63.66 -55.13 25.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.474 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.436 HD11 ' CE2' ' A' ' 93' ' ' TYR . 35.5 tp -62.71 -40.85 98.45 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.61 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.94 -48.17 77.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.639 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -44.45 93.23 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.043 0.449 . . . . 0.0 110.868 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 68' ' ' LEU . 62.6 mt -64.05 -41.34 92.16 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.77 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.688 ' OE1' ' HA ' ' A' ' 91' ' ' TRP . 26.3 tp60 -51.83 -40.61 60.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.42 -41.57 72.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.974 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.06 19.13 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -59.78 -34.4 72.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.6 84.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.836 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.86 -40.39 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.981 0.419 . . . . 0.0 110.694 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.469 ' NE1' HD13 ' A' ' 140' ' ' ILE . 15.3 m0 -67.27 -38.35 84.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.384 0.611 . . . . 0.0 110.405 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -81.97 -8.8 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.391 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.3 -49.23 78.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.876 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -152.19 64.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.369 0.604 . . . . 0.0 110.706 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.8 m -161.9 -39.74 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.613 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.0 21.08 76.94 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.662 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.2 p -81.93 125.57 39.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.066 0.46 . . . . 0.0 111.888 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -108.46 158.14 17.8 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.233 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 53' ' ' ILE . 42.8 mt -99.02 134.16 42.26 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.021 0.438 . . . . 0.0 110.843 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.608 HG23 HD13 ' A' ' 96' ' ' LEU . 90.8 mt -102.75 101.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -88.54 122.89 32.5 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.1 p -120.54 130.5 74.41 Favored 'Isoleucine or valine' 0 C--O 1.256 1.412 0 CA-C-O 121.594 0.711 . . . . 0.0 111.769 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 82' ' ' VAL . 24.1 p -83.37 132.01 35.02 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.898 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.524 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 45.1 pt -87.49 19.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 125.369 1.668 . . . . 0.0 113.858 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -122.38 -159.26 0.82 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.733 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.527 ' HB2' HE22 ' A' ' 77' ' ' GLN . 49.2 mt-10 -96.17 179.83 4.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.749 0.309 . . . . 0.0 110.381 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.563 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . -61.84 -43.32 99.38 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.527 HE22 ' HB2' ' A' ' 75' ' ' GLU . 6.0 pm0 -64.38 -41.78 96.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.648 0.724 . . . . 0.0 112.306 -177.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -77.03 -38.84 52.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.873 0.368 . . . . 0.0 111.549 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -71.46 -5.66 34.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 86.3 mm-40 -60.75 -24.1 65.47 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.919 -0.488 . . . . 0.0 110.722 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.699 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 30.6 mtpp -84.05 -9.83 58.32 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.725 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.637 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.6 t -65.75 -48.23 83.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.698 0.761 . . . . 0.0 112.53 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.9 mtpm? -66.65 -41.85 41.71 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.144 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.2 Cg_endo -62.9 -28.99 75.74 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.175 1.25 . . . . 0.0 110.884 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 97.5 mt -62.51 -42.84 99.78 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.42 91.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.797 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.85 -46.4 53.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.99 94.32 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.439 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -75.33 -23.95 57.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.797 0.332 . . . . 0.0 111.153 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.09 37.7 28.2 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.728 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.688 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 26.4 m0 -59.67 -42.28 92.53 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 66.13 27.3 10.49 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.611 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 6.1 m-85 -111.91 -167.65 1.21 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.475 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -104.3 129.21 52.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.496 0.665 . . . . 0.0 111.954 -172.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.608 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -114.32 133.94 55.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.343 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 76' ' ' GLY . 10.4 tt -108.71 111.85 23.84 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.253 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.617 ' HA ' HD22 ' A' ' 14' ' ' LEU . 68.2 t0 -80.12 128.19 33.21 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.271 174.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -110.09 0.65 18.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.991 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -114.23 -36.2 4.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 87.41 7.61 75.82 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.02 -21.97 25.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.554 ' CE1' HG21 ' A' ' 24' ' ' THR . 52.3 t80 -64.15 -35.42 80.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 110.22 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 52.1 mtmt -59.8 -44.84 93.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.55 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.1 -37.96 72.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.07 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.56 82.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.173 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.5 mmm -91.64 -10.4 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.244 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 64.71 69.25 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.379 0.609 . . . . 0.0 110.466 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.86 120.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.805 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.3 t -95.79 -75.88 0.51 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.227 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.499 HD21 HG22 ' A' ' 132' ' ' THR . 41.6 tp -98.26 160.73 14.1 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.2 pt -116.05 153.05 48.33 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.2 Cg_endo -79.56 156.9 89.71 Favored 'Cis proline' 0 C--O 1.241 0.656 0 C-N-CA 123.882 -1.299 . . . . 0.0 112.801 1.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -113.17 135.13 54.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.465 HG22 ' HG3' ' A' ' 49' ' ' GLU . 22.1 t -120.29 131.45 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -173.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.478 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 89.7 m-85 -126.73 112.83 15.88 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 173.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.5 mt -99.82 123.17 52.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.76 127.95 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.867 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.401 ' OD1' HD22 ' A' ' 146' ' ' LEU . 10.2 t70 -70.05 163.01 27.09 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 110.952 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -18.33 43.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.13 -0.486 . . . . 0.0 113.473 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -86.6 1.57 51.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.813 0.307 . . . . 0.0 111.085 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 83.55 26.38 43.01 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.005 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -124.98 157.0 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.943 0.372 . . . . 0.0 110.056 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 8' ' ' GLN . 96.2 mt -79.4 115.37 21.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.138 0.494 . . . . 0.0 110.055 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 146' ' ' LEU . 7.8 p -94.67 -38.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.15 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.438 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 72.0 t80 -134.26 128.73 34.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.203 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -131.21 128.93 40.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.411 . . . . 0.0 110.219 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 12.7 t60 -138.38 102.85 4.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 102.65 15.39 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.199 0.523 . . . . 0.0 111.911 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.17 105.45 0.75 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.653 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.562 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 3.6 p90 -138.23 163.78 30.88 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.662 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.7 p -109.62 -42.28 4.34 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.001 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -172.94 151.69 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.68 79.95 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.85 -34.33 8.43 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.5 pm0 -61.4 -15.55 37.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.35 0.66 . . . . 0.0 112.143 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.92 94.46 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.519 0.676 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.88 -26.82 36.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.227 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.1 mp -62.07 -49.31 76.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.721 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.469 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.8 tp -68.9 -34.84 66.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.879 0.371 . . . . 0.0 110.257 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 41.8 ttmt -58.91 -49.07 79.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.176 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -66.21 -36.73 83.83 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LEU . 72.8 t -59.76 -45.07 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.123 0.487 . . . . 0.0 109.804 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 144' ' ' ARG . 30.9 mmt180 -72.0 -25.02 61.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.209 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 75.7 mm-40 -64.37 -36.09 83.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.461 HD21 HG11 ' A' ' 125' ' ' VAL . 81.8 mt . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 121.353 0.597 . . . . 0.0 109.487 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.442 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 4.4 t . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.329 0.585 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.474 ' N ' ' HA3' ' A' ' 122' ' ' GLY . 85.7 m-85 -87.8 -90.57 0.12 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.314 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.587 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 169.92 -25.49 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.579 -176.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.519 HE21 ' HD2' ' A' ' 123' ' ' LYS . 8.5 tt0 65.9 83.14 0.17 Allowed 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.547 -176.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 24' ' ' THR . 15.7 mt -133.19 167.28 23.74 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.385 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.71 159.87 49.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.913 2.409 . . . . 0.0 111.109 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.42 83.44 3.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -126.36 134.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.209 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.1 p -98.7 112.76 24.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.204 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -117.67 176.4 5.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -108.63 135.28 50.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.437 0.16 . . . . 0.0 110.607 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -87.23 -171.92 3.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.527 HG23 ' H ' ' A' ' 95' ' ' VAL . 27.5 pt -66.21 -24.04 32.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -77.42 -30.81 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.491 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.85 14.95 21.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.2 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -93.78 147.76 22.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.8 m -75.07 115.86 15.17 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.281 0.562 . . . . 0.0 110.269 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.44 131.65 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.895 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.592 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 44.2 mt-30 -98.06 132.7 43.38 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.71 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.618 HG21 ' CE1' ' A' ' 103' ' ' PHE . 14.8 p -68.17 -24.36 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -78.7 -4.04 47.16 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.815 0.34 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -134.25 11.9 3.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -67.89 124.81 24.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -147.88 161.8 40.57 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.6 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 35.1 p-10 -107.27 -56.48 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.94 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.86 25.59 0.03 OUTLIER Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 29' ' ' ASN . 14.4 mptt -129.13 151.22 77.34 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.67 153.57 77.58 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.324 2.016 . . . . 0.0 111.753 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.6 ' SD ' ' HB3' ' A' ' 29' ' ' ASN . 74.4 mtm -136.62 155.43 49.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.918 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.13 123.15 61.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.1 123.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -113.96 124.46 52.21 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 60.9 m-85 -93.76 119.76 33.15 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.621 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 24.2 p90 -137.94 170.16 16.53 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.606 0.566 . . . . 0.0 111.95 -175.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.65 33.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.565 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p . . . . . 0 C--N 1.314 -0.964 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.921 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.591 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 8.2 mt . . . . . 0 CA--C 1.509 -0.622 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -64.45 -39.5 93.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.728 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.577 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -67.96 -52.76 32.28 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.547 HD11 ' CE2' ' A' ' 93' ' ' TYR . 43.6 tp -61.6 -41.25 97.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.806 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.07 -49.68 76.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.513 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.05 -44.09 66.5 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.853 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 49' ' ' GLU . 66.6 mt -63.72 -42.44 96.0 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.767 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.691 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -52.7 -40.32 62.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -68.32 -44.8 74.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.36 20.51 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -60.81 -32.68 72.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.761 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.9 92.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.818 0.342 . . . . 0.0 110.407 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -66.8 -39.05 87.6 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.37 -36.37 82.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.545 0.688 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -82.39 -9.12 59.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.579 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.83 -52.94 63.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.502 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.04 -50.46 2.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 143' ' ' VAL . 6.5 m -61.77 -38.8 89.36 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.33 29.04 74.17 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.431 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.66 127.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.92 0.391 . . . . 0.0 111.865 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -106.37 140.49 39.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.605 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 72.1 mt -84.63 144.62 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.593 HD11 ' SD ' ' A' ' 34' ' ' MET . 94.8 mt -119.5 109.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.621 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -100.38 127.99 46.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.35 136.43 59.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 CA-C-O 121.612 0.72 . . . . 0.0 111.706 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 82' ' ' VAL . 37.2 p -83.61 126.34 32.73 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.437 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 pt -80.79 16.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 125.107 1.504 . . . . 0.0 112.351 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.6 ' OD1' ' HB2' ' A' ' 78' ' ' ASN . 4.2 t70 -130.14 165.88 21.39 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -78.43 175.38 10.35 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.338 0.399 . . . . 0.0 111.268 -174.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 80' ' ' GLN . . . -56.83 -22.85 42.7 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.111 -177.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -65.04 -57.57 8.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.119 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.6 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 91.7 m-20 -85.42 -38.97 18.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.137 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -71.94 -3.2 21.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.456 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 6.7 tt0 -63.98 -12.28 36.32 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.766 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.7 mmtm -95.77 -3.08 46.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.975 0.51 . . . . 0.0 112.054 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.7 t -65.26 -49.19 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.39 0.614 . . . . 0.0 112.547 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.4 mtpt -65.62 -43.69 62.19 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.803 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.15 -28.45 79.73 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.23 1.287 . . . . 0.0 111.312 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.6 mt -62.87 -41.94 99.58 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.97 92.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.9 -46.81 83.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.28 -40.76 80.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.631 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -92.97 -0.4 57.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.66 38.93 61.06 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.358 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -81.78 96.5 7.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.7 70.84 7.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 50' ' ' LEU . 11.2 m-85 -145.47 172.13 13.65 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.87 120.34 20.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.527 ' H ' HG23 ' A' ' 17' ' ' ILE . 20.7 t -109.21 123.75 65.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.495 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -111.23 138.1 48.11 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.646 0.736 . . . . 0.0 111.525 -176.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.8 tp -103.76 109.36 21.05 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.792 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.548 ' HA ' HD22 ' A' ' 14' ' ' LEU . 68.0 t0 -82.27 116.37 21.76 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 117.751 -1.58 . . . . 0.0 108.531 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -107.27 5.48 27.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.202 0.525 . . . . 0.0 110.185 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -110.8 -43.62 3.78 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.951 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.02 -1.97 78.57 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.682 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -83.18 -25.57 31.68 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.602 -0.352 . . . . 0.0 111.454 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 24' ' ' THR . 47.6 t80 -64.01 -44.46 92.52 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -61.49 -36.71 81.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.852 0.358 . . . . 0.0 110.61 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -70.24 -41.57 73.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 110.359 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.62 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.591 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.9 mmt -86.76 -8.29 57.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.021 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.2 t30 59.03 71.18 0.6 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.379 0.609 . . . . 0.0 111.26 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 38' ' ' PHE . 44.8 t -98.76 96.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.21 0.529 . . . . 0.0 110.63 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -88.89 -62.24 1.53 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.432 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.443 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 47.1 tp -105.93 129.9 53.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.281 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.7 pt -91.55 152.87 43.91 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 67.2 Cg_endo -83.62 157.04 72.06 Favored 'Cis proline' 0 C--O 1.242 0.721 0 C-N-CA 124.277 -1.135 . . . . 0.0 112.859 1.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -112.98 130.03 56.28 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.54 127.87 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-O 121.327 0.584 . . . . 0.0 112.161 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 86.6 m-85 -127.64 112.69 15.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.765 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.2 mt -101.74 130.73 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.213 0.53 . . . . 0.0 110.874 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 76.4 t -107.61 129.54 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.26 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.45 -175.42 5.46 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.301 0.376 . . . . 0.0 111.177 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.7 61.64 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.713 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -86.04 -1.66 57.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.479 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.474 ' HA3' ' N ' ' A' ' 6' ' ' TYR . . . 70.89 42.6 60.13 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.395 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.519 ' HD2' HE21 ' A' ' 8' ' ' GLN . 72.2 mmtt -127.11 155.54 43.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 7' ' ' ALA . 88.5 mt -71.66 100.14 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 146' ' ' LEU . 13.8 p -90.8 -34.16 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.457 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 87.7 t80 -132.5 130.33 40.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.723 0.296 . . . . 0.0 110.701 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.431 HD21 HG23 ' A' ' 129' ' ' THR . 2.1 t-20 -131.74 115.9 16.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.049 0.452 . . . . 0.0 110.78 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.465 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 2.0 t60 -132.81 102.87 5.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.405 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.431 HG23 HD21 ' A' ' 127' ' ' ASN . 0.6 OUTLIER -97.02 116.32 29.01 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.089 -178.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 78.5 65.35 1.86 Allowed Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.41 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.477 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 2.7 p90 -104.58 154.77 19.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.832 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.9 p -142.68 94.62 2.66 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.257 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 63.73 108.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.731 0.812 . . . . 0.0 112.273 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.17 23.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.862 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.34 -18.97 40.19 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.944 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.57 -30.28 67.04 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.368 0.667 . . . . 0.0 111.174 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.23 -40.26 93.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.787 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.42 -36.66 79.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.789 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.2 mp -63.0 -48.81 77.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.713 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.507 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.2 tp -67.82 -39.76 82.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.903 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 27.8 ttpp -60.43 -45.51 93.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.803 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.648 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 37.8 tptt -66.38 -35.72 81.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.31 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -59.48 -46.73 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 0.0 110.711 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 4.6 ptp180 -78.98 -18.57 53.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.059 0.457 . . . . 0.0 110.91 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' LYS . 31.0 tt0 -69.93 -37.51 75.92 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.862 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 58.1 mt . . . . . 0 N--CA 1.465 0.286 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.667 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 41.7 m-85 -97.89 -135.64 0.26 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.246 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.415 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -153.57 11.52 0.44 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 52.8 tp60 51.74 31.75 8.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.826 0.822 . . . . 0.0 111.656 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 33.1 mt -79.87 161.68 65.25 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.022 -177.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.13 154.09 72.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.457 2.105 . . . . 0.0 111.133 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.28 76.64 1.33 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.312 0.577 . . . . 0.0 111.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.21 134.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 9.7 t -97.33 114.94 26.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.097 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 98' ' ' ASP . 30.0 mt -105.33 173.64 6.22 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -113.48 127.08 55.97 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.505 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.409 ' ND2' ' HD3' ' A' ' 20' ' ' LYS . 86.8 m-20 -79.59 178.71 7.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.074 0.464 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.569 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 47.3 pt -65.57 -26.2 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.186 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.99 -17.54 60.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.21 19.58 60.52 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 44.6 tttp -79.81 136.16 36.65 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.728 -0.736 . . . . 0.0 109.918 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -83.71 108.76 16.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.74 144.32 38.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.021 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.633 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 85.9 mt-30 -103.99 135.19 45.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.425 HG21 ' CE1' ' A' ' 103' ' ' PHE . 12.8 p -64.38 -30.68 71.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -73.66 -14.2 61.12 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.071 0.462 . . . . 0.0 111.068 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.633 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -114.65 8.88 16.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 111.297 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 38.4 tp -80.51 115.8 20.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.231 -175.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 160.73 36.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.314 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.507 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 8.3 p30 -112.89 -58.21 2.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.645 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.96 -45.54 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.565 0.746 . . . . 0.0 109.882 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.87 26.57 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.828 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -119.46 152.01 52.31 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.48 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 12.3 Cg_exo -72.1 158.89 51.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.932 2.421 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.507 ' SD ' ' ND2' ' A' ' 29' ' ' ASN . 5.0 mpp? -132.14 156.96 45.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.93 123.66 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -103.43 121.66 55.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.72 122.83 46.51 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 71.7 m-85 -96.1 119.63 34.94 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -147.83 161.46 41.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.984 0.421 . . . . 0.0 111.692 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.29 152.7 32.32 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.242 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 74' ' ' ASP . 3.1 p . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -61.26 -38.19 85.84 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.202 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.678 ' OE2' ' HB2' ' A' ' 113' ' ' PRO . 50.7 mt-10 -53.04 -67.28 0.26 Allowed 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.659 0.742 . . . . 0.0 110.235 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.6 HD11 ' CE2' ' A' ' 93' ' ' TYR . 30.4 tp -60.86 -41.04 95.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.747 -173.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.52 -53.98 43.43 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.095 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 -42.74 94.77 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.8 mt -65.03 -42.77 95.48 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.949 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.68 -38.05 71.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.652 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.88 -35.7 81.37 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.869 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -120.59 25.26 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 53' ' ' ILE . 86.9 t80 -60.53 -34.45 74.13 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.54 92.21 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.425 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.89 -42.32 94.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.796 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.406 ' NE1' HD11 ' A' ' 140' ' ' ILE . 11.7 m0 -63.77 -35.76 81.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.754 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -79.13 -15.63 57.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.272 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.94 -43.73 98.24 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.75 -58.8 1.93 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.541 -0.463 . . . . 0.0 112.025 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 m -62.69 -39.62 94.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.684 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.43 28.16 73.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.656 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.72 131.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 122.658 0.383 . . . . 0.0 111.929 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -106.79 146.52 30.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.627 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 60.8 mt -91.69 148.12 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.402 0.62 . . . . 0.0 111.457 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 92.3 mt -122.44 118.68 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.575 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.44 111.56 23.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.52 127.83 72.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 CA-C-O 121.66 0.743 . . . . 0.0 111.245 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.563 ' HB2' HG21 ' A' ' 82' ' ' VAL . 35.0 t -85.6 133.11 34.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.713 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.408 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 44.0 pt -84.93 2.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.843 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 41' ' ' THR . 49.2 m-20 -102.33 157.27 17.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.71 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.03 156.42 5.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.492 0.495 . . . . 0.0 111.07 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.23 -34.04 72.46 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.489 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.61 -40.57 92.35 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.701 0.286 . . . . 0.0 111.708 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.412 HD22 ' HB3' ' A' ' 74' ' ' ASP . 42.6 t30 -85.3 -32.52 22.46 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.384 0.612 . . . . 0.0 110.367 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.31 -4.24 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.624 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.65 -8.97 11.52 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.025 -0.422 . . . . 0.0 110.143 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.645 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 35.4 mmtp -85.93 -17.56 35.12 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.183 0.593 . . . . 0.0 111.788 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 79' ' ' ALA . 11.6 t -64.48 -46.25 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.843 0.83 . . . . 0.0 111.324 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 18.7 mtmt -68.53 -44.23 33.28 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.17 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.4 Cg_endo -60.2 -32.39 94.36 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.009 1.139 . . . . 0.0 110.785 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.3 mt -64.35 -42.45 96.22 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -60.48 -41.82 95.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.783 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.82 -41.53 95.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.532 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.65 -51.67 6.36 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.314 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.71 -34.81 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.95 2.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.216 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -88.35 104.96 17.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.01 65.33 2.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 110.035 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.6 ' CE2' HD11 ' A' ' 50' ' ' LEU . 11.4 m-85 -140.12 178.96 6.91 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.79 120.87 24.66 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.569 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 20.0 t -107.12 126.7 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.678 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.52 139.89 53.38 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.128 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.55 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.4 mp -110.49 118.74 37.06 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.557 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.1 t0 -72.09 115.44 11.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.527 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.0 t -94.99 6.4 49.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.497 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -124.9 -38.73 2.32 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.097 0.475 . . . . 0.0 110.855 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 90.0 4.1 72.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -97.91 -20.65 17.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 24' ' ' THR . 74.0 t80 -62.19 -43.77 98.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.949 0.404 . . . . 0.0 110.158 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 73' ' ' ILE . 21.1 ptmt -58.02 -41.67 83.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.699 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -70.5 -39.52 74.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 111.026 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.21 99.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.317 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.65 -12.98 59.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 68.19 79.9 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.042 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.7 t -110.57 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.346 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.8 m -75.65 -46.52 31.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.2 tp -136.12 132.61 36.3 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.879 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.4 pt -87.38 154.0 53.84 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 95.2 Cg_endo -80.38 153.71 84.74 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.569 -0.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -116.17 125.97 53.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.326 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.462 HG22 ' CD ' ' A' ' 49' ' ' GLU . 13.7 t -101.34 124.93 55.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.8 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -124.73 112.63 16.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.729 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.24 128.87 53.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.124 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 76.4 t -106.38 129.72 59.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.678 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 12.0 t70 -70.68 157.77 37.41 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.922 0.764 . . . . 0.0 109.568 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.32 -25.52 62.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.315 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.28 -25.11 66.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.118 0.485 . . . . 0.0 110.59 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 26.06 6.72 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.644 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.97 157.01 38.89 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 122.491 0.316 . . . . 0.0 110.548 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 7' ' ' ALA . 69.3 mt -71.28 122.44 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.5 p -109.03 -32.64 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 58.0 t80 -147.62 131.5 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.297 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.017 0.437 . . . . 0.0 110.17 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.521 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 36.9 t60 -143.57 106.48 4.49 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.5 m -100.41 123.29 44.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.043 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.98 60.11 5.09 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.315 0.886 . . . . 0.0 115.315 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.662 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 27.2 p90 -86.18 -39.53 16.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 117.637 0.719 . . . . 0.0 109.597 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.0 p 73.39 -44.99 0.6 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.979 1.711 . . . . 0.0 113.53 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.07 138.95 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.04 18.65 74.3 Favored Glycine 0 C--N 1.327 0.059 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.848 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.662 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.91 -25.72 19.06 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.452 -177.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -60.93 -25.69 66.95 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.06 94.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 110.391 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.54 -38.32 89.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.511 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.1 mp -63.33 -47.14 83.46 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.685 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 140' ' ' ILE . 5.4 mm -61.63 -41.45 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.709 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.2 ttpp -57.29 -49.94 74.49 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.889 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 32.9 mmmt -68.39 -38.21 81.13 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 139' ' ' LEU . 52.6 t -58.94 -46.55 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.854 0.359 . . . . 0.0 111.575 -177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.93 -22.42 42.72 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.638 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 73.6 mm-40 -66.28 -37.29 85.1 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.513 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 80.6 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.53 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.681 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 94.9 m . . . . . 0 C--O 1.215 -0.723 0 CA-C-O 121.156 0.503 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 54.9 m-85 -124.15 -112.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -171.62 159.57 5.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.471 ' H ' HG13 ' A' ' 124' ' ' ILE . 8.4 tt0 -81.65 80.66 7.93 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.478 HD13 ' HB ' ' A' ' 24' ' ' THR . 60.6 mt -120.5 151.75 54.35 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 17.2 Cg_exo -67.94 147.86 75.11 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.8 2.333 . . . . 0.0 108.358 170.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.7 94.77 1.04 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.258 0.551 . . . . 0.0 111.467 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.9 149.33 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.948 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 p -110.21 117.29 33.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 98' ' ' ASP . 42.3 mt -112.03 175.06 5.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.326 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 32.8 mmtp -105.37 136.59 44.63 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.821 0.343 . . . . 0.0 111.513 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.77 -173.86 2.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.455 HG22 ' HB ' ' A' ' 95' ' ' VAL . 34.0 pt -67.14 -21.02 27.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.357 0.599 . . . . 0.0 110.354 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -86.02 -15.53 41.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.13 20.01 51.02 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -87.96 140.12 29.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.9 m -79.7 115.07 19.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.227 0.537 . . . . 0.0 110.892 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 m -119.39 130.6 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.391 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.3 mt-30 -89.13 134.9 33.84 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.503 HG21 ' CE1' ' A' ' 103' ' ' PHE . 22.8 p -63.69 -30.53 71.62 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.857 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.415 HD22 ' N ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -78.96 -4.46 50.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.83 -178.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.63 13.78 7.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.1 tp -71.37 112.48 7.54 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.464 -177.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -137.3 143.3 42.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -178.012 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.42 ' HB2' ' NH2' ' A' ' 67' ' ' ARG . 35.6 p-10 -112.01 -38.22 4.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 29' ' ' ASN . . . 167.79 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.51 0.506 . . . . 0.0 111.525 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.84 32.63 58.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.496 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -125.04 151.88 69.67 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 122.269 0.228 . . . . 0.0 110.913 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 149.76 89.28 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.245 1.963 . . . . 0.0 110.741 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.6 mtm -135.51 144.91 46.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.587 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.406 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.9 mt -120.43 122.46 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.33 112.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.04 124.07 48.37 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.47 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 63.5 m-85 -96.11 119.57 34.84 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.984 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -143.57 178.64 7.64 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.529 0.518 . . . . 0.0 111.271 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.2 155.25 25.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.522 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.428 -1.54 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.503 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.223 -0.3 0 CA-C-O 120.701 0.286 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -57.91 -45.75 86.03 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 53' ' ' ILE . 77.0 tt0 -55.96 -59.88 4.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.275 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.7 -41.78 99.3 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.871 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 54.8 tptt -64.05 -46.82 82.72 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.66 94.21 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.738 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.1 mt -65.0 -40.94 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.908 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.467 ' HA ' ' OH ' ' A' ' 93' ' ' TYR . 63.9 tt0 -53.61 -39.96 65.36 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 110.984 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 42.9 mm-40 -67.32 -40.24 85.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.18 18.95 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.64 -36.89 82.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.19 84.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.566 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.99 -43.57 98.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.198 0.523 . . . . 0.0 110.388 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.423 ' HH2' ' HB3' ' A' ' 139' ' ' LEU . 15.7 m0 -69.23 -42.38 75.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -72.11 -15.23 61.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.909 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.54 -47.95 83.53 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.337 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.21 -49.28 1.44 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.401 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -62.38 -41.02 98.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.528 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.61 31.0 77.3 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.045 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 133.08 30.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 122.532 0.333 . . . . 0.0 111.271 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' NH2' ' HB2' ' A' ' 29' ' ' ASN . 10.5 mtm180 -104.79 158.22 16.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 78.6 mt -107.14 135.82 48.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.079 0.466 . . . . 0.0 110.629 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.18 110.83 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.11 104.84 16.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.836 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.69 127.62 67.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.553 0.692 . . . . 0.0 111.067 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -91.02 137.27 32.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.539 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.9 pt -73.56 -20.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.997 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -67.79 142.58 56.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.098 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 31.6 mp0 -65.09 176.16 1.36 Allowed 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.614 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.55 -45.82 92.71 Favored Glycine 0 N--CA 1.461 0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.123 -174.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 28.9 pt20 -70.5 -32.44 69.94 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -85.48 -24.12 27.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.165 0.507 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -85.62 -3.45 58.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.383 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 13.9 pt20 -64.98 -4.42 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.715 -0.615 . . . . 0.0 110.743 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.601 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.9 mttm -97.97 -10.66 24.11 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.355 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 79' ' ' ALA . 13.3 t -64.88 -47.1 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 121.949 0.88 . . . . 0.0 110.822 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.6 mtpt -65.62 -46.76 68.02 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.248 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.6 Cg_endo -59.51 -29.06 89.05 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.336 1.358 . . . . 0.0 111.32 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.5 mt -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -61.27 -34.29 74.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.69 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -65.94 -29.11 69.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.189 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.18 -49.25 3.56 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.349 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 12.0 p30 -77.88 -27.04 49.59 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.1 46.38 4.17 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.903 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.6 95.86 4.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 0.0 109.977 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -78.8 42.72 0.46 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.582 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -127.05 168.53 14.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.18 113.38 19.98 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.31 0.576 . . . . 0.0 109.469 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 17' ' ' ILE . 13.7 t -97.31 136.89 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.788 -175.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 95' ' ' VAL . 11.2 mp -129.09 148.32 51.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.237 -175.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.578 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.7 mp -114.42 117.73 31.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.141 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.603 ' OD2' ' HG2' ' A' ' 104' ' ' LYS . 11.9 t70 -90.74 114.96 27.44 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.636 172.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 30.5 m -93.99 -88.97 0.23 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.51 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -112.27 19.46 17.68 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.322 0.582 . . . . 0.0 110.273 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.23 73.52 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.634 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.403 ' CG ' ' HE ' ' A' ' 105' ' ' ARG . 18.4 t70 55.05 23.85 5.54 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 109.902 -174.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 24' ' ' THR . 69.5 t80 -62.26 -42.45 99.34 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -177.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.603 ' HG2' ' OD2' ' A' ' 98' ' ' ASP . 11.4 pttm -54.78 -50.72 67.79 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HE ' ' CG ' ' A' ' 102' ' ' ASP . 17.6 ttp180 -70.55 -36.12 73.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.659 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.03 87.62 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.074 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 35.8 mmm -82.54 -8.73 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.564 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 76.08 53.64 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.653 0.739 . . . . 0.0 111.553 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.435 HG12 HG22 ' A' ' 112' ' ' ILE . 47.5 t -98.88 129.86 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.38 177.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -130.98 -71.52 0.57 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.592 ' O ' HG12 ' A' ' 112' ' ' ILE . 52.1 tp -64.35 -39.16 93.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.861 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 111' ' ' LEU . 4.2 pt 64.55 145.21 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 125.081 1.352 . . . . 0.0 111.319 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.657 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.6 Cg_endo -82.29 179.05 27.98 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.933 -0.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -133.75 142.75 48.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.768 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 128' ' ' HIS . 21.9 t -117.99 126.57 74.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 123.466 0.479 . . . . 0.0 111.36 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 69.9 m-85 -126.44 114.93 18.82 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 139' ' ' LEU . 64.8 mt -106.06 125.63 61.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-O 121.287 0.565 . . . . 0.0 111.835 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.28 130.6 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.7 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -81.27 -173.32 4.27 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.539 0.524 . . . . 0.0 111.602 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.07 -34.02 88.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.611 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -64.62 -40.59 95.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.163 0.506 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 114.44 33.89 1.68 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.257 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.21 155.05 46.9 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.471 HG13 ' H ' ' A' ' 8' ' ' GLN . 96.7 mt -74.55 108.82 6.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.429 HG11 HD21 ' A' ' 146' ' ' LEU . 12.2 p -97.91 -29.28 3.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.123 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.598 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 89.8 t80 -129.71 132.7 46.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.147 0.499 . . . . 0.0 111.328 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -128.87 127.99 42.94 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.772 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.598 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 2.2 t60 -134.27 101.63 5.08 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.1 p -109.7 116.64 32.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.14 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.79 19.05 7.98 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.823 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.657 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -75.98 143.39 41.55 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.0 p -119.68 -43.3 2.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.236 -0.585 . . . . 0.0 112.019 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -160.32 125.19 3.83 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.11 17.13 41.48 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.025 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.23 -14.86 55.32 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 139' ' ' LEU . 2.2 mp0 -59.75 -26.99 66.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.129 0.49 . . . . 0.0 111.063 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.26 90.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.21 -31.62 71.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.744 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.0 mm? -61.3 -56.66 17.99 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.402 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 tp -66.45 -38.5 81.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 120.914 0.388 . . . . 0.0 111.388 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.26 -48.99 79.39 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.671 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 20.3 tptp -67.6 -31.39 71.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.261 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.1 t -59.33 -44.48 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 144' ' ' ARG . 38.5 mmt180 -67.79 -33.06 74.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.567 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 50.8 mm-40 -56.34 -33.15 65.37 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.153 0.501 . . . . 0.0 109.928 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.429 HD21 HG11 ' A' ' 125' ' ' VAL . 84.3 mt . . . . . 0 CA--C 1.531 0.243 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.07 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.555 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.7 m . . . . . 0 N--CA 1.448 -0.571 0 CA-C-O 120.812 0.339 . . . . 0.0 110.627 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.532 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 60.3 m-85 -87.38 -112.5 0.05 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.082 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . . . -162.89 11.56 0.06 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.566 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 52.58 42.31 31.41 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.995 0.903 . . . . 0.0 110.714 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 44.3 mt -96.6 164.01 19.13 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.406 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.19 157.16 63.06 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.736 2.291 . . . . 0.0 110.854 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.18 82.87 2.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.958 0.409 . . . . 0.0 111.354 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.18 134.85 65.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 p -95.08 114.59 26.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.989 0.423 . . . . 0.0 110.608 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -112.0 172.86 6.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 35.3 mmtm -97.84 131.89 43.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.385 0.612 . . . . 0.0 112.243 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -85.86 166.21 16.19 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.514 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.45 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 36.6 pt -61.45 -24.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.344 . . . . 0.0 111.671 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -77.26 -4.9 47.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.57 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.23 16.65 75.9 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -95.68 140.44 30.49 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.891 -0.654 . . . . 0.0 109.827 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.8 m -74.57 120.34 20.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.6 131.72 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.2 mt-30 -91.09 134.93 34.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.901 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.54 HG21 ' CE1' ' A' ' 103' ' ' PHE . 10.2 p -64.33 -31.9 73.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.923 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.36 -10.8 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.703 0.287 . . . . 0.0 111.593 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -119.08 3.49 11.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.09 -0.382 . . . . 0.0 111.214 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.36 109.45 19.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.527 0.68 . . . . 0.0 111.911 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.532 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.8 mt-10 -117.1 132.23 56.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.16 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.538 ' ND2' HH21 ' A' ' 67' ' ' ARG . 2.4 t-20 -72.3 -71.19 0.3 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.233 178.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.27 35.74 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.798 0.332 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.43 24.24 59.25 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.165 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -117.93 152.54 50.31 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.251 -0.475 . . . . 0.0 110.25 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.61 151.76 58.75 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.389 2.059 . . . . 0.0 111.893 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -134.98 156.27 49.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.04 0.448 . . . . 0.0 111.571 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.502 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 83.7 mt -126.64 126.68 69.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.68 125.36 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 120.688 0.28 . . . . 0.0 110.456 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -110.11 120.06 41.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.861 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 67.5 m-85 -96.37 121.98 38.76 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.177 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 16.3 p90 -147.68 169.35 19.88 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.5 0.5 . . . . 0.0 110.818 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.67 140.28 32.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.027 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.447 HG22 ' CG ' ' A' ' 74' ' ' ASP . 15.4 t . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.346 -179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 111.455 0.169 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.44 -79.58 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.169 0.588 . . . . 0.0 112.118 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.512 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 8.5 tm-20 -42.29 -60.58 1.43 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.952 1.701 . . . . 0.0 112.104 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD11 ' CE2' ' A' ' 93' ' ' TYR . 32.7 tp -61.21 -39.07 88.86 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.576 -176.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.28 -48.69 69.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.259 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.03 97.55 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-O 121.344 0.592 . . . . 0.0 111.072 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.2 mt -64.14 -41.38 92.24 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.86 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -52.81 -38.83 61.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.29 -38.42 87.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.444 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.57 24.33 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 53' ' ' ILE . 83.5 t80 -62.99 -40.63 98.32 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.68 85.11 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.035 0.445 . . . . 0.0 110.383 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.14 -43.3 99.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.247 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.427 ' NE1' HD13 ' A' ' 140' ' ' ILE . 24.8 m0 -65.47 -37.56 87.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.408 HE21 ' HG2' ' A' ' 67' ' ' ARG . 85.0 mt-30 -74.5 -9.16 58.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.64 -64.33 0.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -115.78 -39.59 3.48 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.472 HG21 HG13 ' A' ' 143' ' ' VAL . 7.4 m -62.29 -40.23 95.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.32 33.29 86.3 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.111 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.05 138.95 18.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.754 0.311 . . . . 0.0 110.649 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.538 HH21 ' ND2' ' A' ' 29' ' ' ASN . 23.8 mtm180 -123.65 152.87 41.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.052 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.502 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 62.9 mt -96.43 144.88 26.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.1 mt -119.73 112.52 37.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB1' ' HE1' ' A' ' 39' ' ' PHE . . . -93.81 120.1 33.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.682 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.92 130.65 73.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.478 0.656 . . . . 0.0 111.262 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 p -88.77 135.83 33.31 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.487 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.8 pt -82.24 -11.26 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.149 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.447 ' CG ' HG22 ' A' ' 41' ' ' THR . 8.3 m-20 -83.2 149.75 26.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.429 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -58.75 168.57 1.18 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.312 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.0 -35.98 86.19 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 114.28 0.472 . . . . 0.0 114.28 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.45 -53.26 57.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.186 0.493 . . . . 0.0 111.067 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -68.67 -37.94 80.0 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -66.88 -6.66 17.3 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.589 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.57 -17.57 62.97 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.397 0.617 . . . . 0.0 109.422 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.6 mttm -93.75 -8.28 41.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.284 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 79' ' ' ALA . 13.6 t -66.45 -46.23 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.73 0.776 . . . . 0.0 110.767 -177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.3 mtpt -62.55 -48.86 85.56 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.872 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -60.6 -29.93 89.51 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.357 1.371 . . . . 0.0 111.403 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.4 mt -63.68 -43.99 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.92 98.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.494 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.28 -50.1 67.03 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.833 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.61 85.48 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.337 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -73.32 -23.42 60.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.87 0.335 . . . . 0.0 111.607 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.05 39.55 19.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.892 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.587 ' HB3' ' CD2' ' A' ' 93' ' ' TYR . 26.6 m0 -64.4 -47.2 80.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.758 0.313 . . . . 0.0 111.644 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 32.9 tt0 72.11 1.97 4.13 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 2.8 m-85 -88.18 174.15 8.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.11 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.72 137.03 45.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.404 ' HB ' HG22 ' A' ' 17' ' ' ILE . 25.5 t -122.66 128.02 75.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.759 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 11.2 mp -124.09 137.36 54.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.703 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.94 116.49 32.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.493 ' HA ' HD22 ' A' ' 14' ' ' LEU . 49.6 t0 -86.13 113.7 22.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.552 174.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.0 t -97.21 -10.64 25.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.021 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -82.52 -48.39 11.08 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.897 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.61 1.05 78.19 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.17 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -91.97 -24.61 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.79 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.54 ' CE1' HG21 ' A' ' 24' ' ' THR . 81.1 t80 -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 -177.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.67 -33.09 74.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.442 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.8 ttm-85 -69.96 -43.03 72.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.935 0.398 . . . . 0.0 110.468 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.7 91.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.228 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.3 mmt -76.01 -23.72 55.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.991 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t30 72.42 84.29 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.201 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.445 ' HA ' HG21 ' A' ' 129' ' ' THR . 61.9 t -105.65 97.48 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.54 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -73.31 -54.58 8.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' HB3' ' HA2' ' A' ' 130' ' ' GLY . 58.3 tp -138.71 138.05 37.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.652 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.31 154.08 46.62 Favored Pre-proline 0 C--N 1.313 -1.022 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.516 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.2 Cg_endo -76.32 150.36 93.23 Favored 'Cis proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.852 1.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -111.1 136.42 50.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.986 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.25 126.25 74.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.209 0.528 . . . . 0.0 111.969 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -126.37 116.08 20.64 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.943 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 59.9 mt -104.72 131.51 53.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 111.099 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.4 130.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.413 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.02 -175.41 5.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.626 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.67 -16.0 49.44 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.814 -0.63 . . . . 0.0 114.058 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -88.82 -1.2 57.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.008 0.404 . . . . 0.0 110.576 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 71.2 34.27 64.45 Favored Glycine 0 CA--C 1.501 -0.797 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.653 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -124.8 157.78 34.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 83.1 mt -74.79 116.24 17.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.01 -26.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.29 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.528 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 90.3 t80 -147.34 135.74 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.502 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.51 122.05 21.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.968 0.413 . . . . 0.0 110.723 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.528 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.9 t60 -134.56 102.3 5.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.445 HG21 ' HA ' ' A' ' 109' ' ' VAL . 30.3 m -117.63 124.22 48.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.624 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 111' ' ' LEU . . . 118.27 -8.3 13.98 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.702 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -67.13 148.12 52.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.8 p -116.23 -47.29 2.76 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.701 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -156.4 131.94 9.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.667 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.77 15.54 56.34 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.915 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.19 -14.1 56.5 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.75 -18.49 55.08 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.997 0.919 . . . . 0.0 111.943 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.07 -39.21 94.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.467 0.651 . . . . 0.0 111.136 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.57 -32.13 67.75 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -62.47 -48.02 81.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.386 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.427 HD13 ' NE1' ' A' ' 60' ' ' TRP . 5.4 tp -66.21 -37.13 79.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.505 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.669 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.4 ttpp -60.73 -46.54 90.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.683 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.34 -35.69 81.22 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.694 0.283 . . . . 0.0 111.495 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 139' ' ' LEU . 96.0 t -59.93 -44.37 94.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 109.395 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 12.9 mmm180 -69.26 -34.86 75.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.056 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.6 mm-40 -55.75 -42.53 75.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.038 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 52.3 mt . . . . . 0 CA--C 1.533 0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.533 -179.379 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.426 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 18.0 m . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 121.102 0.477 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -87.48 -137.21 0.09 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.7 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -135.17 -23.81 1.47 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.252 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 67.38 70.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.691 0.758 . . . . 0.0 111.205 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 162.49 26.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.416 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.599 ' HG2' ' SD ' ' A' ' 107' ' ' MET . 8.8 Cg_exo -39.93 138.03 1.13 Allowed 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.091 3.194 . . . . 0.0 113.111 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.77 97.24 9.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.099 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.43 134.67 61.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 t -80.1 112.08 17.08 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.913 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 98' ' ' ASP . 19.0 mt -121.99 169.85 10.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -105.47 130.13 53.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.813 0.339 . . . . 0.0 111.572 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -83.29 -167.91 1.88 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.043 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.589 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 41.9 pt -71.32 -17.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.23 -14.01 51.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.715 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.64 15.35 76.01 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -93.7 145.67 24.4 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.377 -0.912 . . . . 0.0 109.461 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -74.03 118.67 17.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.349 0.595 . . . . 0.0 110.926 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -128.82 132.44 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.412 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 95.6 mt-30 -95.33 135.21 37.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.556 HG21 ' CE1' ' A' ' 103' ' ' PHE . 15.9 p -61.5 -34.83 76.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.14 -20.69 63.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.02 0.438 . . . . 0.0 111.397 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.08 11.36 20.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 110.719 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.0 tp -97.06 125.19 41.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.289 0.566 . . . . 0.0 111.067 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -125.11 155.66 39.52 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.543 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.711 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 22.8 t-20 -78.97 -75.38 0.24 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.198 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.68 22.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.944 0.402 . . . . 0.0 110.682 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 97.53 -10.19 64.8 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -105.08 151.45 39.51 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.247 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -65.02 160.1 43.21 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.933 2.422 . . . . 0.0 112.522 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.711 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 11.2 ptt? -149.32 164.3 35.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.939 -175.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.412 ' CD1' ' HZ3' ' A' ' 60' ' ' TRP . 76.5 mt -128.46 127.92 67.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 92.9 mt -99.85 115.14 40.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -104.48 130.65 52.39 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.869 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.616 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 66.7 m-85 -96.38 121.14 37.86 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.22 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.541 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 24.9 p90 -142.0 164.38 30.32 Favored 'General case' 0 C--O 1.238 0.493 0 O-C-N 123.97 0.793 . . . . 0.0 110.494 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.13 17.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.663 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.523 ' HE ' ' HB3' ' A' ' 133' ' ' GLU . 29.2 mmt180 -58.48 -46.2 87.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.6 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.541 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.7 pt-20 -62.87 -49.57 74.34 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.038 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.432 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 42.6 tp -62.25 -41.41 98.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.138 -177.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 tttt -63.67 -49.37 73.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.58 96.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.331 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.9 mt -64.4 -42.71 96.12 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -58.77 -36.39 74.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 62.1 mm-40 -66.58 -39.09 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.697 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.26 24.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.884 0.373 . . . . 0.0 111.886 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -58.67 -39.52 80.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.79 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.92 92.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.02 -38.43 90.87 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.638 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.511 ' CZ2' HG12 ' A' ' 140' ' ' ILE . 17.7 m0 -67.6 -37.03 81.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.576 0.703 . . . . 0.0 110.22 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -75.58 -8.11 55.94 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.675 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.09 -43.76 70.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.345 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -142.72 -40.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.958 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.468 HG21 HG13 ' A' ' 143' ' ' VAL . 7.8 m -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.811 0.339 . . . . 0.0 110.313 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.6 24.5 73.94 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 5.6 p -78.37 124.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 122.864 0.465 . . . . 0.0 111.715 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HB2' HD21 ' A' ' 29' ' ' ASN . 43.0 mtm-85 -106.17 165.58 11.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.639 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 84.3 mt -108.06 146.12 33.04 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.279 0.561 . . . . 0.0 111.853 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.566 HG23 HD13 ' A' ' 96' ' ' LEU . 93.7 mt -120.88 110.36 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.201 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -92.45 118.6 31.12 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.0 132.52 68.66 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.495 ' HB3' HG21 ' A' ' 82' ' ' VAL . 25.3 p -84.17 128.42 34.55 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.254 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.547 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 42.4 pt -76.4 -14.83 14.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 O-C-N 124.78 1.3 . . . . 0.0 111.344 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 7.0 m-20 -77.63 175.76 9.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.075 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -88.69 178.87 6.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.532 ' HA2' HD21 ' A' ' 97' ' ' LEU . . . -58.04 -23.27 51.5 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.987 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.5 -65.09 0.74 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.89 0.376 . . . . 0.0 111.234 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.505 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 63.9 m-20 -66.35 -35.33 80.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.691 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.567 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -65.81 -4.72 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -64.48 -9.37 18.2 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.311 0.577 . . . . 0.0 110.523 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.783 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 94.4 mttt -92.98 -12.75 29.95 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.745 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 72' ' ' SER . 50.6 t -64.88 -49.71 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 17' ' ' ILE . 13.1 mptt -68.76 -41.6 21.62 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 14.5 Cg_endo -60.3 -31.06 92.39 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.025 1.15 . . . . 0.0 110.946 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.7 mt -63.72 -40.92 97.96 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.305 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.431 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -54.72 -48.25 72.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.619 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.91 -42.94 84.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.88 82.87 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.774 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -99.59 3.3 45.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.26 43.34 93.13 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.4 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.431 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.1 m0 -82.33 98.85 9.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.231 0.539 . . . . 0.0 110.159 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -86.5 44.95 1.19 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.005 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -145.89 -176.91 5.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -71.77 136.65 47.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.306 0.574 . . . . 0.0 111.505 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.69 130.31 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.231 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.566 HD13 HG23 ' A' ' 69' ' ' ILE . 10.6 mp -122.03 154.71 36.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.642 0.734 . . . . 0.0 111.695 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.567 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.8 tt -125.43 113.95 18.19 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.868 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.686 ' HA ' HD22 ' A' ' 14' ' ' LEU . 66.5 t0 -77.6 117.24 18.84 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 118.175 -1.41 . . . . 0.0 108.439 174.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -88.06 -32.3 18.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.413 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -79.02 -38.28 37.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.726 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.43 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 84.64 12.02 76.03 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -177.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.56 -6.04 15.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.556 ' CE1' HG21 ' A' ' 24' ' ' THR . 79.6 t80 -64.24 -39.5 94.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.192 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.547 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 24.5 pttm -59.62 -37.2 77.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.269 176.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -70.5 -41.49 72.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.667 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.62 92.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.942 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.599 ' SD ' ' HG2' ' A' ' 10' ' ' PRO . 42.0 mmm -88.66 -11.89 44.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.72 83.3 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.741 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.3 109.1 20.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -69.83 -58.53 3.76 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.175 0.512 . . . . 0.0 110.052 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.483 ' HB3' ' HA2' ' A' ' 130' ' ' GLY . 59.5 tp -143.47 136.28 27.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.6 pt -83.27 153.08 65.73 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.589 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -74.77 155.91 99.91 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.767 -1.347 . . . . 0.0 112.777 0.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.32 130.55 54.49 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.877 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.459 HG22 ' CD ' ' A' ' 49' ' ' GLU . 21.7 t -112.0 129.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.39 0.431 . . . . 0.0 111.997 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.14 113.7 15.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.039 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.7 mt -102.93 129.83 54.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-O 121.245 0.545 . . . . 0.0 110.791 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.18 131.52 63.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.827 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.3 165.34 23.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.632 0.582 . . . . 0.0 110.851 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.81 -21.39 51.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.208 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -73.3 -9.2 58.45 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.999 0.4 . . . . 0.0 111.105 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' A' ' 123' ' ' LYS . . . 91.23 18.56 45.69 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.951 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HD2' ' O ' ' A' ' 122' ' ' GLY . 4.0 mptp? -125.56 150.39 47.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.891 0.346 . . . . 0.0 110.612 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.1 mt -65.07 125.97 23.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.439 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.72 -18.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.556 ' HB2' ' HD3' ' A' ' 142' ' ' LYS . 89.3 t80 -150.56 132.08 14.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.924 0.392 . . . . 0.0 111.707 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -128.64 128.92 45.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.832 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.7 t60 -133.26 108.94 9.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.819 0.342 . . . . 0.0 110.828 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 p -120.94 135.14 55.27 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.838 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 111' ' ' LEU . . . 103.93 0.39 45.24 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.393 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.589 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -82.52 149.14 27.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.1 p -123.79 -47.65 1.93 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.986 0.422 . . . . 0.0 110.735 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.523 ' HB3' ' HE ' ' A' ' 48' ' ' ARG . 11.0 pt-20 -160.59 144.74 13.93 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.147 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.49 72.17 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.89 -13.93 55.77 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.1 mp0 -60.21 -26.2 66.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.066 0.546 . . . . 0.0 111.234 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.88 90.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.587 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.62 -38.54 87.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.992 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.657 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.14 -52.4 64.0 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.457 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.511 HG12 ' CZ2' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -65.47 -38.89 83.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 -175.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.715 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 40.0 ttmt -59.57 -53.28 59.94 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.556 ' HD3' ' HB2' ' A' ' 126' ' ' TYR . 64.5 tttt -69.47 -30.3 68.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.066 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 139' ' ' LEU . 55.8 t -58.91 -46.06 91.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.923 0.392 . . . . 0.0 110.178 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 5.5 mmm180 -71.77 -34.61 69.59 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.767 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.715 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 5.7 mm-40 -56.01 -34.64 65.99 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 62.7 mt . . . . . 0 C--O 1.227 -0.108 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.51 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 7.4 t . . . . . 0 CA--C 1.565 1.542 0 CA-C-O 120.991 0.424 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -117.88 1.25 12.07 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.032 0.444 . . . . 0.0 111.123 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 118' ' ' VAL . . . 74.61 11.55 3.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.258 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 54.82 36.48 26.57 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.772 0.796 . . . . 0.0 110.501 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 80.5 mt -80.45 153.79 73.86 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.346 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.16 157.43 61.77 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.093 2.529 . . . . 0.0 111.132 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.98 82.45 2.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.0 133.46 68.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.129 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -91.35 105.0 17.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.03 0.443 . . . . 0.0 110.629 -177.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mp -100.54 176.47 5.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.313 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -114.61 125.15 53.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -90.28 -172.46 3.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.253 0.549 . . . . 0.0 112.19 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.571 ' HA ' ' CD ' ' A' ' 83' ' ' LYS . 37.5 pt -65.01 -28.6 45.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.308 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.62 -25.93 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.413 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.83 49.27 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -100.03 144.26 29.28 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.459 -0.87 . . . . 0.0 110.148 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.24 106.17 13.01 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.23 137.87 56.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.135 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.608 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 37.5 mt-30 -89.16 139.2 30.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.428 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 p -65.32 -32.17 73.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.96 -14.41 62.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.847 0.356 . . . . 0.0 111.29 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -116.62 5.85 13.31 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.645 -179.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -92.57 120.25 32.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 4.9 pt-20 -118.68 145.26 45.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.136 0.493 . . . . 0.0 111.94 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.444 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 26.5 t-20 -76.13 -67.81 0.64 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.924 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 169.23 -25.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.032 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.12 -6.57 1.55 Allowed Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.084 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.3 mptm? -97.21 151.6 37.78 Favored Pre-proline 0 C--N 1.315 -0.926 0 C-N-CA 122.765 0.426 . . . . 0.0 110.774 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.6 Cg_exo -66.66 158.64 54.95 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.971 2.447 . . . . 0.0 112.427 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.448 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 4.1 ptt? -147.46 154.68 41.11 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.637 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.446 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.1 mt -125.91 130.77 72.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.5 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -110.93 118.75 36.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.443 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.8 m-85 -95.29 117.75 30.84 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -144.41 168.76 19.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 123.73 0.644 . . . . 0.0 110.506 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.69 146.26 29.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.74 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.494 HG22 ' OD2' ' A' ' 74' ' ' ASP . 13.4 t . . . . . 0 C--N 1.313 -0.988 0 CA-C-O 121.079 0.466 . . . . 0.0 110.879 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 C--O 1.222 -0.381 0 CA-C-O 120.869 0.366 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 14.8 mmm180 -58.08 -44.78 87.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.274 0.559 . . . . 0.0 110.713 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.4 tm-20 -62.8 -55.19 28.66 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.536 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.558 HD11 ' CE2' ' A' ' 93' ' ' TYR . 33.2 tp -65.4 -41.06 94.06 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.45 -48.51 77.41 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.8 89.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.093 0.473 . . . . 0.0 110.881 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.5 mt -63.76 -41.07 91.36 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.844 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.928 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -50.78 -40.46 55.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.882 0.373 . . . . 0.0 110.829 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -70.42 -40.82 73.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -110.24 21.15 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -62.14 -40.46 96.03 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.646 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.01 82.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.813 0.339 . . . . 0.0 110.395 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.87 -41.79 99.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.269 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -69.26 -38.93 78.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.572 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.473 HE21 ' HG2' ' A' ' 67' ' ' ARG . 39.8 mt-30 -77.88 -8.34 57.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.59 -50.23 68.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.254 0.346 . . . . 0.0 111.758 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.46 -38.2 1.19 Allowed 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.314 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.486 HG21 HG13 ' A' ' 143' ' ' VAL . 9.5 m -63.57 -41.48 98.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.07 78.56 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.247 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 8.3 p -74.63 137.26 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.773 0.321 . . . . 0.0 111.763 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG2' HE21 ' A' ' 61' ' ' GLN . 44.4 mtm-85 -115.46 169.15 9.38 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 78.5 mt -114.11 139.95 48.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.305 0.574 . . . . 0.0 111.319 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.517 HG23 HD13 ' A' ' 96' ' ' LEU . 88.6 mt -111.78 99.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.96 115.63 24.48 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.9 129.49 75.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.346 0.593 . . . . 0.0 110.737 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.7 t -89.34 136.27 33.12 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.522 ' HB ' ' HE3' ' A' ' 104' ' ' LYS . 46.3 pt -75.25 -19.02 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.616 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.494 ' OD2' HG22 ' A' ' 41' ' ' THR . 13.4 m-20 -72.2 142.99 49.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.559 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 60.0 mt-10 -68.5 171.05 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -52.71 -41.81 58.08 Favored Glycine 0 C--N 1.329 0.159 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -172.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.97 -55.59 27.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.23 0.515 . . . . 0.0 111.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -69.96 -36.97 75.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.948 0.404 . . . . 0.0 111.704 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.01 -4.19 9.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 27.3 mt-30 -61.25 -10.12 6.27 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.761 -0.587 . . . . 0.0 110.892 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.641 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.4 mttm -92.85 -13.04 29.57 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.538 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -65.54 -46.21 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.588 0.709 . . . . 0.0 111.249 -177.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.571 ' CD ' ' HA ' ' A' ' 17' ' ' ILE . 28.7 mtmt -73.65 -37.68 3.62 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.0 Cg_endo -61.61 -31.08 86.7 Favored 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 120.372 1.168 . . . . 0.0 110.058 171.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -63.94 -42.4 97.34 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -57.48 -47.68 81.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.775 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.98 -45.65 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.144 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.48 92.04 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.204 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.54 -33.32 66.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.56 50.29 2.98 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.019 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.464 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 45.6 m0 -80.77 122.59 27.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.06 0.457 . . . . 0.0 109.949 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.67 32.88 1.17 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.041 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -139.63 171.07 14.77 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.285 -0.259 . . . . 0.0 110.797 -176.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.15 136.25 37.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.057 0.455 . . . . 0.0 111.249 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' C ' HD12 ' A' ' 96' ' ' LEU . 45.8 t -118.17 131.14 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.031 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.517 HD13 HG23 ' A' ' 69' ' ' ILE . 10.2 mp -121.2 145.82 47.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.362 0.601 . . . . 0.0 111.201 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.554 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.6 mp -112.91 119.58 38.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 64.7 t0 -85.5 114.39 22.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 117.846 -1.542 . . . . 0.0 108.715 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.1 t -93.24 -3.87 52.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.147 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . 7.0 m-80 -103.22 -58.3 1.9 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.398 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 100.53 -13.25 59.73 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 100' ' ' ASN . 45.5 m-20 -64.08 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.416 0.686 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.4 -42.25 98.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.869 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HE3' ' HB ' ' A' ' 73' ' ' ILE . 4.4 mtpm? -59.16 -43.78 92.12 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -68.26 -39.01 82.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.696 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.19 79.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.697 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 25.8 mmt -88.9 -7.38 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.207 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 57.91 52.78 7.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 0.0 110.539 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.77 89.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -77.05 -49.36 15.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.964 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 tp -127.35 138.65 53.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.291 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.1 pt -102.21 154.19 37.56 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 84.5 Cg_endo -78.62 147.05 80.76 Favored 'Cis proline' 0 C--O 1.241 0.635 0 C-N-CA 123.619 -1.409 . . . . 0.0 112.108 -0.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -108.94 138.06 45.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -122.92 131.4 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 84.3 m-85 -128.63 118.32 22.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.007 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.641 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.95 131.92 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.159 0.504 . . . . 0.0 110.694 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.639 HG21 ' HB1' ' A' ' 7' ' ' ALA . 53.6 t -115.61 134.0 60.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.925 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.49 -175.15 4.61 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.414 0.446 . . . . 0.0 111.509 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.16 89.22 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.31 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.25 -14.59 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.504 0.669 . . . . 0.0 110.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 85.17 41.64 7.4 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.949 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -121.76 155.81 34.48 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 7' ' ' ALA . 89.7 mt -77.43 125.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 p -120.03 -30.06 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.835 0.35 . . . . 0.0 111.902 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.641 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.6 t80 -121.86 126.83 49.63 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 122.175 -0.328 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.515 ' ND2' ' HE2' ' A' ' 116' ' ' PHE . 9.0 t-20 -131.85 109.31 10.02 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.334 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -147.82 109.03 4.28 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.072 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 p -91.23 106.14 18.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.608 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.2 72.08 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.596 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.588 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 31.7 p90 -70.85 -42.83 69.63 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.353 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.435 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 27.0 p 49.81 84.64 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.912 -1.494 . . . . 0.0 113.392 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 64.85 112.82 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.227 1.011 . . . . 0.0 112.8 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.08 -8.87 50.05 Favored Glycine 0 CA--C 1.51 -0.24 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.588 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -68.65 -37.88 85.29 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.344 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -52.89 -30.86 36.61 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.913 0.885 . . . . 0.0 111.531 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.56 99.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.481 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -73.82 -29.82 62.36 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.379 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.669 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -61.36 -48.43 81.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.926 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.6 tp -66.68 -36.04 76.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.591 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 41.2 ttmt -57.92 -48.03 81.11 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.416 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 20.8 mttp -76.85 -22.19 53.91 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 139' ' ' LEU . 77.0 t -60.64 -44.28 96.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -68.51 -36.85 79.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.031 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 25.9 mt-10 -63.43 -30.59 71.69 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 120.649 0.261 . . . . 0.0 110.855 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.5 mt . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 121.376 0.608 . . . . 0.0 109.665 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.545 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 6.9 m . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 121.575 0.703 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.467 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 71.3 m-85 -97.57 -122.89 0.13 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.779 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -152.23 14.04 0.59 Allowed 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.377 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 47.6 tt0 50.43 33.8 8.26 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.619 0.723 . . . . 0.0 111.424 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 51.8 mt -83.28 151.43 62.78 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.005 -176.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 32.3 Cg_exo -60.18 150.38 79.83 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.925 2.416 . . . . 0.0 110.559 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.74 84.69 2.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.987 0.422 . . . . 0.0 111.698 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.3 t -125.75 133.67 68.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 p -86.84 103.92 15.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.773 0.321 . . . . 0.0 111.176 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 103' ' ' PHE . 34.0 mt -99.6 176.31 5.52 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -112.88 134.06 54.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.563 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -86.46 165.55 16.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.966 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 pt -67.7 -17.35 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -84.24 -3.67 58.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.858 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.97 78.07 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.76 142.5 27.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.247 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -82.18 111.86 18.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.417 0.627 . . . . 0.0 110.01 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -116.11 128.32 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.643 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.543 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.1 mt-30 -89.58 134.34 34.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.436 HG21 ' CE1' ' A' ' 103' ' ' PHE . 8.5 p -65.85 -29.85 70.37 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -68.55 -20.7 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.936 0.398 . . . . 0.0 110.942 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.21 13.95 20.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.978 179.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.65 102.66 3.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.239 0.543 . . . . 0.0 112.01 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 46.5 mt-10 -114.78 104.24 11.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.361 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -71.56 -44.9 63.71 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.44 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.545 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 64.4 31.48 81.0 Favored Glycine 0 C--O 1.227 -0.306 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.177 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -128.55 153.6 79.43 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 123.106 0.562 . . . . 0.0 109.717 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 32.0 Cg_exo -56.59 146.78 73.97 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 122.264 1.976 . . . . 0.0 111.563 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.517 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 25.2 mtt -135.18 170.6 15.67 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.068 -173.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.745 HG23 HD23 ' A' ' 68' ' ' LEU . 7.6 tt -150.1 127.11 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.433 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.1 mt -101.61 126.05 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.122 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -104.15 111.83 24.59 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.398 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 23.6 m-85 -94.03 119.58 33.1 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.18 168.54 20.13 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.843 0.714 . . . . 0.0 110.717 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.7 -167.59 0.72 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.113 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 74' ' ' ASP . 16.7 p . . . . . 0 C--N 1.316 -0.852 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.43 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.1 mt . . . . . 0 CA--C 1.516 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -58.23 -41.75 84.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.029 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 tm-20 -62.93 -58.73 6.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.136 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD11 ' CE2' ' A' ' 93' ' ' TYR . 40.4 tp -62.68 -41.47 99.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.238 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.54 -46.71 87.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.87 92.72 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.099 0.476 . . . . 0.0 110.663 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.4 mt -68.71 -33.24 58.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.438 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -56.23 -27.72 55.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.226 0.536 . . . . 0.0 110.377 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -85.55 -41.23 15.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.881 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.7 15.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 84.1 t80 -61.07 -40.63 94.4 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.672 0.272 . . . . 0.0 111.511 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.39 80.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.082 0.468 . . . . 0.0 110.42 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.38 -41.26 98.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.053 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.433 ' NE1' HD13 ' A' ' 140' ' ' ILE . 20.7 m0 -69.88 -36.13 75.22 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.481 0.658 . . . . 0.0 110.441 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -78.04 -7.12 56.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.118 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -53.99 -50.81 65.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.836 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 -30.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.204 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 m -62.53 -41.85 99.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 0.0 111.413 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.91 25.06 74.78 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.061 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -77.53 133.75 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.577 0.227 . . . . 0.0 111.086 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtm-85 -117.67 148.16 42.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.65 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.745 HD23 HG23 ' A' ' 35' ' ' ILE . 78.2 mt -86.37 135.46 33.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.577 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 75.0 mt -112.84 101.42 12.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.27 103.6 14.36 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.171 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.5 127.3 73.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.501 0.667 . . . . 0.0 111.883 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -89.13 138.81 31.09 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.836 176.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.6 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 38.1 pt -90.86 -3.89 10.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 O-C-N 125.133 1.521 . . . . 0.0 113.615 -171.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 41' ' ' THR . 21.4 m-20 -86.38 176.7 7.74 Favored 'General case' 0 C--O 1.214 -0.763 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.423 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.49 176.21 9.1 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.512 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -60.99 -34.04 86.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.661 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.21 -55.0 40.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.269 0.557 . . . . 0.0 110.813 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -67.93 -37.27 81.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.014 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -70.63 -5.0 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 81.1 mt-30 -61.87 -19.51 62.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.697 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 51.8 mtmt -90.02 -10.61 44.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.815 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 79' ' ' ALA . 57.7 t -63.89 -47.75 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.0 mptp? -73.71 -38.71 4.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.9 Cg_endo -60.37 -32.91 94.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 119.909 1.003 . . . . 0.0 110.283 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.2 mt -64.52 -42.39 95.82 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.624 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -56.73 -50.36 72.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.675 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -68.35 -44.52 75.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.756 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.81 98.14 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.172 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -79.87 -32.66 40.41 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.69 45.98 3.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.217 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.624 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 40.2 m0 -82.79 114.52 21.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 111.054 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.18 37.38 0.72 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.502 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.453 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -130.58 167.03 19.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.36 116.97 19.16 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.805 0.812 . . . . 0.0 110.313 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 t -98.88 132.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.356 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 tp -109.87 163.28 13.68 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.443 ' HB2' ' HE2' ' A' ' 83' ' ' LYS . 11.7 tp -126.68 99.63 5.86 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 66.2 t0 -75.57 117.57 17.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 117.542 -1.663 . . . . 0.0 108.101 172.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 p -97.79 -5.22 35.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.152 0.501 . . . . 0.0 110.954 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -101.02 -42.17 6.5 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.701 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 82.8 5.23 89.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -97.51 -14.66 20.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.787 0.327 . . . . 0.0 111.312 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.436 ' CE1' HG21 ' A' ' 24' ' ' THR . 44.9 t80 -64.42 -38.54 91.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.844 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.6 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 22.1 pttm -55.41 -44.32 76.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.801 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -65.68 -42.94 90.69 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.249 0.547 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.59 85.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -86.23 -3.68 59.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.619 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.71 36.35 2.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.512 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -73.07 88.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.646 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 t -74.31 -45.68 45.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.613 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.85 149.98 50.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.169 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.2 pt -105.86 155.33 38.47 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.44 142.23 68.12 Favored 'Cis proline' 0 C--O 1.239 0.561 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.603 -0.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -106.11 132.58 52.02 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.11 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.555 HG21 HD21 ' A' ' 139' ' ' LEU . 70.9 t -117.8 129.66 73.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 94.1 m-85 -125.48 115.66 20.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.416 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.8 mt -101.28 130.03 51.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.166 0.508 . . . . 0.0 110.51 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.517 ' HB ' ' H ' ' A' ' 34' ' ' MET . 74.2 t -103.91 131.06 53.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.705 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -83.52 -175.53 5.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.12 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.88 8.29 37.59 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.1 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -111.44 -1.27 15.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.683 0.754 . . . . 0.0 109.475 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.87 23.83 63.3 Favored Glycine 0 CA--C 1.504 -0.638 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.206 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 8.3 mptt -115.89 163.15 16.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.848 0.356 . . . . 0.0 110.484 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.45 102.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.298 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.25 -35.37 9.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.74 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 76.2 t80 -137.45 133.11 34.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.707 0.289 . . . . 0.0 110.861 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -141.22 124.6 16.62 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.153 0.502 . . . . 0.0 110.649 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -141.53 116.11 9.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.601 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 p -96.61 109.01 21.71 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.41 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.47 64.12 2.84 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.821 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.72 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.5 p90 -63.57 -41.54 98.38 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.321 0.581 . . . . 0.0 109.934 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.425 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 79.8 p 56.35 79.23 0.18 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.633 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 70.7 113.55 0.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.793 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.0 13.22 46.96 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.938 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.72 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -92.1 -36.88 6.15 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.501 -0.38 . . . . 0.0 112.474 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.2 pm0 -60.37 -18.9 53.44 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.984 0.513 . . . . 0.0 112.284 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.95 94.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.88 -33.52 68.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.593 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -60.98 -50.62 72.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.265 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.3 tp -66.24 -39.19 83.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.4 ttpp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.582 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 14.8 tptp -66.87 -33.95 76.73 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.152 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 139' ' ' LEU . 72.9 t -60.01 -44.84 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.33 0.586 . . . . 0.0 109.62 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 22.6 mmm180 -71.41 -23.61 61.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.43 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 55.9 mm-40 -62.06 -38.5 89.03 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 109.479 175.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 mt . . . . . 0 N--CA 1.462 0.134 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 178.341 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.511 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 26.0 m . . . . . 0 CA--C 1.538 0.515 0 CA-C-O 120.881 0.372 . . . . 0.0 111.656 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -102.78 -134.11 0.31 Allowed 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.716 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -137.73 -4.01 1.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.609 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 54.52 74.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.656 0.741 . . . . 0.0 110.25 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.403 HD13 ' HB ' ' A' ' 24' ' ' THR . 23.4 mt -122.67 162.1 40.35 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 -175.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.7 148.92 91.95 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.141 1.894 . . . . 0.0 110.215 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.24 80.19 0.99 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.211 0.529 . . . . 0.0 111.307 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.5 134.53 65.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.219 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -92.89 113.17 25.37 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 98' ' ' ASP . 29.1 mt -110.9 176.59 4.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -110.12 134.52 52.1 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.313 0.577 . . . . 0.0 112.017 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -75.97 177.02 7.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.325 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.462 HG22 ' HB ' ' A' ' 95' ' ' VAL . 33.3 pt -55.0 -41.53 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -81.44 -8.41 59.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.12 20.18 31.25 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.21 -176.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -78.3 141.18 38.67 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 m -78.66 108.24 11.92 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.007 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.58 134.4 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.219 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 77.9 mt-30 -100.9 134.75 43.41 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.589 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -64.74 -30.24 71.24 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -72.09 -13.15 61.5 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -125.12 14.88 8.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.2 tp -74.69 125.03 27.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.4 OUTLIER -136.69 140.23 42.53 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.411 HD22 ' HG2' ' A' ' 34' ' ' MET . 93.0 m-20 -101.22 -48.87 4.25 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.597 -178.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 168.73 31.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.735 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.511 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 71.38 36.09 63.2 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.581 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 46.1 mmtm -128.39 151.2 76.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.879 -0.16 . . . . 0.0 111.262 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 22.0 Cg_exo -62.69 151.66 82.45 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.691 2.261 . . . . 0.0 111.547 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.543 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 38.4 mtt -131.75 152.77 50.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -172.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.9 mt -130.22 118.13 42.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 86.0 mt -94.12 123.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.5 m -112.39 116.97 31.18 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.252 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 53.8 m-85 -88.16 111.22 21.37 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.444 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 30.7 p90 -123.86 154.72 39.26 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 123.68 0.613 . . . . 0.0 110.776 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.42 153.15 23.57 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.124 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.305 -1.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.475 -177.788 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.236 0.358 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -64.63 -39.91 94.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.32 -176.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.649 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -64.34 -48.54 75.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.729 -179.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 93' ' ' TYR . 52.2 tp -63.62 -42.38 98.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.71 -46.32 88.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.963 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -61.91 -40.7 96.36 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.258 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.1 mt -64.79 -41.43 92.18 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.646 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -54.34 -30.97 53.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.24 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -79.47 -31.86 42.47 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 52' ' ' ALA . 16.1 m -122.42 23.68 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.0 t80 -63.37 -41.56 98.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.312 -0.242 . . . . 0.0 111.206 -177.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.3 83.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.164 0.507 . . . . 0.0 110.185 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.68 -43.1 94.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.39 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.487 ' NE1' HD13 ' A' ' 140' ' ' ILE . 19.0 m0 -70.05 -37.77 75.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -79.13 -6.81 57.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.869 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.2 -49.65 66.31 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.739 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -160.54 73.82 0.51 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.523 0.678 . . . . 0.0 110.27 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -158.95 -41.64 0.06 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.345 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' LYS . . . 72.02 32.1 63.67 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.479 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.27 121.51 42.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.076 0.465 . . . . 0.0 110.914 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -105.85 164.19 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.687 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.488 HD11 HG21 ' A' ' 53' ' ' ILE . 49.1 mt -105.37 134.48 48.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.499 . . . . 0.0 111.568 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.1 mt -109.56 109.17 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -95.71 123.72 39.41 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.233 -178.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.73 131.6 72.76 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.378 0.609 . . . . 0.0 111.32 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' HG21 ' A' ' 82' ' ' VAL . 17.0 p -83.57 134.53 34.81 Favored 'General case' 0 C--O 1.257 1.473 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.242 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.7 pt -78.9 -14.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.698 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 178.51 5.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.06 179.7 5.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.545 ' HA2' HD21 ' A' ' 97' ' ' LEU . . . -59.3 -33.1 74.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.943 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -63.54 -47.11 82.97 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -89.99 -29.63 18.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.6 -3.68 15.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -59.52 -24.04 63.33 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 121.798 -0.564 . . . . 0.0 111.274 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.726 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 73.9 mmtt -88.69 -1.21 57.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 72' ' ' SER . 95.4 t -65.49 -46.71 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -67.41 -42.77 39.72 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.886 -176.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.7 Cg_endo -62.2 -29.84 81.06 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 121.104 1.203 . . . . 0.0 110.902 175.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -62.88 -41.6 99.46 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -59.7 -42.38 92.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.698 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -45.41 65.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.76 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.57 -36.72 92.82 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.126 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -92.58 5.2 51.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.31 40.86 91.92 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.263 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.593 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 51.1 m0 -88.32 95.45 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.87 59.85 5.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.348 0.594 . . . . 0.0 110.737 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -137.56 -172.41 3.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.35 134.35 35.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 17' ' ' ILE . 42.8 t -119.95 132.66 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.536 0.684 . . . . 0.0 110.738 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -120.16 152.25 37.93 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.451 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.594 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 10.1 tt -120.71 117.78 28.38 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.377 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.624 ' HA ' HD22 ' A' ' 14' ' ' LEU . 13.3 t0 -81.52 117.25 21.77 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.762 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 t -113.86 -11.18 12.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 1.6 m120 -84.83 -41.69 15.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 110.726 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.5 ' HA2' ' NZ ' ' A' ' 104' ' ' LYS . . . 94.92 -18.32 57.53 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.59 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 100' ' ' ASN . 5.2 p-10 -91.38 -8.55 47.66 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CE1' HG21 ' A' ' 24' ' ' THR . 88.0 t80 -63.85 -49.14 73.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.184 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.5 ' NZ ' ' HA2' ' A' ' 101' ' ' GLY . 13.1 pttm -62.42 -36.15 81.46 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.961 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -66.91 -43.54 83.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.283 0.563 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.86 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.939 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 107' ' ' MET . 1.7 mmt -78.5 -7.91 57.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.243 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.54 43.09 3.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.67 0.748 . . . . 0.0 111.043 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.23 98.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.328 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -85.83 -66.4 0.91 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.569 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 57.2 tp -107.89 129.65 55.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 pt -85.55 148.16 48.47 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 85.2 Cg_endo -82.75 166.91 67.92 Favored 'Cis proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.242 -1.149 . . . . 0.0 112.882 0.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -125.75 144.36 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.724 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.97 131.69 70.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 86.5 m-85 -126.64 124.15 39.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.4 mt -109.77 129.21 65.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.178 0.513 . . . . 0.0 110.467 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.543 ' HB ' ' H ' ' A' ' 34' ' ' MET . 85.5 t -103.62 128.74 56.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 20.3 t70 -75.88 162.73 27.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.653 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.59 -22.6 52.98 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.878 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -69.46 -18.87 63.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.996 0.426 . . . . 0.0 110.882 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 93.88 31.14 8.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.192 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.78 154.61 51.53 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.3 mt -69.9 123.87 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.371 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 13.7 p -105.08 -30.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.9 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.572 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.5 t80 -132.89 125.26 29.53 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.019 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -131.24 122.35 26.35 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.274 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -145.39 107.9 4.43 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.846 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.3 p -102.15 107.19 18.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.658 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 114.92 74.65 0.6 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.767 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.628 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -126.76 156.76 40.69 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 32.6 p -124.92 -58.46 1.47 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.015 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -144.39 136.07 25.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.418 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 3.98 63.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.288 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.18 -20.96 53.94 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.077 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.17 -22.7 64.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.271 0.558 . . . . 0.0 111.116 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.3 94.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.038 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -71.49 -31.63 67.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.694 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -61.64 -48.88 78.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.276 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.487 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.1 tp -67.96 -38.11 79.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.34 -42.25 98.37 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.9 mmpt? -65.45 -40.39 93.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LEU . 99.2 t -59.84 -46.68 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.359 0.6 . . . . 0.0 110.213 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -66.94 -36.32 81.96 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.517 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -60.38 -34.1 73.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.58 0.229 . . . . 0.0 111.207 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 59.2 mt . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.209 0.528 . . . . 0.0 109.921 177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 16.3 m . . . . . 0 N--CA 1.442 -0.845 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 43.5 m-85 -82.85 -140.39 0.05 Allowed 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.411 0.624 . . . . 0.0 109.791 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.6 12.89 1.17 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.843 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 49.33 60.76 3.53 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.654 0.74 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.2 mt -112.56 158.8 36.36 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.427 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.0 159.21 53.06 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.049 2.5 . . . . 0.0 110.681 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.22 82.34 2.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 103' ' ' PHE . 57.6 t -119.04 134.96 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.572 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.0 p -92.76 108.13 19.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.979 0.418 . . . . 0.0 111.131 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -112.58 174.93 5.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.592 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -108.81 136.57 48.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.793 0.33 . . . . 0.0 110.799 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -90.86 -171.43 3.01 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.783 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.19 -20.04 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -86.0 -21.65 27.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.243 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.98 10.35 58.75 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -175.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -85.85 146.33 26.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -74.4 116.91 15.6 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.404 0.621 . . . . 0.0 109.828 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.644 ' HB ' HD21 ' A' ' 27' ' ' LEU . 3.3 m -117.52 128.04 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.404 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 48.5 mt-30 -90.01 132.17 35.51 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.492 ' HA ' HD12 ' A' ' 27' ' ' LEU . 15.0 p -65.9 -29.47 69.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.629 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.44 -34.44 78.19 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -98.39 5.23 48.33 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.644 HD21 ' HB ' ' A' ' 22' ' ' VAL . 85.5 mt -73.51 117.0 14.75 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.734 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -132.5 154.18 50.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.566 177.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.584 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 63.3 t30 -89.52 -80.95 0.29 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.783 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 172.57 32.33 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.633 0.583 . . . . 0.0 110.755 -176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.66 -14.76 62.8 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 4.0 mptp? -100.14 143.42 26.48 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.7 164.73 34.73 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.209 2.606 . . . . 0.0 112.846 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 69' ' ' ILE . 73.4 mtm -138.69 160.5 39.48 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.729 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.491 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 73.1 mt -129.43 125.67 62.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.8 mt -97.11 126.78 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 m -114.47 122.24 45.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.188 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 73.1 m-85 -97.45 115.06 27.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -135.55 163.04 31.0 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.86 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.86 162.93 13.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.486 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 CA--C 1.54 0.571 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.296 -178.861 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 C--O 1.226 -0.157 0 CA-C-O 121.169 0.509 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 23.4 mmm180 -58.87 -48.95 79.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.247 -175.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.578 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.38 -52.62 31.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.614 -176.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.566 HD11 ' CE1' ' A' ' 93' ' ' TYR . 29.8 tp -63.55 -42.27 98.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.824 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -66.61 -49.53 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.69 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -63.21 -42.65 99.31 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.233 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.1 mt -64.03 -43.04 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.414 ' HB2' ' OH ' ' A' ' 93' ' ' TYR . 9.0 tt0 -59.23 -40.32 85.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.679 0.276 . . . . 0.0 110.846 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -66.7 -37.21 84.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 52' ' ' ALA . 31.3 m -107.36 19.17 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.071 0.462 . . . . 0.0 111.19 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -58.15 -40.49 81.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.883 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.6 81.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.619 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.43 -41.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.527 ' CH2' HG12 ' A' ' 53' ' ' ILE . 16.8 m0 -73.58 -42.42 61.62 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.253 0.549 . . . . 0.0 110.552 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.401 HE22 ' C ' ' A' ' 66' ' ' VAL . 2.2 mp0 -70.36 -9.8 57.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.208 0.603 . . . . 0.0 111.941 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.5 -49.35 64.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.063 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -136.6 -36.32 0.71 Allowed 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.036 -0.666 . . . . 0.0 112.77 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 143' ' ' VAL . 17.6 m -65.74 -43.32 89.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.813 0.34 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 32' ' ' LYS . . . 62.65 41.98 99.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.775 -177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.401 ' C ' HE22 ' A' ' 61' ' ' GLN . 6.8 p -91.33 117.71 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -94.5 162.98 13.59 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.503 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 62.7 mt -105.47 148.19 27.46 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.265 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.585 HD11 ' SD ' ' A' ' 34' ' ' MET . 88.9 mt -122.11 110.82 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.39 111.15 22.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.412 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 ' HZ1' ' A' ' 104' ' ' LYS . 9.0 p -116.59 123.49 71.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 CA-C-O 121.587 0.708 . . . . 0.0 111.555 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.625 ' HB2' HG21 ' A' ' 82' ' ' VAL . 35.4 t -80.06 131.89 35.86 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.83 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.608 ' HA ' ' HZ3' ' A' ' 104' ' ' LYS . 40.5 pt -79.96 -13.92 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.397 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.71 -177.89 5.95 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -94.99 176.99 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.48 66.5 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.205 -0.452 . . . . 0.0 114.065 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.75 -49.47 75.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.176 0.512 . . . . 0.0 111.54 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -90.41 -37.05 14.23 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.619 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.557 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -76.79 -3.95 40.99 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -63.02 -13.53 36.57 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.447 -0.783 . . . . 0.0 111.104 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.674 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 58.4 mttp -85.53 -8.3 58.4 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.8 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.625 HG21 ' HB2' ' A' ' 72' ' ' SER . 59.6 t -66.58 -46.0 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.692 0.758 . . . . 0.0 111.723 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 10.7 mtpp -67.32 -41.61 34.06 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.913 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.3 Cg_endo -61.97 -30.64 83.62 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 120.965 1.11 . . . . 0.0 110.6 173.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.98 -42.74 97.12 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -57.25 -48.28 79.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.992 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.06 -44.58 46.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.816 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.72 -47.71 80.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.256 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -73.93 -34.8 64.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.941 0.401 . . . . 0.0 111.308 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.79 49.21 1.98 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -77.27 109.36 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.136 0.493 . . . . 0.0 110.044 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.0 42.31 0.92 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.338 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.566 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -152.93 -179.72 7.91 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -72.75 140.16 47.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.384 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.27 129.57 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.494 HD13 HG23 ' A' ' 69' ' ' ILE . 11.1 mp -119.71 135.8 54.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.518 0.675 . . . . 0.0 111.58 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.0 tp -105.85 105.49 15.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.678 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.637 ' OD2' ' HE3' ' A' ' 104' ' ' LYS . 47.6 t0 -86.42 138.07 32.06 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 118.072 -1.451 . . . . 0.0 109.639 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.9 m -123.11 -0.36 8.92 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.397 0.617 . . . . 0.0 109.751 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.49 -59.22 1.92 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.278 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.52 -11.87 63.12 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.123 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.2 -24.37 43.2 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.433 ' HB2' HG11 ' A' ' 12' ' ' VAL . 75.8 t80 -61.46 -43.49 98.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.637 ' HE3' ' OD2' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.49 -41.99 95.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.042 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -66.72 -36.51 82.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.129 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.99 74.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.542 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 mmt -90.48 -9.35 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.069 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 63.19 59.86 1.24 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.352 0.596 . . . . 0.0 110.829 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 114' ' ' ALA . 65.5 t -77.32 93.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.335 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.3 t -79.31 -58.82 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.648 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.3 tp -110.75 138.43 47.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.924 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 pt -100.25 152.98 37.99 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.618 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.7 Cg_endo -82.86 154.77 74.83 Favored 'Cis proline' 0 N--CA 1.476 0.487 0 C-N-CA 124.039 -1.234 . . . . 0.0 112.012 -1.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -105.57 138.66 41.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.397 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 139' ' ' LEU . 77.3 t -126.5 130.79 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.63 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.19 125.53 33.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.093 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.662 HD11 HD13 ' A' ' 139' ' ' LEU . 59.4 mt -106.73 132.62 53.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 6' ' ' TYR . 55.8 t -109.52 130.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.043 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.91 166.6 23.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.223 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -23.58 58.42 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.751 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -71.26 -11.05 60.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.76 0.79 . . . . 0.0 109.559 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.84 34.51 Favored Glycine 0 CA--C 1.498 -0.971 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.823 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.29 154.03 36.9 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 94.6 mt -76.26 117.7 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 -20.57 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 69.1 t80 -137.53 126.6 24.38 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -134.91 114.91 13.01 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.159 0.504 . . . . 0.0 110.595 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -146.51 116.39 7.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.942 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 p -95.82 106.24 18.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.102 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.67 69.45 1.3 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.454 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 39.6 p90 -65.99 -44.83 83.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.999 0.4 . . . . 0.0 110.326 177.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p 49.07 85.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.305 1.042 . . . . 0.0 112.68 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 68.05 130.46 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.255 1.022 . . . . 0.0 112.489 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.77 2.33 90.5 Favored Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.644 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -70.94 -42.01 60.73 Favored Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 121.543 -0.36 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -58.55 -25.37 62.41 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.937 0.399 . . . . 0.0 111.384 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 96.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.497 0.665 . . . . 0.0 109.765 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.03 -30.21 63.58 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.08 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.662 HD13 HD11 ' A' ' 117' ' ' ILE . 4.4 mm? -60.13 -50.71 72.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.862 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -70.37 -36.77 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.314 0.578 . . . . 0.0 109.881 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -61.37 -44.9 96.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 41.0 tptt -66.57 -31.31 71.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 110.38 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.0 t -58.97 -44.23 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -66.32 -28.53 68.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.279 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 61.3 mm-40 -63.79 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.241 176.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.9 mt . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.223 0.535 . . . . 0.0 110.611 178.426 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 p30 . . . . . 0 C--O 1.237 0.44 0 CA-C-O 120.851 0.358 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.506 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 35.0 m -155.26 72.83 0.84 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.331 177.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.523 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 38.2 m-85 -92.1 -143.22 0.2 Allowed 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.348 0.594 . . . . 0.0 109.907 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -140.55 14.72 2.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.841 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.477 ' HB3' HG13 ' A' ' 124' ' ' ILE . 52.4 tt0 50.42 42.85 26.78 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.862 0.839 . . . . 0.0 110.507 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 75.4 mt -92.56 152.01 41.68 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.746 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -63.52 156.72 55.05 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.343 2.695 . . . . 0.0 111.403 177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.64 80.55 0.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 111.159 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.7 t -125.94 134.29 66.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -90.6 116.58 28.6 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 120.713 0.292 . . . . 0.0 110.45 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 1.1 tp -116.09 173.66 6.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.745 -178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? -117.22 128.07 54.72 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -91.53 -175.31 4.17 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.769 -0.373 . . . . 0.0 110.869 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 95' ' ' VAL . 29.6 pt -66.66 -21.43 28.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.913 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -82.17 -10.6 59.1 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.943 0.402 . . . . 0.0 110.491 -178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.94 20.19 68.45 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -100.03 141.32 33.01 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.3 m -75.62 110.83 10.35 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.186 0.517 . . . . 0.0 109.897 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 m -116.32 131.02 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.684 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 89.2 mt-30 -90.28 133.06 35.19 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.583 HG21 ' CE1' ' A' ' 103' ' ' PHE . 16.9 p -66.84 -29.78 69.79 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -62.64 -34.32 76.83 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.29 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.516 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -101.94 8.46 41.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.695 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.9 tp -70.45 117.22 11.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.251 -175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.523 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 46.7 mt-10 -130.09 141.56 50.69 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.815 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.758 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 28.1 t-20 -82.16 -75.97 0.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.12 29.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.378 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.506 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 93.98 2.3 64.64 Favored Glycine 0 C--O 1.23 -0.15 0 C-N-CA 120.229 -0.986 . . . . 0.0 112.138 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -109.63 151.85 42.49 Favored Pre-proline 0 C--N 1.321 -0.643 0 C-N-CA 122.387 0.275 . . . . 0.0 110.999 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 19.9 Cg_exo -63.46 154.16 70.27 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.038 2.492 . . . . 0.0 112.033 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.758 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 73.6 mtm -132.91 147.86 52.29 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.683 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.528 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 78.1 mt -121.91 120.68 62.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 176.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 77.9 mt -99.36 119.27 47.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.0 m -102.58 119.21 38.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.85 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.665 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 72.5 m-85 -93.96 118.1 31.02 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.535 ' O ' HG12 ' A' ' 73' ' ' ILE . 20.2 p90 -144.09 162.99 34.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 O-C-N 123.634 0.584 . . . . 0.0 110.795 -177.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.434 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -81.01 176.53 9.74 Favored 'General case' 0 C--O 1.216 -0.664 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.013 -177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -84.35 7.41 19.56 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -161.88 82.16 0.57 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.707 0.289 . . . . 0.0 110.566 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 84.7 m -151.12 148.0 27.75 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.554 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.552 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 59.9 mttp -127.65 -61.27 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.864 176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.552 ' HD2' ' H ' ' A' ' 44' ' ' LYS . 63.1 Cg_endo -72.97 -16.87 25.56 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 121.815 1.677 . . . . 0.0 111.923 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 46.9 m -69.86 -25.84 63.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.504 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.5 mt -85.98 58.16 4.89 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -63.33 -45.59 90.58 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.709 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.555 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -70.92 -45.21 64.64 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.862 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD11 ' CE1' ' A' ' 93' ' ' TYR . 27.2 tp -61.74 -43.43 98.87 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.23 -175.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.61 -48.42 77.41 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.41 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.37 -46.12 87.98 Favored 'General case' 0 C--O 1.248 1.001 0 CA-C-O 121.395 0.617 . . . . 0.0 111.197 -178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.2 mt -64.08 -41.73 93.38 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.468 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.933 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -54.36 -41.31 68.99 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 120.563 0.22 . . . . 0.0 111.452 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -66.79 -38.12 85.9 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.64 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.5 m -110.17 21.96 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-O 121.281 0.563 . . . . 0.0 111.401 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -58.28 -44.48 88.47 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.408 0.683 . . . . 0.0 112.391 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.26 -36.83 84.97 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.937 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.21 -40.98 99.03 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 120.979 0.419 . . . . 0.0 110.823 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -69.94 -40.68 75.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 55.1 mt-30 -64.61 -32.62 74.36 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-O 121.183 0.516 . . . . 0.0 110.739 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -62.46 -39.79 94.55 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.737 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -86.78 -86.2 0.15 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.394 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.566 HG23 ' H ' ' A' ' 66' ' ' VAL . 3.1 t -79.49 -16.04 56.73 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.876 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 71.86 17.63 77.0 Favored Glycine 0 C--N 1.314 -0.687 0 C-N-CA 119.978 -1.106 . . . . 0.0 112.407 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.566 ' H ' HG23 ' A' ' 64' ' ' THR . 10.7 p -63.63 140.21 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.127 0.489 . . . . 0.0 112.232 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.423 ' NE ' HD21 ' A' ' 29' ' ' ASN . 0.6 OUTLIER -113.59 163.98 14.26 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.633 177.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.623 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 58.5 mt -112.16 134.56 53.63 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.482 0.658 . . . . 0.0 111.511 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.539 HG23 HD13 ' A' ' 96' ' ' LEU . 95.0 mt -111.44 109.95 30.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.809 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.11 111.2 22.25 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.9 p -114.27 133.9 58.89 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-O 121.959 0.885 . . . . 0.0 112.32 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.659 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.0 m -85.08 120.23 26.36 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.133 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 39' ' ' PHE . 45.5 pt -84.68 36.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 O-C-N 123.987 0.804 . . . . 0.0 110.656 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -131.1 -167.88 1.91 Allowed 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -95.06 165.92 12.19 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 176.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . -60.28 -37.21 92.67 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.384 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.409 ' HG3' ' N ' ' A' ' 78' ' ' ASN . 27.7 pt20 -60.38 -42.58 96.16 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.915 0.388 . . . . 0.0 111.324 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.409 ' N ' ' HG3' ' A' ' 77' ' ' GLN . 86.8 m-20 -81.69 -32.99 31.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.578 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -68.95 -5.63 22.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.424 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 15.6 mm100 -62.35 -12.85 23.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.824 0.345 . . . . 0.0 110.714 176.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.744 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 37.3 mtmm -93.7 -11.78 30.76 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.713 178.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.659 HG21 ' OG ' ' A' ' 72' ' ' SER . 20.1 t -68.58 -47.54 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 121.669 0.747 . . . . 0.0 111.571 -176.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.8 mtpt -64.27 -44.65 77.1 Favored Pre-proline 0 C--N 1.309 -1.194 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.722 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 13.1 Cg_endo -60.36 -32.29 93.82 Favored 'Trans proline' 0 C--N 1.358 1.066 0 C-N-CA 121.194 1.263 . . . . 0.0 111.276 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.94 -43.63 98.28 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.36 92.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.127 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -70.69 -46.5 63.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.257 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.86 -48.22 68.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.296 -178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -67.88 -34.56 76.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.666 0.269 . . . . 0.0 111.519 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.24 52.31 1.25 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.354 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 54.0 m0 -84.81 132.62 34.39 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.929 0.395 . . . . 0.0 110.345 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -103.8 33.07 3.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.188 -175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -145.33 -179.95 6.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -176.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -81.8 141.96 33.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.246 0.546 . . . . 0.0 112.267 -175.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.559 ' O ' HG23 ' A' ' 17' ' ' ILE . 38.9 t -120.76 134.75 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.172 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.539 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -121.48 138.57 54.23 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.763 -178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.578 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.6 mp -111.2 120.04 40.94 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 63.2 t0 -74.3 117.69 16.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.494 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.1 p -93.8 2.6 56.18 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.71 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -121.96 -37.53 2.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.812 0.339 . . . . 0.0 111.145 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.492 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 90.69 8.49 65.46 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.968 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.73 -17.35 17.77 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -177.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.583 ' CE1' HG21 ' A' ' 24' ' ' THR . 68.9 t80 -63.07 -43.62 98.09 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.872 0.368 . . . . 0.0 110.582 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -59.23 -36.06 74.77 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.791 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 105' ' ' ARG . 36.3 ttm180 -71.95 -41.12 68.14 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.321 0.581 . . . . 0.0 110.308 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.13 -37.33 84.75 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.678 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 31.0 mmm -96.76 -11.08 25.48 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.164 -0.614 . . . . 0.0 110.739 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 68.84 93.08 0.08 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.556 0.743 . . . . 0.0 112.006 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.88 83.05 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 176.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.8 m -62.15 -48.9 78.02 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.973 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.0 tp -151.48 132.43 14.24 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.592 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.3 pt -83.32 148.16 55.11 Favored Pre-proline 0 C--N 1.314 -0.938 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 176.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.51 147.82 87.76 Favored 'Cis proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.699 -1.375 . . . . 0.0 112.588 0.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.665 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -114.72 128.98 56.61 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.537 -0.465 . . . . 0.0 109.851 175.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 139' ' ' LEU . 41.8 t -114.23 122.9 69.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -175.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -120.77 115.26 22.96 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.585 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 61.7 mt -103.86 131.51 52.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.274 0.559 . . . . 0.0 110.512 -177.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 66.8 t -108.95 130.43 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.946 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.82 165.21 25.52 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.366 0.666 . . . . 0.0 111.071 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.79 -20.34 47.3 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 115.998 -0.546 . . . . 0.0 113.073 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -84.31 4.11 32.59 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.876 0.338 . . . . 0.0 111.06 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.33 33.54 48.4 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.88 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -126.68 152.53 46.62 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.477 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.6 mt -75.01 118.54 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -107.98 -30.69 2.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.268 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.585 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 90.0 t80 -141.58 140.39 33.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.956 0.408 . . . . 0.0 111.721 -177.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -136.06 130.7 33.85 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.193 176.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -141.2 104.1 4.56 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 177.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 4.1 m -104.17 120.19 40.58 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.045 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 66.69 47.76 66.11 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 176.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.667 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 31.6 p90 -67.59 -43.96 79.27 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.441 0.639 . . . . 0.0 109.562 176.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.461 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 61.0 p 57.01 87.74 0.06 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.863 1.265 . . . . 0.0 113.036 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 73.4 mt-10 72.07 127.71 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.118 0.967 . . . . 0.0 112.29 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.51 68.07 Favored Glycine 0 CA--C 1.51 -0.264 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.063 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.667 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -73.07 -21.6 79.7 Favored Glycine 0 N--CA 1.44 -1.046 0 CA-C-N 115.249 -0.476 . . . . 0.0 112.257 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 1.4 mp0 -56.27 -30.6 62.67 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.249 0.62 . . . . 0.0 110.818 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.75 92.28 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -71.34 -31.24 67.14 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.678 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.0 mm? -60.38 -52.27 65.96 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.683 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.42 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.8 tp -69.4 -32.79 54.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.203 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.8 ttpp -62.68 -47.34 84.08 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.939 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.412 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -66.34 -32.19 73.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.891 0.377 . . . . 0.0 110.257 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 139' ' ' LEU . 55.4 t -59.41 -43.12 89.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.734 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 27.1 mmt180 -64.62 -36.02 82.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.302 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 67.2 mm-40 -58.53 -42.3 87.48 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.715 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 56.9 mt -64.81 -40.3 94.99 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.314 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 143' ' ' VAL . 99.6 t -62.47 -46.72 95.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.773 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -64.69 -37.01 86.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.602 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -68.03 -33.11 73.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.043 0.449 . . . . 0.0 110.02 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -75.17 82.03 0.9 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.566 ' HB3' ' O ' ' A' ' 154' ' ' HIS . 42.7 t-80 -75.02 148.34 39.95 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -80.04 113.34 18.13 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 60.33 17.77 7.4 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.595 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.566 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 25.9 t-80 -159.91 176.59 11.7 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.5 p-80 -122.01 10.49 10.13 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.721 0.296 . . . . 0.0 111.513 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 25.9 t60 . . . . . 0 C--N 1.315 -0.914 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.194 -178.807 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 6' ' ' TYR . 92.9 m-20 . . . . . 0 CA--C 1.507 -0.674 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -100.96 61.65 0.97 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.22 0.534 . . . . 0.0 111.946 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.558 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 31.6 m-85 -98.96 -134.02 0.26 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 174.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.95 155.82 40.65 Favored 'General case' 0 N--CA 1.427 -1.597 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.456 ' H ' HG13 ' A' ' 124' ' ' ILE . 53.4 tt0 -74.52 75.84 1.96 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 81.4 mt -117.98 140.29 27.65 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.885 -174.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.461 ' HG2' ' HB1' ' A' ' 106' ' ' ALA . 22.6 Cg_exo -64.19 155.75 63.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.15 2.567 . . . . 0.0 110.673 174.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.91 91.22 0.46 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.891 0.377 . . . . 0.0 110.863 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -133.26 154.53 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.888 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.2 t -98.01 134.04 41.65 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.7 tp -131.89 165.31 24.17 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 20' ' ' LYS . 1.2 tppp? -113.2 129.61 56.46 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.223 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 20' ' ' LYS . 46.5 p30 -94.67 -174.88 3.43 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 95' ' ' VAL . 32.4 pt -68.42 -18.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.953 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -84.04 -12.4 55.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.924 0.392 . . . . 0.0 110.432 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 16.87 72.16 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' HB3' HD21 ' A' ' 16' ' ' ASN . 86.4 tttt -96.1 145.63 25.33 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.413 -0.894 . . . . 0.0 110.601 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.7 m -80.38 114.0 18.96 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.877 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.6 m -120.65 134.11 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.969 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.423 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.1 mt-30 -88.91 134.95 33.78 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.569 HG21 ' CE1' ' A' ' 103' ' ' PHE . 25.0 p -65.48 -31.04 71.91 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.2 -28.62 69.87 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.254 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -108.22 16.44 23.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.045 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.6 tp -79.03 101.27 7.73 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.058 0.456 . . . . 0.0 111.95 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.558 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.1 mt-10 -119.11 122.89 43.12 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.987 177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -70.88 -43.06 69.18 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.27 -38.85 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 0.0 109.464 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.91 33.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.395 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -128.67 151.74 77.54 Favored Pre-proline 0 C--N 1.325 -0.499 0 C-N-CA 122.415 0.286 . . . . 0.0 110.864 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.95 155.5 49.53 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.713 2.275 . . . . 0.0 111.621 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.421 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 38.2 mtt -129.92 153.43 48.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.93 0.395 . . . . 0.0 111.805 -171.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.408 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.8 mt -128.3 117.28 44.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 173.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 82.1 mt -96.79 118.16 42.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.6 m -104.88 116.07 31.37 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.062 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -90.8 115.78 28.13 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -138.2 168.48 19.64 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.207 0.527 . . . . 0.0 112.119 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -94.05 166.98 11.88 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.336 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.48 125.77 29.68 Favored 'General case' 0 N--CA 1.427 -1.612 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.593 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.7 t30 57.99 35.59 25.38 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.601 -1.182 . . . . 0.0 113.458 176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.473 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 78.2 m -106.34 84.55 2.04 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 48.2 mttm -64.59 -55.45 29.27 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -173.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 11.4 Cg_exo -67.71 -20.3 46.57 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 122.634 2.222 . . . . 0.0 112.899 -176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 58.8 m -72.13 -19.14 61.83 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 43' ' ' CYS . 17.3 mt -87.37 60.34 6.02 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.094 0.473 . . . . 0.0 110.678 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -63.87 -45.96 87.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.58 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.582 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -66.2 -46.37 77.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.137 -176.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.598 ' HG ' HE21 ' A' ' 54' ' ' GLN . 33.8 tp -63.8 -42.51 97.69 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.769 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -61.6 -48.44 80.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.562 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -61.37 -42.56 98.9 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.006 0.432 . . . . 0.0 111.02 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.3 mt -64.96 -42.27 94.32 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.046 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.598 HE21 ' HG ' ' A' ' 50' ' ' LEU . 78.5 mt-30 -55.49 -40.86 72.24 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.922 0.391 . . . . 0.0 111.298 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -66.28 -38.13 87.07 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.742 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 52' ' ' ALA . 18.1 m -116.22 27.03 3.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.002 0.43 . . . . 0.0 111.741 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 53' ' ' ILE . 65.0 t80 -58.64 -39.6 81.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.627 -176.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.45 87.02 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.641 0.258 . . . . 0.0 110.846 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -64.55 -41.71 96.16 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.297 0.57 . . . . 0.0 110.417 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.612 ' O ' ' HB ' ' A' ' 64' ' ' THR . 11.9 m0 -71.18 -37.03 72.18 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.714 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -80.2 -8.92 59.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.787 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.57 -60.43 3.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.182 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -132.11 -4.25 3.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.758 0.314 . . . . 0.0 111.796 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 18.1 m -96.11 -35.54 11.3 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.253 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.08 31.33 65.12 Favored Glycine 0 N--CA 1.468 0.779 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.853 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.95 128.93 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 CA-C-O 121.447 0.641 . . . . 0.0 112.117 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -94.15 152.24 18.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.381 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 39.3 mt -111.94 130.11 55.95 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-O 121.138 0.494 . . . . 0.0 111.165 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.557 HG23 HD13 ' A' ' 96' ' ' LEU . 91.0 mt -110.01 106.44 20.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.16 113.21 25.42 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.616 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 10.8 p -122.47 130.86 74.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.254 0.55 . . . . 0.0 111.84 -177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.6 p -88.66 143.48 26.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.719 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.0 pt -78.31 -13.99 13.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 114.992 -1.003 . . . . 0.0 111.111 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -84.39 153.97 23.12 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.707 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -68.57 168.1 13.64 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 123.52 0.513 . . . . 0.0 110.087 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.548 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -55.47 -40.77 78.73 Favored Glycine 0 C--O 1.222 -0.604 0 N-CA-C 114.142 0.417 . . . . 0.0 114.142 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -62.2 -39.37 92.51 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.224 0.512 . . . . 0.0 111.32 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -83.32 -32.65 26.19 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.362 0.601 . . . . 0.0 110.53 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -79.01 -2.06 38.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.173 -0.921 . . . . 0.0 113.094 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 99.1 mt-30 -57.86 -16.09 10.63 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 121.916 -0.49 . . . . 0.0 111.146 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.686 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.7 mttp -84.91 -14.82 46.56 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.431 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 79' ' ' ALA . 49.8 t -65.68 -47.13 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.805 0.812 . . . . 0.0 112.272 -175.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.0 mtpm? -67.34 -42.87 41.02 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.898 -1.046 . . . . 0.0 113.55 -176.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.622 ' HA ' ' OD2' ' A' ' 87' ' ' ASP . 17.9 Cg_endo -61.89 -28.63 81.4 Favored 'Trans proline' 0 C--N 1.362 1.285 0 C-N-CA 121.107 1.204 . . . . 0.0 111.001 175.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.96 -42.2 97.36 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' CD2' ' A' ' 91' ' ' TRP . . . -57.99 -49.12 77.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.773 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.622 ' OD2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 p30 -75.0 -35.96 61.99 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.996 -177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.28 -49.59 56.17 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.877 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -74.6 -34.1 62.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.921 0.391 . . . . 0.0 111.924 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 102.25 59.24 0.76 Allowed Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.217 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 54.4 m0 -95.09 117.79 30.79 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -100.35 47.88 0.93 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -175.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.544 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -149.23 -169.62 3.42 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.795 -0.184 . . . . 0.0 110.576 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -89.09 135.84 33.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.428 0.633 . . . . 0.0 111.983 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 17' ' ' ILE . 58.8 t -118.07 132.45 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.767 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 8.1 mp -130.3 146.12 51.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.947 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -126.36 127.68 45.88 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.288 178.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -61.01 133.59 56.24 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.1 t -114.75 7.28 15.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.537 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -142.94 -30.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.53 63.09 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.968 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -74.59 -36.87 63.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.418 0.151 . . . . 0.0 111.136 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.569 ' CE1' HG21 ' A' ' 24' ' ' THR . 79.9 t80 -62.19 -48.65 79.07 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -173.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -61.59 -35.01 76.63 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.851 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -70.56 -42.43 71.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.375 0.607 . . . . 0.0 110.063 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 10' ' ' PRO . . . -61.43 -37.65 84.3 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.315 -178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.449 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 28.5 mmm -82.64 -22.77 34.56 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.317 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.0 t30 72.13 81.75 0.14 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.462 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -96.91 99.79 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.266 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.2 m -71.71 -69.57 0.38 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.803 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.405 HD21 ' CG2' ' A' ' 132' ' ' THR . 60.4 tp -115.43 131.12 57.03 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 23.6 pt -88.67 144.42 33.36 Favored Pre-proline 0 C--N 1.31 -1.143 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -80.45 161.58 83.9 Favored 'Cis proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.838 -1.318 . . . . 0.0 113.564 0.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.22 145.08 49.57 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.958 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.1 t -122.49 130.15 74.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.108 0.48 . . . . 0.0 112.168 -175.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 82.4 m-85 -125.41 124.86 42.39 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.592 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 75.7 mt -114.2 131.07 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.051 0.453 . . . . 0.0 111.057 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 54.8 t -108.92 132.93 55.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 123.886 0.874 . . . . 0.0 110.057 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -95.04 -171.91 2.55 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.269 0.356 . . . . 0.0 111.111 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.06 -23.87 66.44 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 116.198 -0.455 . . . . 0.0 113.983 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -75.09 -2.02 25.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.987 0.393 . . . . 0.0 111.338 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 73.78 30.96 60.88 Favored Glycine 0 CA--C 1.504 -0.633 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.032 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 48.2 mmtm -133.01 168.47 18.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 8' ' ' GLN . 98.2 mt -90.24 112.37 24.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.082 0.468 . . . . 0.0 110.349 -178.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.2 p -90.69 -31.83 5.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.489 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.592 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.4 t80 -124.55 130.71 52.95 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.043 0.449 . . . . 0.0 111.337 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -130.06 120.67 25.05 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.057 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -144.36 102.84 3.9 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.884 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 18.2 p -102.79 106.76 17.42 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.327 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 113.21 71.14 0.56 Allowed Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.991 178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.584 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -122.22 157.06 32.45 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 172.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.405 ' CG2' HD21 ' A' ' 111' ' ' LEU . 27.9 p -127.02 -41.85 1.77 Allowed 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.869 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 72.8 tt0 -167.89 124.05 1.07 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.18 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.39 -3.19 32.83 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.39 -18.71 65.9 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.77 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.0 mp0 -60.22 -20.83 60.48 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.094 0.557 . . . . 0.0 111.369 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.6 94.9 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.483 0.659 . . . . 0.0 110.706 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -70.7 -32.06 69.14 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.708 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.527 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -61.82 -47.52 84.73 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.395 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.515 HD13 ' NE1' ' A' ' 60' ' ' TRP . 5.1 tp -68.54 -39.54 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.721 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.3 ttpp -60.65 -45.86 92.5 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.155 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.425 ' HD2' ' HA ' ' A' ' 142' ' ' LYS . 42.1 tptt -66.06 -35.16 79.78 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.385 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -60.78 -42.7 93.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 144' ' ' ARG . 6.3 mmp_? -64.38 -34.53 78.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.129 176.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 51.7 mm-40 -61.6 -35.08 76.84 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.438 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 56.7 mt -64.5 -38.98 92.91 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.11 -27.33 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.236 178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.562 ' HB3' ' O ' ' A' ' 145' ' ' GLU . 10.8 tmtt? -58.78 -38.01 77.58 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.477 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 23.4 tp10 -72.81 2.0 7.53 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.003 0.43 . . . . 0.0 111.681 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -61.95 -32.97 83.98 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 69.3 m-70 -121.95 133.82 54.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.299 -0.451 . . . . 0.0 109.968 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -79.17 167.51 20.9 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.639 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 73.04 -67.05 0.28 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.699 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -161.13 136.59 7.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 148' ' ' LYS . 34.9 t-80 -62.05 -45.76 92.14 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.792 0.329 . . . . 0.0 111.198 -178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 . . . . . 0 C--N 1.314 -0.968 0 CA-C-O 118.282 -0.865 . . . . 0.0 109.884 178.302 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 CA--C 1.514 -0.442 0 CA-C-O 121.017 0.437 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.638 HG22 ' HE1' ' A' ' 34' ' ' MET . 37.3 m -79.72 81.19 6.02 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.12 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.482 ' CE2' ' HA ' ' A' ' 26' ' ' LYS . 93.2 m-85 -103.48 -80.58 0.52 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.315 178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.56 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 166.98 -10.77 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 O-C-N 124.514 1.134 . . . . 0.0 110.334 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 55.3 tp60 63.88 44.79 4.65 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.915 0.864 . . . . 0.0 110.298 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.499 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 18.9 mt -98.16 159.42 30.76 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.912 -176.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -61.63 148.19 93.59 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.301 2.001 . . . . 0.0 109.617 173.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.02 84.06 2.27 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.063 0.458 . . . . 0.0 111.2 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -117.92 132.95 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.5 p -87.97 109.83 20.12 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.09 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.768 HD22 ' HA ' ' A' ' 98' ' ' ASP . 33.3 mt -116.75 175.92 5.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.949 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -103.57 138.58 40.05 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.389 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.494 HD21 ' HB3' ' A' ' 20' ' ' LYS . 5.6 p30 -101.77 -175.04 2.73 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.439 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 32.4 pt -63.77 -22.57 31.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -177.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -78.97 -12.31 60.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.877 0.37 . . . . 0.0 110.712 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.94 12.09 81.69 Favored Glycine 0 CA--C 1.503 -0.689 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.494 ' HB3' HD21 ' A' ' 16' ' ' ASN . 37.1 ttpt -96.45 141.16 30.08 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 36.6 m -73.43 115.09 12.39 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 16' ' ' ASN . 8.6 m -122.16 132.04 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.72 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.87 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.469 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 79.0 mt-30 -87.77 134.53 33.66 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.499 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 6.7 p -63.76 -28.54 69.94 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.475 -0.784 . . . . 0.0 113.106 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -75.84 -10.68 59.63 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.72 0.295 . . . . 0.0 111.34 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.482 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -126.48 12.96 7.56 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.489 0.185 . . . . 0.0 111.349 -178.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.09 -48.89 78.19 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -172.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 33.06 97.98 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.419 1.104 . . . . 0.0 113.904 -175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' OD1' ' HG2' ' A' ' 34' ' ' MET . 13.1 m120 -66.16 -58.39 5.53 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 113.938 -1.483 . . . . 0.0 112.367 -174.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.69 19.94 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.72 4.89 89.88 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 119.924 -1.132 . . . . 0.0 112.159 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -112.67 150.89 43.42 Favored Pre-proline 0 C--N 1.317 -0.808 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.57 150.45 81.63 Favored 'Trans proline' 0 C--O 1.242 0.699 0 C-N-CA 122.87 2.38 . . . . 0.0 111.751 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.638 ' HE1' HG22 ' A' ' 5' ' ' THR . 0.6 OUTLIER -131.42 154.89 48.19 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.087 0.47 . . . . 0.0 111.065 -176.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.55 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.3 mt -123.08 122.85 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 76.1 mt -95.73 122.46 47.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.42 ' HB3' ' OE1' ' A' ' 49' ' ' GLU . 3.5 m -104.85 118.85 37.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.069 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 72.1 m-85 -95.19 116.86 29.3 Favored 'General case' 0 C--O 1.25 1.127 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.49 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 28.1 p90 -142.56 171.42 14.08 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.605 0.566 . . . . 0.0 112.153 -176.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.57 32.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.406 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.429 ' CG2' HG22 ' A' ' 82' ' ' VAL . 48.6 p -78.28 -12.68 60.02 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.301 -0.409 . . . . 0.0 112.087 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -103.4 9.63 37.72 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -175.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.497 ' SG ' ' HB2' ' A' ' 46' ' ' CYS . 17.2 t -143.32 122.21 12.73 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.547 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 52.4 mtmt -87.26 -48.55 0.47 Allowed Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 44' ' ' LYS . 27.3 Cg_endo -63.78 -20.55 68.81 Favored 'Trans proline' 0 C--N 1.367 1.523 0 C-N-CA 122.423 2.082 . . . . 0.0 112.058 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 44.1 t -68.73 -17.9 64.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 176.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 6.6 mt -85.51 40.82 0.86 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.311 0.577 . . . . 0.0 109.607 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.3 tpt85 -57.52 -39.82 77.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.938 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.589 ' HA ' ' OH ' ' A' ' 131' ' ' TYR . 3.8 tm-20 -66.99 -54.83 18.04 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.523 -1.217 . . . . 0.0 111.914 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.2 tp -63.11 -40.78 98.63 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.059 -176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.0 tttt -62.13 -45.24 94.31 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.212 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -58.77 -46.66 87.0 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.683 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.498 ' CG2' HD11 ' A' ' 68' ' ' LEU . 58.8 mt -64.69 -43.16 96.61 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.407 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.168 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -54.62 -42.01 70.68 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.08 0.467 . . . . 0.0 110.993 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 51.2 mm-40 -65.88 -37.56 86.46 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.901 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 52' ' ' ALA . 30.7 m -110.99 17.92 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.21 -41.38 92.91 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.79 86.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.78 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 62' ' ' ASP . 19.0 t70 -64.5 -41.75 96.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.148 0.499 . . . . 0.0 110.439 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.497 ' NE1' HD13 ' A' ' 140' ' ' ILE . 28.8 m0 -72.31 -42.33 65.58 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.263 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.435 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 18.6 mm-40 -65.79 -24.11 66.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.236 0.541 . . . . 0.0 110.604 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 59' ' ' ASP . 36.1 t70 -59.62 -46.41 89.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.455 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -103.52 -70.11 0.77 Allowed 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.491 HG23 ' N ' ' A' ' 66' ' ' VAL . 2.8 t -77.41 -22.12 52.06 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.076 0.465 . . . . 0.0 111.221 -176.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 66.45 32.17 80.97 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.28 -176.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.491 ' N ' HG23 ' A' ' 64' ' ' THR . 14.8 p -63.28 136.56 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -102.63 156.38 17.66 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.069 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.575 HD12 ' CE2' ' A' ' 93' ' ' TYR . 68.9 mt -116.18 133.15 56.33 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 121.075 0.464 . . . . 0.0 111.206 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.548 HG23 HD13 ' A' ' 96' ' ' LEU . 86.4 mt -110.02 102.99 14.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 176.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.67 118.06 29.81 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.2 p -122.43 133.1 69.67 Favored 'Isoleucine or valine' 0 C--O 1.252 1.212 0 CA-C-O 121.634 0.731 . . . . 0.0 111.727 -177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.664 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 21.4 p -84.71 140.86 30.98 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.551 179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.413 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 43.0 pt -80.81 -15.52 12.66 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.28 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.664 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 0.0 OUTLIER -84.63 159.46 20.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.687 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.504 ' HB2' ' OE1' ' A' ' 77' ' ' GLN . 43.2 mt-10 -72.38 178.22 4.1 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.277 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.64 -48.99 67.64 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 115.423 0.929 . . . . 0.0 115.423 -173.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.504 ' OE1' ' HB2' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -65.43 -40.7 93.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.734 0.767 . . . . 0.0 111.338 -178.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -69.13 -39.63 78.75 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.229 0.537 . . . . 0.0 110.959 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.65 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -72.22 -4.16 27.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.152 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.6 -13.69 15.86 Favored 'General case' 0 C--N 1.318 -0.765 0 O-C-N 121.656 -0.653 . . . . 0.0 111.346 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.717 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.9 tttp -92.58 -10.45 37.49 Favored 'General case' 0 N--CA 1.419 -2.0 0 C-N-CA 122.764 0.425 . . . . 0.0 111.817 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.6 t -66.96 -47.36 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-O 121.547 0.689 . . . . 0.0 111.804 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 43.2 mtpt -63.64 -45.32 82.51 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.987 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -61.06 -31.16 90.62 Favored 'Trans proline' 0 C--N 1.359 1.124 0 C-N-CA 121.091 1.194 . . . . 0.0 111.098 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.717 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -62.64 -44.2 96.87 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 174.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -42.22 98.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.415 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -63.22 -50.88 68.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.523 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.8 -44.86 46.35 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 121.256 -0.497 . . . . 0.0 113.789 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.46 -34.45 77.2 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.58 41.91 3.05 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.411 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.423 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 53.2 m0 -83.35 108.31 16.45 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.0 42.28 1.08 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.575 ' CE2' HD12 ' A' ' 68' ' ' LEU . 0.2 OUTLIER -146.23 177.62 8.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.845 -0.161 . . . . 0.0 111.303 -178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -75.78 137.77 40.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.391 0.615 . . . . 0.0 112.394 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -119.76 132.5 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.868 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.548 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -125.36 144.87 50.3 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.94 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.83 121.92 46.54 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.768 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.1 t0 -70.08 115.28 9.11 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 118.343 -1.343 . . . . 0.0 107.648 175.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.6 t -83.41 -15.25 50.47 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -173.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -120.18 -29.89 4.77 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.28 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.11 1.4 62.92 Favored Glycine 0 N--CA 1.434 -1.465 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.839 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -92.53 -14.19 28.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.448 ' CE1' HG21 ' A' ' 24' ' ' THR . 87.5 t80 -64.91 -44.96 87.85 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.021 0.438 . . . . 0.0 110.669 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.413 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 25.6 pttm -63.19 -38.47 91.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.522 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -68.2 -34.8 76.94 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.245 178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.29 -36.78 76.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.105 176.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 38' ' ' PHE . 23.6 mmt -84.87 -18.25 35.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.395 178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 68.22 78.91 0.22 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.441 0.696 . . . . 0.0 110.332 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.42 89.4 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.6 m -68.83 -44.85 72.61 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.792 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.2 tp -137.12 134.74 36.74 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.556 179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.412 HG13 ' SG ' ' A' ' 46' ' ' CYS . 11.5 pt -91.36 156.33 43.59 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.61 151.48 94.57 Favored 'Cis proline' 0 C--O 1.238 0.492 0 C-N-CA 124.157 -1.185 . . . . 0.0 112.503 0.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -115.33 130.53 56.93 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 176.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 49' ' ' GLU . 24.2 t -110.99 126.27 68.37 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 O-C-N 123.291 0.369 . . . . 0.0 111.373 -176.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 69.9 m-85 -128.03 115.06 17.9 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 174.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 60.5 mt -105.71 132.55 52.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.295 0.569 . . . . 0.0 111.452 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -109.68 134.88 50.36 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.478 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -90.16 -172.76 3.6 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 123.238 0.336 . . . . 0.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.93 -30.32 76.95 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.447 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -69.41 -14.53 62.95 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.58 0.705 . . . . 0.0 109.67 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 82.75 31.74 28.87 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.478 -0.867 . . . . 0.0 111.601 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.444 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 10.2 mptt -123.43 157.38 33.56 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.031 0.443 . . . . 0.0 110.111 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 7' ' ' ALA . 49.7 mt -74.66 100.55 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.035 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.5 p -88.03 -39.0 12.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.675 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.577 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 81.9 t80 -131.81 136.63 47.67 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.818 0.342 . . . . 0.0 111.652 -177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -131.03 134.63 46.85 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.099 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.577 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.2 t60 -148.95 103.09 3.32 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.5 m -103.2 118.88 37.77 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.11 0.481 . . . . 0.0 111.829 -175.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.74 45.41 44.26 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.702 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 15.0 p90 -68.08 -37.51 81.31 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 119.093 -1.043 . . . . 0.0 110.081 176.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 43.2 p 77.41 -59.94 0.45 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.163 1.785 . . . . 0.0 112.278 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -147.8 142.87 27.06 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.582 176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.11 19.17 67.72 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.702 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.98 -27.02 20.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 115.255 -0.473 . . . . 0.0 113.122 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.418 ' O ' HG22 ' A' ' 140' ' ' ILE . 5.7 pm0 -60.51 -22.18 63.28 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 122.337 0.255 . . . . 0.0 111.662 -177.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.89 -42.12 99.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.398 0.618 . . . . 0.0 110.112 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -73.0 -37.7 66.89 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.414 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -63.21 -46.56 86.42 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.543 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.497 HD13 ' NE1' ' A' ' 60' ' ' TRP . 7.2 tp -66.34 -34.79 72.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.819 0.342 . . . . 0.0 110.403 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.1 ttmt -56.43 -54.3 47.31 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.888 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 29.0 mmmt -66.04 -32.81 74.5 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 139' ' ' LEU . 52.9 t -62.0 -43.74 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 121.287 0.565 . . . . 0.0 109.934 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.425 ' NE ' HD11 ' A' ' 140' ' ' ILE . 78.2 mtt180 -84.27 -18.63 35.77 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.312 -178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 61.2 mm-40 -69.92 -30.16 67.5 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.415 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.0 mt -61.4 -40.49 94.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.923 0.392 . . . . 0.0 110.105 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 58.6 t -65.85 -44.02 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 121.487 0.66 . . . . 0.0 109.712 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.421 ' HD3' ' OE1' ' A' ' 145' ' ' GLU . 71.5 tttt -59.84 -44.3 94.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.194 178.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -77.06 7.79 4.57 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.093 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -68.04 -5.42 40.36 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.697 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 154' ' ' HIS . 69.6 t60 -49.77 -25.68 3.24 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 123.701 0.8 . . . . 0.0 111.499 176.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -57.76 -36.93 72.77 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.813 0.34 . . . . 0.0 110.13 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -81.51 -60.67 2.18 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 151' ' ' HIS . 48.5 p-80 -158.07 156.73 31.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.516 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -72.99 99.75 2.8 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.718 0.294 . . . . 0.0 111.324 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 62.2 m80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.314 -0.85 . . . . 0.0 112.551 176.572 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.0 p30 . . . . . 0 N--CA 1.444 -0.774 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.444 ' HA ' ' CA ' ' A' ' 122' ' ' GLY . 40.0 m 65.54 76.12 0.33 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.334 0.588 . . . . 0.0 110.76 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.546 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 89.1 m-85 -100.87 -101.38 0.25 Allowed 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 177.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -177.41 11.5 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 25.4 tt0 54.57 34.8 22.06 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.793 0.806 . . . . 0.0 110.579 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.429 HD13 ' OG1' ' A' ' 24' ' ' THR . 79.3 mt -89.84 150.45 43.87 Favored Pre-proline 0 C--N 1.309 -1.188 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.652 -176.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -63.44 151.89 82.75 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.717 2.278 . . . . 0.0 111.476 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.31 84.13 2.45 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.905 0.383 . . . . 0.0 110.981 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' HG22 ' A' ' 24' ' ' THR . 72.3 t -121.38 136.76 57.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.984 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 p -78.07 126.35 30.69 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 96' ' ' LEU . 1.9 tp -134.34 173.07 12.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.536 -176.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -116.28 133.56 55.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -97.84 -179.89 4.58 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 95' ' ' VAL . 17.5 pt -64.3 -22.17 30.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -77.94 -16.64 58.01 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.901 0.381 . . . . 0.0 110.828 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.28 18.56 58.83 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -101.92 140.36 36.31 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.17 -0.515 . . . . 0.0 109.673 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.1 m -74.38 116.54 15.17 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.119 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.82 156.81 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.976 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -104.22 134.83 46.8 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 176.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 12' ' ' VAL . 0.0 OUTLIER -67.16 -16.38 64.28 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -176.378 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -93.05 7.52 43.8 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 121.774 -0.579 . . . . 0.0 112.09 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.411 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -136.45 16.35 3.17 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.836 -0.54 . . . . 0.0 111.297 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.8 -67.52 0.38 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.34 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.546 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 35.1 mt-10 64.52 175.66 0.19 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-O 121.701 0.762 . . . . 0.0 112.516 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.409 ' HB2' ' HE2' ' A' ' 34' ' ' MET . 0.3 OUTLIER -139.25 -78.27 0.33 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.539 178.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.77 31.13 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.261 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.45 34.15 29.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.298 -176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 71.7 mmtt -123.47 145.9 48.23 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 122.141 0.176 . . . . 0.0 111.008 -177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 12.8 Cg_exo -67.82 155.22 70.72 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.813 2.342 . . . . 0.0 111.832 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.409 ' HE2' ' HB2' ' A' ' 29' ' ' ASN . 36.6 mtt -133.97 160.68 36.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.169 0.509 . . . . 0.0 111.61 -174.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 97.2 mt -132.48 118.78 36.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -99.37 118.17 45.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.7 m -104.1 122.97 46.4 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.178 0.513 . . . . 0.0 110.191 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 62.8 m-85 -94.16 114.88 27.09 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.236 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.547 ' HB2' HD22 ' A' ' 47' ' ' LEU . 25.0 p90 -135.25 170.73 15.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 123.641 0.588 . . . . 0.0 111.284 -176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.81 153.92 29.52 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.998 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p -69.86 -21.23 63.36 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -94.37 12.64 26.34 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.747 0.308 . . . . 0.0 111.452 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 61.0 m -126.55 126.49 43.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.744 0.307 . . . . 0.0 111.497 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.574 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 57.4 mttp -117.71 -58.5 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.133 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.515 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 3.3 Cg_exo -79.79 -22.16 7.86 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.095 1.864 . . . . 0.0 112.446 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.7 m -76.42 -3.97 39.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.991 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.547 HD22 ' HB2' ' A' ' 39' ' ' PHE . 34.8 mt -62.97 -38.44 91.13 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.826 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? 61.15 -80.89 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 176.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 53' ' ' ILE . 13.4 pt-20 -52.87 -52.86 55.86 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 123.188 0.595 . . . . 0.0 112.229 -176.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.422 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 47.0 tp -61.51 -42.7 99.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.634 0.254 . . . . 0.0 110.598 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.525 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 88.6 tttt -67.09 -46.92 72.8 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.626 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.95 97.56 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.0 mt -64.01 -41.38 92.31 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.817 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.726 177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.51 -36.99 67.29 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.768 0.318 . . . . 0.0 110.986 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 13.6 mm-40 -69.92 -39.65 76.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.488 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.5 m -114.84 27.35 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 121.178 0.513 . . . . 0.0 112.116 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 85.7 t80 -59.4 -35.61 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.749 -177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.31 -37.98 85.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.669 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -64.72 -42.98 94.84 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.115 0.483 . . . . 0.0 110.951 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -69.56 -36.81 76.65 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.433 0.635 . . . . 0.0 110.59 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -82.08 -7.67 59.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.7 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -58.03 -48.99 78.42 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.039 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -131.95 -44.19 0.96 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -39.67 94.43 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.895 0.378 . . . . 0.0 110.872 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.64 40.79 96.11 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.117 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.3 p -92.54 133.12 34.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 120.989 0.423 . . . . 0.0 111.147 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -102.79 159.78 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.221 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 54.7 mt -108.28 139.3 43.17 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.267 0.556 . . . . 0.0 111.196 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.434 HG23 HD13 ' A' ' 96' ' ' LEU . 79.2 mt -115.81 110.94 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.535 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.611 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -92.76 114.1 26.56 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.4 p -112.52 131.75 63.16 Favored 'Isoleucine or valine' 0 C--O 1.252 1.186 0 CA-C-O 121.936 0.874 . . . . 0.0 111.627 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.576 ' OG ' HG21 ' A' ' 82' ' ' VAL . 2.1 m -88.69 119.39 29.12 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.146 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 pt -77.75 -17.69 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 123.939 0.774 . . . . 0.0 109.738 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.512 ' HB3' ' CB ' ' A' ' 78' ' ' ASN . 4.5 m-20 -73.09 146.34 45.85 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.155 178.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -77.5 -173.82 3.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.18 0.514 . . . . 0.0 112.159 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.511 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -43.13 -58.32 3.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 114.858 -1.064 . . . . 0.0 115.403 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 13.9 pt20 -65.85 -45.17 83.14 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.408 0.604 . . . . 0.0 112.088 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.512 ' CB ' ' HB3' ' A' ' 74' ' ' ASP . 7.3 m-20 -66.7 -41.4 88.07 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -72.88 -5.31 37.48 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -176.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 79.4 mt-30 -66.01 -10.56 40.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.381 0.61 . . . . 0.0 109.802 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.76 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 96.0 mttt -94.87 -11.04 29.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.549 -178.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 79' ' ' ALA . 14.1 t -68.65 -50.77 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -173.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 40.6 mtpt -66.26 -40.35 34.78 Favored Pre-proline 0 C--N 1.302 -1.496 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.605 -176.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 5.9 Cg_endo -58.69 -34.3 98.84 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 121.185 1.256 . . . . 0.0 110.334 172.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -64.05 -42.21 97.11 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.435 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -61.08 -43.48 98.82 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.633 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -72.25 -40.41 67.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.89 -42.32 92.92 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.309 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -88.86 -15.73 33.73 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.952 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 69.6 61.09 4.61 Favored Glycine 0 N--CA 1.442 -0.912 0 CA-C-N 115.734 -0.667 . . . . 0.0 113.276 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.435 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 31.4 m0 -82.41 134.54 35.24 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.896 0.379 . . . . 0.0 110.323 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -94.65 30.83 1.92 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.383 -176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.527 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -132.15 171.52 13.55 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 120.393 -0.523 . . . . 0.0 111.921 -172.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -81.85 136.17 35.38 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.805 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 17' ' ' ILE . 13.9 t -116.66 144.19 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 CA-C-O 121.072 0.463 . . . . 0.0 110.59 -176.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 14' ' ' LEU . 11.3 mp -124.64 142.46 51.36 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.037 -177.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.738 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 9.9 mp -114.76 117.38 30.61 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.196 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -81.16 115.16 20.44 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 174.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 t -96.17 -8.19 33.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.383 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -111.65 -30.98 7.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.835 0.35 . . . . 0.0 111.163 -176.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 85.27 14.54 68.62 Favored Glycine 0 N--CA 1.441 -1.002 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -177.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -94.56 -27.15 16.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.927 -177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -62.52 -45.92 90.79 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.043 0.449 . . . . 0.0 110.782 -175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -62.82 -38.91 92.61 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.191 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -70.69 -41.5 71.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.421 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.52 -32.59 74.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.882 178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -86.57 -9.65 55.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.898 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.83 52.23 3.54 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.978 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 25.0 t -76.31 89.72 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.707 -0.678 . . . . 0.0 109.928 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 39.6 m -69.33 -45.34 69.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.317 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.5 tp -139.92 142.28 36.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.983 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 26.4 pt -101.83 153.12 38.16 Favored Pre-proline 0 C--N 1.318 -0.802 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.551 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 96.0 Cg_endo -78.52 154.32 92.23 Favored 'Cis proline' 0 C--O 1.244 0.778 0 C-N-CA 123.713 -1.37 . . . . 0.0 112.186 0.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -116.65 136.25 53.13 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.089 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.5 t -114.91 127.9 72.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.089 0.471 . . . . 0.0 111.651 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -128.19 114.56 17.13 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.281 174.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.524 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.5 mt -103.05 129.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 CA-C-O 121.199 0.523 . . . . 0.0 110.627 -178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 62.8 t -106.46 128.52 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.114 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -76.61 161.89 28.2 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.59 -21.45 21.41 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 114.08 0.392 . . . . 0.0 114.08 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.485 ' OD1' ' HB2' ' A' ' 123' ' ' LYS . 6.3 p30 -74.07 -16.45 61.03 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.687 0.743 . . . . 0.0 111.253 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 5' ' ' THR . . . 101.38 17.91 20.63 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.222 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.485 ' HB2' ' OD1' ' A' ' 121' ' ' ASN . 13.6 mptt -121.94 152.16 39.96 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.227 0.537 . . . . 0.0 111.796 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 79.1 mt -75.45 111.54 11.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.583 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.12 -19.12 6.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.809 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.524 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 68.2 t80 -144.43 130.25 19.25 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.292 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -138.3 129.04 26.64 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.957 0.408 . . . . 0.0 110.305 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -138.71 112.64 8.49 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.092 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 20.8 p -95.8 106.67 18.83 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.776 0.322 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.24 59.14 2.46 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.992 -0.623 . . . . 0.0 114.23 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.594 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 41.4 p90 -67.55 -35.81 79.77 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 109.052 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 80.7 p 69.37 -88.33 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.216 1.807 . . . . 0.0 113.622 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -119.2 119.1 33.12 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.098 -0.377 . . . . 0.0 111.386 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.58 33.56 16.05 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.527 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.594 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -89.89 -27.11 22.54 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.694 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 140' ' ' ILE . 9.2 pt-20 -54.83 -26.0 32.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.641 0.776 . . . . 0.0 112.804 -176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -45.19 94.69 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.371 0.605 . . . . 0.0 110.856 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -71.93 -33.41 68.24 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.547 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.68 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.6 -53.38 55.52 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.492 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 136' ' ' GLU . 6.2 tp -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 121.103 0.478 . . . . 0.0 110.961 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -63.03 -44.38 96.09 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.16 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.442 ' HG2' ' HB2' ' A' ' 126' ' ' TYR . 44.6 tptt -68.33 -31.34 70.68 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.897 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 139' ' ' LEU . 69.3 t -59.17 -42.45 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.279 0.561 . . . . 0.0 109.489 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -64.31 -35.75 81.88 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.091 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 56.0 mm-40 -62.07 -32.02 72.51 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.601 178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.22 -41.38 98.34 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.243 0.544 . . . . 0.0 110.038 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 53.8 t -64.56 -43.35 96.79 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.033 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -61.54 -45.25 94.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.183 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -65.74 -36.97 85.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.015 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -116.28 59.45 0.45 Allowed Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.815 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.627 ' HB2' ' O ' ' A' ' 147' ' ' VAL . 21.8 t-80 -119.57 -60.25 1.74 Allowed 'General case' 0 CA--C 1.508 -0.639 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.494 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -100.05 150.14 22.77 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.232 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -60.64 -42.07 96.19 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 123.332 0.395 . . . . 0.0 111.027 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.465 ' O ' ' HB2' ' A' ' 155' ' ' HIS . 27.7 p-80 -101.06 -2.43 31.6 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.542 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 77.6 m80 72.61 143.96 0.07 Allowed 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.805 0.69 . . . . 0.0 110.012 -174.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 43.8 m80 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 123.158 0.583 . . . . 0.0 111.981 178.439 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.47 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 14.4 m120 . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.21 0.529 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -91.02 64.31 5.34 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.944 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' CE2' ' HA ' ' A' ' 4' ' ' ASN . 29.0 m-85 -92.68 -136.57 0.17 Allowed 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.473 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -144.54 19.27 1.69 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.825 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.469 ' HB3' HG13 ' A' ' 124' ' ' ILE . 50.9 tt0 53.67 38.83 29.26 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.012 0.91 . . . . 0.0 110.444 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 65.6 mt -92.3 162.28 30.48 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.75 -175.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.68 168.6 23.26 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.273 2.649 . . . . 0.0 110.963 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.69 79.12 6.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.114 0.483 . . . . 0.0 110.61 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.22 134.43 66.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.848 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.1 m -96.68 116.18 28.69 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.849 0.357 . . . . 0.0 110.157 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.567 HD22 ' HA ' ' A' ' 98' ' ' ASP . 47.4 mt -113.35 176.28 5.09 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.799 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -109.41 127.24 54.23 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.288 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.434 HD21 ' HB3' ' A' ' 20' ' ' LYS . 47.8 p30 -89.71 -174.34 4.26 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.111 0.481 . . . . 0.0 111.706 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.487 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 39.5 pt -71.41 -14.74 17.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.403 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -93.84 -1.61 54.65 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.774 0.321 . . . . 0.0 111.184 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.46 24.07 68.93 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HB3' HD21 ' A' ' 16' ' ' ASN . 62.6 tttp -101.54 139.53 37.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.3 m -82.51 109.82 17.07 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.08 142.67 23.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.791 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.46 ' H ' ' HE3' ' A' ' 26' ' ' LYS . 87.9 mt-30 -100.32 133.11 45.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.875 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.415 HG21 ' CE1' ' A' ' 103' ' ' PHE . 20.9 p -68.89 -32.31 71.86 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -175.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -70.05 -17.21 63.24 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.448 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' HE3' ' H ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -117.98 8.68 12.58 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.907 0.384 . . . . 0.0 110.819 179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.1 tp -79.96 105.83 11.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.331 0.586 . . . . 0.0 112.044 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 56.4 mt-10 -108.63 139.69 43.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.078 175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.821 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 15.1 t-20 -76.05 -75.66 0.18 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.004 0.43 . . . . 0.0 110.328 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.55 33.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.249 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 79.54 28.51 51.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 66.4 mmtt -123.0 148.97 55.67 Favored Pre-proline 0 N--CA 1.452 -0.352 0 CA-C-N 115.462 -0.369 . . . . 0.0 110.123 -177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 19.3 Cg_exo -65.28 149.86 88.0 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.34 2.027 . . . . 0.0 110.634 176.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.821 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 67.2 mtm -133.66 145.65 50.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.462 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 92.5 mt -122.63 125.45 72.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.9 mt -99.38 122.37 51.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.238 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -106.47 115.87 30.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.604 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 66.3 m-85 -94.21 118.24 31.28 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -146.36 167.03 24.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.574 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -100.01 146.56 26.6 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.578 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.446 HG22 ' OD2' ' A' ' 74' ' ' ASP . 7.0 t -72.99 -13.75 61.29 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 120.857 0.36 . . . . 0.0 111.4 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -94.52 2.75 55.69 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 120.978 0.418 . . . . 0.0 111.293 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 30.1 p -124.82 119.45 28.91 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.309 -0.557 . . . . 0.0 111.805 -178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 52.8 mtmt -104.2 -49.66 0.14 Allowed Pre-proline 0 CA--C 1.56 1.33 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 177.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.512 ' HD2' ' H ' ' A' ' 44' ' ' LYS . 55.5 Cg_endo -72.51 -8.96 23.47 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 122.248 1.966 . . . . 0.0 112.228 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 43' ' ' CYS . 61.3 m -78.88 -15.87 57.78 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 176.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt -84.99 56.93 4.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.531 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 26.1 mmt85 -64.11 -39.93 95.11 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.443 0.639 . . . . 0.0 109.537 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.556 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.9 tm-20 -64.04 -55.21 23.86 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.545 -177.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD11 ' CE2' ' A' ' 93' ' ' TYR . 43.4 tp -62.12 -41.22 98.03 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.618 -178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 58.7 tttm -62.21 -48.64 79.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.911 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -63.57 -39.72 95.13 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.245 0.545 . . . . 0.0 110.925 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 49' ' ' GLU . 58.9 mt -65.33 -42.73 94.43 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.617 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.466 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -60.21 -30.33 69.31 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.804 0.335 . . . . 0.0 110.301 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 77.9 mm-40 -59.2 -48.25 82.33 Favored 'General case' 0 C--O 1.225 -0.203 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.786 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.2 m -122.02 30.86 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.488 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' ILE . 88.9 t80 -59.12 -34.74 72.4 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -177.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.46 -39.69 88.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.607 0.241 . . . . 0.0 110.471 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.28 -42.33 93.28 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 110.87 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.507 ' O ' ' HB ' ' A' ' 64' ' ' THR . 12.0 m0 -65.57 -37.2 85.98 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.307 0.575 . . . . 0.0 110.468 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 -84.37 -8.22 59.06 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.932 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -53.55 -64.24 0.89 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.61 -31.22 3.25 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 19.0 m -63.05 -41.83 99.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.065 0.459 . . . . 0.0 110.07 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.76 31.98 79.92 Favored Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.194 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -75.02 131.78 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-O 121.603 0.716 . . . . 0.0 111.438 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.532 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 9.1 mmm180 -102.58 141.42 35.43 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.386 -177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.611 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 50.0 mt -102.24 138.0 39.77 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.003 0.43 . . . . 0.0 110.295 177.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.533 HD11 ' SD ' ' A' ' 34' ' ' MET . 91.8 mt -115.06 113.28 43.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 176.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.44 113.61 25.5 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.738 -177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 14.4 p -121.59 132.13 71.47 Favored 'Isoleucine or valine' 0 C--O 1.249 1.069 0 CA-C-O 121.466 0.651 . . . . 0.0 111.751 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.9 p -88.55 131.55 34.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.557 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 40' ' ' ALA . 46.8 pt -77.67 -16.93 14.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 124.357 1.036 . . . . 0.0 110.864 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.446 ' OD2' HG22 ' A' ' 41' ' ' THR . 29.2 m-20 -80.5 160.66 25.17 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.987 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.89 171.96 7.25 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 120.83 0.348 . . . . 0.0 110.982 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -56.5 -41.14 88.25 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.804 -0.634 . . . . 0.0 114.151 -175.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -62.47 -43.44 98.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 117.07 0.435 . . . . 0.0 111.59 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -72.75 -39.3 66.96 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.4 0.619 . . . . 0.0 110.925 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.53 -4.85 12.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.268 -0.878 . . . . 0.0 113.201 -176.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 47.2 mt-30 -63.88 -9.51 15.58 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 122.013 -0.429 . . . . 0.0 110.39 177.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.697 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.8 mttm -96.2 -10.51 27.93 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -63.66 -47.1 92.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 121.683 0.754 . . . . 0.0 111.836 -175.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.514 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 23.2 mtmt -70.69 -43.13 14.98 Favored Pre-proline 0 C--N 1.305 -1.343 0 CA-C-N 114.945 -1.025 . . . . 0.0 113.159 -175.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.5 Cg_endo -61.17 -30.54 88.92 Favored 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 121.012 1.141 . . . . 0.0 110.932 174.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -64.96 -41.27 95.62 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -60.62 -40.13 90.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.587 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.61 -46.21 66.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.126 0.489 . . . . 0.0 111.006 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.1 -43.26 93.67 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.63 -0.713 . . . . 0.0 113.998 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -87.36 -16.18 35.74 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.304 0.552 . . . . 0.0 112.053 -176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.31 40.42 6.93 Favored Glycine 0 C--O 1.226 -0.346 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.725 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -89.04 104.36 16.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -99.1 73.33 1.92 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.353 0.597 . . . . 0.0 109.995 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.611 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -137.18 167.23 21.97 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 67' ' ' ARG . 2.2 mp0 -70.39 102.6 2.21 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 48.0 t -92.74 128.36 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.148 0.499 . . . . 0.0 110.465 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.447 HD13 HG23 ' A' ' 69' ' ' ILE . 10.7 mp -124.75 138.07 54.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.349 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.58 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.1 mp -108.02 117.61 34.58 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.567 ' HA ' HD22 ' A' ' 14' ' ' LEU . 63.5 t0 -78.46 115.62 18.29 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.712 174.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 35.3 p -82.6 -9.85 59.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -127.81 -21.76 3.66 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.423 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 84.4 19.5 60.3 Favored Glycine 0 C--N 1.319 -0.408 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.918 176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.419 ' HA ' ' HD3' ' A' ' 105' ' ' ARG . 11.9 m-20 -93.95 -21.57 19.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.249 0.525 . . . . 0.0 112.107 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 24' ' ' THR . 75.0 t80 -63.68 -43.3 97.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 0.0 110.542 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.404 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 63.1 pttt -63.06 -33.14 74.79 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.9 176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.419 ' HD3' ' HA ' ' A' ' 102' ' ' ASP . 60.6 mtp85 -69.52 -39.59 77.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.168 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.25 -37.01 83.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.248 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.3 mmt -88.04 -3.3 58.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.737 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.72 44.06 14.67 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.688 0.756 . . . . 0.0 110.615 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.62 96.93 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.426 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.9 m -88.4 -58.94 2.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.9 tp -112.37 127.09 55.91 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.951 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.9 pt -87.52 156.84 53.32 Favored Pre-proline 0 C--N 1.31 -1.131 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.488 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.5 Cg_endo -82.17 150.11 72.39 Favored 'Cis proline' 0 C--O 1.242 0.715 0 C-N-CA 123.91 -1.287 . . . . 0.0 112.304 -0.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -111.19 134.36 52.85 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.07 127.47 75.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.397 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 72.0 m-85 -128.46 116.95 20.5 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 71.9 mt -105.52 130.02 57.54 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-O 121.092 0.472 . . . . 0.0 110.993 -176.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 54.9 t -114.18 133.53 59.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.745 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -85.46 -172.27 4.05 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.968 0.414 . . . . 0.0 111.23 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.8 -22.53 68.4 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.706 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -85.08 2.07 45.0 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.785 0.326 . . . . 0.0 110.711 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 73.55 28.44 65.51 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.401 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' VAL . 71.3 mmtt -115.73 153.97 30.41 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.469 HG13 ' HB3' ' A' ' 8' ' ' GLN . 80.8 mt -80.93 114.87 22.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.44 -19.17 6.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.403 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.626 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 67.0 t80 -144.33 136.99 26.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.716 0.293 . . . . 0.0 110.587 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.88 135.21 24.2 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.839 177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -158.36 122.85 4.16 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.146 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.8 p -103.79 112.35 25.27 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.128 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.93 66.52 1.8 Allowed Glycine 0 CA--C 1.521 0.449 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.856 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.669 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 27.9 p90 -69.03 -40.02 78.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.256 0.55 . . . . 0.0 110.26 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 81.5 p 55.47 81.5 0.11 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.764 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 64.72 120.85 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.032 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.99 16.54 55.93 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.85 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.669 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -90.73 -37.58 6.41 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.644 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 1.9 pm0 -60.78 -17.51 49.64 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.235 0.614 . . . . 0.0 111.849 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.42 -41.44 96.59 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.526 0.679 . . . . 0.0 109.739 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -73.41 -31.95 64.16 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.354 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -62.24 -47.89 82.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.144 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.7 tp -68.66 -37.31 77.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.064 0.459 . . . . 0.0 110.072 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -60.06 -46.44 89.55 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.772 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.532 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 42.4 tptt -65.21 -36.06 82.98 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.266 -178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 139' ' ' LEU . 66.7 t -60.66 -46.47 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.172 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.495 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 5.4 mmp_? -68.76 -36.19 78.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.573 0.701 . . . . 0.0 109.767 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 142' ' ' LYS . 34.6 tt0 -62.06 -27.27 68.78 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.19 178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 94.4 mt -62.15 -37.91 87.0 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.21 -42.94 98.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.596 177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.6 mmtt -76.72 -10.38 59.34 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.555 178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -66.48 -36.39 82.64 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -79.87 157.8 41.94 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 70.73 13.44 7.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.314 0.578 . . . . 0.0 110.449 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -62.54 100.47 0.19 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.384 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 29.1 t60 59.53 86.68 0.09 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.792 -176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 25.8 m80 69.28 174.13 0.29 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.894 -177.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 30.3 p80 -116.09 153.05 32.43 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.389 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 57.5 t60 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.371 -178.273 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.85 0.357 . . . . 0.0 111.416 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.551 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 23.8 m -86.56 85.34 7.3 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.208 0.528 . . . . 0.0 111.405 -178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -116.16 -120.08 0.31 Allowed 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -151.42 13.48 0.66 Allowed 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.445 178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' A' ' 8' ' ' GLN . 61.7 tt0 50.38 33.43 7.59 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.867 0.841 . . . . 0.0 110.98 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.491 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 74.7 mt -80.85 156.11 72.68 Favored Pre-proline 0 C--N 1.312 -1.049 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.111 -176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -63.56 155.3 63.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.871 2.381 . . . . 0.0 110.798 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.17 80.04 1.28 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.125 0.488 . . . . 0.0 111.315 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.9 t -121.89 132.77 70.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.753 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.8 m -92.42 105.33 17.54 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.308 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 98' ' ' ASP . 71.2 mt -104.41 178.15 4.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.971 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.484 ' HD2' ' C ' ' A' ' 19' ' ' GLY . 3.2 tppp? -108.54 135.91 49.02 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.105 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -91.69 -179.96 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.404 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 42.3 pt -68.32 -11.99 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -96.24 -4.66 41.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 111.098 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.484 ' C ' ' HD2' ' A' ' 15' ' ' LYS . . . 82.32 20.28 62.75 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.576 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -107.43 149.6 27.72 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.5 m -75.12 122.69 23.98 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.057 0.455 . . . . 0.0 110.875 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.0 m -125.09 135.73 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.645 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 94.4 mt-30 -95.62 133.99 39.03 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.466 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.6 p -67.41 -27.74 67.33 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -63.56 -33.74 76.26 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.204 0.526 . . . . 0.0 110.224 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -105.03 13.0 31.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.246 -178.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.35 124.11 29.1 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.155 0.502 . . . . 0.0 112.105 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -146.74 173.81 12.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.258 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' OD1' ' HB2' ' A' ' 32' ' ' LYS . 8.2 p30 -112.61 -56.71 2.37 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.082 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -174.35 39.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.377 0.671 . . . . 0.0 109.651 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.24 26.86 72.77 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.741 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 45.6 mmtm -117.19 152.84 49.53 Favored Pre-proline 0 C--N 1.326 -0.455 0 C-N-CA 122.239 0.216 . . . . 0.0 110.713 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.81 151.83 78.39 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.625 2.217 . . . . 0.0 111.398 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.52 ' SD ' HD11 ' A' ' 69' ' ' ILE . 56.7 mtm -136.32 154.53 50.83 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -175.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 84.0 mt -127.01 125.66 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 174.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -101.0 118.98 48.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.8 m -102.93 123.43 46.54 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.563 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -97.15 115.99 28.54 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.675 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -137.3 166.13 24.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.67 0.606 . . . . 0.0 111.212 -177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' A' ' 73' ' ' ILE . . . -110.03 161.46 15.49 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.669 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.3 p -65.14 -32.79 74.66 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.029 0.443 . . . . 0.0 111.376 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -94.79 63.92 2.86 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.541 0.686 . . . . 0.0 110.822 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 18.3 p -61.14 128.08 34.66 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.568 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.539 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 29.4 ttpp -117.26 -39.05 0.06 OUTLIER Pre-proline 0 CA--C 1.56 1.331 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.539 ' CD ' ' H ' ' A' ' 44' ' ' LYS . 94.5 Cg_endo -85.19 21.02 1.15 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.584 1.522 . . . . 0.0 112.578 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 56.0 m 61.69 15.97 7.39 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.171 0.588 . . . . 0.0 111.277 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.6 mt 47.26 72.38 0.25 Allowed 'General case' 0 C--N 1.353 0.718 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -58.45 -47.25 84.61 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.013 -170.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.587 ' O ' HG13 ' A' ' 53' ' ' ILE . 15.5 pt-20 -58.43 -56.51 21.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.946 0.403 . . . . 0.0 111.237 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.567 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 34.6 tp -65.73 -42.85 90.53 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.975 -174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 22.0 tptm -65.08 -47.47 77.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.02 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.02 -41.47 99.56 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-O 120.822 0.344 . . . . 0.0 110.976 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.0 mt -65.55 -42.53 93.26 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.706 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.719 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -53.9 -40.06 66.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.898 0.38 . . . . 0.0 110.654 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 47.0 mm-40 -62.45 -46.43 88.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.233 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.29 26.86 2.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.615 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.3 t80 -59.79 -39.44 84.94 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.276 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.25 -37.29 82.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.494 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.81 -42.51 81.4 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.3 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -67.21 -40.51 86.45 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.341 0.591 . . . . 0.0 110.304 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 32.0 mm-40 -73.6 -15.8 61.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.366 177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -61.12 -45.73 93.48 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.799 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -114.14 -68.23 0.94 Allowed 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.636 -0.425 . . . . 0.0 111.304 -176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.8 m -62.83 -31.32 72.3 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.722 -176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 63.17 45.37 95.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.147 -178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.79 131.68 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.413 0.625 . . . . 0.0 112.295 -176.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.506 ' HB2' ' HG2' ' A' ' 34' ' ' MET . 13.3 mmm180 -96.57 159.02 15.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.948 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.491 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 76.0 mt -121.01 129.41 53.38 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 120.891 0.377 . . . . 0.0 111.285 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.52 HD11 ' SD ' ' A' ' 34' ' ' MET . 89.8 mt -109.32 108.64 25.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.81 107.43 19.21 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.01 131.47 56.9 Favored 'Isoleucine or valine' 0 C--O 1.253 1.285 0 CA-C-O 121.913 0.863 . . . . 0.0 112.396 -175.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.648 ' HB3' HG21 ' A' ' 82' ' ' VAL . 26.1 p -84.16 127.89 34.21 Favored 'General case' 0 N--CA 1.424 -1.741 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.465 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 46.4 pt -83.46 -15.09 11.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.346 1.029 . . . . 0.0 111.001 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -85.28 152.09 23.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.014 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.16 171.36 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.508 -175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -55.19 -49.41 63.54 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 115.926 1.13 . . . . 0.0 115.926 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -66.76 -41.86 87.07 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 117.748 0.774 . . . . 0.0 111.178 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -67.74 -38.27 83.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.879 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -72.56 -4.97 33.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.321 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -62.73 -9.51 9.53 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.961 -0.462 . . . . 0.0 110.948 177.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.704 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 98.9 mttt -92.68 -11.26 34.55 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.523 179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.648 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.3 t -65.3 -49.28 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 121.631 0.729 . . . . 0.0 112.356 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 14.1 mtpp -71.04 -38.9 7.61 Favored Pre-proline 0 C--N 1.301 -1.502 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.02 -28.41 80.43 Favored 'Trans proline' 0 C--N 1.364 1.37 0 CA-C-N 120.051 1.054 . . . . 0.0 110.666 173.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.704 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.8 mt -62.08 -45.92 91.4 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.473 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -60.43 -36.94 79.37 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.787 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.03 -32.25 73.88 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.159 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -88.77 -44.58 5.12 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 120.772 -0.727 . . . . 0.0 113.902 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.473 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 17.9 p30 -82.29 -15.77 51.76 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -178.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.27 58.44 3.65 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.456 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 48.3 m0 -78.05 112.79 15.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.99 35.79 1.51 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.714 0.769 . . . . 0.0 110.754 -175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.531 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -141.21 -171.33 3.26 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.478 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -89.39 137.36 32.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.628 0.728 . . . . 0.0 112.689 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.489 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 19.4 t -106.71 140.3 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.965 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.1 131.56 54.34 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -111.98 95.06 5.26 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.612 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.437 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.3 t0 -77.49 116.07 17.76 Favored 'General case' 0 C--O 1.219 -0.507 0 C-N-CA 118.479 -1.288 . . . . 0.0 108.085 174.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.3 p -89.82 -14.35 34.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.462 HD22 ' HB2' ' A' ' 102' ' ' ASP . 5.8 t30 -104.07 -39.19 6.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.97 0.414 . . . . 0.0 110.983 -177.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 90.78 19.64 43.09 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.462 ' HB2' HD22 ' A' ' 100' ' ' ASN . 19.3 t70 -89.76 -29.59 18.58 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.0 -177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.466 ' CE1' HG21 ' A' ' 24' ' ' THR . 86.0 t80 -60.58 -43.34 97.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.84 -176.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.517 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 21.8 pttp -62.44 -38.2 88.82 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.709 0.29 . . . . 0.0 111.279 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -66.01 -42.63 89.45 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.1 -35.37 80.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.897 178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.44 ' O ' ' HB2' ' A' ' 108' ' ' ASN . 2.1 mmt -84.9 -5.06 59.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.264 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 107' ' ' MET . 93.0 m-20 71.43 35.47 1.5 Allowed 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.297 0.373 . . . . 0.0 111.803 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 104' ' ' LYS . 92.4 t -83.07 108.61 15.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 120.931 0.396 . . . . 0.0 110.906 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.9 m -100.66 -64.44 1.04 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.831 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.9 tp -95.46 126.25 40.63 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.2 pt -94.31 147.73 33.84 Favored Pre-proline 0 C--N 1.306 -1.306 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.68 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 83.0 Cg_endo -82.75 167.05 67.61 Favored 'Cis proline' 0 CA--C 1.542 0.908 0 C-N-CA 124.117 -1.201 . . . . 0.0 112.971 1.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -131.73 141.94 49.66 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.9 t -115.45 127.34 73.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 O-C-N 123.344 0.402 . . . . 0.0 111.507 -177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -126.17 118.45 25.24 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.639 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 67.8 mt -106.96 131.72 56.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.201 0.524 . . . . 0.0 110.763 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 54.4 t -107.4 131.26 58.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -74.82 -179.54 4.26 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.009 0.818 . . . . 0.0 112.557 -175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.2 -30.83 78.8 Favored Glycine 0 C--N 1.332 0.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.749 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.459 ' O ' ' HA ' ' A' ' 5' ' ' THR . 3.3 t-20 -67.25 -41.07 86.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.917 0.389 . . . . 0.0 110.169 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 121.5 21.23 3.06 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.7 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.414 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 0.7 OUTLIER -113.56 163.45 14.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.033 0.444 . . . . 0.0 110.683 -179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 58.4 mt -80.02 109.88 15.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 8.4 p -97.0 -40.22 10.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.27 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 70.1 t80 -128.29 122.49 31.75 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.809 0.338 . . . . 0.0 110.62 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.5 120.91 29.36 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.116 0.484 . . . . 0.0 110.82 178.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -136.79 105.83 5.96 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.335 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 5.8 p -97.34 123.96 41.32 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.249 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 92.71 49.29 2.76 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.017 -1.087 . . . . 0.0 114.509 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.68 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 1.0 OUTLIER -90.11 135.82 33.43 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 173.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 77.6 p -123.67 69.0 1.03 Allowed 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.501 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 69.85 119.41 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.462 -1.245 . . . . 0.0 112.176 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.04 8.8 35.68 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.67 -18.1 46.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.77 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -59.73 -19.84 52.61 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.78 95.88 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.39 0.614 . . . . 0.0 109.907 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -71.34 -32.94 69.14 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.678 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -62.02 -51.35 68.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.632 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.24 -36.87 74.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.624 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.3 ttpp -60.03 -48.17 82.83 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.049 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 55.0 tptt -66.16 -30.27 70.71 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.213 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 139' ' ' LEU . 70.2 t -58.88 -44.64 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 144' ' ' ARG . 4.6 mmp_? -68.32 -37.86 80.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.347 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.5 mm-40 -59.73 -36.29 76.28 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.722 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 83.1 mt -59.74 -42.35 92.96 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 121.024 0.44 . . . . 0.0 110.27 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 50.6 t -64.99 -46.21 92.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.184 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -69.33 -47.84 63.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.049 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -72.0 -37.42 69.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.904 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 107.77 -57.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.696 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -126.8 -76.26 0.58 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.621 0.248 . . . . 0.0 111.606 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -120.97 -46.47 2.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.964 0.411 . . . . 0.0 110.789 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -147.05 -34.44 0.26 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.418 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -119.12 167.38 11.86 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -61.14 -34.94 75.8 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.25 -0.881 . . . . 0.0 109.778 177.138 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.6 m120 . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.417 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 m -146.25 65.92 1.2 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.36 0.6 . . . . 0.0 110.536 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.434 ' O ' HG11 ' A' ' 118' ' ' VAL . 21.0 m-85 -97.37 -134.23 0.23 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.832 ' HB3' HD22 ' A' ' 9' ' ' LEU . . . -145.24 21.14 1.56 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.792 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.463 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 51.0 tt0 50.28 38.14 16.83 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.878 0.847 . . . . 0.0 109.504 -178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.832 HD22 ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -103.9 147.93 35.05 Favored Pre-proline 0 N--CA 1.434 -1.26 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.175 -174.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.647 ' HD2' ' SD ' ' A' ' 107' ' ' MET . 48.1 Cg_exo -55.14 146.7 58.0 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 123.647 2.898 . . . . 0.0 112.474 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 25' ' ' ASN . . . -72.44 90.45 1.31 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.755 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.0 t -119.4 132.7 68.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.53 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 p -77.5 100.22 5.97 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.187 0.517 . . . . 0.0 109.964 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.434 HD23 HD23 ' A' ' 96' ' ' LEU . 4.7 tp -106.33 177.23 4.92 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.177 -176.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' CE ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -118.76 137.75 53.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.476 -0.49 . . . . 0.0 111.02 178.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 40.9 p30 -98.9 -178.8 4.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.041 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 95' ' ' VAL . 33.2 pt -67.05 -19.55 25.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.674 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -81.42 -10.81 59.44 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.326 0.584 . . . . 0.0 110.236 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.43 17.45 75.95 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' HE3' ' A' ' 15' ' ' LYS . 88.3 tttt -95.71 137.12 35.22 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.235 -0.483 . . . . 0.0 109.9 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.472 ' HA ' ' CE ' ' A' ' 15' ' ' LYS . 99.7 m -74.6 100.69 3.99 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.346 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.6 p -117.17 132.3 67.35 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.294 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.506 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 48.3 mt-30 -82.62 136.7 34.72 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.146 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.586 ' HB ' ' CD1' ' A' ' 9' ' ' LEU . 20.1 p -64.15 -36.24 83.4 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.43 -176.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 11' ' ' ALA . 64.1 t30 -69.43 -16.95 63.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.844 0.354 . . . . 0.0 111.575 -178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.506 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -110.08 6.74 23.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.814 0.34 . . . . 0.0 111.042 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 35.8 tp -87.08 113.56 22.94 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 121.001 0.429 . . . . 0.0 109.984 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -125.68 154.94 41.65 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.233 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.73 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 25.6 t30 -87.53 -68.19 0.77 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.099 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 174.45 -22.59 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.581 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.417 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 150.08 -13.58 0.97 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.507 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.2 mptm? -91.4 147.96 36.53 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-N 115.753 -0.224 . . . . 0.0 110.61 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.584 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 17.9 Cg_exo -65.06 156.6 61.81 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 123.199 2.599 . . . . 0.0 112.832 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.73 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 70.6 mtm -138.67 159.75 41.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.74 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.441 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 81.4 mt -129.65 128.63 65.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.6 mt -99.81 122.12 51.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 6.9 m -115.84 122.82 46.52 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.02 0.438 . . . . 0.0 110.602 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.51 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 56.3 m-85 -88.71 117.14 27.47 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.467 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 22.0 p90 -134.91 167.9 20.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 123.439 0.462 . . . . 0.0 110.681 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.619 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -110.5 149.01 30.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.605 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.1 -32.38 73.74 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.933 -177.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -99.5 10.46 41.33 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 86.8 m -104.85 137.78 42.11 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.532 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.617 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 66.9 mttm -130.62 -57.3 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.754 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.617 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 8.4 Cg_exo -68.65 -25.53 34.14 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.137 1.892 . . . . 0.0 111.304 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 51.6 m -66.08 -23.67 66.56 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.743 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.1 mt -87.18 61.54 6.78 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.923 -177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' OE2' ' A' ' 136' ' ' GLU . 12.0 mmm180 -60.21 -43.51 95.89 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.418 0.628 . . . . 0.0 109.681 176.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 74.0 tt0 -52.63 -64.37 0.84 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.663 176.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.524 HD11 ' CE2' ' A' ' 93' ' ' TYR . 34.2 tp -62.85 -41.54 99.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.272 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.05 -47.68 83.64 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.054 0.221 . . . . 0.0 111.281 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.44 -42.42 87.67 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.682 0.277 . . . . 0.0 111.042 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.9 mt -65.26 -41.01 90.46 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.229 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -52.83 -30.3 32.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.056 0.455 . . . . 0.0 111.016 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -82.67 -37.61 24.61 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.978 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.24 23.99 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -62.65 -35.09 78.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.764 0.316 . . . . 0.0 111.115 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.35 88.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.605 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -63.27 -43.87 96.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.095 0.474 . . . . 0.0 110.607 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.436 ' NE1' HD13 ' A' ' 140' ' ' ILE . 13.8 m0 -68.7 -31.65 70.9 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.701 0.762 . . . . 0.0 110.136 178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -81.36 -6.6 59.08 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.575 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.68 -51.76 46.39 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.09 -34.23 0.55 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.422 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 60' ' ' TRP . 15.3 m -60.57 -42.58 96.94 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.4 28.87 74.0 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.839 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 11.2 p -75.62 127.43 37.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.112 0.482 . . . . 0.0 111.07 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 18.9 mtm180 -106.39 163.58 12.73 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.715 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 53' ' ' ILE . 61.2 mt -109.05 129.7 55.47 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.09 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.507 HG23 HD13 ' A' ' 96' ' ' LEU . 97.3 mt -101.25 107.01 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 175.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -93.89 113.81 25.91 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.307 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.4 129.49 67.84 Favored 'Isoleucine or valine' 0 C--O 1.253 1.247 0 CA-C-O 121.379 0.609 . . . . 0.0 111.418 -177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 97' ' ' LEU . 39.4 p -83.94 130.47 34.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.311 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.0 pt -72.2 -23.75 21.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.35 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -82.54 147.11 28.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.923 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 89.7 mt-10 -61.48 163.53 6.74 Favored 'General case' 0 C--O 1.214 -0.804 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.491 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -53.13 -39.48 57.92 Favored Glycine 0 C--O 1.23 -0.124 0 N-CA-C 114.778 0.671 . . . . 0.0 114.778 -174.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -63.87 -38.94 92.96 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 117.386 0.593 . . . . 0.0 111.114 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -79.89 -37.24 35.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.306 0.574 . . . . 0.0 110.096 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -65.53 -3.9 5.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.793 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -61.12 -11.21 8.03 Favored 'General case' 0 C--N 1.317 -0.831 0 O-C-N 122.016 -0.427 . . . . 0.0 110.54 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.731 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.0 mttp -96.55 -10.91 26.21 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.387 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 79' ' ' ALA . 14.6 t -66.53 -47.12 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-O 121.668 0.747 . . . . 0.0 111.627 -177.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 17' ' ' ILE . 41.7 mtpt -64.13 -45.06 79.23 Favored Pre-proline 0 C--N 1.302 -1.489 0 CA-C-N 114.954 -1.021 . . . . 0.0 113.054 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.8 Cg_endo -62.08 -29.82 81.78 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 121.115 1.21 . . . . 0.0 111.19 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -63.09 -41.46 99.4 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.24 -42.29 86.02 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.167 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -69.27 -46.56 66.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.355 177.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.41 -37.15 92.5 Favored Glycine 0 CA--C 1.516 0.149 0 CA-C-N 115.905 -0.588 . . . . 0.0 114.123 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -91.37 -11.14 38.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.912 0.356 . . . . 0.0 111.706 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.28 38.83 28.29 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.872 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -82.19 111.8 18.63 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 0.0 110.5 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -97.07 60.38 1.7 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.084 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.524 ' CE2' HD11 ' A' ' 50' ' ' LEU . 6.0 m-85 -138.18 -177.79 4.99 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 116.218 -0.446 . . . . 0.0 109.961 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.98 117.75 31.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.657 ' O ' HG23 ' A' ' 17' ' ' ILE . 12.4 t -99.27 139.27 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.24 -174.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.507 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -125.92 142.89 51.31 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.795 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.613 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.7 mp -113.74 121.56 44.45 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 59.8 t0 -74.04 115.14 13.17 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 118.176 -1.41 . . . . 0.0 107.96 175.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.6 p -96.02 -6.0 39.81 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.962 -177.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -117.65 -39.39 3.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.764 0.316 . . . . 0.0 111.647 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.67 -8.51 68.58 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -175.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.16 -30.66 66.73 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 114.868 -0.666 . . . . 0.0 111.388 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.497 ' O ' ' HG2' ' A' ' 107' ' ' MET . 44.7 t80 -61.43 -43.44 98.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.817 -176.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.28 -42.18 94.91 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.181 0.515 . . . . 0.0 110.265 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 37.1 ttp85 -69.56 -42.31 74.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.86 -42.53 94.78 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.138 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.647 ' SD ' ' HD2' ' A' ' 10' ' ' PRO . 39.2 mmm -84.49 -24.12 29.56 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.629 -0.429 . . . . 0.0 111.204 -178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.425 ' O ' HG21 ' A' ' 129' ' ' THR . 55.5 t30 75.23 100.89 0.07 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.778 0.831 . . . . 0.0 111.041 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 70.8 t -107.04 132.78 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.365 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 p -84.52 -96.01 0.06 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.4 pt? -119.47 3.34 11.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.16 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.2 pt 61.29 151.06 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 124.828 1.251 . . . . 0.0 111.888 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.3 Cg_endo -76.58 157.89 97.48 Favored 'Cis proline' 0 N--CA 1.479 0.633 0 C-N-CA 124.19 -1.171 . . . . 0.0 112.303 -1.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -114.78 136.21 53.33 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 26.2 t -116.67 127.27 74.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.767 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 77.9 m-85 -124.93 113.0 17.27 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 173.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.0 mt -100.68 124.75 54.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 CA-C-O 121.027 0.441 . . . . 0.0 110.049 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.476 HG21 ' HB1' ' A' ' 7' ' ' ALA . 54.1 t -116.87 132.88 65.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.774 -175.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -78.97 164.58 24.28 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.649 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.1 -20.64 50.57 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.612 -0.267 . . . . 0.0 112.984 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -73.57 -5.65 41.61 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.279 0.561 . . . . 0.0 110.196 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.15 19.73 64.26 Favored Glycine 0 CA--C 1.5 -0.863 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.763 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 74.6 mmtt -116.87 151.1 37.29 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.434 HG13 ' HB3' ' A' ' 8' ' ' GLN . 87.3 mt -77.95 127.95 38.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.406 HG11 HD21 ' A' ' 146' ' ' LEU . 10.9 p -104.92 -28.61 2.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.809 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.479 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.7 t80 -141.56 133.19 27.03 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.793 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -137.12 123.78 21.07 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -151.02 111.79 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.987 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 108' ' ' ASN . 19.6 p -93.51 111.63 23.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.136 -178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 83.57 68.11 1.43 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.986 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.608 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.7 p90 -68.86 -39.66 79.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.955 0.407 . . . . 0.0 111.158 178.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 64.2 p 53.31 80.67 0.1 Allowed 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.296 1.038 . . . . 0.0 113.581 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.96 108.51 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.1 0.96 . . . . 0.0 112.776 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.97 -2.77 27.16 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.608 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -72.2 -41.81 52.34 Favored Glycine 0 N--CA 1.437 -1.28 0 CA-C-N 115.1 -0.55 . . . . 0.0 112.783 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.448 ' OE2' ' HB3' ' A' ' 48' ' ' ARG . 1.7 pm0 -53.59 -24.17 13.04 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.61 88.01 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.513 0.673 . . . . 0.0 110.674 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 142' ' ' LYS . 44.5 mt-10 -73.4 -32.3 64.37 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.841 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.78 -47.94 81.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.439 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.436 HD13 ' NE1' ' A' ' 60' ' ' TRP . 8.8 tp -66.57 -33.49 63.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 CA-C-O 120.816 0.341 . . . . 0.0 110.278 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -58.67 -51.59 69.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.779 177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.525 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 31.1 mmmt -68.47 -34.42 75.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.196 -178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.4 t -59.97 -45.37 95.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.045 0.45 . . . . 0.0 110.778 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 36.5 mmt180 -72.83 -29.33 63.15 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.466 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -64.99 -30.02 70.98 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.586 175.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 95.6 mt -60.84 -39.98 91.14 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.319 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 83.5 t -60.62 -46.9 94.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.658 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -67.18 -34.64 77.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.227 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.4 -37.75 87.89 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.29 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -64.43 -49.38 65.62 Favored Glycine 0 C--N 1.328 0.117 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.265 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 155' ' ' HIS . 58.3 m-70 -130.08 99.13 4.96 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.937 0.398 . . . . 0.0 110.464 177.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -70.23 -41.05 74.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.412 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -97.0 91.4 5.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.01 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 63.5 111.02 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.995 0.809 . . . . 0.0 111.431 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 151' ' ' HIS . 38.5 t60 -58.91 -48.99 79.49 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.198 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 7.6 p80 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.356 179.056 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.1 m -146.12 73.36 1.33 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.531 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 72.7 m-85 -101.54 -133.78 0.29 Allowed 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.551 178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -149.45 9.25 0.72 Allowed 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.991 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 47.42 67.69 0.77 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.684 0.754 . . . . 0.0 110.824 -178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 24' ' ' THR . 32.4 mt -118.84 161.5 35.84 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.852 -175.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.12 160.05 46.59 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.706 2.271 . . . . 0.0 111.169 177.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.6 81.25 2.0 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.208 0.528 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t -123.34 136.47 59.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.824 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -98.07 116.2 29.8 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.454 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD22 ' HA ' ' A' ' 98' ' ' ASP . 56.3 mt -123.77 177.19 5.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.928 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 30.2 mmtp -107.18 140.57 39.84 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.769 0.318 . . . . 0.0 110.798 177.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -91.31 -173.47 3.62 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 28.9 pt -67.45 -13.78 17.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -90.03 -10.98 42.87 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.201 0.524 . . . . 0.0 110.144 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.98 19.82 66.59 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -92.8 149.06 21.53 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.7 m -79.35 110.02 14.24 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-O 121.272 0.558 . . . . 0.0 110.187 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 137.07 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.051 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -95.78 133.68 39.61 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.487 HG21 ' CE1' ' A' ' 103' ' ' PHE . 23.6 p -65.86 -32.41 73.91 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.287 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.6 -31.73 73.07 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.951 0.405 . . . . 0.0 110.778 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.575 ' O ' ' HD3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -103.02 8.78 38.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.343 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 36.3 tp -65.91 121.71 15.7 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -177.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -133.27 156.92 46.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.22 0.533 . . . . 0.0 112.002 -174.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.607 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 45.2 t-20 -99.5 -83.23 0.43 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.583 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 170.02 25.27 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 O-C-N 123.92 0.762 . . . . 0.0 110.775 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.47 -2.37 39.75 Favored Glycine 0 C--O 1.225 -0.457 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.233 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -110.08 150.23 41.17 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.408 0.146 . . . . 0.0 110.925 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -68.53 159.88 51.64 Favored 'Trans proline' 0 C--O 1.243 0.727 0 C-N-CA 123.218 2.612 . . . . 0.0 112.782 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.607 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 72.5 mtm -139.83 153.11 46.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.106 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 91.1 mt -128.33 127.71 67.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 177.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.1 mt -99.57 124.56 53.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -113.04 122.75 48.53 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.698 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.648 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 57.9 m-85 -93.85 122.41 36.3 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.55 ' HB2' ' CD2' ' A' ' 47' ' ' LEU . 25.4 p90 -140.38 165.16 28.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 123.502 0.501 . . . . 0.0 111.542 -177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.88 151.37 24.64 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.897 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.45 ' CG2' HG22 ' A' ' 82' ' ' VAL . 9.6 p -78.83 30.67 0.2 Allowed 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -158.37 -33.96 0.07 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.027 0.442 . . . . 0.0 111.086 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 34.2 m -77.92 66.21 3.52 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.478 -178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.439 ' N ' ' HD2' ' A' ' 45' ' ' PRO . 39.6 ttpt -62.72 -50.31 78.51 Favored Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 44' ' ' LYS . 37.8 Cg_endo -67.21 -17.18 50.04 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 122.12 1.88 . . . . 0.0 112.045 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 59.9 m -78.27 -14.64 59.34 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.876 177.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.55 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 15.0 mt -81.17 57.66 3.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.953 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -58.59 -42.35 87.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.551 178.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.554 ' CD ' HG22 ' A' ' 115' ' ' VAL . 75.2 tt0 -55.08 -64.69 0.76 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.959 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.57 HD11 ' CE2' ' A' ' 93' ' ' TYR . 44.0 tp -61.85 -41.15 97.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.6 -175.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.42 -47.84 83.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.98 -42.48 76.48 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.999 0.428 . . . . 0.0 111.304 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.3 mt -64.38 -41.66 93.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.458 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.164 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -52.63 -42.0 64.23 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.711 0.291 . . . . 0.0 110.926 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -65.59 -42.26 91.92 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.183 -0.462 . . . . 0.0 112.17 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.8 m -105.24 15.65 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.25 -38.44 83.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.788 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.33 -37.38 85.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.834 178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.16 -36.24 71.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 110.837 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -69.15 -38.35 78.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.505 0.669 . . . . 0.0 109.553 176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -76.59 -11.13 59.81 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.151 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -60.62 -41.26 94.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.341 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -134.96 -45.51 0.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.802 0.334 . . . . 0.0 110.549 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.13 23.59 77.1 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.83 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -78.83 129.2 37.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.0 0.429 . . . . 0.0 111.379 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.8 mtm-85 -104.77 165.71 10.88 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.47 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 73.9 mt -109.84 140.02 44.26 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -113.8 106.47 20.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -94.28 112.19 23.98 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.28 -176.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.3 p -110.72 132.03 60.28 Favored 'Isoleucine or valine' 0 C--O 1.251 1.175 0 CA-C-O 121.636 0.731 . . . . 0.0 112.229 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.519 ' HB3' HG21 ' A' ' 82' ' ' VAL . 20.8 p -81.29 141.39 34.12 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.692 -1.14 . . . . 0.0 109.871 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.9 pt -95.73 -6.91 9.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.463 1.102 . . . . 0.0 111.09 -178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 72' ' ' SER . 13.9 p-10 -93.88 152.35 18.93 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.1 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -63.13 174.04 1.27 Allowed 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -175.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.33 -42.45 88.91 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 115.277 0.871 . . . . 0.0 115.277 -172.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.9 -46.59 81.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 117.549 0.674 . . . . 0.0 111.012 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -69.62 -41.77 75.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.57 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.76 -6.59 33.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.238 -176.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -64.36 -14.95 59.32 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.346 0.593 . . . . 0.0 109.941 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.747 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 62.9 mttp -94.16 -6.23 45.32 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.873 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 79' ' ' ALA . 51.2 t -63.96 -48.37 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-O 121.569 0.7 . . . . 0.0 111.747 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 19.4 mtpp -68.17 -42.32 29.97 Favored Pre-proline 0 C--N 1.305 -1.326 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.221 -176.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.5 Cg_endo -62.33 -28.99 79.17 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 120.902 1.068 . . . . 0.0 110.783 174.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.5 mt -64.16 -41.69 97.04 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 173.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.428 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -58.49 -45.39 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.677 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.93 -40.68 91.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.301 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.06 88.56 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.821 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -89.42 -14.42 35.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.993 0.396 . . . . 0.0 112.011 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.84 37.96 12.44 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.431 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.428 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 39.3 m0 -79.02 96.44 5.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.84 0.352 . . . . 0.0 110.268 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -84.74 68.67 10.51 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.072 0.463 . . . . 0.0 111.93 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.57 ' CE2' HD11 ' A' ' 50' ' ' LEU . 4.5 m-85 -144.03 177.04 8.84 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.98 113.48 25.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.81 0.814 . . . . 0.0 109.43 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.8 t -83.71 137.3 21.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.005 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 71' ' ' VAL . 12.1 tp -115.63 131.18 57.01 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -176.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 15' ' ' LYS . 6.9 tp -105.71 100.87 10.42 Favored 'General case' 0 C--N 1.285 -2.208 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.301 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.675 ' HA ' HD22 ' A' ' 14' ' ' LEU . 66.3 t0 -77.89 115.22 17.47 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 118.13 -1.428 . . . . 0.0 108.304 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 51.2 p -108.73 -6.04 16.08 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.934 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.409 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 60.4 m-20 -93.71 -41.27 9.78 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.419 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 86.59 8.49 76.98 Favored Glycine 0 N--CA 1.441 -1.028 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.183 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HB2' ' A' ' 100' ' ' ASN . 9.6 p-10 -99.43 -22.31 15.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.199 . . . . 0.0 111.302 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.487 ' CE1' HG21 ' A' ' 24' ' ' THR . 71.4 t80 -62.67 -44.46 96.21 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -64.45 -32.76 74.53 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.326 176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -68.96 -41.55 77.81 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.098 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.43 88.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.35 177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.8 mmt -83.72 -9.4 58.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.431 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 66.9 t30 61.18 47.03 7.47 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.424 0.63 . . . . 0.0 110.654 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.62 96.05 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.112 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.4 m -81.36 -55.34 4.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.537 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.03 147.79 45.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.1 pt -103.43 154.49 37.76 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.1 Cg_endo -77.71 153.45 93.9 Favored 'Cis proline' 0 C--O 1.242 0.718 0 C-N-CA 124.101 -1.208 . . . . 0.0 112.598 0.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.648 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -112.36 123.98 51.47 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.554 HG22 ' CD ' ' A' ' 49' ' ' GLU . 17.9 t -108.4 130.04 61.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-O 121.08 0.467 . . . . 0.0 112.133 -173.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 96.5 m-85 -131.71 112.96 13.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.616 175.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.3 mt -99.91 130.29 49.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.864 0.364 . . . . 0.0 110.395 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 53.5 t -113.46 133.35 59.66 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.779 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -85.29 -175.91 5.91 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.314 0.384 . . . . 0.0 111.269 -177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.29 -31.07 77.93 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.993 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -73.5 -6.0 43.62 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.326 0.584 . . . . 0.0 110.501 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 78.63 35.04 33.39 Favored Glycine 0 N--CA 1.433 -1.546 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.764 178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 47.0 mmtm -126.36 156.33 40.66 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.0 mt -76.54 113.48 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.057 0.456 . . . . 0.0 110.262 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -93.81 -28.56 4.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.913 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.508 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 86.7 t80 -139.23 127.55 22.76 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.507 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -132.06 125.48 31.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -144.87 106.06 4.2 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.64 108.1 18.93 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.035 -177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.18 77.3 1.26 Allowed Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.52 -0.764 . . . . 0.0 114.657 175.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.622 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -104.53 143.54 32.91 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 172.002 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 73.9 p -104.68 -49.5 3.51 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.063 -173.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.64 147.41 25.29 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.689 0.281 . . . . 0.0 111.384 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 68.89 28.41 73.08 Favored Glycine 0 N--CA 1.453 -0.231 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.105 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.3 -33.1 7.83 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.242 -177.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -56.01 -20.64 17.48 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.466 0.706 . . . . 0.0 112.439 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.76 93.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.39 0.614 . . . . 0.0 110.215 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -70.51 -37.35 74.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.373 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.6 mp -61.43 -48.21 82.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.208 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -32.0 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.03 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 39.7 ttmt -61.06 -50.21 74.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.471 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.583 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 45.1 mttp -68.69 -29.86 68.4 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 139' ' ' LEU . 54.5 t -59.31 -45.31 93.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.109 0.48 . . . . 0.0 109.898 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -68.38 -34.35 75.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.404 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 62.7 mm-40 -56.41 -40.88 75.43 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.146 0.498 . . . . 0.0 110.322 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 49.7 mt -64.51 -40.95 96.6 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.593 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 39.9 t -65.21 -23.42 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.587 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -60.51 -23.29 64.43 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -177.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -95.79 -6.17 40.17 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 120.948 0.404 . . . . 0.0 111.828 179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 83.16 -166.58 44.44 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.156 -179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -95.07 -0.77 53.26 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.865 0.364 . . . . 0.0 111.544 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -129.42 -94.7 0.41 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.265 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 24.8 t60 -157.13 129.84 7.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 30.0 t60 57.7 25.0 11.26 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.102 0.477 . . . . 0.0 109.774 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 33.4 p80 48.85 22.4 0.55 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.466 1.106 . . . . 0.0 112.601 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.633 -0.699 . . . . 0.0 110.004 -179.301 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 28' ' ' GLU . 43.4 m -153.33 67.06 0.77 Allowed 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.803 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -88.71 -124.03 0.05 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.067 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.627 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -151.43 16.75 0.72 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.844 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' ' 123' ' ' LYS . 45.2 tt0 50.93 41.49 27.07 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.802 0.81 . . . . 0.0 110.418 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 65.7 mt -87.74 155.74 53.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.085 -175.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.71 156.85 55.04 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.302 2.668 . . . . 0.0 110.875 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.69 84.59 3.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.008 0.432 . . . . 0.0 111.671 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.18 138.84 53.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.158 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.0 p -90.83 113.62 25.82 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.353 0.597 . . . . 0.0 111.776 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 98' ' ' ASP . 6.1 mp -107.41 167.22 10.09 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.196 178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -112.45 125.87 54.7 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -87.54 -169.15 2.48 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.87 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.418 HG22 ' HZ2' ' A' ' 83' ' ' LYS . 26.4 pt -75.48 -12.76 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.537 -176.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -88.26 -11.74 45.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.067 0.461 . . . . 0.0 110.732 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.08 14.34 72.27 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -92.43 141.57 28.38 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.022 -0.589 . . . . 0.0 110.103 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.6 m -77.58 117.7 19.27 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.774 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 m -118.0 162.32 16.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.286 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.572 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 49.0 mt-30 -119.77 132.33 55.59 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.419 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.8 p -67.37 -32.25 73.04 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -63.26 -36.91 85.24 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 120.896 0.379 . . . . 0.0 111.021 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -103.46 12.5 35.12 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.597 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.83 123.15 30.13 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.232 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 5' ' ' THR . 8.1 pt-20 -148.03 162.61 39.01 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.656 175.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' H ' ' HE2' ' A' ' 34' ' ' MET . 8.5 t30 -85.74 -71.93 0.51 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.113 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.64 47.23 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.183 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.453 ' HA2' ' CB ' ' A' ' 5' ' ' THR . . . 80.08 26.86 54.56 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.24 -0.981 . . . . 0.0 112.903 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -122.94 151.66 61.54 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 122.22 0.208 . . . . 0.0 111.018 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.34 155.01 60.98 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.929 2.419 . . . . 0.0 111.403 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.533 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 20.5 mtt -139.99 165.45 27.31 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.603 -171.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.645 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 82.5 mt -138.03 125.22 28.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 84.3 mt -101.83 131.2 50.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.961 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.2 m -118.93 122.63 42.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.925 0.393 . . . . 0.0 111.234 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.709 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 54.4 m-85 -94.45 125.82 39.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.249 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.419 ' CZ ' HG13 ' A' ' 82' ' ' VAL . 32.0 p90 -137.87 169.82 17.13 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 123.722 0.639 . . . . 0.0 111.086 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.77 -169.24 1.89 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.774 -177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -41.88 79.05 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.573 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -148.65 101.2 3.19 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.418 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 46' ' ' CYS . 47.9 t -152.26 153.39 33.66 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.855 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 51.4 mtmt -132.45 -62.78 0.02 OUTLIER Pre-proline 0 CA--C 1.56 1.345 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.524 ' HD2' ' H ' ' A' ' 44' ' ' LYS . 56.3 Cg_endo -70.27 -22.24 30.0 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.474 2.116 . . . . 0.0 114.157 -174.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.669 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 64.8 m -72.5 -21.46 61.2 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.6 68.78 9.95 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -61.5 -45.67 93.26 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.659 -175.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -74.29 -44.94 50.68 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -177.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.3 tp -61.6 -41.99 98.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.256 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.82 -47.0 82.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.743 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.66 -48.42 72.17 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 120.985 0.422 . . . . 0.0 111.368 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.3 mt -63.82 -30.92 51.21 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.537 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.367 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -59.1 -38.53 79.73 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.161 0.505 . . . . 0.0 110.485 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -73.89 -39.72 63.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.781 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -107.03 17.76 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 89.3 t80 -59.75 -37.83 80.08 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 122.433 0.293 . . . . 0.0 111.701 -177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.07 81.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.757 0.313 . . . . 0.0 110.825 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -66.09 -41.91 90.03 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.924 0.392 . . . . 0.0 111.41 178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -68.83 -34.91 76.27 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.521 0.677 . . . . 0.0 110.748 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 66' ' ' VAL . 6.2 mm-40 -85.15 -7.1 59.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.73 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.24 -60.62 3.07 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.87 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.23 -32.68 1.56 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.19 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 m -61.78 -41.51 97.82 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.38 32.09 29.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.165 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 61' ' ' GLN . 7.5 t -67.94 122.55 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.204 0.526 . . . . 0.0 111.936 -178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -110.14 129.85 55.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.666 178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.645 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 39.8 mt -97.53 142.96 28.72 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.307 0.575 . . . . 0.0 111.642 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.466 HG23 HD13 ' A' ' 96' ' ' LEU . 91.4 mt -123.75 116.88 49.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.8 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -98.8 115.63 29.23 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 5.5 p -123.14 127.45 74.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 121.43 0.633 . . . . 0.0 111.145 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.0 t -90.14 148.76 22.78 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.703 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 44.3 pt -71.29 -17.69 19.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.804 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -87.26 164.77 16.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.973 0.416 . . . . 0.0 111.757 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.792 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 3.4 pt-20 -92.65 -88.75 0.21 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -175.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.533 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -119.92 -68.86 0.3 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.14 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -41.41 -65.36 0.45 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.588 0.755 . . . . 0.0 112.168 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -66.37 -41.71 89.06 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.002 0.43 . . . . 0.0 112.144 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -71.38 -2.35 16.16 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 98.2 mt-30 -57.36 -21.62 36.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.932 0.396 . . . . 0.0 111.068 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.731 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 59.2 mttp -83.55 -12.82 55.69 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 122.853 0.461 . . . . 0.0 111.417 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 85' ' ' LEU . 58.4 t -64.69 -48.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-O 121.52 0.676 . . . . 0.0 112.504 -175.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.7 OUTLIER -69.02 -39.77 14.14 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 6.6 Cg_endo -59.77 -32.07 94.99 Favored 'Trans proline' 0 C--N 1.357 1.025 0 CA-C-N 120.074 1.062 . . . . 0.0 110.002 174.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 92.5 mt -63.73 -41.78 97.99 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 174.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.439 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -55.48 -45.49 76.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.343 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -73.68 -46.47 46.25 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.244 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -62.75 -45.23 96.19 Favored Glycine 0 C--O 1.224 -0.511 0 CA-C-N 116.076 -0.511 . . . . 0.0 113.255 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -76.09 -30.66 58.37 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.681 0.277 . . . . 0.0 111.404 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.42 46.84 3.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.06 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.5 m0 -80.99 117.58 21.72 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.885 0.374 . . . . 0.0 110.497 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -96.13 27.13 3.8 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.724 0.773 . . . . 0.0 109.863 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.628 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.3 OUTLIER -117.78 -179.97 3.9 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.855 -177.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -84.77 128.79 34.78 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.024 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.485 ' C ' HD12 ' A' ' 96' ' ' LEU . 24.3 t -106.98 128.24 61.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.071 -177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.485 HD12 ' C ' ' A' ' 95' ' ' VAL . 9.6 mp -130.47 148.52 52.29 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.259 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.561 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.3 mp -118.06 124.97 49.39 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.792 ' O ' ' HA ' ' A' ' 75' ' ' GLU . 65.8 t0 -67.65 113.42 5.43 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 118.981 -1.087 . . . . 0.0 108.258 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.7 t -89.81 -6.39 55.96 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.861 -175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -104.94 -27.0 11.95 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 120.955 0.407 . . . . 0.0 110.34 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.51 21.4 79.55 Favored Glycine 0 N--CA 1.439 -1.108 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -113.66 -20.62 11.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.637 -0.281 . . . . 0.0 111.286 -176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 24' ' ' THR . 45.3 t80 -62.91 -39.75 95.48 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -177.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 105' ' ' ARG . 18.9 ptpt -52.16 -47.04 65.67 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.252 173.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.49 ' N ' ' HG3' ' A' ' 104' ' ' LYS . 50.0 mtm-85 -71.89 -40.25 69.03 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.076 -178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.75 -42.16 88.18 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.495 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 33.3 mmm -92.64 -10.72 36.34 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.445 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 62.11 88.24 0.09 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.761 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 112' ' ' ILE . 66.7 t -92.88 129.76 42.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.251 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 37.3 t -79.28 -95.72 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.648 ' O ' HG12 ' A' ' 112' ' ' ILE . 2.5 pt? -116.14 6.09 13.89 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.405 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 111' ' ' LEU . 3.6 pt 61.1 152.24 0.1 Allowed Pre-proline 0 N--CA 1.49 1.541 0 C-N-CA 124.579 1.151 . . . . 0.0 111.06 -175.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 87.0 Cg_endo -75.58 160.44 96.05 Favored 'Cis proline' 0 CA--C 1.546 1.099 0 C-N-CA 124.794 -0.919 . . . . 0.0 112.973 0.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.709 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.7 131.74 54.71 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.534 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.2 t -116.73 129.38 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.803 0.335 . . . . 0.0 111.19 -177.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 80.8 m-85 -127.71 115.25 18.43 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 175.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.626 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 68.3 mt -100.52 132.74 45.59 Favored 'Isoleucine or valine' 0 C--O 1.249 1.036 0 CA-C-O 121.271 0.558 . . . . 0.0 110.468 -178.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.533 ' HB ' ' H ' ' A' ' 34' ' ' MET . 57.1 t -106.43 126.85 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.86 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.483 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 7.9 t70 -70.7 162.18 29.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 124.479 1.112 . . . . 0.0 110.56 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.07 -20.61 35.39 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 116.471 -0.331 . . . . 0.0 113.807 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 54.6 m-80 -86.76 7.01 28.65 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.972 0.415 . . . . 0.0 111.181 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 73.22 40.86 48.6 Favored Glycine 0 CA--C 1.503 -0.696 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.42 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HD2' ' OE1' ' A' ' 8' ' ' GLN . 49.4 mmtm -134.56 152.77 52.01 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.627 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.7 mt -70.03 127.07 31.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.609 -0.437 . . . . 0.0 109.899 178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.4 p -118.9 -17.34 7.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.659 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.626 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 74.9 t80 -150.11 128.51 12.16 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.591 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -126.88 120.88 30.28 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.343 0.592 . . . . 0.0 110.654 177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.53 101.37 7.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 3.5 p -98.29 106.47 18.76 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.341 0.591 . . . . 0.0 112.238 -176.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.2 64.8 2.32 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-N 115.235 -0.893 . . . . 0.0 113.542 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.419 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 1.2 p90 -96.31 154.99 16.95 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p -142.77 89.99 2.18 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.253 -176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 69.04 131.67 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.83 2.48 75.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.784 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.52 -22.3 29.41 Favored Glycine 0 N--CA 1.437 -1.276 0 C-N-CA 121.063 -0.589 . . . . 0.0 112.513 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.443 ' H ' ' CD ' ' A' ' 136' ' ' GLU . 1.4 mp0 -58.76 -38.49 78.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.412 0.625 . . . . 0.0 109.835 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -60.81 -39.08 87.63 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.948 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.85 -38.53 83.28 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.637 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.653 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -63.04 -50.39 70.83 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.373 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.3 tp -66.92 -38.48 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.321 0 CA-C-O 121.144 0.497 . . . . 0.0 110.928 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -60.89 -45.73 93.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.904 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 18.6 tptm -66.14 -30.81 71.36 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.526 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 139' ' ' LEU . 95.4 t -64.75 -41.95 93.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.936 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -73.85 -24.29 59.74 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.33 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -61.44 -39.23 90.05 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 60.8 mt -61.63 -41.11 97.04 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.238 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.49 -44.67 98.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.308 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 58.3 mtmt -64.95 -35.97 82.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.473 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -63.68 -38.95 93.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.903 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -95.64 92.97 1.51 Allowed Glycine 0 C--O 1.236 0.273 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.427 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -116.44 -34.53 4.56 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.927 0.394 . . . . 0.0 111.57 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -111.17 141.32 44.83 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.818 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 63.0 -85.66 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.288 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -133.64 -60.87 0.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.86 0.362 . . . . 0.0 110.387 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -134.12 21.48 3.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.25 0.547 . . . . 0.0 109.718 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.018 -178.438 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 p30 . . . . . 0 CA--C 1.515 -0.384 0 CA-C-O 121.363 0.602 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.418 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 14.7 m -94.49 68.47 3.49 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.697 -178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 28' ' ' GLU . 91.5 m-85 -74.52 -112.64 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.215 0.531 . . . . 0.0 110.609 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.606 ' HB3' HD13 ' A' ' 9' ' ' LEU . . . -173.08 -7.7 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.329 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.409 ' H ' ' H ' ' A' ' 7' ' ' ALA . 56.6 tp60 69.12 62.16 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.399 0.68 . . . . 0.0 111.14 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.606 HD13 ' HB3' ' A' ' 7' ' ' ALA . 10.5 mp -116.15 159.92 37.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.029 -178.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -67.96 158.39 57.55 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.814 2.343 . . . . 0.0 110.816 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.92 81.09 2.16 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.092 0.472 . . . . 0.0 111.161 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -124.57 133.37 69.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.328 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 28.8 m -89.41 110.28 21.11 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.591 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 98' ' ' ASP . 29.8 mt -107.3 173.25 6.41 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.924 0.392 . . . . 0.0 109.974 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -112.59 127.63 56.14 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.474 HD21 ' HB3' ' A' ' 20' ' ' LYS . 3.8 p30 -98.0 -176.62 3.49 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.431 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.3 pt -61.57 -22.59 28.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -81.14 -8.26 59.73 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.181 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.24 14.94 81.69 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' HB3' HD21 ' A' ' 16' ' ' ASN . 87.6 tttt -99.84 139.27 35.75 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 114.782 -0.709 . . . . 0.0 109.564 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.6 m -74.48 118.6 17.62 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.315 0.579 . . . . 0.0 110.209 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 m -120.86 130.74 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.712 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 71.5 mt-30 -92.0 134.02 35.19 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.457 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -66.16 -29.3 69.56 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -64.63 -34.84 79.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.323 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -101.39 6.09 42.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.646 -178.257 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.73 122.03 28.53 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -134.87 153.52 52.02 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.89 178.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.583 ' OD1' ' HB2' ' A' ' 32' ' ' LYS . 23.7 t-20 -79.91 -80.77 0.13 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.338 -177.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 171.87 28.58 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.788 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.418 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 95.3 0.26 63.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.491 -176.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.583 ' HB2' ' OD1' ' A' ' 29' ' ' ASN . 1.4 mptm? -104.48 150.75 38.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.787 0.327 . . . . 0.0 110.548 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.2 159.58 33.3 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.967 2.445 . . . . 0.0 111.496 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.57 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 74.1 mtm -141.09 159.53 42.02 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-O 120.781 0.324 . . . . 0.0 111.795 -175.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.439 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.2 mt -128.09 124.86 63.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 79.5 mt -97.99 119.88 46.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 m -107.7 121.56 44.94 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.281 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 58.5 m-85 -94.27 117.75 30.57 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.877 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.49 ' HB2' HD21 ' A' ' 47' ' ' LEU . 26.5 p90 -138.48 165.47 26.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 123.856 0.722 . . . . 0.0 111.588 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.35 164.09 13.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.521 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.5 p -64.93 118.63 9.35 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.477 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.9 t30 63.67 87.68 0.11 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.403 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 19.7 p -156.64 151.0 25.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.009 -0.996 . . . . 0.0 108.528 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.473 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 24.1 ttpp -139.46 -51.73 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 44' ' ' LYS . 36.0 Cg_exo -60.45 -31.05 92.07 Favored 'Trans proline' 0 C--N 1.372 1.791 0 C-N-CA 122.154 1.902 . . . . 0.0 111.699 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 54.0 t -69.82 -16.32 63.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.409 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 39' ' ' PHE . 18.9 mt -98.95 52.47 0.97 Allowed 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.664 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -61.33 -38.9 88.55 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.368 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 53' ' ' ILE . 12.3 pt-20 -60.01 -51.74 68.35 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.045 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.482 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 40.8 tp -63.08 -41.08 99.35 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.402 -177.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -59.92 -48.78 80.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.474 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.19 -41.64 70.04 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.845 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 49' ' ' GLU . 61.9 mt -63.76 -41.54 92.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.113 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -52.83 -36.38 58.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.014 0.435 . . . . 0.0 110.361 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.82 -46.73 67.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.883 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.16 25.65 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -59.45 -40.56 87.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.868 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.97 -39.93 93.83 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.752 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.12 -41.0 97.4 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.903 0.382 . . . . 0.0 111.236 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.407 ' NE1' HD13 ' A' ' 140' ' ' ILE . 17.4 m0 -66.84 -38.52 86.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.252 0.548 . . . . 0.0 110.201 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.444 ' HA ' ' HA2' ' A' ' 65' ' ' GLY . 30.1 mm-40 -70.17 -21.51 63.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.216 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -59.59 -48.88 79.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.625 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -104.59 -68.55 0.85 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-O 121.265 0.555 . . . . 0.0 111.859 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.1 m -63.73 -32.36 73.83 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.846 -176.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . 62.6 41.01 99.85 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.052 -177.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.54 132.44 35.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.085 0.469 . . . . 0.0 112.253 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.403 ' HG2' ' NE2' ' A' ' 61' ' ' GLN . 13.2 mtm180 -104.9 163.6 12.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.481 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 58.8 mt -110.86 138.1 47.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.188 0.518 . . . . 0.0 111.398 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.496 HG23 HD13 ' A' ' 96' ' ' LEU . 87.9 mt -110.78 110.48 32.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 176.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -96.16 116.05 28.38 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 12.9 p -121.59 131.69 72.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.055 0 CA-C-O 121.478 0.656 . . . . 0.0 112.178 -176.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.475 ' CB ' HG21 ' A' ' 82' ' ' VAL . 23.3 p -86.38 134.93 33.68 Favored 'General case' 0 C--O 1.256 1.403 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.07 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.443 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 43.1 pt -86.49 -5.17 9.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.238 -178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 15.1 m-20 -95.82 157.48 15.88 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.766 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -63.17 179.71 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 123.689 0.618 . . . . 0.0 112.565 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.47 -45.3 95.76 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 114.526 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -61.38 -46.08 91.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.371 0.605 . . . . 0.0 110.758 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.459 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 14.3 m120 -67.0 -39.17 87.05 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.903 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.582 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -68.27 -9.77 49.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.601 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.29 -22.32 52.33 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.04 0.448 . . . . 0.0 110.74 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.75 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 97.8 mttt -89.41 -13.7 37.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.699 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.582 HG23 ' HA ' ' A' ' 79' ' ' ALA . 61.2 t -64.6 -50.2 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 CA-C-O 121.497 0.665 . . . . 0.0 112.549 -174.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 3.3 mtpm? -68.52 -42.26 26.43 Favored Pre-proline 0 C--N 1.301 -1.527 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -175.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.7 Cg_endo -61.41 -29.56 85.62 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.014 1.143 . . . . 0.0 110.821 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.9 mt -63.43 -42.28 98.7 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.427 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -58.07 -46.4 85.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.748 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -65.74 -45.76 81.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.994 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.71 -41.57 88.94 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 115.883 -0.599 . . . . 0.0 113.536 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -87.76 -3.12 58.97 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 46.17 45.76 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.386 177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.427 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 53.8 m0 -82.78 100.99 10.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.408 0.623 . . . . 0.0 110.655 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -84.71 47.05 1.32 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.021 -177.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 1.8 m-85 -138.32 175.95 9.13 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -82.88 126.42 32.44 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 121.146 0.498 . . . . 0.0 109.87 177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.7 t -110.9 131.61 61.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.07 0.462 . . . . 0.0 110.102 -176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.496 HD13 HG23 ' A' ' 69' ' ' ILE . 10.9 mp -121.17 134.29 55.21 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.683 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.9 mp -110.18 115.9 30.55 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.476 ' HA ' HD22 ' A' ' 14' ' ' LEU . 45.8 t0 -79.0 114.8 18.24 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 117.799 -1.56 . . . . 0.0 109.158 175.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 p -85.63 -13.06 49.85 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.194 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -90.42 -45.65 8.86 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.223 0.535 . . . . 0.0 110.948 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.436 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 89.8 8.85 66.88 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -174.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -96.24 -25.06 15.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.441 -0.88 . . . . 0.0 111.766 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 24' ' ' THR . 62.3 t80 -61.47 -43.85 98.14 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.652 0.263 . . . . 0.0 111.268 -175.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.443 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 22.9 pttp -58.92 -40.11 83.57 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.305 177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -71.07 -41.85 70.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.972 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.08 -48.55 81.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.37 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -76.67 -25.33 53.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.069 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.52 95.22 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.228 1.011 . . . . 0.0 111.966 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.68 115.7 50.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.169 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.2 p -82.77 -57.98 3.08 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.683 0.754 . . . . 0.0 110.076 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 46.3 tp -130.57 134.47 47.04 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.625 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 39.8 pt -87.59 151.36 50.33 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.567 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.8 Cg_endo -82.88 161.55 74.99 Favored 'Cis proline' 0 CA--C 1.538 0.712 0 C-N-CA 124.111 -1.204 . . . . 0.0 112.704 0.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.61 136.65 54.76 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.759 -0.377 . . . . 0.0 110.448 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.6 t -119.44 124.97 73.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 CA-C-O 120.889 0.376 . . . . 0.0 111.188 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.432 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 61.1 m-85 -122.05 118.04 27.78 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 62.0 mt -105.86 130.47 57.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.153 0.501 . . . . 0.0 111.0 -178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.464 HG21 ' HB1' ' A' ' 7' ' ' ALA . 53.3 t -104.87 135.2 43.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.988 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 125' ' ' VAL . 3.2 p-10 -87.66 -174.73 4.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.187 0.518 . . . . 0.0 111.014 -178.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.12 -18.43 69.07 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.414 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -88.86 -4.34 58.5 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 122.545 -0.386 . . . . 0.0 110.981 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . 84.39 28.94 31.64 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.336 178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 122' ' ' GLY . 2.0 mppt? -124.21 154.09 40.65 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.161 0.505 . . . . 0.0 111.481 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.0 mt -70.59 99.51 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.246 179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.433 HG11 HD21 ' A' ' 146' ' ' LEU . 7.2 p -83.87 -31.49 8.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.64 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.618 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.1 t80 -130.67 129.06 42.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.535 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -132.36 121.93 24.26 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -146.37 102.01 3.55 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.414 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 36.3 p -94.81 116.15 28.38 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.527 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 97.02 50.75 1.72 Allowed Glycine 0 N--CA 1.435 -1.398 0 C-N-CA 120.34 -0.934 . . . . 0.0 114.109 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.567 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.5 OUTLIER -81.64 138.52 35.3 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 174.363 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.0 p -123.35 -16.11 6.97 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.026 -1.07 . . . . 0.0 113.372 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -140.5 -101.63 0.15 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -81.35 30.13 2.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 121.272 -0.49 . . . . 0.0 113.955 -175.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.77 -25.65 74.05 Favored Glycine 0 C--N 1.318 -0.455 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.053 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -57.6 -29.72 64.72 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 123.232 0.613 . . . . 0.0 110.626 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.58 -40.19 96.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.06 -35.12 77.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.579 -178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.733 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -61.22 -53.58 55.09 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.29 179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.407 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.1 tp -67.75 -39.08 81.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.089 0.471 . . . . 0.0 111.395 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.578 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 34.1 ttpt -59.06 -48.4 81.74 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.469 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.532 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 39.9 tptt -67.79 -30.97 70.54 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.216 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 139' ' ' LEU . 48.0 t -58.15 -44.46 87.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.535 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 21.3 mtp180 -77.14 -24.85 51.56 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.029 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 52.0 mm-40 -64.04 -33.71 76.36 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.198 0.523 . . . . 0.0 110.135 177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 88.8 mt -63.11 -41.79 99.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.068 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.8 t -69.18 -26.41 31.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.57 0.7 . . . . 0.0 110.236 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -66.62 -30.88 71.25 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.239 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -63.56 -38.44 91.13 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.781 0.324 . . . . 0.0 111.63 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.41 -114.73 4.36 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.243 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 71.9 -30.76 0.21 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.187 0.995 . . . . 0.0 112.779 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -57.72 -43.48 85.28 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.084 0.468 . . . . 0.0 109.984 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -124.12 80.25 1.81 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 33.7 p80 47.83 -164.33 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.091 0.956 . . . . 0.0 112.013 -176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -98.0 120.26 38.08 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.151 179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 118.32 -0.848 . . . . 0.0 110.287 -179.299 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 CA--C 1.511 -0.535 0 CA-C-O 121.316 0.579 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.666 ' O ' ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -86.26 128.76 34.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.992 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -151.79 -140.21 0.09 Allowed 'General case' 0 CA--C 1.491 -1.324 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -141.74 14.85 2.13 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.407 ' HB3' HG13 ' A' ' 124' ' ' ILE . 51.5 tt0 49.94 51.07 17.31 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.763 0.792 . . . . 0.0 109.964 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.404 HD13 ' HB ' ' A' ' 24' ' ' THR . 78.6 mt -106.66 154.71 39.88 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.327 -174.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.87 152.57 78.17 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.499 2.799 . . . . 0.0 110.913 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.96 87.05 0.72 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.131 0.491 . . . . 0.0 111.565 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 81.7 t -126.31 136.54 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.222 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.8 m -96.98 112.89 24.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.782 0.325 . . . . 0.0 110.789 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 98' ' ' ASP . 53.2 mt -116.48 176.55 5.06 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -105.33 139.86 39.33 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.472 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.7 p30 -92.73 -175.14 3.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.285 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 30.6 pt -68.73 -11.37 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.836 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.91 -15.54 27.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.41 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.27 15.85 61.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.818 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -99.99 146.29 26.89 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -73.73 120.16 18.94 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.469 0.652 . . . . 0.0 110.716 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.71 131.39 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.577 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.611 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.6 mt-30 -92.28 134.57 34.78 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.436 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 103' ' ' PHE . 7.1 p -67.28 -21.58 65.69 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -79.57 -9.9 59.7 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 121.0 0.429 . . . . 0.0 110.495 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.25 16.09 7.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.67 -178.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 42.3 tp -99.76 125.88 45.74 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.746 -176.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.666 ' HB3' ' O ' ' A' ' 5' ' ' THR . 3.9 pt-20 -141.91 158.65 43.52 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.084 177.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.46 HD22 ' HB2' ' A' ' 32' ' ' LYS . 37.0 t30 -81.14 -71.5 0.47 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.64 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 176.09 38.96 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.448 0.467 . . . . 0.0 110.963 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.6 ' HA2' HG21 ' A' ' 5' ' ' THR . . . 91.83 4.06 67.73 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.042 -177.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.46 ' HB2' HD22 ' A' ' 29' ' ' ASN . 1.0 OUTLIER -107.64 151.73 41.17 Favored Pre-proline 0 C--N 1.324 -0.513 0 C-N-CA 122.652 0.381 . . . . 0.0 110.387 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.534 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.2 Cg_exo -66.91 155.67 69.69 Favored 'Trans proline' 0 C--O 1.244 0.819 0 C-N-CA 122.994 2.463 . . . . 0.0 112.343 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 65.4 mtm -138.97 149.33 44.6 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.65 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.43 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 89.7 mt -127.88 126.11 66.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.478 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 77.4 mt -91.52 126.89 44.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.168 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.8 m -111.03 112.96 25.15 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.181 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.566 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 40.7 m-85 -86.98 109.46 19.39 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 173.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.61 ' HB2' HD22 ' A' ' 47' ' ' LEU . 28.5 p90 -126.21 157.07 39.15 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.853 0.721 . . . . 0.0 110.872 -175.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.96 147.66 34.84 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.803 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 m -63.07 -43.39 98.73 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.251 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -124.44 27.5 6.96 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.486 ' HG ' ' HG ' ' A' ' 46' ' ' CYS . 17.6 t -133.59 135.38 44.22 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.174 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' H ' ' HD2' ' A' ' 45' ' ' PRO . 95.9 mttt -101.75 -47.83 0.19 Allowed Pre-proline 0 CA--C 1.564 1.481 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.51 ' HD2' ' H ' ' A' ' 44' ' ' LYS . 29.6 Cg_endo -64.12 -22.1 67.6 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.187 1.924 . . . . 0.0 113.225 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.493 ' O ' ' HD3' ' A' ' 113' ' ' PRO . 71.3 m -76.0 -15.71 60.1 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.986 0.422 . . . . 0.0 110.227 176.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.61 HD22 ' HB2' ' A' ' 39' ' ' PHE . 9.6 mt -90.31 61.01 4.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.0 -178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 132' ' ' THR . 27.0 mmt180 -61.1 -43.39 98.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.268 0.556 . . . . 0.0 109.842 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' HG13 ' A' ' 53' ' ' ILE . 3.8 tm-20 -63.66 -55.13 25.89 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.474 -178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD11 ' CE2' ' A' ' 93' ' ' TYR . 35.5 tp -62.71 -40.85 98.45 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.61 -177.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.94 -48.17 77.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.639 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -44.45 93.23 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.043 0.449 . . . . 0.0 110.868 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.586 HG21 HD11 ' A' ' 68' ' ' LEU . 62.6 mt -64.05 -41.34 92.16 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.379 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.77 178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.688 ' OE1' ' HA ' ' A' ' 91' ' ' TRP . 26.3 tp60 -51.83 -40.61 60.77 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.801 0.334 . . . . 0.0 111.238 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -70.42 -41.57 72.74 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.974 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.06 19.13 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -59.78 -34.4 72.96 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.6 84.92 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.836 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -67.86 -40.39 83.65 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.981 0.419 . . . . 0.0 110.694 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.469 ' NE1' HD13 ' A' ' 140' ' ' ILE . 15.3 m0 -67.27 -38.35 84.97 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.384 0.611 . . . . 0.0 110.405 178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -81.97 -8.8 59.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.391 178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.3 -49.23 78.44 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.876 -178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -152.19 64.51 0.83 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.369 0.604 . . . . 0.0 110.706 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.8 m -161.9 -39.74 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.613 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.0 21.08 76.94 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.662 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.2 p -81.93 125.57 39.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.066 0.46 . . . . 0.0 111.888 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 25.5 mtm180 -108.46 158.14 17.8 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.233 177.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.586 HD11 HG21 ' A' ' 53' ' ' ILE . 42.8 mt -99.02 134.16 42.26 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.021 0.438 . . . . 0.0 110.843 178.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.608 HG23 HD13 ' A' ' 96' ' ' LEU . 90.8 mt -102.75 101.1 11.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -88.54 122.89 32.5 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.16 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' LEU . 8.1 p -120.54 130.5 74.41 Favored 'Isoleucine or valine' 0 C--O 1.256 1.412 0 CA-C-O 121.594 0.711 . . . . 0.0 111.769 -178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.637 ' HB3' HG21 ' A' ' 82' ' ' VAL . 24.1 p -83.37 132.01 35.02 Favored 'General case' 0 C--O 1.261 1.677 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.898 178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.524 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 45.1 pt -87.49 19.06 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 O-C-N 125.369 1.668 . . . . 0.0 113.858 -173.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -122.38 -159.26 0.82 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.733 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.527 ' HB2' HE22 ' A' ' 77' ' ' GLN . 49.2 mt-10 -96.17 179.83 4.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.749 0.309 . . . . 0.0 110.381 178.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.563 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . -61.84 -43.32 99.38 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 114.885 0.714 . . . . 0.0 114.885 -175.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.527 HE22 ' HB2' ' A' ' 75' ' ' GLU . 6.0 pm0 -64.38 -41.78 96.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 117.648 0.724 . . . . 0.0 112.306 -177.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -77.03 -38.84 52.01 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.873 0.368 . . . . 0.0 111.549 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -71.46 -5.66 34.61 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 86.3 mm-40 -60.75 -24.1 65.47 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.919 -0.488 . . . . 0.0 110.722 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.699 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 30.6 mtpp -84.05 -9.83 58.32 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.725 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.637 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.6 t -65.75 -48.23 83.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.698 0.761 . . . . 0.0 112.53 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 7.9 mtpm? -66.65 -41.85 41.71 Favored Pre-proline 0 C--N 1.295 -1.791 0 CA-C-N 115.025 -0.988 . . . . 0.0 113.144 -176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.2 Cg_endo -62.9 -28.99 75.74 Favored 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 121.175 1.25 . . . . 0.0 110.884 174.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 97.5 mt -62.51 -42.84 99.78 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 174.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -58.92 -43.42 91.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.797 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.85 -46.4 53.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.459 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.29 -43.99 94.32 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.197 -0.525 . . . . 0.0 113.439 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -75.33 -23.95 57.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.797 0.332 . . . . 0.0 111.153 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.09 37.7 28.2 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.728 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.688 ' HA ' ' OE1' ' A' ' 54' ' ' GLN . 26.4 m0 -59.67 -42.28 92.53 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 66.13 27.3 10.49 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.611 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 6.1 m-85 -111.91 -167.65 1.21 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 120.062 -0.655 . . . . 0.0 109.475 176.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -104.3 129.21 52.16 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.1 t -111.78 134.51 53.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.496 0.665 . . . . 0.0 111.954 -172.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.608 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -114.32 133.94 55.31 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.343 178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 76' ' ' GLY . 10.4 tt -108.71 111.85 23.84 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.253 -176.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.617 ' HA ' HD22 ' A' ' 14' ' ' LEU . 68.2 t0 -80.12 128.19 33.21 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.271 174.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -110.09 0.65 18.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.991 -177.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -114.23 -36.2 4.76 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.979 0.419 . . . . 0.0 110.439 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.425 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 87.41 7.61 75.82 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -87.02 -21.97 25.78 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.554 ' CE1' HG21 ' A' ' 24' ' ' THR . 52.3 t80 -64.15 -35.42 80.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.033 0.444 . . . . 0.0 110.22 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.524 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 52.1 mtmt -59.8 -44.84 93.78 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.55 177.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -71.1 -37.96 72.37 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.07 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.56 82.08 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.173 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 45.5 mmm -91.64 -10.4 40.47 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.244 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 64.71 69.25 0.51 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.379 0.609 . . . . 0.0 110.466 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.86 120.97 51.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.805 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.3 t -95.79 -75.88 0.51 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.227 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.499 HD21 HG22 ' A' ' 132' ' ' THR . 41.6 tp -98.26 160.73 14.1 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 19.2 pt -116.05 153.05 48.33 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.562 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 91.2 Cg_endo -79.56 156.9 89.71 Favored 'Cis proline' 0 C--O 1.241 0.656 0 C-N-CA 123.882 -1.299 . . . . 0.0 112.801 1.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -113.17 135.13 54.15 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.465 HG22 ' HG3' ' A' ' 49' ' ' GLU . 22.1 t -120.29 131.45 72.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -173.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.478 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 89.7 m-85 -126.73 112.83 15.88 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 173.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.5 mt -99.82 123.17 52.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 CA-C-O 120.964 0.411 . . . . 0.0 110.247 -178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 68.5 t -104.76 127.95 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.867 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.401 ' OD1' HD22 ' A' ' 146' ' ' LEU . 10.2 t70 -70.05 163.01 27.09 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 110.952 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -18.33 43.89 Favored Glycine 0 CA--C 1.527 0.808 0 CA-C-N 116.13 -0.486 . . . . 0.0 113.473 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -86.6 1.57 51.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.813 0.307 . . . . 0.0 111.085 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 83.55 26.38 43.01 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.988 -0.625 . . . . 0.0 114.005 176.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -124.98 157.0 37.19 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.943 0.372 . . . . 0.0 110.056 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 8' ' ' GLN . 96.2 mt -79.4 115.37 21.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.138 0.494 . . . . 0.0 110.055 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 146' ' ' LEU . 7.8 p -94.67 -38.08 8.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.15 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.438 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 72.0 t80 -134.26 128.73 34.45 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.203 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -131.21 128.93 40.95 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 120.962 0.411 . . . . 0.0 110.219 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 12.7 t60 -138.38 102.85 4.74 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.41 102.65 15.39 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 121.199 0.523 . . . . 0.0 111.911 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 86.17 105.45 0.75 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 115.659 -0.7 . . . . 0.0 114.653 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.562 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 3.6 p90 -138.23 163.78 30.88 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 171.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.662 ' O ' ' HG3' ' A' ' 48' ' ' ARG . 69.7 p -109.62 -42.28 4.34 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.337 -0.945 . . . . 0.0 112.001 -174.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -172.94 151.69 2.24 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.29 14.68 79.95 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 -176.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.85 -34.33 8.43 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.55 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.5 pm0 -61.4 -15.55 37.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.35 0.66 . . . . 0.0 112.143 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.92 94.46 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.519 0.676 . . . . 0.0 109.957 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -80.88 -26.82 36.62 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.227 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.1 mp -62.07 -49.31 76.47 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.721 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.469 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.8 tp -68.9 -34.84 66.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 120.879 0.371 . . . . 0.0 110.257 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.557 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 41.8 ttmt -58.91 -49.07 79.18 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.176 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -66.21 -36.73 83.83 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LEU . 72.8 t -59.76 -45.07 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 121.123 0.487 . . . . 0.0 109.804 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 144' ' ' ARG . 30.9 mmt180 -72.0 -25.02 61.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.209 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.557 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 75.7 mm-40 -64.37 -36.09 83.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 175.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.461 HD21 HG11 ' A' ' 125' ' ' VAL . 81.8 mt -62.44 -43.84 97.86 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.353 0.597 . . . . 0.0 109.487 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.0 t -67.76 -39.76 82.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.672 178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -60.36 -41.29 93.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.541 -178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.0 -12.99 45.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.238 0.542 . . . . 0.0 110.863 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -86.35 102.49 2.71 Favored Glycine 0 C--N 1.315 -0.634 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.507 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -115.07 -179.53 3.66 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 122.61 -0.347 . . . . 0.0 110.578 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -63.64 -38.24 90.38 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -94.81 163.26 13.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.073 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -71.09 89.3 0.82 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.854 0.359 . . . . 0.0 111.884 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 54.2 m80 68.59 -45.25 0.53 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.327 1.051 . . . . 0.0 113.693 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 . . . . . 0 C--N 1.312 -1.022 0 CA-C-O 118.464 -0.779 . . . . 0.0 110.431 -178.767 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.442 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 4.4 t -84.18 89.7 7.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.329 0.585 . . . . 0.0 110.471 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.474 ' N ' ' HA3' ' A' ' 122' ' ' GLY . 85.7 m-85 -87.8 -90.57 0.12 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.314 -179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.587 ' O ' HG13 ' A' ' 124' ' ' ILE . . . 169.92 -25.49 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.713 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.579 -176.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.519 HE21 ' HD2' ' A' ' 123' ' ' LYS . 8.5 tt0 65.9 83.14 0.17 Allowed 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.547 -176.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 24' ' ' THR . 15.7 mt -133.19 167.28 23.74 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.385 -174.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.71 159.87 49.13 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.913 2.409 . . . . 0.0 111.109 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.42 83.44 3.15 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.996 0.427 . . . . 0.0 111.095 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -126.36 134.91 65.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.209 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.1 p -98.7 112.76 24.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.204 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.548 HD22 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -117.67 176.4 5.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -108.63 135.28 50.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.437 0.16 . . . . 0.0 110.607 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -87.23 -171.92 3.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.527 HG23 ' H ' ' A' ' 95' ' ' VAL . 27.5 pt -66.21 -24.04 32.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -77.42 -30.81 53.63 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.061 0.458 . . . . 0.0 110.491 179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.85 14.95 21.83 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.2 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -93.78 147.76 22.76 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 87.8 m -75.07 115.86 15.17 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 121.281 0.562 . . . . 0.0 110.269 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 m -115.44 131.65 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.668 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.895 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.592 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 44.2 mt-30 -98.06 132.7 43.38 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.205 -0.907 . . . . 0.0 108.71 -177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.618 HG21 ' CE1' ' A' ' 103' ' ' PHE . 14.8 p -68.17 -24.36 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 -174.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -78.7 -4.04 47.16 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.815 0.34 . . . . 0.0 111.5 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HG3' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -134.25 11.9 3.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.82 177.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -67.89 124.81 24.39 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.815 -176.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -147.88 161.8 40.57 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 175.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.6 ' HB3' ' SD ' ' A' ' 34' ' ' MET . 35.1 p-10 -107.27 -56.48 2.2 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -178.94 -34.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.934 0.397 . . . . 0.0 110.628 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.86 25.59 0.03 OUTLIER Glycine 0 C--O 1.228 -0.258 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.556 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' HB2' HD21 ' A' ' 29' ' ' ASN . 14.4 mptt -129.13 151.22 77.34 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.67 153.57 77.58 Favored 'Trans proline' 0 C--O 1.245 0.845 0 C-N-CA 122.324 2.016 . . . . 0.0 111.753 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.6 ' SD ' ' HB3' ' A' ' 29' ' ' ASN . 74.4 mtm -136.62 155.43 49.92 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.918 -175.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 83.1 mt -127.13 123.15 61.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.5 mt -94.1 123.81 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.5 m -113.96 124.46 52.21 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.146 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 60.9 m-85 -93.76 119.76 33.15 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 175.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.621 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 24.2 p90 -137.94 170.16 16.53 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 123.606 0.566 . . . . 0.0 111.95 -175.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.65 33.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.565 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -68.69 -35.75 77.6 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -103.54 17.11 24.82 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.55 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 63.8 m -123.34 107.47 11.68 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.099 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 50.5 mtmt -93.87 -53.73 0.24 Allowed Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 35.2 Cg_exo -65.11 -22.34 61.82 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.692 2.261 . . . . 0.0 111.447 -178.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.55 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 67.9 m -65.93 -31.62 72.65 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.727 177.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.591 ' CD2' ' HB2' ' A' ' 39' ' ' PHE . 8.2 mt -81.62 66.6 7.25 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.9 tpp85 -64.45 -39.5 93.94 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.728 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.577 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -67.96 -52.76 32.28 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.954 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.547 HD11 ' CE2' ' A' ' 93' ' ' TYR . 43.6 tp -61.6 -41.25 97.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.806 -176.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -60.07 -49.68 76.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.513 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.05 -44.09 66.5 Favored 'General case' 0 C--O 1.253 1.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.853 -177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.577 HG13 ' O ' ' A' ' 49' ' ' GLU . 66.6 mt -63.72 -42.44 96.0 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.767 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.691 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -52.7 -40.32 62.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.717 0.294 . . . . 0.0 111.114 -179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -68.32 -44.8 74.58 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.6 m -105.36 20.51 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -60.81 -32.68 72.04 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.761 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.45 -39.9 92.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.818 0.342 . . . . 0.0 110.407 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -66.8 -39.05 87.6 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.177 177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.37 -36.37 82.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.545 0.688 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -82.39 -9.12 59.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.579 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.83 -52.94 63.4 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.502 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -121.04 -50.46 2.15 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 143' ' ' VAL . 6.5 m -61.77 -38.8 89.36 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.33 29.04 74.17 Favored Glycine 0 N--CA 1.46 0.265 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.431 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.66 127.7 37.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.92 0.391 . . . . 0.0 111.865 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.4 mtm180 -106.37 140.49 39.21 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.605 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 72.1 mt -84.63 144.62 28.48 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.148 0.499 . . . . 0.0 110.767 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.593 HD11 ' SD ' ' A' ' 34' ' ' MET . 94.8 mt -119.5 109.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.621 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -100.38 127.99 46.55 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.3 p -122.35 136.43 59.22 Favored 'Isoleucine or valine' 0 C--O 1.256 1.408 0 CA-C-O 121.612 0.72 . . . . 0.0 111.706 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.773 ' HB3' HG21 ' A' ' 82' ' ' VAL . 37.2 p -83.61 126.34 32.73 Favored 'General case' 0 C--O 1.26 1.61 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.437 179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 pt -80.79 16.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 O-C-N 125.107 1.504 . . . . 0.0 112.351 -177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.6 ' OD1' ' HB2' ' A' ' 78' ' ' ASN . 4.2 t70 -130.14 165.88 21.39 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -78.43 175.38 10.35 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.338 0.399 . . . . 0.0 111.268 -174.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 80' ' ' GLN . . . -56.83 -22.85 42.7 Favored Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.81 -0.632 . . . . 0.0 114.111 -177.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -65.04 -57.57 8.34 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.024 0.44 . . . . 0.0 111.119 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.6 ' HB2' ' OD1' ' A' ' 74' ' ' ASP . 91.7 m-20 -85.42 -38.97 18.07 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.137 -177.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.622 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -71.94 -3.2 21.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.456 -177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 6.7 tt0 -63.98 -12.28 36.32 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.158 0.504 . . . . 0.0 111.017 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.766 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 44.7 mmtm -95.77 -3.08 46.43 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 122.975 0.51 . . . . 0.0 112.054 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.773 HG21 ' HB3' ' A' ' 72' ' ' SER . 61.7 t -65.26 -49.19 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 121.39 0.614 . . . . 0.0 112.547 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.4 mtpt -65.62 -43.69 62.19 Favored Pre-proline 0 C--N 1.3 -1.579 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.803 -177.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.0 Cg_endo -62.15 -28.45 79.73 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.23 1.287 . . . . 0.0 111.312 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.6 mt -62.87 -41.94 99.58 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.22 -40.97 92.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.465 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.9 -46.81 83.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.23 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -69.28 -40.76 80.78 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.328 -0.851 . . . . 0.0 114.631 -177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -92.97 -0.4 57.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.66 38.93 61.06 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.358 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.7 m0 -81.78 96.5 7.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -89.7 70.84 7.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.093 0.473 . . . . 0.0 110.089 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.547 ' CE2' HD11 ' A' ' 50' ' ' LEU . 11.2 m-85 -145.47 172.13 13.65 Favored 'General case' 0 CA--C 1.503 -0.838 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -74.87 120.34 20.29 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.527 ' H ' HG23 ' A' ' 17' ' ' ILE . 20.7 t -109.21 123.75 65.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.495 HD13 HG23 ' A' ' 69' ' ' ILE . 11.0 mp -111.23 138.1 48.11 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.646 0.736 . . . . 0.0 111.525 -176.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.8 tp -103.76 109.36 21.05 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.792 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.548 ' HA ' HD22 ' A' ' 14' ' ' LEU . 68.0 t0 -82.27 116.37 21.76 Favored 'General case' 0 C--O 1.217 -0.612 0 C-N-CA 117.751 -1.58 . . . . 0.0 108.531 175.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -107.27 5.48 27.63 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.202 0.525 . . . . 0.0 110.185 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -110.8 -43.62 3.78 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.951 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 91.02 -1.97 78.57 Favored Glycine 0 N--CA 1.438 -1.188 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.682 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -83.18 -25.57 31.68 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.602 -0.352 . . . . 0.0 111.454 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.618 ' CE1' HG21 ' A' ' 24' ' ' THR . 47.6 t80 -64.01 -44.46 92.52 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 42.9 pttt -61.49 -36.71 81.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.852 0.358 . . . . 0.0 110.61 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -70.24 -41.57 73.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 110.359 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.38 -39.62 87.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.591 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 24.9 mmt -86.76 -8.29 57.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.021 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.2 t30 59.03 71.18 0.6 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.379 0.609 . . . . 0.0 111.26 178.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 38' ' ' PHE . 44.8 t -98.76 96.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-O 121.21 0.529 . . . . 0.0 110.63 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -88.89 -62.24 1.53 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.432 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.443 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 47.1 tp -105.93 129.9 53.99 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.281 178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 33.7 pt -91.55 152.87 43.91 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 67.2 Cg_endo -83.62 157.04 72.06 Favored 'Cis proline' 0 C--O 1.242 0.721 0 C-N-CA 124.277 -1.135 . . . . 0.0 112.859 1.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.577 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -112.98 130.03 56.28 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.9 t -115.54 127.87 72.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-O 121.327 0.584 . . . . 0.0 112.161 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 86.6 m-85 -127.64 112.69 15.14 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.765 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.2 mt -101.74 130.73 50.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-O 121.213 0.53 . . . . 0.0 110.874 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 123' ' ' LYS . 76.4 t -107.61 129.54 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.26 -179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -86.45 -175.42 5.46 Favored 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.301 0.376 . . . . 0.0 111.177 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.7 61.64 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.713 -178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -86.04 -1.66 57.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.875 0.369 . . . . 0.0 110.479 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.474 ' HA3' ' N ' ' A' ' 6' ' ' TYR . . . 70.89 42.6 60.13 Favored Glycine 0 N--CA 1.434 -1.48 0 C-N-CA 120.776 -0.725 . . . . 0.0 112.395 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.519 ' HD2' HE21 ' A' ' 8' ' ' GLN . 72.2 mmtt -127.11 155.54 43.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 7' ' ' ALA . 88.5 mt -71.66 100.14 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 176.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 146' ' ' LEU . 13.8 p -90.8 -34.16 6.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.457 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 87.7 t80 -132.5 130.33 40.31 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.723 0.296 . . . . 0.0 110.701 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.431 HD21 HG23 ' A' ' 129' ' ' THR . 2.1 t-20 -131.74 115.9 16.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.049 0.452 . . . . 0.0 110.78 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.465 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 2.0 t60 -132.81 102.87 5.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.405 176.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.431 HG23 HD21 ' A' ' 127' ' ' ASN . 0.6 OUTLIER -97.02 116.32 29.01 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.089 -178.009 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 78.5 65.35 1.86 Allowed Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.759 -0.734 . . . . 0.0 114.41 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.477 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 2.7 p90 -104.58 154.77 19.52 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.832 174.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.9 p -142.68 94.62 2.66 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.601 -0.44 . . . . 0.0 111.257 -177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 63.73 108.97 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.731 0.812 . . . . 0.0 112.273 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 114.23 -3.17 23.83 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.862 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.34 -18.97 40.19 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.944 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -58.57 -30.28 67.04 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.368 0.667 . . . . 0.0 111.174 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.23 -40.26 93.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.787 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -68.42 -36.66 79.4 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.789 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.647 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.2 mp -63.0 -48.81 77.23 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.713 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.507 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.2 tp -67.82 -39.76 82.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.903 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 27.8 ttpp -60.43 -45.51 93.39 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.803 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.648 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 37.8 tptt -66.38 -35.72 81.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.31 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 139' ' ' LEU . 53.3 t -59.48 -46.73 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-O 120.994 0.426 . . . . 0.0 110.711 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 4.6 ptp180 -78.98 -18.57 53.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.059 0.457 . . . . 0.0 110.91 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 141' ' ' LYS . 31.0 tt0 -69.93 -37.51 75.92 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.862 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 58.1 mt -64.08 -40.1 95.52 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.667 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 62.0 t -61.81 -31.68 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.117 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -62.2 -39.86 94.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.751 -0.658 . . . . 0.0 112.564 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.76 -27.13 14.47 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.972 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -80.63 85.07 1.36 Allowed Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.334 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.57 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 95.7 m-70 -92.7 37.04 1.01 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 68.68 -96.64 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.626 178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -93.84 -33.88 13.37 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.267 0.556 . . . . 0.0 110.219 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.57 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 58.4 m80 -89.03 144.18 26.33 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.451 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -75.54 -33.09 60.65 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.22 0.533 . . . . 0.0 110.162 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 24.1 t-80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.594 -0.717 . . . . 0.0 110.343 179.704 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m120 . . . . . 0 CA--C 1.519 -0.235 0 CA-C-O 121.151 0.5 . . . . 0.0 111.975 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 t -144.84 99.89 3.41 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.224 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 41.7 m-85 -97.89 -135.64 0.26 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.246 -177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -153.57 11.52 0.44 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 8' ' ' GLN . 52.8 tp60 51.74 31.75 8.51 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.826 0.822 . . . . 0.0 111.656 179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 33.1 mt -79.87 161.68 65.25 Favored Pre-proline 0 C--N 1.308 -1.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.022 -177.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -64.13 154.09 72.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.457 2.105 . . . . 0.0 111.133 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.28 76.64 1.33 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.312 0.577 . . . . 0.0 111.409 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -124.21 134.64 66.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 9.7 t -97.33 114.94 26.81 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.097 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 98' ' ' ASP . 30.0 mt -105.33 173.64 6.22 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -113.48 127.08 55.97 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.505 -177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.409 ' ND2' ' HD3' ' A' ' 20' ' ' LYS . 86.8 m-20 -79.59 178.71 7.95 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.074 0.464 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.569 ' CG2' ' HB ' ' A' ' 95' ' ' VAL . 47.3 pt -65.57 -26.2 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.186 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -73.99 -17.54 60.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.105 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.21 19.58 60.52 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -171.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 44.6 tttp -79.81 136.16 36.65 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.728 -0.736 . . . . 0.0 109.918 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -83.71 108.76 16.97 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.5 p -128.74 144.32 38.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.021 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.633 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 85.9 mt-30 -103.99 135.19 45.97 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.425 HG21 ' CE1' ' A' ' 103' ' ' PHE . 12.8 p -64.38 -30.68 71.72 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -73.66 -14.2 61.12 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.071 0.462 . . . . 0.0 111.068 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.633 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -114.65 8.88 16.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.68 0.276 . . . . 0.0 111.297 -178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 38.4 tp -80.51 115.8 20.22 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.231 -175.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.13 160.73 36.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.314 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.507 ' ND2' ' SD ' ' A' ' 34' ' ' MET . 8.3 p30 -112.89 -58.21 2.18 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.645 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.96 -45.54 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 123.565 0.746 . . . . 0.0 109.882 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 166.87 26.57 0.02 OUTLIER Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.828 -178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -119.46 152.01 52.31 Favored Pre-proline 0 C--N 1.32 -0.686 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.48 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 12.3 Cg_exo -72.1 158.89 51.32 Favored 'Trans proline' 0 C--O 1.244 0.82 0 C-N-CA 122.932 2.421 . . . . 0.0 112.501 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.507 ' SD ' ' ND2' ' A' ' 29' ' ' ASN . 5.0 mpp? -132.14 156.96 45.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.992 0.425 . . . . 0.0 111.223 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.93 123.66 54.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 66.5 mt -103.43 121.66 55.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.72 122.83 46.51 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.609 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 71.7 m-85 -96.1 119.63 34.94 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.092 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -147.83 161.46 41.22 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.984 0.421 . . . . 0.0 111.692 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.29 152.7 32.32 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.242 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 74' ' ' ASP . 3.1 p -43.3 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -97.64 77.03 2.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 122.182 0.992 . . . . 0.0 109.781 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 8.4 t -89.88 -175.83 4.73 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.44 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.576 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 64.6 mttp -109.17 -175.12 0.33 Allowed Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.462 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' A' ' 44' ' ' LYS . 52.4 Cg_exo -59.77 19.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.744 2.962 . . . . 0.0 114.151 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.54 ' H ' ' C ' ' A' ' 44' ' ' LYS . 49.8 m -72.66 -15.64 61.7 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 173.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 mt -72.91 54.54 0.37 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.447 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -61.26 -38.19 85.84 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.202 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.678 ' OE2' ' HB2' ' A' ' 113' ' ' PRO . 50.7 mt-10 -53.04 -67.28 0.26 Allowed 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.659 0.742 . . . . 0.0 110.235 177.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.6 HD11 ' CE2' ' A' ' 93' ' ' TYR . 30.4 tp -60.86 -41.04 95.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.747 -173.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -63.52 -53.98 43.43 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 120.675 -0.41 . . . . 0.0 112.095 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 -42.74 94.77 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-O 121.263 0.554 . . . . 0.0 111.177 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.493 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.8 mt -65.03 -42.77 95.48 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.949 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.101 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -56.68 -38.05 71.69 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.028 0.442 . . . . 0.0 110.652 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -65.88 -35.7 81.37 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.869 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -120.59 25.26 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 53' ' ' ILE . 86.9 t80 -60.53 -34.45 74.13 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -176.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.85 -39.54 92.21 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.425 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.89 -42.32 94.89 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.796 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.406 ' NE1' HD11 ' A' ' 140' ' ' ILE . 11.7 m0 -63.77 -35.76 81.65 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.754 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -79.13 -15.63 57.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.272 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.94 -43.73 98.24 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -118.75 -58.8 1.93 Allowed 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 120.541 -0.463 . . . . 0.0 112.025 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.0 m -62.69 -39.62 94.56 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.684 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.43 28.16 73.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.656 -176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.72 131.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 C-N-CA 122.658 0.383 . . . . 0.0 111.929 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -106.79 146.52 30.78 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.627 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 60.8 mt -91.69 148.12 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.402 0.62 . . . . 0.0 111.457 -179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 92.3 mt -122.44 118.68 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.575 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -95.44 111.56 23.43 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.7 p -115.52 127.83 72.96 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 CA-C-O 121.66 0.743 . . . . 0.0 111.245 -178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.563 ' HB2' HG21 ' A' ' 82' ' ' VAL . 35.0 t -85.6 133.11 34.07 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.713 177.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.408 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 44.0 pt -84.93 2.32 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.843 -179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 41' ' ' THR . 49.2 m-20 -102.33 157.27 17.02 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.71 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.03 156.42 5.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 123.492 0.495 . . . . 0.0 111.07 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.23 -34.04 72.46 Favored Glycine 0 N--CA 1.446 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 113.489 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.61 -40.57 92.35 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.701 0.286 . . . . 0.0 111.708 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.412 HD22 ' HB3' ' A' ' 74' ' ' ASP . 42.6 t30 -85.3 -32.52 22.46 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.384 0.612 . . . . 0.0 110.367 178.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.692 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.31 -4.24 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.624 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -63.65 -8.97 11.52 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 122.025 -0.422 . . . . 0.0 110.143 175.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.645 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 35.4 mmtp -85.93 -17.56 35.12 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.183 0.593 . . . . 0.0 111.788 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 79' ' ' ALA . 11.6 t -64.48 -46.25 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.843 0.83 . . . . 0.0 111.324 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 18.7 mtmt -68.53 -44.23 33.28 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.17 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.4 Cg_endo -60.2 -32.39 94.36 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.009 1.139 . . . . 0.0 110.785 174.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.645 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.3 mt -64.35 -42.45 96.22 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 173.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -60.48 -41.82 95.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.783 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.82 -41.53 95.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.532 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -76.65 -51.67 6.36 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.659 -0.782 . . . . 0.0 113.314 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -67.71 -34.81 77.6 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 98.2 45.95 2.29 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.216 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -88.35 104.96 17.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.507 -0.183 . . . . 0.0 110.507 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.01 65.33 2.05 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 110.035 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.6 ' CE2' HD11 ' A' ' 50' ' ' LEU . 11.4 m-85 -140.12 178.96 6.91 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -177.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.79 120.87 24.66 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.569 ' HB ' ' CG2' ' A' ' 17' ' ' ILE . 20.0 t -107.12 126.7 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.678 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.52 139.89 53.38 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.128 -175.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.55 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.4 mp -110.49 118.74 37.06 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.557 ' HA ' HD22 ' A' ' 14' ' ' LEU . 67.1 t0 -72.09 115.44 11.33 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.527 176.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.0 t -94.99 6.4 49.19 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.497 -175.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -124.9 -38.73 2.32 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.097 0.475 . . . . 0.0 110.855 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.421 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 90.0 4.1 72.47 Favored Glycine 0 N--CA 1.445 -0.737 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -97.91 -20.65 17.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 24' ' ' THR . 74.0 t80 -62.19 -43.77 98.08 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.949 0.404 . . . . 0.0 110.158 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 73' ' ' ILE . 21.1 ptmt -58.02 -41.67 83.66 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.699 175.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -70.5 -39.52 74.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.841 0.353 . . . . 0.0 111.026 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.21 99.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.317 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -80.65 -12.98 59.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.725 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 68.19 79.9 0.21 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.042 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 51.7 t -110.57 90.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.346 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.8 m -75.65 -46.52 31.02 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.226 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.2 tp -136.12 132.61 36.3 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.879 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.4 pt -87.38 154.0 53.84 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.678 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 95.2 Cg_endo -80.38 153.71 84.74 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.755 -1.352 . . . . 0.0 112.569 -0.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.609 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -116.17 125.97 53.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.326 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.462 HG22 ' CD ' ' A' ' 49' ' ' GLU . 13.7 t -101.34 124.93 55.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.716 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.8 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -124.73 112.63 16.96 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.729 172.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.24 128.87 53.1 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.124 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.48 ' O ' ' HB3' ' A' ' 33' ' ' PRO . 76.4 t -106.38 129.72 59.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.678 -178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 12.0 t70 -70.68 157.77 37.41 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.922 0.764 . . . . 0.0 109.568 178.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.32 -25.52 62.76 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 121.239 -0.505 . . . . 0.0 112.315 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -66.28 -25.11 66.71 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 121.118 0.485 . . . . 0.0 110.59 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 104.4 26.06 6.72 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.644 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -125.97 157.01 38.89 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 122.491 0.316 . . . . 0.0 110.548 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 7' ' ' ALA . 69.3 mt -71.28 122.44 23.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 11.5 p -109.03 -32.64 2.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 112.268 0.469 . . . . 0.0 112.268 -177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.436 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 58.0 t80 -147.62 131.5 17.09 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.021 -0.672 . . . . 0.0 111.297 -178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.017 0.437 . . . . 0.0 110.17 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.521 ' CD2' ' HB3' ' A' ' 131' ' ' TYR . 36.9 t60 -143.57 106.48 4.49 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.5 m -100.41 123.29 44.45 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.043 -174.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 69.98 60.11 5.09 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 115.315 0.886 . . . . 0.0 115.315 175.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.662 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 27.2 p90 -86.18 -39.53 16.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 117.637 0.719 . . . . 0.0 109.597 175.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 44.0 p 73.39 -44.99 0.6 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.979 1.711 . . . . 0.0 113.53 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -154.07 138.95 17.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.04 18.65 74.3 Favored Glycine 0 C--N 1.327 0.059 0 C-N-CA 121.087 -0.578 . . . . 0.0 111.848 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.662 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -92.91 -25.72 19.06 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.452 -177.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -60.93 -25.69 66.95 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -61.99 -40.06 94.36 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.316 0.579 . . . . 0.0 110.391 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -65.54 -38.32 89.27 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.511 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.619 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.1 mp -63.33 -47.14 83.46 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.685 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 140' ' ' ILE . 5.4 mm -61.63 -41.45 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.566 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.709 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.2 ttpp -57.29 -49.94 74.49 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.889 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.509 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 32.9 mmmt -68.39 -38.21 81.13 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 139' ' ' LEU . 52.6 t -58.94 -46.55 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 120.854 0.359 . . . . 0.0 111.575 -177.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -79.93 -22.42 42.72 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.638 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.709 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 73.6 mm-40 -66.28 -37.29 85.1 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.513 175.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 80.6 mt -61.38 -41.58 97.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.53 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 99.9 t -62.93 -47.61 91.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.86 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -66.68 -44.95 80.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.615 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -68.5 -38.62 81.11 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.961 -176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -90.35 33.77 4.41 Favored Glycine 0 C--N 1.316 -0.577 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.851 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -158.36 -45.27 0.06 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -99.18 144.81 27.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 27.4 m170 70.43 -78.2 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.979 0.911 . . . . 0.0 112.007 175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -112.71 92.98 4.21 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -114.15 126.85 55.54 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.093 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 37.2 t60 . . . . . 0 C--N 1.313 -1.018 0 CA-C-O 118.14 -0.933 . . . . 0.0 110.227 179.487 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.672 0.272 . . . . 0.0 111.724 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.681 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 94.9 m -102.18 87.72 3.14 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.156 0.503 . . . . 0.0 111.227 -177.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 54.9 m-85 -124.15 -112.79 0.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -171.62 159.57 5.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.471 ' H ' HG13 ' A' ' 124' ' ' ILE . 8.4 tt0 -81.65 80.66 7.93 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.478 HD13 ' HB ' ' A' ' 24' ' ' THR . 60.6 mt -120.5 151.75 54.35 Favored Pre-proline 0 C--N 1.309 -1.159 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 17.2 Cg_exo -67.94 147.86 75.11 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.8 2.333 . . . . 0.0 108.358 170.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.7 94.77 1.04 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.258 0.551 . . . . 0.0 111.467 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.9 149.33 32.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.948 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 p -110.21 117.29 33.28 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.517 HD22 ' HA ' ' A' ' 98' ' ' ASP . 42.3 mt -112.03 175.06 5.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.326 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 97' ' ' LEU . 32.8 mmtp -105.37 136.59 44.63 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 120.821 0.343 . . . . 0.0 111.513 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -75.77 -173.86 2.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.455 HG22 ' HB ' ' A' ' 95' ' ' VAL . 34.0 pt -67.14 -21.02 27.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 121.357 0.599 . . . . 0.0 110.354 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -86.02 -15.53 41.12 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.097 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.13 20.01 51.02 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 -174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -87.96 140.12 29.82 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 57.9 m -79.7 115.07 19.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.227 0.537 . . . . 0.0 110.892 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.2 m -119.39 130.6 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.391 177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.3 mt-30 -89.13 134.9 33.84 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.503 HG21 ' CE1' ' A' ' 103' ' ' PHE . 22.8 p -63.69 -30.53 71.62 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.857 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.415 HD22 ' N ' ' A' ' 25' ' ' ASN . 0.9 OUTLIER -78.96 -4.46 50.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.83 -178.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -126.63 13.78 7.52 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 177.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 6' ' ' TYR . 41.1 tp -71.37 112.48 7.54 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.464 -177.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.681 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.6 OUTLIER -137.3 143.3 42.05 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -178.012 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.42 ' HB2' ' NH2' ' A' ' 67' ' ' ARG . 35.6 p-10 -112.01 -38.22 4.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -176.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 29' ' ' ASN . . . 167.79 23.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 O-C-N 123.51 0.506 . . . . 0.0 111.525 -174.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.84 32.63 58.79 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.496 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -125.04 151.88 69.67 Favored Pre-proline 0 C--N 1.324 -0.542 0 C-N-CA 122.269 0.228 . . . . 0.0 110.913 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.15 149.76 89.28 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.245 1.963 . . . . 0.0 110.741 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 71.6 mtm -135.51 144.91 46.58 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.587 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.406 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.9 mt -120.43 122.46 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.6 mt -99.33 112.25 31.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.0 m -104.04 124.07 48.37 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.47 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 63.5 m-85 -96.11 119.57 34.84 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.984 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -143.57 178.64 7.64 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 123.529 0.518 . . . . 0.0 111.271 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . . . -113.2 155.25 25.36 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.522 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.3 t -72.67 156.6 38.79 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.535 ' H ' HD11 ' A' ' 85' ' ' LEU . 95.5 m-20 59.73 35.3 22.18 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 40' ' ' ALA . 81.4 m -130.48 152.76 49.51 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.025 0.441 . . . . 0.0 111.655 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.659 ' H ' ' CD ' ' A' ' 45' ' ' PRO . 58.7 mttm -134.52 -43.34 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.397 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.748 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.659 ' CD ' ' H ' ' A' ' 44' ' ' LYS . 50.7 Cg_exo -57.36 -36.52 98.88 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.497 2.132 . . . . 0.0 113.532 -176.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 56.0 m -86.95 5.99 34.43 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.087 0.47 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -97.04 21.97 9.07 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.442 -176.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -57.91 -45.75 86.03 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.643 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 53' ' ' ILE . 77.0 tt0 -55.96 -59.88 4.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.275 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.8 tp -62.7 -41.78 99.3 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.871 -176.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 54.8 tptt -64.05 -46.82 82.72 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.66 94.21 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.738 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.1 mt -65.0 -40.94 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.908 177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.467 ' HA ' ' OH ' ' A' ' 93' ' ' TYR . 63.9 tt0 -53.61 -39.96 65.36 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 120.874 0.369 . . . . 0.0 110.984 178.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 42.9 mm-40 -67.32 -40.24 85.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.315 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.18 18.95 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -178.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -61.64 -36.89 82.08 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.2 -37.19 84.36 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.566 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.99 -43.57 98.43 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.198 0.523 . . . . 0.0 110.388 177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.423 ' HH2' ' HB3' ' A' ' 139' ' ' LEU . 15.7 m0 -69.23 -42.38 75.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.779 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -72.11 -15.23 61.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.909 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -59.54 -47.95 83.53 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.337 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -127.21 -49.28 1.44 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.401 -174.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.9 m -62.38 -41.02 98.31 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.918 0.39 . . . . 0.0 110.528 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.61 31.0 77.3 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.045 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.12 133.08 30.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 122.532 0.333 . . . . 0.0 111.271 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' NH2' ' HB2' ' A' ' 29' ' ' ASN . 10.5 mtm180 -104.79 158.22 16.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.582 ' O ' ' HB3' ' A' ' 93' ' ' TYR . 78.6 mt -107.14 135.82 48.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.079 0.466 . . . . 0.0 110.629 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.2 mt -106.18 110.83 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.11 104.84 16.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.836 -177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.6 p -110.69 127.62 67.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.553 0.692 . . . . 0.0 111.067 -177.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.7 p -91.02 137.27 32.49 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.539 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.9 pt -73.56 -20.4 18.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.997 177.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -67.79 142.58 56.16 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.098 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 31.6 mp0 -65.09 176.16 1.36 Allowed 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.614 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.55 -45.82 92.71 Favored Glycine 0 N--CA 1.461 0.318 0 C-N-CA 120.793 -0.718 . . . . 0.0 114.123 -174.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 28.9 pt20 -70.5 -32.44 69.94 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 120.875 0.369 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -85.48 -24.12 27.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.165 0.507 . . . . 0.0 111.283 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.708 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -85.62 -3.45 58.88 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.383 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 13.9 pt20 -64.98 -4.42 4.58 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 121.715 -0.615 . . . . 0.0 110.743 177.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.601 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.9 mttm -97.97 -10.66 24.11 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.355 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 79' ' ' ALA . 13.3 t -64.88 -47.1 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-O 121.949 0.88 . . . . 0.0 110.822 -178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 39.6 mtpt -65.62 -46.76 68.02 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.248 -176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.6 Cg_endo -59.51 -29.06 89.05 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 121.336 1.358 . . . . 0.0 111.32 177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.5 mt -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 173.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.514 ' HA ' ' OD1' ' A' ' 89' ' ' ASN . . . -61.27 -34.29 74.94 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.69 -177.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -65.94 -29.11 69.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.189 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -89.18 -49.25 3.56 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.349 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 86' ' ' ALA . 12.0 p30 -77.88 -27.04 49.59 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.1 46.38 4.17 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.38 -0.914 . . . . 0.0 112.903 179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.6 95.86 4.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.138 0.494 . . . . 0.0 109.977 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -78.8 42.72 0.46 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.494 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.582 ' HB3' ' O ' ' A' ' 68' ' ' LEU . 6.0 m-85 -127.05 168.53 14.47 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 -176.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -82.18 113.38 19.98 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.31 0.576 . . . . 0.0 109.469 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 17' ' ' ILE . 13.7 t -97.31 136.89 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.788 -175.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 95' ' ' VAL . 11.2 mp -129.09 148.32 51.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.237 -175.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.578 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.7 mp -114.42 117.73 31.85 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.141 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.603 ' OD2' ' HG2' ' A' ' 104' ' ' LYS . 11.9 t70 -90.74 114.96 27.44 Favored 'General case' 0 CA--C 1.513 -0.454 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.636 172.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' GLU . 30.5 m -93.99 -88.97 0.23 Allowed 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.51 -178.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -112.27 19.46 17.68 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 121.322 0.582 . . . . 0.0 110.273 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.78 -15.23 73.52 Favored Glycine 0 N--CA 1.426 -1.979 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.634 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.403 ' CG ' ' HE ' ' A' ' 105' ' ' ARG . 18.4 t70 55.05 23.85 5.54 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.22 0.533 . . . . 0.0 109.902 -174.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.503 ' CE1' HG21 ' A' ' 24' ' ' THR . 69.5 t80 -62.26 -42.45 99.34 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.721 -177.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.603 ' HG2' ' OD2' ' A' ' 98' ' ' ASP . 11.4 pttm -54.78 -50.72 67.79 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HE ' ' CG ' ' A' ' 102' ' ' ASP . 17.6 ttp180 -70.55 -36.12 73.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.659 -178.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.03 87.62 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.074 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 103' ' ' PHE . 35.8 mmm -82.54 -8.73 59.6 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.564 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 76.08 53.64 0.05 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 121.653 0.739 . . . . 0.0 111.553 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.435 HG12 HG22 ' A' ' 112' ' ' ILE . 47.5 t -98.88 129.86 48.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.38 177.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -130.98 -71.52 0.57 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.592 ' O ' HG12 ' A' ' 112' ' ' ILE . 52.1 tp -64.35 -39.16 93.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.861 -177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 111' ' ' LEU . 4.2 pt 64.55 145.21 0.08 OUTLIER Pre-proline 0 N--CA 1.487 1.411 0 C-N-CA 125.081 1.352 . . . . 0.0 111.319 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.657 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 95.6 Cg_endo -82.29 179.05 27.98 Favored 'Cis proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.933 -0.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.416 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -133.75 142.75 48.08 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.768 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 128' ' ' HIS . 21.9 t -117.99 126.57 74.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 O-C-N 123.466 0.479 . . . . 0.0 111.36 -176.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 69.9 m-85 -126.44 114.93 18.82 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 173.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.501 HD11 HD13 ' A' ' 139' ' ' LEU . 64.8 mt -106.06 125.63 61.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.904 0 CA-C-O 121.287 0.565 . . . . 0.0 111.835 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.2 t -101.28 130.6 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-N 114.717 -1.129 . . . . 0.0 108.7 177.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -81.27 -173.32 4.27 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 123.539 0.524 . . . . 0.0 111.602 -174.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.07 -34.02 88.83 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.611 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -64.62 -40.59 95.76 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.163 0.506 . . . . 0.0 109.812 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 114.44 33.89 1.68 Allowed Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.257 179.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -130.21 155.05 46.9 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.471 HG13 ' H ' ' A' ' 8' ' ' GLN . 96.7 mt -74.55 108.82 6.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.187 -0.605 . . . . 0.0 109.691 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.429 HG11 HD21 ' A' ' 146' ' ' LEU . 12.2 p -97.91 -29.28 3.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.123 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.598 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 89.8 t80 -129.71 132.7 46.71 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.147 0.499 . . . . 0.0 111.328 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -128.87 127.99 42.94 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.772 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.598 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 2.2 t60 -134.27 101.63 5.08 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 13.1 p -109.7 116.64 32.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.14 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.79 19.05 7.98 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 119.7 -1.238 . . . . 0.0 114.823 176.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.657 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -75.98 143.39 41.55 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 174.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.0 p -119.68 -43.3 2.59 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.236 -0.585 . . . . 0.0 112.019 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -160.32 125.19 3.83 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.11 17.13 41.48 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.025 -178.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.23 -14.86 55.32 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 139' ' ' LEU . 2.2 mp0 -59.75 -26.99 66.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.129 0.49 . . . . 0.0 111.063 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.26 90.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.261 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -68.21 -31.62 71.26 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.744 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 143' ' ' VAL . 4.0 mm? -61.3 -56.66 17.99 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.402 179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.4 tp -66.45 -38.5 81.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 120.914 0.388 . . . . 0.0 111.388 -177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -60.26 -48.99 79.39 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.671 -178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 20.3 tptp -67.6 -31.39 71.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.261 -179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.1 t -59.33 -44.48 92.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.436 ' HA ' ' HD3' ' A' ' 144' ' ' ARG . 38.5 mmt180 -67.79 -33.06 74.08 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.567 175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 50.8 mm-40 -56.34 -33.15 65.37 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.153 0.501 . . . . 0.0 109.928 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.429 HD21 HG11 ' A' ' 125' ' ' VAL . 84.3 mt -63.6 -43.71 96.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.07 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.9 t -71.41 -21.48 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.709 0.766 . . . . 0.0 110.051 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -79.29 -4.1 49.19 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.733 -176.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.47 -16.17 14.06 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -175.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -57.15 -44.44 93.16 Favored Glycine 0 C--O 1.229 -0.188 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.522 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -114.04 117.68 31.97 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -66.43 -37.5 85.32 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.526 -173.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -111.87 -60.26 1.88 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -124.33 123.68 40.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.456 0.17 . . . . 0.0 110.895 -178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -66.48 -31.95 73.0 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.146 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 46.2 t60 . . . . . 0 C--O 1.247 0.927 0 CA-C-O 118.845 -0.598 . . . . 0.0 109.56 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.555 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.7 m -94.16 58.52 2.52 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.627 -175.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.532 ' CD1' ' HG3' ' A' ' 28' ' ' GLU . 60.3 m-85 -87.38 -112.5 0.05 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.082 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' HB3' ' CD1' ' A' ' 9' ' ' LEU . . . -162.89 11.56 0.06 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.566 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 52.58 42.31 31.41 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 121.995 0.903 . . . . 0.0 110.714 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 24' ' ' THR . 44.3 mt -96.6 164.01 19.13 Favored Pre-proline 0 C--N 1.314 -0.941 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.406 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.19 157.16 63.06 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.736 2.291 . . . . 0.0 110.854 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.18 82.87 2.35 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.958 0.409 . . . . 0.0 111.354 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.18 134.85 65.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.981 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 p -95.08 114.59 26.41 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.989 0.423 . . . . 0.0 110.608 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 98' ' ' ASP . 36.3 mt -112.0 172.86 6.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.867 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 96' ' ' LEU . 35.3 mmtm -97.84 131.89 43.93 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.385 0.612 . . . . 0.0 112.243 178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -85.86 166.21 16.19 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.514 176.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.45 ' HA ' ' HD2' ' A' ' 83' ' ' LYS . 36.6 pt -61.45 -24.68 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.823 0.344 . . . . 0.0 111.671 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -77.26 -4.9 47.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.57 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.23 16.65 75.9 Favored Glycine 0 CA--C 1.499 -0.925 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -95.68 140.44 30.49 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 114.891 -0.654 . . . . 0.0 109.827 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.8 m -74.57 120.34 20.0 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -126.6 131.72 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.184 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 78.2 mt-30 -91.09 134.93 34.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.901 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.54 HG21 ' CE1' ' A' ' 103' ' ' PHE . 10.2 p -64.33 -31.9 73.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.923 -176.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -77.36 -10.8 59.66 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 120.703 0.287 . . . . 0.0 111.593 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -119.08 3.49 11.44 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 122.09 -0.382 . . . . 0.0 111.214 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.36 109.45 19.56 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.527 0.68 . . . . 0.0 111.911 -175.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.532 ' HG3' ' CD1' ' A' ' 6' ' ' TYR . 47.8 mt-10 -117.1 132.23 56.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.16 175.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.538 ' ND2' HH21 ' A' ' 67' ' ' ARG . 2.4 t-20 -72.3 -71.19 0.3 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.233 178.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -167.27 35.74 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.798 0.332 . . . . 0.0 110.534 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.43 24.24 59.25 Favored Glycine 0 C--O 1.228 -0.244 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.165 -177.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -117.93 152.54 50.31 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.251 -0.475 . . . . 0.0 110.25 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -71.61 151.76 58.75 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.389 2.059 . . . . 0.0 111.893 176.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -134.98 156.27 49.31 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.04 0.448 . . . . 0.0 111.571 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.502 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 83.7 mt -126.64 126.68 69.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 175.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.4 mt -98.68 125.36 52.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 120.688 0.28 . . . . 0.0 110.456 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.9 m -110.11 120.06 41.25 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.861 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.629 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 67.5 m-85 -96.37 121.98 38.76 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.177 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HE1' ' HB1' ' A' ' 70' ' ' ALA . 16.3 p90 -147.68 169.35 19.88 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 123.5 0.5 . . . . 0.0 110.818 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.67 140.28 32.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.027 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.447 HG22 ' CG ' ' A' ' 74' ' ' ASP . 15.4 t -67.21 -33.02 74.48 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.115 0.483 . . . . 0.0 110.346 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -99.08 69.56 1.75 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.0 t -131.88 175.31 9.32 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.121 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.64 167.7 20.97 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.267 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -42.66 82.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 124.149 3.232 . . . . 0.0 115.641 -179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.3 m -147.51 5.54 0.81 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.754 172.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.0 mt -66.5 -39.85 88.92 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.455 -176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 61.44 -79.58 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.169 0.588 . . . . 0.0 112.118 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.512 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 8.5 tm-20 -42.29 -60.58 1.43 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.952 1.701 . . . . 0.0 112.104 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD11 ' CE2' ' A' ' 93' ' ' TYR . 32.7 tp -61.21 -39.07 88.86 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.576 -176.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.28 -48.69 69.59 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.259 179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.03 97.55 Favored 'General case' 0 C--O 1.252 1.208 0 CA-C-O 121.344 0.592 . . . . 0.0 111.072 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 49' ' ' GLU . 63.2 mt -64.14 -41.38 92.24 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.935 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.86 178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -52.81 -38.83 61.77 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.99 0.424 . . . . 0.0 110.915 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -66.29 -38.42 87.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.444 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.3 m -119.57 24.33 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 53' ' ' ILE . 83.5 t80 -62.99 -40.63 98.32 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -176.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.81 -36.68 85.11 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.035 0.445 . . . . 0.0 110.383 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.14 -43.3 99.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.247 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.427 ' NE1' HD13 ' A' ' 140' ' ' ILE . 24.8 m0 -65.47 -37.56 87.19 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.777 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.408 HE21 ' HG2' ' A' ' 67' ' ' ARG . 85.0 mt-30 -74.5 -9.16 58.31 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.64 -64.33 0.86 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -115.78 -39.59 3.48 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.472 HG21 HG13 ' A' ' 143' ' ' VAL . 7.4 m -62.29 -40.23 95.59 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.353 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.32 33.29 86.3 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.111 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.0 p -86.05 138.95 18.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 120.754 0.311 . . . . 0.0 110.649 -177.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.538 HH21 ' ND2' ' A' ' 29' ' ' ASN . 23.8 mtm180 -123.65 152.87 41.53 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.622 -0.431 . . . . 0.0 111.052 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.502 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 62.9 mt -96.43 144.88 26.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.07 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.1 mt -119.73 112.52 37.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 174.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' HB1' ' HE1' ' A' ' 39' ' ' PHE . . . -93.81 120.1 33.63 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.682 -177.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.4 p -118.92 130.65 73.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.478 0.656 . . . . 0.0 111.262 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.4 p -88.77 135.83 33.31 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.487 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.8 pt -82.24 -11.26 12.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.149 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.447 ' CG ' HG22 ' A' ' 41' ' ' THR . 8.3 m-20 -83.2 149.75 26.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.429 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -58.75 168.57 1.18 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.312 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.0 -35.98 86.19 Favored Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 114.28 0.472 . . . . 0.0 114.28 -174.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -62.45 -53.26 57.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.186 0.493 . . . . 0.0 111.067 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -68.67 -37.94 80.0 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.058 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -66.88 -6.66 17.3 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.589 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -63.57 -17.57 62.97 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.397 0.617 . . . . 0.0 109.422 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 67.6 mttm -93.75 -8.28 41.15 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.284 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 79' ' ' ALA . 13.6 t -66.45 -46.23 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.73 0.776 . . . . 0.0 110.767 -177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 44.3 mtpt -62.55 -48.86 85.56 Favored Pre-proline 0 C--N 1.309 -1.186 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.872 -177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 19.1 Cg_endo -60.6 -29.93 89.51 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.357 1.371 . . . . 0.0 111.403 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.4 mt -63.68 -43.99 95.03 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.92 98.91 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.494 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -65.28 -50.1 67.03 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.833 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -66.2 -45.61 85.48 Favored Glycine 0 C--N 1.332 0.332 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.337 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -73.32 -23.42 60.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.87 0.335 . . . . 0.0 111.607 -179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.05 39.55 19.49 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.892 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.587 ' HB3' ' CD2' ' A' ' 93' ' ' TYR . 26.6 m0 -64.4 -47.2 80.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.758 0.313 . . . . 0.0 111.644 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 92' ' ' GLU . 32.9 tt0 72.11 1.97 4.13 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 176.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CD2' ' HB3' ' A' ' 91' ' ' TRP . 2.8 m-85 -88.18 174.15 8.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.11 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.72 137.03 45.68 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.404 ' HB ' HG22 ' A' ' 17' ' ' ILE . 25.5 t -122.66 128.02 75.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.759 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 11.2 mp -124.09 137.36 54.58 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.703 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.94 116.49 32.09 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.493 ' HA ' HD22 ' A' ' 14' ' ' LEU . 49.6 t0 -86.13 113.7 22.38 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 118.385 -1.326 . . . . 0.0 108.552 174.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.0 t -97.21 -10.64 25.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.021 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -82.52 -48.39 11.08 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 115.237 -0.892 . . . . 0.0 108.897 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.61 1.05 78.19 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.17 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -91.97 -24.61 19.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.79 -177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.54 ' CE1' HG21 ' A' ' 24' ' ' THR . 81.1 t80 -61.62 -45.93 91.96 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.799 0.333 . . . . 0.0 110.887 -177.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -63.67 -33.09 74.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.442 177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 32.8 ttm-85 -69.96 -43.03 72.38 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.935 0.398 . . . . 0.0 110.468 178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.7 91.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.228 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.3 mmt -76.01 -23.72 55.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.991 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.7 t30 72.42 84.29 0.13 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.201 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.445 ' HA ' HG21 ' A' ' 129' ' ' THR . 61.9 t -105.65 97.48 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.54 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.2 t -73.31 -54.58 8.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.349 0.595 . . . . 0.0 110.218 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' HB3' ' HA2' ' A' ' 130' ' ' GLY . 58.3 tp -138.71 138.05 37.36 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.652 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.7 pt -90.31 154.08 46.62 Favored Pre-proline 0 C--N 1.313 -1.022 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.516 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.2 Cg_endo -76.32 150.36 93.23 Favored 'Cis proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.805 -1.331 . . . . 0.0 112.852 1.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -111.1 136.42 50.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.986 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 52.2 t -117.25 126.25 74.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 CA-C-O 121.209 0.528 . . . . 0.0 111.969 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -126.37 116.08 20.64 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.943 174.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 59.9 mt -104.72 131.51 53.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 CA-C-O 121.188 0.518 . . . . 0.0 111.099 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -112.4 130.32 66.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.413 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -87.02 -175.41 5.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 111.626 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.67 -16.0 49.44 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.814 -0.63 . . . . 0.0 114.058 -177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -88.82 -1.2 57.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.008 0.404 . . . . 0.0 110.576 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 71.2 34.27 64.45 Favored Glycine 0 CA--C 1.501 -0.797 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.653 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -124.8 157.78 34.97 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 83.1 mt -74.79 116.24 17.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.7 p -104.01 -26.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.29 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.528 ' CE2' ' HB2' ' A' ' 128' ' ' HIS . 90.3 t80 -147.34 135.74 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.502 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -134.51 122.05 21.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.968 0.413 . . . . 0.0 110.723 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.528 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.9 t60 -134.56 102.3 5.26 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.445 HG21 ' HA ' ' A' ' 109' ' ' VAL . 30.3 m -117.63 124.22 48.06 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.624 -179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 111' ' ' LEU . . . 118.27 -8.3 13.98 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.702 -178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.516 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -67.13 148.12 52.25 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 33.8 p -116.23 -47.29 2.76 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.701 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -156.4 131.94 9.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.667 178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.77 15.54 56.34 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.915 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.19 -14.1 56.5 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -60.75 -18.49 55.08 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 123.997 0.919 . . . . 0.0 111.943 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.07 -39.21 94.05 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.467 0.651 . . . . 0.0 111.136 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.57 -32.13 67.75 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.026 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.648 ' O ' HG23 ' A' ' 143' ' ' VAL . 11.0 mp -62.47 -48.02 81.46 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.386 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.427 HD13 ' NE1' ' A' ' 60' ' ' TRP . 5.4 tp -66.21 -37.13 79.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 120.843 0.354 . . . . 0.0 110.505 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.669 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.4 ttpp -60.73 -46.54 90.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.683 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -63.34 -35.69 81.22 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.694 0.283 . . . . 0.0 111.495 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 139' ' ' LEU . 96.0 t -59.93 -44.37 94.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.41 0.624 . . . . 0.0 109.395 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 12.9 mmm180 -69.26 -34.86 75.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.056 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 14.6 mm-40 -55.75 -42.53 75.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.038 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 52.3 mt -61.87 -41.04 97.36 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.533 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.48 -42.61 87.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.299 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 65.4 tttp -61.94 -48.25 81.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.028 -178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 145' ' ' GLU . 12.9 pt-20 -67.51 -39.06 85.14 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.74 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 69.94 -48.54 0.65 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 173.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.7 m170 69.42 77.44 0.22 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.889 0.476 . . . . 0.0 109.739 -175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -168.82 -40.69 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.015 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -153.74 -62.52 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.244 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -82.16 167.63 18.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.531 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -136.32 -42.1 0.63 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.275 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 . . . . . 0 C--O 1.242 0.69 0 CA-C-O 118.549 -0.738 . . . . 0.0 110.619 -178.739 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.426 ' OG1' ' HA2' ' A' ' 31' ' ' GLY . 18.0 m -113.77 65.22 0.66 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.102 0.477 . . . . 0.0 111.262 -177.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -87.48 -137.21 0.09 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.7 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -135.17 -23.81 1.47 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.252 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 67.38 70.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.691 0.758 . . . . 0.0 111.205 -176.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.03 162.49 26.68 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.416 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.599 ' HG2' ' SD ' ' A' ' 107' ' ' MET . 8.8 Cg_exo -39.93 138.03 1.13 Allowed 'Trans proline' 0 C--N 1.364 1.346 0 C-N-CA 124.091 3.194 . . . . 0.0 113.111 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.77 97.24 9.05 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.099 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.6 t -118.43 134.67 61.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.3 t -80.1 112.08 17.08 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.913 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 98' ' ' ASP . 19.0 mt -121.99 169.85 10.41 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -105.47 130.13 53.62 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.813 0.339 . . . . 0.0 111.572 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -83.29 -167.91 1.88 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.043 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.589 ' HA ' ' HE2' ' A' ' 83' ' ' LYS . 41.9 pt -71.32 -17.16 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -84.23 -14.01 51.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.715 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.64 15.35 76.01 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -175.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -93.7 145.67 24.4 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.377 -0.912 . . . . 0.0 109.461 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 58.4 m -74.03 118.67 17.25 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.349 0.595 . . . . 0.0 110.926 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.7 m -128.82 132.44 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.754 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.412 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 95.6 mt-30 -95.33 135.21 37.23 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.556 HG21 ' CE1' ' A' ' 103' ' ' PHE . 15.9 p -61.5 -34.83 76.16 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 -174.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -70.14 -20.69 63.14 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.02 0.438 . . . . 0.0 111.397 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.522 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.08 11.36 20.44 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.95 0.405 . . . . 0.0 110.719 -179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.0 tp -97.06 125.19 41.34 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-O 121.289 0.566 . . . . 0.0 111.067 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -125.11 155.66 39.52 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.543 178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.711 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 22.8 t-20 -78.97 -75.38 0.24 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.198 -178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.68 22.32 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.944 0.402 . . . . 0.0 110.682 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.426 ' HA2' ' OG1' ' A' ' 5' ' ' THR . . . 97.53 -10.19 64.8 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -175.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -105.08 151.45 39.51 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 114.904 -0.648 . . . . 0.0 110.247 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 35.8 Cg_endo -65.02 160.1 43.21 Favored 'Trans proline' 0 C--O 1.24 0.615 0 C-N-CA 122.933 2.422 . . . . 0.0 112.522 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.711 ' SD ' ' HB2' ' A' ' 29' ' ' ASN . 11.2 ptt? -149.32 164.3 35.26 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.939 -175.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.412 ' CD1' ' HZ3' ' A' ' 60' ' ' TRP . 76.5 mt -128.46 127.92 67.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 92.9 mt -99.85 115.14 40.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -104.48 130.65 52.39 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.869 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.616 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 66.7 m-85 -96.38 121.14 37.86 Favored 'General case' 0 C--O 1.252 1.198 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.22 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.541 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 24.9 p90 -142.0 164.38 30.32 Favored 'General case' 0 C--O 1.238 0.493 0 O-C-N 123.97 0.793 . . . . 0.0 110.494 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.22 158.13 17.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.707 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p -65.49 -17.61 64.68 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -132.04 85.27 2.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.943 0.402 . . . . 0.0 110.396 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 46' ' ' CYS . 33.2 t -164.48 165.11 21.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.201 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 29.3 tptp -154.02 -62.83 0.02 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 112.584 0.586 . . . . 0.0 112.584 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 44' ' ' LYS . 57.1 Cg_endo -69.45 -29.05 25.98 Favored 'Trans proline' 0 C--N 1.372 1.789 0 C-N-CA 122.267 1.978 . . . . 0.0 113.439 -177.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.638 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 58.5 m -67.39 -18.54 65.17 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.007 0.432 . . . . 0.0 110.048 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.9 mt -80.09 62.07 4.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.523 ' HE ' ' HB3' ' A' ' 133' ' ' GLU . 29.2 mmt180 -58.48 -46.2 87.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.6 -177.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.541 ' O ' HG13 ' A' ' 53' ' ' ILE . 6.7 pt-20 -62.87 -49.57 74.34 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.038 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.432 ' N ' ' HG3' ' A' ' 49' ' ' GLU . 42.6 tp -62.25 -41.41 98.41 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.138 -177.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 55' ' ' GLU . 87.5 tttt -63.67 -49.37 73.45 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.004 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.58 96.02 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.331 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.9 mt -64.4 -42.71 96.12 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.432 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.202 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -58.77 -36.39 74.31 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.026 0.441 . . . . 0.0 110.868 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 51' ' ' LYS . 62.1 mm-40 -66.58 -39.09 88.27 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.697 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.26 24.89 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.884 0.373 . . . . 0.0 111.886 -178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -58.67 -39.52 80.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.79 -176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.92 92.0 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.9 0.381 . . . . 0.0 110.54 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.02 -38.43 90.87 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.638 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.511 ' CZ2' HG12 ' A' ' 140' ' ' ILE . 17.7 m0 -67.6 -37.03 81.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.576 0.703 . . . . 0.0 110.22 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -75.58 -8.11 55.94 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.675 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.09 -43.76 70.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.345 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -142.72 -40.67 0.33 Allowed 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.958 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.468 HG21 HG13 ' A' ' 143' ' ' VAL . 7.8 m -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 120.811 0.339 . . . . 0.0 110.313 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.6 24.5 73.94 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.72 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 5.6 p -78.37 124.72 37.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 122.864 0.465 . . . . 0.0 111.715 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HB2' HD21 ' A' ' 29' ' ' ASN . 43.0 mtm-85 -106.17 165.58 11.13 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.639 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 84.3 mt -108.06 146.12 33.04 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.279 0.561 . . . . 0.0 111.853 -177.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.566 HG23 HD13 ' A' ' 96' ' ' LEU . 93.7 mt -120.88 110.36 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.201 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -92.45 118.6 31.12 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.809 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.0 132.52 68.66 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.495 ' HB3' HG21 ' A' ' 82' ' ' VAL . 25.3 p -84.17 128.42 34.55 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.254 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.547 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 42.4 pt -76.4 -14.83 14.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 O-C-N 124.78 1.3 . . . . 0.0 111.344 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 78' ' ' ASN . 7.0 m-20 -77.63 175.76 9.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.075 178.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -88.69 178.87 6.37 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.852 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.532 ' HA2' HD21 ' A' ' 97' ' ' LEU . . . -58.04 -23.27 51.5 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.759 -0.655 . . . . 0.0 113.987 -176.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -68.5 -65.09 0.74 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.89 0.376 . . . . 0.0 111.234 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.505 ' HB2' ' HB3' ' A' ' 74' ' ' ASP . 63.9 m-20 -66.35 -35.33 80.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.691 -178.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.567 ' HB1' ' HG ' ' A' ' 97' ' ' LEU . . . -65.81 -4.72 7.15 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -64.48 -9.37 18.2 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.311 0.577 . . . . 0.0 110.523 177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.783 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 94.4 mttt -92.98 -12.75 29.95 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.745 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 72' ' ' SER . 50.6 t -64.88 -49.71 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -173.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 17' ' ' ILE . 13.1 mptt -68.76 -41.6 21.62 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 14.5 Cg_endo -60.3 -31.06 92.39 Favored 'Trans proline' 0 C--N 1.362 1.269 0 C-N-CA 121.025 1.15 . . . . 0.0 110.946 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.7 mt -63.72 -40.92 97.96 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.305 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.431 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -54.72 -48.25 72.75 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.619 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -66.91 -42.94 84.57 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.43 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -67.48 -33.88 82.87 Favored Glycine 0 CA--C 1.522 0.515 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.774 -178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -99.59 3.3 45.27 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.26 43.34 93.13 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.4 177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.431 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 50.1 m0 -82.33 98.85 9.02 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.231 0.539 . . . . 0.0 110.159 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -86.5 44.95 1.19 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.005 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -145.89 -176.91 5.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.984 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -71.77 136.65 47.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.306 0.574 . . . . 0.0 111.505 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.69 130.31 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.231 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.566 HD13 HG23 ' A' ' 69' ' ' ILE . 10.6 mp -122.03 154.71 36.91 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.642 0.734 . . . . 0.0 111.695 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.567 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 8.8 tt -125.43 113.95 18.19 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.868 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.686 ' HA ' HD22 ' A' ' 14' ' ' LEU . 66.5 t0 -77.6 117.24 18.84 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 118.175 -1.41 . . . . 0.0 108.439 174.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.9 t -88.06 -32.3 18.82 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.413 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -79.02 -38.28 37.0 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.726 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 84.64 12.02 76.03 Favored Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -177.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -109.56 -6.04 15.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.556 ' CE1' HG21 ' A' ' 24' ' ' THR . 79.6 t80 -64.24 -39.5 94.09 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.989 0.423 . . . . 0.0 110.192 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.547 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 24.5 pttm -59.62 -37.2 77.97 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.269 176.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 42.1 ttm-85 -70.5 -41.49 72.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.667 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.62 92.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.942 -178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.599 ' SD ' ' HG2' ' A' ' 10' ' ' PRO . 42.0 mmm -88.66 -11.89 44.03 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.975 179.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 64.72 83.3 0.17 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.741 178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.4 t -92.3 109.1 20.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.895 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -69.83 -58.53 3.76 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.175 0.512 . . . . 0.0 110.052 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.483 ' HB3' ' HA2' ' A' ' 130' ' ' GLY . 59.5 tp -143.47 136.28 27.53 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 31.6 pt -83.27 153.08 65.73 Favored Pre-proline 0 C--N 1.322 -0.62 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.589 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 91.3 Cg_endo -74.77 155.91 99.91 Favored 'Cis proline' 0 CA--C 1.536 0.608 0 C-N-CA 123.767 -1.347 . . . . 0.0 112.777 0.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.616 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -120.32 130.55 54.49 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.877 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.459 HG22 ' CD ' ' A' ' 49' ' ' GLU . 21.7 t -112.0 129.04 68.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 O-C-N 123.39 0.431 . . . . 0.0 111.997 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -129.14 113.7 15.41 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.039 174.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 66.7 mt -102.93 129.83 54.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-O 121.245 0.545 . . . . 0.0 110.791 -177.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.18 131.52 63.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.827 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.3 165.34 23.98 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.632 0.582 . . . . 0.0 110.851 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.81 -21.39 51.28 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.241 -0.436 . . . . 0.0 113.208 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -73.3 -9.2 58.45 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.999 0.4 . . . . 0.0 111.105 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' A' ' 123' ' ' LYS . . . 91.23 18.56 45.69 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.951 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' HD2' ' O ' ' A' ' 122' ' ' GLY . 4.0 mptp? -125.56 150.39 47.52 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.891 0.346 . . . . 0.0 110.612 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.7 HG13 ' O ' ' A' ' 7' ' ' ALA . 60.1 mt -65.07 125.97 23.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.439 177.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.72 -18.3 7.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.556 ' HB2' ' HD3' ' A' ' 142' ' ' LYS . 89.3 t80 -150.56 132.08 14.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.924 0.392 . . . . 0.0 111.707 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -128.64 128.92 45.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.832 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . 0.549 ' HB2' ' CE2' ' A' ' 126' ' ' TYR . 1.7 t60 -133.26 108.94 9.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.819 0.342 . . . . 0.0 110.828 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 32.0 p -120.94 135.14 55.27 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.838 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 111' ' ' LEU . . . 103.93 0.39 45.24 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.393 178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.589 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -82.52 149.14 27.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 70.1 p -123.79 -47.65 1.93 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.986 0.422 . . . . 0.0 110.735 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.523 ' HB3' ' HE ' ' A' ' 48' ' ' ARG . 11.0 pt-20 -160.59 144.74 13.93 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.147 175.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.49 72.17 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -92.89 -13.93 55.77 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.1 mp0 -60.21 -26.2 66.2 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.066 0.546 . . . . 0.0 111.234 -177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.26 -38.88 90.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.587 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.62 -38.54 87.17 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.992 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.657 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -62.14 -52.4 64.0 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.457 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.511 HG12 ' CZ2' ' A' ' 60' ' ' TRP . 0.3 OUTLIER -65.47 -38.89 83.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.217 -175.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.715 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 40.0 ttmt -59.57 -53.28 59.94 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -177.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.556 ' HD3' ' HB2' ' A' ' 126' ' ' TYR . 64.5 tttt -69.47 -30.3 68.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.066 -176.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 139' ' ' LEU . 55.8 t -58.91 -46.06 91.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.923 0.392 . . . . 0.0 110.178 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 5.5 mmm180 -71.77 -34.61 69.59 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.767 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.715 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 5.7 mm-40 -56.01 -34.64 65.99 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.93 0.395 . . . . 0.0 110.4 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 62.7 mt -60.98 -42.76 98.98 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.007 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.5 t -76.82 -49.68 22.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.472 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -63.76 -45.78 88.26 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -174.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -113.86 -39.47 3.98 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 65.55 39.04 95.33 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 119.854 -1.165 . . . . 0.0 110.944 -176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 50.7 p-80 -58.65 140.62 54.27 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.003 0.521 . . . . 0.0 111.943 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -105.91 -48.26 3.66 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.613 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -108.51 -32.68 7.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.672 0.272 . . . . 0.0 111.656 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 29.0 p80 -148.91 138.06 21.56 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.654 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -83.7 -22.63 31.98 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.884 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 47.7 t60 . . . . . 0 C--N 1.323 -0.571 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.35 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 56.6 t30 . . . . . 0 N--CA 1.471 0.581 0 CA-C-O 120.328 0.109 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.51 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 7.4 t -176.82 98.18 0.05 Allowed 'General case' 0 CA--C 1.565 1.542 0 O-C-N 123.469 0.48 . . . . 0.0 110.875 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -117.88 1.25 12.07 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.032 0.444 . . . . 0.0 111.123 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.639 ' HB1' HG21 ' A' ' 118' ' ' VAL . . . 74.61 11.55 3.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.258 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 54.82 36.48 26.57 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.772 0.796 . . . . 0.0 110.501 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 80.5 mt -80.45 153.79 73.86 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.346 -176.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -67.16 157.43 61.77 Favored 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.093 2.529 . . . . 0.0 111.132 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.98 82.45 2.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.287 0.565 . . . . 0.0 110.921 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.0 133.46 68.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.129 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -91.35 105.0 17.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.03 0.443 . . . . 0.0 110.629 -177.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 mp -100.54 176.47 5.32 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.313 -178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -114.61 125.15 53.43 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 41.1 p30 -90.28 -172.46 3.47 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.253 0.549 . . . . 0.0 112.19 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.571 ' HA ' ' CD ' ' A' ' 83' ' ' LYS . 37.5 pt -65.01 -28.6 45.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.308 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -69.62 -25.93 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.413 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.01 18.83 49.27 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -174.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -100.03 144.26 29.28 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.459 -0.87 . . . . 0.0 110.148 -178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.24 106.17 13.01 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.12 0.486 . . . . 0.0 109.885 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 p -126.23 137.87 56.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.135 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.608 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 37.5 mt-30 -89.16 139.2 30.71 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.428 -176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 p -65.32 -32.17 73.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -70.96 -14.41 62.35 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.847 0.356 . . . . 0.0 111.29 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.608 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -116.62 5.85 13.31 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.645 -179.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.7 tp -92.57 120.25 32.83 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 4.9 pt-20 -118.68 145.26 45.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.136 0.493 . . . . 0.0 111.94 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.444 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 26.5 t-20 -76.13 -67.81 0.64 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.924 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 169.23 -25.64 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.032 -177.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.12 -6.57 1.55 Allowed Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.084 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 1.3 mptm? -97.21 151.6 37.78 Favored Pre-proline 0 C--N 1.315 -0.926 0 C-N-CA 122.765 0.426 . . . . 0.0 110.774 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 15.6 Cg_exo -66.66 158.64 54.95 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.971 2.447 . . . . 0.0 112.427 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.448 ' O ' ' HB ' ' A' ' 118' ' ' VAL . 4.1 ptt? -147.46 154.68 41.11 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.637 -177.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.446 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 86.1 mt -125.91 130.77 72.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.5 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -110.93 118.75 36.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.443 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 38.8 m-85 -95.29 117.75 30.84 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -144.41 168.76 19.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 123.73 0.644 . . . . 0.0 110.506 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -105.69 146.26 29.99 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.74 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.494 HG22 ' OD2' ' A' ' 74' ' ' ASP . 13.4 t -69.05 -16.8 63.78 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.079 0.466 . . . . 0.0 110.879 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -84.95 -37.95 19.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.638 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 26.9 p -77.42 141.94 39.49 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.922 0.392 . . . . 0.0 111.627 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.576 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 30.7 mmtp -120.48 -55.15 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.41 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' A' ' 44' ' ' LYS . 10.4 Cg_exo -67.96 -21.38 43.61 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 122.319 2.013 . . . . 0.0 112.258 -178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 59.8 m -69.21 -15.97 63.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.295 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.3 mt -81.37 47.21 1.01 Allowed 'General case' 0 C--O 1.222 -0.381 0 CA-C-O 120.869 0.366 . . . . 0.0 111.305 -178.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.435 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 14.8 mmm180 -58.08 -44.78 87.76 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.274 0.559 . . . . 0.0 110.713 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 53' ' ' ILE . 5.4 tm-20 -62.8 -55.19 28.66 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.536 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.558 HD11 ' CE2' ' A' ' 93' ' ' TYR . 33.2 tp -65.4 -41.06 94.06 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -63.45 -48.51 77.41 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.57 -44.8 89.56 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 121.093 0.473 . . . . 0.0 110.881 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 49' ' ' GLU . 65.5 mt -63.76 -41.07 91.36 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.844 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.928 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -50.78 -40.46 55.22 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.882 0.373 . . . . 0.0 110.829 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -70.42 -40.82 73.6 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.237 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 m -110.24 21.15 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -62.14 -40.46 96.03 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.646 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.5 -37.01 82.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.813 0.339 . . . . 0.0 110.395 176.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.87 -41.79 99.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.269 177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -69.26 -38.93 78.65 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.572 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.473 HE21 ' HG2' ' A' ' 67' ' ' ARG . 39.8 mt-30 -77.88 -8.34 57.95 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 178.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.59 -50.23 68.52 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.254 0.346 . . . . 0.0 111.758 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -131.46 -38.2 1.19 Allowed 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.314 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.486 HG21 HG13 ' A' ' 143' ' ' VAL . 9.5 m -63.57 -41.48 98.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.629 178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.74 23.07 78.56 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.247 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 8.3 p -74.63 137.26 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-O 120.773 0.321 . . . . 0.0 111.763 -177.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.473 ' HG2' HE21 ' A' ' 61' ' ' GLN . 44.4 mtm-85 -115.46 169.15 9.38 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 120.728 0.299 . . . . 0.0 110.82 177.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.446 ' CD2' ' HB ' ' A' ' 35' ' ' ILE . 78.5 mt -114.11 139.95 48.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.305 0.574 . . . . 0.0 111.319 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.517 HG23 HD13 ' A' ' 96' ' ' LEU . 88.6 mt -111.78 99.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 175.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -86.96 115.63 24.48 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.914 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.9 129.49 75.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 121.346 0.593 . . . . 0.0 110.737 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.7 t -89.34 136.27 33.12 Favored 'General case' 0 N--CA 1.425 -1.689 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.297 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.522 ' HB ' ' HE3' ' A' ' 104' ' ' LYS . 46.3 pt -75.25 -19.02 16.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.616 178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.494 ' OD2' HG22 ' A' ' 41' ' ' THR . 13.4 m-20 -72.2 142.99 49.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.559 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 98' ' ' ASP . 60.0 mt-10 -68.5 171.05 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.932 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -52.71 -41.81 58.08 Favored Glycine 0 C--N 1.329 0.159 0 N-CA-C 115.009 0.764 . . . . 0.0 115.009 -172.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -61.97 -55.59 27.86 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.23 0.515 . . . . 0.0 111.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -69.96 -36.97 75.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 120.948 0.404 . . . . 0.0 111.704 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.661 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -67.01 -4.19 9.09 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 27.3 mt-30 -61.25 -10.12 6.27 Favored 'General case' 0 C--N 1.315 -0.922 0 O-C-N 121.761 -0.587 . . . . 0.0 110.892 176.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.641 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 68.4 mttm -92.85 -13.04 29.57 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.538 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 79' ' ' ALA . 12.4 t -65.54 -46.21 90.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 121.588 0.709 . . . . 0.0 111.249 -177.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.571 ' CD ' ' HA ' ' A' ' 17' ' ' ILE . 28.7 mtmt -73.65 -37.68 3.62 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -174.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 18.0 Cg_endo -61.61 -31.08 86.7 Favored 'Trans proline' 0 C--N 1.358 1.028 0 CA-C-N 120.372 1.168 . . . . 0.0 110.058 171.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.9 mt -63.94 -42.4 97.34 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -57.48 -47.68 81.25 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.775 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -69.98 -45.65 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.144 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.81 -44.48 92.04 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 121.13 -0.557 . . . . 0.0 113.204 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -72.54 -33.32 66.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.925 0.393 . . . . 0.0 110.972 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.56 50.29 2.98 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.019 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.464 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 45.6 m0 -80.77 122.59 27.34 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.06 0.457 . . . . 0.0 109.949 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -92.67 32.88 1.17 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.041 -175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.558 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -139.63 171.07 14.77 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.285 -0.259 . . . . 0.0 110.797 -176.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -79.15 136.25 37.06 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.057 0.455 . . . . 0.0 111.249 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' C ' HD12 ' A' ' 96' ' ' LEU . 45.8 t -118.17 131.14 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.031 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.517 HD13 HG23 ' A' ' 69' ' ' ILE . 10.2 mp -121.2 145.82 47.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.362 0.601 . . . . 0.0 111.201 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.554 ' HG ' ' HB1' ' A' ' 79' ' ' ALA . 7.6 mp -112.91 119.58 38.45 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 64.7 t0 -85.5 114.39 22.49 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 117.846 -1.542 . . . . 0.0 108.715 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.1 t -93.24 -3.87 52.91 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.147 -178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HB3' ' OD2' ' A' ' 102' ' ' ASP . 7.0 m-80 -103.22 -58.3 1.9 Allowed 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.398 -176.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 100.53 -13.25 59.73 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -174.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 100' ' ' ASN . 45.5 m-20 -64.08 -37.59 87.99 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 123.416 0.686 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -61.4 -42.25 98.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.869 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.522 ' HE3' ' HB ' ' A' ' 73' ' ' ILE . 4.4 mtpm? -59.16 -43.78 92.12 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.941 176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -68.26 -39.01 82.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.696 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.19 79.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.697 178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 25.8 mmt -88.9 -7.38 56.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.207 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 57.91 52.78 7.52 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 0.0 110.539 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.77 89.82 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.662 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.4 m -77.05 -49.36 15.53 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.964 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 54.5 tp -127.35 138.65 53.08 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.291 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 44.1 pt -102.21 154.19 37.56 Favored Pre-proline 0 C--N 1.31 -1.109 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 176.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.445 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 84.5 Cg_endo -78.62 147.05 80.76 Favored 'Cis proline' 0 C--O 1.241 0.635 0 C-N-CA 123.619 -1.409 . . . . 0.0 112.108 -0.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -108.94 138.06 45.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.6 t -122.92 131.4 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 CA-C-O 121.174 0.511 . . . . 0.0 111.363 -176.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 107' ' ' MET . 84.3 m-85 -128.63 118.32 22.74 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.007 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.641 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.1 mt -101.95 131.92 48.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.159 0.504 . . . . 0.0 110.694 -177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.639 HG21 ' HB1' ' A' ' 7' ' ' ALA . 53.6 t -115.61 134.0 60.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.925 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -79.49 -175.15 4.61 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 123.414 0.446 . . . . 0.0 111.509 -176.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.22 -34.16 89.22 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.31 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -73.25 -14.59 61.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.504 0.669 . . . . 0.0 110.084 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 85.17 41.64 7.4 Favored Glycine 0 N--CA 1.427 -1.932 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.949 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -121.76 155.81 34.48 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 7' ' ' ALA . 89.7 mt -77.43 125.58 37.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.7 p -120.03 -30.06 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.835 0.35 . . . . 0.0 111.902 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.641 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 82.6 t80 -121.86 126.83 49.63 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 122.175 -0.328 . . . . 0.0 110.356 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.515 ' ND2' ' HE2' ' A' ' 116' ' ' PHE . 9.0 t-20 -131.85 109.31 10.02 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.334 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.1 t60 -147.82 109.03 4.28 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.072 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 23.6 p -91.23 106.14 18.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.608 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.2 72.08 1.3 Allowed Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.596 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.588 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 31.7 p90 -70.85 -42.83 69.63 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.513 0.673 . . . . 0.0 109.353 175.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.435 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 27.0 p 49.81 84.64 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 113.912 -1.494 . . . . 0.0 113.392 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 64.85 112.82 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.227 1.011 . . . . 0.0 112.8 178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.08 -8.87 50.05 Favored Glycine 0 CA--C 1.51 -0.24 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.588 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -68.65 -37.88 85.29 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.284 -0.458 . . . . 0.0 112.344 178.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -52.89 -30.86 36.61 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.913 0.885 . . . . 0.0 111.531 -175.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.56 99.77 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.481 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -73.82 -29.82 62.36 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.379 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.669 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -61.36 -48.43 81.34 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.926 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 6.6 tp -66.68 -36.04 76.29 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.591 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 41.2 ttmt -57.92 -48.03 81.11 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.416 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.703 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 20.8 mttp -76.85 -22.19 53.91 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 139' ' ' LEU . 77.0 t -60.64 -44.28 96.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 173.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -68.51 -36.85 79.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.031 177.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 25.9 mt-10 -63.43 -30.59 71.69 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-O 120.649 0.261 . . . . 0.0 110.855 178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.703 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 92.5 mt -61.49 -39.94 92.78 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.376 0.608 . . . . 0.0 109.665 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.42 HG13 ' CG ' ' A' ' 151' ' ' HIS . 61.1 t -63.47 -24.38 35.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.377 178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -87.7 -4.89 58.89 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.289 -176.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.92 -24.78 26.45 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 120.91 0.386 . . . . 0.0 111.225 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 159.85 82.73 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 111.076 -0.809 . . . . 0.0 111.076 -178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 80.3 t60 -114.58 80.78 1.45 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.809 0.338 . . . . 0.0 111.267 -175.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 151' ' ' HIS . 12.9 t-80 171.3 -75.33 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' A' ' 152' ' ' HIS . 18.9 p-80 174.85 -34.92 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 175.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -113.35 100.11 8.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.017 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -82.1 -33.95 29.51 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.911 0.386 . . . . 0.0 111.617 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.7 -178.311 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 . . . . . 0 N--CA 1.466 0.325 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.545 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 6.9 m 65.2 76.08 0.34 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.575 0.703 . . . . 0.0 110.391 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.467 ' CD2' ' HG3' ' A' ' 28' ' ' GLU . 71.3 m-85 -97.57 -122.89 0.13 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.322 -0.853 . . . . 0.0 108.779 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HB3' ' HG ' ' A' ' 9' ' ' LEU . . . -152.23 14.04 0.59 Allowed 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.377 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.474 ' HB2' ' HA ' ' A' ' 123' ' ' LYS . 47.6 tt0 50.43 33.8 8.26 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.619 0.723 . . . . 0.0 111.424 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.438 ' HG ' ' HB3' ' A' ' 7' ' ' ALA . 51.8 mt -83.28 151.43 62.78 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.005 -176.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' LEU . 32.3 Cg_exo -60.18 150.38 79.83 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.925 2.416 . . . . 0.0 110.559 175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.74 84.69 2.14 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.987 0.422 . . . . 0.0 111.698 -177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.3 t -125.75 133.67 68.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.9 p -86.84 103.92 15.71 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 120.773 0.321 . . . . 0.0 111.176 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' A' ' 103' ' ' PHE . 34.0 mt -99.6 176.31 5.52 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -112.88 134.06 54.57 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.563 -177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -86.46 165.55 16.22 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.966 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 42.7 pt -67.7 -17.35 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-O 120.981 0.419 . . . . 0.0 111.122 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -84.24 -3.67 58.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.858 177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.97 78.07 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -92.76 142.5 27.27 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.152 -0.524 . . . . 0.0 110.247 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.4 m -82.18 111.86 18.68 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.417 0.627 . . . . 0.0 110.01 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 5.3 m -116.11 128.32 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.643 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.543 ' O ' ' HG3' ' A' ' 26' ' ' LYS . 97.1 mt-30 -89.58 134.34 34.18 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.436 HG21 ' CE1' ' A' ' 103' ' ' PHE . 8.5 p -65.85 -29.85 70.37 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -177.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -68.55 -20.7 64.56 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.936 0.398 . . . . 0.0 110.942 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -112.21 13.95 20.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.887 0.375 . . . . 0.0 110.978 179.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.65 102.66 3.36 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.239 0.543 . . . . 0.0 112.01 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.467 ' HG3' ' CD2' ' A' ' 6' ' ' TYR . 46.5 mt-10 -114.78 104.24 11.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.361 175.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -71.56 -44.9 63.71 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.44 21.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.545 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 64.4 31.48 81.0 Favored Glycine 0 C--O 1.227 -0.306 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.177 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -128.55 153.6 79.43 Favored Pre-proline 0 C--N 1.322 -0.616 0 C-N-CA 123.106 0.562 . . . . 0.0 109.717 -177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 32.0 Cg_exo -56.59 146.78 73.97 Favored 'Trans proline' 0 C--O 1.249 1.064 0 C-N-CA 122.264 1.976 . . . . 0.0 111.563 178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.517 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 25.2 mtt -135.18 170.6 15.67 Favored 'General case' 0 CA--C 1.481 -1.684 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.068 -173.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.745 HG23 HD23 ' A' ' 68' ' ' LEU . 7.6 tt -150.1 127.11 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.458 0 CA-C-N 114.634 -1.166 . . . . 0.0 108.433 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 72.1 mt -101.61 126.05 55.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.122 -178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -104.15 111.83 24.59 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.398 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.576 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 23.6 m-85 -94.03 119.58 33.1 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.24 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -145.18 168.54 20.13 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 123.843 0.714 . . . . 0.0 110.717 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.7 -167.59 0.72 Allowed 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.113 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.411 ' CG2' ' HB2' ' A' ' 74' ' ' ASP . 16.7 p -103.34 -1.4 28.76 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.43 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -147.81 86.7 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.2 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.3 p -170.68 152.12 3.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.299 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HB3' ' HD3' ' A' ' 45' ' ' PRO . 83.4 tttt -147.96 -52.83 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.465 176.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 44' ' ' LYS . 31.5 Cg_exo -61.64 -25.52 79.2 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 122.005 1.804 . . . . 0.0 112.193 176.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 45.5 t -78.82 -9.22 59.39 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.096 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 28.1 mt -89.04 62.32 6.23 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.029 0.443 . . . . 0.0 110.343 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -58.23 -41.75 84.8 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.029 177.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.7 tm-20 -62.93 -58.73 6.35 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.136 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD11 ' CE2' ' A' ' 93' ' ' TYR . 40.4 tp -62.68 -41.47 99.11 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.238 -177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -62.54 -46.71 87.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.5 -41.87 92.72 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.099 0.476 . . . . 0.0 110.663 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 49' ' ' GLU . 64.4 mt -68.71 -33.24 58.54 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.48 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.438 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -56.23 -27.72 55.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.226 0.536 . . . . 0.0 110.377 177.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -85.55 -41.23 15.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.881 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.2 m -108.7 15.56 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 53' ' ' ILE . 84.1 t80 -61.07 -40.63 94.4 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.672 0.272 . . . . 0.0 111.511 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.39 80.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.082 0.468 . . . . 0.0 110.42 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.38 -41.26 98.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.053 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.433 ' NE1' HD13 ' A' ' 140' ' ' ILE . 20.7 m0 -69.88 -36.13 75.22 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.481 0.658 . . . . 0.0 110.441 177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -78.04 -7.12 56.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.118 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -53.99 -50.81 65.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.836 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.55 -30.95 0.82 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.204 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.4 m -62.53 -41.85 99.14 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.852 0.358 . . . . 0.0 111.413 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.91 25.06 74.78 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.061 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 33' ' ' PRO . 7.3 p -77.53 133.75 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.577 0.227 . . . . 0.0 111.086 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 30.7 mtm-85 -117.67 148.16 42.23 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 120.111 -0.636 . . . . 0.0 112.65 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.745 HD23 HG23 ' A' ' 35' ' ' ILE . 78.2 mt -86.37 135.46 33.5 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.577 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 75.0 mt -112.84 101.42 12.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.27 103.6 14.36 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.171 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.5 127.3 73.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-O 121.501 0.667 . . . . 0.0 111.883 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.5 m -89.13 138.81 31.09 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.836 176.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.6 ' HB ' ' HD3' ' A' ' 104' ' ' LYS . 38.1 pt -90.86 -3.89 10.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 O-C-N 125.133 1.521 . . . . 0.0 113.615 -171.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 41' ' ' THR . 21.4 m-20 -86.38 176.7 7.74 Favored 'General case' 0 C--O 1.214 -0.763 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.423 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.49 176.21 9.1 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.512 178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 80' ' ' GLN . . . -60.99 -34.04 86.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.002 -0.544 . . . . 0.0 113.661 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -59.21 -55.0 40.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.269 0.557 . . . . 0.0 110.813 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -67.93 -37.27 81.45 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.014 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HA ' HG23 ' A' ' 82' ' ' VAL . . . -70.63 -5.0 26.21 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 76' ' ' GLY . 81.1 mt-30 -61.87 -19.51 62.72 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.163 0.506 . . . . 0.0 110.53 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.697 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 51.8 mtmt -90.02 -10.61 44.28 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.815 -178.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 79' ' ' ALA . 57.7 t -63.89 -47.75 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -175.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.567 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 4.0 mptp? -73.71 -38.71 4.15 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 11.9 Cg_endo -60.37 -32.91 94.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 CA-C-N 119.909 1.003 . . . . 0.0 110.283 173.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.2 mt -64.52 -42.39 95.82 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.624 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -56.73 -50.36 72.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.675 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -68.35 -44.52 75.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.756 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -63.44 -39.81 98.14 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.938 -0.573 . . . . 0.0 113.172 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -79.87 -32.66 40.41 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.69 45.98 3.82 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.217 -179.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.624 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 40.2 m0 -82.79 114.52 21.18 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 111.054 -178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -86.18 37.38 0.72 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.502 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.453 ' CE1' HD12 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -130.58 167.03 19.38 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -176.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -78.36 116.97 19.16 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.805 0.812 . . . . 0.0 110.313 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.5 t -98.88 132.26 44.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.356 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 6.6 tp -109.87 163.28 13.68 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -172.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.443 ' HB2' ' HE2' ' A' ' 83' ' ' LYS . 11.7 tp -126.68 99.63 5.86 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.745 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 101' ' ' GLY . 66.2 t0 -75.57 117.57 17.49 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 117.542 -1.663 . . . . 0.0 108.101 172.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.0 p -97.79 -5.22 35.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.152 0.501 . . . . 0.0 110.954 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -101.02 -42.17 6.5 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.701 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' A' ' 98' ' ' ASP . . . 82.8 5.23 89.59 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -97.51 -14.66 20.96 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.787 0.327 . . . . 0.0 111.312 -177.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.436 ' CE1' HG21 ' A' ' 24' ' ' THR . 44.9 t80 -64.42 -38.54 91.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.844 -177.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.6 ' HD3' ' HB ' ' A' ' 73' ' ' ILE . 22.1 pttm -55.41 -44.32 76.09 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 120.771 -0.372 . . . . 0.0 110.801 175.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 64.9 ttp85 -65.68 -42.94 90.69 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.249 0.547 . . . . 0.0 109.763 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.59 85.27 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.232 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -86.23 -3.68 59.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.619 178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.71 36.35 2.14 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.512 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -73.07 88.59 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.345 0.593 . . . . 0.0 110.646 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 t -74.31 -45.68 45.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.613 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 56.9 tp -134.85 149.98 50.41 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.169 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 37.2 pt -105.86 155.33 38.47 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -78.44 142.23 68.12 Favored 'Cis proline' 0 C--O 1.239 0.561 0 C-N-CA 123.68 -1.383 . . . . 0.0 111.603 -0.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -106.11 132.58 52.02 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.11 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.555 HG21 HD21 ' A' ' 139' ' ' LEU . 70.9 t -117.8 129.66 73.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.049 -176.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 35' ' ' ILE . 94.1 m-85 -125.48 115.66 20.58 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.416 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.531 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 65.8 mt -101.28 130.03 51.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.166 0.508 . . . . 0.0 110.51 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.517 ' HB ' ' H ' ' A' ' 34' ' ' MET . 74.2 t -103.91 131.06 53.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.705 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -83.52 -175.53 5.87 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.12 -177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.88 8.29 37.59 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.1 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -111.44 -1.27 15.97 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.683 0.754 . . . . 0.0 109.475 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.87 23.83 63.3 Favored Glycine 0 CA--C 1.504 -0.638 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.206 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 8.3 mptt -115.89 163.15 16.29 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 120.848 0.356 . . . . 0.0 110.484 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 51.2 mt -83.45 102.07 8.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.298 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.5 p -85.25 -35.37 9.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.74 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.531 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 76.2 t80 -137.45 133.11 34.31 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.707 0.289 . . . . 0.0 110.861 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -141.22 124.6 16.62 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.153 0.502 . . . . 0.0 110.649 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -141.53 116.11 9.63 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.601 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 60.4 p -96.61 109.01 21.71 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.906 -0.318 . . . . 0.0 111.41 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 71.47 64.12 2.84 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 115.968 -0.56 . . . . 0.0 113.821 176.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.72 ' CG ' ' HA3' ' A' ' 135' ' ' GLY . 29.5 p90 -63.57 -41.54 98.38 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-O 121.321 0.581 . . . . 0.0 109.934 176.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.425 ' N ' ' CD1' ' A' ' 131' ' ' TYR . 79.8 p 56.35 79.23 0.18 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.49 -1.232 . . . . 0.0 112.633 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 70.7 113.55 0.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.793 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.0 13.22 46.96 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.982 -0.627 . . . . 0.0 111.938 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.72 ' HA3' ' CG ' ' A' ' 131' ' ' TYR . . . -92.1 -36.88 6.15 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.501 -0.38 . . . . 0.0 112.474 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 136' ' ' GLU . 2.2 pm0 -60.37 -18.9 53.44 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.984 0.513 . . . . 0.0 112.284 -176.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.95 94.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.622 0.725 . . . . 0.0 109.973 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -71.88 -33.52 68.44 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.593 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.8 mp -60.98 -50.62 72.63 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.265 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 144' ' ' ARG . 6.3 tp -66.24 -39.19 83.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.9 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 28.4 ttpp -59.81 -47.73 84.52 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.582 178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 14.8 tptp -66.87 -33.95 76.73 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.152 -177.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 139' ' ' LEU . 72.9 t -60.01 -44.84 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.33 0.586 . . . . 0.0 109.62 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 140' ' ' ILE . 22.6 mmm180 -71.41 -23.61 61.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.43 -178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 55.9 mm-40 -62.06 -38.5 89.03 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.317 0.58 . . . . 0.0 109.479 175.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 mt -63.28 -41.52 99.0 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.552 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.81 -41.28 87.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.313 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -62.32 -6.98 3.64 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.199 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -59.07 -37.67 77.62 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 150.43 -177.05 28.75 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.988 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 67.3 m80 -106.38 146.86 29.94 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -62.67 -40.89 98.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.096 0.474 . . . . 0.0 110.783 -177.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -122.27 121.36 36.6 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.543 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 20.5 p80 50.47 -169.47 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.974 0.91 . . . . 0.0 111.91 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -133.67 121.23 21.68 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 177.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 C--O 1.242 0.708 0 CA-C-O 118.63 -0.7 . . . . 0.0 110.9 179.224 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.3 m120 . . . . . 0 C--O 1.236 0.36 0 CA-C-O 120.792 0.33 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.511 ' HB ' ' HA2' ' A' ' 31' ' ' GLY . 26.0 m -85.07 84.93 7.54 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.656 -177.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -102.78 -134.11 0.31 Allowed 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.716 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -137.73 -4.01 1.82 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.609 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 54.52 74.69 0.33 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.656 0.741 . . . . 0.0 110.25 -175.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.403 HD13 ' HB ' ' A' ' 24' ' ' THR . 23.4 mt -122.67 162.1 40.35 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.998 -175.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.7 148.92 91.95 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.141 1.894 . . . . 0.0 110.215 176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.24 80.19 0.99 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.211 0.529 . . . . 0.0 111.307 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.5 134.53 65.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.219 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 29.3 t -92.89 113.17 25.37 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.307 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 98' ' ' ASP . 29.1 mt -110.9 176.59 4.97 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -110.12 134.52 52.1 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.313 0.577 . . . . 0.0 112.017 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -75.97 177.02 7.36 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.981 -1.008 . . . . 0.0 109.325 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.462 HG22 ' HB ' ' A' ' 95' ' ' VAL . 33.3 pt -55.0 -41.53 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -81.44 -8.41 59.73 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.12 20.18 31.25 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.369 -0.919 . . . . 0.0 111.21 -176.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -78.3 141.18 38.67 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.1 m -78.66 108.24 11.92 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.007 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 m -124.58 134.4 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.219 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.541 ' HB2' ' HG2' ' A' ' 26' ' ' LYS . 77.9 mt-30 -100.9 134.75 43.41 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.589 HG21 ' CE1' ' A' ' 103' ' ' PHE . 13.1 p -64.74 -30.24 71.24 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -72.09 -13.15 61.5 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.96 0.409 . . . . 0.0 110.942 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' HG2' ' HB2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -125.12 14.88 8.44 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 110.902 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 50.2 tp -74.69 125.03 27.83 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.917 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 5' ' ' THR . 0.4 OUTLIER -136.69 140.23 42.53 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.411 HD22 ' HG2' ' A' ' 34' ' ' MET . 93.0 m-20 -101.22 -48.87 4.25 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.597 -178.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 168.73 31.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.735 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.511 ' HA2' ' HB ' ' A' ' 5' ' ' THR . . . 71.38 36.09 63.2 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.581 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 46.1 mmtm -128.39 151.2 76.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.879 -0.16 . . . . 0.0 111.262 -175.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 22.0 Cg_exo -62.69 151.66 82.45 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.691 2.261 . . . . 0.0 111.547 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.543 ' H ' ' HB ' ' A' ' 118' ' ' VAL . 38.4 mtt -131.75 152.77 50.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.246 -172.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 89.9 mt -130.22 118.13 42.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 116' ' ' PHE . 86.0 mt -94.12 123.91 46.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.5 m -112.39 116.97 31.18 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.252 179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 53.8 m-85 -88.16 111.22 21.37 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 175.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.444 ' CE1' ' HB1' ' A' ' 70' ' ' ALA . 30.7 p90 -123.86 154.72 39.26 Favored 'General case' 0 N--CA 1.434 -1.248 0 O-C-N 123.68 0.613 . . . . 0.0 110.776 -176.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.42 153.15 23.57 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.124 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -69.32 95.13 0.76 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.475 -177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 p30 45.37 35.32 1.83 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.743 1.217 . . . . 0.0 113.408 177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 54.1 t -76.98 -81.34 0.09 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.807 0.337 . . . . 0.0 111.873 -177.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -142.92 158.35 59.35 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.489 -177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -65.38 44.83 0.16 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 124.166 3.244 . . . . 0.0 113.413 175.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 59.9 m -80.5 -4.74 55.03 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 173.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.2 mt -77.0 58.17 1.46 Allowed 'General case' 0 C--N 1.345 0.37 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.877 178.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -64.63 -39.91 94.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.32 -176.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.649 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -64.34 -48.54 75.15 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.729 -179.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 93' ' ' TYR . 52.2 tp -63.62 -42.38 98.19 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.866 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -62.71 -46.32 88.65 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.963 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -61.91 -40.7 96.36 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.258 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.649 HG13 ' O ' ' A' ' 49' ' ' GLU . 62.1 mt -64.79 -41.43 92.18 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.646 178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -54.34 -30.97 53.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.24 177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -79.47 -31.86 42.47 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.85 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 52' ' ' ALA . 16.1 m -122.42 23.68 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -178.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 53' ' ' ILE . 75.0 t80 -63.37 -41.56 98.82 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 122.312 -0.242 . . . . 0.0 111.206 -177.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.06 -36.3 83.57 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.164 0.507 . . . . 0.0 110.185 176.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.68 -43.1 94.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.39 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.487 ' NE1' HD13 ' A' ' 140' ' ' ILE . 19.0 m0 -70.05 -37.77 75.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.276 0.56 . . . . 0.0 110.727 177.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -79.13 -6.81 57.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.869 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.2 -49.65 66.31 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.739 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -160.54 73.82 0.51 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.523 0.678 . . . . 0.0 110.27 176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.0 m -158.95 -41.64 0.06 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.345 178.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' LYS . . . 72.02 32.1 63.67 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.479 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.27 121.51 42.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-O 121.076 0.465 . . . . 0.0 110.914 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -105.85 164.19 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.687 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.488 HD11 HG21 ' A' ' 53' ' ' ILE . 49.1 mt -105.37 134.48 48.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.149 0.499 . . . . 0.0 111.568 -178.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.1 mt -109.56 109.17 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 175.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB1' ' CE1' ' A' ' 39' ' ' PHE . . . -95.71 123.72 39.41 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.233 -178.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.7 p -123.73 131.6 72.76 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.378 0.609 . . . . 0.0 111.32 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.473 ' CB ' HG21 ' A' ' 82' ' ' VAL . 17.0 p -83.57 134.53 34.81 Favored 'General case' 0 C--O 1.257 1.473 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.242 178.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.7 pt -78.9 -14.56 13.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 114.318 -1.31 . . . . 0.0 111.698 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.17 178.51 5.68 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.492 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -95.06 179.7 5.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.545 ' HA2' HD21 ' A' ' 97' ' ' LEU . . . -59.3 -33.1 74.04 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.25 -0.5 . . . . 0.0 113.943 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -63.54 -47.11 82.97 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -89.99 -29.63 18.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 -176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.6 -3.68 15.99 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -175.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -59.52 -24.04 63.33 Favored 'General case' 0 CA--C 1.55 0.963 0 O-C-N 121.798 -0.564 . . . . 0.0 111.274 178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.726 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 73.9 mmtt -88.69 -1.21 57.95 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' CB ' ' A' ' 72' ' ' SER . 95.4 t -65.49 -46.71 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 121.416 0.627 . . . . 0.0 112.377 -178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 97' ' ' LEU . 0.6 OUTLIER -67.41 -42.77 39.72 Favored Pre-proline 0 C--N 1.293 -1.881 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.886 -176.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 17.7 Cg_endo -62.2 -29.84 81.06 Favored 'Trans proline' 0 C--N 1.363 1.32 0 C-N-CA 121.104 1.203 . . . . 0.0 110.902 175.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 95.8 mt -62.88 -41.6 99.46 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.593 ' HA ' ' CE3' ' A' ' 91' ' ' TRP . . . -59.7 -42.38 92.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.698 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -45.41 65.19 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.76 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.57 -36.72 92.82 Favored Glycine 0 CA--C 1.524 0.629 0 CA-C-N 115.798 -0.637 . . . . 0.0 114.126 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -92.58 5.2 51.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.31 40.86 91.92 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.263 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.593 ' CE3' ' HA ' ' A' ' 86' ' ' ALA . 51.1 m0 -88.32 95.45 10.2 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.87 59.85 5.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.348 0.594 . . . . 0.0 110.737 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.429 ' CE2' HD11 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -137.56 -172.41 3.22 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -92.35 134.35 35.0 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 17' ' ' ILE . 42.8 t -119.95 132.66 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.536 0.684 . . . . 0.0 110.738 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -120.16 152.25 37.93 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.451 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.594 ' HB2' ' HE3' ' A' ' 83' ' ' LYS . 10.1 tt -120.71 117.78 28.38 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.377 -176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.624 ' HA ' HD22 ' A' ' 14' ' ' LEU . 13.3 t0 -81.52 117.25 21.77 Favored 'General case' 0 C--O 1.215 -0.714 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.762 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.4 t -113.86 -11.18 12.88 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' HB3' ' OD1' ' A' ' 102' ' ' ASP . 1.6 m120 -84.83 -41.69 15.82 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 110.726 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.5 ' HA2' ' NZ ' ' A' ' 104' ' ' LYS . . . 94.92 -18.32 57.53 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.59 178.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.491 ' OD1' ' HB3' ' A' ' 100' ' ' ASN . 5.2 p-10 -91.38 -8.55 47.66 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CE1' HG21 ' A' ' 24' ' ' THR . 88.0 t80 -63.85 -49.14 73.95 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.184 178.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.5 ' NZ ' ' HA2' ' A' ' 101' ' ' GLY . 13.1 pttm -62.42 -36.15 81.46 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.961 175.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 44.8 ttm-85 -66.91 -43.54 83.1 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.283 0.563 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.68 -36.86 84.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.939 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 107' ' ' MET . 1.7 mmt -78.5 -7.91 57.98 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.243 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.54 43.09 3.45 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.67 0.748 . . . . 0.0 111.043 176.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -76.23 98.41 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.328 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.7 m -85.83 -66.4 0.91 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.569 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 57.2 tp -107.89 129.65 55.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 109.676 -0.491 . . . . 0.0 109.676 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.8 pt -85.55 148.16 48.47 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.628 ' HD2' ' O ' ' A' ' 131' ' ' TYR . 85.2 Cg_endo -82.75 166.91 67.92 Favored 'Cis proline' 0 CA--C 1.542 0.889 0 C-N-CA 124.242 -1.149 . . . . 0.0 112.882 0.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.463 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -125.75 144.36 50.66 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.724 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.9 t -126.97 131.69 70.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.443 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 86.5 m-85 -126.64 124.15 39.22 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' A' ' 126' ' ' TYR . 70.4 mt -109.77 129.21 65.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.178 0.513 . . . . 0.0 110.467 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.543 ' HB ' ' H ' ' A' ' 34' ' ' MET . 85.5 t -103.62 128.74 56.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.871 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.464 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . 20.3 t70 -75.88 162.73 27.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.653 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -58.59 -22.6 52.98 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.878 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -69.46 -18.87 63.75 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.996 0.426 . . . . 0.0 110.882 178.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 5' ' ' THR . . . 93.88 31.14 8.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.192 -179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -134.78 154.61 51.53 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 7' ' ' ALA . 96.3 mt -69.9 123.87 24.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.371 177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 119' ' ' ASP . 13.7 p -105.08 -30.12 2.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.9 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.572 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 81.5 t80 -132.89 125.26 29.53 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.019 178.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -131.24 122.35 26.35 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.274 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -145.39 107.9 4.43 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.846 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 7.3 p -102.15 107.19 18.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.658 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 111' ' ' LEU . . . 114.92 74.65 0.6 Allowed Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.767 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.628 ' O ' ' HD2' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -126.76 156.76 40.69 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 173.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 32.6 p -124.92 -58.46 1.47 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.015 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -144.39 136.07 25.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.418 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.8 3.98 63.83 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.288 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -86.18 -20.96 53.94 Favored Glycine 0 N--CA 1.442 -0.963 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.077 -178.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.17 -22.7 64.97 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.271 0.558 . . . . 0.0 111.116 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.3 94.24 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.038 -176.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -71.49 -31.63 67.34 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.694 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.601 ' O ' HG23 ' A' ' 143' ' ' VAL . 10.9 mp -61.64 -48.88 78.87 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.276 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.487 HD13 ' NE1' ' A' ' 60' ' ' TRP . 6.1 tp -67.96 -38.11 79.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.89 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.34 -42.25 98.37 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.521 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 146' ' ' LEU . 5.9 mmpt? -65.45 -40.39 93.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 139' ' ' LEU . 99.2 t -59.84 -46.68 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 CA-C-O 121.359 0.6 . . . . 0.0 110.213 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.42 ' O ' ' HG3' ' A' ' 148' ' ' LYS . 22.1 mmm180 -66.94 -36.32 81.96 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.517 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.417 ' HA ' ' CG ' ' A' ' 148' ' ' LYS . 68.2 mm-40 -60.38 -34.1 73.41 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.58 0.229 . . . . 0.0 111.207 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 142' ' ' LYS . 59.2 mt -63.43 -43.22 98.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.209 0.528 . . . . 0.0 109.921 177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.86 -48.54 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 115.505 -0.77 . . . . 0.0 112.092 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -66.39 -31.31 72.0 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -74.09 -22.52 59.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.187 0.517 . . . . 0.0 110.424 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -81.27 83.37 1.5 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.194 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.429 ' O ' ' HA ' ' A' ' 155' ' ' HIS . 57.5 m80 -84.51 123.92 30.81 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -84.54 -18.84 34.4 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.137 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -60.39 -50.08 75.02 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.082 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.8 8.33 2.79 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -177.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 151' ' ' HIS . 70.7 m80 63.28 13.74 7.23 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.876 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 65.1 t60 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.215 -0.897 . . . . 0.0 110.97 179.759 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.7 t30 . . . . . 0 CA--C 1.512 -0.493 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 16.3 m -156.8 60.9 0.53 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.132 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.643 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 43.5 m-85 -82.85 -140.39 0.05 Allowed 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.411 0.624 . . . . 0.0 109.791 -179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -146.6 12.89 1.17 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.843 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 49.33 60.76 3.53 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.654 0.74 . . . . 0.0 110.335 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.2 mt -112.56 158.8 36.36 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.427 -175.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -67.0 159.21 53.06 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.049 2.5 . . . . 0.0 110.681 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.22 82.34 2.36 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.02 0.438 . . . . 0.0 110.946 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 103' ' ' PHE . 57.6 t -119.04 134.96 60.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.572 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.0 p -92.76 108.13 19.75 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 120.979 0.418 . . . . 0.0 111.131 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.0 mt -112.58 174.93 5.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.592 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -108.81 136.57 48.15 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.793 0.33 . . . . 0.0 110.799 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -90.86 -171.43 3.01 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.783 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 40.8 pt -63.19 -20.04 25.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.722 0.268 . . . . 0.0 111.722 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -86.0 -21.65 27.7 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.243 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.98 10.35 58.75 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -175.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -85.85 146.33 26.79 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.808 -0.696 . . . . 0.0 109.503 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.1 m -74.4 116.91 15.6 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-O 121.404 0.621 . . . . 0.0 109.828 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.644 ' HB ' HD21 ' A' ' 27' ' ' LEU . 3.3 m -117.52 128.04 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.404 176.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.551 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 48.5 mt-30 -90.01 132.17 35.51 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.492 ' HA ' HD12 ' A' ' 27' ' ' LEU . 15.0 p -65.9 -29.47 69.91 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.629 -176.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.44 -34.44 78.19 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.097 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -98.39 5.23 48.33 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.387 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.644 HD21 ' HB ' ' A' ' 22' ' ' VAL . 85.5 mt -73.51 117.0 14.75 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.734 -178.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 5' ' ' THR . 0.1 OUTLIER -132.5 154.18 50.19 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.566 177.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.584 ' HB2' ' SD ' ' A' ' 34' ' ' MET . 63.3 t30 -89.52 -80.95 0.29 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.783 -177.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 172.57 32.33 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.81 0 O-C-N 123.633 0.583 . . . . 0.0 110.755 -176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.66 -14.76 62.8 Favored Glycine 0 C--N 1.324 -0.112 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.785 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 65' ' ' GLY . 4.0 mptp? -100.14 143.42 26.48 Favored Pre-proline 0 C--N 1.317 -0.82 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.7 164.73 34.73 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.209 2.606 . . . . 0.0 112.846 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . 0.585 ' SD ' HD11 ' A' ' 69' ' ' ILE . 73.4 mtm -138.69 160.5 39.48 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.729 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.491 ' HB ' ' CD2' ' A' ' 68' ' ' LEU . 73.1 mt -129.43 125.67 62.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.8 mt -97.11 126.78 49.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.8 m -114.47 122.24 45.98 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.188 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.589 ' HB2' ' HB3' ' A' ' 114' ' ' ALA . 73.1 m-85 -97.45 115.06 27.05 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -135.55 163.04 31.0 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.86 -177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.86 162.93 13.9 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.486 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.2 p -66.12 -41.71 90.16 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.296 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -101.31 86.35 2.98 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.1 p -67.48 121.42 15.77 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.796 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 67.1 mttm -102.71 -37.66 0.21 Allowed Pre-proline 0 CA--C 1.555 1.142 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.777 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 44' ' ' LYS . 89.1 Cg_endo -84.2 11.68 3.26 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 121.879 1.719 . . . . 0.0 111.15 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.4 m 62.0 16.89 8.53 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.501 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 84.7 mt 55.91 85.13 0.07 Allowed 'General case' 0 C--N 1.345 0.399 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.787 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.54 ' HB2' ' OH ' ' A' ' 131' ' ' TYR . 23.4 mmm180 -58.87 -48.95 79.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.247 -175.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.578 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.38 -52.62 31.03 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.614 -176.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.566 HD11 ' CE1' ' A' ' 93' ' ' TYR . 29.8 tp -63.55 -42.27 98.39 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.824 -174.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -66.61 -49.53 65.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.69 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' HG22 ' A' ' 56' ' ' VAL . . . -63.21 -42.65 99.31 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.233 -176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.578 HG13 ' O ' ' A' ' 49' ' ' GLU . 67.1 mt -64.03 -43.04 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.414 ' HB2' ' OH ' ' A' ' 93' ' ' TYR . 9.0 tt0 -59.23 -40.32 85.51 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.679 0.276 . . . . 0.0 110.846 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -66.7 -37.21 84.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 52' ' ' ALA . 31.3 m -107.36 19.17 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.071 0.462 . . . . 0.0 111.19 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -58.15 -40.49 81.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.883 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.43 -37.6 81.43 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.904 0.383 . . . . 0.0 110.619 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -64.43 -41.07 96.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.743 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.527 ' CH2' HG12 ' A' ' 53' ' ' ILE . 16.8 m0 -73.58 -42.42 61.62 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-O 121.253 0.549 . . . . 0.0 110.552 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.401 HE22 ' C ' ' A' ' 66' ' ' VAL . 2.2 mp0 -70.36 -9.8 57.25 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 123.208 0.603 . . . . 0.0 111.941 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -52.5 -49.35 64.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.063 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -136.6 -36.32 0.71 Allowed 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 120.036 -0.666 . . . . 0.0 112.77 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 143' ' ' VAL . 17.6 m -65.74 -43.32 89.36 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 120.813 0.34 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 32' ' ' LYS . . . 62.65 41.98 99.75 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.775 -177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.401 ' C ' HE22 ' A' ' 61' ' ' GLN . 6.8 p -91.33 117.71 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 CA-C-O 120.945 0.402 . . . . 0.0 111.449 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 43.4 mtm180 -94.5 162.98 13.59 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.503 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 62.7 mt -105.47 148.19 27.46 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.265 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.585 HD11 ' SD ' ' A' ' 34' ' ' MET . 88.9 mt -122.11 110.82 28.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 174.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -93.39 111.15 22.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.412 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.477 HG22 ' HZ1' ' A' ' 104' ' ' LYS . 9.0 p -116.59 123.49 71.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.124 0 CA-C-O 121.587 0.708 . . . . 0.0 111.555 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.625 ' HB2' HG21 ' A' ' 82' ' ' VAL . 35.4 t -80.06 131.89 35.86 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.83 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.608 ' HA ' ' HZ3' ' A' ' 104' ' ' LYS . 40.5 pt -79.96 -13.92 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.397 -176.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.71 -177.89 5.95 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -94.99 176.99 6.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 121.183 -0.207 . . . . 0.0 110.982 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.48 66.5 Favored Glycine 0 C--N 1.336 0.575 0 CA-C-N 116.205 -0.452 . . . . 0.0 114.065 -175.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -56.75 -49.47 75.15 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.176 0.512 . . . . 0.0 111.54 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -90.41 -37.05 14.23 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.619 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.557 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -76.79 -3.95 40.99 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -63.02 -13.53 36.57 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.447 -0.783 . . . . 0.0 111.104 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.674 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 58.4 mttp -85.53 -8.3 58.4 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.8 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.625 HG21 ' HB2' ' A' ' 72' ' ' SER . 59.6 t -66.58 -46.0 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.692 0.758 . . . . 0.0 111.723 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.516 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 10.7 mtpp -67.32 -41.61 34.06 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.913 -176.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 83' ' ' LYS . 16.3 Cg_endo -61.97 -30.64 83.62 Favored 'Trans proline' 0 C--N 1.364 1.348 0 C-N-CA 120.965 1.11 . . . . 0.0 110.6 173.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 81' ' ' LYS . 96.1 mt -63.98 -42.74 97.12 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 172.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . -57.25 -48.28 79.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.992 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -75.06 -44.58 46.8 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.816 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -64.72 -47.71 80.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.256 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -73.93 -34.8 64.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.941 0.401 . . . . 0.0 111.308 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 96.79 49.21 1.98 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.301 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 46.5 m0 -77.27 109.36 11.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.136 0.493 . . . . 0.0 110.044 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -85.0 42.31 0.92 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.338 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.566 ' CE1' HD11 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -152.93 -179.72 7.91 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -72.75 140.16 47.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.384 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.27 129.57 74.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.494 HD13 HG23 ' A' ' 69' ' ' ILE . 11.1 mp -119.71 135.8 54.69 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.518 0.675 . . . . 0.0 111.58 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.0 tp -105.85 105.49 15.55 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.678 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.637 ' OD2' ' HE3' ' A' ' 104' ' ' LYS . 47.6 t0 -86.42 138.07 32.06 Favored 'General case' 0 C--O 1.216 -0.664 0 C-N-CA 118.072 -1.451 . . . . 0.0 109.639 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.9 m -123.11 -0.36 8.92 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.397 0.617 . . . . 0.0 109.751 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.49 -59.22 1.92 Allowed 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.278 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.52 -11.87 63.12 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.123 -178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.2 -24.37 43.2 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.433 ' HB2' HG11 ' A' ' 12' ' ' VAL . 75.8 t80 -61.46 -43.49 98.78 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.06 0.457 . . . . 0.0 110.602 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.637 ' HE3' ' OD2' ' A' ' 98' ' ' ASP . 0.0 OUTLIER -60.49 -41.99 95.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.042 176.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -66.72 -36.51 82.65 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.129 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.99 74.53 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.542 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.0 mmt -90.48 -9.35 47.7 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.069 178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 63.19 59.86 1.24 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.352 0.596 . . . . 0.0 110.829 178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 114' ' ' ALA . 65.5 t -77.32 93.99 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.335 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.3 t -79.31 -58.82 3.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.648 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 62.3 tp -110.75 138.43 47.15 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.924 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 22.4 pt -100.25 152.98 37.99 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.618 ' HG2' ' CE2' ' A' ' 131' ' ' TYR . 92.7 Cg_endo -82.86 154.77 74.83 Favored 'Cis proline' 0 N--CA 1.476 0.487 0 C-N-CA 124.039 -1.234 . . . . 0.0 112.012 -1.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.589 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -105.57 138.66 41.4 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.397 -178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.537 HG11 HD11 ' A' ' 139' ' ' LEU . 77.3 t -126.5 130.79 71.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.63 -177.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.19 125.53 33.22 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.093 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.662 HD11 HD13 ' A' ' 139' ' ' LEU . 59.4 mt -106.73 132.62 53.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.437 HG11 ' O ' ' A' ' 6' ' ' TYR . 55.8 t -109.52 130.13 63.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.043 -178.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.91 166.6 23.27 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.223 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -59.52 -23.58 58.42 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.353 -0.451 . . . . 0.0 112.751 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 41.5 t-20 -71.26 -11.05 60.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.76 0.79 . . . . 0.0 109.559 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 82.64 29.84 34.51 Favored Glycine 0 CA--C 1.498 -0.971 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.823 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -121.29 154.03 36.9 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 94.6 mt -76.26 117.7 21.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.5 p -106.12 -20.57 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.398 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.574 ' HB3' ' HB ' ' A' ' 117' ' ' ILE . 69.1 t80 -137.53 126.6 24.38 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -134.91 114.91 13.01 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.159 0.504 . . . . 0.0 110.595 177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -146.51 116.39 7.27 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.942 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 22.9 p -95.82 106.24 18.35 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 120.889 0.376 . . . . 0.0 111.102 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.67 69.45 1.3 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.454 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.618 ' CE2' ' HG2' ' A' ' 113' ' ' PRO . 39.6 p90 -65.99 -44.83 83.7 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.999 0.4 . . . . 0.0 110.326 177.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 69.1 p 49.07 85.23 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.305 1.042 . . . . 0.0 112.68 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 68.05 130.46 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.255 1.022 . . . . 0.0 112.489 -178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.77 2.33 90.5 Favored Glycine 0 C--N 1.321 -0.262 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.644 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.571 ' HA3' ' CD1' ' A' ' 131' ' ' TYR . . . -70.94 -42.01 60.73 Favored Glycine 0 N--CA 1.436 -1.352 0 C-N-CA 121.543 -0.36 . . . . 0.0 112.313 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -58.55 -25.37 62.41 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 120.937 0.399 . . . . 0.0 111.384 -177.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -63.44 -43.59 96.99 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.497 0.665 . . . . 0.0 109.765 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -73.03 -30.21 63.58 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.08 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.662 HD13 HD11 ' A' ' 117' ' ' ILE . 4.4 mm? -60.13 -50.71 72.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.862 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.462 ' O ' ' HB ' ' A' ' 143' ' ' VAL . 0.2 OUTLIER -70.37 -36.77 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.314 0.578 . . . . 0.0 109.881 -178.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -61.37 -44.9 96.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.337 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 145' ' ' GLU . 41.0 tptt -66.57 -31.31 71.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.26 0.553 . . . . 0.0 110.38 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 139' ' ' LEU . 56.0 t -58.97 -44.23 90.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -66.32 -28.53 68.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.279 177.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 142' ' ' LYS . 61.3 mm-40 -63.79 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.922 0.391 . . . . 0.0 110.241 176.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 48.9 mt -76.82 -16.18 59.51 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.223 0.535 . . . . 0.0 110.611 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.6 t -98.55 3.68 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.719 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 47.0 tttp -58.64 -38.95 79.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -171.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -88.86 -11.87 43.48 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.11 0.481 . . . . 0.0 111.314 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -79.88 -151.98 7.22 Favored Glycine 0 C--N 1.309 -0.942 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.35 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.641 ' HB2' ' O ' ' A' ' 154' ' ' HIS . 0.3 OUTLIER -74.52 43.0 0.17 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -57.75 -45.11 86.32 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -92.79 -30.69 15.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.743 0.306 . . . . 0.0 111.051 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.641 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 52.5 t-80 -176.6 -63.58 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -179.04 -68.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.622 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 79.1 t60 . . . . . 0 C--N 1.315 -0.902 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.273 178.058 . . . . . . . . 0 0 . 1 stop_ save_